sentence	label	sentence-id
@PROTEIN$ enables Ca2+-activated @COMPOUND$-conductance in epithelia.	1	17003041-302
Calcium-dependent Cl (-) currents were activated by @COMPOUND$ in HEK293 cells expressing @PROTEIN$.	0	17003041-304
Calcium-dependent @COMPOUND$ (-) currents were activated by ATP in HEK293 cells expressing @PROTEIN$.	0	17003041-304
The absorption spectrum of the @PROTEIN$ enzyme showed an absorption peak at 425nm indicating that the enzyme had iron-@COMPOUND$ clusters.	1	17321121-703
When Vitreoscilla were grown in medium containing 60mM @COMPOUND$ under both normal and limited aeration conditions, the levels of Vitreoscilla @PROTEIN$ (VHb) were decreased by greater than 90%, while the levels of the terminal respiratory oxidase, cytochrome bo, were increased 350% under normal aeration and 7-23% under limited aeration.	1	17403602-1067
@COMPOUND$) suppresses beta-amyloid-induced neurotoxicity through inhibiting c-Abl/FE65 nuclear translocation and @PROTEIN$ activation.	1	17590240-1233
@COMPOUND$) suppresses beta-amyloid-induced neurotoxicity through inhibiting c-@PROTEIN$/FE65 nuclear translocation and GSK3 beta activation.	1	17590240-1233
@COMPOUND$) suppresses beta-amyloid-induced neurotoxicity through inhibiting c-Abl/@PROTEIN$ nuclear translocation and GSK3 beta activation.	1	17590240-1233
Here, we used a human neuronal cell line MC65 conditional expression of an amyloid precursor protein fragment (@PROTEIN$) to investigate the protection mechanism of epigallocatechin gallate (EGCG), the main constituent of @COMPOUND$.	0	17590240-1234
Here, we used a human neuronal cell line MC65 conditional expression of an amyloid precursor protein fragment (@PROTEIN$) to investigate the protection mechanism of @COMPOUND$), the main constituent of green tea.	0	17590240-1234
The @PROTEIN$ was purified to homogeneity using ammonium @COMPOUND$ precipitation, and ion exchange chromatography with a fold purification of 1.8 and a recovery of 49%.	0	17616381-938
The @PROTEIN$ was purified to homogeneity using @COMPOUND$ sulfate precipitation, and ion exchange chromatography with a fold purification of 1.8 and a recovery of 49%.	0	17616381-938
In addition, we demonstrated that Hsp20, @PROTEIN$ and HspB8 induced interleukin-6 production in cultured pericytes and astrocytes, which could be antagonized by @COMPOUND$, whereas other sHsps and A beta were inactive, suggesting that sHsps may be among the key mediators of the local inflammatory response associated with HCHWA-D and AD lesions.	0	17629591-228
In addition, we demonstrated that Hsp20, HspB2 and HspB8 induced @PROTEIN$ production in cultured pericytes and astrocytes, which could be antagonized by @COMPOUND$, whereas other sHsps and A beta were inactive, suggesting that sHsps may be among the key mediators of the local inflammatory response associated with HCHWA-D and AD lesions.	1	17629591-228
In addition, we demonstrated that Hsp20, HspB2 and @PROTEIN$ induced interleukin-6 production in cultured pericytes and astrocytes, which could be antagonized by @COMPOUND$, whereas other sHsps and A beta were inactive, suggesting that sHsps may be among the key mediators of the local inflammatory response associated with HCHWA-D and AD lesions.	0	17629591-228
Furthermore, @COMPOUND$ was found to be capable of significantly preventing the inhibitory effect of @PROTEIN$ on Abeta oligomer formation.	1	17692997-193
The scavenger receptor, class B, type I (@PROTEIN$) is critical in maintaining the homeostasis of cholesterol and @COMPOUND$.	1	17719144-1171
The scavenger receptor, class B, type I (@PROTEIN$) is critical in maintaining the homeostasis of @COMPOUND$ and alpha-tocopherol.	1	17719144-1171
SR-BI binds @PROTEIN$ (HDL) and mediates the selective transfer of cholesteryl esters and @COMPOUND$ from circulating HDL to cells.	0	17719144-1172
@PROTEIN$ binds high-density lipoproteins (HDL) and mediates the selective transfer of cholesteryl esters and @COMPOUND$ from circulating HDL to cells.	1	17719144-1172
Thus, @PROTEIN$ influences neural and cognitive processes, a finding that highlights the contribution of @COMPOUND$ and alpha-tocopherol homeostasis in proper cognitive function.	0	17719144-1173
Thus, @PROTEIN$ influences neural and cognitive processes, a finding that highlights the contribution of cholesterol and @COMPOUND$ homeostasis in proper cognitive function.	0	17719144-1173
@COMPOUND$ is believed to confer its diabetogenic effect by inhibiting pancreatic @PROTEIN$ activity, leading to pancreatic beta-cell death.	1	17768029-984
@COMPOUND$ supplementation prevents the exercise-induced reduction of serum paraoxonase 1/@PROTEIN$ activities in healthy individuals.	1	17882129-602
Although @PROTEIN$4 has been repeatedly associated with altered sphingomyelin and @COMPOUND$ levels in tissue culture and rodent models, there has not been a direct quantification of sphingomyelin or sterol levels in the brains of patients with different forms of ApoE.	1	17888544-779
@PROTEIN$ modified the association between cholesterol and cognitive decline, and the association between the ratio of @COMPOUND$ to cholesterol and cognitive functioning.	1	17888546-781
@PROTEIN$ modified the association between @COMPOUND$ and cognitive decline, and the association between the ratio of 27-hydroxycholesterol to cholesterol and cognitive functioning.	1	17888546-781
Here we show that during growth in media containing @COMPOUND$ and in complex medium without glucose RamB activates expression of the @PROTEIN$ gene, encoding the E1p subunit of the pyruvate dehydrogenase complex.	0	17890844-955
The mood stabilizers @COMPOUND$ and valproate selectively activate the promoter IV of @PROTEIN$ in neurons.	1	17925795-1037
The mood stabilizers lithium and @COMPOUND$ selectively activate the promoter IV of @PROTEIN$ in neurons.	1	17925795-1037
Treatment of cultured rat cortical neurons with therapeutic concentrations of @COMPOUND$ or VPA selectively increased the levels of exon IV (formerly rat exon III)-containing @PROTEIN$ mRNA, and the activity of BDNF promoter IV.	1	17925795-1038
We showed that @COMPOUND$-induced activation of promoter IV was mimicked by pharmacological inhibition of GSK-3 or short interfering RNA (siRNA)-mediated gene silencing of @PROTEIN$ or GSK-3beta isoforms.	1	17925795-1039
We showed that @COMPOUND$-induced activation of promoter IV was mimicked by pharmacological inhibition of GSK-3 or short interfering RNA (siRNA)-mediated gene silencing of GSK-3alpha or @PROTEIN$ isoforms.	1	17925795-1039
We showed that @COMPOUND$-induced activation of promoter IV was mimicked by pharmacological inhibition of @PROTEIN$ or short interfering RNA (siRNA)-mediated gene silencing of GSK-3alpha or GSK-3beta isoforms.	1	17925795-1039
Furthermore, treatment with other HDAC inhibitors, @COMPOUND$ and trichostatin A, or transfection with an HDAC1-specific siRNA also activated @PROTEIN$ promoter IV.	1	17925795-1040
Furthermore, treatment with other HDAC inhibitors, sodium butyrate and @COMPOUND$, or transfection with an HDAC1-specific siRNA also activated @PROTEIN$ promoter IV.	1	17925795-1040
Our study demonstrates for the first time that @PROTEIN$ and HDAC are respective initial targets for @COMPOUND$ and VPA to activate BDNF promoter IV, and that this BDNF induction involves a novel responsive region in promoter IV of the BDNF gene.	1	17925795-1041
Our study demonstrates for the first time that GSK-3 and HDAC are respective initial targets for @COMPOUND$ and VPA to activate @PROTEIN$ promoter IV, and that this BDNF induction involves a novel responsive region in promoter IV of the BDNF gene.	0	17925795-1041
Addition of biphasic @PROTEIN$ aspart 30 to optimized metformin and @COMPOUND$ treatment of type 2 diabetes mellitus: The ACTION Study (Achieving Control Through Insulin plus Oral ageNts).	0	17941873-845
Addition of biphasic @PROTEIN$ aspart 30 to optimized @COMPOUND$ and pioglitazone treatment of type 2 diabetes mellitus: The ACTION Study (Achieving Control Through Insulin plus Oral ageNts).	0	17941873-845
Addition of biphasic insulin aspart 30 to optimized metformin and @COMPOUND$ treatment of type 2 diabetes mellitus: The ACTION Study (Achieving Control Through @PROTEIN$ plus Oral ageNts).	0	17941873-845
Addition of biphasic insulin aspart 30 to optimized @COMPOUND$ and pioglitazone treatment of type 2 diabetes mellitus: The ACTION Study (Achieving Control Through @PROTEIN$ plus Oral ageNts).	0	17941873-845
Efficacy and safety of biphasic @PROTEIN$ aspart (BIAsp 30, 30% short-acting and 70% intermediate-acting insulin aspart) added to an optimized treatment of metformin and @COMPOUND$ (met/pio) were compared with treatment with optimized met/pio in type 2 diabetes patients.	0	17941873-846
Efficacy and safety of biphasic @PROTEIN$ aspart (BIAsp 30, 30% short-acting and 70% intermediate-acting insulin aspart) added to an optimized treatment of @COMPOUND$ and pioglitazone (met/pio) were compared with treatment with optimized met/pio in type 2 diabetes patients.	0	17941873-846
@COMPOUND$ (NAA) is converted into aspartate and acetate by @PROTEIN$.	1	17943458-544
N-acetylaspartic acid (NAA) is converted into @COMPOUND$ and acetate by @PROTEIN$.	1	17943458-544
N-acetylaspartic acid (NAA) is converted into aspartate and @COMPOUND$ by @PROTEIN$.	1	17943458-544
In addition, treatment with @COMPOUND$ increased interleukin-4 (@PROTEIN$) mRNA and reversed the age-related decrease in hippocampal IL-4 concentration.	1	17950491-1121
Serum @PROTEIN$ levels were increased and plasma levels of @COMPOUND$ and MHPG were decreased according to the recovery from the active phase of the disease.	0	17965987-545
Serum @PROTEIN$ levels were increased and plasma levels of HVA and @COMPOUND$ were decreased according to the recovery from the active phase of the disease.	0	17965987-545
These results suggest that dysfunctions of catecholaminergic neurons and @PROTEIN$ might exist in Sydenham's chorea, and the decreasing catecholamine activities in response to @COMPOUND$ might be associated with the improvement of the disease.	0	17965987-546
Based on these validities we identified alterations in the @PROTEIN$ gene in the CA1 and amygdala regions, specifically in exposed PTSD-like rats, which were normalized after treatment with @COMPOUND$.	1	17968352-734
@PROTEIN$ (Cox-2) is a key enzyme in the conversion of @COMPOUND$ to prostaglandins that has been shown to have a particular importance in the progression of several malignancies including nasopharyngeal carcinoma (NPC).	1	17968676-958
Cyclooxygenase-2 (@PROTEIN$) is a key enzyme in the conversion of @COMPOUND$ to prostaglandins that has been shown to have a particular importance in the progression of several malignancies including nasopharyngeal carcinoma (NPC).	1	17968676-958
Other potential treatments discussed for possible use with long-acting @PROTEIN$ overdoses include incision and drainage of the injection site, glucagon, and @COMPOUND$.	0	17976762-900
@COMPOUND$ inhalation induced: (1) a transient bronchial inflammation, dominated by neutrophils; (2) a neutrophilia of the blood that persisted for up to 4 weeks; (3) a transient increased bronchial reactivity, and (4) a significant increase in @PROTEIN$ activity in the BALF.	1	18037312-321
To assess whether follicle-stimulating hormone (FSH) and basic fibroblast growth factor (bFGF) modulate @COMPOUND$ production in Sertoli cells by regulating the expression of GCLC, @PROTEIN$ and/or GR, we performed in vitro studies using rat Sertoli cells in primary culture.	0	18042181-811
To assess whether follicle-stimulating hormone (FSH) and @PROTEIN$ (bFGF) modulate @COMPOUND$ production in Sertoli cells by regulating the expression of GCLC, GCLM and/or GR, we performed in vitro studies using rat Sertoli cells in primary culture.	0	18042181-811
To assess whether follicle-stimulating hormone (FSH) and basic fibroblast growth factor (bFGF) modulate @COMPOUND$ production in Sertoli cells by regulating the expression of @PROTEIN$, GCLM and/or GR, we performed in vitro studies using rat Sertoli cells in primary culture.	0	18042181-811
In conclusion, our results show that FSH and bFGF increase @COMPOUND$ levels in Sertoli cells through stimulation of the de novo synthesis and recycling by upregulating @PROTEIN$ and GR expression respectively.	0	18042181-812
Compared to the control, both the stresses individually and in combination led to in reductions in growth, photosynthetic pigments, @COMPOUND$, catalase (CAT) activity and yield, whereas a reverse trend was observed for flavonoids, thiols and proline contents, superoxide dismutase (SOD) and @PROTEIN$ (POD) activities, and LPO.	0	18061671-207
Compared to the control, both the stresses individually and in combination led to in reductions in growth, photosynthetic pigments, ascorbic acid, catalase (CAT) activity and yield, whereas a reverse trend was observed for flavonoids, thiols and @COMPOUND$ contents, superoxide dismutase (SOD) and @PROTEIN$ (POD) activities, and LPO.	0	18061671-207
Compared to the control, both the stresses individually and in combination led to in reductions in growth, photosynthetic pigments, ascorbic acid, catalase (@PROTEIN$) activity and yield, whereas a reverse trend was observed for flavonoids, thiols and @COMPOUND$ contents, superoxide dismutase (SOD) and peroxidase (POD) activities, and LPO.	0	18061671-207
Compared to the control, both the stresses individually and in combination led to in reductions in growth, photosynthetic pigments, @COMPOUND$, @PROTEIN$ (CAT) activity and yield, whereas a reverse trend was observed for flavonoids, thiols and proline contents, superoxide dismutase (SOD) and peroxidase (POD) activities, and LPO.	0	18061671-207
Compared to the control, both the stresses individually and in combination led to in reductions in growth, photosynthetic pigments, ascorbic acid, catalase (CAT) activity and yield, whereas a reverse trend was observed for flavonoids, thiols and @COMPOUND$ contents, superoxide dismutase (@PROTEIN$) and peroxidase (POD) activities, and LPO.	0	18061671-207
Compared to the control, both the stresses individually and in combination led to in reductions in growth, photosynthetic pigments, @COMPOUND$, catalase (CAT) activity and yield, whereas a reverse trend was observed for flavonoids, thiols and proline contents, superoxide dismutase (SOD) and peroxidase (@PROTEIN$) activities, and LPO.	0	18061671-207
Compared to the control, both the stresses individually and in combination led to in reductions in growth, photosynthetic pigments, @COMPOUND$, catalase (@PROTEIN$) activity and yield, whereas a reverse trend was observed for flavonoids, thiols and proline contents, superoxide dismutase (SOD) and peroxidase (POD) activities, and LPO.	0	18061671-207
Compared to the control, both the stresses individually and in combination led to in reductions in growth, photosynthetic pigments, @COMPOUND$, catalase (CAT) activity and yield, whereas a reverse trend was observed for flavonoids, thiols and proline contents, superoxide dismutase (@PROTEIN$) and peroxidase (POD) activities, and LPO.	0	18061671-207
Compared to the control, both the stresses individually and in combination led to in reductions in growth, photosynthetic pigments, ascorbic acid, catalase (CAT) activity and yield, whereas a reverse trend was observed for flavonoids, thiols and @COMPOUND$ contents, superoxide dismutase (SOD) and peroxidase (POD) activities, and @PROTEIN$.	0	18061671-207
Compared to the control, both the stresses individually and in combination led to in reductions in growth, photosynthetic pigments, ascorbic acid, catalase (CAT) activity and yield, whereas a reverse trend was observed for flavonoids, thiols and @COMPOUND$ contents, @PROTEIN$ (SOD) and peroxidase (POD) activities, and LPO.	0	18061671-207
Compared to the control, both the stresses individually and in combination led to in reductions in growth, photosynthetic pigments, ascorbic acid, catalase (CAT) activity and yield, whereas a reverse trend was observed for flavonoids, thiols and @COMPOUND$ contents, superoxide dismutase (SOD) and peroxidase (@PROTEIN$) activities, and LPO.	0	18061671-207
Compared to the control, both the stresses individually and in combination led to in reductions in growth, photosynthetic pigments, ascorbic acid, @PROTEIN$ (CAT) activity and yield, whereas a reverse trend was observed for flavonoids, thiols and @COMPOUND$ contents, superoxide dismutase (SOD) and peroxidase (POD) activities, and LPO.	0	18061671-207
Compared to the control, both the stresses individually and in combination led to in reductions in growth, photosynthetic pigments, @COMPOUND$, catalase (CAT) activity and yield, whereas a reverse trend was observed for flavonoids, thiols and proline contents, superoxide dismutase (SOD) and peroxidase (POD) activities, and @PROTEIN$.	0	18061671-207
Compared to the control, both the stresses individually and in combination led to in reductions in growth, photosynthetic pigments, @COMPOUND$, catalase (CAT) activity and yield, whereas a reverse trend was observed for flavonoids, thiols and proline contents, @PROTEIN$ (SOD) and peroxidase (POD) activities, and LPO.	0	18061671-207
Selenium and @COMPOUND$ levels were not associated to @PROTEIN$ Abeta42.	0	18068270-465
In vitro, the degradation of synthetic Abeta substrate added to @PROTEIN$ was markedly accelerated by low levels (2microM) of exogenous zinc and @COMPOUND$.	1	18068270-466
@PROTEIN$ mutation impairs cholinergic modulation of synaptic plasticity and suppresses @COMPOUND$ currents in hippocampus slices.	1	18068871-859
Similarly, mutant @PROTEIN$ impairs the ability of the cholinesterase inhibitor @COMPOUND$ to enhance LTP.	1	18068871-860
It was found that the expression of SSAT and @PROTEIN$ were upregulated after reperfusion and the concentrations of spermidine and @COMPOUND$ were significantly decreased, while putrescine concentration was significantly increased.	1	18077014-827
It was found that the expression of @PROTEIN$ and ODC were upregulated after reperfusion and the concentrations of spermidine and spermine were significantly decreased, while @COMPOUND$ concentration was significantly increased.	1	18077014-827
It was found that the expression of @PROTEIN$ and ODC were upregulated after reperfusion and the concentrations of spermidine and @COMPOUND$ were significantly decreased, while putrescine concentration was significantly increased.	1	18077014-827
It was found that the expression of SSAT and @PROTEIN$ were upregulated after reperfusion and the concentrations of spermidine and spermine were significantly decreased, while @COMPOUND$ concentration was significantly increased.	1	18077014-827
It was found that the expression of @PROTEIN$ and ODC were upregulated after reperfusion and the concentrations of @COMPOUND$ and spermine were significantly decreased, while putrescine concentration was significantly increased.	1	18077014-827
It was found that the expression of SSAT and @PROTEIN$ were upregulated after reperfusion and the concentrations of @COMPOUND$ and spermine were significantly decreased, while putrescine concentration was significantly increased.	1	18077014-827
In the present study, we investigated the effects of @COMPOUND$ on memory impairment and pathological changes in an amyloid precursor protein (APP)/@PROTEIN$ (PS-1) double transgenic mouse model of Alzheimer's disease (AD).	0	18079026-797
In the present study, we investigated the effects of @COMPOUND$ on memory impairment and pathological changes in an amyloid precursor protein (APP)/presenilin-1 (@PROTEIN$) double transgenic mouse model of Alzheimer's disease (AD).	0	18079026-797
In the present study, we investigated the effects of @COMPOUND$ on memory impairment and pathological changes in an amyloid precursor protein (@PROTEIN$)/presenilin-1 (PS-1) double transgenic mouse model of Alzheimer's disease (AD).	0	18079026-797
@COMPOUND$ also decreased brain Abeta peptides, beta-secretase activity and expression, and the level of @PROTEIN$ (an APP C-terminal fragment following cleavage by beta-secretase) in the transgenic mice.	1	18079026-798
@COMPOUND$ also decreased brain Abeta peptides, beta-secretase activity and expression, and the level of C99 (an @PROTEIN$ C-terminal fragment following cleavage by beta-secretase) in the transgenic mice.	1	18079026-798
Furthermore, @COMPOUND$ attenuated anxiety-like behavior, up-regulated cerebral @PROTEIN$ protein, and decreased cerebral nitrotyrosine in the transgenic mice.	1	18079026-799
@COMPOUND$ rapidly phosphorylated Akt and endothelial @PROTEIN$ (eNOS) in human endothelial cells.	1	18162361-61
@COMPOUND$ rapidly phosphorylated Akt and endothelial nitric oxide synthase (@PROTEIN$) in human endothelial cells.	1	18162361-61
@COMPOUND$ rapidly phosphorylated @PROTEIN$ and endothelial nitric oxide synthase (eNOS) in human endothelial cells.	1	18162361-61
Our findings indicate that @COMPOUND$ protects endothelial cells from death with phosphorylation of Akt and @PROTEIN$.	1	18162361-62
Our findings indicate that @COMPOUND$ protects endothelial cells from death with phosphorylation of @PROTEIN$ and eNOS.	1	18162361-62
@PROTEIN$ and glutathione peroxidase antioxidant enzyme activities and malondialdehyde levels were found to be increased; however, beta-carotene, @COMPOUND$, vitamin C, vitamin E, reduced glutathione, and albumin levels were observed to be significantly decreased.	0	18164165-377
@PROTEIN$ and glutathione peroxidase antioxidant enzyme activities and malondialdehyde levels were found to be increased; however, beta-carotene, retinol, @COMPOUND$, vitamin E, reduced glutathione, and albumin levels were observed to be significantly decreased.	0	18164165-377
Superoxide dismutase and @PROTEIN$ antioxidant enzyme activities and @COMPOUND$ levels were found to be increased; however, beta-carotene, retinol, vitamin C, vitamin E, reduced glutathione, and albumin levels were observed to be significantly decreased.	0	18164165-377
@PROTEIN$ and glutathione peroxidase antioxidant enzyme activities and malondialdehyde levels were found to be increased; however, beta-carotene, retinol, vitamin C, vitamin E, @COMPOUND$, and albumin levels were observed to be significantly decreased.	0	18164165-377
Superoxide dismutase and @PROTEIN$ antioxidant enzyme activities and malondialdehyde levels were found to be increased; however, beta-carotene, retinol, vitamin C, @COMPOUND$, reduced glutathione, and albumin levels were observed to be significantly decreased.	0	18164165-377
@PROTEIN$ and glutathione peroxidase antioxidant enzyme activities and malondialdehyde levels were found to be increased; however, beta-carotene, retinol, vitamin C, @COMPOUND$, reduced glutathione, and albumin levels were observed to be significantly decreased.	0	18164165-377
Superoxide dismutase and @PROTEIN$ antioxidant enzyme activities and malondialdehyde levels were found to be increased; however, beta-carotene, retinol, @COMPOUND$, vitamin E, reduced glutathione, and albumin levels were observed to be significantly decreased.	0	18164165-377
Superoxide dismutase and @PROTEIN$ antioxidant enzyme activities and malondialdehyde levels were found to be increased; however, beta-carotene, @COMPOUND$, vitamin C, vitamin E, reduced glutathione, and albumin levels were observed to be significantly decreased.	0	18164165-377
Superoxide dismutase and @PROTEIN$ antioxidant enzyme activities and malondialdehyde levels were found to be increased; however, beta-carotene, retinol, vitamin C, vitamin E, @COMPOUND$, and albumin levels were observed to be significantly decreased.	0	18164165-377
@PROTEIN$ and glutathione peroxidase antioxidant enzyme activities and @COMPOUND$ levels were found to be increased; however, beta-carotene, retinol, vitamin C, vitamin E, reduced glutathione, and albumin levels were observed to be significantly decreased.	0	18164165-377
@PROTEIN$ and glutathione peroxidase antioxidant enzyme activities and malondialdehyde levels were found to be increased; however, @COMPOUND$, retinol, vitamin C, vitamin E, reduced glutathione, and albumin levels were observed to be significantly decreased.	0	18164165-377
Superoxide dismutase and @PROTEIN$ antioxidant enzyme activities and malondialdehyde levels were found to be increased; however, @COMPOUND$, retinol, vitamin C, vitamin E, reduced glutathione, and albumin levels were observed to be significantly decreased.	0	18164165-377
Structure-function studies of nitrated @PROTEIN$ in aging heart and skeletal muscle demonstrate stoichiometric nitration of vicinal tyrosines, Tyr (294) and Tyr (295), on the lumenal side of the membrane-spanning helix, @COMPOUND$, which correlates with partial inhibition of Ca(2+)-ATPase activity suggesting a possible regulatory function in down-regulating mitochondrial energy production and the associated generation of reactive oxygen/nitrogen species.	0	18172601-392
Structure-function studies of nitrated @PROTEIN$ in aging heart and skeletal muscle demonstrate stoichiometric nitration of vicinal tyrosines, Tyr (294) and Tyr (295), on the lumenal side of the membrane-spanning helix, M4, which correlates with partial inhibition of Ca(2+)-ATPase activity suggesting a possible regulatory function in down-regulating mitochondrial energy production and the associated generation of reactive @COMPOUND$/nitrogen species.	0	18172601-392
Structure-function studies of nitrated @PROTEIN$ in aging heart and skeletal muscle demonstrate stoichiometric nitration of vicinal tyrosines, Tyr (294) and Tyr (295), on the lumenal side of the membrane-spanning helix, M4, which correlates with partial inhibition of Ca(2+)-ATPase activity suggesting a possible regulatory function in down-regulating mitochondrial energy production and the associated generation of reactive oxygen/@COMPOUND$ species.	0	18172601-392
@COMPOUND$ is an endogenous vasodilator gas produced by the enzyme @PROTEIN$ (HO).	1	18177531-936
The long pentraxin 3 (@PROTEIN$) is a multifunctional soluble pattern recognition receptor, involved in several processes ranging from innate resistance and inflammation to clearance of apoptotic cells and organization of @COMPOUND$-rich extracellular matrices.	1	18179560-930
The @PROTEIN$ gene product forms part of a complex with the glucocorticoid receptor and can modulate @COMPOUND$-binding affinity.	1	18180755-369
The FKBP5 gene product forms part of a complex with the @PROTEIN$ and can modulate @COMPOUND$-binding affinity.	1	18180755-369
Several studies have shown that epsilon 2 carriers have lower low-density lipoprotein and apo B levels and higher @PROTEIN$ @COMPOUND$ and apo A-I levels than epsilon 3 carriers.	1	18190985-361
Several studies have shown that @PROTEIN$ 2 carriers have lower low-density lipoprotein and apo B levels and higher high-density lipoprotein @COMPOUND$ and apo A-I levels than epsilon 3 carriers.	1	18190985-361
Toxicity and characterization of @PROTEIN$-inhibition induced by @COMPOUND$ in Artemia salina larvae.	1	18191451-670
@COMPOUND$-induced depressive-like behavior is mediated by @PROTEIN$ activation in mice.	1	18195714-756
We report that peripheral administration of @COMPOUND$ (LPS) activates @PROTEIN$ and culminates in a distinct depressive-like behavioral syndrome, measured by increased duration of immobility in both the forced-swim and tail suspension tests.	1	18195714-757
Administration of L-@COMPOUND$, a metabolite of tryptophan that is generated by @PROTEIN$, to naive mice dose dependently induces depressive-like behavior.	1	18195714-758
Administration of L-kynurenine, a metabolite of @COMPOUND$ that is generated by @PROTEIN$, to naive mice dose dependently induces depressive-like behavior.	1	18195714-758
Serum adipocyte @PROTEIN$ levels in patients with type 2 diabetes mellitus and obesity: the influence of @COMPOUND$ treatment.	0	18198986-243
Serum @PROTEIN$ levels were 2.5-fold higher in T2DM group relative to C and were not affected by @COMPOUND$ treatment (C: 20.6+/-2.1 microg/l, T2DM before F: 55.6+/-5.7 microg/l, T2DM after F: 54.2+/-5.4 microg/l, p 0.0001 for C vs. T2DM before F).	0	18198986-245
FABP levels positively correlated with BMI, triglyceride levels, blood @COMPOUND$, glycated @PROTEIN$, atherogenic index and insulin levels.	0	18198986-246
@PROTEIN$ levels positively correlated with BMI, triglyceride levels, blood @COMPOUND$, glycated hemoglobin, atherogenic index and insulin levels.	1	18198986-246
FABP levels positively correlated with BMI, triglyceride levels, blood @COMPOUND$, glycated hemoglobin, atherogenic index and @PROTEIN$ levels.	0	18198986-246
@COMPOUND$ enemas upregulate @PROTEIN$ genes expression but decrease adherent mucus thickness in mice colon.	1	18198997-256
We demonstrated that @COMPOUND$ stimulated the gene expression of both secreted (@PROTEIN$) and membrane-linked (Muc1, Muc3, Muc4) mucins.	1	18198997-257
We demonstrated that @COMPOUND$ stimulated the gene expression of both secreted (Muc2) and membrane-linked (@PROTEIN$, Muc3, Muc4) mucins.	1	18198997-257
@COMPOUND$ especially induced a 6-fold increase in @PROTEIN$ gene expression in proximal colon.	1	18198997-258
However, @COMPOUND$ enemas did not modify the number of epithelial cells containing the protein @PROTEIN$, and caused a 2-fold decrease in the thickness of adherent mucus layer.	0	18198997-259
We examined the association of @PROTEIN$ C677T and A1298C, and changes in plasma @COMPOUND$ in 352 Tunisian patients with angiographically-demonstrated CAD, and 390 age and gender-matched healthy subjects.	0	18204887-141
However, we also observed that @COMPOUND$ (1alpha-hydroxylase inhibitor) enhanced 25(OH)D(3)-induced @PROTEIN$ expression in breast cancer cells.	1	18205042-213
Expression of senescence-associated beta-galactosidase (SA-beta-@PROTEIN$) by human skin fibroblasts, effect of advanced glycation end-products and @COMPOUND$ or rhamnose-rich polysaccharides.	0	18207583-646
Expression of senescence-associated @PROTEIN$ (SA-beta-Gal) by human skin fibroblasts, effect of advanced glycation end-products and @COMPOUND$ or rhamnose-rich polysaccharides.	0	18207583-646
Short-term withdrawal of @COMPOUND$ induces endothelial dysfunction in patients with coronary artery disease: a dose-response effect dependent on endothelial @PROTEIN$.	1	18221806-436
It has been shown that the removal efficiency of @PROTEIN$ increased with the increasing applied current density and increasing PAC and @COMPOUND$ (2)SO(4) dosage and the most effective removal capacity was achieved at the pH 7.	1	18222028-559
The protective effects of novel synthetic organoselenium compounds (Se I and Se II) against DMBA-induced changes in levels of some (superoxide dismutase (SOD), catalase (@PROTEIN$), @COMPOUND$ peroxidase (GPx), and glutathione reductase (GR) activities and total glutathione (GSH), malonedialdehyde (MDA)) parameters in rat lung and kidney were investigated.	0	18222543-918
The protective effects of novel synthetic organoselenium compounds (Se I and Se II) against @COMPOUND$-induced changes in levels of some (superoxide dismutase (SOD), catalase (CAT), @PROTEIN$ (GPx), and glutathione reductase (GR) activities and total glutathione (GSH), malonedialdehyde (MDA)) parameters in rat lung and kidney were investigated.	0	18222543-918
The protective effects of novel synthetic organoselenium compounds (Se I and Se II) against DMBA-induced changes in levels of some (superoxide dismutase (@PROTEIN$), catalase (CAT), glutathione peroxidase (GPx), and glutathione reductase (GR) activities and total glutathione (@COMPOUND$), malonedialdehyde (MDA)) parameters in rat lung and kidney were investigated.	0	18222543-918
The protective effects of novel synthetic organoselenium compounds (Se I and Se II) against DMBA-induced changes in levels of some (superoxide dismutase (SOD), catalase (CAT), @PROTEIN$ (GPx), and glutathione reductase (GR) activities and total glutathione (@COMPOUND$), malonedialdehyde (MDA)) parameters in rat lung and kidney were investigated.	0	18222543-918
The protective effects of novel synthetic organoselenium compounds (Se I and Se II) against DMBA-induced changes in levels of some (superoxide dismutase (@PROTEIN$), catalase (CAT), @COMPOUND$ peroxidase (GPx), and glutathione reductase (GR) activities and total glutathione (GSH), malonedialdehyde (MDA)) parameters in rat lung and kidney were investigated.	0	18222543-918
The protective effects of novel synthetic organoselenium compounds (Se I and Se II) against @COMPOUND$-induced changes in levels of some (superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), and @PROTEIN$ (GR) activities and total glutathione (GSH), malonedialdehyde (MDA)) parameters in rat lung and kidney were investigated.	0	18222543-918
The protective effects of novel synthetic organoselenium compounds (Se I and Se II) against DMBA-induced changes in levels of some (@PROTEIN$ (SOD), catalase (CAT), glutathione peroxidase (GPx), and glutathione reductase (GR) activities and total glutathione (@COMPOUND$), malonedialdehyde (MDA)) parameters in rat lung and kidney were investigated.	0	18222543-918
The protective effects of novel synthetic organoselenium compounds (Se I and Se II) against @COMPOUND$-induced changes in levels of some (superoxide dismutase (@PROTEIN$), catalase (CAT), glutathione peroxidase (GPx), and glutathione reductase (GR) activities and total glutathione (GSH), malonedialdehyde (MDA)) parameters in rat lung and kidney were investigated.	0	18222543-918
The protective effects of novel synthetic organoselenium compounds (Se I and Se II) against @COMPOUND$-induced changes in levels of some (@PROTEIN$ (SOD), catalase (CAT), glutathione peroxidase (GPx), and glutathione reductase (GR) activities and total glutathione (GSH), malonedialdehyde (MDA)) parameters in rat lung and kidney were investigated.	0	18222543-918
The protective effects of novel synthetic organoselenium compounds (Se I and Se II) against @COMPOUND$-induced changes in levels of some (superoxide dismutase (SOD), @PROTEIN$ (CAT), glutathione peroxidase (GPx), and glutathione reductase (GR) activities and total glutathione (GSH), malonedialdehyde (MDA)) parameters in rat lung and kidney were investigated.	0	18222543-918
The protective effects of novel synthetic organoselenium compounds (Se I and Se II) against DMBA-induced changes in levels of some (superoxide dismutase (SOD), catalase (@PROTEIN$), glutathione peroxidase (GPx), and glutathione reductase (GR) activities and total glutathione (@COMPOUND$), malonedialdehyde (MDA)) parameters in rat lung and kidney were investigated.	0	18222543-918
The protective effects of novel synthetic organoselenium compounds (Se I and Se II) against DMBA-induced changes in levels of some (@PROTEIN$ (SOD), catalase (CAT), @COMPOUND$ peroxidase (GPx), and glutathione reductase (GR) activities and total glutathione (GSH), malonedialdehyde (MDA)) parameters in rat lung and kidney were investigated.	0	18222543-918
The protective effects of novel synthetic organoselenium compounds (Se I and Se II) against DMBA-induced changes in levels of some (superoxide dismutase (SOD), catalase (CAT), @COMPOUND$ peroxidase (GPx), and @PROTEIN$ (GR) activities and total glutathione (GSH), malonedialdehyde (MDA)) parameters in rat lung and kidney were investigated.	0	18222543-918
The protective effects of novel synthetic organoselenium compounds (Se I and Se II) against DMBA-induced changes in levels of some (superoxide dismutase (SOD), @PROTEIN$ (CAT), glutathione peroxidase (GPx), and glutathione reductase (GR) activities and total glutathione (@COMPOUND$), malonedialdehyde (MDA)) parameters in rat lung and kidney were investigated.	0	18222543-918
The protective effects of novel synthetic organoselenium compounds (Se I and Se II) against DMBA-induced changes in levels of some (superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), and @PROTEIN$ (GR) activities and total glutathione (@COMPOUND$), malonedialdehyde (MDA)) parameters in rat lung and kidney were investigated.	0	18222543-918
The protective effects of novel synthetic organoselenium compounds (Se I and Se II) against @COMPOUND$-induced changes in levels of some (superoxide dismutase (SOD), catalase (@PROTEIN$), glutathione peroxidase (GPx), and glutathione reductase (GR) activities and total glutathione (GSH), malonedialdehyde (MDA)) parameters in rat lung and kidney were investigated.	0	18222543-918
The protective effects of novel synthetic organoselenium compounds (Se I and Se II) against DMBA-induced changes in levels of some (superoxide dismutase (SOD), @PROTEIN$ (CAT), @COMPOUND$ peroxidase (GPx), and glutathione reductase (GR) activities and total glutathione (GSH), malonedialdehyde (MDA)) parameters in rat lung and kidney were investigated.	0	18222543-918
Abnormally high CSF 3-OMD occurs frequently for RLS patients indicating either increased @COMPOUND$ synthesis, limitations in l-dopa decarboxylation or increased @PROTEIN$/COMT activity, or some combination of these.	0	18226951-1110
Abnormally high CSF 3-OMD occurs frequently for RLS patients indicating either increased @COMPOUND$ synthesis, limitations in l-dopa decarboxylation or increased MAT/@PROTEIN$ activity, or some combination of these.	0	18226951-1110
To test this hypothesis, we investigated whether disruption of the oxytocin gene (@PROTEIN$-/-) made mice more susceptible to the psychosis-related effects of amphetamine (Amp), @COMPOUND$ (Apo) and phencyclidine (PCP).	0	18227836-349
To test this hypothesis, we investigated whether disruption of the @PROTEIN$ gene (Oxt-/-) made mice more susceptible to the psychosis-related effects of amphetamine (@COMPOUND$), apomorphine (Apo) and phencyclidine (PCP).	0	18227836-349
To test this hypothesis, we investigated whether disruption of the @PROTEIN$ gene (Oxt-/-) made mice more susceptible to the psychosis-related effects of amphetamine (Amp), @COMPOUND$ (Apo) and phencyclidine (PCP).	0	18227836-349
To test this hypothesis, we investigated whether disruption of the @PROTEIN$ gene (Oxt-/-) made mice more susceptible to the psychosis-related effects of @COMPOUND$ (Amp), apomorphine (Apo) and phencyclidine (PCP).	0	18227836-349
To test this hypothesis, we investigated whether disruption of the oxytocin gene (@PROTEIN$-/-) made mice more susceptible to the psychosis-related effects of @COMPOUND$ (Amp), apomorphine (Apo) and phencyclidine (PCP).	0	18227836-349
To test this hypothesis, we investigated whether disruption of the oxytocin gene (@PROTEIN$-/-) made mice more susceptible to the psychosis-related effects of amphetamine (Amp), apomorphine (Apo) and @COMPOUND$ (PCP).	0	18227836-349
To test this hypothesis, we investigated whether disruption of the @PROTEIN$ gene (Oxt-/-) made mice more susceptible to the psychosis-related effects of amphetamine (Amp), apomorphine (Apo) and @COMPOUND$ (PCP).	0	18227836-349
To test this hypothesis, we investigated whether disruption of the oxytocin gene (@PROTEIN$-/-) made mice more susceptible to the psychosis-related effects of amphetamine (@COMPOUND$), apomorphine (Apo) and phencyclidine (PCP).	0	18227836-349
The mood stabilizers @COMPOUND$ and valproate activate the @PROTEIN$ pathway in prefrontal cortex and hippocampus and potentiate ERK pathway-mediated neurite growth, neuronal survival and hippocampal neurogenesis.	1	18227838-352
The mood stabilizers lithium and @COMPOUND$ activate the @PROTEIN$ pathway in prefrontal cortex and hippocampus and potentiate ERK pathway-mediated neurite growth, neuronal survival and hippocampal neurogenesis.	1	18227838-352
In the root soluble fraction, the suicide inhibitor alpha-@COMPOUND$-lysine suppressed the activity of lysine decarboxylase and of ornithine decarboxylase to the same extent, but had no effect on @PROTEIN$ activity.	0	18227970-442
In the root soluble fraction, the suicide inhibitor alpha-difluoromethyl-@COMPOUND$ suppressed the activity of lysine decarboxylase and of ornithine decarboxylase to the same extent, but had no effect on @PROTEIN$ activity.	0	18227970-442
In the root soluble fraction, the suicide inhibitor alpha-@COMPOUND$-lysine suppressed the activity of lysine decarboxylase and of @PROTEIN$ to the same extent, but had no effect on arginine decarboxylase activity.	1	18227970-442
In the root soluble fraction, the suicide inhibitor alpha-difluoromethyl-@COMPOUND$ suppressed the activity of lysine decarboxylase and of @PROTEIN$ to the same extent, but had no effect on arginine decarboxylase activity.	1	18227970-442
In the root soluble fraction, the suicide inhibitor alpha-@COMPOUND$-lysine suppressed the activity of @PROTEIN$ and of ornithine decarboxylase to the same extent, but had no effect on arginine decarboxylase activity.	1	18227970-442
In the root soluble fraction, the suicide inhibitor alpha-difluoromethyl-@COMPOUND$ suppressed the activity of @PROTEIN$ and of ornithine decarboxylase to the same extent, but had no effect on arginine decarboxylase activity.	1	18227970-442
RT(2) Profiler PCR Array was used to identify differentially expressed genes in Dox and/or @COMPOUND$ treatment groups, based on significance of results 4 genes were selected: MDR1, Bcl2, P53 and @PROTEIN$ D1.	1	18228136-547
RT(2) Profiler PCR Array was used to identify differentially expressed genes in Dox and/or @COMPOUND$ treatment groups, based on significance of results 4 genes were selected: MDR1, Bcl2, @PROTEIN$ and Cyclin D1.	1	18228136-547
RT(2) Profiler PCR Array was used to identify differentially expressed genes in Dox and/or @COMPOUND$ treatment groups, based on significance of results 4 genes were selected: @PROTEIN$, Bcl2, P53 and Cyclin D1.	1	18228136-547
RT(2) Profiler PCR Array was used to identify differentially expressed genes in Dox and/or @COMPOUND$ treatment groups, based on significance of results 4 genes were selected: MDR1, @PROTEIN$, P53 and Cyclin D1.	1	18228136-547
The array and western blotting showed that Bcl2 and @PROTEIN$ D1 expression were down regulated; P53 expression was not affected while MDR1 was over expressed by combination of @COMPOUND$ with Dox.	1	18228136-548
The array and western blotting showed that Bcl2 and Cyclin D1 expression were down regulated; P53 expression was not affected while @PROTEIN$ was over expressed by combination of @COMPOUND$ with Dox.	1	18228136-548
The array and western blotting showed that Bcl2 and Cyclin D1 expression were down regulated; @PROTEIN$ expression was not affected while MDR1 was over expressed by combination of @COMPOUND$ with Dox.	0	18228136-548
The array and western blotting showed that @PROTEIN$ and Cyclin D1 expression were down regulated; P53 expression was not affected while MDR1 was over expressed by combination of @COMPOUND$ with Dox.	1	18228136-548
In conclusion, @COMPOUND$ chemosensitizes resistant breast cancer cells to Dox cytotoxicity by down regulating expression of Bcl2 and @PROTEIN$ D1, augmenting caspase 3 activity as well as inducing cell cycle block in G(1) and S phases.	1	18228136-549
In conclusion, @COMPOUND$ chemosensitizes resistant breast cancer cells to Dox cytotoxicity by down regulating expression of @PROTEIN$ and Cyclin D1, augmenting caspase 3 activity as well as inducing cell cycle block in G(1) and S phases.	1	18228136-549
Randomised trials have demonstrated that the efficacy of anti-tumour necrosis factor (@PROTEIN$) agents is significantly increased by concomitant @COMPOUND$ (MTX) in rheumatoid arthritis (RA).	1	18230627-837
Neither @PROTEIN$ nor ATP altered production of reactive oxygen intermediates (ROI) or reactive @COMPOUND$ intermediates (RNI) by bovine monocytes.	0	18243311-231
Neither @PROTEIN$ nor ATP altered production of reactive @COMPOUND$ intermediates (ROI) or reactive nitrogen intermediates (RNI) by bovine monocytes.	0	18243311-231
Neither @PROTEIN$ nor @COMPOUND$ altered production of reactive oxygen intermediates (ROI) or reactive nitrogen intermediates (RNI) by bovine monocytes.	0	18243311-231
In this systematic review, we have analyzed the results of 52 clinical trials, including 72 intervention groups and 6290 patients, on @COMPOUND$ supplementation in order to evaluate the experimental evidence and the effects of age and chronic immobility on responses of parathyroid hormone (@PROTEIN$).	1	18243368-1130
The @COMPOUND$ supplementation of the chronically immobile patients resulted in a smaller decrease in @PROTEIN$ 0.001).	1	18243368-1131
Our results also suggest that @PROTEIN$ decreases quite linearly during @COMPOUND$ supplementation at any given 25-OHD level.	1	18243368-1132
@PROTEIN$ did not show any effect in long photoperiod but decreased proliferation by stimulating @COMPOUND$ in short photoperiod.	1	18248398-140
To compare the changes in body composition and in @PROTEIN$ levels in postmenopausal women receiving hormone therapy (HT) or @COMPOUND$.	1	18249383-1046
Common 677C--&gt;T mutation of the @PROTEIN$ gene affects follicular @COMPOUND$ synthesis.	1	18249399-1054
Surprisingly, a deletion of the @PROTEIN$ gene affected not only insoluble @COMPOUND$) reduction, which requires pili, but also soluble Fe(III) reduction, which, in contrast, does not require pili.	1	18253022-733
Furthermore, the suppressive effects of P on @PROTEIN$ release and caspase-9 and caspase-3 activation in serum-deprived MC3T3-E1 cells were also reversed by @COMPOUND$.	1	18253697-765
Therapeutic @COMPOUND$/@PROTEIN$ activation promotes the angiogenic phenotype in the ERalpha negative MDA-MB-435 breast cancer model.	1	18256928-624
However, when ERalpha negative MDA-MB-435 cells were treated with @COMPOUND$, they demonstrated increased expression of vascular endothelial growth factor (VEGF) in an @PROTEIN$ dependent manner; while the ERalpha positive MCF-7 cells did not.	1	18256928-625
However, when ERalpha negative MDA-MB-435 cells were treated with @COMPOUND$, they demonstrated increased expression of vascular endothelial growth factor (@PROTEIN$) in an AMPK dependent manner; while the ERalpha positive MCF-7 cells did not.	1	18256928-625
The @COMPOUND$-treated group showed increased @PROTEIN$ expression, intratumoral microvascular density and reduced necrosis.	1	18256928-626
@COMPOUND$ treatment was sufficient, however, to reduce systemic @PROTEIN$ and the proliferation rate of tumor cells in vascularized regions.	1	18256928-627
@PROTEIN$, MCP-1, MIP-1alpha, IL-8, IL-6, IL-1beta, VEGF, IL-1ra, and IL-10 were measured from monocyte/macrophage cultures at different stages of activation and differentiation seeded onto polyethylene, polyurethane, expanded polytetrafluoroethylene, @COMPOUND$, and a hydrogel copolymer of 2-hydroxyethyl methacrylate, 1-vinyl-2-pyrrolidinone, and polyethylene glycol acrylate in tissue culture polystyrene (TCPS) plates.	0	18260130-109
TNF-alpha, MCP-1, MIP-1alpha, IL-8, IL-6, IL-1beta, VEGF, IL-1ra, and @PROTEIN$ were measured from monocyte/macrophage cultures at different stages of activation and differentiation seeded onto polyethylene, polyurethane, expanded polytetrafluoroethylene, polymethyl methacrylate, and a hydrogel copolymer of 2-hydroxyethyl methacrylate, @COMPOUND$, and polyethylene glycol acrylate in tissue culture polystyrene (TCPS) plates.	0	18260130-109
TNF-alpha, MCP-1, MIP-1alpha, IL-8, IL-6, IL-1beta, @PROTEIN$, IL-1ra, and IL-10 were measured from monocyte/macrophage cultures at different stages of activation and differentiation seeded onto polyethylene, @COMPOUND$, expanded polytetrafluoroethylene, polymethyl methacrylate, and a hydrogel copolymer of 2-hydroxyethyl methacrylate, 1-vinyl-2-pyrrolidinone, and polyethylene glycol acrylate in tissue culture polystyrene (TCPS) plates.	0	18260130-109
TNF-alpha, MCP-1, MIP-1alpha, IL-8, @PROTEIN$, IL-1beta, VEGF, IL-1ra, and IL-10 were measured from monocyte/macrophage cultures at different stages of activation and differentiation seeded onto polyethylene, @COMPOUND$, expanded polytetrafluoroethylene, polymethyl methacrylate, and a hydrogel copolymer of 2-hydroxyethyl methacrylate, 1-vinyl-2-pyrrolidinone, and polyethylene glycol acrylate in tissue culture polystyrene (TCPS) plates.	0	18260130-109
TNF-alpha, @PROTEIN$, MIP-1alpha, IL-8, IL-6, IL-1beta, VEGF, IL-1ra, and IL-10 were measured from monocyte/macrophage cultures at different stages of activation and differentiation seeded onto polyethylene, polyurethane, expanded polytetrafluoroethylene, @COMPOUND$, and a hydrogel copolymer of 2-hydroxyethyl methacrylate, 1-vinyl-2-pyrrolidinone, and polyethylene glycol acrylate in tissue culture polystyrene (TCPS) plates.	0	18260130-109
TNF-alpha, MCP-1, MIP-1alpha, IL-8, IL-6, IL-1beta, VEGF, @PROTEIN$, and IL-10 were measured from monocyte/macrophage cultures at different stages of activation and differentiation seeded onto polyethylene, polyurethane, expanded polytetrafluoroethylene, polymethyl methacrylate, and a hydrogel copolymer of 2-hydroxyethyl methacrylate, 1-vinyl-2-pyrrolidinone, and polyethylene glycol acrylate in tissue culture @COMPOUND$ (TCPS) plates.	0	18260130-109
@PROTEIN$, MCP-1, MIP-1alpha, IL-8, IL-6, IL-1beta, VEGF, IL-1ra, and IL-10 were measured from monocyte/macrophage cultures at different stages of activation and differentiation seeded onto polyethylene, polyurethane, expanded polytetrafluoroethylene, polymethyl methacrylate, and a hydrogel copolymer of 2-hydroxyethyl methacrylate, @COMPOUND$, and polyethylene glycol acrylate in tissue culture polystyrene (TCPS) plates.	0	18260130-109
TNF-alpha, MCP-1, @PROTEIN$, IL-8, IL-6, IL-1beta, VEGF, IL-1ra, and IL-10 were measured from monocyte/macrophage cultures at different stages of activation and differentiation seeded onto polyethylene, polyurethane, expanded polytetrafluoroethylene, polymethyl methacrylate, and a hydrogel copolymer of @COMPOUND$, 1-vinyl-2-pyrrolidinone, and polyethylene glycol acrylate in tissue culture polystyrene (TCPS) plates.	0	18260130-109
TNF-alpha, @PROTEIN$, MIP-1alpha, IL-8, IL-6, IL-1beta, VEGF, IL-1ra, and IL-10 were measured from monocyte/macrophage cultures at different stages of activation and differentiation seeded onto polyethylene, polyurethane, expanded polytetrafluoroethylene, polymethyl methacrylate, and a hydrogel copolymer of @COMPOUND$, 1-vinyl-2-pyrrolidinone, and polyethylene glycol acrylate in tissue culture polystyrene (TCPS) plates.	0	18260130-109
TNF-alpha, @PROTEIN$, MIP-1alpha, IL-8, IL-6, IL-1beta, VEGF, IL-1ra, and IL-10 were measured from monocyte/macrophage cultures at different stages of activation and differentiation seeded onto polyethylene, polyurethane, expanded polytetrafluoroethylene, polymethyl methacrylate, and a hydrogel copolymer of 2-hydroxyethyl methacrylate, 1-vinyl-2-pyrrolidinone, and polyethylene glycol acrylate in tissue culture @COMPOUND$ (TCPS) plates.	0	18260130-109
TNF-alpha, MCP-1, MIP-1alpha, IL-8, IL-6, IL-1beta, VEGF, @PROTEIN$, and IL-10 were measured from monocyte/macrophage cultures at different stages of activation and differentiation seeded onto polyethylene, polyurethane, expanded polytetrafluoroethylene, @COMPOUND$, and a hydrogel copolymer of 2-hydroxyethyl methacrylate, 1-vinyl-2-pyrrolidinone, and polyethylene glycol acrylate in tissue culture polystyrene (TCPS) plates.	0	18260130-109
TNF-alpha, MCP-1, MIP-1alpha, IL-8, @PROTEIN$, IL-1beta, VEGF, IL-1ra, and IL-10 were measured from monocyte/macrophage cultures at different stages of activation and differentiation seeded onto polyethylene, polyurethane, expanded polytetrafluoroethylene, polymethyl methacrylate, and a hydrogel copolymer of 2-hydroxyethyl methacrylate, 1-vinyl-2-pyrrolidinone, and polyethylene glycol acrylate in tissue culture @COMPOUND$ (TCPS) plates.	0	18260130-109
TNF-alpha, MCP-1, MIP-1alpha, IL-8, IL-6, IL-1beta, @PROTEIN$, IL-1ra, and IL-10 were measured from monocyte/macrophage cultures at different stages of activation and differentiation seeded onto polyethylene, polyurethane, expanded polytetrafluoroethylene, polymethyl methacrylate, and a hydrogel copolymer of 2-hydroxyethyl methacrylate, 1-vinyl-2-pyrrolidinone, and polyethylene glycol acrylate in tissue culture @COMPOUND$ (TCPS) plates.	0	18260130-109
TNF-alpha, @PROTEIN$, MIP-1alpha, IL-8, IL-6, IL-1beta, VEGF, IL-1ra, and IL-10 were measured from monocyte/macrophage cultures at different stages of activation and differentiation seeded onto polyethylene, @COMPOUND$, expanded polytetrafluoroethylene, polymethyl methacrylate, and a hydrogel copolymer of 2-hydroxyethyl methacrylate, 1-vinyl-2-pyrrolidinone, and polyethylene glycol acrylate in tissue culture polystyrene (TCPS) plates.	0	18260130-109
TNF-alpha, MCP-1, MIP-1alpha, IL-8, IL-6, @PROTEIN$, VEGF, IL-1ra, and IL-10 were measured from monocyte/macrophage cultures at different stages of activation and differentiation seeded onto polyethylene, polyurethane, expanded polytetrafluoroethylene, polymethyl methacrylate, and a hydrogel copolymer of 2-hydroxyethyl methacrylate, @COMPOUND$, and polyethylene glycol acrylate in tissue culture polystyrene (TCPS) plates.	0	18260130-109
TNF-alpha, MCP-1, MIP-1alpha, IL-8, IL-6, IL-1beta, VEGF, IL-1ra, and @PROTEIN$ were measured from monocyte/macrophage cultures at different stages of activation and differentiation seeded onto polyethylene, @COMPOUND$, expanded polytetrafluoroethylene, polymethyl methacrylate, and a hydrogel copolymer of 2-hydroxyethyl methacrylate, 1-vinyl-2-pyrrolidinone, and polyethylene glycol acrylate in tissue culture polystyrene (TCPS) plates.	0	18260130-109
TNF-alpha, MCP-1, MIP-1alpha, @PROTEIN$, IL-6, IL-1beta, VEGF, IL-1ra, and IL-10 were measured from monocyte/macrophage cultures at different stages of activation and differentiation seeded onto polyethylene, @COMPOUND$, expanded polytetrafluoroethylene, polymethyl methacrylate, and a hydrogel copolymer of 2-hydroxyethyl methacrylate, 1-vinyl-2-pyrrolidinone, and polyethylene glycol acrylate in tissue culture polystyrene (TCPS) plates.	0	18260130-109
@PROTEIN$, MCP-1, MIP-1alpha, IL-8, IL-6, IL-1beta, VEGF, IL-1ra, and IL-10 were measured from monocyte/macrophage cultures at different stages of activation and differentiation seeded onto polyethylene, polyurethane, expanded polytetrafluoroethylene, polymethyl methacrylate, and a hydrogel copolymer of 2-hydroxyethyl methacrylate, 1-vinyl-2-pyrrolidinone, and polyethylene glycol acrylate in tissue culture @COMPOUND$ (TCPS) plates.	0	18260130-109
TNF-alpha, MCP-1, MIP-1alpha, IL-8, IL-6, IL-1beta, @PROTEIN$, IL-1ra, and IL-10 were measured from monocyte/macrophage cultures at different stages of activation and differentiation seeded onto polyethylene, polyurethane, expanded polytetrafluoroethylene, polymethyl methacrylate, and a hydrogel copolymer of 2-hydroxyethyl methacrylate, @COMPOUND$, and polyethylene glycol acrylate in tissue culture polystyrene (TCPS) plates.	0	18260130-109
TNF-alpha, MCP-1, MIP-1alpha, IL-8, IL-6, IL-1beta, VEGF, IL-1ra, and @PROTEIN$ were measured from monocyte/macrophage cultures at different stages of activation and differentiation seeded onto polyethylene, polyurethane, expanded polytetrafluoroethylene, polymethyl methacrylate, and a hydrogel copolymer of 2-hydroxyethyl methacrylate, 1-vinyl-2-pyrrolidinone, and polyethylene glycol acrylate in tissue culture @COMPOUND$ (TCPS) plates.	0	18260130-109
TNF-alpha, MCP-1, MIP-1alpha, IL-8, IL-6, @PROTEIN$, VEGF, IL-1ra, and IL-10 were measured from monocyte/macrophage cultures at different stages of activation and differentiation seeded onto polyethylene, polyurethane, expanded polytetrafluoroethylene, @COMPOUND$, and a hydrogel copolymer of 2-hydroxyethyl methacrylate, 1-vinyl-2-pyrrolidinone, and polyethylene glycol acrylate in tissue culture polystyrene (TCPS) plates.	0	18260130-109
TNF-alpha, MCP-1, MIP-1alpha, IL-8, @PROTEIN$, IL-1beta, VEGF, IL-1ra, and IL-10 were measured from monocyte/macrophage cultures at different stages of activation and differentiation seeded onto polyethylene, polyurethane, expanded polytetrafluoroethylene, @COMPOUND$, and a hydrogel copolymer of 2-hydroxyethyl methacrylate, 1-vinyl-2-pyrrolidinone, and polyethylene glycol acrylate in tissue culture polystyrene (TCPS) plates.	0	18260130-109
TNF-alpha, MCP-1, @PROTEIN$, IL-8, IL-6, IL-1beta, VEGF, IL-1ra, and IL-10 were measured from monocyte/macrophage cultures at different stages of activation and differentiation seeded onto polyethylene, polyurethane, expanded polytetrafluoroethylene, @COMPOUND$, and a hydrogel copolymer of 2-hydroxyethyl methacrylate, 1-vinyl-2-pyrrolidinone, and polyethylene glycol acrylate in tissue culture polystyrene (TCPS) plates.	0	18260130-109
TNF-alpha, MCP-1, @PROTEIN$, IL-8, IL-6, IL-1beta, VEGF, IL-1ra, and IL-10 were measured from monocyte/macrophage cultures at different stages of activation and differentiation seeded onto polyethylene, polyurethane, expanded polytetrafluoroethylene, polymethyl methacrylate, and a hydrogel copolymer of 2-hydroxyethyl methacrylate, @COMPOUND$, and polyethylene glycol acrylate in tissue culture polystyrene (TCPS) plates.	0	18260130-109
TNF-alpha, MCP-1, MIP-1alpha, IL-8, IL-6, IL-1beta, VEGF, @PROTEIN$, and IL-10 were measured from monocyte/macrophage cultures at different stages of activation and differentiation seeded onto polyethylene, polyurethane, expanded polytetrafluoroethylene, polymethyl methacrylate, and a hydrogel copolymer of 2-hydroxyethyl methacrylate, @COMPOUND$, and polyethylene glycol acrylate in tissue culture polystyrene (TCPS) plates.	0	18260130-109
TNF-alpha, MCP-1, MIP-1alpha, IL-8, IL-6, IL-1beta, VEGF, @PROTEIN$, and IL-10 were measured from monocyte/macrophage cultures at different stages of activation and differentiation seeded onto polyethylene, @COMPOUND$, expanded polytetrafluoroethylene, polymethyl methacrylate, and a hydrogel copolymer of 2-hydroxyethyl methacrylate, 1-vinyl-2-pyrrolidinone, and polyethylene glycol acrylate in tissue culture polystyrene (TCPS) plates.	0	18260130-109
TNF-alpha, MCP-1, MIP-1alpha, IL-8, IL-6, IL-1beta, @PROTEIN$, IL-1ra, and IL-10 were measured from monocyte/macrophage cultures at different stages of activation and differentiation seeded onto polyethylene, polyurethane, expanded polytetrafluoroethylene, @COMPOUND$, and a hydrogel copolymer of 2-hydroxyethyl methacrylate, 1-vinyl-2-pyrrolidinone, and polyethylene glycol acrylate in tissue culture polystyrene (TCPS) plates.	0	18260130-109
@PROTEIN$, MCP-1, MIP-1alpha, IL-8, IL-6, IL-1beta, VEGF, IL-1ra, and IL-10 were measured from monocyte/macrophage cultures at different stages of activation and differentiation seeded onto polyethylene, @COMPOUND$, expanded polytetrafluoroethylene, polymethyl methacrylate, and a hydrogel copolymer of 2-hydroxyethyl methacrylate, 1-vinyl-2-pyrrolidinone, and polyethylene glycol acrylate in tissue culture polystyrene (TCPS) plates.	0	18260130-109
TNF-alpha, MCP-1, MIP-1alpha, IL-8, IL-6, @PROTEIN$, VEGF, IL-1ra, and IL-10 were measured from monocyte/macrophage cultures at different stages of activation and differentiation seeded onto polyethylene, polyurethane, expanded polytetrafluoroethylene, polymethyl methacrylate, and a hydrogel copolymer of @COMPOUND$, 1-vinyl-2-pyrrolidinone, and polyethylene glycol acrylate in tissue culture polystyrene (TCPS) plates.	0	18260130-109
TNF-alpha, MCP-1, @PROTEIN$, IL-8, IL-6, IL-1beta, VEGF, IL-1ra, and IL-10 were measured from monocyte/macrophage cultures at different stages of activation and differentiation seeded onto polyethylene, @COMPOUND$, expanded polytetrafluoroethylene, polymethyl methacrylate, and a hydrogel copolymer of 2-hydroxyethyl methacrylate, 1-vinyl-2-pyrrolidinone, and polyethylene glycol acrylate in tissue culture polystyrene (TCPS) plates.	0	18260130-109
TNF-alpha, MCP-1, MIP-1alpha, IL-8, IL-6, IL-1beta, @PROTEIN$, IL-1ra, and IL-10 were measured from monocyte/macrophage cultures at different stages of activation and differentiation seeded onto polyethylene, polyurethane, expanded polytetrafluoroethylene, polymethyl methacrylate, and a hydrogel copolymer of @COMPOUND$, 1-vinyl-2-pyrrolidinone, and polyethylene glycol acrylate in tissue culture polystyrene (TCPS) plates.	0	18260130-109
TNF-alpha, MCP-1, MIP-1alpha, IL-8, IL-6, IL-1beta, VEGF, IL-1ra, and @PROTEIN$ were measured from monocyte/macrophage cultures at different stages of activation and differentiation seeded onto polyethylene, polyurethane, expanded polytetrafluoroethylene, @COMPOUND$, and a hydrogel copolymer of 2-hydroxyethyl methacrylate, 1-vinyl-2-pyrrolidinone, and polyethylene glycol acrylate in tissue culture polystyrene (TCPS) plates.	0	18260130-109
TNF-alpha, MCP-1, MIP-1alpha, @PROTEIN$, IL-6, IL-1beta, VEGF, IL-1ra, and IL-10 were measured from monocyte/macrophage cultures at different stages of activation and differentiation seeded onto polyethylene, polyurethane, expanded polytetrafluoroethylene, polymethyl methacrylate, and a hydrogel copolymer of 2-hydroxyethyl methacrylate, @COMPOUND$, and polyethylene glycol acrylate in tissue culture polystyrene (TCPS) plates.	0	18260130-109
TNF-alpha, MCP-1, MIP-1alpha, IL-8, @PROTEIN$, IL-1beta, VEGF, IL-1ra, and IL-10 were measured from monocyte/macrophage cultures at different stages of activation and differentiation seeded onto polyethylene, polyurethane, expanded polytetrafluoroethylene, polymethyl methacrylate, and a hydrogel copolymer of @COMPOUND$, 1-vinyl-2-pyrrolidinone, and polyethylene glycol acrylate in tissue culture polystyrene (TCPS) plates.	0	18260130-109
TNF-alpha, MCP-1, MIP-1alpha, IL-8, IL-6, @PROTEIN$, VEGF, IL-1ra, and IL-10 were measured from monocyte/macrophage cultures at different stages of activation and differentiation seeded onto polyethylene, @COMPOUND$, expanded polytetrafluoroethylene, polymethyl methacrylate, and a hydrogel copolymer of 2-hydroxyethyl methacrylate, 1-vinyl-2-pyrrolidinone, and polyethylene glycol acrylate in tissue culture polystyrene (TCPS) plates.	0	18260130-109
@PROTEIN$, MCP-1, MIP-1alpha, IL-8, IL-6, IL-1beta, VEGF, IL-1ra, and IL-10 were measured from monocyte/macrophage cultures at different stages of activation and differentiation seeded onto polyethylene, polyurethane, expanded polytetrafluoroethylene, polymethyl methacrylate, and a hydrogel copolymer of @COMPOUND$, 1-vinyl-2-pyrrolidinone, and polyethylene glycol acrylate in tissue culture polystyrene (TCPS) plates.	0	18260130-109
TNF-alpha, MCP-1, MIP-1alpha, @PROTEIN$, IL-6, IL-1beta, VEGF, IL-1ra, and IL-10 were measured from monocyte/macrophage cultures at different stages of activation and differentiation seeded onto polyethylene, polyurethane, expanded polytetrafluoroethylene, @COMPOUND$, and a hydrogel copolymer of 2-hydroxyethyl methacrylate, 1-vinyl-2-pyrrolidinone, and polyethylene glycol acrylate in tissue culture polystyrene (TCPS) plates.	0	18260130-109
TNF-alpha, @PROTEIN$, MIP-1alpha, IL-8, IL-6, IL-1beta, VEGF, IL-1ra, and IL-10 were measured from monocyte/macrophage cultures at different stages of activation and differentiation seeded onto polyethylene, polyurethane, expanded polytetrafluoroethylene, polymethyl methacrylate, and a hydrogel copolymer of 2-hydroxyethyl methacrylate, @COMPOUND$, and polyethylene glycol acrylate in tissue culture polystyrene (TCPS) plates.	0	18260130-109
TNF-alpha, MCP-1, MIP-1alpha, @PROTEIN$, IL-6, IL-1beta, VEGF, IL-1ra, and IL-10 were measured from monocyte/macrophage cultures at different stages of activation and differentiation seeded onto polyethylene, polyurethane, expanded polytetrafluoroethylene, polymethyl methacrylate, and a hydrogel copolymer of @COMPOUND$, 1-vinyl-2-pyrrolidinone, and polyethylene glycol acrylate in tissue culture polystyrene (TCPS) plates.	0	18260130-109
TNF-alpha, MCP-1, MIP-1alpha, IL-8, @PROTEIN$, IL-1beta, VEGF, IL-1ra, and IL-10 were measured from monocyte/macrophage cultures at different stages of activation and differentiation seeded onto polyethylene, polyurethane, expanded polytetrafluoroethylene, polymethyl methacrylate, and a hydrogel copolymer of 2-hydroxyethyl methacrylate, @COMPOUND$, and polyethylene glycol acrylate in tissue culture polystyrene (TCPS) plates.	0	18260130-109
TNF-alpha, MCP-1, MIP-1alpha, IL-8, IL-6, @PROTEIN$, VEGF, IL-1ra, and IL-10 were measured from monocyte/macrophage cultures at different stages of activation and differentiation seeded onto polyethylene, polyurethane, expanded polytetrafluoroethylene, polymethyl methacrylate, and a hydrogel copolymer of 2-hydroxyethyl methacrylate, 1-vinyl-2-pyrrolidinone, and polyethylene glycol acrylate in tissue culture @COMPOUND$ (TCPS) plates.	0	18260130-109
TNF-alpha, MCP-1, MIP-1alpha, IL-8, IL-6, IL-1beta, VEGF, @PROTEIN$, and IL-10 were measured from monocyte/macrophage cultures at different stages of activation and differentiation seeded onto polyethylene, polyurethane, expanded polytetrafluoroethylene, polymethyl methacrylate, and a hydrogel copolymer of @COMPOUND$, 1-vinyl-2-pyrrolidinone, and polyethylene glycol acrylate in tissue culture polystyrene (TCPS) plates.	0	18260130-109
TNF-alpha, MCP-1, MIP-1alpha, @PROTEIN$, IL-6, IL-1beta, VEGF, IL-1ra, and IL-10 were measured from monocyte/macrophage cultures at different stages of activation and differentiation seeded onto polyethylene, polyurethane, expanded polytetrafluoroethylene, polymethyl methacrylate, and a hydrogel copolymer of 2-hydroxyethyl methacrylate, 1-vinyl-2-pyrrolidinone, and polyethylene glycol acrylate in tissue culture @COMPOUND$ (TCPS) plates.	0	18260130-109
TNF-alpha, MCP-1, @PROTEIN$, IL-8, IL-6, IL-1beta, VEGF, IL-1ra, and IL-10 were measured from monocyte/macrophage cultures at different stages of activation and differentiation seeded onto polyethylene, polyurethane, expanded polytetrafluoroethylene, polymethyl methacrylate, and a hydrogel copolymer of 2-hydroxyethyl methacrylate, 1-vinyl-2-pyrrolidinone, and polyethylene glycol acrylate in tissue culture @COMPOUND$ (TCPS) plates.	0	18260130-109
TNF-alpha, MCP-1, MIP-1alpha, IL-8, IL-6, IL-1beta, VEGF, IL-1ra, and @PROTEIN$ were measured from monocyte/macrophage cultures at different stages of activation and differentiation seeded onto polyethylene, polyurethane, expanded polytetrafluoroethylene, polymethyl methacrylate, and a hydrogel copolymer of @COMPOUND$, 1-vinyl-2-pyrrolidinone, and polyethylene glycol acrylate in tissue culture polystyrene (TCPS) plates.	0	18260130-109
Systemic administration of @PROTEIN$ vesicle elevates tumor tissue @COMPOUND$ tension and modifies tumor response to irradiation.	1	18262559-301
The participation of protein kinase A (PKA), protein kinase C (@PROTEIN$) and protein tyrosine kinase (PTK) in capacitation induced by ONOO (-) was evaluated by incubation with specific inhibitors (50 microM H-89, 0.1 microM @COMPOUND$, and 3 microM genistein, respectively).	0	18262738-416
The participation of @PROTEIN$ (PKA), protein kinase C (PKC) and protein tyrosine kinase (PTK) in capacitation induced by ONOO (-) was evaluated by incubation with specific inhibitors (50 microM H-89, 0.1 microM @COMPOUND$, and 3 microM genistein, respectively).	0	18262738-416
The participation of @PROTEIN$ (PKA), protein kinase C (PKC) and protein tyrosine kinase (PTK) in capacitation induced by @COMPOUND$ (-) was evaluated by incubation with specific inhibitors (50 microM H-89, 0.1 microM bisindolylmaleimide I, and 3 microM genistein, respectively).	0	18262738-416
The participation of protein kinase A (PKA), @PROTEIN$ (PKC) and protein tyrosine kinase (PTK) in capacitation induced by @COMPOUND$ (-) was evaluated by incubation with specific inhibitors (50 microM H-89, 0.1 microM bisindolylmaleimide I, and 3 microM genistein, respectively).	0	18262738-416
The participation of @PROTEIN$ (PKA), protein kinase C (PKC) and protein tyrosine kinase (PTK) in capacitation induced by ONOO (-) was evaluated by incubation with specific inhibitors (50 microM H-89, 0.1 microM bisindolylmaleimide I, and 3 microM @COMPOUND$, respectively).	0	18262738-416
The participation of protein kinase A (PKA), @PROTEIN$ (PKC) and protein tyrosine kinase (PTK) in capacitation induced by ONOO (-) was evaluated by incubation with specific inhibitors (50 microM H-89, 0.1 microM bisindolylmaleimide I, and 3 microM @COMPOUND$, respectively).	0	18262738-416
The participation of protein kinase A (PKA), protein kinase C (@PROTEIN$) and protein tyrosine kinase (PTK) in capacitation induced by @COMPOUND$ (-) was evaluated by incubation with specific inhibitors (50 microM H-89, 0.1 microM bisindolylmaleimide I, and 3 microM genistein, respectively).	0	18262738-416
The participation of protein kinase A (PKA), protein kinase C (@PROTEIN$) and protein tyrosine kinase (PTK) in capacitation induced by ONOO (-) was evaluated by incubation with specific inhibitors (50 microM H-89, 0.1 microM bisindolylmaleimide I, and 3 microM @COMPOUND$, respectively).	0	18262738-416
The participation of protein kinase A (PKA), @PROTEIN$ (PKC) and protein tyrosine kinase (PTK) in capacitation induced by ONOO (-) was evaluated by incubation with specific inhibitors (50 microM H-89, 0.1 microM @COMPOUND$, and 3 microM genistein, respectively).	0	18262738-416
At the time, @PROTEIN$ activity was significantly inhibited and gamma-glutamyl @COMPOUND$ increased by ACA exposure.	0	18266054-1214
The effect of the polymorphism is non-conservative and results in a glutamine to @COMPOUND$ change (Gln460Arg), which is likely to affect @PROTEIN$ dimerization and protein-protein interactions.	1	18268501-1260
The effect of the polymorphism is non-conservative and results in a @COMPOUND$ to arginine change (Gln460Arg), which is likely to affect @PROTEIN$ dimerization and protein-protein interactions.	1	18268501-1260
Increased @COMPOUND$ tone and decreased @PROTEIN$ concentrations may also contribute to reduced GH levels.	0	18270841-348
Inhibition of LTP by beta-amyloid is prevented by activation of @PROTEIN$ and stimulation of the @COMPOUND$/PKA signalling pathway.	0	18272254-1258
) @COMPOUND$ (-) and H2O2 in H. plumaeforme was respectively related to the low activity of @PROTEIN$ and the decreased activity of CAT.	1	18274872-320
) O2 (-) and @COMPOUND$ in H. plumaeforme was respectively related to the low activity of SOD and the decreased activity of @PROTEIN$.	1	18274872-320
) O2 (-) and @COMPOUND$ in H. plumaeforme was respectively related to the low activity of @PROTEIN$ and the decreased activity of CAT.	1	18274872-320
) @COMPOUND$ (-) and H2O2 in H. plumaeforme was respectively related to the low activity of SOD and the decreased activity of @PROTEIN$.	1	18274872-320
A novel oligodeoxynuleotides containing 11 @COMPOUND$ motifs was synthesized and inserted into the VR1020 plasmid containing pig @PROTEIN$ (IL-6) gene (VPIL6) to construct recombinant plasmid, VPIL6C.	0	18279956-684
A novel oligodeoxynuleotides containing 11 @COMPOUND$ motifs was synthesized and inserted into the VR1020 plasmid containing pig interleukin-6 (@PROTEIN$) gene (VPIL6) to construct recombinant plasmid, VPIL6C.	0	18279956-684
Furthermore, it has also been reported that @COMPOUND$-treated pigs significantly increase mean arterial blood pressure compared with controls and that the decrease in @PROTEIN$ synthesis and release contributes to the elevated blood pressure.	1	18280595-101
Since then, the efforts of numerous investigators have led to the following conclusions: (a) This enzyme is indeed the molecular machine for the @COMPOUND$-dependent and-coupled transport of Na (+) and K(+) across the plasma membrane of a living cell in which such a process (@PROTEIN$) is detected.	1	18283487-569
Since then, the efforts of numerous investigators have led to the following conclusions: (a) This enzyme is indeed the molecular machine for the ATP-dependent and-coupled transport of @COMPOUND$ (+) and K(+) across the plasma membrane of a living cell in which such a process (@PROTEIN$) is detected.	1	18283487-569
Affinity electrophoresis analysis provided evidence that carboxymethylated dextran polymers grafted with high amounts of @COMPOUND$ groups (named DMCB) interact with @PROTEIN$.	1	18286621-29
Affinity electrophoresis analysis provided evidence that carboxymethylated @COMPOUND$ polymers grafted with high amounts of benzylamide groups (named DMCB) interact with @PROTEIN$.	1	18286621-29
A screening study provided evidence that the potentiating effects of the dextran derivatives on the BMP-2-induced @PROTEIN$ activity improved with their @COMPOUND$ groups content and, therefore, with their affinity for the growth factor.	1	18286621-30
A screening study provided evidence that the potentiating effects of the @COMPOUND$ derivatives on the @PROTEIN$-induced alkaline phosphatase activity improved with their benzylamide groups content and, therefore, with their affinity for the growth factor.	1	18286621-30
A screening study provided evidence that the potentiating effects of the @COMPOUND$ derivatives on the BMP-2-induced @PROTEIN$ activity improved with their benzylamide groups content and, therefore, with their affinity for the growth factor.	1	18286621-30
A screening study provided evidence that the potentiating effects of the dextran derivatives on the @PROTEIN$-induced alkaline phosphatase activity improved with their @COMPOUND$ groups content and, therefore, with their affinity for the growth factor.	1	18286621-30
Since @COMPOUND$ is metabolized through @PROTEIN$, we genotyped six genetic polymorphisms previously described in poor metabolizers but could not confirm these pharmacogenetic bases in this case.	1	18294936-104
Mitochondrial dysfunction was associated with higher levels of reactive @COMPOUND$ species, an altered Bcl-xL/Bax ratio and reduction of @PROTEIN$ IV activity.	0	18295378-334
Mitochondrial dysfunction was associated with higher levels of reactive @COMPOUND$ species, an altered Bcl-xL/@PROTEIN$ ratio and reduction of COX IV activity.	0	18295378-334
Peripheral venous levels of @COMPOUND$, @PROTEIN$, follicle stimulating hormone (FSH), luteinizing hormone (LH), thyroid stimulating hormone (TSH), malondialdehyde and glycosylated haemoglobin (HbA(1)c) were obtained in all subjects.	0	18298568-1058
Peripheral venous levels of testosterone, @PROTEIN$, follicle stimulating hormone (FSH), luteinizing hormone (LH), thyroid stimulating hormone (TSH), @COMPOUND$ and glycosylated haemoglobin (HbA(1)c) were obtained in all subjects.	0	18298568-1058
Our results showed that @PROTEIN$ abolished the effect of the oxidant, protecting spermatozoa against reactive @COMPOUND$ species, and improving both sperm motility and chromatin status during incubation.	1	18298570-1059
Intranasal and intravenous administration of live Cpn and Aa, respectively induced an accumulation of activated mast cells in the aortic sinus of apolipoprotein E-deficient mice, however, with varying responses in the systemic levels of @COMPOUND$ (LPS) and @PROTEIN$.	0	18298659-1127
@PROTEIN$ and two additional catalase isozymes were induced by @COMPOUND$ or bensulfuron-methyl in S. maltophilia WZ2, but not in E. coli K12.	1	18304632-1001
MnSOD and two additional @PROTEIN$ isozymes were induced by @COMPOUND$ or bensulfuron-methyl in S. maltophilia WZ2, but not in E. coli K12.	1	18304632-1001
@PROTEIN$ and two additional catalase isozymes were induced by quinclorac or @COMPOUND$ in S. maltophilia WZ2, but not in E. coli K12.	1	18304632-1001
MnSOD and two additional @PROTEIN$ isozymes were induced by quinclorac or @COMPOUND$ in S. maltophilia WZ2, but not in E. coli K12.	1	18304632-1001
Results indicate that @PROTEIN$ has a much weakly role in the defense against @COMPOUND$ or bensulfuron-methyl induced oxidative stress, whereas SOD could be critical.	1	18304632-1002
Results indicate that catalase has a much weakly role in the defense against quinclorac or @COMPOUND$ induced oxidative stress, whereas @PROTEIN$ could be critical.	1	18304632-1002
Results indicate that @PROTEIN$ has a much weakly role in the defense against quinclorac or @COMPOUND$ induced oxidative stress, whereas SOD could be critical.	1	18304632-1002
Results indicate that catalase has a much weakly role in the defense against @COMPOUND$ or bensulfuron-methyl induced oxidative stress, whereas @PROTEIN$ could be critical.	1	18304632-1002
Moreover, @PROTEIN$ (except gamma4) reduce the ion channel block by the synthetic Joro spider toxin analog @COMPOUND$ (NASP).	1	18304748-1077
Moreover, @PROTEIN$ (except gamma4) reduce the ion channel block by the synthetic @COMPOUND$ analog 1-naphthylacetyl spermine (NASP).	0	18304748-1077
SMC cultured on P(100/0) films modified by covalently attached @PROTEIN$ or fibrin layers proliferated at a rate comparable to that observed on control tissue culture @COMPOUND$.	0	18306310-763
However, prewetting P(70/30) with a @COMPOUND$ buffer prior to aminolysis significantly improved cell numbers following immobilization of @PROTEIN$.	0	18306310-764
The dose of @PROTEIN$ (2.5 microg/kg) was chosen to mimic the @COMPOUND$ concentrations seen during mixing of unfamiliar sows.	0	18308488-862
Our data suggest HumDN1 genotypes are related to total @COMPOUND$ levels in Han Chinese MI patients, but @PROTEIN$ gene polymorphisms are not associated with susceptibility to MI in Han Chinese.	0	18311594-236
Specifically, @COMPOUND$ was shown to alter S. mutans gene expression levels of gtfB, a known virulence factor, and yfiV, a putative @PROTEIN$ of cell-surface fatty acid genes.	1	18314895-1018
Specifically, @COMPOUND$ was shown to alter S. mutans gene expression levels of @PROTEIN$, a known virulence factor, and yfiV, a putative transcriptional regulator of cell-surface fatty acid genes.	1	18314895-1018
Degradation analysis over 8 weeks in the presence of 10 mg/L @PROTEIN$ showed a 50% decrease in total weight and an 80% decrease in @COMPOUND$ molecular weight.	1	18314898-1022
Fluo-3 staining used in flow cytometry and video microscopy revealed an oxysterol-induced @COMPOUND$+) influx, varying according to the oxysterol studied, leading to the activation of the MEK/@PROTEIN$/2 pathway as demonstrated by Western blot analysis.	1	18317936-346
"To determine if response to endocrine therapy of breast cancer can be predicted by either a metabolic ""flare reaction"" detected by positron emission tomography (PET) with 2-((18)F)-fluoro-@COMPOUND$ (FDG), induced by an estradiol challenge, or by @PROTEIN$ (ER) status, determined by PET with the estrogen analog 16alpha-((18)F)fluoroestradiol-17beta (FES)."	0	18327670-82
"To determine if response to endocrine therapy of breast cancer can be predicted by either a metabolic ""flare reaction"" detected by positron emission tomography (PET) with 2-((18)F)-fluoro-2-deoxyglucose (FDG), induced by an @COMPOUND$ challenge, or by @PROTEIN$ (ER) status, determined by PET with the estrogen analog 16alpha-((18)F)fluoroestradiol-17beta (FES)."	0	18327670-82
Depletion of @COMPOUND$ levels was accompanied by the induction of @PROTEIN$ (GR) after 24h exposure with each of the four carbamates to CHO-K1 cells.	1	18328561-582
@COMPOUND$ and wortmannin inhibited the upregulation induced by @PROTEIN$ stimulation and amino acid deprivation but not that induced by osmotic shock.	1	18330498-512
Chloroquine and @COMPOUND$ inhibited the upregulation induced by @PROTEIN$ stimulation and amino acid deprivation but not that induced by osmotic shock.	1	18330498-512
Moreover, PD98059 and SP600125 inhibited only amino acid deprivation-induced upregulation and @COMPOUND$ inhibited only @PROTEIN$-induced upregulation.	1	18330498-513
Moreover, PD98059 and @COMPOUND$ inhibited only amino acid deprivation-induced upregulation and SB202190 inhibited only @PROTEIN$-induced upregulation.	0	18330498-513
Moreover, @COMPOUND$ and SP600125 inhibited only amino acid deprivation-induced upregulation and SB202190 inhibited only @PROTEIN$-induced upregulation.	0	18330498-513
The role of phosphorylated @PROTEIN$ (p-Akt) in oral carcinogenesis induced by @COMPOUND$ and alkaline environments was investigated.	0	18331557-1201
Sera from a population sample of infants with cryptorchidism (n = 43), hypospadias (n = 41) and controls (n = 113) were analyzed for inhibin B, anti-Mllerian hormone (@PROTEIN$), @COMPOUND$, luteinizing hormone (LH), follicle stimulating hormone (FSH) and sex hormone binding globulin (SHBG).	0	18336537-456
Sera from a population sample of infants with cryptorchidism (n = 43), hypospadias (n = 41) and controls (n = 113) were analyzed for inhibin B, anti-Mllerian hormone (AMH), @COMPOUND$, luteinizing hormone (LH), follicle stimulating hormone (FSH) and sex hormone binding globulin (@PROTEIN$).	0	18336537-456
Myeloperoxidase (@PROTEIN$) is an endogenous oxidant enzyme that generates reactive @COMPOUND$ species (ROS).	1	18340529-389
In present study, we investigated the combined effect of @COMPOUND$ and baicalin on pancreatic damage and pancreatitis associated lung injury, as well as tissue @PROTEIN$ expression in the setting of AP.	0	18343629-1064
In present study, we investigated the combined effect of emodin and @COMPOUND$ on pancreatic damage and pancreatitis associated lung injury, as well as tissue @PROTEIN$ expression in the setting of AP.	0	18343629-1064
The results showed that combination of emodin and @COMPOUND$ significantly reduced serum amylase, tumor necrosis factor-alpha and interleukin-6, attenuated pancreatic and pulmonary damage, also suppressed @PROTEIN$ expression in pancreas and lung.	1	18343629-1065
The results showed that combination of @COMPOUND$ and baicalin significantly reduced serum amylase, tumor necrosis factor-alpha and interleukin-6, attenuated pancreatic and pulmonary damage, also suppressed @PROTEIN$ expression in pancreas and lung.	1	18343629-1065
The results showed that combination of @COMPOUND$ and baicalin significantly reduced serum amylase, @PROTEIN$-alpha and interleukin-6, attenuated pancreatic and pulmonary damage, also suppressed TLR4 expression in pancreas and lung.	1	18343629-1065
The results showed that combination of emodin and @COMPOUND$ significantly reduced serum amylase, tumor necrosis factor-alpha and @PROTEIN$, attenuated pancreatic and pulmonary damage, also suppressed TLR4 expression in pancreas and lung.	1	18343629-1065
The results showed that combination of @COMPOUND$ and baicalin significantly reduced serum amylase, tumor necrosis factor-alpha and @PROTEIN$, attenuated pancreatic and pulmonary damage, also suppressed TLR4 expression in pancreas and lung.	1	18343629-1065
The results showed that combination of emodin and @COMPOUND$ significantly reduced serum amylase, @PROTEIN$-alpha and interleukin-6, attenuated pancreatic and pulmonary damage, also suppressed TLR4 expression in pancreas and lung.	1	18343629-1065
Results showed that a moderate dose of leptin (250 microg/kg body weight/day) injected during the re-feeding period: (i) promoted the recovery of the regressed ovary as evidenced by an increase in ovary weight and recovery of yellow hierarchical follicles; (ii) elevated the plasma @COMPOUND$ (E(2)) level; (iii) increased the mRNA levels of ovary follicle-stimulating hormone receptor (FSHR), luteinizing hormone receptor (@PROTEIN$) and estrogen receptor-beta (ER-beta).	0	18346857-498
Results showed that a moderate dose of leptin (250 microg/kg body weight/day) injected during the re-feeding period: (i) promoted the recovery of the regressed ovary as evidenced by an increase in ovary weight and recovery of yellow hierarchical follicles; (ii) elevated the plasma @COMPOUND$ (E(2)) level; (iii) increased the mRNA levels of ovary follicle-stimulating hormone receptor (FSHR), luteinizing hormone receptor (LHR) and @PROTEIN$ (ER-beta).	0	18346857-498
Results showed that a moderate dose of leptin (250 microg/kg body weight/day) injected during the re-feeding period: (i) promoted the recovery of the regressed ovary as evidenced by an increase in ovary weight and recovery of yellow hierarchical follicles; (ii) elevated the plasma @COMPOUND$ (E(2)) level; (iii) increased the mRNA levels of ovary follicle-stimulating hormone receptor (FSHR), @PROTEIN$ (LHR) and estrogen receptor-beta (ER-beta).	0	18346857-498
Results showed that a moderate dose of leptin (250 microg/kg body weight/day) injected during the re-feeding period: (i) promoted the recovery of the regressed ovary as evidenced by an increase in ovary weight and recovery of yellow hierarchical follicles; (ii) elevated the plasma @COMPOUND$ (E(2)) level; (iii) increased the mRNA levels of ovary follicle-stimulating hormone receptor (FSHR), luteinizing hormone receptor (LHR) and estrogen receptor-beta (@PROTEIN$).	0	18346857-498
Results showed that a moderate dose of leptin (250 microg/kg body weight/day) injected during the re-feeding period: (i) promoted the recovery of the regressed ovary as evidenced by an increase in ovary weight and recovery of yellow hierarchical follicles; (ii) elevated the plasma @COMPOUND$ (E(2)) level; (iii) increased the mRNA levels of ovary follicle-stimulating hormone receptor (@PROTEIN$), luteinizing hormone receptor (LHR) and estrogen receptor-beta (ER-beta).	0	18346857-498
Results showed that a moderate dose of @PROTEIN$ (250 microg/kg body weight/day) injected during the re-feeding period: (i) promoted the recovery of the regressed ovary as evidenced by an increase in ovary weight and recovery of yellow hierarchical follicles; (ii) elevated the plasma @COMPOUND$ (E(2)) level; (iii) increased the mRNA levels of ovary follicle-stimulating hormone receptor (FSHR), luteinizing hormone receptor (LHR) and estrogen receptor-beta (ER-beta).	1	18346857-498
The anti-neoplastic drug @COMPOUND$ binds to @PROTEIN$ to prevent tumor cell division, promoting cell death.	1	18357521-771
In the current study, we knocked down @PROTEIN$ expression using cognate siRNA during low-dose @COMPOUND$ treatment to induce apoptosis in two human glioblastoma U138MG and U251MG cell lines.	1	18357521-772
The cells were treated with either 100 nM @COMPOUND$ or 100 nM Bcl-2 siRNA or both for 72 h. Immunofluorescent stainings for calpain and active caspase-3 showed increases in expression and co-localization of these @PROTEIN$ in apoptotic cells.	1	18357521-773
Our current study demonstrated that Bcl-2 siRNA significantly augmented @COMPOUND$ mediated apoptosis in different human glioblastoma cells through induction of @PROTEIN$ and caspase proteolytic activities.	1	18357521-774
Based on these findings, altered expression of @PROTEIN$ in most areas of the striatum suggests that widespread changes to the myelin structure could be associated with the adaptive changes following chronic @COMPOUND$ abuse.	1	18357522-775
No correlation was detected between serum @PROTEIN$ level and @COMPOUND$-25(OH)D3, which was under normal range in 60% of the patients.	0	18359113-478
The higher @PROTEIN$ levels in women was accompanied by higher serum levels of glucose, albumin, Ca, @COMPOUND$, Na and FT4.	1	18359113-479
The higher @PROTEIN$ levels in women was accompanied by higher serum levels of glucose, albumin, Ca, cholesterol, @COMPOUND$ and FT4.	1	18359113-479
The higher @PROTEIN$ levels in women was accompanied by higher serum levels of @COMPOUND$, albumin, Ca, cholesterol, Na and FT4.	1	18359113-479
Comparison of 50 patients with the lowest @PROTEIN$ levels (mean of 3.4ng/ml) to 50 patients with highest leptin levels (mean of 34ng/ml), did not indicate differences in both @COMPOUND$ and ICTP between these two populations in spite of the highly significant difference in leptin levels.	0	18359113-480
The effects on the early secretory pathway in HEK293 cells were: reduction of the rate of ER-to-Golgi transport of the vesicular stomatitis virus glycoprotein (VSVG), slowed accumulation of a Golgi marker plasmid in pre-Golgi structures after @COMPOUND$ treatment and inhibition of cargo concentration of the neuronal glutamate transporter @PROTEIN$ (EAAC1) into transpor complexes in HEK293 cells, an effect that could be completely reversed in the presence of an excess of Rab1.	0	18363836-902
The effects on the early secretory pathway in HEK293 cells were: reduction of the rate of ER-to-Golgi transport of the vesicular stomatitis virus @PROTEIN$ (VSVG), slowed accumulation of a Golgi marker plasmid in pre-Golgi structures after @COMPOUND$ treatment and inhibition of cargo concentration of the neuronal glutamate transporter excitatory amino-acid carrier 1 (EAAC1) into transpor complexes in HEK293 cells, an effect that could be completely reversed in the presence of an excess of Rab1.	0	18363836-902
The effects on the early secretory pathway in HEK293 cells were: reduction of the rate of ER-to-Golgi transport of the vesicular stomatitis virus glycoprotein (VSVG), slowed accumulation of a Golgi marker plasmid in pre-Golgi structures after @COMPOUND$ treatment and inhibition of cargo concentration of the neuronal glutamate transporter excitatory amino-acid carrier 1 (EAAC1) into transpor complexes in HEK293 cells, an effect that could be completely reversed in the presence of an excess of @PROTEIN$.	0	18363836-902
The effects on the early secretory pathway in HEK293 cells were: reduction of the rate of ER-to-Golgi transport of the vesicular stomatitis virus glycoprotein (VSVG), slowed accumulation of a Golgi marker plasmid in pre-Golgi structures after @COMPOUND$ treatment and inhibition of cargo concentration of the neuronal glutamate transporter excitatory amino-acid carrier 1 (@PROTEIN$) into transpor complexes in HEK293 cells, an effect that could be completely reversed in the presence of an excess of Rab1.	0	18363836-902
Resveratrol did not attenuate GA-induced generation of @COMPOUND$, but it did block GA-induced phosphorylation of connexin 43 (@PROTEIN$), a key modulator of GJIC.	0	18367388-537
@COMPOUND$ did not attenuate GA-induced generation of hydrogen peroxide, but it did block GA-induced phosphorylation of connexin 43 (@PROTEIN$), a key modulator of GJIC.	1	18367388-537
Resveratrol did not attenuate GA-induced generation of @COMPOUND$, but it did block GA-induced phosphorylation of @PROTEIN$ (Cx43), a key modulator of GJIC.	0	18367388-537
@COMPOUND$ did not attenuate GA-induced generation of hydrogen peroxide, but it did block GA-induced phosphorylation of @PROTEIN$ (Cx43), a key modulator of GJIC.	1	18367388-537
Furthermore, @COMPOUND$ down-regulated GA-induced phosphorylation of extracellular signal-regulated kinase (@PROTEIN$)1/2, one of the critical regulators of Cx43.	1	18367388-538
Furthermore, @COMPOUND$ down-regulated GA-induced phosphorylation of extracellular signal-regulated kinase (ERK)1/2, one of the critical regulators of @PROTEIN$.	1	18367388-538
@COMPOUND$ accumulated cells in S phase of the cell cycle and reduced @PROTEIN$ expression.	1	18368465-1220
Indeed, treatment of cells with 1 muM @COMPOUND$ (ATRA) or 1 muM 13-cis retinoic acid (13-CRA) for 7 days induced astrocytic differentiation with upregulation of glial fibrillary @PROTEIN$ (GFAP) and down regulation of telomerase activity.	1	18368485-1240
Indeed, treatment of cells with 1 muM all-trans @COMPOUND$ (ATRA) or 1 muM 13-cis retinoic acid (13-CRA) for 7 days induced astrocytic differentiation with upregulation of glial fibrillary acidic protein (@PROTEIN$) and down regulation of telomerase activity.	1	18368485-1240
Indeed, treatment of cells with 1 muM @COMPOUND$ (ATRA) or 1 muM 13-cis retinoic acid (13-CRA) for 7 days induced astrocytic differentiation with upregulation of glial fibrillary acidic protein (@PROTEIN$) and down regulation of telomerase activity.	1	18368485-1240
Indeed, treatment of cells with 1 muM all-trans retinoic acid (@COMPOUND$) or 1 muM 13-cis retinoic acid (13-CRA) for 7 days induced astrocytic differentiation with upregulation of glial fibrillary @PROTEIN$ (GFAP) and down regulation of telomerase activity.	1	18368485-1240
Indeed, treatment of cells with 1 muM all-trans @COMPOUND$ (ATRA) or 1 muM 13-cis retinoic acid (13-CRA) for 7 days induced astrocytic differentiation with upregulation of glial fibrillary @PROTEIN$ (GFAP) and down regulation of telomerase activity.	1	18368485-1240
Indeed, treatment of cells with 1 muM all-trans retinoic acid (@COMPOUND$) or 1 muM 13-cis retinoic acid (13-CRA) for 7 days induced astrocytic differentiation with upregulation of glial fibrillary acidic protein (@PROTEIN$) and down regulation of telomerase activity.	1	18368485-1240
Wright staining and ApopTag assay showed, respectively, morphological and biochemical features of apoptosis in glioblastoma cells following exposure to 200 units/ml @PROTEIN$ for 48 h. Induction of differentiation was associated with decreases in levels of nuclear factor kappa B (NFkappaB), inducible @COMPOUND$ synthase (iNOS), and production of nitric oxide (NO) so as to increase sensitivity to IFN-gamma for apoptosis.	0	18368485-1241
Wright staining and ApopTag assay showed, respectively, morphological and biochemical features of apoptosis in glioblastoma cells following exposure to 200 units/ml IFN-gamma for 48 h. Induction of differentiation was associated with decreases in levels of nuclear factor kappa B (NFkappaB), inducible @COMPOUND$ synthase (@PROTEIN$), and production of nitric oxide (NO) so as to increase sensitivity to IFN-gamma for apoptosis.	0	18368485-1241
Because @PROTEIN$ binds @COMPOUND$, this study is using this feature to select functional spermatozoa.	1	18371961-849
@COMPOUND$) promotes cytoprotection by activating @PROTEIN$-mediated up-regulation of antioxidant defence.	1	18373731-672
Here, we addressed this issue and found that @COMPOUND$) triggered nuclear accumulation of @PROTEIN$ (Nrf2), a transcription factor that up-regulates antioxidant-/electrophile-responsive element (ARE-EpRE)-related genes, in PC12 cells.	1	18373731-674
Here, we addressed this issue and found that @COMPOUND$) triggered nuclear accumulation of NF-E2-related factor-2 (@PROTEIN$), a transcription factor that up-regulates antioxidant-/electrophile-responsive element (ARE-EpRE)-related genes, in PC12 cells.	1	18373731-674
In women, @PROTEIN$ levels were higher in individuals with diagnosed ischemic heart disease (IHD) and increased with triglycerides (TG) and @COMPOUND$ level.	0	18374997-195
To investigate overnight variations in absolute values and patterns of cytokines including interleukin 6 (@PROTEIN$) and tumour necrosis factor alpha (TNFalpha) in rheumatoid arthritis (RA), and to relate any changes to those occurring in blood @COMPOUND$.	0	18375536-500
To investigate overnight variations in absolute values and patterns of cytokines including interleukin 6 (IL6) and tumour necrosis factor alpha (@PROTEIN$) in rheumatoid arthritis (RA), and to relate any changes to those occurring in blood @COMPOUND$.	0	18375536-500
To investigate overnight variations in absolute values and patterns of cytokines including @PROTEIN$ (IL6) and tumour necrosis factor alpha (TNFalpha) in rheumatoid arthritis (RA), and to relate any changes to those occurring in blood @COMPOUND$.	0	18375536-500
Using a cell culture model of synaptic NMDA receptor-dependent synaptic potentiation, we find that this is mediated exclusively by NR2B-containing @PROTEIN$, as implicated by NR2B-specific antagonists and the use of selective vs. non-selective doses of the NR2A-preferring antagonist @COMPOUND$-AAM077.	1	18378405-1044
@COMPOUND$ protects against doxorubicin-induced cardiomyopathy: upregulation of @PROTEIN$ and Erk phosphorylation in a rat model.	1	18379782-593
Intracellular oxidative status was assessed by analysis of @COMPOUND$/GSSG levels and time course of ROS production and @PROTEIN$ (GR) activity.	0	18380536-252
Intracellular oxidative status was assessed by analysis of GSH/@COMPOUND$ levels and time course of ROS production and @PROTEIN$ (GR) activity.	0	18380536-252
A recently discussed cardiovascular risk factor, asymmetric dimethylarginine (@COMPOUND$), is known to act as an endogenous inhibitor of endothelial @PROTEIN$.	1	18380539-1099
A recently discussed cardiovascular risk factor, @COMPOUND$ (ADMA), is known to act as an endogenous inhibitor of endothelial @PROTEIN$.	1	18380539-1099
The net exercise-induced increase in 6-keto-PGF (1alpha) concentration, expressed as the difference between the end-exercise minus pre-exercise concentration positively correlated with VO(2max) (r=0.78, p=0.004) as well as with the net VO(2) increase at exhaustion (r=0.81, p=0.003), but not with other respiratory, cardiac, metabolic or inflammatory parameters of the exercise (minute ventilation, heart rate, plasma @COMPOUND$, IL-6 or @PROTEIN$ concentrations).	0	18380542-1100
The net exercise-induced increase in 6-keto-PGF (1alpha) concentration, expressed as the difference between the end-exercise minus pre-exercise concentration positively correlated with VO(2max) (r=0.78, p=0.004) as well as with the net VO(2) increase at exhaustion (r=0.81, p=0.003), but not with other respiratory, cardiac, metabolic or inflammatory parameters of the exercise (minute ventilation, heart rate, plasma @COMPOUND$, @PROTEIN$ or TNF-alpha concentrations).	0	18380542-1100
The net exercise-induced increase in 6-keto-@PROTEIN$ (1alpha) concentration, expressed as the difference between the end-exercise minus pre-exercise concentration positively correlated with VO(2max) (r=0.78, p=0.004) as well as with the net VO(2) increase at exhaustion (r=0.81, p=0.003), but not with other respiratory, cardiac, metabolic or inflammatory parameters of the exercise (minute ventilation, heart rate, plasma @COMPOUND$, IL-6 or TNF-alpha concentrations).	0	18380542-1100
Adenosine A(3) receptor agonist N(6)-(3-iodobenzyl) adenosine-5 '-N-methyluronamide (@COMPOUND$) has been tested from the point of view of potentiating the effects of hematopoietic growth factors interleukin-3 (IL-3), stem cell factor (SCF), @PROTEIN$ (GM-CSF), and granulocyte colony-stimulating factor (G-CSF) on the growth of hematopoietic progenitor cells for granulocytes and macrophages (GM-CFC) in suspension of normal mouse bone marrow cells in vitro.	0	18380545-1104
Adenosine A(3) receptor agonist N(6)-(3-iodobenzyl) adenosine-5 '-N-methyluronamide (@COMPOUND$) has been tested from the point of view of potentiating the effects of @PROTEIN$ interleukin-3 (IL-3), stem cell factor (SCF), granulocyte-macrophage colony-stimulating factor (GM-CSF), and granulocyte colony-stimulating factor (G-CSF) on the growth of hematopoietic progenitor cells for granulocytes and macrophages (GM-CFC) in suspension of normal mouse bone marrow cells in vitro.	0	18380545-1104
Adenosine A(3) receptor agonist N(6)-(3-iodobenzyl) adenosine-5 '-N-methyluronamide (@COMPOUND$) has been tested from the point of view of potentiating the effects of hematopoietic growth factors interleukin-3 (IL-3), stem cell factor (SCF), granulocyte-macrophage colony-stimulating factor (GM-CSF), and granulocyte colony-stimulating factor (@PROTEIN$) on the growth of hematopoietic progenitor cells for granulocytes and macrophages (GM-CFC) in suspension of normal mouse bone marrow cells in vitro.	0	18380545-1104
Adenosine A(3) receptor agonist N(6)-(3-iodobenzyl) adenosine-5 '-N-methyluronamide (@COMPOUND$) has been tested from the point of view of potentiating the effects of hematopoietic growth factors interleukin-3 (IL-3), stem cell factor (SCF), granulocyte-macrophage colony-stimulating factor (GM-CSF), and @PROTEIN$ (G-CSF) on the growth of hematopoietic progenitor cells for granulocytes and macrophages (GM-CFC) in suspension of normal mouse bone marrow cells in vitro.	0	18380545-1104
Adenosine A(3) receptor agonist N(6)-(3-iodobenzyl) adenosine-5 '-N-methyluronamide (@COMPOUND$) has been tested from the point of view of potentiating the effects of hematopoietic growth factors interleukin-3 (@PROTEIN$), stem cell factor (SCF), granulocyte-macrophage colony-stimulating factor (GM-CSF), and granulocyte colony-stimulating factor (G-CSF) on the growth of hematopoietic progenitor cells for granulocytes and macrophages (GM-CFC) in suspension of normal mouse bone marrow cells in vitro.	0	18380545-1104
Adenosine A(3) receptor agonist N(6)-(3-iodobenzyl) adenosine-5 '-N-methyluronamide (@COMPOUND$) has been tested from the point of view of potentiating the effects of hematopoietic growth factors interleukin-3 (IL-3), stem cell factor (@PROTEIN$), granulocyte-macrophage colony-stimulating factor (GM-CSF), and granulocyte colony-stimulating factor (G-CSF) on the growth of hematopoietic progenitor cells for granulocytes and macrophages (GM-CFC) in suspension of normal mouse bone marrow cells in vitro.	0	18380545-1104
Adenosine A(3) receptor agonist N(6)-(3-iodobenzyl) adenosine-5 '-N-methyluronamide (@COMPOUND$) has been tested from the point of view of potentiating the effects of hematopoietic growth factors interleukin-3 (IL-3), @PROTEIN$ (SCF), granulocyte-macrophage colony-stimulating factor (GM-CSF), and granulocyte colony-stimulating factor (G-CSF) on the growth of hematopoietic progenitor cells for granulocytes and macrophages (GM-CFC) in suspension of normal mouse bone marrow cells in vitro.	0	18380545-1104
Adenosine A(3) receptor agonist N(6)-(3-iodobenzyl) adenosine-5 '-N-methyluronamide (@COMPOUND$) has been tested from the point of view of potentiating the effects of hematopoietic growth factors interleukin-3 (IL-3), stem cell factor (SCF), granulocyte-macrophage colony-stimulating factor (@PROTEIN$), and granulocyte colony-stimulating factor (G-CSF) on the growth of hematopoietic progenitor cells for granulocytes and macrophages (GM-CFC) in suspension of normal mouse bone marrow cells in vitro.	0	18380545-1104
Significant elevation of numbers of GM-CFC evoked by the combinations of @COMPOUND$ with IL-3, @PROTEIN$, or GM-CSF as compared with these growth factors alone has been noted.	0	18380545-1105
Significant elevation of numbers of GM-CFC evoked by the combinations of @COMPOUND$ with @PROTEIN$, SCF, or GM-CSF as compared with these growth factors alone has been noted.	0	18380545-1105
Combination of @COMPOUND$ with @PROTEIN$ did not induce significantly higher numbers of GM-CFC in comparison with G-CSF alone.	0	18380545-1106
Joint action of three drugs, namely of @COMPOUND$+ IL-3+ @PROTEIN$, produced significantly higher numbers of GM-CFC in comparison with the combinations of IB-MECA+ IL-3, IB-MECA+ GM-CSF, or IL-3+ GM-CSF.	0	18380545-1107
Joint action of three drugs, namely of @COMPOUND$+ @PROTEIN$+ GM-CSF, produced significantly higher numbers of GM-CFC in comparison with the combinations of IB-MECA+ IL-3, IB-MECA+ GM-CSF, or IL-3+ GM-CSF.	0	18380545-1107
Rabbit marrow mesenchymal stem cells (MSCs) and gelatin microparticles (MPs) loaded with insulin-like growth factor-1 (IGF-1), transforming growth factor-beta1 (@PROTEIN$), or a combination of both growth factors were mixed with OPF, a poly(ethylene glycol)-diacrylate crosslinker and the radical initiators ammonium persulfate and @COMPOUND$, and then crosslinked at 37 degrees C for 8 min to form hydrogel composites.	0	18381637-476
Rabbit marrow mesenchymal stem cells (MSCs) and gelatin microparticles (MPs) loaded with insulin-like growth factor-1 (@PROTEIN$), transforming growth factor-beta1 (TGF-beta1), or a combination of both growth factors were mixed with OPF, a poly(ethylene glycol)-diacrylate crosslinker and the radical initiators ammonium persulfate and @COMPOUND$, and then crosslinked at 37 degrees C for 8 min to form hydrogel composites.	0	18381637-476
Rabbit marrow mesenchymal stem cells (MSCs) and gelatin microparticles (MPs) loaded with insulin-like growth factor-1 (IGF-1), transforming growth factor-beta1 (@PROTEIN$), or a combination of both growth factors were mixed with OPF, a @COMPOUND$ crosslinker and the radical initiators ammonium persulfate and N,N,N',N'-tetramethylethylenediamine, and then crosslinked at 37 degrees C for 8 min to form hydrogel composites.	0	18381637-476
Rabbit marrow mesenchymal stem cells (MSCs) and gelatin microparticles (MPs) loaded with @PROTEIN$-like growth factor-1 (IGF-1), transforming growth factor-beta1 (TGF-beta1), or a combination of both growth factors were mixed with OPF, a poly(ethylene glycol)-diacrylate crosslinker and the radical initiators ammonium persulfate and @COMPOUND$, and then crosslinked at 37 degrees C for 8 min to form hydrogel composites.	0	18381637-476
Rabbit marrow mesenchymal stem cells (MSCs) and gelatin microparticles (MPs) loaded with insulin-like growth factor-1 (@PROTEIN$), transforming growth factor-beta1 (TGF-beta1), or a combination of both growth factors were mixed with OPF, a @COMPOUND$ crosslinker and the radical initiators ammonium persulfate and N,N,N',N'-tetramethylethylenediamine, and then crosslinked at 37 degrees C for 8 min to form hydrogel composites.	0	18381637-476
Rabbit marrow mesenchymal stem cells (MSCs) and gelatin microparticles (MPs) loaded with @PROTEIN$-like growth factor-1 (IGF-1), transforming growth factor-beta1 (TGF-beta1), or a combination of both growth factors were mixed with OPF, a @COMPOUND$ crosslinker and the radical initiators ammonium persulfate and N,N,N',N'-tetramethylethylenediamine, and then crosslinked at 37 degrees C for 8 min to form hydrogel composites.	0	18381637-476
@PROTEIN$ modulates osteoblast behavior on @COMPOUND$.	1	18381638-477
Real-time RT-PCR showed that the expression of osteoblast marker genes such as CBFalpha1 and @PROTEIN$ was increased in hyaluronic acid-based hydrogel, and the expression level was dependent on the molecular weight of hyaluronic acid, @COMPOUND$, and BMP-2.	1	18384163-783
Real-time RT-PCR showed that the expression of osteoblast marker genes such as CBFalpha1 and alkaline phosphatase was increased in hyaluronic acid-based hydrogel, and the expression level was dependent on the molecular weight of hyaluronic acid, @COMPOUND$, and @PROTEIN$.	0	18384163-783
Real-time RT-PCR showed that the expression of osteoblast marker genes such as CBFalpha1 and @PROTEIN$ was increased in @COMPOUND$-based hydrogel, and the expression level was dependent on the molecular weight of hyaluronic acid, RGD peptide, and BMP-2.	1	18384163-783
Real-time RT-PCR showed that the expression of osteoblast marker genes such as @PROTEIN$ and alkaline phosphatase was increased in hyaluronic acid-based hydrogel, and the expression level was dependent on the molecular weight of hyaluronic acid, @COMPOUND$, and BMP-2.	1	18384163-783
Real-time RT-PCR showed that the expression of osteoblast marker genes such as CBFalpha1 and alkaline phosphatase was increased in @COMPOUND$-based hydrogel, and the expression level was dependent on the molecular weight of hyaluronic acid, RGD peptide, and @PROTEIN$.	0	18384163-783
Real-time RT-PCR showed that the expression of osteoblast marker genes such as @PROTEIN$ and alkaline phosphatase was increased in @COMPOUND$-based hydrogel, and the expression level was dependent on the molecular weight of hyaluronic acid, RGD peptide, and BMP-2.	1	18384163-783
Treatment of H9c2 cell with low concentrations of Dox causes alterations in fibrous @PROTEIN$ including the nuclear lamina and sarcomeric cardiac myosin, as well as mitochondrial depolarization and fragmentation, membrane blebbing with cell shape changes, and @COMPOUND$ externalization.	0	18386138-732
We monitored bcr-@PROTEIN$ transcript levels by quantitative real time PCR in 50 tunisian patients treated with @COMPOUND$ for chronic myeloid leukemia in chronic phase for a median of 29 months (3-60) after they started imatinib.	0	18387753-460
We monitored @PROTEIN$-abl transcript levels by quantitative real time PCR in 50 tunisian patients treated with @COMPOUND$ for chronic myeloid leukemia in chronic phase for a median of 29 months (3-60) after they started imatinib.	0	18387753-460
The non-covalent interaction of @COMPOUND$ (BR) with @PROTEIN$ was investigated by the UV spectrometry, circular dichroism (CD) and isothermal titration calorimetry (ITC).	1	18389169-121
Recent studies suggest that crystals of monosodium urate (MSU), deposited in joints of patients with acute gouty arthritis, activate the NACHT domain, @COMPOUND$-rich repeat and @PROTEIN$ domain-containing protein (NALP)3 inflammasome.	0	18390571-968
Recent studies suggest that crystals of @COMPOUND$ (MSU), deposited in joints of patients with acute gouty arthritis, activate the NACHT domain, leucine-rich repeat and @PROTEIN$ domain-containing protein (NALP)3 inflammasome.	1	18390571-968
Nicotine, @COMPOUND$, and chlorpyrifos induced the phosphorylation of @PROTEIN$ and 2.	1	18393628-298
Nicotine, muscarine, and @COMPOUND$ induced the phosphorylation of @PROTEIN$ and 2.	1	18393628-298
@COMPOUND$, muscarine, and chlorpyrifos induced the phosphorylation of @PROTEIN$ and 2.	1	18393628-298
Adult bone marrow (BM)-derived @PROTEIN$-producing cells (IPCs) are capable of regulating blood @COMPOUND$ levels in chemically induced hyperglycemic mice.	1	18393672-326
Treatment with @COMPOUND$ activated glucose metabolism in INS-1 cells in high-glucose culture conditions, and appeared to maximize the BM-derived IPCs ability to synthesize @PROTEIN$.	1	18393672-328
Treatment with benfotiamine activated @COMPOUND$ metabolism in INS-1 cells in high-glucose culture conditions, and appeared to maximize the BM-derived IPCs ability to synthesize @PROTEIN$.	0	18393672-328
Benfotiamine was not shown to induce the glucose receptor Glut-2, however it was shown to activate @PROTEIN$, the enzyme responsible for conversion of glucose to @COMPOUND$.	1	18393672-329
Benfotiamine was not shown to induce the glucose receptor @PROTEIN$, however it was shown to activate glucokinase, the enzyme responsible for conversion of glucose to @COMPOUND$.	0	18393672-329
@COMPOUND$ was not shown to induce the glucose receptor Glut-2, however it was shown to activate @PROTEIN$, the enzyme responsible for conversion of glucose to glucose-6-phosphate.	1	18393672-329
@COMPOUND$ was not shown to induce the glucose receptor @PROTEIN$, however it was shown to activate glucokinase, the enzyme responsible for conversion of glucose to glucose-6-phosphate.	0	18393672-329
However, in cells where the pentose phosphate pathway was blocked by @COMPOUND$ treatment, there was a clear downregulation of Glut-2, glucokinase, insulin, and @PROTEIN$.	1	18393672-330
However, in cells where the pentose phosphate pathway was blocked by @COMPOUND$ treatment, there was a clear downregulation of Glut-2, @PROTEIN$, insulin, and GAPDH.	1	18393672-330
However, in cells where the pentose phosphate pathway was blocked by @COMPOUND$ treatment, there was a clear downregulation of Glut-2, glucokinase, @PROTEIN$, and GAPDH.	1	18393672-330
However, in cells where the pentose phosphate pathway was blocked by @COMPOUND$ treatment, there was a clear downregulation of @PROTEIN$, glucokinase, insulin, and GAPDH.	1	18393672-330
) and two @COMPOUND$ tensions (5 and 20%) were compared for their ability to sustain blastocyst survival and @PROTEIN$ production from days 8 to 11 post-insemination.	0	18394828-1061
In conclusion, culturing blastocysts of cattle in a 5% @COMPOUND$ environment with M199 containing serum sustains embryo viability and permits constitutive and inducible @PROTEIN$ production.	1	18394828-1062
Incubation in 20% @COMPOUND$ increases @PROTEIN$ production.	1	18394828-1063
Histologic examination investigated deposition of extracellular matrix (ECM) including collagen, elastin, @COMPOUND$ (HA), @PROTEIN$, and decorin in the lamina propria of the scarred vocal folds.	0	18395421-172
Histologic examination investigated deposition of extracellular matrix (ECM) including collagen, @PROTEIN$, @COMPOUND$ (HA), fibronectin, and decorin in the lamina propria of the scarred vocal folds.	0	18395421-172
Histologic examination investigated deposition of extracellular matrix (@PROTEIN$) including collagen, elastin, @COMPOUND$ (HA), fibronectin, and decorin in the lamina propria of the scarred vocal folds.	0	18395421-172
A series of novel bis-pyridinium oximes connected by bis-@COMPOUND$, 1,4-bis-methoxymethyl (cis)-but-2-ene and 1,4-bis-methoxymethyl but-2-yne linkers were synthesized and their in vitro reactivation efficacy was evaluated against diisopropyl phosphorofluoridate (DFP) inhibited @PROTEIN$ (AChE) and compared with the established antidote 2-PAM and obidoxime.	0	18396353-715
A series of novel bis-pyridinium oximes connected by bis-@COMPOUND$, 1,4-bis-methoxymethyl (cis)-but-2-ene and 1,4-bis-methoxymethyl but-2-yne linkers were synthesized and their in vitro reactivation efficacy was evaluated against diisopropyl phosphorofluoridate (DFP) inhibited acetylcholinesterase (@PROTEIN$) and compared with the established antidote 2-PAM and obidoxime.	0	18396353-715
A series of novel bis-pyridinium oximes connected by bis-methoxymethyl benzene, 1,4-bis-methoxymethyl (cis)-but-2-ene and 1,4-bis-methoxymethyl but-2-yne linkers were synthesized and their in vitro reactivation efficacy was evaluated against @COMPOUND$ (DFP) inhibited acetylcholinesterase (@PROTEIN$) and compared with the established antidote 2-PAM and obidoxime.	0	18396353-715
A series of novel bis-pyridinium oximes connected by bis-methoxymethyl benzene, 1,4-bis-methoxymethyl (cis)-but-2-ene and 1,4-bis-methoxymethyl but-2-yne linkers were synthesized and their in vitro reactivation efficacy was evaluated against diisopropyl phosphorofluoridate (DFP) inhibited @PROTEIN$ (AChE) and compared with the established antidote 2-PAM and @COMPOUND$.	0	18396353-715
A series of novel bis-pyridinium oximes connected by bis-methoxymethyl benzene, 1,4-bis-methoxymethyl (cis)-but-2-ene and 1,4-bis-methoxymethyl but-2-yne linkers were synthesized and their in vitro reactivation efficacy was evaluated against diisopropyl phosphorofluoridate (DFP) inhibited acetylcholinesterase (@PROTEIN$) and compared with the established antidote 2-PAM and @COMPOUND$.	0	18396353-715
A series of novel bis-pyridinium oximes connected by bis-methoxymethyl benzene, 1,4-bis-methoxymethyl (cis)-but-2-ene and 1,4-bis-methoxymethyl but-2-yne linkers were synthesized and their in vitro reactivation efficacy was evaluated against @COMPOUND$ (DFP) inhibited @PROTEIN$ (AChE) and compared with the established antidote 2-PAM and obidoxime.	0	18396353-715
In-vitro regeneration of @COMPOUND$ inhibited electric eel @PROTEIN$ by bis-pyridinium oximes bearing xylene linker.	1	18396355-716
In-vitro regeneration of sarin inhibited electric eel @PROTEIN$ by bis-pyridinium oximes bearing @COMPOUND$ linker.	1	18396355-716
A series of bis-pyridinium oximes connected by @COMPOUND$ linker were synthesized and their in-vitro reactivation potential was evaluated against @PROTEIN$ (AChE) inhibited by nerve agent, sarin.	0	18396355-717
A series of bis-pyridinium oximes connected by xylene linker were synthesized and their in-vitro reactivation potential was evaluated against @PROTEIN$ (AChE) inhibited by nerve agent, @COMPOUND$.	0	18396355-717
A series of bis-pyridinium oximes connected by @COMPOUND$ linker were synthesized and their in-vitro reactivation potential was evaluated against acetylcholinesterase (@PROTEIN$) inhibited by nerve agent, sarin.	0	18396355-717
A series of bis-pyridinium oximes connected by xylene linker were synthesized and their in-vitro reactivation potential was evaluated against acetylcholinesterase (@PROTEIN$) inhibited by nerve agent, @COMPOUND$.	0	18396355-717
Among the synthesized compounds, alpha,alpha'xylene-bis-(3,3'-(hydroxyiminomethyl) pyridinium) dibromide (3b) was found to be most potent reactivator for @PROTEIN$ inhibited by @COMPOUND$.	1	18396355-718
Of the compounds synthesized, @COMPOUND$, which has a primary amide at warhead region of the inhibitor most potently inhibited mu-@PROTEIN$ with an IC(50) value of 2.81+/-1.26 microM, which is ca.	1	18396356-720
Recent studies have focused on possible functional disorders of the enteric nervous system within the abomasal wall, since cattle with abomasal displacement have an increased activity of neuronal @PROTEIN$, as well as decreased @COMPOUND$ sensitivity.	0	18397836-365
Earlier publications have suggested a possible role for the efflux transporter breast cancer resistance protein (@PROTEIN$) in acquired resistance to disease-modifying antirheumatic drugs (DMARDs) such as leflunomide and its metabolite A771726 (@COMPOUND$).	1	18397960-447
Earlier publications have suggested a possible role for the efflux transporter breast cancer resistance protein (@PROTEIN$) in acquired resistance to disease-modifying antirheumatic drugs (DMARDs) such as @COMPOUND$ and its metabolite A771726 (teriflunomide).	1	18397960-447
Earlier publications have suggested a possible role for the efflux transporter @PROTEIN$ (BCRP) in acquired resistance to disease-modifying antirheumatic drugs (DMARDs) such as leflunomide and its metabolite @COMPOUND$ (teriflunomide).	1	18397960-447
Earlier publications have suggested a possible role for the efflux transporter @PROTEIN$ (BCRP) in acquired resistance to disease-modifying antirheumatic drugs (DMARDs) such as @COMPOUND$ and its metabolite A771726 (teriflunomide).	1	18397960-447
Earlier publications have suggested a possible role for the efflux transporter @PROTEIN$ (BCRP) in acquired resistance to disease-modifying antirheumatic drugs (DMARDs) such as leflunomide and its metabolite A771726 (@COMPOUND$).	1	18397960-447
Earlier publications have suggested a possible role for the efflux transporter breast cancer resistance protein (@PROTEIN$) in acquired resistance to disease-modifying antirheumatic drugs (DMARDs) such as leflunomide and its metabolite @COMPOUND$ (teriflunomide).	1	18397960-447
Inhibition of @PROTEIN$ by zebularine enhances the antineoplastic action of @COMPOUND$.	0	18398609-866
Inhibition of @PROTEIN$ by @COMPOUND$ enhances the antineoplastic action of 5-aza-2'-deoxycytidine.	1	18398609-866
An individual's response to @COMPOUND$ may be influenced by the amount of @PROTEIN$ (+) and CD8(+) T-lymphocyte suppression.	1	18398611-867
We hypothesise that @COMPOUND$ acts as a chemical or pharmacological chaperone, and suggest amino acid supplementation as a possible therapy in @PROTEIN$ mutations with mild phenotypes.	0	18398624-876
mRNA expressions of matrix metallopeptidase-9, inducible @PROTEIN$ and pro-inflammatory cytokines interleukin-1 beta and tumour necrosis factor-alpha in EAN sciatic nerves were greatly decreased by administration of @COMPOUND$ as well.	1	18400050-469
Then the review evaluates the involvement of @PROTEIN$ activated by the endogenous agonist @COMPOUND$ in the generation and propagation of epileptiform activity.	1	18400404-699
Glutamate @COMPOUND$ ligase (@PROTEIN$), synthesizing gamma-glutamylcysteine from glutamate and cysteine, is the rate-limiting enzyme in glutathione (GSH) biosynthesis.	1	18403016-272
Glutamate cysteine ligase (@PROTEIN$), synthesizing gamma-glutamylcysteine from glutamate and cysteine, is the rate-limiting enzyme in glutathione (@COMPOUND$) biosynthesis.	1	18403016-272
@PROTEIN$ (GCL), synthesizing gamma-glutamylcysteine from @COMPOUND$ and cysteine, is the rate-limiting enzyme in glutathione (GSH) biosynthesis.	1	18403016-272
Glutamate cysteine ligase (@PROTEIN$), synthesizing @COMPOUND$ from glutamate and cysteine, is the rate-limiting enzyme in glutathione (GSH) biosynthesis.	1	18403016-272
@PROTEIN$ (GCL), synthesizing @COMPOUND$ from glutamate and cysteine, is the rate-limiting enzyme in glutathione (GSH) biosynthesis.	1	18403016-272
Glutamate cysteine ligase (@PROTEIN$), synthesizing gamma-glutamylcysteine from @COMPOUND$ and cysteine, is the rate-limiting enzyme in glutathione (GSH) biosynthesis.	1	18403016-272
@PROTEIN$ (GCL), synthesizing gamma-glutamylcysteine from glutamate and cysteine, is the rate-limiting enzyme in @COMPOUND$ (GSH) biosynthesis.	1	18403016-272
Glutamate cysteine ligase (@PROTEIN$), synthesizing gamma-glutamylcysteine from glutamate and cysteine, is the rate-limiting enzyme in @COMPOUND$ (GSH) biosynthesis.	1	18403016-272
@PROTEIN$ (GCL), synthesizing gamma-glutamylcysteine from glutamate and cysteine, is the rate-limiting enzyme in glutathione (@COMPOUND$) biosynthesis.	1	18403016-272
We observed that @COMPOUND$ inhibited the proteasome activities and increased the level and insolubility of different @PROTEIN$ species, including phosphorylated tau.	1	18403053-226
Serine and cysteine @PROTEIN$ proved to be suitable tools for the production of amino acids and peptides conjugated to @COMPOUND$, whereas metalloproteases do not seem to be very qualified for accepting this nucleophile.	0	18404246-532
Role of serotonin @PROTEIN$ receptors in the antidepressant-like effect and the antinociceptive effect of @COMPOUND$ in mice.	1	18405417-151
The present study was undertaken to evaluate the potential role of @PROTEIN$ receptors in the antidepressant-like effect and antinociceptive effect of @COMPOUND$.	0	18405417-152
These findings show that @PROTEIN$ receptors play differing roles in modulating the antidepressant-like and antinociceptive effects of @COMPOUND$ in the models investigated.	1	18405417-154
In contrast, the antinociceptive effect of @COMPOUND$ is probably potentiated due to the blockade of somatodendritic @PROTEIN$ receptors in the same raphe nuclei, facilitating the descending monoaminergic pain control system.	1	18405417-155
Moreover, @PROTEIN$ hydrolysis of baicalin sequentially yielded glucuronic acid and @COMPOUND$ as confirmed by co-TLC with authentic samples.	1	18407279-655
Moreover, @PROTEIN$ hydrolysis of @COMPOUND$ sequentially yielded glucuronic acid and baicalein as confirmed by co-TLC with authentic samples.	1	18407279-655
The effect of this diet alone or after 2 weeks of treatment with @COMPOUND$ or glimepiride on glucose homeostasis, lipid profile, and levels of resistin and @PROTEIN$ was studied.	0	18407527-68
The effect of this diet alone or after 2 weeks of treatment with rosiglitazone or @COMPOUND$ on glucose homeostasis, lipid profile, and levels of resistin and @PROTEIN$ was studied.	0	18407527-68
Rosiglitazone corrected the altered parameters measured, except for liver TGs ; similarly, @COMPOUND$ reinstated the inverted parameters but raised @PROTEIN$ level and, consequently, the HOMA index.	1	18407527-71
@COMPOUND$ corrected the altered parameters measured, except for liver TGs ; similarly, glimepiride reinstated the inverted parameters but raised @PROTEIN$ level and, consequently, the HOMA index.	0	18407527-71
Rosiglitazone corrected the altered parameters measured, except for liver @COMPOUND$ ; similarly, glimepiride reinstated the inverted parameters but raised @PROTEIN$ level and, consequently, the HOMA index.	0	18407527-71
@COMPOUND$ inhibited tumor growth in a manner independent of dose and inhibited phosphorylation of @PROTEIN$ and paxillin in a dose-dependent manner in a Calu-6 xenograft model.	1	18409068-1012
@COMPOUND$ inhibited tumor growth in a manner independent of dose and inhibited phosphorylation of FAK and @PROTEIN$ in a dose-dependent manner in a Calu-6 xenograft model.	1	18409068-1012
Activation of ErbB3, @PROTEIN$ and Erk is essential for growth of human breast cancer cell lines with acquired resistance to @COMPOUND$.	0	18409071-995
Treatment with the EGFR inhibitor @COMPOUND$ preferentially inhibited growth and reduced the S phase fraction in the resistant cell lines concomitant with inhibition of Erk and unaltered @PROTEIN$ activation.	0	18409071-997
@COMPOUND$ protects from hepatic reperfusion injury through inhibition of IKK and @PROTEIN$ pathways and modification of cell proliferation.	1	18410309-540
@COMPOUND$ significantly improved animal survival and decreased transaminase levels, the indices for necrosis, liver damage, leukocyte infiltration, and @PROTEIN$ expression.	1	18410309-541
At the same time, @COMPOUND$ reduced the expression of both @PROTEIN$ 0.05).	1	18410309-542
@COMPOUND$ is hepatoprotective most likely via mechanisms including inhibition of IKK and @PROTEIN$ pathways and regulation of cell proliferation.	1	18410309-543
Here, we report that the citrus bioflavonoid @COMPOUND$ reduces amyloid-beta (Abeta) peptide generation in both human 'Swedish' mutant @PROTEIN$ transgene-bearing neuron-like cells and primary neurons.	1	18410522-611
Here, we report that the citrus @COMPOUND$ luteolin reduces amyloid-beta (Abeta) peptide generation in both human 'Swedish' mutant @PROTEIN$ transgene-bearing neuron-like cells and primary neurons.	1	18410522-611
We also find that @COMPOUND$ induces changes consistent with GSK-3 inhibition that (i) decrease amyloidogenic gamma-secretase @PROTEIN$ processing, and (ii) promote presenilin-1 (PS1) carboxyl-terminal fragment (CTF) phosphorylation.	1	18410522-612
We also find that @COMPOUND$ induces changes consistent with GSK-3 inhibition that (i) decrease amyloidogenic gamma-secretase APP processing, and (ii) promote @PROTEIN$ (PS1) carboxyl-terminal fragment (CTF) phosphorylation.	1	18410522-612
We also find that @COMPOUND$ induces changes consistent with GSK-3 inhibition that (i) decrease amyloidogenic gamma-secretase APP processing, and (ii) promote presenilin-1 (@PROTEIN$) carboxyl-terminal fragment (CTF) phosphorylation.	1	18410522-612
We also find that @COMPOUND$ induces changes consistent with @PROTEIN$ inhibition that (i) decrease amyloidogenic gamma-secretase APP processing, and (ii) promote presenilin-1 (PS1) carboxyl-terminal fragment (CTF) phosphorylation.	1	18410522-612
As validation of these findings in vivo, we find that @COMPOUND$, when applied to the Tg2576 mouse model of AD, decreases soluble Abeta levels, reduces GSK-3 activity, and disrupts PS1-@PROTEIN$ association.	1	18410522-613
As validation of these findings in vivo, we find that @COMPOUND$, when applied to the Tg2576 mouse model of AD, decreases soluble Abeta levels, reduces GSK-3 activity, and disrupts @PROTEIN$-APP association.	1	18410522-613
As validation of these findings in vivo, we find that @COMPOUND$, when applied to the Tg2576 mouse model of AD, decreases soluble Abeta levels, reduces @PROTEIN$ activity, and disrupts PS1-APP association.	1	18410522-613
Since biliverdin and @COMPOUND$ are downstream products of heme degradation by @PROTEIN$ (HO), it has been suggested that HO-activity protects against curcumin-induced apoptosis.	1	18410527-619
Since biliverdin and bilirubin are downstream products of @COMPOUND$ degradation by @PROTEIN$ (HO), it has been suggested that HO-activity protects against curcumin-induced apoptosis.	0	18410527-619
Since @COMPOUND$ and bilirubin are downstream products of heme degradation by @PROTEIN$ (HO), it has been suggested that HO-activity protects against curcumin-induced apoptosis.	1	18410527-619
Here, we examine the effect of resistin on @COMPOUND$ uptake in human trophoblast cells and we demonstrate that transplacental glucose transport is mediated by @PROTEIN$ (GLUT)-1.	1	18410529-629
ERK1 and 2 activation stimulated @PROTEIN$ synthesis and resulted in increase of placental @COMPOUND$ uptake.	1	18410529-630
@PROTEIN$ and 2 activation stimulated GLUT-1 synthesis and resulted in increase of placental @COMPOUND$ uptake.	1	18410529-630
High resistin levels (50-100 ng/ml) seem able to affect @COMPOUND$-uptake, presumably by decreasing the cell surface @PROTEIN$.	1	18410529-631
@COMPOUND$ methylation as well as histone H3 methylation of lysines 9 and 27 contribute independently to @PROTEIN$ gene silencing in adenocarcinoma cell lines and can be reversed by 5-aza-2'-deoxycytidine.	1	18410530-134
CpG methylation as well as histone H3 methylation of lysines 9 and 27 contribute independently to @PROTEIN$ gene silencing in adenocarcinoma cell lines and can be reversed by @COMPOUND$.	1	18410530-134
@COMPOUND$-, Gly-Pro-Met- and Ala-Ala-Phe-N'-(2-hexyl-1,3-dioxo-2,3-dihydro-1H-benzo(de)isoquinolin-6-yl)-hydrazides are synthesized by guanidinium/uronium type condensing reagent and used as fluorogenic substrates to localize @PROTEIN$ and tripeptidyl peptidase I activities in mammalian tissue sections.	1	18410982-929
Gly-Pro-, Gly-Pro-Met- and Ala-Ala-Phe-N'-(2-hexyl-1,3-dioxo-2,3-dihydro-1H-benzo(de)isoquinolin-6-yl)-hydrazides are synthesized by @COMPOUND$/uronium type condensing reagent and used as fluorogenic substrates to localize @PROTEIN$ and tripeptidyl peptidase I activities in mammalian tissue sections.	1	18410982-929
@COMPOUND$-, Gly-Pro-Met- and Ala-Ala-Phe-N'-(2-hexyl-1,3-dioxo-2,3-dihydro-1H-benzo(de)isoquinolin-6-yl)-hydrazides are synthesized by guanidinium/uronium type condensing reagent and used as fluorogenic substrates to localize dipeptidyl peptidase IV and @PROTEIN$ activities in mammalian tissue sections.	1	18410982-929
Gly-Pro-, Gly-Pro-Met- and Ala-Ala-Phe-N'-(2-hexyl-1,3-dioxo-2,3-dihydro-1H-benzo(de)isoquinolin-6-yl)-hydrazides are synthesized by @COMPOUND$/uronium type condensing reagent and used as fluorogenic substrates to localize dipeptidyl peptidase IV and @PROTEIN$ activities in mammalian tissue sections.	0	18410982-929
However, increased blood @COMPOUND$ (200 mg/dl) significantly impaired the inhibitory effect of ASA (84% for @PROTEIN$.005; 48% for P-selectin, P=NS).	0	18413191-1010
The expressions of @PROTEIN$ mRNA in renal tissues were markedly up-regulated in untreated diabetic rats, and these could be notably reduced by @COMPOUND$ treatment.	1	18413206-1026
In conclusion, @COMPOUND$ may have a potential therapeutic target in DN, which may be partly attributed to lowering of the expression of @PROTEIN$ in the local kidney and the urinary excretion of MCP-1.	1	18413206-1027
The homomeric @PROTEIN$ (7) receptor is extraordinary in that in addition to distinctive localization and biological functions it exhibits several hallmark properties, for example, the receptor is potently inhibited by divalent cations such as calcium, magnesium, zinc and @COMPOUND$.	1	18414844-751
The homomeric @PROTEIN$ (7) receptor is extraordinary in that in addition to distinctive localization and biological functions it exhibits several hallmark properties, for example, the receptor is potently inhibited by divalent cations such as calcium, @COMPOUND$, zinc and copper.	1	18414844-751
Replacement doses of hydrocortisone (HC) (10 mg/m2/day) failed to produce a feedback inhibition of @PROTEIN$ (ACTH), and @COMPOUND$ levels remained high.	0	18414894-793
Replacement doses of @COMPOUND$ (HC) (10 mg/m2/day) failed to produce a feedback inhibition of adrenocorticotropic hormone (@PROTEIN$), and testosterone levels remained high.	0	18414894-793
Replacement doses of hydrocortisone (HC) (10 mg/m2/day) failed to produce a feedback inhibition of adrenocorticotropic hormone (@PROTEIN$), and @COMPOUND$ levels remained high.	0	18414894-793
Replacement doses of @COMPOUND$ (HC) (10 mg/m2/day) failed to produce a feedback inhibition of @PROTEIN$ (ACTH), and testosterone levels remained high.	0	18414894-793
Cadmium exposure diminished the activities of enzymatic antioxidants, superoxide dismutase (SOD), catalase (CAT), glutathione-S-transferase (@PROTEIN$), glutathione reductase (GR), glutathione peroxidase (GPx) and glucose-6-phosphate dehydrogenase (G6PD) as well as non-enzymatic antioxidant, reduced glutathione (@COMPOUND$) and total thiols.	0	18414974-853
Cadmium exposure diminished the activities of enzymatic antioxidants, superoxide dismutase (SOD), catalase (CAT), glutathione-S-transferase (@PROTEIN$), glutathione reductase (GR), glutathione peroxidase (GPx) and glucose-6-phosphate dehydrogenase (G6PD) as well as non-enzymatic antioxidant, @COMPOUND$ (GSH) and total thiols.	0	18414974-853
@COMPOUND$ exposure diminished the activities of enzymatic antioxidants, superoxide dismutase (SOD), @PROTEIN$ (CAT), glutathione-S-transferase (GST), glutathione reductase (GR), glutathione peroxidase (GPx) and glucose-6-phosphate dehydrogenase (G6PD) as well as non-enzymatic antioxidant, reduced glutathione (GSH) and total thiols.	1	18414974-853
Cadmium exposure diminished the activities of enzymatic antioxidants, @PROTEIN$ (SOD), catalase (CAT), glutathione-S-transferase (GST), glutathione reductase (GR), glutathione peroxidase (GPx) and glucose-6-phosphate dehydrogenase (G6PD) as well as non-enzymatic antioxidant, reduced glutathione (@COMPOUND$) and total thiols.	0	18414974-853
Cadmium exposure diminished the activities of enzymatic antioxidants, superoxide dismutase (SOD), catalase (CAT), @PROTEIN$ (GST), glutathione reductase (GR), glutathione peroxidase (GPx) and glucose-6-phosphate dehydrogenase (G6PD) as well as non-enzymatic antioxidant, @COMPOUND$ (GSH) and total thiols.	0	18414974-853
Cadmium exposure diminished the activities of enzymatic antioxidants, superoxide dismutase (SOD), catalase (@PROTEIN$), glutathione-S-transferase (GST), glutathione reductase (GR), glutathione peroxidase (GPx) and glucose-6-phosphate dehydrogenase (G6PD) as well as non-enzymatic antioxidant, @COMPOUND$ (GSH) and total thiols.	0	18414974-853
Cadmium exposure diminished the activities of enzymatic antioxidants, superoxide dismutase (SOD), @PROTEIN$ (CAT), glutathione-S-transferase (GST), glutathione reductase (GR), glutathione peroxidase (GPx) and glucose-6-phosphate dehydrogenase (G6PD) as well as non-enzymatic antioxidant, @COMPOUND$ (GSH) and total thiols.	0	18414974-853
Cadmium exposure diminished the activities of enzymatic antioxidants, superoxide dismutase (@PROTEIN$), catalase (CAT), glutathione-S-transferase (GST), glutathione reductase (GR), glutathione peroxidase (GPx) and glucose-6-phosphate dehydrogenase (G6PD) as well as non-enzymatic antioxidant, @COMPOUND$ (GSH) and total thiols.	0	18414974-853
Cadmium exposure diminished the activities of enzymatic antioxidants, superoxide dismutase (SOD), catalase (@PROTEIN$), glutathione-S-transferase (GST), glutathione reductase (GR), glutathione peroxidase (GPx) and glucose-6-phosphate dehydrogenase (G6PD) as well as non-enzymatic antioxidant, reduced glutathione (@COMPOUND$) and total thiols.	0	18414974-853
@COMPOUND$ exposure diminished the activities of enzymatic antioxidants, superoxide dismutase (SOD), catalase (CAT), glutathione-S-transferase (@PROTEIN$), glutathione reductase (GR), glutathione peroxidase (GPx) and glucose-6-phosphate dehydrogenase (G6PD) as well as non-enzymatic antioxidant, reduced glutathione (GSH) and total thiols.	1	18414974-853
Cadmium exposure diminished the activities of enzymatic antioxidants, superoxide dismutase (SOD), catalase (CAT), glutathione-S-transferase (GST), @PROTEIN$ (GR), glutathione peroxidase (GPx) and glucose-6-phosphate dehydrogenase (G6PD) as well as non-enzymatic antioxidant, reduced glutathione (@COMPOUND$) and total thiols.	0	18414974-853
@COMPOUND$ exposure diminished the activities of enzymatic antioxidants, superoxide dismutase (SOD), catalase (CAT), glutathione-S-transferase (GST), glutathione reductase (GR), glutathione peroxidase (GPx) and glucose-6-phosphate dehydrogenase (@PROTEIN$) as well as non-enzymatic antioxidant, reduced glutathione (GSH) and total thiols.	1	18414974-853
Cadmium exposure diminished the activities of enzymatic antioxidants, superoxide dismutase (@PROTEIN$), catalase (CAT), glutathione-S-transferase (GST), glutathione reductase (GR), glutathione peroxidase (GPx) and glucose-6-phosphate dehydrogenase (G6PD) as well as non-enzymatic antioxidant, reduced glutathione (@COMPOUND$) and total thiols.	0	18414974-853
@COMPOUND$ exposure diminished the activities of enzymatic antioxidants, superoxide dismutase (@PROTEIN$), catalase (CAT), glutathione-S-transferase (GST), glutathione reductase (GR), glutathione peroxidase (GPx) and glucose-6-phosphate dehydrogenase (G6PD) as well as non-enzymatic antioxidant, reduced glutathione (GSH) and total thiols.	1	18414974-853
Cadmium exposure diminished the activities of enzymatic antioxidants, superoxide dismutase (SOD), catalase (CAT), glutathione-S-transferase (GST), glutathione reductase (GR), @PROTEIN$ (GPx) and glucose-6-phosphate dehydrogenase (G6PD) as well as non-enzymatic antioxidant, reduced glutathione (@COMPOUND$) and total thiols.	0	18414974-853
Cadmium exposure diminished the activities of enzymatic antioxidants, superoxide dismutase (SOD), catalase (CAT), glutathione-S-transferase (GST), glutathione reductase (GR), glutathione peroxidase (GPx) and glucose-6-phosphate dehydrogenase (@PROTEIN$) as well as non-enzymatic antioxidant, @COMPOUND$ (GSH) and total thiols.	0	18414974-853
Cadmium exposure diminished the activities of enzymatic antioxidants, @PROTEIN$ (SOD), catalase (CAT), glutathione-S-transferase (GST), glutathione reductase (GR), glutathione peroxidase (GPx) and glucose-6-phosphate dehydrogenase (G6PD) as well as non-enzymatic antioxidant, @COMPOUND$ (GSH) and total thiols.	0	18414974-853
@COMPOUND$ exposure diminished the activities of enzymatic antioxidants, @PROTEIN$ (SOD), catalase (CAT), glutathione-S-transferase (GST), glutathione reductase (GR), glutathione peroxidase (GPx) and glucose-6-phosphate dehydrogenase (G6PD) as well as non-enzymatic antioxidant, reduced glutathione (GSH) and total thiols.	1	18414974-853
Cadmium exposure diminished the activities of enzymatic antioxidants, superoxide dismutase (SOD), catalase (CAT), glutathione-S-transferase (GST), glutathione reductase (GR), @PROTEIN$ (GPx) and glucose-6-phosphate dehydrogenase (G6PD) as well as non-enzymatic antioxidant, @COMPOUND$ (GSH) and total thiols.	0	18414974-853
@COMPOUND$ exposure diminished the activities of enzymatic antioxidants, superoxide dismutase (SOD), catalase (CAT), glutathione-S-transferase (GST), @PROTEIN$ (GR), glutathione peroxidase (GPx) and glucose-6-phosphate dehydrogenase (G6PD) as well as non-enzymatic antioxidant, reduced glutathione (GSH) and total thiols.	1	18414974-853
@COMPOUND$ exposure diminished the activities of enzymatic antioxidants, superoxide dismutase (SOD), catalase (CAT), glutathione-S-transferase (GST), glutathione reductase (GR), @PROTEIN$ (GPx) and glucose-6-phosphate dehydrogenase (G6PD) as well as non-enzymatic antioxidant, reduced glutathione (GSH) and total thiols.	1	18414974-853
Cadmium exposure diminished the activities of enzymatic antioxidants, superoxide dismutase (SOD), catalase (CAT), @PROTEIN$ (GST), glutathione reductase (GR), glutathione peroxidase (GPx) and glucose-6-phosphate dehydrogenase (G6PD) as well as non-enzymatic antioxidant, reduced glutathione (@COMPOUND$) and total thiols.	0	18414974-853
@COMPOUND$ exposure diminished the activities of enzymatic antioxidants, superoxide dismutase (SOD), catalase (CAT), @PROTEIN$ (GST), glutathione reductase (GR), glutathione peroxidase (GPx) and glucose-6-phosphate dehydrogenase (G6PD) as well as non-enzymatic antioxidant, reduced glutathione (GSH) and total thiols.	1	18414974-853
Cadmium exposure diminished the activities of enzymatic antioxidants, superoxide dismutase (SOD), catalase (CAT), glutathione-S-transferase (GST), @PROTEIN$ (GR), glutathione peroxidase (GPx) and glucose-6-phosphate dehydrogenase (G6PD) as well as non-enzymatic antioxidant, @COMPOUND$ (GSH) and total thiols.	0	18414974-853
@COMPOUND$ exposure diminished the activities of enzymatic antioxidants, superoxide dismutase (SOD), catalase (@PROTEIN$), glutathione-S-transferase (GST), glutathione reductase (GR), glutathione peroxidase (GPx) and glucose-6-phosphate dehydrogenase (G6PD) as well as non-enzymatic antioxidant, reduced glutathione (GSH) and total thiols.	1	18414974-853
Cadmium exposure diminished the activities of enzymatic antioxidants, superoxide dismutase (SOD), @PROTEIN$ (CAT), glutathione-S-transferase (GST), glutathione reductase (GR), glutathione peroxidase (GPx) and glucose-6-phosphate dehydrogenase (G6PD) as well as non-enzymatic antioxidant, reduced glutathione (@COMPOUND$) and total thiols.	0	18414974-853
Cadmium exposure diminished the activities of enzymatic antioxidants, superoxide dismutase (SOD), catalase (CAT), glutathione-S-transferase (GST), glutathione reductase (GR), glutathione peroxidase (GPx) and glucose-6-phosphate dehydrogenase (@PROTEIN$) as well as non-enzymatic antioxidant, reduced glutathione (@COMPOUND$) and total thiols.	0	18414974-853
On the other hand, the levels of oxidized glutathione (@COMPOUND$), lipid peroxidation, protein carbonylation, DNA fragmentation, concentration of superoxide radicals and activities of cytochrome P450 enzymes (@PROTEIN$ P450s) have been found to increase due to cadmium intoxication.	0	18414974-854
On the other hand, the levels of oxidized glutathione (GSSG), lipid peroxidation, protein carbonylation, DNA fragmentation, concentration of superoxide radicals and activities of cytochrome P450 enzymes (@PROTEIN$ P450s) have been found to increase due to @COMPOUND$ intoxication.	1	18414974-854
On the other hand, the levels of oxidized glutathione (@COMPOUND$), lipid peroxidation, protein carbonylation, DNA fragmentation, concentration of superoxide radicals and activities of @PROTEIN$ enzymes (CYP P450s) have been found to increase due to cadmium intoxication.	0	18414974-854
On the other hand, the levels of @COMPOUND$ (GSSG), lipid peroxidation, protein carbonylation, DNA fragmentation, concentration of superoxide radicals and activities of @PROTEIN$ enzymes (CYP P450s) have been found to increase due to cadmium intoxication.	0	18414974-854
On the other hand, the levels of oxidized glutathione (GSSG), lipid peroxidation, protein carbonylation, DNA fragmentation, concentration of superoxide radicals and activities of @PROTEIN$ enzymes (CYP P450s) have been found to increase due to @COMPOUND$ intoxication.	1	18414974-854
On the other hand, the levels of oxidized glutathione (GSSG), lipid peroxidation, protein carbonylation, DNA fragmentation, concentration of @COMPOUND$ radicals and activities of cytochrome P450 enzymes (@PROTEIN$ P450s) have been found to increase due to cadmium intoxication.	0	18414974-854
On the other hand, the levels of @COMPOUND$ (GSSG), lipid peroxidation, protein carbonylation, DNA fragmentation, concentration of superoxide radicals and activities of cytochrome P450 enzymes (@PROTEIN$ P450s) have been found to increase due to cadmium intoxication.	0	18414974-854
On the other hand, the levels of oxidized glutathione (GSSG), lipid peroxidation, protein carbonylation, DNA fragmentation, concentration of @COMPOUND$ radicals and activities of @PROTEIN$ enzymes (CYP P450s) have been found to increase due to cadmium intoxication.	0	18414974-854
This paper describes (1) the preparation of the intact oligosaccharides from @PROTEIN$ (II(3)NeuAcGgOse(4) Cer) and GbOse(4) Cer as examples to show the use of CGase to prepare intact @COMPOUND$ chains from GSLs, and (2) the specificity and detergent requirements of Rhodococcal EGCases for the release of glycan chains from different GSLs.	0	18415015-878
The discovery of the PLN/@PROTEIN$ interaction therefore unveils an important new link between @COMPOUND$+) homeostasis and cell survival, with significant therapeutic potential.	0	18415121-949
The discovery of the @PROTEIN$/HAX-1 interaction therefore unveils an important new link between @COMPOUND$+) homeostasis and cell survival, with significant therapeutic potential.	0	18415121-949
@COMPOUND$ alone evoked effects similar to low N/@PROTEIN$ doses, suggesting tonic inhibitory control over forelimb movement by endogenous N/OFQ.	0	18418358-391
Treating MCF-7 cells with @COMPOUND$-1642 Qdots, but not unconjugated Qdots alone, downregulated @PROTEIN$ levels and rendered cells refractory to IGF-I stimulation.	1	18418709-605
Treating MCF-7 cells with @COMPOUND$-1642 Qdots, but not unconjugated Qdots alone, downregulated IGF1R levels and rendered cells refractory to @PROTEIN$ stimulation.	1	18418709-605
Our data suggest that @COMPOUND$-1642 Qdots can be used to detect @PROTEIN$ expression and measure changes in cell surface receptor levels.	1	18418709-606
Although previous studies indicated reduced levels of @COMPOUND$ residues during apoptosis, elevated Sambucus nigra agglutinin (SNA) reactivity might be due to the degradation of high molecular weight @PROTEIN$ (probably including cadherin) that masked the SNA-binding residues of the plasma membrane prior to apoptosis.	0	18420260-309
Although previous studies indicated reduced levels of @COMPOUND$ residues during apoptosis, elevated Sambucus nigra @PROTEIN$ (SNA) reactivity might be due to the degradation of high molecular weight glycoproteins (probably including cadherin) that masked the SNA-binding residues of the plasma membrane prior to apoptosis.	1	18420260-309
We detected a marked decrease in target mRNA, an accumulation of short interfering RNAs (siRNAs), and a decrease in quercetin content relative to @COMPOUND$ in leaf tissues, indicating that sequence-specific mRNA degradation of the @PROTEIN$ gene was induced.	0	18423787-1115
We detected a marked decrease in target mRNA, an accumulation of short interfering RNAs (siRNAs), and a decrease in @COMPOUND$ relative to kaempferol in leaf tissues, indicating that sequence-specific mRNA degradation of the @PROTEIN$ gene was induced.	0	18423787-1115
Polyhydroxy phenolic compounds, such as flavonoids, vitamin E, @COMPOUND$ and aristolochic acid, are able to inhibit @PROTEIN$ (2) from different sources.	1	18423943-93
Polyhydroxy phenolic compounds, such as flavonoids, @COMPOUND$, rosmarinic acid and aristolochic acid, are able to inhibit @PROTEIN$ (2) from different sources.	1	18423943-93
Polyhydroxy phenolic compounds, such as flavonoids, vitamin E, rosmarinic acid and @COMPOUND$, are able to inhibit @PROTEIN$ (2) from different sources.	1	18423943-93
Analysis of the protein domain features indicated typical conserved @COMPOUND$ residues containing a single whey acidic protein (@PROTEIN$) domain at the C-terminus.	0	18425600-1102
Analysis of the protein domain features indicated typical conserved @COMPOUND$ residues containing a single @PROTEIN$ (WAP) domain at the C-terminus.	0	18425600-1102
Cross-linked @PROTEIN$ (1/2) heteromers showed strongly reduced or absent function that was selectively recovered upon treatment with @COMPOUND$.	1	18427801-1197
Permeabilization of K. marxianus cells in relation to @PROTEIN$ activity was carried out using cetyltrimethyl ammonium bromide (@COMPOUND$) to avoid the problem of enzyme extraction.	1	18431601-998
Permeabilization of K. marxianus cells in relation to @PROTEIN$ activity was carried out using cetyltrimethyl @COMPOUND$ (CTAB) to avoid the problem of enzyme extraction.	1	18431601-998
Although the levels of IL-4, IL-13, IL-10, and @PROTEIN$/KC were affected by polymer implantation, but not dependent on a specific polymer, IL-6 and TNFalpha were significantly greater in those animals implanted with @COMPOUND$ and SR, materials that do not promote fusion.	0	18431759-1114
Although the levels of @PROTEIN$, IL-13, IL-10, and GRO/KC were affected by polymer implantation, but not dependent on a specific polymer, IL-6 and TNFalpha were significantly greater in those animals implanted with @COMPOUND$ and SR, materials that do not promote fusion.	0	18431759-1114
Although the levels of IL-4, @PROTEIN$, IL-10, and GRO/KC were affected by polymer implantation, but not dependent on a specific polymer, IL-6 and TNFalpha were significantly greater in those animals implanted with @COMPOUND$ and SR, materials that do not promote fusion.	0	18431759-1114
Although the levels of IL-4, IL-13, IL-10, and GRO/KC were affected by polymer implantation, but not dependent on a specific polymer, IL-6 and @PROTEIN$ were significantly greater in those animals implanted with @COMPOUND$ and SR, materials that do not promote fusion.	0	18431759-1114
Although the levels of IL-4, IL-13, @PROTEIN$, and GRO/KC were affected by polymer implantation, but not dependent on a specific polymer, IL-6 and TNFalpha were significantly greater in those animals implanted with @COMPOUND$ and SR, materials that do not promote fusion.	0	18431759-1114
Although the levels of IL-4, IL-13, IL-10, and GRO/KC were affected by polymer implantation, but not dependent on a specific polymer, @PROTEIN$ and TNFalpha were significantly greater in those animals implanted with @COMPOUND$ and SR, materials that do not promote fusion.	1	18431759-1114
Incorporation of bromodeoxyuridine into newly synthesized DNA and the concentration of vinculin, beta-actin, osteopontin, and @PROTEIN$ in cells on the scaffolds of all pore sizes were similar to the values obtained on standard tissue culture @COMPOUND$, which indicated good biocompatibility of the scaffolds.	0	18431773-1123
Incorporation of @COMPOUND$ into newly synthesized DNA and the concentration of @PROTEIN$, beta-actin, osteopontin, and osteocalcin in cells on the scaffolds of all pore sizes were similar to the values obtained on standard tissue culture polystyrene, which indicated good biocompatibility of the scaffolds.	0	18431773-1123
Incorporation of bromodeoxyuridine into newly synthesized DNA and the concentration of @PROTEIN$, beta-actin, osteopontin, and osteocalcin in cells on the scaffolds of all pore sizes were similar to the values obtained on standard tissue culture @COMPOUND$, which indicated good biocompatibility of the scaffolds.	0	18431773-1123
Incorporation of @COMPOUND$ into newly synthesized DNA and the concentration of vinculin, @PROTEIN$, osteopontin, and osteocalcin in cells on the scaffolds of all pore sizes were similar to the values obtained on standard tissue culture polystyrene, which indicated good biocompatibility of the scaffolds.	0	18431773-1123
Incorporation of @COMPOUND$ into newly synthesized DNA and the concentration of vinculin, beta-actin, osteopontin, and @PROTEIN$ in cells on the scaffolds of all pore sizes were similar to the values obtained on standard tissue culture polystyrene, which indicated good biocompatibility of the scaffolds.	0	18431773-1123
Incorporation of bromodeoxyuridine into newly synthesized DNA and the concentration of vinculin, @PROTEIN$, osteopontin, and osteocalcin in cells on the scaffolds of all pore sizes were similar to the values obtained on standard tissue culture @COMPOUND$, which indicated good biocompatibility of the scaffolds.	0	18431773-1123
To determine the capabilities of previously used microsphere scaffold to deliver growth factors simultaneously, this work investigated a long-term (about three months) release of bovine serum albumin (@PROTEIN$) from microsphere scaffolds fabricated by using two different polymers, poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV, 8% PHV), poly(lactide-co-glycolide) acid (@COMPOUND$, 5050) and a blend of PLGA and PHBV.	0	18431776-1124
To determine the capabilities of previously used microsphere scaffold to deliver growth factors simultaneously, this work investigated a long-term (about three months) release of bovine @PROTEIN$ (BSA) from microsphere scaffolds fabricated by using two different polymers, @COMPOUND$) (PHBV, 8% PHV), poly(lactide-co-glycolide) acid (PLGA, 5050) and a blend of PLGA and PHBV.	0	18431776-1124
To determine the capabilities of previously used microsphere scaffold to deliver growth factors simultaneously, this work investigated a long-term (about three months) release of bovine @PROTEIN$ (BSA) from microsphere scaffolds fabricated by using two different polymers, poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV, 8% PHV), poly(lactide-co-glycolide) acid (@COMPOUND$, 5050) and a blend of PLGA and PHBV.	0	18431776-1124
To determine the capabilities of previously used microsphere scaffold to deliver growth factors simultaneously, this work investigated a long-term (about three months) release of bovine serum albumin (@PROTEIN$) from microsphere scaffolds fabricated by using two different polymers, poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV, 8% PHV), @COMPOUND$) acid (PLGA, 5050) and a blend of PLGA and PHBV.	0	18431776-1124
To determine the capabilities of previously used microsphere scaffold to deliver growth factors simultaneously, this work investigated a long-term (about three months) release of bovine serum albumin (@PROTEIN$) from microsphere scaffolds fabricated by using two different polymers, @COMPOUND$) (PHBV, 8% PHV), poly(lactide-co-glycolide) acid (PLGA, 5050) and a blend of PLGA and PHBV.	0	18431776-1124
To determine the capabilities of previously used microsphere scaffold to deliver growth factors simultaneously, this work investigated a long-term (about three months) release of bovine @PROTEIN$ (BSA) from microsphere scaffolds fabricated by using two different polymers, poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV, 8% PHV), @COMPOUND$) acid (PLGA, 5050) and a blend of PLGA and PHBV.	0	18431776-1124
Prediction of @PROTEIN$ receptor binding affinity of substituted 1-(3,3-diphenylpropyl)-@COMPOUND$ amides and ureas based on the heuristic method, support vector machine and projection pursuit regression.	1	18433938-1194
Quantitative structure-activity relationship (QSAR) models were developed to predict for @PROTEIN$ binding affinity of substituted 1-(3,3-diphenylpropyl)-@COMPOUND$ amides and ureas using linear free energy relationship (LFER).	1	18433938-1195
It is suggested that @COMPOUND$ acting through the GABA(A) receptor mechanism on the expression of GnRH gene and @PROTEIN$ gene in the hypothalamus may be involved in two processes: the biosynthesis of GnRH and the release of this neurohormone in the hypothalamus.	1	18434046-291
It is suggested that @COMPOUND$ acting through the GABA(A) receptor mechanism on the expression of @PROTEIN$ gene and GnRH-R gene in the hypothalamus may be involved in two processes: the biosynthesis of GnRH and the release of this neurohormone in the hypothalamus.	1	18434046-291
It is suggested that @COMPOUND$ acting through the @PROTEIN$ mechanism on the expression of GnRH gene and GnRH-R gene in the hypothalamus may be involved in two processes: the biosynthesis of GnRH and the release of this neurohormone in the hypothalamus.	1	18434046-291
TT-induced increases in @COMPOUND$, adrenocorticotropic hormone and prolactin were reduced only after 3-h @PROTEIN$.	0	18435693-994
TT-induced increases in @COMPOUND$, @PROTEIN$ and prolactin were reduced only after 3-h REC.	0	18435693-994
TT-induced increases in @COMPOUND$, adrenocorticotropic hormone and @PROTEIN$ were reduced only after 3-h REC.	0	18435693-994
@COMPOUND$ inhibits vascular superoxide production induced by endothelin-1 : Role of NADPH oxidase, uncoupled eNOS and @PROTEIN$.	0	18436224-84
@COMPOUND$ inhibits vascular superoxide production induced by endothelin-1 : Role of NADPH oxidase, uncoupled @PROTEIN$ and PKC.	0	18436224-84
Quercetin inhibits vascular @COMPOUND$ production induced by endothelin-1 : Role of NADPH oxidase, uncoupled eNOS and @PROTEIN$.	0	18436224-84
Quercetin inhibits vascular @COMPOUND$ production induced by endothelin-1 : Role of NADPH oxidase, uncoupled @PROTEIN$ and PKC.	0	18436224-84
Quercetin inhibits vascular @COMPOUND$ production induced by @PROTEIN$ : Role of NADPH oxidase, uncoupled eNOS and PKC.	1	18436224-84
@COMPOUND$ inhibits vascular superoxide production induced by @PROTEIN$ : Role of NADPH oxidase, uncoupled eNOS and PKC.	1	18436224-84
Furthermore, ET-1 increased intracellular O(2*)(-) production in all layers of the vessel, protein expression of NADPH oxidase subunit @PROTEIN$ (phox) without affecting p22 (phox) expression and lucigenin-enhanced chemiluminescence signal stimulated by @COMPOUND$.	0	18436224-87
Furthermore, ET-1 increased intracellular O(2*)(-) production in all layers of the vessel, protein expression of NADPH oxidase subunit p47 (phox) without affecting @PROTEIN$ (phox) expression and lucigenin-enhanced chemiluminescence signal stimulated by @COMPOUND$.	0	18436224-87
Moreover, quercetin but not @COMPOUND$, inhibited the increased @PROTEIN$ activity induced by ET-1.	0	18436224-89
Moreover, @COMPOUND$ but not isorhamnetin, inhibited the increased @PROTEIN$ activity induced by ET-1.	1	18436224-89
Taken together these results indicate that ET-1-induced NADPH oxidase up-regulation and @PROTEIN$ uncoupling via PKC leading to endothelial dysfunction and these effects were prevented by quercetin and @COMPOUND$.	1	18436224-90
Taken together these results indicate that ET-1-induced NADPH oxidase up-regulation and eNOS uncoupling via @PROTEIN$ leading to endothelial dysfunction and these effects were prevented by quercetin and @COMPOUND$.	1	18436224-90
Taken together these results indicate that ET-1-induced NADPH oxidase up-regulation and @PROTEIN$ uncoupling via PKC leading to endothelial dysfunction and these effects were prevented by @COMPOUND$ and isorhamnetin.	1	18436224-90
Taken together these results indicate that ET-1-induced NADPH oxidase up-regulation and eNOS uncoupling via @PROTEIN$ leading to endothelial dysfunction and these effects were prevented by @COMPOUND$ and isorhamnetin.	1	18436224-90
We hypothesized that variants in @PROTEIN$ that lower LDL @COMPOUND$ levels are associated with reduced prevalence and incidence of peripheral artery disease (PAD).	1	18436227-91
A series of 2-aryl-naphtho(1,2-d) @COMPOUND$ derivatives have been synthesized and evaluated for @PROTEIN$ inhibitory activity.	0	18436346-156
A new series of @COMPOUND$ and aurone derivatives have been synthesized and tested for in vitro @PROTEIN$ inhibitory activity by modified Ellman method.	0	18436348-931
@COMPOUND$ differentially alter @PROTEIN$ (2alpha) and PGE (2) release from bovine trophoblast and endometrial tissues during short-term culture.	1	18436399-180
@COMPOUND$ differentially alter PGF (2alpha) and @PROTEIN$ (2) release from bovine trophoblast and endometrial tissues during short-term culture.	1	18436399-180
Two studies tested the hypothesis that eicosapentaenoic (20:5omega3; EPA), docosahexaenoic acids (22:6omega3; DHA) or linoleic acid (C18 :2omega6; @COMPOUND$) reduced bovine endometrial and trophoblast prostaglandin F(2alpha) (PGF (2alpha)) and prostaglandin E(2) (@PROTEIN$ (2)) release during short-term culture.	1	18436399-181
Two studies tested the hypothesis that eicosapentaenoic (20:5omega3; EPA), docosahexaenoic acids (22:6omega3; DHA) or linoleic acid (C18 :2omega6; @COMPOUND$) reduced bovine endometrial and trophoblast prostaglandin F(2alpha) (@PROTEIN$ (2alpha)) and prostaglandin E(2) (PGE (2)) release during short-term culture.	1	18436399-181
Two studies tested the hypothesis that eicosapentaenoic (20:5omega3; EPA), @COMPOUND$ (22:6omega3; DHA) or linoleic acid (C18 :2omega6; LIN) reduced bovine endometrial and trophoblast prostaglandin F(2alpha) (PGF (2alpha)) and prostaglandin E(2) (@PROTEIN$ (2)) release during short-term culture.	1	18436399-181
Two studies tested the hypothesis that eicosapentaenoic (20:5omega3; EPA), docosahexaenoic acids (22:6omega3; DHA) or @COMPOUND$ (C18 :2omega6; LIN) reduced bovine endometrial and trophoblast prostaglandin F(2alpha) (PGF (2alpha)) and prostaglandin E(2) (@PROTEIN$ (2)) release during short-term culture.	1	18436399-181
Two studies tested the hypothesis that eicosapentaenoic (20:5omega3; EPA), docosahexaenoic acids (22:6omega3; DHA) or @COMPOUND$ (C18 :2omega6; LIN) reduced bovine endometrial and trophoblast prostaglandin F(2alpha) (@PROTEIN$ (2alpha)) and prostaglandin E(2) (PGE (2)) release during short-term culture.	1	18436399-181
Two studies tested the hypothesis that eicosapentaenoic (20:5omega3; EPA), @COMPOUND$ (22:6omega3; DHA) or linoleic acid (C18 :2omega6; LIN) reduced bovine endometrial and trophoblast prostaglandin F(2alpha) (@PROTEIN$ (2alpha)) and prostaglandin E(2) (PGE (2)) release during short-term culture.	1	18436399-181
@PROTEIN$ (DXS) catalyses the first committed step of the 2C-methyl-D-erythritol-4-phosphate (@COMPOUND$) pathway, which is an alternative isoprenoids biosynthetic route that has been recently discovered.	1	18437529-872
@PROTEIN$ (DXS) catalyses the first committed step of the 2C-methyl-@COMPOUND$ (MEP) pathway, which is an alternative isoprenoids biosynthetic route that has been recently discovered.	1	18437529-872
To get insight into the underlying mechanisms, we compared the ability of recombinant wild type and variant (D327N) @PROTEIN$ to influence @COMPOUND$ effects in MCF-7 breast cancer cells.	1	18437557-896
D327N @PROTEIN$ was more effective than wild type protein in inhibiting @COMPOUND$-induced cell proliferation and anti-apoptosis.	1	18437557-897
Our results suggest that @COMPOUND$)-induced changes in cytokine secretion by monocytes are diverse and may be influenced by Nrf2 but are not likely influenced by changes in whole-cell @PROTEIN$ levels.	1	18437699-978
Our results suggest that @COMPOUND$)-induced changes in cytokine secretion by monocytes are diverse and may be influenced by @PROTEIN$ but are not likely influenced by changes in whole-cell Trx1 levels.	1	18437699-978
To test the hypothesis that increasing @COMPOUND$ levels is associated with improved @PROTEIN$ resistance in patients with polycystic ovary syndrome (PCOS).	1	18439591-271
Packed cell volume, total protein, creatinine, blood @COMPOUND$ nitrogen, and @PROTEIN$ concentrations decreased while foals were on PN, while serum chloride concentration increased.	0	18440842-362
Packed cell volume, total protein, creatinine, blood urea nitrogen, and @PROTEIN$ concentrations decreased while foals were on PN, while serum @COMPOUND$ concentration increased.	0	18440842-362
Packed cell volume, total protein, creatinine, blood urea @COMPOUND$, and @PROTEIN$ concentrations decreased while foals were on PN, while serum chloride concentration increased.	0	18440842-362
Packed cell volume, total protein, @COMPOUND$, blood urea nitrogen, and @PROTEIN$ concentrations decreased while foals were on PN, while serum chloride concentration increased.	0	18440842-362
The gene expressions of CYP1A1 and @PROTEIN$ in the placenta increased significantly in @COMPOUND$-treated groups on GD 15 and GD 18, but returned to the level similar to the corresponding control on GD 21.	1	18442069-1161
The gene expressions of @PROTEIN$ and CYP2E1 in the placenta increased significantly in @COMPOUND$-treated groups on GD 15 and GD 18, but returned to the level similar to the corresponding control on GD 21.	1	18442069-1161
In @COMPOUND$ group, there was a decrease of @PROTEIN$ expression on GD 15, GD 18, and GD 21, with the most significant decrease on GD 15.	1	18442069-1162
The present study was designed to understand the effects of sublethal concentrations of @COMPOUND$ (DIC) on hematological constituent (red blood corpuscles, white blood corpuscles (WBC), mean cell volume, mean corpuscular hemoglobin, mean corpuscular hemoglobin concentration, platelet counts, hemoglobin and hematocrite levels) and serum damage marker enzymes (@PROTEIN$, alanin aminotransferase, alkaline phosphatase, and lactate dehydrogenase) in rats at subacute period under laboratory conditions.	0	18442070-1163
The present study was designed to understand the effects of sublethal concentrations of @COMPOUND$ (DIC) on hematological constituent (red blood corpuscles, white blood corpuscles (WBC), mean cell volume, mean corpuscular hemoglobin, mean corpuscular hemoglobin concentration, platelet counts, hemoglobin and hematocrite levels) and serum damage marker enzymes (aspartate aminotransferase, alanin aminotransferase, @PROTEIN$, and lactate dehydrogenase) in rats at subacute period under laboratory conditions.	0	18442070-1163
The present study was designed to understand the effects of sublethal concentrations of @COMPOUND$ (DIC) on hematological constituent (red blood corpuscles, white blood corpuscles (WBC), mean cell volume, mean corpuscular @PROTEIN$, mean corpuscular hemoglobin concentration, platelet counts, hemoglobin and hematocrite levels) and serum damage marker enzymes (aspartate aminotransferase, alanin aminotransferase, alkaline phosphatase, and lactate dehydrogenase) in rats at subacute period under laboratory conditions.	0	18442070-1163
Melatonin altered PHZ-induced responses significantly to a greater degree than @COMPOUND$ as evidenced by LPO status, @PROTEIN$ activity, and ABTS radical cation scavenging activity of antioxidants.	0	18442075-634
@COMPOUND$ altered PHZ-induced responses significantly to a greater degree than vitamin E as evidenced by LPO status, @PROTEIN$ activity, and ABTS radical cation scavenging activity of antioxidants.	1	18442075-634
@COMPOUND$ altered PHZ-induced responses significantly to a greater degree than vitamin E as evidenced by @PROTEIN$ status, SOD activity, and ABTS radical cation scavenging activity of antioxidants.	1	18442075-634
Melatonin altered @COMPOUND$-induced responses significantly to a greater degree than vitamin E as evidenced by LPO status, @PROTEIN$ activity, and ABTS radical cation scavenging activity of antioxidants.	0	18442075-634
Melatonin altered PHZ-induced responses significantly to a greater degree than vitamin E as evidenced by @PROTEIN$ status, SOD activity, and @COMPOUND$ scavenging activity of antioxidants.	0	18442075-634
Melatonin altered PHZ-induced responses significantly to a greater degree than vitamin E as evidenced by LPO status, @PROTEIN$ activity, and @COMPOUND$ scavenging activity of antioxidants.	0	18442075-634
Melatonin altered @COMPOUND$-induced responses significantly to a greater degree than vitamin E as evidenced by @PROTEIN$ status, SOD activity, and ABTS radical cation scavenging activity of antioxidants.	0	18442075-634
Melatonin altered PHZ-induced responses significantly to a greater degree than @COMPOUND$ as evidenced by @PROTEIN$ status, SOD activity, and ABTS radical cation scavenging activity of antioxidants.	0	18442075-634
The hydrolysis reaction of @COMPOUND$ catalyzed by @PROTEIN$ was followed with in situ UV/vis diode array spectrophotometry.	1	18443829-973
Five enzymes-Candida antarctica @PROTEIN$ B and Fusarium solani pisi cutinase wild-type and three single-mutation variants-were tested as catalysts in homogeneous conditions and immobilized on zeolite NaY, on a @COMPOUND$ support and as cross-linked aggregates.	0	18443829-974
Five enzymes-Candida antarctica @PROTEIN$ B and Fusarium solani pisi cutinase wild-type and three single-mutation variants-were tested as catalysts in homogeneous conditions and immobilized on zeolite @COMPOUND$, on a polyacrylate support and as cross-linked aggregates.	0	18443829-974
At term, the impact of their coexposure was assessed by evaluating lipid peroxidation (LPO), activities of superoxide dismutase (SOD), catalase, glutathione peroxidase (GPx), glutathione-S-transferase (@PROTEIN$), different ATPases and acetylcholinesterase (AChE) in erythrocytes, serum glucose, and levels of glutathione (@COMPOUND$) and glycosylated hemoglobin (GHb) in blood.	0	18443843-1157
At term, the impact of their coexposure was assessed by evaluating lipid peroxidation (LPO), activities of superoxide dismutase (SOD), catalase, @COMPOUND$ peroxidase (GPx), glutathione-S-transferase (@PROTEIN$), different ATPases and acetylcholinesterase (AChE) in erythrocytes, serum glucose, and levels of glutathione (GSH) and glycosylated hemoglobin (GHb) in blood.	0	18443843-1157
At term, the impact of their coexposure was assessed by evaluating lipid peroxidation (LPO), activities of superoxide dismutase (SOD), @PROTEIN$, glutathione peroxidase (GPx), glutathione-S-transferase (GST), different ATPases and acetylcholinesterase (AChE) in erythrocytes, serum @COMPOUND$, and levels of glutathione (GSH) and glycosylated hemoglobin (GHb) in blood.	0	18443843-1157
At term, the impact of their coexposure was assessed by evaluating lipid peroxidation (LPO), activities of @PROTEIN$ (SOD), catalase, glutathione peroxidase (GPx), glutathione-S-transferase (GST), different ATPases and acetylcholinesterase (AChE) in erythrocytes, serum glucose, and levels of glutathione (@COMPOUND$) and glycosylated hemoglobin (GHb) in blood.	0	18443843-1157
At term, the impact of their coexposure was assessed by evaluating lipid peroxidation (LPO), activities of superoxide dismutase (SOD), catalase, glutathione peroxidase (GPx), glutathione-S-transferase (GST), different ATPases and acetylcholinesterase (AChE) in erythrocytes, serum glucose, and levels of glutathione (@COMPOUND$) and glycosylated @PROTEIN$ (GHb) in blood.	0	18443843-1157
At term, the impact of their coexposure was assessed by evaluating lipid peroxidation (LPO), activities of superoxide dismutase (@PROTEIN$), catalase, glutathione peroxidase (GPx), glutathione-S-transferase (GST), different ATPases and acetylcholinesterase (AChE) in erythrocytes, serum glucose, and levels of glutathione (@COMPOUND$) and glycosylated hemoglobin (GHb) in blood.	0	18443843-1157
At term, the impact of their coexposure was assessed by evaluating lipid peroxidation (LPO), activities of superoxide dismutase (SOD), catalase, @COMPOUND$ peroxidase (GPx), glutathione-S-transferase (GST), different ATPases and acetylcholinesterase (@PROTEIN$) in erythrocytes, serum glucose, and levels of glutathione (GSH) and glycosylated hemoglobin (GHb) in blood.	0	18443843-1157
At term, the impact of their coexposure was assessed by evaluating lipid peroxidation (@PROTEIN$), activities of superoxide dismutase (SOD), catalase, glutathione peroxidase (GPx), glutathione-S-transferase (GST), different ATPases and acetylcholinesterase (AChE) in erythrocytes, serum glucose, and levels of glutathione (@COMPOUND$) and glycosylated hemoglobin (GHb) in blood.	0	18443843-1157
At term, the impact of their coexposure was assessed by evaluating lipid peroxidation (LPO), activities of superoxide dismutase (SOD), catalase, glutathione peroxidase (GPx), @PROTEIN$ (GST), different ATPases and acetylcholinesterase (AChE) in erythrocytes, serum @COMPOUND$, and levels of glutathione (GSH) and glycosylated hemoglobin (GHb) in blood.	0	18443843-1157
At term, the impact of their coexposure was assessed by evaluating lipid peroxidation (LPO), activities of superoxide dismutase (SOD), catalase, glutathione peroxidase (GPx), glutathione-S-transferase (GST), different ATPases and @PROTEIN$ (AChE) in erythrocytes, serum @COMPOUND$, and levels of glutathione (GSH) and glycosylated hemoglobin (GHb) in blood.	0	18443843-1157
At term, the impact of their coexposure was assessed by evaluating lipid peroxidation (LPO), activities of superoxide dismutase (@PROTEIN$), catalase, @COMPOUND$ peroxidase (GPx), glutathione-S-transferase (GST), different ATPases and acetylcholinesterase (AChE) in erythrocytes, serum glucose, and levels of glutathione (GSH) and glycosylated hemoglobin (GHb) in blood.	0	18443843-1157
At term, the impact of their coexposure was assessed by evaluating lipid peroxidation (LPO), activities of @PROTEIN$ (SOD), catalase, glutathione peroxidase (GPx), glutathione-S-transferase (GST), different ATPases and acetylcholinesterase (AChE) in erythrocytes, serum @COMPOUND$, and levels of glutathione (GSH) and glycosylated hemoglobin (GHb) in blood.	0	18443843-1157
At term, the impact of their coexposure was assessed by evaluating lipid peroxidation (LPO), activities of superoxide dismutase (SOD), catalase, @PROTEIN$ (GPx), glutathione-S-transferase (GST), different ATPases and acetylcholinesterase (AChE) in erythrocytes, serum @COMPOUND$, and levels of glutathione (GSH) and glycosylated hemoglobin (GHb) in blood.	0	18443843-1157
At term, the impact of their coexposure was assessed by evaluating lipid peroxidation (LPO), activities of superoxide dismutase (SOD), @PROTEIN$, @COMPOUND$ peroxidase (GPx), glutathione-S-transferase (GST), different ATPases and acetylcholinesterase (AChE) in erythrocytes, serum glucose, and levels of glutathione (GSH) and glycosylated hemoglobin (GHb) in blood.	0	18443843-1157
At term, the impact of their coexposure was assessed by evaluating lipid peroxidation (LPO), activities of superoxide dismutase (SOD), catalase, @COMPOUND$ peroxidase (GPx), glutathione-S-transferase (GST), different ATPases and @PROTEIN$ (AChE) in erythrocytes, serum glucose, and levels of glutathione (GSH) and glycosylated hemoglobin (GHb) in blood.	0	18443843-1157
At term, the impact of their coexposure was assessed by evaluating lipid peroxidation (LPO), activities of superoxide dismutase (SOD), catalase, glutathione peroxidase (GPx), glutathione-S-transferase (GST), different ATPases and acetylcholinesterase (AChE) in erythrocytes, serum @COMPOUND$, and levels of glutathione (GSH) and glycosylated @PROTEIN$ (GHb) in blood.	0	18443843-1157
At term, the impact of their coexposure was assessed by evaluating lipid peroxidation (LPO), activities of superoxide dismutase (SOD), catalase, @PROTEIN$ (GPx), glutathione-S-transferase (GST), different ATPases and acetylcholinesterase (AChE) in erythrocytes, serum glucose, and levels of glutathione (@COMPOUND$) and glycosylated hemoglobin (GHb) in blood.	0	18443843-1157
At term, the impact of their coexposure was assessed by evaluating lipid peroxidation (@PROTEIN$), activities of superoxide dismutase (SOD), catalase, @COMPOUND$ peroxidase (GPx), glutathione-S-transferase (GST), different ATPases and acetylcholinesterase (AChE) in erythrocytes, serum glucose, and levels of glutathione (GSH) and glycosylated hemoglobin (GHb) in blood.	0	18443843-1157
At term, the impact of their coexposure was assessed by evaluating lipid peroxidation (LPO), activities of superoxide dismutase (SOD), catalase, glutathione peroxidase (GPx), glutathione-S-transferase (GST), different ATPases and acetylcholinesterase (@PROTEIN$) in erythrocytes, serum @COMPOUND$, and levels of glutathione (GSH) and glycosylated hemoglobin (GHb) in blood.	0	18443843-1157
At term, the impact of their coexposure was assessed by evaluating lipid peroxidation (LPO), activities of superoxide dismutase (SOD), catalase, glutathione peroxidase (GPx), @PROTEIN$ (GST), different ATPases and acetylcholinesterase (AChE) in erythrocytes, serum glucose, and levels of glutathione (@COMPOUND$) and glycosylated hemoglobin (GHb) in blood.	0	18443843-1157
At term, the impact of their coexposure was assessed by evaluating lipid peroxidation (LPO), activities of @PROTEIN$ (SOD), catalase, @COMPOUND$ peroxidase (GPx), glutathione-S-transferase (GST), different ATPases and acetylcholinesterase (AChE) in erythrocytes, serum glucose, and levels of glutathione (GSH) and glycosylated hemoglobin (GHb) in blood.	0	18443843-1157
At term, the impact of their coexposure was assessed by evaluating lipid peroxidation (LPO), activities of superoxide dismutase (@PROTEIN$), catalase, glutathione peroxidase (GPx), glutathione-S-transferase (GST), different ATPases and acetylcholinesterase (AChE) in erythrocytes, serum @COMPOUND$, and levels of glutathione (GSH) and glycosylated hemoglobin (GHb) in blood.	0	18443843-1157
At term, the impact of their coexposure was assessed by evaluating lipid peroxidation (@PROTEIN$), activities of superoxide dismutase (SOD), catalase, glutathione peroxidase (GPx), glutathione-S-transferase (GST), different ATPases and acetylcholinesterase (AChE) in erythrocytes, serum @COMPOUND$, and levels of glutathione (GSH) and glycosylated hemoglobin (GHb) in blood.	0	18443843-1157
At term, the impact of their coexposure was assessed by evaluating lipid peroxidation (LPO), activities of superoxide dismutase (SOD), catalase, glutathione peroxidase (GPx), glutathione-S-transferase (GST), different ATPases and @PROTEIN$ (AChE) in erythrocytes, serum glucose, and levels of glutathione (@COMPOUND$) and glycosylated hemoglobin (GHb) in blood.	0	18443843-1157
At term, the impact of their coexposure was assessed by evaluating lipid peroxidation (LPO), activities of superoxide dismutase (SOD), catalase, glutathione peroxidase (GPx), glutathione-S-transferase (GST), different ATPases and acetylcholinesterase (@PROTEIN$) in erythrocytes, serum glucose, and levels of glutathione (@COMPOUND$) and glycosylated hemoglobin (GHb) in blood.	0	18443843-1157
At term, the impact of their coexposure was assessed by evaluating lipid peroxidation (LPO), activities of superoxide dismutase (SOD), catalase, @COMPOUND$ peroxidase (GPx), @PROTEIN$ (GST), different ATPases and acetylcholinesterase (AChE) in erythrocytes, serum glucose, and levels of glutathione (GSH) and glycosylated hemoglobin (GHb) in blood.	0	18443843-1157
At term, the impact of their coexposure was assessed by evaluating lipid peroxidation (LPO), activities of superoxide dismutase (SOD), catalase, @COMPOUND$ peroxidase (GPx), glutathione-S-transferase (GST), different ATPases and acetylcholinesterase (AChE) in erythrocytes, serum glucose, and levels of glutathione (GSH) and glycosylated @PROTEIN$ (GHb) in blood.	0	18443843-1157
At term, the impact of their coexposure was assessed by evaluating lipid peroxidation (LPO), activities of superoxide dismutase (SOD), @PROTEIN$, glutathione peroxidase (GPx), glutathione-S-transferase (GST), different ATPases and acetylcholinesterase (AChE) in erythrocytes, serum glucose, and levels of glutathione (@COMPOUND$) and glycosylated hemoglobin (GHb) in blood.	0	18443843-1157
At term, the impact of their coexposure was assessed by evaluating lipid peroxidation (LPO), activities of superoxide dismutase (SOD), catalase, glutathione peroxidase (GPx), glutathione-S-transferase (@PROTEIN$), different ATPases and acetylcholinesterase (AChE) in erythrocytes, serum @COMPOUND$, and levels of glutathione (GSH) and glycosylated hemoglobin (GHb) in blood.	0	18443843-1157
@PROTEIN$ was decreased with @COMPOUND$ and the coexposure, but not with arsenic, whereas GSH was decreased with arsenic and endosulfan, but not with the coexposure.	1	18443843-1158
@PROTEIN$ was decreased with endosulfan and the coexposure, but not with arsenic, whereas @COMPOUND$ was decreased with arsenic and endosulfan, but not with the coexposure.	0	18443843-1158
@PROTEIN$ activity was decreased in the @COMPOUND$-treated and the coexposed birds.	1	18443843-1159
mRNA and protein levels of @PROTEIN$, Fas, and caspase-8, which are closely related to cell apoptosis by a death ligand/receptor-dependent apoptosis pathway, were increased by @COMPOUND$ treatment.	1	18443897-1003
mRNA and protein levels of TNF-alpha, @PROTEIN$, and caspase-8, which are closely related to cell apoptosis by a death ligand/receptor-dependent apoptosis pathway, were increased by @COMPOUND$ treatment.	1	18443897-1003
In addition, @COMPOUND$ treatment regulated mitochondria-dependent apoptosis pathways by inducing the up-regulation of caspase-9 and caspase-3 and the down-regulation of @PROTEIN$ in hepa1c1c 7 cells.	1	18443897-1004
Taken together, the findings of this study have demonstrated that @COMPOUND$ could induce apoptosis in hepa1c1c7 cells by regulating @PROTEIN$ and inhibiting the expression of Bcl-2.	1	18443897-1005
Taken together, the findings of this study have demonstrated that @COMPOUND$ could induce apoptosis in hepa1c1c7 cells by regulating Fas ligands and inhibiting the expression of @PROTEIN$.	1	18443897-1005
@COMPOUND$ is known to bind @PROTEIN$, beta1 integrin and focal adhesion kinase, members of focal contacts, multi-protein complexes that mediate cell adhesion to the extracellular matrix.	1	18445079-363
Furthermore, free radical overproduction and oxidative stress were associated with a significant decrease in hepatic @COMPOUND$ levels in septic mice, and with an excessive NO production attributed to the induction of the inducible isoform of NO synthase (@PROTEIN$).	0	18445307-585
In fact, hepatic @COMPOUND$ levels were significantly increased in the group of mice receiving the probiotic, and the increased @PROTEIN$ expression both in the colon and lungs was down-regulated in those mice treated with L. fermentum.	1	18445307-586
Furthermore, supplementation of specific inhibitors of @PROTEIN$, C4H and 4CL in elicited cell cultures led to suppressed accumulation of @COMPOUND$, which opens up interesting questions regarding the probable route of the biosynthesis of this phenolic acid in C. nucifera.	1	18448193-1146
Furthermore, supplementation of specific inhibitors of PAL, C4H and @PROTEIN$ in elicited cell cultures led to suppressed accumulation of @COMPOUND$, which opens up interesting questions regarding the probable route of the biosynthesis of this phenolic acid in C. nucifera.	1	18448193-1146
Furthermore, supplementation of specific inhibitors of PAL, @PROTEIN$ and 4CL in elicited cell cultures led to suppressed accumulation of @COMPOUND$, which opens up interesting questions regarding the probable route of the biosynthesis of this phenolic acid in C. nucifera.	1	18448193-1146
Imatinib is transported by P-glycoprotein (P-gp) and Breast Cancer Resistance Protein (@PROTEIN$), however, the exact impact of these transporters on absorption, distribution, metabolism and excretion (ADME) of @COMPOUND$ is not fully understood due to incomplete data.	1	18449471-648
Imatinib is transported by P-glycoprotein (P-gp) and @PROTEIN$ (BCRP), however, the exact impact of these transporters on absorption, distribution, metabolism and excretion (ADME) of @COMPOUND$ is not fully understood due to incomplete data.	1	18449471-648
@COMPOUND$ is transported by P-@PROTEIN$ (P-gp) and Breast Cancer Resistance Protein (BCRP), however, the exact impact of these transporters on absorption, distribution, metabolism and excretion (ADME) of imatinib is not fully understood due to incomplete data.	1	18449471-648
@COMPOUND$ is transported by P-glycoprotein (P-gp) and Breast Cancer Resistance Protein (@PROTEIN$), however, the exact impact of these transporters on absorption, distribution, metabolism and excretion (ADME) of imatinib is not fully understood due to incomplete data.	1	18449471-648
@COMPOUND$ is transported by P-glycoprotein (P-gp) and @PROTEIN$ (BCRP), however, the exact impact of these transporters on absorption, distribution, metabolism and excretion (ADME) of imatinib is not fully understood due to incomplete data.	1	18449471-648
Imatinib is transported by P-@PROTEIN$ (P-gp) and Breast Cancer Resistance Protein (BCRP), however, the exact impact of these transporters on absorption, distribution, metabolism and excretion (ADME) of @COMPOUND$ is not fully understood due to incomplete data.	1	18449471-648
In conclusion, P-gp and @PROTEIN$ have only a modest effect on the ADME of @COMPOUND$ in comparison to metabolic elimination.	1	18449471-650
The considerable drug-drug interaction observed with elacridar or @COMPOUND$ is only partly mediated by inhibition of P-gp and @PROTEIN$ and far more by the inhibition of other elimination pathways.	1	18449471-651
The considerable drug-drug interaction observed with @COMPOUND$ or pantoprazole is only partly mediated by inhibition of P-gp and @PROTEIN$ and far more by the inhibition of other elimination pathways.	1	18449471-651
There is clear evidence for TREK-1 and @PROTEIN$-1 in the heart and these channels are likely to regulate cardiac action potential duration through their regulation by stretch, @COMPOUND$, pH, and neurotransmitters.	1	18449536-687
There is clear evidence for @PROTEIN$-1 and TASK-1 in the heart and these channels are likely to regulate cardiac action potential duration through their regulation by stretch, @COMPOUND$, pH, and neurotransmitters.	1	18449536-687
@PROTEIN$-1 may also have a critical role in mediating the vasodilator response of resistance arteries to @COMPOUND$, thus contributing to their protective effect on the cardiovascular system.	1	18449536-688
Alumina ceramic particles, in comparison with @COMPOUND$ particles, hardly affect the expression of RANK-, @PROTEIN$-, and OPG-mRNA in the THP-1 human monocytic cell line.	0	18449944-953
Alumina ceramic particles, in comparison with @COMPOUND$ particles, hardly affect the expression of @PROTEIN$-, TNF-alpha-, and OPG-mRNA in the THP-1 human monocytic cell line.	0	18449944-953
Alumina ceramic particles, in comparison with @COMPOUND$ particles, hardly affect the expression of RANK-, TNF-alpha-, and @PROTEIN$-mRNA in the THP-1 human monocytic cell line.	0	18449944-953
@COMPOUND$-induced growth inhibition was associated with induction of Cdk inhibitor p21, inhibition of @PROTEIN$ D1 and activation of caspase-3.	1	18450412-1248
Three proteins, porcine somatotropin, bovine @PROTEIN$, and immunoglobulin, as well as materials with a strong calorimetric glass transition (T(g)), that is, @COMPOUND$ and poly(vinypyrrolidone) (PVP), were studied by both TSC and differential scanning calorimetry (DSC).	0	18452177-145
Three proteins, porcine @PROTEIN$, bovine serum albumin, and immunoglobulin, as well as materials with a strong calorimetric glass transition (T(g)), that is, @COMPOUND$ and poly(vinypyrrolidone) (PVP), were studied by both TSC and differential scanning calorimetry (DSC).	0	18452177-145
The recombinant protein exhibited high @PROTEIN$ activity and could catalyze the conversion of L:-Phe to @COMPOUND$.	0	18454352-1155
Only the @PROTEIN$ of pI 5.4 and superior to 7.6 hydrolyze the @COMPOUND$.	1	18456422-1170
To investigate this relationship, we used actively growing young Sprague-Dawley rats and @COMPOUND$, one of the angiogenesis inhibitor (AI) to reveal the relationship of angiogenesis in the effect of @PROTEIN$.	0	18457934-815
Functional polymorphisms in the @PROTEIN$ and serotonin transporter genes, and depression and fatigue induced by interferon-alpha and @COMPOUND$ treatment.	1	18458677-190
An alpha-numeric code for representing N-linked @COMPOUND$ structures in secreted @PROTEIN$.	1	18458952-1204
Towards this end, we propose a fixed-length alpha-numeric code for representing N-linked @COMPOUND$ structures commonly found in secreted @PROTEIN$ from mammalian cell cultures.	1	18458952-1205
There was a significant increase in @PROTEIN$ oxidase activity at 2.5 mg/L, which might indicate @COMPOUND$'s disruption of the mitochondrial membrane and subsequently ATP synthesis.	1	18458994-119
There was a significant increase in @PROTEIN$ oxidase activity at 2.5 mg/L, which might indicate irgarol's disruption of the mitochondrial membrane and subsequently @COMPOUND$ synthesis.	1	18458994-119
Treatment of A549, which express wild-type @PROTEIN$, and H1299, which are p53-deficient, human lung cancer cells with @COMPOUND$ resulted in inhibition of cell proliferation and an increase in apoptotic cell death ; however, A549 cells were more sensitive to the berberine-induced cytotoxic effects than H1299 cells.	1	18459128-282
Furthermore @COMPOUND$ treatment markedly decreased the levels of TNF-alpha, IL-6 and MCP-1, reduced myocardial infiltration of macrophages and significantly increased myocardial and serum levels of the anti-inflammatory cytokine @PROTEIN$.	1	18459941-785
Furthermore @COMPOUND$ treatment markedly decreased the levels of TNF-alpha, IL-6 and @PROTEIN$, reduced myocardial infiltration of macrophages and significantly increased myocardial and serum levels of the anti-inflammatory cytokine IL-10.	1	18459941-785
Furthermore @COMPOUND$ treatment markedly decreased the levels of TNF-alpha, @PROTEIN$ and MCP-1, reduced myocardial infiltration of macrophages and significantly increased myocardial and serum levels of the anti-inflammatory cytokine IL-10.	1	18459941-785
Furthermore @COMPOUND$ treatment markedly decreased the levels of @PROTEIN$, IL-6 and MCP-1, reduced myocardial infiltration of macrophages and significantly increased myocardial and serum levels of the anti-inflammatory cytokine IL-10.	1	18459941-785
Our study suggests that the modulation of the balance between pro- and anti-inflammatory cytokines towards the anti-inflammatory cytokine @PROTEIN$ is one salutary mechanism underlying how @COMPOUND$ influences post-MI remodelling and thus improves LV function.	1	18459941-787
In addition, @COMPOUND$ treatment attenuated macrophage infiltration and inhibited urinary excretion of @PROTEIN$ (monocyte chemoattractant protein-1) and kidney cortex MCP-1 gene expression.	1	18459944-788
In addition, @COMPOUND$ treatment attenuated macrophage infiltration and inhibited urinary excretion of MCP-1 (@PROTEIN$) and kidney cortex MCP-1 gene expression.	1	18459944-788
Exogenous spermidine, arsenic and @COMPOUND$ modulate tobacco resistance to tobacco mosaic virus, and affect local and systemic glucosylsalicylic acid levels and @PROTEIN$ gene expression in tobacco leaves.	1	18462831-74
Exogenous @COMPOUND$, arsenic and beta-aminobutyric acid modulate tobacco resistance to tobacco mosaic virus, and affect local and systemic glucosylsalicylic acid levels and @PROTEIN$ gene expression in tobacco leaves.	1	18462831-74
Moreover, this phenotypic response was correlated with changes in the endogenous concentration of the SAR-related molecule @COMPOUND$ and in transcript levels of some pathogenesis/stress-related genes (pathogenesis-related proteins PR-1a and PR-2 and @PROTEIN$ (ADC)).	1	18462831-75
Moreover, this phenotypic response was correlated with changes in the endogenous concentration of the SAR-related molecule @COMPOUND$ and in transcript levels of some pathogenesis/stress-related genes (@PROTEIN$ PR-1a and PR-2 and arginine decarboxylase (ADC)).	1	18462831-75
Moreover, this phenotypic response was correlated with changes in the endogenous concentration of the SAR-related molecule @COMPOUND$ and in transcript levels of some pathogenesis/stress-related genes (pathogenesis-related proteins PR-1a and PR-2 and arginine decarboxylase (@PROTEIN$)).	1	18462831-75
Moreover, this phenotypic response was correlated with changes in the endogenous concentration of the SAR-related molecule @COMPOUND$ and in transcript levels of some pathogenesis/stress-related genes (pathogenesis-related proteins PR-1a and @PROTEIN$ and arginine decarboxylase (ADC)).	1	18462831-75
She had a mutation in @PROTEIN$ gene consisting of an aminoacid change of Alanine to @COMPOUND$ in exon 5 (A382V).	1	18462962-149
She had a mutation in @PROTEIN$ gene consisting of an aminoacid change of @COMPOUND$ to Valine in exon 5 (A382V).	1	18462962-149
Decreased hepatic @PROTEIN$ secretion is correlated with reduced hepatic @COMPOUND$ production but is not associated with insulin resistance in patients with liver cirrhosis.	1	18466349-969
Decreased hepatic RBP4 secretion is correlated with reduced hepatic @COMPOUND$ production but is not associated with @PROTEIN$ resistance in patients with liver cirrhosis.	0	18466349-969
@COMPOUND$-induced growth suppression was associated with inactivation of downstream targets of mTOR, reduction in VEGF expression and microvessel density, inhibition of cell proliferation, up-regulation of p27 (Kip1) and down-regulation of p21 (@PROTEIN$/Waf1), Cdk-6, Cdk-2, Cdk-4, cdc-25C, cyclin B1 and c-Myc.	1	18466352-971
@COMPOUND$-induced growth suppression was associated with inactivation of downstream targets of mTOR, reduction in VEGF expression and microvessel density, inhibition of cell proliferation, up-regulation of @PROTEIN$ (Kip1) and down-regulation of p21 (Cip1/Waf1), Cdk-6, Cdk-2, Cdk-4, cdc-25C, cyclin B1 and c-Myc.	1	18466352-971
@COMPOUND$-induced growth suppression was associated with inactivation of downstream targets of mTOR, reduction in @PROTEIN$ expression and microvessel density, inhibition of cell proliferation, up-regulation of p27 (Kip1) and down-regulation of p21 (Cip1/Waf1), Cdk-6, Cdk-2, Cdk-4, cdc-25C, cyclin B1 and c-Myc.	1	18466352-971
@COMPOUND$-induced growth suppression was associated with inactivation of downstream targets of mTOR, reduction in VEGF expression and microvessel density, inhibition of cell proliferation, up-regulation of p27 (Kip1) and down-regulation of p21 (Cip1/Waf1), @PROTEIN$-6, Cdk-2, Cdk-4, cdc-25C, cyclin B1 and c-Myc.	1	18466352-971
@COMPOUND$-induced growth suppression was associated with inactivation of downstream targets of mTOR, reduction in VEGF expression and microvessel density, inhibition of cell proliferation, up-regulation of p27 (Kip1) and down-regulation of p21 (Cip1/Waf1), Cdk-6, Cdk-2, Cdk-4, cdc-25C, cyclin B1 and @PROTEIN$.	1	18466352-971
@COMPOUND$-induced growth suppression was associated with inactivation of downstream targets of mTOR, reduction in VEGF expression and microvessel density, inhibition of cell proliferation, up-regulation of p27 (Kip1) and down-regulation of p21 (Cip1/@PROTEIN$), Cdk-6, Cdk-2, Cdk-4, cdc-25C, cyclin B1 and c-Myc.	1	18466352-971
@COMPOUND$-induced growth suppression was associated with inactivation of downstream targets of mTOR, reduction in VEGF expression and microvessel density, inhibition of cell proliferation, up-regulation of p27 (Kip1) and down-regulation of @PROTEIN$ (Cip1/Waf1), Cdk-6, Cdk-2, Cdk-4, cdc-25C, cyclin B1 and c-Myc.	1	18466352-971
@COMPOUND$-induced growth suppression was associated with inactivation of downstream targets of mTOR, reduction in VEGF expression and microvessel density, inhibition of cell proliferation, up-regulation of p27 (Kip1) and down-regulation of p21 (Cip1/Waf1), Cdk-6, Cdk-2, Cdk-4, cdc-25C, @PROTEIN$ B1 and c-Myc.	1	18466352-971
@COMPOUND$-induced growth suppression was associated with inactivation of downstream targets of @PROTEIN$, reduction in VEGF expression and microvessel density, inhibition of cell proliferation, up-regulation of p27 (Kip1) and down-regulation of p21 (Cip1/Waf1), Cdk-6, Cdk-2, Cdk-4, cdc-25C, cyclin B1 and c-Myc.	1	18466352-971
A series of @COMPOUND$-substituted 4-(6-alkylpyridin-2-yl)-5-(quinoxalin-6-yl)imidazoles have been synthesized and evaluated for their @PROTEIN$ inhibitory activity in cell-based luciferase reporter assays.	1	18467006-128
Genetic variation in @PROTEIN$ (cholesteryl ester transfer protein) has been clearly associated with HDL @COMPOUND$ levels but its association with cardiovascular disease and related phenotypes has been more controversial, possibly due to variability of polymorphisms and their frequencies across different ethnic populations.	1	18468607-1101
Genetic variation in CETP (@PROTEIN$) has been clearly associated with HDL @COMPOUND$ levels but its association with cardiovascular disease and related phenotypes has been more controversial, possibly due to variability of polymorphisms and their frequencies across different ethnic populations.	1	18468607-1101
However, @COMPOUND$ exhibited more potency in reducing @PROTEIN$ activity than methiocarb.	1	18470629-1072
However, methomyl exhibited more potency in reducing @PROTEIN$ activity than @COMPOUND$.	1	18470629-1072
Early and late 2-cell and late 4-cell stage embryos, prepared by in vitro fertilization (IVF), parthenogenetic activation (PG), and nuclear transfer of mouse embryonic fibroblast (MEF) and mouse HM1 embryonic stem cells (HM1), were processed for autoradiography following (3)H-@COMPOUND$ incubation (transcriptional activity), transmission electron microscopy (ultrastructure) and immunofluorescence (nucleolar proteins; upstream binding factor, UBF and @PROTEIN$, B23).	0	18470874-1230
Early and late 2-cell and late 4-cell stage embryos, prepared by in vitro fertilization (IVF), parthenogenetic activation (PG), and nuclear transfer of mouse embryonic fibroblast (MEF) and mouse HM1 embryonic stem cells (HM1), were processed for autoradiography following (3)H-@COMPOUND$ incubation (transcriptional activity), transmission electron microscopy (ultrastructure) and immunofluorescence (nucleolar proteins; upstream binding factor, @PROTEIN$ and nucleophosmin, B23).	0	18470874-1230
Early and late 2-cell and late 4-cell stage embryos, prepared by in vitro fertilization (IVF), parthenogenetic activation (PG), and nuclear transfer of mouse embryonic fibroblast (MEF) and mouse HM1 embryonic stem cells (HM1), were processed for autoradiography following (3)H-@COMPOUND$ incubation (transcriptional activity), transmission electron microscopy (ultrastructure) and immunofluorescence (nucleolar proteins; upstream binding factor, UBF and nucleophosmin, @PROTEIN$).	0	18470874-1230
Furthermore, among the ROS scavenging antioxidant defense genes studied here, mRNA levels of salicylic acid-binding (SAbind) catalase (CAT) and lignin-forming @PROTEIN$ (POX) were found to be increased by proline and @COMPOUND$ under salt stress.	1	18471929-584
Furthermore, among the ROS scavenging antioxidant defense genes studied here, mRNA levels of salicylic acid-binding (SAbind) catalase (CAT) and lignin-forming peroxidase (@PROTEIN$) were found to be increased by @COMPOUND$ and betaine under salt stress.	1	18471929-584
Furthermore, among the ROS scavenging antioxidant defense genes studied here, mRNA levels of salicylic acid-binding (SAbind) catalase (CAT) and lignin-forming @PROTEIN$ (POX) were found to be increased by @COMPOUND$ and betaine under salt stress.	1	18471929-584
Furthermore, among the ROS scavenging antioxidant defense genes studied here, mRNA levels of salicylic acid-binding (SAbind) catalase (@PROTEIN$) and lignin-forming peroxidase (POX) were found to be increased by @COMPOUND$ and betaine under salt stress.	1	18471929-584
Furthermore, among the ROS scavenging antioxidant defense genes studied here, mRNA levels of salicylic acid-binding (SAbind) catalase (@PROTEIN$) and lignin-forming peroxidase (POX) were found to be increased by proline and @COMPOUND$ under salt stress.	1	18471929-584
Furthermore, among the ROS scavenging antioxidant defense genes studied here, mRNA levels of salicylic acid-binding (SAbind) @PROTEIN$ (CAT) and lignin-forming peroxidase (POX) were found to be increased by @COMPOUND$ and betaine under salt stress.	1	18471929-584
Furthermore, among the ROS scavenging antioxidant defense genes studied here, mRNA levels of salicylic acid-binding (SAbind) @PROTEIN$ (CAT) and lignin-forming peroxidase (POX) were found to be increased by proline and @COMPOUND$ under salt stress.	1	18471929-584
Furthermore, among the ROS scavenging antioxidant defense genes studied here, mRNA levels of salicylic acid-binding (SAbind) catalase (CAT) and lignin-forming peroxidase (@PROTEIN$) were found to be increased by proline and @COMPOUND$ under salt stress.	1	18471929-584
Significant @PROTEIN$ activity changes, sensitivity of isozyme patterns (Mr of 60, 64, and 85kDa) and increased variation in ALP plasticity during acute exposure to @COMPOUND$ point to its possible aplication as an exposure biomarker.	1	18472163-737
To decrease the level of androgen @COMPOUND$ in the prostate, we are interested in developing inhibitors of 17beta-hydroxysteroid dehydrogenase type 5 (@PROTEIN$).	0	18472187-928
To decrease the level of androgen @COMPOUND$ in the prostate, we are interested in developing inhibitors of @PROTEIN$ (17beta-HSD5).	0	18472187-928
A role for guanosine 3',5'-cyclic monophosphate (cGMP) and the @PROTEIN$ G (PKG) pathway in synaptic long-term depression (LTD) in the hippocampal CA1 region has been proposed, based on observations in vitro, where, for example, increases of (cGMP) result in short-term depression (STD) coupled with a reduction in presynaptic @COMPOUND$ release.	0	18472342-221
A role for @COMPOUND$ (cGMP) and the @PROTEIN$ G (PKG) pathway in synaptic long-term depression (LTD) in the hippocampal CA1 region has been proposed, based on observations in vitro, where, for example, increases of (cGMP) result in short-term depression (STD) coupled with a reduction in presynaptic glutamate release.	0	18472342-221
A role for guanosine 3',5'-cyclic monophosphate (@COMPOUND$) and the @PROTEIN$ G (PKG) pathway in synaptic long-term depression (LTD) in the hippocampal CA1 region has been proposed, based on observations in vitro, where, for example, increases of (cGMP) result in short-term depression (STD) coupled with a reduction in presynaptic glutamate release.	0	18472342-221
Application of an inhibitor of soluble guanylate @PROTEIN$ prevented LTD induced by low-frequency stimulation (LFS), and impaired LFS-STD elicited in the presence of @COMPOUND$.	0	18472342-222
Application of an inhibitor of soluble guanylate cyclase prevented LTD induced by low-frequency stimulation (LFS), and impaired LFS-@PROTEIN$ elicited in the presence of @COMPOUND$.	1	18472342-222
@PROTEIN$ (EC 3.2.1.52) are lysosomal enzymes that remove terminal beta-glycosidically bound N-acetylglucosamine and @COMPOUND$ residues from a number of glycoconjugates.	1	18473163-133
@PROTEIN$ (EC 3.2.1.52) are lysosomal enzymes that remove terminal beta-glycosidically bound @COMPOUND$ and N-acetylgalactosamine residues from a number of glycoconjugates.	1	18473163-133
Overexpression of @PROTEIN$ induces HepG2 cells death by the AMP kinase activator @COMPOUND$ (AICAR).	1	18473182-143
Distribution of the @PROTEIN$ in the diencephalon and the pituitary gland in goats: Co-localisation with corticotrophin releasing hormone, @COMPOUND$ and corticotrophs.	0	18474445-915
@COMPOUND$ induced apoptosis in androgen-dependent PWR-1E cells via a caspase-dependent and @PROTEIN$-independent mechanism.	1	18475288-1020
In androgen-independent PC-3 cells, @COMPOUND$ also induced apoptosis by mechanisms that were partially inhibited by pan-caspase inhibition but were partially @PROTEIN$ dependent.	1	18475288-1021
A differential regulation of the two @COMPOUND$ synthesizing enzymes (GAD65 and @PROTEIN$) parallels GABAergic neuron differentiation.	1	18477686-347
A differential regulation of the two @COMPOUND$ synthesizing enzymes (@PROTEIN$ and GAD67) parallels GABAergic neuron differentiation.	1	18477686-347
The results showed that portal pressure and IHR, hepatic levels of PIIINP, hepatic collagen deposition, mRNA expression of PIIIP-alpha1 and TGF-beta1, protein expression of @PROTEIN$ and TXS, and production of @COMPOUND$ in liver perfusates were significantly decreased in UDCA-treated BDL rats.	0	18479249-96
The results showed that portal pressure and IHR, hepatic levels of PIIINP, hepatic collagen deposition, mRNA expression of PIIIP-@PROTEIN$ and TGF-beta1, protein expression of iNOS and TXS, and production of @COMPOUND$ in liver perfusates were significantly decreased in UDCA-treated BDL rats.	0	18479249-96
The results showed that portal pressure and IHR, hepatic levels of PIIINP, hepatic collagen deposition, mRNA expression of PIIIP-alpha1 and @PROTEIN$, protein expression of iNOS and TXS, and production of @COMPOUND$ in liver perfusates were significantly decreased in UDCA-treated BDL rats.	0	18479249-96
The results showed that portal pressure and IHR, hepatic levels of PIIINP, hepatic collagen deposition, mRNA expression of PIIIP-alpha1 and TGF-beta1, protein expression of iNOS and @PROTEIN$, and production of @COMPOUND$ in liver perfusates were significantly decreased in UDCA-treated BDL rats.	0	18479249-96
The increased levels of hepatic @COMPOUND$ and @PROTEIN$ activity and decreased levels of TBARS and nitrite were also observed in UDCA-treated BDL rats.	0	18479249-97
The production of rhG-@PROTEIN$ was induced by switching from growth on @COMPOUND$ to growth on methanol.	0	18479251-501
The production of rhG-@PROTEIN$ was induced by switching from growth on glycerol to growth on @COMPOUND$.	1	18479251-501
In the induction phase, the @COMPOUND$ feed rate had a significant effect on the specific expression rate of rhG-@PROTEIN$.	1	18479251-502
Under this condition, a maximum concentration of 300 mg/l of rhG-@PROTEIN$ and the expression yield of 0.6 mg of rhG-CSF/g of @COMPOUND$ were attained.	1	18479251-503
Among seven additives tested, @COMPOUND$, Tween 80 and betaine exhibited the best results in respect of preventing the formation of rhG-@PROTEIN$ protein aggregates.	1	18479251-504
Among seven additives tested, Tween 20, Tween 80 and @COMPOUND$ exhibited the best results in respect of preventing the formation of rhG-@PROTEIN$ protein aggregates.	1	18479251-504
@COMPOUND$ potently reduces vascular inflammation and arteriosclerosis in @PROTEIN$-deficient ApoE ko mice.	1	18479686-323
Hypercholesterolemia is associated with decreased vascular @COMPOUND$ bioavailability and deletion of endothelial nitric oxide synthase (@PROTEIN$) markedly accelerates atherosclerosis development in apolipoprotein E knockout (apoE ko) mice.	0	18479686-324
Hypercholesterolemia is associated with decreased vascular @COMPOUND$ bioavailability and deletion of endothelial @PROTEIN$ (eNOS) markedly accelerates atherosclerosis development in apolipoprotein E knockout (apoE ko) mice.	0	18479686-324
@COMPOUND$ induces apoptosis in colorectal carcinoma cells by modulating the @PROTEIN$ and p38 MAPK pathways.	1	18479896-454
@COMPOUND$ induces apoptosis in colorectal carcinoma cells by modulating the PI3 kinase and @PROTEIN$ pathways.	1	18479896-454
The protein inhibitors wortmannin (phosphoinositide 3 kinase inhibitor), PD 98059 (MEK inhibitor) and @COMPOUND$ (p38 inhibitor) as well as silencing RNA (small interfering RNA (siRNA)) of the @PROTEIN$ protein, were used to investigate cross-talk between signalling pathways.	0	18479896-455
The protein inhibitors wortmannin (@COMPOUND$ 3 kinase inhibitor), PD 98059 (MEK inhibitor) and SB 203580 (p38 inhibitor) as well as silencing RNA (small interfering RNA (siRNA)) of the @PROTEIN$ protein, were used to investigate cross-talk between signalling pathways.	0	18479896-455
The protein inhibitors @COMPOUND$ (phosphoinositide 3 kinase inhibitor), PD 98059 (MEK inhibitor) and SB 203580 (p38 inhibitor) as well as silencing RNA (small interfering RNA (siRNA)) of the @PROTEIN$ protein, were used to investigate cross-talk between signalling pathways.	0	18479896-455
The protein inhibitors wortmannin (phosphoinositide 3 kinase inhibitor), @COMPOUND$ (MEK inhibitor) and SB 203580 (p38 inhibitor) as well as silencing RNA (small interfering RNA (siRNA)) of the @PROTEIN$ protein, were used to investigate cross-talk between signalling pathways.	0	18479896-455
Feeding long-chain n-3 polyunsaturated fatty acids during gestation increases intestinal @COMPOUND$ absorption potentially via the acute activation of @PROTEIN$.	0	18479897-371
Feeding long-chain n-3 @COMPOUND$ during gestation increases intestinal glucose absorption potentially via the acute activation of @PROTEIN$.	1	18479897-371
Furthermore, adding @COMPOUND$ (DHA) or an AMP-activated protein kinase (@PROTEIN$.05) in intestinal preparations obtained from the offspring fed the control diet, devoid of the PFO product and containing minimal concentrations of n-3 PUFA.	0	18479897-373
Furthermore, adding @COMPOUND$ (DHA) or an AMP-activated @PROTEIN$ (AMPK.05) in intestinal preparations obtained from the offspring fed the control diet, devoid of the PFO product and containing minimal concentrations of n-3 PUFA.	0	18479897-373
Furthermore, adding @COMPOUND$ (DHA) or an @PROTEIN$-activated protein kinase (AMPK.05) in intestinal preparations obtained from the offspring fed the control diet, devoid of the PFO product and containing minimal concentrations of n-3 PUFA.	0	18479897-373
Prior to @COMPOUND$ supplementation, exercise induced a significant decrease in @PROTEIN$ activity, EMF, vitamin E concentration and a significant increase in MDA concentration at t+1d.	0	18479950-485
Prior to vitamin E supplementation, exercise induced a significant decrease in @PROTEIN$ activity, @COMPOUND$, vitamin E concentration and a significant increase in MDA concentration at t+1d.	0	18479950-485
After a 10 week vitamin E supplementation period, these exercise-induced changes in @PROTEIN$ activity, @COMPOUND$ and MDA concentration were still significant in the control group, but not in the supplemented group.	0	18479950-486
After a 10 week @COMPOUND$ supplementation period, these exercise-induced changes in @PROTEIN$ activity, EMF and MDA concentration were still significant in the control group, but not in the supplemented group.	1	18479950-486
In adulthood, @COMPOUND$ secreted by the testes is converted into estrogens by the preoptic @PROTEIN$.	1	18481266-77
The model was used to investigate how on-treatment @PROTEIN$ related to baseline CRP and estimated treatment effects with @COMPOUND$.	1	18481276-83
Hepatocyte growth factor, keratinocyte growth factor or @PROTEIN$ prevented the effect of @COMPOUND$ on cell permeability, but not on PGE (2) release.	1	18481313-107
Hepatocyte growth factor, keratinocyte growth factor or insulin prevented the effect of @COMPOUND$ on cell permeability, but not on @PROTEIN$ (2) release.	0	18481313-107
@PROTEIN$ stimulated PGE (2) release mediated the reversible effect of @COMPOUND$ on tight junctions and, meanwhile, contributed to cell survival.	1	18481313-108
Cyclooxygenase-2 stimulated @PROTEIN$ (2) release mediated the reversible effect of @COMPOUND$ on tight junctions and, meanwhile, contributed to cell survival.	1	18481313-108
Interestingly, @COMPOUND$ inhibited the expression of ICAM and @PROTEIN$, followed by the suppression of macrophage recruitment into the aortic wall at 1 week after operation.	1	18482727-966
In addition, synthesis of collagen and @PROTEIN$ in the vascular wall were significantly increased by @COMPOUND$.	1	18482727-967
Organic cations (@COMPOUND$) are primarily excreted via vectorial transport by various renal organic cation transporters (@PROTEIN$).	1	18484100-516
In a rat ARF model, induction of ARF by @COMPOUND$ (UN) treatment significantly decreased the levels of @PROTEIN$ (slc22a2) mRNA and protein in the kidney medulla.	1	18484100-517
In all final products, @COMPOUND$ used to prepare the @PROTEIN$/lipid mixture was below 20 ppm.	1	18484622-1118
Platelet reactivity and @COMPOUND$ resistance are associated with the H2 haplotype of the P2Y12-@PROTEIN$ receptor gene.	1	18485500-951
Platelet reactivity and @COMPOUND$ resistance are associated with the H2 haplotype of the @PROTEIN$-ADP receptor gene.	1	18485500-951
@COMPOUND$ up-regulates and activates @PROTEIN$-zeta in EBV-infected and EBV-transformed human B-cells.	1	18486150-336
We have proposed that @COMPOUND$ (CsA), despite being a @PROTEIN$, will activate PKC in B cells, thus promoting Epstein-Barr virus (EBV)-induced transformation.	1	18486150-337
We have proposed that @COMPOUND$ (CsA), despite being a calcineurin inhibitor, will activate @PROTEIN$ in B cells, thus promoting Epstein-Barr virus (EBV)-induced transformation.	1	18486150-337
Our results showed 2a, 2d and 2g as the most active compounds that inhibited the HIV-1 reverse @PROTEIN$ catalytic activity with cytotoxicity lower than @COMPOUND$ and SI higher than DDC and DDI.	1	18486994-189
@COMPOUND$ (4,3',5'-trihydroxystilbene) is a naturally occurring antioxidant that inhibits cyclooxygenase-1 (COX-1), @PROTEIN$ (COX-2) and the transcription factor NF-kappaB.	1	18487053-332
@COMPOUND$ (4,3',5'-trihydroxystilbene) is a naturally occurring antioxidant that inhibits @PROTEIN$ (COX-1), cyclooxygenase-2 (COX-2) and the transcription factor NF-kappaB.	1	18487053-332
@COMPOUND$ (4,3',5'-trihydroxystilbene) is a naturally occurring antioxidant that inhibits cyclooxygenase-1 (@PROTEIN$), cyclooxygenase-2 (COX-2) and the transcription factor NF-kappaB.	1	18487053-332
@COMPOUND$ (4,3',5'-trihydroxystilbene) is a naturally occurring antioxidant that inhibits cyclooxygenase-1 (COX-1), cyclooxygenase-2 (@PROTEIN$) and the transcription factor NF-kappaB.	1	18487053-332
After @COMPOUND$ stimulation of SV-FHAS and neoplastic astrocytes, real-time polymerase chain reaction showed an increase of the CPE, containing @PROTEIN$ splice variant only in astrocytoma cells.	0	18489490-99
Using both physiologically achievable (2 microM) and supraphysiological (10 microM) concentrations, we investigated the ability of @COMPOUND$ and its predominant human metabolites to attenuate the expression of vascular cell adhesion molecule-1 (VCAM-1), intercellular adhesion molecule-1 (ICAM-1) and monocyte chemoattractant protein-1 (MCP-1) in human umbilical artery smooth muscle cells (HUASMC) activated by tumor necrosis factor-alpha (@PROTEIN$).	0	18489909-317
Using both physiologically achievable (2 microM) and supraphysiological (10 microM) concentrations, we investigated the ability of @COMPOUND$ and its predominant human metabolites to attenuate the expression of vascular cell adhesion molecule-1 (VCAM-1), intercellular adhesion molecule-1 (ICAM-1) and @PROTEIN$ (MCP-1) in human umbilical artery smooth muscle cells (HUASMC) activated by tumor necrosis factor-alpha (TNFalpha).	0	18489909-317
Using both physiologically achievable (2 microM) and supraphysiological (10 microM) concentrations, we investigated the ability of @COMPOUND$ and its predominant human metabolites to attenuate the expression of vascular cell adhesion molecule-1 (VCAM-1), intercellular adhesion molecule-1 (ICAM-1) and monocyte chemoattractant protein-1 (MCP-1) in human umbilical artery smooth muscle cells (HUASMC) activated by @PROTEIN$-alpha (TNFalpha).	0	18489909-317
Using both physiologically achievable (2 microM) and supraphysiological (10 microM) concentrations, we investigated the ability of @COMPOUND$ and its predominant human metabolites to attenuate the expression of vascular cell adhesion molecule-1 (VCAM-1), intercellular adhesion molecule-1 (@PROTEIN$) and monocyte chemoattractant protein-1 (MCP-1) in human umbilical artery smooth muscle cells (HUASMC) activated by tumor necrosis factor-alpha (TNFalpha).	0	18489909-317
Using both physiologically achievable (2 microM) and supraphysiological (10 microM) concentrations, we investigated the ability of @COMPOUND$ and its predominant human metabolites to attenuate the expression of vascular cell adhesion molecule-1 (VCAM-1), intercellular adhesion molecule-1 (ICAM-1) and monocyte chemoattractant protein-1 (@PROTEIN$) in human umbilical artery smooth muscle cells (HUASMC) activated by tumor necrosis factor-alpha (TNFalpha).	0	18489909-317
Using both physiologically achievable (2 microM) and supraphysiological (10 microM) concentrations, we investigated the ability of @COMPOUND$ and its predominant human metabolites to attenuate the expression of vascular cell adhesion molecule-1 (@PROTEIN$), intercellular adhesion molecule-1 (ICAM-1) and monocyte chemoattractant protein-1 (MCP-1) in human umbilical artery smooth muscle cells (HUASMC) activated by tumor necrosis factor-alpha (TNFalpha).	0	18489909-317
@COMPOUND$ was able to reduce @PROTEIN$-induced upregulation of VCAM-1, ICAM-1 and MCP-1 at both the protein and transcript (mRNA) level in HUASMC.	1	18489909-318
@COMPOUND$ was able to reduce TNFalpha-induced upregulation of VCAM-1, @PROTEIN$ and MCP-1 at both the protein and transcript (mRNA) level in HUASMC.	1	18489909-318
@COMPOUND$ was able to reduce TNFalpha-induced upregulation of VCAM-1, ICAM-1 and @PROTEIN$ at both the protein and transcript (mRNA) level in HUASMC.	1	18489909-318
@COMPOUND$ was able to reduce TNFalpha-induced upregulation of @PROTEIN$, ICAM-1 and MCP-1 at both the protein and transcript (mRNA) level in HUASMC.	1	18489909-318
However the quercetin metabolites, @COMPOUND$, quercetin 3-glucuronide and 3'-methylquercetin 3-glucuronide, had no effect on @PROTEIN$-induced up regulation of adhesion molecule or chemokine expression, at either concentration tested.	0	18489909-319
In its active form, @COMPOUND$ (TPP), it is a co-enzyme for several enzymes, including @PROTEIN$.	1	18490188-482
Coexpression pattern with @PROTEIN$ provides an indication that @COMPOUND$ could be the modulator of these adaptive responses to involution and dietary P restriction.	1	18492032-354
Dietary chia seed (Salvia hispanica L.) rich in @COMPOUND$ improves adiposity and normalises hypertriacylglycerolaemia and @PROTEIN$ resistance in dyslipaemic rats.	1	18492301-527
The present study investigates the benefits of the dietary intake of chia seed (Salvia hispanica L.) rich in @COMPOUND$ and fibre upon dyslipidaemia and @PROTEIN$ resistance (IR), induced by intake of a sucrose-rich (62.5 %) diet (SRD).	0	18492301-528
The present study investigates the benefits of the dietary intake of chia seed (Salvia hispanica L.) rich in alpha-linolenic acid and fibre upon dyslipidaemia and @PROTEIN$ resistance (IR), induced by intake of a @COMPOUND$-rich (62.5 %) diet (SRD).	0	18492301-528
Pigs fed the high-@COMPOUND$ diet moreover had an increased concentration of trimethyllysine (TML), a reduced mRNA abundance of @PROTEIN$ and reduced concentrations of gamma-butyrobetaine (BB) in muscle, indicating that the conversion of TML into BB in muscle was impaired.	0	18492302-529
Pigs fed the high-lysine diet moreover had an increased concentration of @COMPOUND$ (TML), a reduced mRNA abundance of @PROTEIN$ and reduced concentrations of gamma-butyrobetaine (BB) in muscle, indicating that the conversion of TML into BB in muscle was impaired.	0	18492302-529
Pigs fed the high-lysine diet moreover had an increased concentration of trimethyllysine (TML), a reduced mRNA abundance of @PROTEIN$ and reduced concentrations of @COMPOUND$ (BB) in muscle, indicating that the conversion of TML into BB in muscle was impaired.	0	18492302-529
The cells exposed to 10 microM (@COMPOUND$ for 3 h or to 40 microM (15S)-HETE for 6 h showed increased expression of Fas ligand and @PROTEIN$ (Fas-associated death domain), caspase 8 activation, Bid (BH3-interacting domain death agonist) cleavage, decrease in mitochondrial membrane potential, cytochrome c release, caspase 3 activation, PARP-1 (poly(ADP-ribose) polymerase-1) cleavage and DNA fragmentation, suggesting the involvement of both extrinsic and intrinsic death pathways.	1	18494609-496
The cells exposed to 10 microM (@COMPOUND$ for 3 h or to 40 microM (15S)-HETE for 6 h showed increased expression of @PROTEIN$ ligand and FADD (Fas-associated death domain), caspase 8 activation, Bid (BH3-interacting domain death agonist) cleavage, decrease in mitochondrial membrane potential, cytochrome c release, caspase 3 activation, PARP-1 (poly(ADP-ribose) polymerase-1) cleavage and DNA fragmentation, suggesting the involvement of both extrinsic and intrinsic death pathways.	1	18494609-496
The cells exposed to 10 microM (15S)-HPETE for 3 h or to 40 microM (@COMPOUND$ for 6 h showed increased expression of Fas ligand and FADD (Fas-associated death domain), caspase 8 activation, Bid (@PROTEIN$) cleavage, decrease in mitochondrial membrane potential, cytochrome c release, caspase 3 activation, PARP-1 (poly(ADP-ribose) polymerase-1) cleavage and DNA fragmentation, suggesting the involvement of both extrinsic and intrinsic death pathways.	1	18494609-496
The cells exposed to 10 microM (15S)-HPETE for 3 h or to 40 microM (@COMPOUND$ for 6 h showed increased expression of @PROTEIN$ ligand and FADD (Fas-associated death domain), caspase 8 activation, Bid (BH3-interacting domain death agonist) cleavage, decrease in mitochondrial membrane potential, cytochrome c release, caspase 3 activation, PARP-1 (poly(ADP-ribose) polymerase-1) cleavage and DNA fragmentation, suggesting the involvement of both extrinsic and intrinsic death pathways.	1	18494609-496
The cells exposed to 10 microM (15S)-HPETE for 3 h or to 40 microM (@COMPOUND$ for 6 h showed increased expression of Fas ligand and FADD (Fas-associated death domain), caspase 8 activation, Bid (BH3-interacting domain death agonist) cleavage, decrease in mitochondrial membrane potential, cytochrome c release, caspase 3 activation, PARP-1 (poly(@PROTEIN$-ribose) polymerase-1) cleavage and DNA fragmentation, suggesting the involvement of both extrinsic and intrinsic death pathways.	1	18494609-496
The cells exposed to 10 microM (15S)-HPETE for 3 h or to 40 microM (@COMPOUND$ for 6 h showed increased expression of Fas ligand and FADD (Fas-associated death domain), caspase 8 activation, Bid (BH3-interacting domain death agonist) cleavage, decrease in mitochondrial membrane potential, @PROTEIN$ release, caspase 3 activation, PARP-1 (poly(ADP-ribose) polymerase-1) cleavage and DNA fragmentation, suggesting the involvement of both extrinsic and intrinsic death pathways.	1	18494609-496
The cells exposed to 10 microM (15S)-HPETE for 3 h or to 40 microM (@COMPOUND$ for 6 h showed increased expression of @PROTEIN$ and FADD (Fas-associated death domain), caspase 8 activation, Bid (BH3-interacting domain death agonist) cleavage, decrease in mitochondrial membrane potential, cytochrome c release, caspase 3 activation, PARP-1 (poly(ADP-ribose) polymerase-1) cleavage and DNA fragmentation, suggesting the involvement of both extrinsic and intrinsic death pathways.	1	18494609-496
The cells exposed to 10 microM (@COMPOUND$ for 3 h or to 40 microM (15S)-HETE for 6 h showed increased expression of @PROTEIN$ and FADD (Fas-associated death domain), caspase 8 activation, Bid (BH3-interacting domain death agonist) cleavage, decrease in mitochondrial membrane potential, cytochrome c release, caspase 3 activation, PARP-1 (poly(ADP-ribose) polymerase-1) cleavage and DNA fragmentation, suggesting the involvement of both extrinsic and intrinsic death pathways.	1	18494609-496
The cells exposed to 10 microM (15S)-HPETE for 3 h or to 40 microM (@COMPOUND$ for 6 h showed increased expression of Fas ligand and @PROTEIN$ (Fas-associated death domain), caspase 8 activation, Bid (BH3-interacting domain death agonist) cleavage, decrease in mitochondrial membrane potential, cytochrome c release, caspase 3 activation, PARP-1 (poly(ADP-ribose) polymerase-1) cleavage and DNA fragmentation, suggesting the involvement of both extrinsic and intrinsic death pathways.	1	18494609-496
The cells exposed to 10 microM (@COMPOUND$ for 3 h or to 40 microM (15S)-HETE for 6 h showed increased expression of Fas ligand and FADD (Fas-associated death domain), caspase 8 activation, Bid (BH3-interacting domain death agonist) cleavage, decrease in mitochondrial membrane potential, cytochrome c release, caspase 3 activation, PARP-1 (poly(@PROTEIN$-ribose) polymerase-1) cleavage and DNA fragmentation, suggesting the involvement of both extrinsic and intrinsic death pathways.	1	18494609-496
The cells exposed to 10 microM (15S)-HPETE for 3 h or to 40 microM (@COMPOUND$ for 6 h showed increased expression of Fas ligand and FADD (Fas-associated death domain), caspase 8 activation, Bid (BH3-interacting domain death agonist) cleavage, decrease in mitochondrial membrane potential, cytochrome c release, caspase 3 activation, @PROTEIN$ (poly(ADP-ribose) polymerase-1) cleavage and DNA fragmentation, suggesting the involvement of both extrinsic and intrinsic death pathways.	1	18494609-496
The cells exposed to 10 microM (@COMPOUND$ for 3 h or to 40 microM (15S)-HETE for 6 h showed increased expression of Fas ligand and FADD (Fas-associated death domain), caspase 8 activation, Bid (BH3-interacting domain death agonist) cleavage, decrease in mitochondrial membrane potential, @PROTEIN$ release, caspase 3 activation, PARP-1 (poly(ADP-ribose) polymerase-1) cleavage and DNA fragmentation, suggesting the involvement of both extrinsic and intrinsic death pathways.	1	18494609-496
The cells exposed to 10 microM (@COMPOUND$ for 3 h or to 40 microM (15S)-HETE for 6 h showed increased expression of Fas ligand and FADD (Fas-associated death domain), caspase 8 activation, Bid (@PROTEIN$) cleavage, decrease in mitochondrial membrane potential, cytochrome c release, caspase 3 activation, PARP-1 (poly(ADP-ribose) polymerase-1) cleavage and DNA fragmentation, suggesting the involvement of both extrinsic and intrinsic death pathways.	1	18494609-496
The cells exposed to 10 microM (@COMPOUND$ for 3 h or to 40 microM (15S)-HETE for 6 h showed increased expression of Fas ligand and FADD (Fas-associated death domain), caspase 8 activation, Bid (BH3-interacting domain death agonist) cleavage, decrease in mitochondrial membrane potential, cytochrome c release, caspase 3 activation, @PROTEIN$ (poly(ADP-ribose) polymerase-1) cleavage and DNA fragmentation, suggesting the involvement of both extrinsic and intrinsic death pathways.	1	18494609-496
@COMPOUND$ inhibits vasa vasorum neovascularization in aortas of @PROTEIN$ (-/-)/LDL(-/-) double knockout mice.	0	18495128-1028
@COMPOUND$ attenuates CD40-mediated endothelial cell activation and apoptosis by inhibiting CD40-induced @PROTEIN$ activation.	1	18495129-1029
@COMPOUND$ attenuates @PROTEIN$-mediated endothelial cell activation and apoptosis by inhibiting CD40-induced MAPK activation.	1	18495129-1029
Treatment of ECs with anthocyanins cyanidin-3-O-beta-glucoside (Cy-3-g) and @COMPOUND$ (Pn-3-g) prevents @PROTEIN$-induced endothelial activation by inhibiting production of proinflammatory cytokines and matrix metalloproteinases (MMPs).	1	18495129-1030
Collectively, our findings suggested that the inhibition of JNK and @PROTEIN$ activation interrupts CD40 induced endothelial cell activation and apoptosis, which thereby may represent a mechanism that would explain the anti-inflammatory response of @COMPOUND$ and its athero-protective function.	1	18495129-1031
Collectively, our findings suggested that the inhibition of @PROTEIN$ and p38 activation interrupts CD40 induced endothelial cell activation and apoptosis, which thereby may represent a mechanism that would explain the anti-inflammatory response of @COMPOUND$ and its athero-protective function.	1	18495129-1031
Collectively, our findings suggested that the inhibition of JNK and p38 activation interrupts @PROTEIN$ induced endothelial cell activation and apoptosis, which thereby may represent a mechanism that would explain the anti-inflammatory response of @COMPOUND$ and its athero-protective function.	1	18495129-1031
Postsynaptic action of @COMPOUND$ is mediated through metabotropic P2Y and ionotropic @PROTEIN$ receptors abundantly expressed in neural cells.	1	18495357-1187
However, the @PROTEIN$ C677T genotype, alone or together with a diet, influenced @COMPOUND$ (P=.03) and phosphatidylcholine (P=.03).	1	18495456-706
In addition, the @PROTEIN$ C677T genotype appears to influence the direction and use of @COMPOUND$ moieties in this group of women.	1	18495456-707
@COMPOUND$-induced survival was a rapid event that was accompanied by early and sustained activation of major survival signaling proteins, such as AKT/phosphatidylinositol 3-kinase and extracellular-regulated kinase (activated from 5 min to 18 h), as well as protein kinase C (PKC)-alpha (30 min to 18 h), in concert with unaltered c-@PROTEIN$ N-amino terminal kinase levels and early inactivation of key death-related signals like PKC-delta (5 min to 18 h).	1	18495458-1236
@COMPOUND$-induced survival was a rapid event that was accompanied by early and sustained activation of major survival signaling proteins, such as AKT/phosphatidylinositol 3-kinase and extracellular-regulated kinase (activated from 5 min to 18 h), as well as protein kinase C (@PROTEIN$)-alpha (30 min to 18 h), in concert with unaltered c-jun N-amino terminal kinase levels and early inactivation of key death-related signals like PKC-delta (5 min to 18 h).	1	18495458-1236
@COMPOUND$-induced survival was a rapid event that was accompanied by early and sustained activation of major survival signaling proteins, such as AKT/phosphatidylinositol 3-kinase and extracellular-regulated kinase (activated from 5 min to 18 h), as well as protein kinase C (PKC)-alpha (30 min to 18 h), in concert with unaltered c-jun N-amino terminal kinase levels and early inactivation of key death-related signals like @PROTEIN$ (5 min to 18 h).	1	18495458-1236
@COMPOUND$-induced survival was a rapid event that was accompanied by early and sustained activation of major survival signaling proteins, such as AKT/phosphatidylinositol 3-kinase and extracellular-regulated kinase (activated from 5 min to 18 h), as well as @PROTEIN$ (PKC)-alpha (30 min to 18 h), in concert with unaltered c-jun N-amino terminal kinase levels and early inactivation of key death-related signals like PKC-delta (5 min to 18 h).	1	18495458-1236
Phospholipidosis and down-regulation of the @PROTEIN$-K/PDK-1/Akt signalling pathway are @COMPOUND$ inhibitable events associated with 7-ketocholesterol-induced apoptosis.	1	18495460-1238
Phospholipidosis and down-regulation of the PI3-K/PDK-1/@PROTEIN$ signalling pathway are @COMPOUND$ inhibitable events associated with 7-ketocholesterol-induced apoptosis.	1	18495460-1238
Phospholipidosis and down-regulation of the PI3-K/@PROTEIN$-1/Akt signalling pathway are @COMPOUND$ inhibitable events associated with 7-ketocholesterol-induced apoptosis.	1	18495460-1238
"Lack of @COMPOUND$ significantly changed mucin (MUC) dynamics, as reflected by the enlarged goblet-cell ""cup"" area relative to controls; decreased @PROTEIN$ mRNA expression in the jejunum, ileum and colon of VAD rats and increased MUC3 mRNA expression in the ileum and colon of these rats."	1	18495461-1165
"Lack of @COMPOUND$ significantly changed mucin (MUC) dynamics, as reflected by the enlarged goblet-cell ""cup"" area relative to controls; decreased MUC2 mRNA expression in the jejunum, ileum and colon of VAD rats and increased @PROTEIN$ mRNA expression in the ileum and colon of these rats."	1	18495461-1165
In addition, @COMPOUND$ deficiency down-regulated @PROTEIN$ 6 mRNA expression while up-regulating toll-like receptors 2 and 5 mRNA expressions.	1	18495461-1166
@COMPOUND$, demethoxycurcumin and bisdemethoxycurcumin differentially inhibit cancer cell invasion through the down-regulation of MMPs and @PROTEIN$.	1	18495463-1243
Curcumin, demethoxycurcumin and @COMPOUND$ differentially inhibit cancer cell invasion through the down-regulation of MMPs and @PROTEIN$.	1	18495463-1243
Curcumin, @COMPOUND$ and bisdemethoxycurcumin differentially inhibit cancer cell invasion through the down-regulation of MMPs and @PROTEIN$.	1	18495463-1243
@PROTEIN$ antagonism augments @COMPOUND$-induced downregulation of the 5-HT transporter.	1	18496518-35
In contrast, chronic @COMPOUND$ markedly decreased 5-@PROTEIN$ levels in all regions.	1	18496518-37
This downregulation of 5-@PROTEIN$ by @COMPOUND$ and its enhancement by Org 34850 can explain our recent observation that GR antagonists augment the SSRI-induced increase in extracellular 5-HT.	1	18496518-38
Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants superoxide dismutase (SOD), catalase (CAT), glutathione S-transferase (@PROTEIN$), glutathione peroxidase (GPx), glutathione reductase (GR) and reduced glutathione (@COMPOUND$) were significantly diminished in DMH 0.05) elevated on simultaneous morin supplementation.	0	18496650-691
Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants superoxide dismutase (SOD), catalase (CAT), glutathione S-transferase (@PROTEIN$), glutathione peroxidase (GPx), glutathione reductase (GR) and reduced glutathione (GSH) were significantly diminished in DMH 0.05) elevated on simultaneous @COMPOUND$ supplementation.	1	18496650-691
Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants superoxide dismutase (SOD), catalase (@PROTEIN$), glutathione S-transferase (GST), glutathione peroxidase (GPx), glutathione reductase (GR) and reduced glutathione (GSH) were significantly diminished in DMH 0.05) elevated on simultaneous @COMPOUND$ supplementation.	1	18496650-691
Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants @PROTEIN$ (SOD), catalase (CAT), glutathione S-transferase (GST), glutathione peroxidase (GPx), glutathione reductase (GR) and reduced glutathione (@COMPOUND$) were significantly diminished in DMH 0.05) elevated on simultaneous morin supplementation.	0	18496650-691
Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants superoxide dismutase (SOD), catalase (CAT), glutathione S-transferase (GST), glutathione peroxidase (GPx), @PROTEIN$ (GR) and reduced glutathione (GSH) were significantly diminished in DMH 0.05) elevated on simultaneous @COMPOUND$ supplementation.	1	18496650-691
Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants superoxide dismutase (@PROTEIN$), catalase (CAT), glutathione S-transferase (GST), glutathione peroxidase (GPx), glutathione reductase (GR) and reduced glutathione (@COMPOUND$) were significantly diminished in DMH 0.05) elevated on simultaneous morin supplementation.	0	18496650-691
Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants superoxide dismutase (SOD), catalase (@PROTEIN$), glutathione S-transferase (GST), glutathione peroxidase (GPx), glutathione reductase (GR) and @COMPOUND$ (GSH) were significantly diminished in DMH 0.05) elevated on simultaneous morin supplementation.	0	18496650-691
Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants superoxide dismutase (SOD), catalase (CAT), @PROTEIN$ (GST), glutathione peroxidase (GPx), glutathione reductase (GR) and reduced glutathione (@COMPOUND$) were significantly diminished in DMH 0.05) elevated on simultaneous morin supplementation.	0	18496650-691
Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants superoxide dismutase (SOD), @PROTEIN$ (CAT), glutathione S-transferase (GST), glutathione peroxidase (GPx), glutathione reductase (GR) and @COMPOUND$ (GSH) were significantly diminished in DMH 0.05) elevated on simultaneous morin supplementation.	0	18496650-691
Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants superoxide dismutase (@PROTEIN$), catalase (CAT), glutathione S-transferase (GST), glutathione peroxidase (GPx), glutathione reductase (GR) and @COMPOUND$ (GSH) were significantly diminished in DMH 0.05) elevated on simultaneous morin supplementation.	0	18496650-691
Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants superoxide dismutase (SOD), catalase (CAT), glutathione S-transferase (@PROTEIN$), glutathione peroxidase (GPx), glutathione reductase (GR) and @COMPOUND$ (GSH) were significantly diminished in DMH 0.05) elevated on simultaneous morin supplementation.	0	18496650-691
Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants superoxide dismutase (SOD), catalase (@PROTEIN$), glutathione S-transferase (GST), glutathione peroxidase (GPx), glutathione reductase (GR) and reduced glutathione (@COMPOUND$) were significantly diminished in DMH 0.05) elevated on simultaneous morin supplementation.	0	18496650-691
Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants superoxide dismutase (SOD), catalase (CAT), glutathione S-transferase (GST), glutathione peroxidase (GPx), @PROTEIN$ (GR) and reduced glutathione (@COMPOUND$) were significantly diminished in DMH 0.05) elevated on simultaneous morin supplementation.	0	18496650-691
Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants superoxide dismutase (SOD), @PROTEIN$ (CAT), glutathione S-transferase (GST), glutathione peroxidase (GPx), glutathione reductase (GR) and reduced glutathione (GSH) were significantly diminished in DMH 0.05) elevated on simultaneous @COMPOUND$ supplementation.	1	18496650-691
Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants superoxide dismutase (SOD), catalase (CAT), @PROTEIN$ (GST), glutathione peroxidase (GPx), glutathione reductase (GR) and @COMPOUND$ (GSH) were significantly diminished in DMH 0.05) elevated on simultaneous morin supplementation.	0	18496650-691
Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants superoxide dismutase (SOD), catalase (CAT), @PROTEIN$ (GST), glutathione peroxidase (GPx), glutathione reductase (GR) and reduced glutathione (GSH) were significantly diminished in DMH 0.05) elevated on simultaneous @COMPOUND$ supplementation.	1	18496650-691
Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants superoxide dismutase (SOD), catalase (CAT), glutathione S-transferase (GST), @PROTEIN$ (GPx), glutathione reductase (GR) and reduced glutathione (@COMPOUND$) were significantly diminished in DMH 0.05) elevated on simultaneous morin supplementation.	0	18496650-691
Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants @PROTEIN$ (SOD), catalase (CAT), glutathione S-transferase (GST), glutathione peroxidase (GPx), glutathione reductase (GR) and @COMPOUND$ (GSH) were significantly diminished in DMH 0.05) elevated on simultaneous morin supplementation.	0	18496650-691
Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants @PROTEIN$ (SOD), catalase (CAT), glutathione S-transferase (GST), glutathione peroxidase (GPx), glutathione reductase (GR) and reduced glutathione (GSH) were significantly diminished in DMH 0.05) elevated on simultaneous @COMPOUND$ supplementation.	1	18496650-691
Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants superoxide dismutase (SOD), catalase (CAT), glutathione S-transferase (GST), @PROTEIN$ (GPx), glutathione reductase (GR) and @COMPOUND$ (GSH) were significantly diminished in DMH 0.05) elevated on simultaneous morin supplementation.	0	18496650-691
Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants superoxide dismutase (SOD), catalase (CAT), glutathione S-transferase (GST), @PROTEIN$ (GPx), glutathione reductase (GR) and reduced glutathione (GSH) were significantly diminished in DMH 0.05) elevated on simultaneous @COMPOUND$ supplementation.	1	18496650-691
Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants superoxide dismutase (SOD), catalase (CAT), glutathione S-transferase (GST), glutathione peroxidase (GPx), @PROTEIN$ (GR) and @COMPOUND$ (GSH) were significantly diminished in DMH 0.05) elevated on simultaneous morin supplementation.	0	18496650-691
Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants superoxide dismutase (@PROTEIN$), catalase (CAT), glutathione S-transferase (GST), glutathione peroxidase (GPx), glutathione reductase (GR) and reduced glutathione (GSH) were significantly diminished in DMH 0.05) elevated on simultaneous @COMPOUND$ supplementation.	1	18496650-691
Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants superoxide dismutase (SOD), @PROTEIN$ (CAT), glutathione S-transferase (GST), glutathione peroxidase (GPx), glutathione reductase (GR) and reduced glutathione (@COMPOUND$) were significantly diminished in DMH 0.05) elevated on simultaneous morin supplementation.	0	18496650-691
Using in vitro binding assays we have demonstrated that transcription factors Sp3, ZBP-89 and NF-Y are capable of binding to the @PROTEIN$ promoter region spanning the sequence-200 to-162 relative to ATG and that formation of complexes could be efficiently reduced by @COMPOUND$.	1	18496767-753
Using in vitro binding assays we have demonstrated that @PROTEIN$, ZBP-89 and NF-Y are capable of binding to the SOX18 promoter region spanning the sequence-200 to-162 relative to ATG and that formation of complexes could be efficiently reduced by @COMPOUND$.	1	18496767-753
Treatment with @PROTEIN$ indicates that the dimensions of the small fibrils may be dependent upon the presence of @COMPOUND$ within the matrix.	1	18496861-830
@COMPOUND$ coatings reduce @PROTEIN$ and von Willebrand factor adsorption and platelet adhesion under both static and flow conditions.	1	18496865-833
@COMPOUND$ coatings reduce fibrinogen and @PROTEIN$ adsorption and platelet adhesion under both static and flow conditions.	1	18496865-833
Previous studies have showed that radio-frequency plasma deposited @COMPOUND$ coatings greatly reduced @PROTEIN$ adsorption (Gamma(Fg)) from highly diluted plasmas (0.1 and 1%) and subsequent platelet adhesion under static conditions.	1	18496865-834
Effects of inhibition of @PROTEIN$, iNOS, and nNOS by N-nitro-L-arginine methyl ester (L-NAME), aminoguanidine, and @COMPOUND$, respectively, were determined on the antigen-induced systemic hypotension and portal hypertension in conscious Sprague-Dawley rats sensitized with the ovalbumin antigen.	0	18497703-873
Effects of inhibition of NOS, @PROTEIN$, and nNOS by N-nitro-L-arginine methyl ester (L-NAME), @COMPOUND$, and 7-nitroindazole, respectively, were determined on the antigen-induced systemic hypotension and portal hypertension in conscious Sprague-Dawley rats sensitized with the ovalbumin antigen.	0	18497703-873
Effects of inhibition of @PROTEIN$, iNOS, and nNOS by N-nitro-@COMPOUND$ (L-NAME), aminoguanidine, and 7-nitroindazole, respectively, were determined on the antigen-induced systemic hypotension and portal hypertension in conscious Sprague-Dawley rats sensitized with the ovalbumin antigen.	0	18497703-873
Effects of inhibition of NOS, iNOS, and @PROTEIN$ by N-nitro-@COMPOUND$ (L-NAME), aminoguanidine, and 7-nitroindazole, respectively, were determined on the antigen-induced systemic hypotension and portal hypertension in conscious Sprague-Dawley rats sensitized with the ovalbumin antigen.	0	18497703-873
Effects of inhibition of NOS, iNOS, and @PROTEIN$ by N-nitro-L-arginine methyl ester (L-NAME), @COMPOUND$, and 7-nitroindazole, respectively, were determined on the antigen-induced systemic hypotension and portal hypertension in conscious Sprague-Dawley rats sensitized with the ovalbumin antigen.	0	18497703-873
Effects of inhibition of @PROTEIN$, iNOS, and nNOS by N-nitro-L-arginine methyl ester (L-NAME), @COMPOUND$, and 7-nitroindazole, respectively, were determined on the antigen-induced systemic hypotension and portal hypertension in conscious Sprague-Dawley rats sensitized with the ovalbumin antigen.	0	18497703-873
Effects of inhibition of NOS, @PROTEIN$, and nNOS by N-nitro-@COMPOUND$ (L-NAME), aminoguanidine, and 7-nitroindazole, respectively, were determined on the antigen-induced systemic hypotension and portal hypertension in conscious Sprague-Dawley rats sensitized with the ovalbumin antigen.	0	18497703-873
Effects of inhibition of NOS, iNOS, and @PROTEIN$ by N-nitro-L-arginine methyl ester (L-NAME), aminoguanidine, and @COMPOUND$, respectively, were determined on the antigen-induced systemic hypotension and portal hypertension in conscious Sprague-Dawley rats sensitized with the ovalbumin antigen.	0	18497703-873
Effects of inhibition of NOS, @PROTEIN$, and nNOS by N-nitro-L-arginine methyl ester (L-NAME), aminoguanidine, and @COMPOUND$, respectively, were determined on the antigen-induced systemic hypotension and portal hypertension in conscious Sprague-Dawley rats sensitized with the ovalbumin antigen.	0	18497703-873
Differential gene expression of @PROTEIN$ and interleukin-1 receptor associated kinase-M in peripheral blood mononuclear cells of young and aged rats following preconditioning with @COMPOUND$.	1	18497707-589
The IL-1 receptor-associated kinase 1 (IRAK-1) and @PROTEIN$ are key signaling molecules in cellular responses to @COMPOUND$ initiated through the Toll-like receptors (TLRs).	1	18497707-590
The IL-1 receptor-associated kinase 1 (IRAK-1) and IRAK-M are key signaling molecules in cellular responses to @COMPOUND$ initiated through the Toll-like receptors (@PROTEIN$).	1	18497707-590
The IL-1 receptor-associated kinase 1 (@PROTEIN$) and IRAK-M are key signaling molecules in cellular responses to @COMPOUND$ initiated through the Toll-like receptors (TLRs).	1	18497707-590
The aim of this study was to evaluate the effect of age on the modulation of TLRs and IRAK-1 and @PROTEIN$ in peripheral blood mononuclear cells (PBMCs) exposed in vitro to @COMPOUND$ under conditions that could induce endotoxin tolerance.	0	18497707-591
The aim of this study was to evaluate the effect of age on the modulation of TLRs and @PROTEIN$ and IRAK-M in peripheral blood mononuclear cells (PBMCs) exposed in vitro to @COMPOUND$ under conditions that could induce endotoxin tolerance.	0	18497707-591
The aim of this study was to evaluate the effect of age on the modulation of @PROTEIN$ and IRAK-1 and IRAK-M in peripheral blood mononuclear cells (PBMCs) exposed in vitro to @COMPOUND$ under conditions that could induce endotoxin tolerance.	0	18497707-591
We also previously demonstrated that @COMPOUND$ (GLN) significantly induced @PROTEIN$ in the lower intestinal tract.	0	18497709-959
@COMPOUND$ treatment before HS (MAP of 30 mmHg for 60 min) significantly ameliorated HS-induced mucosal inflammation and apoptotic cell death in the ileum, as judged by significant decreases in gene expression of TNF-alpha, iNOS, intercellular adhesion molecule 1, and vascular cell adhesion molecule 1, myeloperoxidase activity, the number of infiltrated neutrophils, DNA fragmentation by in situ oligo ligation assay, and activated caspase-3 expression, and by increases in gene expression of @PROTEIN$ and Bcl-2.	1	18497709-961
@COMPOUND$ treatment before HS (MAP of 30 mmHg for 60 min) significantly ameliorated HS-induced mucosal inflammation and apoptotic cell death in the ileum, as judged by significant decreases in gene expression of @PROTEIN$, iNOS, intercellular adhesion molecule 1, and vascular cell adhesion molecule 1, myeloperoxidase activity, the number of infiltrated neutrophils, DNA fragmentation by in situ oligo ligation assay, and activated caspase-3 expression, and by increases in gene expression of IL-10 and Bcl-2.	1	18497709-961
Glutamine treatment before @COMPOUND$ (MAP of 30 mmHg for 60 min) significantly ameliorated HS-induced mucosal inflammation and apoptotic cell death in the ileum, as judged by significant decreases in gene expression of TNF-alpha, iNOS, intercellular adhesion molecule 1, and vascular cell adhesion molecule 1, myeloperoxidase activity, the number of infiltrated neutrophils, DNA fragmentation by in situ oligo ligation assay, and activated caspase-3 expression, and by increases in gene expression of @PROTEIN$ and Bcl-2.	0	18497709-961
@COMPOUND$ treatment before HS (MAP of 30 mmHg for 60 min) significantly ameliorated HS-induced mucosal inflammation and apoptotic cell death in the ileum, as judged by significant decreases in gene expression of TNF-alpha, @PROTEIN$, intercellular adhesion molecule 1, and vascular cell adhesion molecule 1, myeloperoxidase activity, the number of infiltrated neutrophils, DNA fragmentation by in situ oligo ligation assay, and activated caspase-3 expression, and by increases in gene expression of IL-10 and Bcl-2.	1	18497709-961
Glutamine treatment before @COMPOUND$ (MAP of 30 mmHg for 60 min) significantly ameliorated HS-induced mucosal inflammation and apoptotic cell death in the ileum, as judged by significant decreases in gene expression of TNF-alpha, @PROTEIN$, intercellular adhesion molecule 1, and vascular cell adhesion molecule 1, myeloperoxidase activity, the number of infiltrated neutrophils, DNA fragmentation by in situ oligo ligation assay, and activated caspase-3 expression, and by increases in gene expression of IL-10 and Bcl-2.	0	18497709-961
@COMPOUND$ treatment before HS (MAP of 30 mmHg for 60 min) significantly ameliorated HS-induced mucosal inflammation and apoptotic cell death in the ileum, as judged by significant decreases in gene expression of TNF-alpha, iNOS, intercellular adhesion molecule 1, and vascular cell adhesion molecule 1, myeloperoxidase activity, the number of infiltrated neutrophils, DNA fragmentation by in situ oligo ligation assay, and activated caspase-3 expression, and by increases in gene expression of IL-10 and @PROTEIN$.	1	18497709-961
Glutamine treatment before @COMPOUND$ (MAP of 30 mmHg for 60 min) significantly ameliorated HS-induced mucosal inflammation and apoptotic cell death in the ileum, as judged by significant decreases in gene expression of TNF-alpha, iNOS, intercellular adhesion molecule 1, and vascular cell adhesion molecule 1, myeloperoxidase activity, the number of infiltrated neutrophils, DNA fragmentation by in situ oligo ligation assay, and activated caspase-3 expression, and by increases in gene expression of IL-10 and @PROTEIN$.	0	18497709-961
Glutamine treatment before @COMPOUND$ (MAP of 30 mmHg for 60 min) significantly ameliorated HS-induced mucosal inflammation and apoptotic cell death in the ileum, as judged by significant decreases in gene expression of @PROTEIN$, iNOS, intercellular adhesion molecule 1, and vascular cell adhesion molecule 1, myeloperoxidase activity, the number of infiltrated neutrophils, DNA fragmentation by in situ oligo ligation assay, and activated caspase-3 expression, and by increases in gene expression of IL-10 and Bcl-2.	0	18497709-961
@COMPOUND$ treatment may thus protect mucosal cells from HS-induced oxidative damage via the anti-inflammatory and antiapoptotic properties of @PROTEIN$.	1	18497709-964
In this work, we identified a high affinity and potency metallocene-containing @COMPOUND$ peptide conjugate that suppresses the interactions of HIV-1 envelope gp120 at both its @PROTEIN$ and co-receptor binding sites.	1	18498083-305
In this work, we identified a high affinity and potency metallocene-containing @COMPOUND$ peptide conjugate that suppresses the interactions of HIV-1 envelope @PROTEIN$ at both its CD4 and co-receptor binding sites.	1	18498083-305
Surface plasmon resonance interaction analysis revealed that, compared to a previously reported phenyl-containing triazole conjugate @COMPOUND$ (105), peptide 156 had a higher direct binding affinity for several subtypes of HIV-1 @PROTEIN$ due mainly to the decreased dissociation rate of the conjugate-gp120 complex.	1	18498083-306
Surface plasmon resonance interaction analysis revealed that, compared to a previously reported phenyl-containing @COMPOUND$ conjugate HNG-105 (105), peptide 156 had a higher direct binding affinity for several subtypes of HIV-1 @PROTEIN$ due mainly to the decreased dissociation rate of the conjugate-gp120 complex.	1	18498083-306
The ferrocene @COMPOUND$ conjugate bound to gp120 of both clade A (92UG037-08) and clade B (YU-2 and SF162) virus subtypes with nanomolar KD in direct binding and inhibited the binding of gp120 to soluble @PROTEIN$ and to antibodies that bind to HIV-1YU-2 gp120 at both the CD4 binding site and CD4-induced binding sites.	1	18498083-307
The ferrocene @COMPOUND$ conjugate bound to @PROTEIN$ of both clade A (92UG037-08) and clade B (YU-2 and SF162) virus subtypes with nanomolar KD in direct binding and inhibited the binding of gp120 to soluble CD4 and to antibodies that bind to HIV-1YU-2 gp120 at both the CD4 binding site and CD4-induced binding sites.	1	18498083-307
Screening of risk factors for thromboembolism revealed that all patients carried a @PROTEIN$ 677C--&gt;T (MTHFR) mutation in a gene involved in folate metabolism, and either borderline or elevated @COMPOUND$ levels.	0	18498357-470
Screening of risk factors for thromboembolism revealed that all patients carried a methylenetetrahydrofolate reductase 677C--&gt;T (@PROTEIN$) mutation in a gene involved in folate metabolism, and either borderline or elevated @COMPOUND$ levels.	0	18498357-470
Circulating leptin was negatively correlated with mRNA expression of adiponectin, LEPR and @PROTEIN$, whereas @COMPOUND$ was positively correlated with levels of PPARGC1A.	0	18498673-382
Circulating @PROTEIN$ was negatively correlated with mRNA expression of adiponectin, LEPR and LPL, whereas @COMPOUND$ was positively correlated with levels of PPARGC1A.	0	18498673-382
Circulating leptin was negatively correlated with mRNA expression of adiponectin, LEPR and LPL, whereas @COMPOUND$ was positively correlated with levels of @PROTEIN$.	1	18498673-382
Circulating leptin was negatively correlated with mRNA expression of adiponectin, @PROTEIN$ and LPL, whereas @COMPOUND$ was positively correlated with levels of PPARGC1A.	0	18498673-382
In the absence of exogenous Ca(2+) and Mg(2+) and in the presence of EGTA, which favours the release of endogenous Ca(2+), the polyamine @COMPOUND$ is able to stimulate the activity of pyruvate dehydrogenase complex (@PROTEIN$) of energized rat liver mitochondria (RLM).	1	18500430-564
In the absence of exogenous @COMPOUND$+) and Mg(2+) and in the presence of EGTA, which favours the release of endogenous Ca(2+), the polyamine spermine is able to stimulate the activity of pyruvate dehydrogenase complex (@PROTEIN$) of energized rat liver mitochondria (RLM).	0	18500430-564
In the absence of exogenous Ca(2+) and Mg(2+) and in the presence of @COMPOUND$, which favours the release of endogenous Ca(2+), the polyamine spermine is able to stimulate the activity of pyruvate dehydrogenase complex (@PROTEIN$) of energized rat liver mitochondria (RLM).	0	18500430-564
At concentrations higher than 0.5 mM, @COMPOUND$ still stimulates @PROTEIN$, when compared with the control, but shows a slight dose-dependent decrease.	1	18500430-565
Changes in @PROTEIN$ stimulation are very close to the phosphorylation level of the E(1alpha) subunit of PDC, which regulates the activity of the complex, but it is also the target of @COMPOUND$.	1	18500430-566
These results provide the first evidence that, when transported in RLM, @COMPOUND$ can interact in various ways with @PROTEIN$, showing dose-dependent behaviour.	1	18500430-567
This study assessed relationships between @PROTEIN$ levels and @COMPOUND$ uptake and cytotoxicity in cultures of human renal proximal tubule cells (hRPTCs) that produce multiple transporter types.	0	18500522-58
Multiple metabolic and neuroendocrine mechanisms are responsible for the CR-mediated anti-inflammatory effects, including reduced adiposity and secretion of pro-inflammatory adipokines, enhanced glucocorticoid production, reduced plasma @COMPOUND$ and advanced glycation end-product concentrations, increased parasympathetic tone, and increased @PROTEIN$ production.	0	18502597-1034
From the known regulatory mechanisms of Arc expression, HFD reduced N-methyl-D-aspartate receptor (NMDAR) activity, as seen by decreases in @COMPOUND$ phosphorylation of @PROTEIN$ and levels of NMDAR1.	1	18503570-926
From the known regulatory mechanisms of Arc expression, HFD reduced @PROTEIN$ (NMDAR) activity, as seen by decreases in @COMPOUND$ phosphorylation of NMDAR2A and levels of NMDAR1.	1	18503570-926
From the known regulatory mechanisms of Arc expression, HFD reduced N-methyl-D-aspartate receptor (NMDAR) activity, as seen by decreases in @COMPOUND$ phosphorylation of NMDAR2A and levels of @PROTEIN$.	0	18503570-926
Additionally, we demonstrated that 27-hydroxy@COMPOUND$, a cholesterol metabolite that enters the brain from the blood, decreases Arc levels as well as NMDAR and @PROTEIN$ kinase activities in rat primary hippocampal neurons.	1	18503570-927
Additionally, we demonstrated that @COMPOUND$, a cholesterol metabolite that enters the brain from the blood, decreases Arc levels as well as NMDAR and @PROTEIN$ kinase activities in rat primary hippocampal neurons.	1	18503570-927
@PROTEIN$, an inducible enzyme important in inflammation, catalyzes the production of prostanoids from @COMPOUND$.	1	18505747-21
cDNA probes have been developed for subsequent use in monitoring the @COMPOUND$ exposure of the clam Ruditapes decussatus and the cockle Cerastoderma glaucum using @PROTEIN$ (MT) gene expression in different tissues of these species.	0	18506596-495
Purified @PROTEIN$ was able to oxidize a variety of substrates including Mn2+, tryptophan, mimosine, L-Dopa, hydroquinone, xylidine, @COMPOUND$, veratryl alcohol, and ten textile dyes of various groups indicating as a versatile peroxidase.	1	18506630-727
Purified @PROTEIN$ was able to oxidize a variety of substrates including Mn2+, tryptophan, mimosine, L-Dopa, @COMPOUND$, xylidine, n-propanol, veratryl alcohol, and ten textile dyes of various groups indicating as a versatile peroxidase.	1	18506630-727
Purified @PROTEIN$ was able to oxidize a variety of substrates including @COMPOUND$+, tryptophan, mimosine, L-Dopa, hydroquinone, xylidine, n-propanol, veratryl alcohol, and ten textile dyes of various groups indicating as a versatile peroxidase.	1	18506630-727
Purified @PROTEIN$ was able to oxidize a variety of substrates including Mn2+, tryptophan, @COMPOUND$, L-Dopa, hydroquinone, xylidine, n-propanol, veratryl alcohol, and ten textile dyes of various groups indicating as a versatile peroxidase.	1	18506630-727
Purified @PROTEIN$ was able to oxidize a variety of substrates including Mn2+, tryptophan, mimosine, @COMPOUND$, hydroquinone, xylidine, n-propanol, veratryl alcohol, and ten textile dyes of various groups indicating as a versatile peroxidase.	1	18506630-727
Purified @PROTEIN$ was able to oxidize a variety of substrates including Mn2+, tryptophan, mimosine, L-Dopa, hydroquinone, xylidine, n-propanol, @COMPOUND$, and ten textile dyes of various groups indicating as a versatile peroxidase.	1	18506630-727
Purified @PROTEIN$ was able to oxidize a variety of substrates including Mn2+, @COMPOUND$, mimosine, L-Dopa, hydroquinone, xylidine, n-propanol, veratryl alcohol, and ten textile dyes of various groups indicating as a versatile peroxidase.	1	18506630-727
@COMPOUND$ stabilizes the @PROTEIN$ activity during decolorization of dyes.	1	18506630-728
To achieve enzymatic production of calcium-stearate at unfavorable conditions, i.e., pH 10 and 60 degrees C, suitable @PROTEIN$ was selected and reaction conditions were optimized using calcium @COMPOUND$ and hydrogenated beef tallow as substrates.	1	18506631-523
To achieve enzymatic production of @COMPOUND$ at unfavorable conditions, i.e., pH 10 and 60 degrees C, suitable @PROTEIN$ was selected and reaction conditions were optimized using calcium hydroxide and hydrogenated beef tallow as substrates.	1	18506631-523
Under optimum conditions, 95% of beef tallow, in 2.5 h, was converted into @COMPOUND$ by using commercial @PROTEIN$ SDL 451.	1	18506631-524
@COMPOUND$ could selectively inhibited @PROTEIN$ expression and PGE2 production.	1	18506760-597
Celecoxib could selectively inhibited @PROTEIN$ expression and @COMPOUND$ production.	0	18506760-597
@COMPOUND$ also inhibited p(473Ser) Akt, raf and p53 expression, and induced apoptosis by release of @PROTEIN$ and activation of caspase 9, 3, and 6, which were more remarkably in HBx positive cells than in control cells.	1	18506760-598
@COMPOUND$ also inhibited p(473Ser) @PROTEIN$, raf and p53 expression, and induced apoptosis by release of cytochrome c and activation of caspase 9, 3, and 6, which were more remarkably in HBx positive cells than in control cells.	1	18506760-598
@COMPOUND$ also inhibited p(473Ser) Akt, @PROTEIN$ and p53 expression, and induced apoptosis by release of cytochrome c and activation of caspase 9, 3, and 6, which were more remarkably in HBx positive cells than in control cells.	1	18506760-598
@COMPOUND$ also inhibited p(473Ser) Akt, raf and @PROTEIN$ expression, and induced apoptosis by release of cytochrome c and activation of caspase 9, 3, and 6, which were more remarkably in HBx positive cells than in control cells.	1	18506760-598
However, the simultaneous presence of the @PROTEIN$ *1B and CYP3A5 *1A alleles was associated with a 64% increase in @COMPOUND$ clearance (P = 0.0015), independent of both sex and CYP3A activity (as determined using the erythromycin breath test).	1	18509327-948
However, the simultaneous presence of the CYP3A4 *1B and @PROTEIN$ *1A alleles was associated with a 64% increase in @COMPOUND$ clearance (P = 0.0015), independent of both sex and CYP3A activity (as determined using the erythromycin breath test).	1	18509327-948
It was found that @COMPOUND$ administration produced lower levels of @PROTEIN$ and alkaline aminotransferase than that of the untreated group.	1	18509591-45
In addition, the levels of hepatic total protein, glutathione and @PROTEIN$ were higher in the @COMPOUND$ treated groups than those in the untreated control or the taurine depleted groups, while hepatic malondialdehyde content exhibited the negative effect.	1	18509591-46
In addition, the levels of hepatic total protein, glutathione and @PROTEIN$ were higher in the taurine treated groups than those in the untreated control or the taurine depleted groups, while hepatic @COMPOUND$ content exhibited the negative effect.	1	18509591-46
In addition, the levels of hepatic total protein, @COMPOUND$ and @PROTEIN$ were higher in the taurine treated groups than those in the untreated control or the taurine depleted groups, while hepatic malondialdehyde content exhibited the negative effect.	0	18509591-46
Moreover, the concentrations of hepatic hydroxyproline, serum hyaluronic acid, interleukin-2, @PROTEIN$, tumor necrosis factor-alpha and @COMPOUND$ were all decreased in the taurine treated groups.	0	18509591-47
Moreover, the concentrations of hepatic hydroxyproline, serum @COMPOUND$, interleukin-2, @PROTEIN$, tumor necrosis factor-alpha and laminin were all decreased in the taurine treated groups.	0	18509591-47
Moreover, the concentrations of hepatic hydroxyproline, serum hyaluronic acid, interleukin-2, interleukin-6, @PROTEIN$-alpha and laminin were all decreased in the @COMPOUND$ treated groups.	1	18509591-47
Moreover, the concentrations of hepatic @COMPOUND$, serum hyaluronic acid, interleukin-2, @PROTEIN$, tumor necrosis factor-alpha and laminin were all decreased in the taurine treated groups.	0	18509591-47
Moreover, the concentrations of hepatic hydroxyproline, serum hyaluronic acid, interleukin-2, @PROTEIN$, tumor necrosis factor-alpha and laminin were all decreased in the @COMPOUND$ treated groups.	1	18509591-47
Moreover, the concentrations of hepatic hydroxyproline, serum hyaluronic acid, interleukin-2, interleukin-6, @PROTEIN$-alpha and @COMPOUND$ were all decreased in the taurine treated groups.	0	18509591-47
Moreover, the concentrations of hepatic @COMPOUND$, serum hyaluronic acid, interleukin-2, interleukin-6, @PROTEIN$-alpha and laminin were all decreased in the taurine treated groups.	0	18509591-47
Moreover, the concentrations of hepatic hydroxyproline, serum @COMPOUND$, interleukin-2, interleukin-6, @PROTEIN$-alpha and laminin were all decreased in the taurine treated groups.	0	18509591-47
Pharmacological (@COMPOUND$) and molecular (shRNA) transcription inhibitor were used to impede formation of @PROTEIN$ transcripts.	1	18509644-1152
Effect of small interference RNA targeting @PROTEIN$ mediated by rAAV combined @COMPOUND$ on pancreatic tumors in athymic mice.	0	18509748-1206
Changes in @PROTEIN$ serum levels in patients with major depression disorder (MDD) after 6 months treatment with sertraline, escitalopram, or @COMPOUND$.	1	18511076-738
Changes in @PROTEIN$ serum levels in patients with major depression disorder (MDD) after 6 months treatment with @COMPOUND$, escitalopram, or venlafaxine.	1	18511076-738
Changes in @PROTEIN$ serum levels in patients with major depression disorder (MDD) after 6 months treatment with sertraline, @COMPOUND$, or venlafaxine.	1	18511076-738
We assessed serum @PROTEIN$ levels in 21 patients with major depressive episode treated with sertraline, escitalopram, or @COMPOUND$ and 20 healthy controls.	1	18511076-739
We assessed serum @PROTEIN$ levels in 21 patients with major depressive episode treated with @COMPOUND$, escitalopram, or venlafaxine and 20 healthy controls.	1	18511076-739
We assessed serum @PROTEIN$ levels in 21 patients with major depressive episode treated with sertraline, @COMPOUND$, or venlafaxine and 20 healthy controls.	1	18511076-739
@COMPOUND$ increased @PROTEIN$ levels after 5 weeks and 6 months of treatment.	1	18511076-740
@COMPOUND$ increased @PROTEIN$ levels only after 6 months.	1	18511076-741
@COMPOUND$ did not affect @PROTEIN$ levels at either time point.	0	18511076-742
The increase of @COMPOUND$ was accompanied by a marked posttranslational down-regulation of liver @PROTEIN$ expression.	0	18513727-1142
Taken together, a diet-induced increase of plasma and hepatic @COMPOUND$ levels leads to a posttranscriptional down-regulation of SR-BI in mouse liver via a mechanism likely involving @PROTEIN$.	0	18513727-1143
Taken together, a diet-induced increase of plasma and hepatic @COMPOUND$ levels leads to a posttranscriptional down-regulation of @PROTEIN$ in mouse liver via a mechanism likely involving PDZK1.	1	18513727-1143
A 5.5 kilobase-pair (kbp) @PROTEIN$-Kpn1 fragment containing gene(s) encoding for @COMPOUND$ degradation was cloned.	1	18513857-1213
However, TXA(2) formation remains elevated in patients with cardiovascular disease on doses of @COMPOUND$ that fully suppress platelet @PROTEIN$, suggesting other tissue sources for TXA(2) formation.	1	18514659-430
However, @COMPOUND$) formation remains elevated in patients with cardiovascular disease on doses of aspirin that fully suppress platelet @PROTEIN$, suggesting other tissue sources for TXA(2) formation.	0	18514659-430
) production increased; metallothionein (MT) and @COMPOUND$ levels increased in most cases, and acetylcholinesterase (@PROTEIN$) activity decreased in summer.	0	18514900-1098
) production increased; metallothionein (MT) and @COMPOUND$ levels increased in most cases, and @PROTEIN$ (AChE) activity decreased in summer.	0	18514900-1098
From these findings, it is suggested that @COMPOUND$ may produce centrally mediated behavioural signs by increasing the ACh levels in the brain, resulting from its @PROTEIN$ and BuChE inhibitions.	1	18515453-577
Using DBA/2OlaHsd mice, we investigated the effects of chronic social defeat and concomitant treatment with @COMPOUND$/NBI 30775 on 1) the behavioural profile in the modified hole board test and 2) in-situ hybridization analysis-based expression of arginine vasopressin (AVP) and @PROTEIN$ mRNA in both the hypothalamic paraventricular nucleus and supraoptic nucleus.	0	18515457-594
Using DBA/2OlaHsd mice, we investigated the effects of chronic social defeat and concomitant treatment with @COMPOUND$/NBI 30775 on 1) the behavioural profile in the modified hole board test and 2) in-situ hybridization analysis-based expression of arginine vasopressin (@PROTEIN$) and CRH mRNA in both the hypothalamic paraventricular nucleus and supraoptic nucleus.	0	18515457-594
@COMPOUND$ also enhanced @PROTEIN$ release from VSMC.	1	18515973-10
@PROTEIN$ release by @COMPOUND$, although significant, was not as remarkable as that induced by TNF-alpha.	1	18515973-11
IL-6 release by @COMPOUND$, although significant, was not as remarkable as that induced by @PROTEIN$.	0	18515973-11
These data suggest that @COMPOUND$ upregulates @PROTEIN$ via mechanisms distinct from TNF-alpha and contributes to the intra- and extracellular IL-6 deposits within the vasculature.	1	18515973-12
These data suggest that @COMPOUND$ upregulates IL-6 via mechanisms distinct from @PROTEIN$ and contributes to the intra- and extracellular IL-6 deposits within the vasculature.	0	18515973-12
@COMPOUND$ upregulates @PROTEIN$ via mechanisms that are distinct from those of tumor necrosis factor-alpha, in vascular smooth muscle cells.	1	18515973-3
@COMPOUND$ upregulates interleukin-6 via mechanisms that are distinct from those of @PROTEIN$-alpha, in vascular smooth muscle cells.	0	18515973-3
Among the 7 IL examined, only @PROTEIN$ transcript was increased by @COMPOUND$ treatment in human aorta smooth muscle cells.	1	18515973-4
@PROTEIN$ transcripts increased up to 24 h after treatment with @COMPOUND$, and this effect was profoundly repressed by treatment with p38 MAPK inhibitors and to a lesser extent JNK inhibitors.	1	18515973-5
@COMPOUND$, 27-hydroxycholesterol or cholesterol, however, did not induce @PROTEIN$ expression.	0	18515973-6
7alpha-Hydroxy@COMPOUND$, 27-hydroxycholesterol or cholesterol, however, did not induce @PROTEIN$ expression.	0	18515973-6
7alpha-Hydroxycholesterol, @COMPOUND$ or cholesterol, however, did not induce @PROTEIN$ expression.	0	18515973-6
Mechanisms of @PROTEIN$ induction by @COMPOUND$ were investigated in comparison with tumor necrosis factor (TNF)-alpha.	1	18515973-7
Mechanisms of IL-6 induction by @COMPOUND$ were investigated in comparison with tumor necrosis factor (@PROTEIN$)-alpha.	0	18515973-7
Mechanisms of IL-6 induction by @COMPOUND$ were investigated in comparison with @PROTEIN$ (TNF)-alpha.	0	18515973-7
Whereas @PROTEIN$ activated IL-6 promoter, which was impaired by p38 MAPK inhibitors or by mutation in the NF-kappaB-binding site within the promoter region, @COMPOUND$ did not affect IL-6 promoter activity.	0	18515973-8
Whereas TNF-alpha activated @PROTEIN$ promoter, which was impaired by p38 MAPK inhibitors or by mutation in the NF-kappaB-binding site within the promoter region, @COMPOUND$ did not affect IL-6 promoter activity.	0	18515973-8
@COMPOUND$ significantly increased the amount of intracellular @PROTEIN$ protein in the presence of brefeldin A.	1	18515973-9
7-ketocholesterol significantly increased the amount of intracellular @PROTEIN$ protein in the presence of @COMPOUND$.	1	18515973-9
@COMPOUND$ is a novel, phenolic antioxidant, and vascular protectant which dose-dependently inhibits @PROTEIN$ biomarkers in vitro.	1	18521540-51
@COMPOUND$ inhibits human cervical cancer cell growth in vitro in association with @PROTEIN$ demethylation and re-expression.	1	18521605-224
Clinically, it has been approved that DNA methylation inhibitors, such as @COMPOUND$ (5-Aza-dC), can reverse @PROTEIN$ promoter methylation, but widespread clinical use of these inhibitors is limited by their toxicity and instability in aqueous solution.	1	18521605-225
Clinically, it has been approved that DNA methylation inhibitors, such as 5-aza-2'-deoxycytidine (@COMPOUND$), can reverse @PROTEIN$ promoter methylation, but widespread clinical use of these inhibitors is limited by their toxicity and instability in aqueous solution.	1	18521605-225
Lastly, we found that the downstream metabolite of @COMPOUND$, 5alpha- androstane-3beta,17beta-diol (3betaAdiol), is estrogenic in breast cancer cells, and induces growth and ER-signaling via activation of @PROTEIN$.	1	18521740-1015
Here we demonstrate that an AR ligand, @COMPOUND$ (DHT), inhibits MCF-7 breast cancer cell growth induced by insulin like growth factor 1 (@PROTEIN$).	1	18521741-219
Here we demonstrate that an AR ligand, 5-alpha-dihydrotestosterone (@COMPOUND$), inhibits MCF-7 breast cancer cell growth induced by insulin like growth factor 1 (@PROTEIN$).	1	18521741-219
Here, we constructed variants to test whether any of these motifs may explain why @PROTEIN$-DeltaN does not respond to stimulation with either ADP ribose or @COMPOUND$.	0	18521748-1184
We found that @COMPOUND$ induced the activation of JNK, @PROTEIN$, and p38 MAPKs.	1	18521846-1089
We found that @COMPOUND$ induced the activation of JNK, ERK, and @PROTEIN$.	1	18521846-1089
We found that @COMPOUND$ induced the activation of @PROTEIN$, ERK, and p38 MAPKs.	1	18521846-1089
@COMPOUND$-induced JNK activation was associated with the induction of apoptosis through the mitochondrial pathways as a result of increased phosphorylation (inactivation) of the anti-apoptotic @PROTEIN$ and Bcl-xL proteins.	1	18521846-1090
@COMPOUND$-induced @PROTEIN$ activation was associated with the induction of apoptosis through the mitochondrial pathways as a result of increased phosphorylation (inactivation) of the anti-apoptotic Bcl-2 and Bcl-xL proteins.	1	18521846-1090
In comparison, @COMPOUND$-induced activation of @PROTEIN$ and p38 in these cells was found to have a protective effect against 2-MeO-E(2)-induced apoptosis.	1	18521846-1091
In comparison, @COMPOUND$-induced activation of ERK and @PROTEIN$ in these cells was found to have a protective effect against 2-MeO-E(2)-induced apoptosis.	1	18521846-1091
Mechanistically, inhibition of @PROTEIN$ and p38 activity was associated with activation of various caspases and PARP cleavage, and it also stabilized the pro-apoptotic proteins Bax and Bim, thereby preventing them from degradation during @COMPOUND$ treatment.	0	18521846-1093
Mechanistically, inhibition of ERK and p38 activity was associated with activation of various caspases and PARP cleavage, and it also stabilized the pro-apoptotic @PROTEIN$ and Bim, thereby preventing them from degradation during @COMPOUND$ treatment.	0	18521846-1093
Mechanistically, inhibition of ERK and p38 activity was associated with activation of various caspases and @PROTEIN$ cleavage, and it also stabilized the pro-apoptotic proteins Bax and Bim, thereby preventing them from degradation during @COMPOUND$ treatment.	0	18521846-1093
Mechanistically, inhibition of ERK and p38 activity was associated with activation of various caspases and PARP cleavage, and it also stabilized the pro-apoptotic proteins Bax and @PROTEIN$, thereby preventing them from degradation during @COMPOUND$ treatment.	0	18521846-1093
Mechanistically, inhibition of ERK and @PROTEIN$ activity was associated with activation of various caspases and PARP cleavage, and it also stabilized the pro-apoptotic proteins Bax and Bim, thereby preventing them from degradation during @COMPOUND$ treatment.	0	18521846-1093
Accumulating evidence suggests that phosphatidylinositol (PI) pathways have been involved in the secretion of @COMPOUND$ (DA) and the regulation of @PROTEIN$, which is a target of methamphetamine (METH).	0	18521859-1108
Accumulating evidence suggests that phosphatidylinositol (PI) pathways have been involved in the secretion of dopamine (DA) and the regulation of @PROTEIN$, which is a target of @COMPOUND$ (METH).	1	18521859-1108
Accumulating evidence suggests that @COMPOUND$ (PI) pathways have been involved in the secretion of dopamine (DA) and the regulation of @PROTEIN$, which is a target of methamphetamine (METH).	1	18521859-1108
@COMPOUND$ caused a 60% reduction in testicular interstitial fluid (IF) prostaglandin E(2) (PGE (2)) concentrations, accompanied by a compensatory increase in @PROTEIN$ mRNA expression.	1	18522674-789
@COMPOUND$ caused a 60% reduction in testicular interstitial fluid (IF) prostaglandin E(2) (@PROTEIN$ (2)) concentrations, accompanied by a compensatory increase in COX-2 mRNA expression.	1	18522674-789
However, @COMPOUND$ had no effect on @PROTEIN$ protein levels or LPS-induced expression of the inflammatory mediators interleukin-1beta, tumour necrosis factor-alpha or inducible nitric-oxide synthase.	0	18522674-790
However, @COMPOUND$ had no effect on COX-2 protein levels or LPS-induced expression of the inflammatory mediators interleukin-1beta, tumour necrosis factor-alpha or inducible @PROTEIN$.	0	18522674-790
These data indicate that @COMPOUND$ reduces intratesticular activity of @PROTEIN$ (as indicated by PGE (2) levels) and inhibits IF formation in the testis, but has no appreciable effect on steroidogenesis or spermatogenesis, at least in the short term.	1	18522674-791
These data indicate that @COMPOUND$ reduces intratesticular activity of COX-2 (as indicated by @PROTEIN$ (2) levels) and inhibits IF formation in the testis, but has no appreciable effect on steroidogenesis or spermatogenesis, at least in the short term.	1	18522674-791
These results indicate significant roles for products of the @PROTEIN$ pathway in testicular vascular control and steroidogenesis, which may have implications for men with marginal fertility taking @COMPOUND$ for extended periods, but also highlight the potential of this drug to ameliorate testicular damage caused by systemic or local inflammation.	1	18522674-792
At the end of the experiment (after 6 weeks), lung histological changes, collagen staining, the activity of glutathione reductase (GR) and contents of reduced glutathione (GSH) and @COMPOUND$ (Hpr) in the lung as well as serum level of tumor necrosis factor-alpha (@PROTEIN$) were evaluated.	0	18528683-286
At the end of the experiment (after 6 weeks), lung histological changes, collagen staining, the activity of glutathione reductase (GR) and contents of @COMPOUND$ (GSH) and hydroxyproline (Hpr) in the lung as well as serum level of tumor necrosis factor-alpha (@PROTEIN$) were evaluated.	0	18528683-286
At the end of the experiment (after 6 weeks), lung histological changes, collagen staining, the activity of @PROTEIN$ (GR) and contents of @COMPOUND$ (GSH) and hydroxyproline (Hpr) in the lung as well as serum level of tumor necrosis factor-alpha (TNF-alpha) were evaluated.	0	18528683-286
At the end of the experiment (after 6 weeks), lung histological changes, collagen staining, the activity of glutathione reductase (GR) and contents of reduced glutathione (@COMPOUND$) and hydroxyproline (Hpr) in the lung as well as serum level of tumor necrosis factor-alpha (@PROTEIN$) were evaluated.	0	18528683-286
At the end of the experiment (after 6 weeks), lung histological changes, collagen staining, the activity of glutathione reductase (GR) and contents of @COMPOUND$ (GSH) and hydroxyproline (Hpr) in the lung as well as serum level of @PROTEIN$-alpha (TNF-alpha) were evaluated.	0	18528683-286
At the end of the experiment (after 6 weeks), lung histological changes, collagen staining, the activity of @PROTEIN$ (GR) and contents of reduced glutathione (@COMPOUND$) and hydroxyproline (Hpr) in the lung as well as serum level of tumor necrosis factor-alpha (TNF-alpha) were evaluated.	0	18528683-286
At the end of the experiment (after 6 weeks), lung histological changes, collagen staining, the activity of glutathione reductase (GR) and contents of reduced glutathione (GSH) and @COMPOUND$ (Hpr) in the lung as well as serum level of @PROTEIN$-alpha (TNF-alpha) were evaluated.	0	18528683-286
At the end of the experiment (after 6 weeks), lung histological changes, collagen staining, the activity of @PROTEIN$ (GR) and contents of reduced glutathione (GSH) and @COMPOUND$ (Hpr) in the lung as well as serum level of tumor necrosis factor-alpha (TNF-alpha) were evaluated.	0	18528683-286
At the end of the experiment (after 6 weeks), lung histological changes, collagen staining, the activity of glutathione reductase (GR) and contents of reduced glutathione (@COMPOUND$) and hydroxyproline (Hpr) in the lung as well as serum level of @PROTEIN$-alpha (TNF-alpha) were evaluated.	0	18528683-286
The obtained data revealed that BCNU induced pathological changes and markedly increased lung collagen and level of @PROTEIN$ but decreased @COMPOUND$ content and GR activity and increased serum TNF-alpha compared to both control and MT-administered rats.	0	18528683-287
The obtained data revealed that @COMPOUND$ induced pathological changes and markedly increased lung collagen and level of @PROTEIN$ but decreased GSH content and GR activity and increased serum TNF-alpha compared to both control and MT-administered rats.	1	18528683-287
The obtained data revealed that @COMPOUND$ induced pathological changes and markedly increased lung collagen and level of Hpr but decreased GSH content and GR activity and increased serum @PROTEIN$ compared to both control and MT-administered rats.	1	18528683-287
The obtained data revealed that BCNU induced pathological changes and markedly increased lung collagen and level of Hpr but decreased @COMPOUND$ content and GR activity and increased serum @PROTEIN$ compared to both control and MT-administered rats.	0	18528683-287
Collectively, @PROTEIN$ supplementation increased concentrations of @COMPOUND$ in intestinal lumen, expression of proglucagon, GLP-2R, and eNOS genes, and net portal absorption of AA.	1	18528747-574
Collectively, HMB supplementation increased concentrations of @COMPOUND$ in intestinal lumen, expression of proglucagon, @PROTEIN$, and eNOS genes, and net portal absorption of AA.	0	18528747-574
Collectively, HMB supplementation increased concentrations of @COMPOUND$ in intestinal lumen, expression of proglucagon, GLP-2R, and @PROTEIN$ genes, and net portal absorption of AA.	0	18528747-574
In search for the pharmacophore and to analyze structure-activity relationships we synthesized a series of truncated derivatives and analogs of RB-2, including 1-amino-2-sulfo-4-ar(alk)ylaminoanthraquinones, 1-amino-2-methyl-4-arylaminoanthraquinones, @COMPOUND$ esters and sulfonamides, and bis-(1-amino-4-bromoanthraquinone) sulfonamides, and investigated them in preparations of rat @PROTEIN$, 2, and 3 using a capillary electrophoresis assay.	0	18528783-293
In search for the pharmacophore and to analyze structure-activity relationships we synthesized a series of truncated derivatives and analogs of @COMPOUND$, including 1-amino-2-sulfo-4-ar(alk)ylaminoanthraquinones, 1-amino-2-methyl-4-arylaminoanthraquinones, 1-amino-4-bromoanthraquinone 2-sulfonic acid esters and sulfonamides, and bis-(1-amino-4-bromoanthraquinone) sulfonamides, and investigated them in preparations of rat @PROTEIN$, 2, and 3 using a capillary electrophoresis assay.	0	18528783-293
Plasma @PROTEIN$ 0.05) following ingestion of GluF than after Glu alone, without any differences between the effects of either intervention on plasma @COMPOUND$ concentrations.	0	18533896-944
No significant differences were observed in plasma concentrations of @COMPOUND$, @PROTEIN$, and insulin-like growth factor or hepatic triglyceride content, but all supplements tended to decrease beta hydroxybutyrate postpartum compared to CTL cows.	0	18534791-223
No significant differences were observed in plasma concentrations of glucose, @PROTEIN$, and insulin-like growth factor or hepatic triglyceride content, but all supplements tended to decrease @COMPOUND$ postpartum compared to CTL cows.	0	18534791-223
The results showed that @COMPOUND$ augmented splenic-specific IgG1 and IL-4 as well as cell proliferation but suppressed specific IgG2a and @PROTEIN$ levels.	1	18534811-234
The results showed that @COMPOUND$ augmented splenic-specific IgG1 and @PROTEIN$ as well as cell proliferation but suppressed specific IgG2a and IFN-gamma levels.	1	18534811-234
@COMPOUND$ (Pfizer, Inc.) is a multitargeted kinase inhibitor that inhibits vascular endothelial growth factor (VEGF) receptor (R)-1, 2 and 3, platelet-derived growth factor receptors (PDGFR)-alpha and beta, Flt3, @PROTEIN$, and Kit.	1	18534874-957
@COMPOUND$ (Pfizer, Inc.) is a multitargeted kinase inhibitor that inhibits vascular endothelial growth factor (VEGF) receptor (R)-1, 2 and 3, platelet-derived growth factor receptors (PDGFR)-alpha and beta, @PROTEIN$, RET, and Kit.	1	18534874-957
@COMPOUND$ (Pfizer, Inc.) is a multitargeted kinase inhibitor that inhibits vascular endothelial growth factor (@PROTEIN$) receptor (R)-1, 2 and 3, platelet-derived growth factor receptors (PDGFR)-alpha and beta, Flt3, RET, and Kit.	1	18534874-957
@PROTEIN$ deletion blocks extinction of @COMPOUND$ place preference conditioning.	1	18536700-664
Accordingly, to assess its potential role in the long-lasting behavioral effects of drugs of abuse, we have investigated the impact of @PROTEIN$ deletion on sustained behavioral responses elicited by repeated @COMPOUND$ administration.	0	18536700-665
Decreased @PROTEIN$ expression increases extracellular @COMPOUND$ and alters its regulation in mouse striatum.	1	18536704-162
injection of @PROTEIN$ provoked a significant increase in plasma @COMPOUND$ level.	1	18536705-163
In 17 adults on a fixed metabolic diet, an 11-day course of @COMPOUND$ increased serum @PROTEIN$ and basal gastric acid output, but not maximal gastric acid output, compared with a placebo.	1	18536954-285
Since @COMPOUND$ was found to be a weak inhibitor of CYP 3A4 and to have no inhibitory effects on esterases, @PROTEIN$, and glucuronyltransferases, it is suggested PSC-833 enhances intestinal mucosal permeation of these cyclic prodrugs by inhibiting their polarized efflux and not by inhibiting their metabolism.	0	18537150-81
Since @COMPOUND$ was found to be a weak inhibitor of CYP 3A4 and to have no inhibitory effects on @PROTEIN$, phenol sulfotransferases, and glucuronyltransferases, it is suggested PSC-833 enhances intestinal mucosal permeation of these cyclic prodrugs by inhibiting their polarized efflux and not by inhibiting their metabolism.	0	18537150-81
We showed that after treatment of HCT116 cells with a low dose of @COMPOUND$ most of them stopped proliferation as documented by SA-@PROTEIN$ activity and the lack of Ki67 expression.	1	18538372-777
Tumor @PROTEIN$ differs from normal MUC1 by modified @COMPOUND$ side chains.	0	18539357-492
Mineralization and dehalogenation of @COMPOUND$ was evidenced by high @PROTEIN$ removal efficiencies (approximately 95%), and by the stoichiometric release of chloride ions from the halogenated compound (approximately 80%).	1	18539387-509
Mineralization and dehalogenation of 2,4,6-TCP was evidenced by high @PROTEIN$ removal efficiencies (approximately 95%), and by the stoichiometric release of @COMPOUND$ ions from the halogenated compound (approximately 80%).	0	18539387-509
@COMPOUND$ can change the conformation of the active sites and decrease obviously the affinities between gliclazide in the active site and enzymes when it is docked in the second active sites in CYP2C9 and @PROTEIN$.	1	18541345-459
Gliclazide can change the conformation of the active sites and decrease obviously the affinities between @COMPOUND$ in the active site and enzymes when it is docked in the second active sites in @PROTEIN$ and CYP2C19.	1	18541345-459
@COMPOUND$ can change the conformation of the active sites and decrease obviously the affinities between gliclazide in the active site and enzymes when it is docked in the second active sites in @PROTEIN$ and CYP2C19.	1	18541345-459
Gliclazide can change the conformation of the active sites and decrease obviously the affinities between @COMPOUND$ in the active site and enzymes when it is docked in the second active sites in CYP2C9 and @PROTEIN$.	1	18541345-459
Metabolism of @COMPOUND$ by @PROTEIN$ in different recombinantly expressed systems and its implications for the in vitro assessment of dextromethorphan metabolism.	1	18543297-399
Metabolism of dextrorphan by @PROTEIN$ in different recombinantly expressed systems and its implications for the in vitro assessment of @COMPOUND$ metabolism.	0	18543297-399
@PROTEIN$ (CYP2D6) mediated formation of dextrorphan (DOR) from @COMPOUND$ (DEX) is widely used as a marker to assess the activity of this enzyme both in vitro and in vivo.	1	18543297-400
@PROTEIN$ (CYP2D6) mediated formation of @COMPOUND$ (DOR) from dextromethorphan (DEX) is widely used as a marker to assess the activity of this enzyme both in vitro and in vivo.	1	18543297-400
Cytochrome P450 2D6 (@PROTEIN$) mediated formation of @COMPOUND$ (DOR) from dextromethorphan (DEX) is widely used as a marker to assess the activity of this enzyme both in vitro and in vivo.	1	18543297-400
Cytochrome P450 2D6 (@PROTEIN$) mediated formation of dextrorphan (DOR) from @COMPOUND$ (DEX) is widely used as a marker to assess the activity of this enzyme both in vitro and in vivo.	1	18543297-400
@PROTEIN$ (CYP2D6) mediated formation of dextrorphan (@COMPOUND$) from dextromethorphan (DEX) is widely used as a marker to assess the activity of this enzyme both in vitro and in vivo.	1	18543297-400
Cytochrome P450 2D6 (@PROTEIN$) mediated formation of dextrorphan (@COMPOUND$) from dextromethorphan (DEX) is widely used as a marker to assess the activity of this enzyme both in vitro and in vivo.	1	18543297-400
The sequential metabolism of @COMPOUND$ during in vitro studies, particularly using recombinant systems (rCYPs) expressing human @PROTEIN$, is assumed to be negligible.	0	18543297-401
The extent of metabolism was investigated for a range of DEX and @COMPOUND$ concentrations in microsomal preparations from three different rCYPs expressing human @PROTEIN$ (yeast, Supersomes and Bactosomes) containing 10 pmol of the enzyme.	0	18543297-402
Two novel @PROTEIN$ related metabolites were identified in Bactosomes, and assigned as single hydroxylations in the phenyl rings of @COMPOUND$ and HYM using ion-trap mass spectrometry.	1	18543297-403
Two novel @PROTEIN$ related metabolites were identified in Bactosomes, and assigned as single hydroxylations in the phenyl rings of DOR and @COMPOUND$ using ion-trap mass spectrometry.	1	18543297-403
The metal-coordinating residues in the active site of @PROTEIN$ include a conserved @COMPOUND$ that clearly distinguishes this protein from previously structurally characterized members of the M20 peptidase family.	1	18543330-427
Finally, the active site of @PROTEIN$ harbors an absolutely conserved @COMPOUND$ (Glu172), which is well positioned to act as a general acid-base residue.	1	18543330-428
In this study, we tested the hypothesis that the Angiopoietin 1 (Ang1)/@PROTEIN$ pathway mediates @COMPOUND$-induced vascular integrity and migration of neuroblasts after stroke.	0	18544044-880
In this study, we tested the hypothesis that the Angiopoietin 1 (@PROTEIN$)/Tie2 pathway mediates @COMPOUND$-induced vascular integrity and migration of neuroblasts after stroke.	0	18544044-880
@COMPOUND$ treatment significantly decreased blood-brain barrier (BBB) leakage and concomitantly, increased Ang1, @PROTEIN$ and Occludin expression in the ischaemic border (IBZ) compared to the MCAo control group.	1	18544044-881
@COMPOUND$ treatment significantly decreased blood-brain barrier (BBB) leakage and concomitantly, increased Ang1, Tie2 and @PROTEIN$ expression in the ischaemic border (IBZ) compared to the MCAo control group.	1	18544044-881
@COMPOUND$ treatment significantly decreased blood-brain barrier (BBB) leakage and concomitantly, increased @PROTEIN$, Tie2 and Occludin expression in the ischaemic border (IBZ) compared to the MCAo control group.	1	18544044-881
@COMPOUND$ also significantly increased doublecortin (@PROTEIN$, a marker of migrating neuroblasts) expression in the IBZ compared to control MCAo rats.	1	18544044-882
The data show that @COMPOUND$ treatment of RBMEC increased Ang1 and @PROTEIN$ gene and protein expression and promoted phosphorylated-Tie2 activity.	1	18544044-883
The data show that @COMPOUND$ treatment of RBMEC increased @PROTEIN$ and Tie2 gene and protein expression and promoted phosphorylated-Tie2 activity.	1	18544044-883
@COMPOUND$ treatment of stroke increases Ang1/@PROTEIN$ expression and thereby reduces BBB leakage and promotes vascular stabilization.	1	18544044-884
@COMPOUND$ treatment of stroke increases @PROTEIN$/Tie2 expression and thereby reduces BBB leakage and promotes vascular stabilization.	1	18544044-884
Ang1/@PROTEIN$ expression induced by @COMPOUND$ treatment promotes neuroblast micro-vascular coupling after stroke.	1	18544044-885
@PROTEIN$/Tie2 expression induced by @COMPOUND$ treatment promotes neuroblast micro-vascular coupling after stroke.	1	18544044-885
Suppressing the activity of @PROTEIN$ in 3T3-L1 adipocytes reduces mitochondrial biogenesis but enhances glycolysis and basal @COMPOUND$ uptake.	1	18544047-888
Therefore, @PROTEIN$ stands at the crossroad of glucose and fatty acid utilization and acts as a homeostatic switch to regulate the flux of TCA cycle, mitochondrial membrane potential and glycolysis to maintain a steady level of @COMPOUND$ production, particularly, when mitochondrial biogenesis is reduced.	1	18544047-891
Therefore, @PROTEIN$ stands at the crossroad of @COMPOUND$ and fatty acid utilization and acts as a homeostatic switch to regulate the flux of TCA cycle, mitochondrial membrane potential and glycolysis to maintain a steady level of ATP production, particularly, when mitochondrial biogenesis is reduced.	1	18544047-891
A significant decrease in mean total nitric oxide (NOx), nitrite, and @COMPOUND$ levels was also found after @PROTEIN$ plus dexamethasone administration.	1	18544592-1218
A significant decrease in mean total nitric oxide (NOx), nitrite, and nitrate levels was also found after @PROTEIN$ plus @COMPOUND$ administration.	0	18544592-1218
A significant decrease in mean total @COMPOUND$ (NOx), nitrite, and nitrate levels was also found after @PROTEIN$ plus dexamethasone administration.	1	18544592-1218
Even if partially compensated with u-PA and @PROTEIN$, increased FVIII and vWF activity, and decreased nitric oxide levels may still partially contribute to progress of thrombosis risk in rhG-CSF plus @COMPOUND$ administered healthy granulocyte donors.	0	18544592-1219
Even if partially compensated with u-PA and protein C, increased FVIII and @PROTEIN$ activity, and decreased @COMPOUND$ levels may still partially contribute to progress of thrombosis risk in rhG-CSF plus dexamethasone administered healthy granulocyte donors.	0	18544592-1219
Even if partially compensated with u-PA and protein C, increased FVIII and @PROTEIN$ activity, and decreased nitric oxide levels may still partially contribute to progress of thrombosis risk in rhG-CSF plus @COMPOUND$ administered healthy granulocyte donors.	0	18544592-1219
Even if partially compensated with u-PA and @PROTEIN$, increased FVIII and vWF activity, and decreased @COMPOUND$ levels may still partially contribute to progress of thrombosis risk in rhG-CSF plus dexamethasone administered healthy granulocyte donors.	0	18544592-1219
Amyloglucosidase from Rhizopus mould and @PROTEIN$ from sweet almond were employed for the preparation of phenolic and vitamin glycosides of vanillin, N-vanillylnonanamide, DL-dopa, dopamine, curcumin, alpha-tocopherol (vitamin E), pyridoxine (vitamin B(6)), ergocalciferol (vitamin D (2)), @COMPOUND$ (vitamin B(1)) and riboflavin (vitamin B(2)).	1	18547170-484
Amyloglucosidase from Rhizopus mould and @PROTEIN$ from sweet almond were employed for the preparation of phenolic and vitamin glycosides of vanillin, N-vanillylnonanamide, DL-dopa, @COMPOUND$, curcumin, alpha-tocopherol (vitamin E), pyridoxine (vitamin B(6)), ergocalciferol (vitamin D (2)), thiamin (vitamin B(1)) and riboflavin (vitamin B(2)).	1	18547170-484
Amyloglucosidase from Rhizopus mould and @PROTEIN$ from sweet almond were employed for the preparation of phenolic and vitamin glycosides of vanillin, N-vanillylnonanamide, DL-dopa, dopamine, curcumin, @COMPOUND$ (vitamin E), pyridoxine (vitamin B(6)), ergocalciferol (vitamin D (2)), thiamin (vitamin B(1)) and riboflavin (vitamin B(2)).	1	18547170-484
Amyloglucosidase from Rhizopus mould and @PROTEIN$ from sweet almond were employed for the preparation of phenolic and vitamin glycosides of vanillin, N-vanillylnonanamide, DL-dopa, dopamine, @COMPOUND$, alpha-tocopherol (vitamin E), pyridoxine (vitamin B(6)), ergocalciferol (vitamin D (2)), thiamin (vitamin B(1)) and riboflavin (vitamin B(2)).	1	18547170-484
Amyloglucosidase from Rhizopus mould and @PROTEIN$ from sweet almond were employed for the preparation of phenolic and vitamin glycosides of vanillin, N-vanillylnonanamide, @COMPOUND$, dopamine, curcumin, alpha-tocopherol (vitamin E), pyridoxine (vitamin B(6)), ergocalciferol (vitamin D (2)), thiamin (vitamin B(1)) and riboflavin (vitamin B(2)).	1	18547170-484
Amyloglucosidase from Rhizopus mould and @PROTEIN$ from sweet almond were employed for the preparation of phenolic and vitamin glycosides of vanillin, N-vanillylnonanamide, DL-dopa, dopamine, curcumin, alpha-tocopherol (vitamin E), @COMPOUND$ (vitamin B(6)), ergocalciferol (vitamin D (2)), thiamin (vitamin B(1)) and riboflavin (vitamin B(2)).	1	18547170-484
Amyloglucosidase from Rhizopus mould and @PROTEIN$ from sweet almond were employed for the preparation of phenolic and vitamin glycosides of vanillin, N-vanillylnonanamide, DL-dopa, dopamine, curcumin, alpha-tocopherol (@COMPOUND$), pyridoxine (vitamin B(6)), ergocalciferol (vitamin D (2)), thiamin (vitamin B(1)) and riboflavin (vitamin B(2)).	1	18547170-484
Amyloglucosidase from Rhizopus mould and @PROTEIN$ from sweet almond were employed for the preparation of phenolic and vitamin glycosides of vanillin, @COMPOUND$, DL-dopa, dopamine, curcumin, alpha-tocopherol (vitamin E), pyridoxine (vitamin B(6)), ergocalciferol (vitamin D (2)), thiamin (vitamin B(1)) and riboflavin (vitamin B(2)).	1	18547170-484
Amyloglucosidase from Rhizopus mould and @PROTEIN$ from sweet almond were employed for the preparation of phenolic and vitamin glycosides of @COMPOUND$, N-vanillylnonanamide, DL-dopa, dopamine, curcumin, alpha-tocopherol (vitamin E), pyridoxine (vitamin B(6)), ergocalciferol (vitamin D (2)), thiamin (vitamin B(1)) and riboflavin (vitamin B(2)).	1	18547170-484
Amyloglucosidase from Rhizopus mould and @PROTEIN$ from sweet almond were employed for the preparation of phenolic and vitamin glycosides of vanillin, N-vanillylnonanamide, DL-dopa, dopamine, curcumin, alpha-tocopherol (vitamin E), pyridoxine (vitamin B(6)), @COMPOUND$ (2)), thiamin (vitamin B(1)) and riboflavin (vitamin B(2)).	1	18547170-484
Amyloglucosidase from Rhizopus mould and @PROTEIN$ from sweet almond were employed for the preparation of phenolic and vitamin glycosides of vanillin, N-vanillylnonanamide, DL-dopa, dopamine, curcumin, alpha-tocopherol (vitamin E), pyridoxine (vitamin B(6)), ergocalciferol (vitamin D (2)), thiamin (vitamin B(1)) and @COMPOUND$ (vitamin B(2)).	1	18547170-484
@COMPOUND$ impairs @PROTEIN$-dependent gene expression in porcine kidney tubulus cells.	1	18547363-1222
Therefore, in the present study, the effects of @COMPOUND$ on the nuclear translocation and transactivation of the transcription factor @PROTEIN$ as well as mRNA levels of Nrf2 target genes including glutathione-S-transferase and gamma-glutamylcysteinyl synthetase have been studied in cultured porcine kidney tubulus cells (LLC-PK1).	0	18547363-1223
Therefore, in the present study, the effects of @COMPOUND$ on the nuclear translocation and transactivation of the transcription factor Nrf2 as well as mRNA levels of Nrf2 target genes including @PROTEIN$ and gamma-glutamylcysteinyl synthetase have been studied in cultured porcine kidney tubulus cells (LLC-PK1).	0	18547363-1223
@PROTEIN$ was induced by @COMPOUND$, a well-known activator of this transcription factor.	1	18547363-1224
@COMPOUND$ significantly decreased gamma-glutamylcysteinyl synthetase and @PROTEIN$ mRNA levels in LLC-PK1 cells.	1	18547363-1225
Furthermore, @COMPOUND$ also lowered @PROTEIN$ mRNA levels.	1	18547363-1226
Current data indicate that @COMPOUND$ nephrotoxicity may be, at least partly, mediated by an @PROTEIN$-dependent signal transduction pathway.	1	18547363-1227
Parthenogenetic porcine blastocysts were generated by the following methods: (1) electroporation followed by blocking the activity of specific @PROTEIN$ with @COMPOUND$ ; (2) electroporation followed by inhibition of protein synthesis using cycloheximide ; and (3) electroporation only (control).	1	18547754-637
Parthenogenetic porcine blastocysts were generated by the following methods: (1) electroporation followed by blocking the activity of specific @PROTEIN$ with butyrolactone I ; (2) electroporation followed by inhibition of protein synthesis using @COMPOUND$ ; and (3) electroporation only (control).	0	18547754-637
The aim of the present study was to investigate differences in the expression of mRNAs for @PROTEIN$, ERbeta and PR in the sow uterus at different stages of the estrous cycle as well as in inseminated sows at estrus and during early pregnancy by use of solution hybridization and in relation to plasma levels of estradiol and @COMPOUND$.	0	18547755-125
The aim of the present study was to investigate differences in the expression of mRNAs for @PROTEIN$, ERbeta and PR in the sow uterus at different stages of the estrous cycle as well as in inseminated sows at estrus and during early pregnancy by use of solution hybridization and in relation to plasma levels of @COMPOUND$ and progesterone.	0	18547755-125
The aim of the present study was to investigate differences in the expression of mRNAs for ERalpha, @PROTEIN$ and PR in the sow uterus at different stages of the estrous cycle as well as in inseminated sows at estrus and during early pregnancy by use of solution hybridization and in relation to plasma levels of estradiol and @COMPOUND$.	0	18547755-125
The aim of the present study was to investigate differences in the expression of mRNAs for ERalpha, @PROTEIN$ and PR in the sow uterus at different stages of the estrous cycle as well as in inseminated sows at estrus and during early pregnancy by use of solution hybridization and in relation to plasma levels of @COMPOUND$ and progesterone.	0	18547755-125
Increased incorporation of dietary plant sterols and @COMPOUND$ correlates with decreased expression of hepatic and intestinal Abcg5 and @PROTEIN$ in diabetic BB rats.	1	18547796-661
Increased incorporation of dietary plant sterols and @COMPOUND$ correlates with decreased expression of hepatic and intestinal @PROTEIN$ and Abcg8 in diabetic BB rats.	1	18547796-661
This increase in @COMPOUND$ and plant sterols and stanols was associated with a marked decrease in hepatic and intestinal Abcg5 (ATP-binding cassette transporter G5) and @PROTEIN$ (ATP-binding cassette transporter G8) expressions in diabetic rats, as well as decreased mRNA levels of several other genes involved in sterol regulation.	1	18547796-662
This increase in @COMPOUND$ and plant sterols and stanols was associated with a marked decrease in hepatic and intestinal @PROTEIN$ (ATP-binding cassette transporter G5) and Abcg8 (ATP-binding cassette transporter G8) expressions in diabetic rats, as well as decreased mRNA levels of several other genes involved in sterol regulation.	1	18547796-662
Therefore, lower expression levels of Abcg5/@PROTEIN$ in diabetic rats may account for the increased accumulation of plant sterols and @COMPOUND$ in these rats.	1	18547796-663
Therefore, lower expression levels of @PROTEIN$/Abcg8 in diabetic rats may account for the increased accumulation of plant sterols and @COMPOUND$ in these rats.	1	18547796-663
Gallic acid, @COMPOUND$ and p-coumaric acid at a dosage of 100 mg kg(-1) body weight significantly increased the activities of cardiac superoxide dismutase, @PROTEIN$ (GPx) and catalase (CAT.05).	1	18547798-666
@COMPOUND$, ferulic acid and p-coumaric acid at a dosage of 100 mg kg(-1) body weight significantly increased the activities of cardiac superoxide dismutase, @PROTEIN$ (GPx) and catalase (CAT.05).	1	18547798-666
Gallic acid, ferulic acid and @COMPOUND$ at a dosage of 100 mg kg(-1) body weight significantly increased the activities of cardiac @PROTEIN$, glutathione peroxidase (GPx) and catalase (CAT.05).	1	18547798-666
Gallic acid, ferulic acid and @COMPOUND$ at a dosage of 100 mg kg(-1) body weight significantly increased the activities of cardiac superoxide dismutase, @PROTEIN$ (GPx) and catalase (CAT.05).	1	18547798-666
Gallic acid, @COMPOUND$ and p-coumaric acid at a dosage of 100 mg kg(-1) body weight significantly increased the activities of cardiac superoxide dismutase, glutathione peroxidase (GPx) and catalase (@PROTEIN$.05).	1	18547798-666
@COMPOUND$, ferulic acid and p-coumaric acid at a dosage of 100 mg kg(-1) body weight significantly increased the activities of cardiac superoxide dismutase, glutathione peroxidase (GPx) and catalase (@PROTEIN$.05).	1	18547798-666
@COMPOUND$, ferulic acid and p-coumaric acid at a dosage of 100 mg kg(-1) body weight significantly increased the activities of cardiac superoxide dismutase, glutathione peroxidase (GPx) and @PROTEIN$ (CAT.05).	1	18547798-666
@COMPOUND$, ferulic acid and p-coumaric acid at a dosage of 100 mg kg(-1) body weight significantly increased the activities of cardiac @PROTEIN$, glutathione peroxidase (GPx) and catalase (CAT.05).	1	18547798-666
Gallic acid, ferulic acid and @COMPOUND$ at a dosage of 100 mg kg(-1) body weight significantly increased the activities of cardiac superoxide dismutase, glutathione peroxidase (GPx) and catalase (@PROTEIN$.05).	1	18547798-666
Gallic acid, ferulic acid and @COMPOUND$ at a dosage of 100 mg kg(-1) body weight significantly increased the activities of cardiac superoxide dismutase, glutathione peroxidase (GPx) and @PROTEIN$ (CAT.05).	1	18547798-666
Gallic acid, @COMPOUND$ and p-coumaric acid at a dosage of 100 mg kg(-1) body weight significantly increased the activities of cardiac superoxide dismutase, glutathione peroxidase (GPx) and @PROTEIN$ (CAT.05).	1	18547798-666
Gallic acid, @COMPOUND$ and p-coumaric acid at a dosage of 100 mg kg(-1) body weight significantly increased the activities of cardiac @PROTEIN$, glutathione peroxidase (GPx) and catalase (CAT.05).	1	18547798-666
These effects of @COMPOUND$ during the differentiation period were associated with down-regulation of @PROTEIN$ and ERbeta expression.	1	18547799-292
These effects of @COMPOUND$ during the differentiation period were associated with down-regulation of ERalpha and @PROTEIN$ expression.	1	18547799-292
Activities of microbial extracellular enzymes involved in carbon, @COMPOUND$, and phosphorus cycling declined appreciably with depth, the only exception being @PROTEIN$.	0	18548182-922
Activities of microbial extracellular enzymes involved in carbon, nitrogen, and @COMPOUND$ cycling declined appreciably with depth, the only exception being @PROTEIN$.	0	18548182-922
@COMPOUND$ (SU) treatment restores insulin secretion in patients with @PROTEIN$ mutations.	0	18548275-801
@COMPOUND$ (SU) treatment restores @PROTEIN$ secretion in patients with KCNJ11 mutations.	1	18548275-801
The purpose of this study was to investigate the effect of three zinc salts (i.e., zinc oxide, @COMPOUND$, and zinc acetate) on @PROTEIN$ encapsulation efficiency (EE), stability, and in vitro release kinetics from poly(lactic-co-glycolic acid) (PLGA) microspheres.	0	18548615-1193
The purpose of this study was to investigate the effect of three zinc salts (i.e., zinc oxide, zinc carbonate, and @COMPOUND$) on @PROTEIN$ encapsulation efficiency (EE), stability, and in vitro release kinetics from poly(lactic-co-glycolic acid) (PLGA) microspheres.	0	18548615-1193
The purpose of this study was to investigate the effect of three zinc salts (i.e., zinc oxide, zinc carbonate, and zinc acetate) on @PROTEIN$ encapsulation efficiency (EE), stability, and in vitro release kinetics from poly(lactic-co-glycolic acid) (@COMPOUND$) microspheres.	0	18548615-1193
The purpose of this study was to investigate the effect of three zinc salts (i.e., @COMPOUND$, zinc carbonate, and zinc acetate) on @PROTEIN$ encapsulation efficiency (EE), stability, and in vitro release kinetics from poly(lactic-co-glycolic acid) (PLGA) microspheres.	0	18548615-1193
@PROTEIN$-alpha inhibition protects against @COMPOUND$-induced endothelial glycocalyx perturbation.	1	18550063-794
In the present study, we investigated whether @COMPOUND$-induced inflammatory reactions lead to a decrease of endothelial glycocalyx thickness in humans and whether @PROTEIN$-alpha (TNFalpha) plays a role in this process.	0	18550063-795
In the present study, we investigated whether @COMPOUND$-induced inflammatory reactions lead to a decrease of endothelial glycocalyx thickness in humans and whether tumor necrosis factor-alpha (@PROTEIN$) plays a role in this process.	0	18550063-795
The amino acid sequence deduced from the coding sequence encodes for @PROTEIN$ of 73 amino acids containing 21 @COMPOUND$ residues.	1	18550164-868
Ultrastructural analysis in the macaque mediodorsal nucleus revealed that thalamic interneurons are a main postsynaptic target of @PROTEIN$-ir axons ; this suggests that the marked expansion of the @COMPOUND$ innervation in the primate in comparison to the rodent thalamus may be related to the presence of a sizable interneuron population in primates.	0	18550594-1147
@PROTEIN$-dependent facilitation in MF synapses of WT mice was attenuated by blocking F-actin polymerization with @COMPOUND$ in hippocampal slices.	1	18550596-1150
Synapsin-dependent facilitation in MF synapses of WT mice was attenuated by blocking F-@PROTEIN$ polymerization with @COMPOUND$ in hippocampal slices.	1	18550596-1150
Transformation was achieved using a vector that targets genes to the rrn16/rps12 intergenic region of the sugar beet plastome, employing the @PROTEIN$ gene as a selectable marker against @COMPOUND$ and the gfp gene for visual screening of plastid transformants.	1	18551377-641
Transformation was achieved using a vector that targets genes to the rrn16/@PROTEIN$ intergenic region of the sugar beet plastome, employing the aadA gene as a selectable marker against @COMPOUND$ and the gfp gene for visual screening of plastid transformants.	0	18551377-641
@COMPOUND$ inhibits serum amyloid a-induced @PROTEIN$ expression in human endothelial cells.	1	18552508-1057
This article investigated the effect of sulfite on total antioxidant capacity (TAC), total oxidant status, lipid @COMPOUND$ (LOOH), and total free sulfydryl groups (-SH) levels in normal and @PROTEIN$-deficient male albino rat plasma.	0	18553142-185
@PROTEIN$ deficiency was established by feeding rats a low molybdenum diet and adding to their drinking water 200 ppm @COMPOUND$.	1	18553142-186
@PROTEIN$ deficiency was established by feeding rats a low @COMPOUND$ diet and adding to their drinking water 200 ppm tungsten.	1	18553142-186
To test the hypothesis that @COMPOUND$S production from DHEA occurs in hepatic cells and that this production is augmented by the presence of sex steroids or @PROTEIN$.	0	18554595-1071
To test the hypothesis that @COMPOUND$ production from DHEA occurs in hepatic cells and that this production is augmented by the presence of sex steroids or @PROTEIN$.	0	18554595-1071
Changes in @PROTEIN$ (TNF) production by lipopolysaccharide-stimulated peripheral blood mononuclear cells significantly correlated with serum P levels in postmenopausal women subjected to estrogen/@COMPOUND$ therapy.	0	18554598-1073
Changes in tumor necrosis factor (@PROTEIN$) production by @COMPOUND$-stimulated peripheral blood mononuclear cells significantly correlated with serum P levels in postmenopausal women subjected to estrogen/medroxyprogesterone therapy.	1	18554598-1073
Changes in @PROTEIN$ (TNF) production by @COMPOUND$-stimulated peripheral blood mononuclear cells significantly correlated with serum P levels in postmenopausal women subjected to estrogen/medroxyprogesterone therapy.	1	18554598-1073
Changes in tumor necrosis factor (@PROTEIN$) production by lipopolysaccharide-stimulated peripheral blood mononuclear cells significantly correlated with serum P levels in postmenopausal women subjected to estrogen/@COMPOUND$ therapy.	0	18554598-1073
The differences in tissue distribution and protein levels of @PROTEIN$-B1 during the programmed cell death indicate that the receptor plays a major role in the modulation and function of @COMPOUND$ activity in Bombyx anterior silk glands.	1	18554690-393
@COMPOUND$, a nutritional supplement with antineoplastic activity, enhances leiomyoma cell apoptosis and decreases @PROTEIN$ expression.	1	18555241-208
Methylthioadenosine phosphorylase (@PROTEIN$) is involved in the metabolism of purines and converts methylthioadenosine (MTA) to @COMPOUND$.	1	18555557-379
Methylation-specific primers were used to analyze methylation of the @PROTEIN$ promoter, using DNA treated with @COMPOUND$.	0	18555557-380
Long-chain @COMPOUND$ also reduced @PROTEIN$-alpha and prostaglandin E(2) production, although the potency of inhibition for the latter was lower.	1	18555679-458
@COMPOUND$ is released from human monocyte-derived macrophages upon stimulation with @PROTEIN$ and is a sensitive indicator for cellular immune activation.	1	18556000-671
Both activity and expression of @PROTEIN$ and APS reductase in plants are modulated by the @COMPOUND$ status of the plant.	1	18556087-712
@PROTEIN$ deficiency is a novel cause of secretory diarrhea and may act via disrupting the supply of @COMPOUND$ (ATP) needed for the maintenance of ion gradients across membranes.	1	18560889-729
@PROTEIN$ deficiency is a novel cause of secretory diarrhea and may act via disrupting the supply of adenosine triphosphate (@COMPOUND$) needed for the maintenance of ion gradients across membranes.	1	18560889-729
This prospective cross-sectional study was performed to investigate the influence of GH excess on @PROTEIN$ and ghrelin levels at baseline and after @COMPOUND$ load in a large group of acromegalic patients.	0	18561093-53
This prospective cross-sectional study was performed to investigate the influence of GH excess on leptin and @PROTEIN$ levels at baseline and after @COMPOUND$ load in a large group of acromegalic patients.	0	18561093-53
@PROTEIN$ digestion, fluorescence anisotropy, and NMR experiments presented here were designed to resolve the issue and show that in arm-dimerization domain, the arms are structured, although differently, in the presence and absence of @COMPOUND$.	0	18561170-499
DNA array studies have revealed that @PROTEIN$ is strongly up-regulated by nitroso-glutathione (@COMPOUND$) and also displays a 12-fold increase in expression during biofilm growth of E. coli 83972 and VR50 in human urine.	1	18561187-110
We found that the third @COMPOUND$ in @PROTEIN$, Cys122, is oxidized to a sulfenic acid.	0	18561187-111
We found that the third cysteine in @PROTEIN$, Cys122, is oxidized to a @COMPOUND$.	0	18561187-111
E. coli thioredoxin reductase and @COMPOUND$ produced ROS and caused oxidation and oligomerization of reduced @PROTEIN$.	1	18561187-112
E. coli @PROTEIN$ and @COMPOUND$ produced ROS and caused oxidation and oligomerization of reduced YhaK.	0	18561187-112
In this report, we investigated the possible role of LA and vmPFC @PROTEIN$s in the consolidation of fear extinction using the NR2B-selective antagonist @COMPOUND$.	0	18562331-1081
In this report, we investigated the possible role of LA and vmPFC @PROTEIN$ in the consolidation of fear extinction using the NR2B-selective antagonist @COMPOUND$.	0	18562331-1081
Patients under clozapine-@COMPOUND$ therapy developed a rise of serum @PROTEIN$ levels.	1	18562423-1156
Patients under @COMPOUND$-risperidone therapy developed a rise of serum @PROTEIN$ levels.	1	18562423-1156
In experiment 3, administration of E(2) or @COMPOUND$ to ovariectomised wildtype, but not betaERKO, mice decreased immobility compared with vehicle administration, these data suggest that @PROTEIN$ may be required for some of the anti-depressant-like effects of E(2).	0	18562442-1178
@COMPOUND$ treatment significantly increased the number of peripheral blood CD34+ CD133+ cells, and serum concentration of vascular endothelial growth factor (@PROTEIN$) and AKT was markedly increased in vivo.	1	18563306-164
In cultured EPC, @COMPOUND$ increased the concentrations of @PROTEIN$, AKT and eNOS.	1	18563306-165
In cultured EPC, @COMPOUND$ increased the concentrations of VEGF, AKT and @PROTEIN$.	1	18563306-165
Western blots analysis showed that simvastatin increased the phosphorylation of @PROTEIN$ and FKHRL1, which can be blocked by the PI3K/AKT pathway blocker @COMPOUND$.	1	18563306-166
Western blots analysis showed that simvastatin increased the phosphorylation of eNOS and @PROTEIN$, which can be blocked by the PI3K/AKT pathway blocker @COMPOUND$.	1	18563306-166
Western blots analysis showed that @COMPOUND$ increased the phosphorylation of @PROTEIN$ and FKHRL1, which can be blocked by the PI3K/AKT pathway blocker LY294002.	1	18563306-166
Western blots analysis showed that @COMPOUND$ increased the phosphorylation of eNOS and @PROTEIN$, which can be blocked by the PI3K/AKT pathway blocker LY294002.	1	18563306-166
In in vitro study, @COMPOUND$ increases the phosphorylation of eNOS and of FKHRL1 through the @PROTEIN$/AKT signaling pathway.	1	18563306-167
In in vitro study, @COMPOUND$ increases the phosphorylation of @PROTEIN$ and of FKHRL1 through the PI3K/AKT signaling pathway.	1	18563306-167
In in vitro study, @COMPOUND$ increases the phosphorylation of eNOS and of @PROTEIN$ through the PI3K/AKT signaling pathway.	1	18563306-167
Only the intracellular @PROTEIN$ response in the lower tertile of IL-2 production was improved with @COMPOUND$ indicating a small influence.	1	18563517-342
The elevation of @COMPOUND$ plasma levels by a perioperative intravenous infusion of L-alanyl-L-glutamine influenced the intracellular expression of @PROTEIN$ in the lower tertile only slightly.	1	18563517-343
Determination of bioactive matter by affinity adsorption solid substrate-room temperature phosphorimetry based on @PROTEIN$ labeled with self-ordered ring of @COMPOUND$.	0	18563542-358
Specific affinity adsorption (AA) reactions could be carried out between the products of concanavalin @PROTEIN$ (Con A), triticum vulgaris lectin (WGA) labeled with ESOR and alpha-fetoprotein variant (AFP-V), alkaline phosphatase (ALP), @COMPOUND$ (G), respectively.	0	18563542-359
Specific affinity adsorption (AA) reactions could be carried out between the products of concanavalin agglutinin (Con A), triticum vulgaris lectin (WGA) labeled with ESOR and alpha-fetoprotein variant (AFP-V), alkaline phosphatase (@PROTEIN$), @COMPOUND$ (G), respectively.	0	18563542-359
Specific affinity adsorption (AA) reactions could be carried out between the products of concanavalin agglutinin (Con A), triticum vulgaris @PROTEIN$ (WGA) labeled with ESOR and alpha-fetoprotein variant (AFP-V), alkaline phosphatase (ALP), @COMPOUND$ (G), respectively.	0	18563542-359
Specific affinity adsorption (AA) reactions could be carried out between the products of concanavalin agglutinin (Con A), triticum vulgaris lectin (WGA) labeled with ESOR and alpha-fetoprotein variant (@PROTEIN$-V), alkaline phosphatase (ALP), @COMPOUND$ (G), respectively.	0	18563542-359
Specific affinity adsorption (AA) reactions could be carried out between the products of concanavalin agglutinin (Con A), triticum vulgaris lectin (WGA) labeled with ESOR and alpha-fetoprotein variant (AFP-V), @PROTEIN$ (ALP), @COMPOUND$ (G), respectively.	0	18563542-359
Specific affinity adsorption (AA) reactions could be carried out between the products of concanavalin agglutinin (@PROTEIN$), triticum vulgaris lectin (WGA) labeled with ESOR and alpha-fetoprotein variant (AFP-V), alkaline phosphatase (ALP), @COMPOUND$ (G), respectively.	0	18563542-359
In this paper we demonstrate that hedgehog signaling antagonists, including @COMPOUND$, and a second compound, CUR0199691, can inhibit growth of @PROTEIN$ (ER)-positive and ER-negative tumorigenic breast cancer cells at elevated doses.	0	18563554-369
The equality of K (D) of @COMPOUND$ binding to blood platelet membranes and to membranes from nerve endings appears to encourage the use of such membranes as a model for brain @PROTEIN$.	0	18563559-375
With supplementation of @COMPOUND$ in diet, lower expression of GFAP and @PROTEIN$ while higher expression of GLAST, GS and GAD in retina of diabetic rats were determinated by RT-PCR 0.05).	1	18563560-376
With supplementation of @COMPOUND$ in diet, lower expression of @PROTEIN$ and VEGF while higher expression of GLAST, GS and GAD in retina of diabetic rats were determinated by RT-PCR 0.05).	1	18563560-376
With supplementation of @COMPOUND$ in diet, lower expression of GFAP and VEGF while higher expression of GLAST, GS and @PROTEIN$ in retina of diabetic rats were determinated by RT-PCR 0.05).	1	18563560-376
With supplementation of @COMPOUND$ in diet, lower expression of GFAP and VEGF while higher expression of @PROTEIN$, GS and GAD in retina of diabetic rats were determinated by RT-PCR 0.05).	1	18563560-376
@PROTEIN$, VEGF, GLAST, GS and GAD expressions in normal controls were not altered by @COMPOUND$ treatment.	0	18563560-377
GFAP, VEGF, @PROTEIN$, GS and GAD expressions in normal controls were not altered by @COMPOUND$ treatment.	0	18563560-377
GFAP, VEGF, GLAST, GS and @PROTEIN$ expressions in normal controls were not altered by @COMPOUND$ treatment.	0	18563560-377
GFAP, @PROTEIN$, GLAST, GS and GAD expressions in normal controls were not altered by @COMPOUND$ treatment.	0	18563560-377
Malondialdehyde (MDA), glutathione (@COMPOUND$), nitric oxide (NO) levels and myeloperoxidase activity (@PROTEIN$) were examined in plasma, liver and brain tissues.	0	18563561-378
@COMPOUND$ (MDA), glutathione (GSH), nitric oxide (NO) levels and myeloperoxidase activity (@PROTEIN$) were examined in plasma, liver and brain tissues.	0	18563561-378
Malondialdehyde (MDA), glutathione (GSH), @COMPOUND$ (NO) levels and myeloperoxidase activity (@PROTEIN$) were examined in plasma, liver and brain tissues.	0	18563561-378
Malondialdehyde (MDA), @COMPOUND$ (GSH), nitric oxide (NO) levels and myeloperoxidase activity (@PROTEIN$) were examined in plasma, liver and brain tissues.	0	18563561-378
@PROTEIN$ (GPX1) is a ubiquitously expressed selenium-dependent enzyme that protects cells against oxidative damage by reducing @COMPOUND$ and a wide range of organic peroxides.	1	18563616-418
Glutathione peroxidase 1 (@PROTEIN$) is a ubiquitously expressed selenium-dependent enzyme that protects cells against oxidative damage by reducing @COMPOUND$ and a wide range of organic peroxides.	1	18563616-418
@COMPOUND$ (NO), which is produced by nitric oxide synthase (@PROTEIN$), may play a role in the development of ASD.	1	18563708-512
@COMPOUND$ (NO), which is produced by @PROTEIN$ (NOS), may play a role in the development of ASD.	1	18563708-512
In conclusion, @COMPOUND$-A has sufficient bonding strength and comparatively low toxicity in clinical use of 0.3 mmol or less of TAD and 0.8 mL of 44 w/w % @PROTEIN$ solution.	0	18563803-210
Long intercalated defects in canine ribs can be repaired successfully using porous @COMPOUND$ (beta-TCP) cylinders, infused with a biodegradable polymer (poly D,L-lactic acid-polyethylene block copolymer) containing recombinant human bone @PROTEIN$-2 (rhBMP-2).	0	18563826-616
In the present study we explored the possibility of using genetic engineering to increase the @COMPOUND$ content of A. annua by suppressing the expression of @PROTEIN$ (squalene synthase), a key enzyme of sterol pathway (a pathway competitive with that of artemisinin biosynthesis) by means of a hairpin-RNA-mediated RNAi (RNA interference) technique.	0	18564056-810
@COMPOUND$ upregulates @PROTEIN$ activity and inhibits cytokine-induced NF-kappaB activation through a phosphoinoside 3-kinase-Akt-dependent pathway.	1	18564176-915
It has been reported that @COMPOUND$ may affect hepatoma cell growth in vitro by suppressing transforming growth factor beta-1 (@PROTEIN$) expression, suggesting that tamoxifen might also retard fibrogenesis.	1	18564211-943
Thus, we examined whether @COMPOUND$ might suppress @PROTEIN$ expression and consequently inhibit the process of hepatic fibrosis in vivo.	0	18564211-944
We also explored the effect of @PROTEIN$ released by @COMPOUND$ because this neuropeptide is known to affect the microvasculature environment.	0	18564281-1010
We also explored the effect of substance P released by @COMPOUND$ because this @PROTEIN$ is known to affect the microvasculature environment.	0	18564281-1010
@COMPOUND$ release and gene expressions of @PROTEIN$ and MCP-1 in porcine alveolar epithelial type II cells.	0	18565553-422
@COMPOUND$ release and gene expressions of IL-8 and @PROTEIN$ in porcine alveolar epithelial type II cells.	0	18565553-422
These findings suggest that AEC IIs play an important role in initial inflammatory reactions of the lung by releasing @COMPOUND$, and that they also modulate later inflammatory reactions, evidenced by consistent elevation of @PROTEIN$ gene expression after and during exogenous challenge in pigs.	0	18565553-424
Whereas their toxicity is due to @PROTEIN$ inhibition, their secondary toxic effects have been related to free @COMPOUND$ radicals.	0	18565581-347
@COMPOUND$ diminished the plasma @PROTEIN$ activity on day 1 post-treatment, although testosterone levels remained unaffected.	1	18565581-348
Diazinon diminished the plasma @PROTEIN$ activity on day 1 post-treatment, although @COMPOUND$ levels remained unaffected.	0	18565581-348
Melatonin pretreatment prevented every alteration induced by @COMPOUND$, except the diminution of @PROTEIN$ plasmatic activity.	1	18565581-349
@COMPOUND$ pretreatment prevented every alteration induced by diazinon, except the diminution of @PROTEIN$ plasmatic activity.	0	18565581-349
Sialic acid-specific O-@PROTEIN$ and O-acetylesterases are responsible for the metabolism of esterified @COMPOUND$.	1	18566887-1426
Sialic acid-specific O-acetyltransferases and O-@PROTEIN$ are responsible for the metabolism of esterified @COMPOUND$.	1	18566887-1426
@COMPOUND$ vector injection also reduced spontaneous pain-related behaviors in the delayed phase of the formalin test and in both CFA and formalin models suppressed spinal c-@PROTEIN$ expression.	1	18567517-267
@COMPOUND$ vector injection also reduced spontaneous pain-related behaviors in the delayed phase of the formalin test and in both @PROTEIN$ and formalin models suppressed spinal c-fos expression.	0	18567517-267
Furthermore, 8-bromo-cGMP and @COMPOUND$ failed to reproduce the inhibitory effect of NO, indicating that NO acts directly on @PROTEIN$ rather than through classical NO signaling pathways.	0	18568363-1000
Furthermore, @COMPOUND$ and peroxynitrite failed to reproduce the inhibitory effect of NO, indicating that NO acts directly on @PROTEIN$ rather than through classical NO signaling pathways.	0	18568363-1000
@COMPOUND$ decreases expression of osmoprotective genes via direct inhibition of @PROTEIN$ transcriptional activity.	1	18568363-998
Because @COMPOUND$ (NO) is abundantly produced in the renal medulla, the present studies addressed the effect of NO on expression of osmoprotective genes and @PROTEIN$ activation in MDCK cells.	0	18568363-999
Ran GTPase guanine nucleotide exchange factor @PROTEIN$ is phosphorylated on @COMPOUND$ 11 by cdc2 kinase in vitro.	0	18568422-1042
Ran GTPase guanine nucleotide exchange factor RCC1 is phosphorylated on @COMPOUND$ 11 by @PROTEIN$ kinase in vitro.	1	18568422-1042
An RCC1 mutant in which all N-terminal serine and @COMPOUND$ residues were substituted with glutamate residues to mimic phosphorylation at these residues showed decreased binding to the karyopherin, @PROTEIN$, compared with wild type RCC1.	0	18568422-1043
An RCC1 mutant in which all N-terminal @COMPOUND$ and threonine residues were substituted with glutamate residues to mimic phosphorylation at these residues showed decreased binding to the karyopherin, @PROTEIN$, compared with wild type RCC1.	0	18568422-1043
An RCC1 mutant in which all N-terminal serine and threonine residues were substituted with @COMPOUND$ residues to mimic phosphorylation at these residues showed decreased binding to the karyopherin, @PROTEIN$, compared with wild type RCC1.	0	18568422-1043
@COMPOUND$, acting on P2X (7) receptors, stimulates changes in intracellular calcium concentrations, maturation, and release of interleukin-1beta (@PROTEIN$), and following prolonged agonist exposure, cell death.	1	18568426-1046
@COMPOUND$, acting on @PROTEIN$ (7) receptors, stimulates changes in intracellular calcium concentrations, maturation, and release of interleukin-1beta (IL-1beta), and following prolonged agonist exposure, cell death.	1	18568426-1046
While the total @PROTEIN$ released during a 1 h @COMPOUND$ stimulation period was the same from islets in each sample, increasing hydrogel crosslinking density contributed to delays in insulin release from hydrogel samples within the 1 h stimulation period.	1	18570315-909
Ischaemia and @PROTEIN$, but not ischaemia and contraction, act synergistically in stimulating muscle @COMPOUND$ uptake in vivo in humans.	1	18570630-1172
In summary, ischaemia and @PROTEIN$ independently stimulate skeletal muscle @COMPOUND$ uptake in vivo in humans, whereas ischaemia and contraction do not.	1	18570630-1173
A comparison of the inhibitory effect of @COMPOUND$ on soluble and immobilized @PROTEIN$ showed that immobilization increased the linearity of the inhibition plot particularly in the range 0.1 nM-0.1 microM.	1	18570631-224
7,12-Dimethyl-benz(a) anthracene (@COMPOUND$) can induce expressions of CYP1A1 and @PROTEIN$ which are known to be responsive to PAH.	1	18570695-1236
7,12-Dimethyl-benz(a) anthracene (@COMPOUND$) can induce expressions of @PROTEIN$ and CYP1B1 which are known to be responsive to PAH.	1	18570695-1236
Extracellular lipase @PROTEIN$ prepared in our lab from the yeast Yarrowia lipolytica was used for the resolution of racemic @COMPOUND$.	1	18571801-413
Extracellular @PROTEIN$ LIP prepared in our lab from the yeast Yarrowia lipolytica was used for the resolution of racemic @COMPOUND$.	1	18571801-413
The high purity (@COMPOUND$ (ee = 0.98) was obtained using lipase @PROTEIN$ to catalyze hydrolysis of (S)-ester in 0.1 M phosphate buffer (pH = 8).	1	18571801-414
The high purity (S)-ibuprofen (ee = 0.98) was obtained using lipase @PROTEIN$ to catalyze hydrolysis of (S)-ester in 0.1 M @COMPOUND$ buffer (pH = 8).	0	18571801-414
The high purity (@COMPOUND$ (ee = 0.98) was obtained using @PROTEIN$ LIP to catalyze hydrolysis of (S)-ester in 0.1 M phosphate buffer (pH = 8).	1	18571801-414
The high purity (S)-ibuprofen (ee = 0.98) was obtained using @PROTEIN$ LIP to catalyze hydrolysis of (S)-ester in 0.1 M @COMPOUND$ buffer (pH = 8).	0	18571801-414
"The potential action of @COMPOUND$ as a ""chemical chaperone"": increase of @PROTEIN$ activity in fibroblasts from an adult GM1-gangliosidosis patient."	1	18571950-552
@COMPOUND$ perfusion marginally increased @PROTEIN$ levels to 7.3 fg/microg/ml on average in the upper arm and control axilla.	1	18571954-554
In contrast, perfusion of the inflamed axilla with @COMPOUND$ significantly enhanced the release of both @PROTEIN$ and BDNF.	1	18571954-555
In contrast, perfusion of the inflamed axilla with @COMPOUND$ significantly enhanced the release of both NGF and @PROTEIN$.	1	18571954-555
@COMPOUND$ induces PON1 expression through p44/42 mitogen-activated @PROTEIN$ signaling cascade in Huh7 cells.	1	18572174-747
@COMPOUND$ induces PON1 expression through @PROTEIN$/42 mitogen-activated protein kinase signaling cascade in Huh7 cells.	1	18572174-747
@COMPOUND$ induces @PROTEIN$ expression through p44/42 mitogen-activated protein kinase signaling cascade in Huh7 cells.	1	18572174-747
Both @PROTEIN$ gene promoter activity and PON1 protein expression were elevated by @COMPOUND$ stimulation.	1	18572174-748
@COMPOUND$ phosphorylated @PROTEIN$/42 MAP kinase.	1	18572174-749
@COMPOUND$ increased the @PROTEIN$-PON1 DNA complex and this effect was attenuated by PD98059.	1	18572174-751
Pitavastatin increased the Sp1-@PROTEIN$ DNA complex and this effect was attenuated by @COMPOUND$.	1	18572174-751
Pitavastatin increased the @PROTEIN$-PON1 DNA complex and this effect was attenuated by @COMPOUND$.	1	18572174-751
@COMPOUND$ increased the Sp1-@PROTEIN$ DNA complex and this effect was attenuated by PD98059.	1	18572174-751
These observations suggest that @COMPOUND$ phosphorylates @PROTEIN$/42 MAP kinase and then activates the transcription of PON1 gene and increases the PON1 protein expression in Huh7 cells.	1	18572174-752
These observations suggest that @COMPOUND$ phosphorylates p44/42 MAP kinase and then activates the transcription of @PROTEIN$ gene and increases the PON1 protein expression in Huh7 cells.	1	18572174-752
Furthermore, we speculate that @COMPOUND$ affects both the phosphorylation of SREBP-2 and the Sp1 binding to PON1 DNA through the activation of @PROTEIN$/42 MAP kinase signaling cascade.	1	18572174-753
Furthermore, we speculate that @COMPOUND$ affects both the phosphorylation of @PROTEIN$ and the Sp1 binding to PON1 DNA through the activation of p44/42 MAP kinase signaling cascade.	0	18572174-753
Furthermore, we speculate that @COMPOUND$ affects both the phosphorylation of SREBP-2 and the @PROTEIN$ binding to PON1 DNA through the activation of p44/42 MAP kinase signaling cascade.	1	18572174-753
Furthermore, we speculate that @COMPOUND$ affects both the phosphorylation of SREBP-2 and the Sp1 binding to @PROTEIN$ DNA through the activation of p44/42 MAP kinase signaling cascade.	1	18572174-753
Inhibition of cyclooxygenase 2 expression by @COMPOUND$ on joint inflammation induced by urate crystal and @PROTEIN$.	0	18573668-277
Inhibition of @PROTEIN$ expression by @COMPOUND$ on joint inflammation induced by urate crystal and IL-1beta.	1	18573668-277
Investigation of the effects of @COMPOUND$ (DAS), a garlic sulfur compound, on joint tissue inflammatory responses induced by monosodium urate (MSU) crystals and interleukin-1beta (@PROTEIN$).	0	18573668-278
Investigation of the effects of diallyl sulfide (DAS), a garlic sulfur compound, on joint tissue inflammatory responses induced by @COMPOUND$ (MSU) crystals and interleukin-1beta (@PROTEIN$).	0	18573668-278
Genetic variants of @PROTEIN$ (CYP2C9) and vitamin K epoxide reductase (VKORC1) are known to influence @COMPOUND$ dose, but the effect of other genes has not been fully elucidated.	1	18574025-577
Genetic variants of cytochrome P450 2C9 (CYP2C9) and vitamin K epoxide reductase (@PROTEIN$) are known to influence @COMPOUND$ dose, but the effect of other genes has not been fully elucidated.	1	18574025-577
Genetic variants of cytochrome P450 2C9 (@PROTEIN$) and vitamin K epoxide reductase (VKORC1) are known to influence @COMPOUND$ dose, but the effect of other genes has not been fully elucidated.	1	18574025-577
In conclusion, CYP2C9 and @PROTEIN$ significantly influenced @COMPOUND$ dose and predicted individuals predisposed to unstable anticoagulation.	1	18574025-578
In conclusion, @PROTEIN$ and VKORC1 significantly influenced @COMPOUND$ dose and predicted individuals predisposed to unstable anticoagulation.	1	18574025-578
BMI and testosterone levels were evaluated for their ability to predict overall survival (OS) and prostate-specific antigen (@PROTEIN$) declines in the TAX327 clinical trial, an international phase III randomized trial of one of the two schedules of @COMPOUND$ and prednisone compared with mitoxantrone and prednisone.	0	18574490-986
BMI and @COMPOUND$ levels were evaluated for their ability to predict overall survival (OS) and prostate-specific antigen (@PROTEIN$) declines in the TAX327 clinical trial, an international phase III randomized trial of one of the two schedules of docetaxel and prednisone compared with mitoxantrone and prednisone.	0	18574490-986
BMI and testosterone levels were evaluated for their ability to predict overall survival (OS) and prostate-specific antigen (@PROTEIN$) declines in the TAX327 clinical trial, an international phase III randomized trial of one of the two schedules of docetaxel and prednisone compared with @COMPOUND$ and prednisone.	0	18574490-986
BMI and testosterone levels were evaluated for their ability to predict overall survival (OS) and prostate-specific antigen (@PROTEIN$) declines in the TAX327 clinical trial, an international phase III randomized trial of one of the two schedules of docetaxel and @COMPOUND$ compared with mitoxantrone and prednisone.	0	18574490-986
In multivariate analysis, neither BMI, presence of obesity, nor baseline @COMPOUND$ was significantly associated with OS or @PROTEIN$ declines.	0	18574490-987
The interaction between PAF and the platelet agonists ADP, @PROTEIN$ and convulxin was analyzed in vitro in whole blood with the use of flow cytometry and was further characterized with the use of receptor antagonists to PAF (ABT-491), P2Y1 (MRS-2179), and P2Y12 (@COMPOUND$) as well as a monoclonal anti-PSGL-1 antibody (anti-CD162).	0	18574670-1109
The interaction between PAF and the platelet agonists ADP, @PROTEIN$ and convulxin was analyzed in vitro in whole blood with the use of flow cytometry and was further characterized with the use of receptor antagonists to PAF (ABT-491), P2Y1 (@COMPOUND$), and P2Y12 (cangrelor) as well as a monoclonal anti-PSGL-1 antibody (anti-CD162).	0	18574670-1109
Aim The present study sought insight into the effects of @COMPOUND$ and fentanyl on LPS-induced release of interleukin-6 (IL-6), tumor necrosis factor-alpha (@PROTEIN$) and IL-10 in human whole blood.	0	18575957-472
Aim The present study sought insight into the effects of @COMPOUND$ and fentanyl on LPS-induced release of interleukin-6 (@PROTEIN$), tumor necrosis factor-alpha (TNF-alpha) and IL-10 in human whole blood.	0	18575957-472
Aim The present study sought insight into the effects of @COMPOUND$ and fentanyl on LPS-induced release of interleukin-6 (IL-6), @PROTEIN$-alpha (TNF-alpha) and IL-10 in human whole blood.	0	18575957-472
Aim The present study sought insight into the effects of @COMPOUND$ and fentanyl on LPS-induced release of @PROTEIN$ (IL-6), tumor necrosis factor-alpha (TNF-alpha) and IL-10 in human whole blood.	0	18575957-472
Aim The present study sought insight into the effects of @COMPOUND$ and fentanyl on LPS-induced release of interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-alpha) and @PROTEIN$ in human whole blood.	0	18575957-472
Effects of @COMPOUND$ and fentanyl on spontaneous and endotoxin (lipopolysaccharide ; 100 ng ml(-1))-stimulated cytokine release were studied in whole blood from volunteers (n = 10) cultured for 6 h. Results IL-6, TNF-alpha and @PROTEIN$ 0.01).	0	18575957-473
Effects of @COMPOUND$ and fentanyl on spontaneous and endotoxin (lipopolysaccharide ; 100 ng ml(-1))-stimulated cytokine release were studied in whole blood from volunteers (n = 10) cultured for 6 h. Results IL-6, @PROTEIN$ and IL-10 0.01).	0	18575957-473
Effects of remifentanyl and fentanyl on spontaneous and @COMPOUND$ ; 100 ng ml(-1))-stimulated cytokine release were studied in whole blood from volunteers (n = 10) cultured for 6 h. Results IL-6, @PROTEIN$ and IL-10 0.01).	0	18575957-473
Effects of remifentanyl and fentanyl on spontaneous and @COMPOUND$ ; 100 ng ml(-1))-stimulated cytokine release were studied in whole blood from volunteers (n = 10) cultured for 6 h. Results @PROTEIN$, TNF-alpha and IL-10 0.01).	0	18575957-473
Effects of remifentanyl and fentanyl on spontaneous and @COMPOUND$ ; 100 ng ml(-1))-stimulated cytokine release were studied in whole blood from volunteers (n = 10) cultured for 6 h. Results IL-6, TNF-alpha and @PROTEIN$ 0.01).	0	18575957-473
Effects of @COMPOUND$ and fentanyl on spontaneous and endotoxin (lipopolysaccharide ; 100 ng ml(-1))-stimulated cytokine release were studied in whole blood from volunteers (n = 10) cultured for 6 h. Results @PROTEIN$, TNF-alpha and IL-10 0.01).	0	18575957-473
@COMPOUND$ and fentanyl could inhibit the expressions of IL-6, @PROTEIN$ and IL-10 induced by LPS.	1	18575957-475
@COMPOUND$ and fentanyl could inhibit the expressions of @PROTEIN$, TNF-alpha and IL-10 induced by LPS.	1	18575957-475
@COMPOUND$ and fentanyl could inhibit the expressions of IL-6, TNF-alpha and @PROTEIN$ induced by LPS.	1	18575957-475
This reduction was associated with the storage of decreased TAG and increased glycogen, which was a result of enhanced @COMPOUND$ phosphorylation of anti-insulin receptor substrate-2 and serine473 phosphporylation of protein kinase B (@PROTEIN$, Akt).	0	18577298-1601
This reduction was associated with the storage of decreased TAG and increased @COMPOUND$, which was a result of enhanced tyrosine phosphorylation of anti-insulin receptor substrate-2 and serine473 phosphporylation of protein kinase B (PKB, @PROTEIN$).	0	18577298-1601
This reduction was associated with the storage of decreased TAG and increased @COMPOUND$, which was a result of enhanced tyrosine phosphorylation of anti-insulin receptor substrate-2 and serine473 phosphporylation of @PROTEIN$ (PKB, Akt).	1	18577298-1601
This reduction was associated with the storage of decreased TAG and increased @COMPOUND$, which was a result of enhanced tyrosine phosphorylation of anti-insulin receptor substrate-2 and serine473 phosphporylation of protein kinase B (@PROTEIN$, Akt).	1	18577298-1601
This reduction was associated with the storage of decreased TAG and increased glycogen, which was a result of enhanced @COMPOUND$ phosphorylation of anti-insulin receptor substrate-2 and serine473 phosphporylation of protein kinase B (PKB, @PROTEIN$).	0	18577298-1601
This reduction was associated with the storage of decreased TAG and increased glycogen, which was a result of enhanced @COMPOUND$ phosphorylation of anti-insulin receptor substrate-2 and serine473 phosphporylation of @PROTEIN$ (PKB, Akt).	0	18577298-1601
Improved hepatic @PROTEIN$ signalling led to decreased phosphoenolpyruvate carboxykinase expression and reduced hepatic @COMPOUND$ output accordingly.	1	18577298-1602
These data provide evidence that CMEC express @PROTEIN$, which is able to respond to physiological agonists by mobilizing @COMPOUND$+) from intracellular InsP(3)-sensitive stores.	1	18577871-351
Inhibition of these enzymes shows that chagasic autoantibodies up-regulation of @PROTEIN$/iNOS mRNA level is under the control of endogenous iNO/@COMPOUND$ signaling system.	1	18579232-1493
Inhibition of these enzymes shows that chagasic autoantibodies up-regulation of COX-2/@PROTEIN$ mRNA level is under the control of endogenous iNO/@COMPOUND$ signaling system.	1	18579232-1493
Pre-synaptic @PROTEIN$s inhibit neurotransmitter release, suggesting that CB1R activation during extinction may decrease CCK peptide release as well as @COMPOUND$ release.	1	18580872-1175
Pre-synaptic CB1Rs inhibit neurotransmitter release, suggesting that CB1R activation during extinction may decrease @PROTEIN$ peptide release as well as @COMPOUND$ release.	0	18580872-1175
Pre-synaptic @PROTEIN$ inhibit neurotransmitter release, suggesting that CB1R activation during extinction may decrease CCK peptide release as well as @COMPOUND$ release.	1	18580872-1175
Acute @COMPOUND$, through D(2) dopamine receptors, induced a dose-response increase in @PROTEIN$ in the cortex, with opposite effects over pFADD (Ser191/194), and no induction of apoptotic cell death (poly-(ADP-ribose) polymerase cleavage).	1	18580876-1179
Acute @COMPOUND$, through @PROTEIN$, induced a dose-response increase in FADD protein in the cortex, with opposite effects over pFADD (Ser191/194), and no induction of apoptotic cell death (poly-(ADP-ribose) polymerase cleavage).	1	18580876-1179
@PROTEIN$ was increased by @COMPOUND$ in cytosol (approximately 142%), membranes (approximately 23%) and nucleus (approximately 54%).	1	18580876-1180
In a second experiment, possible @PROTEIN$ differences were investigated in rats selectively bred for differential responsiveness to novelty, propensity for drug-seeking and @COMPOUND$ sensitization.	0	18580876-1181
@PROTEIN$ have the unique ability to catalyze oxidative cleavage of C-C bonds and @COMPOUND$ (C-O-C) bonds in non-phenolic aromatic substrates of high redox potential.	1	18581264-1465
Manganese @PROTEIN$ oxidize Mn(II) to @COMPOUND$), which facilitates the degradation of phenolic compounds or, in turn, oxidizes a second mediator for the breakdown of non-phenolic compounds.	1	18581264-1466
Manganese @PROTEIN$ oxidize @COMPOUND$) to Mn(III), which facilitates the degradation of phenolic compounds or, in turn, oxidizes a second mediator for the breakdown of non-phenolic compounds.	1	18581264-1466
@PROTEIN$ are multi-@COMPOUND$-containing proteins that catalyze the oxidation of phenolic substrates with concomitant reduction of molecular oxygen to water.	1	18581264-1467
@PROTEIN$ are multi-copper-containing proteins that catalyze the oxidation of phenolic substrates with concomitant reduction of molecular @COMPOUND$ to water.	1	18581264-1467
The co-expression of @PROTEIN$ with M6B results in a significant decrease in SERT-mediated @COMPOUND$ uptake caused by a down-regulation of SERT surface expression.	1	18581270-1477
The co-expression of SERT with @PROTEIN$ results in a significant decrease in SERT-mediated @COMPOUND$ uptake caused by a down-regulation of SERT surface expression.	1	18581270-1477
Hence, resistance to cancer in old Snell dwarf mice may be mediated by neuroendocrine factors that reduce @COMPOUND$ utilization besides elevated adiponectin, reduced IGF-I and a lack of GH, @PROTEIN$ and TSH, seen in both Snell and Ames dwarf mice.	0	18582556-870
Hence, resistance to cancer in old Snell dwarf mice may be mediated by neuroendocrine factors that reduce @COMPOUND$ utilization besides elevated adiponectin, reduced @PROTEIN$ and a lack of GH, PRL and TSH, seen in both Snell and Ames dwarf mice.	0	18582556-870
Therefore, @COMPOUND$, which inhibit the production of @PROTEIN$ by negative feedback, was considered a treatment option to control the evolution of calciphylaxis in a dialysed patient suffering from cholangiocarcinoma.	1	18582992-1242
@COMPOUND$ levels and hormones (Peptide YY(3-36), @PROTEIN$ (GLP-1), leptin, ghrelin, insulin) that regulate EI were measured.	0	18583434-1596
@COMPOUND$ levels and hormones (Peptide YY(3-36), glucagon-like peptide-1 (GLP-1), leptin, ghrelin, @PROTEIN$) that regulate EI were measured.	0	18583434-1596
@COMPOUND$ levels and hormones (Peptide YY(3-36), glucagon-like peptide-1 (GLP-1), leptin, @PROTEIN$, insulin) that regulate EI were measured.	0	18583434-1596
@COMPOUND$ levels and hormones (Peptide YY(3-36), glucagon-like peptide-1 (GLP-1), @PROTEIN$, ghrelin, insulin) that regulate EI were measured.	0	18583434-1596
@COMPOUND$ levels and hormones (Peptide YY(3-36), glucagon-like peptide-1 (@PROTEIN$), leptin, ghrelin, insulin) that regulate EI were measured.	0	18583434-1596
@COMPOUND$ levels and hormones (@PROTEIN$, glucagon-like peptide-1 (GLP-1), leptin, ghrelin, insulin) that regulate EI were measured.	0	18583434-1596
@PROTEIN$ catalyze a calcium-dependent transamidation reaction that produces covalent cross-linking of available substrate @COMPOUND$ residues and modifies the extracellular matrix.	1	18584285-592
We fed rats @COMPOUND$ or valine deficient diet for 4 weeks and examined the mRNA expressions of serine synthesising (3-phosphoglycerate dehydrogenase, @PROTEIN$) and serine/threonine degrading enzymes (serine dehydratase, SDS) in the liver.	0	18584286-593
We fed rats lysine or @COMPOUND$ deficient diet for 4 weeks and examined the mRNA expressions of serine synthesising (3-phosphoglycerate dehydrogenase, @PROTEIN$) and serine/threonine degrading enzymes (serine dehydratase, SDS) in the liver.	0	18584286-593
We fed rats lysine or @COMPOUND$ deficient diet for 4 weeks and examined the mRNA expressions of serine synthesising (3-phosphoglycerate dehydrogenase, PHGDH) and serine/threonine degrading enzymes (serine dehydratase, @PROTEIN$) in the liver.	0	18584286-593
We fed rats @COMPOUND$ or valine deficient diet for 4 weeks and examined the mRNA expressions of serine synthesising (3-phosphoglycerate dehydrogenase, PHGDH) and serine/threonine degrading enzymes (serine dehydratase, @PROTEIN$) in the liver.	0	18584286-593
Dietary deficiency induced marked elevation of hepatic serine and @COMPOUND$ levels associated with enhancement of @PROTEIN$ mRNA expression and repression of SDS mRNA expression.	0	18584286-594
Dietary deficiency induced marked elevation of hepatic @COMPOUND$ and threonine levels associated with enhancement of @PROTEIN$ mRNA expression and repression of SDS mRNA expression.	0	18584286-594
Dietary deficiency induced marked elevation of hepatic serine and @COMPOUND$ levels associated with enhancement of PHGDH mRNA expression and repression of @PROTEIN$ mRNA expression.	0	18584286-594
Dietary deficiency induced marked elevation of hepatic @COMPOUND$ and threonine levels associated with enhancement of PHGDH mRNA expression and repression of @PROTEIN$ mRNA expression.	0	18584286-594
Site-directed mutation test and @COMPOUND$ treatment demonstrated that the ZNF230 promoter contained a functional @PROTEIN$ site.	1	18584306-333
Site-directed mutation test and @COMPOUND$ treatment demonstrated that the @PROTEIN$ promoter contained a functional Sp1 site.	1	18584306-333
@COMPOUND$ effects on neuronal ultrastructure and expression of @PROTEIN$ (MAP2) in rats with acute spinal cord injury.	1	18584320-630
@COMPOUND$ effects on neuronal ultrastructure and expression of microtubule-associated protein 2 (@PROTEIN$) in rats with acute spinal cord injury.	1	18584320-630
(4) Our data indicated that @COMPOUND$ maintained in part neuronal ultrastructure, attenuated chromatolysis, and preclude the loss of @PROTEIN$, suggesting a protective effect during the early phases of spinal cord injury.	1	18584320-631
In conclusion, our results indicate that chronic @COMPOUND$ modulates the expression and subcellular localization of proteins implicated in @PROTEIN$ signaling, calcium-buffering potential, and trafficking.	1	18584336-637
For this purpose, on day 0, male Wistar rats received NTG (120 microg/kg, iv) with or without pre-administration of PKC inhibitor @COMPOUND$ (CHE), capsaicin (CAP) to deplete @PROTEIN$ from sensory nerves or mK(ATP) channel blocker 5-hydroxydecaonic acid (5HD).	0	18584896-1102
For this purpose, on day 0, male Wistar rats received NTG (120 microg/kg, iv) with or without pre-administration of PKC inhibitor chelerythrine (CHE), capsaicin (CAP) to deplete @PROTEIN$ from sensory nerves or mK(ATP) channel blocker 5-hydroxydecaonic acid (@COMPOUND$).	0	18584896-1102
For this purpose, on day 0, male Wistar rats received NTG (120 microg/kg, iv) with or without pre-administration of PKC inhibitor chelerythrine (CHE), @COMPOUND$ (CAP) to deplete @PROTEIN$ from sensory nerves or mK(ATP) channel blocker 5-hydroxydecaonic acid (5HD).	1	18584896-1102
The anti-convulsant @COMPOUND$ acts directly on the @PROTEIN$ as a positive allosteric modulator.	1	18585399-1508
Di-@COMPOUND$ phosphatidylcholine (PC-18:1) stimulates paraoxonase 1 (@PROTEIN$) enzymatic and biological activities: in vitro and in vivo studies.	1	18585720-96
With the exception of specific genetic defects in purine metabolism, increased @COMPOUND$ is generally associated with important risk factors for atherosclerosis like hypertension, abdominal obesity, @PROTEIN$ resistance, the metabolic syndrome and renal failure.	1	18585721-97
With the exception of specific genetic defects in @COMPOUND$ metabolism, increased uric acid is generally associated with important risk factors for atherosclerosis like hypertension, abdominal obesity, @PROTEIN$ resistance, the metabolic syndrome and renal failure.	0	18585721-97
The distribution of sugar moieties within the epididymal region of the Sudani duck was investigated using ten different @COMPOUND$ (FITC) conjugated @PROTEIN$.	0	18585744-108
The distribution of sugar moieties within the epididymal region of the Sudani duck was investigated using ten different fluorescein isothiocyanate (@COMPOUND$) conjugated @PROTEIN$.	0	18585744-108
High @COMPOUND$ and @PROTEIN$ synergistically stimulate MMP-1 expression in U937 macrophages by increasing transcription factor STAT1 activity.	0	18586252-521
High @COMPOUND$ and interferon gamma synergistically stimulate MMP-1 expression in U937 macrophages by increasing transcription factor @PROTEIN$ activity.	1	18586252-521
High @COMPOUND$ and interferon gamma synergistically stimulate @PROTEIN$ expression in U937 macrophages by increasing transcription factor STAT1 activity.	1	18586252-521
To test our hypothesis that hyperglycemia interplays with @PROTEIN$ (IFN gamma), a key factor involved in atherosclerosis, to up-regulate the expression of genes such as matrix metalloproteinases (MMPs) and cytokines that are involved in plaque destabilization, U937 macrophages cultured in medium containing either normal or high @COMPOUND$ were challenged with IFN gamma and the expression of MMPs and cytokines were then quantified by real-time polymerase chain reaction (PCR) and enzyme-linked immunosorbent assay (ELISA).	0	18586252-522
To test our hypothesis that hyperglycemia interplays with interferon gamma (@PROTEIN$), a key factor involved in atherosclerosis, to up-regulate the expression of genes such as matrix metalloproteinases (MMPs) and cytokines that are involved in plaque destabilization, U937 macrophages cultured in medium containing either normal or high @COMPOUND$ were challenged with IFN gamma and the expression of MMPs and cytokines were then quantified by real-time polymerase chain reaction (PCR) and enzyme-linked immunosorbent assay (ELISA).	0	18586252-522
Results showed that high @COMPOUND$ and IFN gamma had a synergistic effect on the expression of MMP-1, MMP-9 and @PROTEIN$.	1	18586252-523
Results showed that high @COMPOUND$ and IFN gamma had a synergistic effect on the expression of @PROTEIN$, MMP-9 and IL-1 beta.	1	18586252-523
Results showed that high @COMPOUND$ and @PROTEIN$ had a synergistic effect on the expression of MMP-1, MMP-9 and IL-1 beta.	0	18586252-523
Results showed that high @COMPOUND$ and IFN gamma had a synergistic effect on the expression of MMP-1, @PROTEIN$ and IL-1 beta.	1	18586252-523
Furthermore, high @COMPOUND$ and IFN gamma exert the synergistic effect on MMP-1 expression by enhancing @PROTEIN$ phosphorylation and STAT1 transcriptional activity.	1	18586252-525
Furthermore, high @COMPOUND$ and @PROTEIN$ exert the synergistic effect on MMP-1 expression by enhancing STAT1 phosphorylation and STAT1 transcriptional activity.	0	18586252-525
Furthermore, high @COMPOUND$ and IFN gamma exert the synergistic effect on @PROTEIN$ expression by enhancing STAT1 phosphorylation and STAT1 transcriptional activity.	1	18586252-525
In Experiment 2, @PROTEIN$ (10 mg/mL) combined with @COMPOUND$ (62.5 microg/mL) inhibited up to 100,200 PFU/mL of virus in cell culture.	0	18586420-663
We systematically investigated whether PD-related stresses including MG132 and epoxomicin (proteasomal impairment), tunicamycin (unfolded protein stress), and @COMPOUND$ (mitochondrial dysfunction) resulted in expressional changes of parkin and other E3 @PROTEIN$ ligases (dorfin, SIAH-1).	0	18586549-790
We systematically investigated whether PD-related stresses including MG132 and epoxomicin (proteasomal impairment), tunicamycin (unfolded protein stress), and @COMPOUND$ (mitochondrial dysfunction) resulted in expressional changes of parkin and other E3 ubiquitin ligases (@PROTEIN$, SIAH-1).	0	18586549-790
We systematically investigated whether PD-related stresses including @COMPOUND$ and epoxomicin (proteasomal impairment), tunicamycin (unfolded protein stress), and rotenone (mitochondrial dysfunction) resulted in expressional changes of parkin and other E3 ubiquitin ligases (@PROTEIN$, SIAH-1).	0	18586549-790
We systematically investigated whether PD-related stresses including @COMPOUND$ and epoxomicin (proteasomal impairment), tunicamycin (unfolded protein stress), and rotenone (mitochondrial dysfunction) resulted in expressional changes of parkin and other E3 @PROTEIN$ ligases (dorfin, SIAH-1).	0	18586549-790
@COMPOUND$, a synthetic triterpenoid, inhibits expression of IL-6 and @PROTEIN$ phosphorylation in multi-drug resistant ovarian cancer cells.	1	18587580-1638
@COMPOUND$, a synthetic triterpenoid, inhibits expression of @PROTEIN$ and Stat3 phosphorylation in multi-drug resistant ovarian cancer cells.	1	18587580-1638
To explore potential therapeutic strategies for interrupting signaling through this pathway, we assessed the ability of CDDO-Me, a synthetic triterpenoid, to inhibit IL-6 secretion, @PROTEIN$ phosphorylation, Stat3 nuclear translocation and @COMPOUND$ sensitivity in several cell line model systems.	0	18587580-1639
To explore potential therapeutic strategies for interrupting signaling through this pathway, we assessed the ability of @COMPOUND$, a synthetic triterpenoid, to inhibit @PROTEIN$ secretion, Stat3 phosphorylation, Stat3 nuclear translocation and paclitaxel sensitivity in several cell line model systems.	0	18587580-1639
To explore potential therapeutic strategies for interrupting signaling through this pathway, we assessed the ability of CDDO-Me, a synthetic triterpenoid, to inhibit @PROTEIN$ secretion, Stat3 phosphorylation, Stat3 nuclear translocation and @COMPOUND$ sensitivity in several cell line model systems.	0	18587580-1639
To explore potential therapeutic strategies for interrupting signaling through this pathway, we assessed the ability of @COMPOUND$, a synthetic triterpenoid, to inhibit IL-6 secretion, @PROTEIN$ phosphorylation, Stat3 nuclear translocation and paclitaxel sensitivity in several cell line model systems.	0	18587580-1639
These studies demonstrated that @COMPOUND$ significantly inhibits IL-6 secretion in paclitaxel-resistant ovarian cancer cells and specifically suppresses IL-6-or oncostatin M-induced @PROTEIN$ nuclear translocation.	1	18587580-1640
These studies demonstrated that @COMPOUND$ significantly inhibits @PROTEIN$ secretion in paclitaxel-resistant ovarian cancer cells and specifically suppresses IL-6-or oncostatin M-induced Stat3 nuclear translocation.	1	18587580-1640
Treatment with @COMPOUND$ significantly decreases the levels of Stat3, @PROTEIN$, and Src phosphorylation in ovarian and breast cancer cell lines with constitutively activated Stat3.	1	18587580-1641
Treatment with @COMPOUND$ significantly decreases the levels of Stat3, Jak2, and @PROTEIN$ phosphorylation in ovarian and breast cancer cell lines with constitutively activated Stat3.	1	18587580-1641
Our data confirm that @COMPOUND$ interrupts the signaling of multiple kinases involved in the IL-6-@PROTEIN$ and Src signaling pathways.	1	18587580-1642
Our data confirm that @COMPOUND$ interrupts the signaling of multiple kinases involved in the IL-6-Stat3 and @PROTEIN$ signaling pathways.	1	18587580-1642
Our data confirm that @COMPOUND$ interrupts the signaling of multiple kinases involved in the @PROTEIN$-Stat3 and Src signaling pathways.	1	18587580-1642
The anti-hyperlipemia effect of EPS and intracellular polysaccharide (IPS) extracted from mycelia were observed that both EPS and IPS can obviously reduce the serum triglyceride (TG), the blood @COMPOUND$ (TC) and serum low density lipoprotein (LDL) level, and increase the @PROTEIN$ (HDL) level of the hyperlipemia mice.	0	18587601-1586
On a molar basis, @COMPOUND$ yields a signal that is approximately 0.67 times that of @PROTEIN$.	0	18587610-1674
@COMPOUND$ regulates expressions of VEGF and @PROTEIN$ stimulated by STZ.	1	18587665-16
@COMPOUND$ regulates expressions of @PROTEIN$ and HIF-1alpha stimulated by STZ.	1	18587665-16
In patients with hypertension and diabetes, @COMPOUND$, ACEi and diuretic treatment increased @PROTEIN$ activation only during the first week.	1	18588512-710
Although the co-expression of @PROTEIN$ and CMP-SAS did not further increase sialylation, an increase in the intracellular pool of CMP-@COMPOUND$ was noted.	1	18590515-661
NOPE-@COMPOUND$ treatment improved @PROTEIN$ 0.0001).	1	18590587-733
A 23.5-fold increase in @COMPOUND$ O-deethylation activity suggested that metabolic resistance through elevated levels of @PROTEIN$ dependent monooxygenase-activity is a possible resistance mechanism.However, synergism studies with different metabolic inhibitors revealed some contrasting resistance mechanisms between the METI-acaricides.	1	18590597-739
The activities of Rho GTPases are predominantly controlled by guanine nucleotide exchange factors (@PROTEIN$), which activate GTPases by catalyzing the exchange of bound @COMPOUND$ for GTP.	1	18592271-409
11beta-Hydroxysteroid dehydrogenase type 1 (@PROTEIN$) enzyme catalyzes interconversion of inactive cortisone to active @COMPOUND$.	1	18592327-379
11beta-Hydroxysteroid dehydrogenase type 1 (@PROTEIN$) enzyme catalyzes interconversion of inactive @COMPOUND$ to active cortisol.	1	18592327-379
Rebinding experiments with Lys-Gly-Asp, an analogue of Arg-Gly-Asp, and other different peptides, such as @PROTEIN$ C-terminal tri- and pentapeptide and @COMPOUND$, further indicated the selectivity of methacrylic acid-trimethylpropane trimethacrylate copolymer for Arg-Gly-Asp giving specific selectivity factor values 1.27, 1.98, 1.31 and 1.67, respectively.	0	18592344-477
Parents (N = 19) of children with autism spectrum disorders (ASD) and adult controls (N = 17) underwent positron emission tomography (PET) using ((18)F) @COMPOUND$ to image cortical serotonin type-2 (@PROTEIN$) receptors.	1	18592367-499
Natural @COMPOUND$ was enzymatically polymerized using soybean @PROTEIN$.	1	18592408-535
Vesicle mobilization requires @COMPOUND$+)-induced Ca2+ release by presynaptic endoplasmic reticulum (ER) ryanodine receptors (@PROTEIN$) that in turn stimulates Ca2+/calmodulin-dependent kinase II (CamKII).	1	18592416-542
These results highlight both the interactions between @PROTEIN$ and NMDA receptors in the determination of schizophreniform behaviours and the potential for the effects of @COMPOUND$ to be mediated by NMDA receptor regulation.	0	18593507-1421
Expression of @PROTEIN$ reduced the intracellular @COMPOUND$ concentration from 140 to 11 mM and resulted in maximal excretion rates of 11.2 nmol min(-1) mg(-1) as compared to 2.3 nmol min(-1) mg(-1) obtained without rhtC expression.	1	18594129-259
In combination with an @PROTEIN$ mutation generated and introduced into the chromosome, an accumulation of up to 54 mM @COMPOUND$ was achieved as compared to 21 mM obtained with the ancestor strain.	1	18594129-260
This additive effect was not observed when glioma cells were pre-treated with @COMPOUND$, which was unable to increase @PROTEIN$ expression in tumor.	0	18594817-847
Furthermore, the CD3(+) T cells co-cultured with @COMPOUND$ treated U-87 and autologous GBM tumor cells showed a significant increase in expression in @PROTEIN$, a key cytokine produced by activated T cells, and accordingly enhanced tumor cytotoxicity.	1	18594817-848
Hypergravity also induced a transient reorganization of @PROTEIN$ fibers in 3 min, which was inhibited by Rho-kinase inhibitor (@COMPOUND$) and tyrosine kinase inhibitors (herbimycin A and tyrphostin 46).	1	18594856-883
Hypergravity also induced a transient reorganization of @PROTEIN$ fibers in 3 min, which was inhibited by Rho-kinase inhibitor (Y27632) and tyrosine kinase inhibitors (@COMPOUND$ and tyrphostin 46).	1	18594856-883
Hypergravity also induced a transient reorganization of @PROTEIN$ fibers in 3 min, which was inhibited by Rho-kinase inhibitor (Y27632) and tyrosine kinase inhibitors (herbimycin A and @COMPOUND$).	1	18594856-883
Collectively, these results indicate that hypergravity induces @COMPOUND$ release and actin reorganization via RhoA activation and @PROTEIN$ phosphorylation, thereby activating cell proliferation and migration in BAECs.	1	18594856-886
Collectively, these results indicate that hypergravity induces @COMPOUND$ release and actin reorganization via @PROTEIN$ activation and FAK phosphorylation, thereby activating cell proliferation and migration in BAECs.	1	18594856-886
Collectively, these results indicate that hypergravity induces @COMPOUND$ release and @PROTEIN$ reorganization via RhoA activation and FAK phosphorylation, thereby activating cell proliferation and migration in BAECs.	0	18594856-886
Cell exposure to 250 microM @COMPOUND$ was able to induce @PROTEIN$ 2 up-regulation and increased in situ transglutaminase activity.	1	18594946-953
Cell exposure to 250 microM @COMPOUND$ was able to induce @PROTEIN$ up-regulation and increased in situ transglutaminase activity.	1	18594946-953
@COMPOUND$ also induced NF-kappaB activation that seemed associated with @PROTEIN$ 2 up-regulation since the specific NF-kappaB inhibition by SN50 was able to reduce transglutaminase expression and activity levels.	1	18594946-954
@COMPOUND$ also induced NF-kappaB activation that seemed associated with @PROTEIN$ up-regulation since the specific NF-kappaB inhibition by SN50 was able to reduce transglutaminase expression and activity levels.	1	18594946-954
@COMPOUND$ can support the formation of membranous structures and an increase in @PROTEIN$ mRNA levels in differentiating oligodendrocytes.	1	18594965-980
There was no correlation between the presence of significant heart-valve regurgitation and @COMPOUND$ cumulative dose, duration of cabergoline treatment, prior use of bromocriptine, age, adenoma size, or @PROTEIN$ levels.	0	18594989-1002
There was no correlation between the presence of significant heart-valve regurgitation and cabergoline cumulative dose, duration of cabergoline treatment, prior use of @COMPOUND$, age, adenoma size, or @PROTEIN$ levels.	0	18594989-1002
@PROTEIN$ elevates @COMPOUND$ levels in the hemolymph by stimulating glycogenolysis in target tissues.	1	18595002-930
Here, we assessed the regulation of pancreatic @PROTEIN$ release by @COMPOUND$+), mitochondrial membrane potential (Delta Psi m), and reactive oxygen species (ROS), the signals involved in acute pancreatitis.	1	18596195-276
Here, we report the efficacy of betaxolol in reducing increases in gene expression of amygdalar corticotropin-releasing factor (@PROTEIN$), a peptide known to be involved in mediating 'anxiety-like' behaviors during initial phases of @COMPOUND$ abstinence.	1	18596687-690
Here, we report the efficacy of @COMPOUND$ in reducing increases in gene expression of amygdalar @PROTEIN$ (CRF), a peptide known to be involved in mediating 'anxiety-like' behaviors during initial phases of cocaine abstinence.	1	18596687-690
Here, we report the efficacy of @COMPOUND$ in reducing increases in gene expression of amygdalar corticotropin-releasing factor (@PROTEIN$), a peptide known to be involved in mediating 'anxiety-like' behaviors during initial phases of cocaine abstinence.	1	18596687-690
Here, we report the efficacy of betaxolol in reducing increases in gene expression of amygdalar @PROTEIN$ (CRF), a peptide known to be involved in mediating 'anxiety-like' behaviors during initial phases of @COMPOUND$ abstinence.	1	18596687-690
Results showed that @COMPOUND$ treatment during early cocaine withdrawal attenuated increases in amygdalar CRF gene expression and cyclic adenosine monophosphate-dependent @PROTEIN$ regulatory and catalytic subunit (nuclear fraction) protein expression.	1	18596687-691
Results showed that betaxolol treatment during early @COMPOUND$ withdrawal attenuated increases in amygdalar @PROTEIN$ gene expression and cyclic adenosine monophosphate-dependent protein kinase regulatory and catalytic subunit (nuclear fraction) protein expression.	0	18596687-691
Results showed that @COMPOUND$ treatment during early cocaine withdrawal attenuated increases in amygdalar @PROTEIN$ gene expression and cyclic adenosine monophosphate-dependent protein kinase regulatory and catalytic subunit (nuclear fraction) protein expression.	1	18596687-691
Results showed that betaxolol treatment during early @COMPOUND$ withdrawal attenuated increases in amygdalar CRF gene expression and cyclic adenosine monophosphate-dependent @PROTEIN$ regulatory and catalytic subunit (nuclear fraction) protein expression.	0	18596687-691
The present findings suggest that the efficacy of betaxolol treatment on @COMPOUND$ withdrawal-induced anxiety may be related, in part, to its effect on amygdalar beta(1)-adrenergic receptor, modulation of its downstream cell-signaling elements and @PROTEIN$ gene expression.	0	18596687-692
The present findings suggest that the efficacy of @COMPOUND$ treatment on cocaine withdrawal-induced anxiety may be related, in part, to its effect on amygdalar beta(1)-adrenergic receptor, modulation of its downstream cell-signaling elements and @PROTEIN$ gene expression.	1	18596687-692
Furthermore, it is demonstrated that this strain has @PROTEIN$ activity, and the activity can be optimized under suitable growing conditions where wheat bran and @COMPOUND$ are the primary sources of carbon and nitrogen.	0	18597051-1012
Furthermore, it is demonstrated that this strain has @PROTEIN$ activity, and the activity can be optimized under suitable growing conditions where wheat bran and urea are the primary sources of carbon and @COMPOUND$.	0	18597051-1012
Glutathione S-transferase (@PROTEIN$) isozymes catalyze nucleophilic attack by reduced Glutathione (@COMPOUND$) on a variety of electrophilic compounds and play a central role in biotransformation of xenobiotics (Hayes et al., Annu Rev Pharmacol Toxicol 45:51-88, 2005).	1	18597073-1033
@PROTEIN$ (GST) isozymes catalyze nucleophilic attack by @COMPOUND$ (GSH) on a variety of electrophilic compounds and play a central role in biotransformation of xenobiotics (Hayes et al., Annu Rev Pharmacol Toxicol 45:51-88, 2005).	1	18597073-1033
Glutathione S-transferase (@PROTEIN$) isozymes catalyze nucleophilic attack by @COMPOUND$ (GSH) on a variety of electrophilic compounds and play a central role in biotransformation of xenobiotics (Hayes et al., Annu Rev Pharmacol Toxicol 45:51-88, 2005).	1	18597073-1033
@PROTEIN$ (GST) isozymes catalyze nucleophilic attack by reduced Glutathione (@COMPOUND$) on a variety of electrophilic compounds and play a central role in biotransformation of xenobiotics (Hayes et al., Annu Rev Pharmacol Toxicol 45:51-88, 2005).	1	18597073-1033
@COMPOUND$ inhibits TNF-alpha-induced IkappaB kinase phosphorylation, IkappaB-alpha degradation and IL-6 production in endothelial cells through PI3K-dependent @PROTEIN$ phosphorylation.	1	18597869-1683
@COMPOUND$ inhibits @PROTEIN$-induced IkappaB kinase phosphorylation, IkappaB-alpha degradation and IL-6 production in endothelial cells through PI3K-dependent AMPK phosphorylation.	0	18597869-1683
@COMPOUND$ inhibits TNF-alpha-induced IkappaB kinase phosphorylation, IkappaB-alpha degradation and IL-6 production in endothelial cells through @PROTEIN$-dependent AMPK phosphorylation.	1	18597869-1683
@COMPOUND$ inhibits TNF-alpha-induced IkappaB kinase phosphorylation, @PROTEIN$ degradation and IL-6 production in endothelial cells through PI3K-dependent AMPK phosphorylation.	1	18597869-1683
@COMPOUND$ inhibits TNF-alpha-induced IkappaB kinase phosphorylation, IkappaB-alpha degradation and @PROTEIN$ production in endothelial cells through PI3K-dependent AMPK phosphorylation.	1	18597869-1683
@COMPOUND$ inhibits TNF-alpha-induced @PROTEIN$ phosphorylation, IkappaB-alpha degradation and IL-6 production in endothelial cells through PI3K-dependent AMPK phosphorylation.	1	18597869-1683
@COMPOUND$ phosphorylated p38 and @PROTEIN$ kinases, and blocking of these kinases with specific inhibitors diminished the palmitate-induced cytokine secretion.	0	18599066-769
Palmitate phosphorylated @PROTEIN$ and JNK kinases, and blocking of these kinases with specific inhibitors diminished the @COMPOUND$-induced cytokine secretion.	0	18599066-769
@COMPOUND$ phosphorylated @PROTEIN$ and JNK kinases, and blocking of these kinases with specific inhibitors diminished the palmitate-induced cytokine secretion.	1	18599066-769
Palmitate phosphorylated p38 and @PROTEIN$ kinases, and blocking of these kinases with specific inhibitors diminished the @COMPOUND$-induced cytokine secretion.	1	18599066-769
@COMPOUND$ also activated the @PROTEIN$ (c-Jun) transcription factor.	1	18599066-770
Characterisation of @COMPOUND$ analogues to cross-link and label @PROTEIN$ receptors.	1	18599093-1004
In this study we determined whether the UV light-reactive @COMPOUND$ analogues 2-azido ATP, ATP azidoanilide (ATP-AA) and 2', 3'-O-(4-benzoylbenzoyl)-ATP (BzATP) can be used to label the ATP binding site of @PROTEIN$ receptors.	1	18599093-1005
In this study we determined whether the UV light-reactive ATP analogues @COMPOUND$, ATP azidoanilide (ATP-AA) and 2', 3'-O-(4-benzoylbenzoyl)-ATP (BzATP) can be used to label the ATP binding site of @PROTEIN$ receptors.	1	18599093-1005
In this study we determined whether the UV light-reactive ATP analogues 2-azido ATP, ATP azidoanilide (ATP-AA) and 2', 3'-O-(4-benzoylbenzoyl)-ATP (@COMPOUND$) can be used to label the ATP binding site of @PROTEIN$ receptors.	1	18599093-1005
In this study we determined whether the UV light-reactive ATP analogues 2-azido ATP, ATP azidoanilide (ATP-AA) and 2', @COMPOUND$ (BzATP) can be used to label the ATP binding site of @PROTEIN$ receptors.	1	18599093-1005
cross-linked to @PROTEIN$ receptors and this binding was reduced by co-incubation with @COMPOUND$.	1	18599093-1006
These studies demonstrate that photo-reactive @COMPOUND$ analogues can be used to label @PROTEIN$ receptor and may prove useful in elucidating the ATP binding site at this novel class of ATP binding proteins.	1	18599093-1007
@PROTEIN$ treatment for 72 h also induced EMT in the A549 cells and this transition led to resistance to @COMPOUND$.	1	18599154-1053
@PROTEIN$-antagonistic effects of hormones, cytokines and excess metabolic substrates such as @COMPOUND$ and fatty acids may be exerted via common mechanisms involving for example reactive oxygen species (ROS) accumulation and associated inflammatory responses.	1	18599191-1078
Optimization of decolorization of @COMPOUND$ (MB) dye by @PROTEIN$ (LiP) enzyme produced by white-rot fungus Phanerochaete chrysosporium using sewage treatment plant (STP) sludge as a major substrate was carried out in the laboratory.	1	18599210-1087
Glycine release was potentiated by the activation of @PROTEIN$ and diminished by increasing cyclic guanosine monophosphate levels with a phosphodiesterase inhibitor, @COMPOUND$.	0	18600448-401
Glycine release was potentiated by the activation of @PROTEIN$ and diminished by increasing @COMPOUND$ levels with a phosphodiesterase inhibitor, zaprinast.	0	18600448-401
@COMPOUND$ release was potentiated by the activation of @PROTEIN$ and diminished by increasing cyclic guanosine monophosphate levels with a phosphodiesterase inhibitor, zaprinast.	1	18600448-401
Our study demonstrates that @COMPOUND$ causes evident damage to acinar cells, impairing both calcium homeostasis and secretory response to @PROTEIN$.	1	18600455-406
Enteric neuronal dopamine (DA) inhibits @COMPOUND$ release and gastric motility; this has been thought to be mediated via neuronal dopamine-2 receptor (@PROTEIN$).	1	18600456-407
As compared with parental B16 cells, the inhibitory effects of @PROTEIN$ and activin A on @COMPOUND$ content were relative smaller in B16 F10 cells, a subline of B16 cells that contain more pigment.	1	18600473-984
ATP-gated @PROTEIN$ receptors on excitatory nerve terminals onto interneurons initiate a form of asynchronous @COMPOUND$ release.	1	18601937-1660
However asynchronous EPSCs were increased following synaptic depression and a component of these appeared to be initiated by endogenously released @COMPOUND$ acting on presynaptic @PROTEIN$ receptors.	1	18601937-1662
Unexpectedly, the data suggest @PROTEIN$ receptor activation initiates a form of asynchronous @COMPOUND$ release, rather than detectably affecting the vesicles underlying action potential evoked release.	1	18601937-1663
The second enzyme of @COMPOUND$ synthesis, GSH synthase (GS) is also regulated in a coordinated manner as @PROTEIN$ subunits and its up-regulation can further enhance the capacity of the cell to synthesize GSH.	1	18601945-1673
The rise in (@COMPOUND$+))(i) elicited by hGH is associated with an enhanced insulin secretion, effects that are mediated mainly through the @PROTEIN$ receptor.	1	18602447-1075
The rise in (@COMPOUND$+))(i) elicited by hGH is associated with an enhanced @PROTEIN$ secretion, effects that are mediated mainly through the prolactin receptor.	1	18602447-1075
These mechanisms indicate that a rise in (@COMPOUND$+))(i) elicited by activation of PRLR is @PROTEIN$-dependent and is associated with enhanced insulin secretion.	1	18602447-1076
These mechanisms indicate that a rise in (@COMPOUND$+))(i) elicited by activation of PRLR is JAK2-dependent and is associated with enhanced @PROTEIN$ secretion.	1	18602447-1076
These mechanisms indicate that a rise in (@COMPOUND$+))(i) elicited by activation of @PROTEIN$ is JAK2-dependent and is associated with enhanced insulin secretion.	1	18602447-1076
In contrast, GH receptor-mediated increase in (@COMPOUND$+))(i) is @PROTEIN$-independent and is dissociated from insulin secretion.	1	18602447-1077
In contrast, GH receptor-mediated increase in (@COMPOUND$+))(i) is JAK2-independent and is dissociated from @PROTEIN$ secretion.	0	18602447-1077
In contrast, @PROTEIN$-mediated increase in (@COMPOUND$+))(i) is JAK2-independent and is dissociated from insulin secretion.	1	18602447-1077
SEMG I expression is upregulated by @PROTEIN$, IL-6 and @COMPOUND$.	0	18602691-569
@PROTEIN$ I expression is upregulated by IL-4, IL-6 and @COMPOUND$.	1	18602691-569
SEMG I expression is upregulated by IL-4, @PROTEIN$ and @COMPOUND$.	0	18602691-569
@COMPOUND$ down-regulates @PROTEIN$ transcript and protein levels in MCF-7 breast cancer cells.	1	18602794-652
Consumption of the trichothecene mycotoxin @COMPOUND$ (DON) induces @PROTEIN$ (IL-6)-dependent IgA nephropathy (IgAN) in mice.	1	18602807-667
Consumption of the trichothecene mycotoxin @COMPOUND$ (DON) induces interleukin-6 (@PROTEIN$)-dependent IgA nephropathy (IgAN) in mice.	1	18602807-667
The purpose of this study was to identify the signal transduction pathways by which DON up-regulates @PROTEIN$ in the peritoneal macrophage and how consumption of fish oil enriched with the n-3 PUFA @COMPOUND$ (DHA) suppresses these processes.	1	18602807-668
The aim of the present study was to determine the effects of niacin and @COMPOUND$ on HDL formation by investigating the changes in @PROTEIN$ and ApoA-1 transcription in the human hepatoblastoma cell line (HepG2 cells).	0	18602814-672
The aim of the present study was to determine the effects of @COMPOUND$ and chromium on HDL formation by investigating the changes in @PROTEIN$ and ApoA-1 transcription in the human hepatoblastoma cell line (HepG2 cells).	0	18602814-672
Niacin and @COMPOUND$ cotreatment significantly induced the expression of @PROTEIN$ (PPARalpha) mRNA by approximately 1.3-1.8-fold.	1	18602814-674
Niacin and @COMPOUND$ cotreatment significantly induced the expression of peroxisome proliferator-activated receptor-alpha (@PROTEIN$) mRNA by approximately 1.3-1.8-fold.	1	18602814-674
@COMPOUND$ and chromium cotreatment significantly induced the expression of @PROTEIN$ (PPARalpha) mRNA by approximately 1.3-1.8-fold.	1	18602814-674
@COMPOUND$ and chromium cotreatment significantly induced the expression of peroxisome proliferator-activated receptor-alpha (@PROTEIN$) mRNA by approximately 1.3-1.8-fold.	1	18602814-674
A combination of @COMPOUND$ and chromium chloride did not significantly increase (3+1 mM) but instead reduced (1+3 mM) @PROTEIN$ gene expression.	1	18602814-675
A combination of niacin and @COMPOUND$ did not significantly increase (3+1 mM) but instead reduced (1+3 mM) @PROTEIN$ gene expression.	1	18602814-675
We hypothesize that the stimulation of @PROTEIN$ gene expression causes an enhanced @COMPOUND$ efflux, perhaps mediated by PPARalpha pathway(s).	1	18602814-676
We hypothesize that the stimulation of ABCA1 gene expression causes an enhanced @COMPOUND$ efflux, perhaps mediated by @PROTEIN$ pathway(s).	1	18602814-676
@COMPOUND$ inhibited cell proliferation with IC(50) values at 24 and 48 h of 12.5 and 7.5 muM doses, respectively, and decreased @PROTEIN$ protein expression at concentrations between 2.5 and 30 muM.	1	18602823-684
30 muM, the SUL-induced suppression of @PROTEIN$ protein was reversed by preincubation with the proteasome inhibitor @COMPOUND$ and was accompanied by an increase in protein levels of the 20S catalytic core subunit PSMB5.	1	18602823-685
30 muM, the SUL-induced suppression of ERalpha protein was reversed by preincubation with the proteasome inhibitor @COMPOUND$ and was accompanied by an increase in protein levels of the 20S catalytic core subunit @PROTEIN$.	0	18602823-685
Of importance, treatment with @COMPOUND$ significantly improved endothelial dysfunction as assessed by the vasodilator response to acetylcholine, accompanied by inhibition of interleukin-6 mRNA and an increase in endothelial nitric oxide synthase (@PROTEIN$) mRNA in the aorta.	1	18603252-1055
Of importance, treatment with ezetimibe significantly improved endothelial dysfunction as assessed by the vasodilator response to @COMPOUND$, accompanied by inhibition of @PROTEIN$ mRNA and an increase in endothelial nitric oxide synthase (eNOS) mRNA in the aorta.	0	18603252-1055
Of importance, treatment with ezetimibe significantly improved endothelial dysfunction as assessed by the vasodilator response to @COMPOUND$, accompanied by inhibition of interleukin-6 mRNA and an increase in endothelial @PROTEIN$ (eNOS) mRNA in the aorta.	0	18603252-1055
Of importance, treatment with @COMPOUND$ significantly improved endothelial dysfunction as assessed by the vasodilator response to acetylcholine, accompanied by inhibition of @PROTEIN$ mRNA and an increase in endothelial nitric oxide synthase (eNOS) mRNA in the aorta.	1	18603252-1055
Of importance, treatment with ezetimibe significantly improved endothelial dysfunction as assessed by the vasodilator response to @COMPOUND$, accompanied by inhibition of interleukin-6 mRNA and an increase in endothelial nitric oxide synthase (@PROTEIN$) mRNA in the aorta.	0	18603252-1055
Of importance, treatment with @COMPOUND$ significantly improved endothelial dysfunction as assessed by the vasodilator response to acetylcholine, accompanied by inhibition of interleukin-6 mRNA and an increase in endothelial @PROTEIN$ (eNOS) mRNA in the aorta.	1	18603252-1055
A series of @COMPOUND$ derivatives of thiazolyl-N-substituted amides were synthesized in a three-step reaction and tested for anti-inflammatory activity as well as @PROTEIN$ and cycloxygenase inhibitory actions.	0	18603333-1106
@PROTEIN$ involvement in the discriminative stimulus effects in rats of LSD, but not the @COMPOUND$ hallucinogen DOI.	0	18604600-443
@PROTEIN$ involvement in the discriminative stimulus effects in rats of @COMPOUND$, but not the phenethylamine hallucinogen DOI.	1	18604600-443
@PROTEIN$ involvement in the discriminative stimulus effects in rats of LSD, but not the phenethylamine hallucinogen @COMPOUND$.	0	18604600-443
Plasma levels of @COMPOUND$, zinc and carotenoids did not vary across quintiles, but weak negative correlations were observed with serum ferritin and @PROTEIN$ saturation.	1	18606045-1675
Plasma levels of @COMPOUND$, zinc and carotenoids did not vary across quintiles, but weak negative correlations were observed with serum @PROTEIN$ and transferrin saturation.	1	18606045-1675
Two major groups of ligand-activated nuclear receptors/xenosensors evolved: the Ah receptor (activated by aryl hydrocarbons and drugs such as omeprazole) and type 2 steroid receptors such as @PROTEIN$ and CAR, activated by drugs such as rifampicin, carbamazepin and @COMPOUND$.	1	18606396-239
Two major groups of ligand-activated nuclear receptors/xenosensors evolved: the @PROTEIN$ (activated by aryl hydrocarbons and drugs such as omeprazole) and type 2 steroid receptors such as PXR and CAR, activated by drugs such as @COMPOUND$, carbamazepin and phenytoin.	0	18606396-239
Two major groups of ligand-activated nuclear receptors/xenosensors evolved: the Ah receptor (activated by aryl hydrocarbons and drugs such as omeprazole) and type 2 steroid receptors such as @PROTEIN$ and CAR, activated by drugs such as @COMPOUND$, carbamazepin and phenytoin.	1	18606396-239
Two major groups of ligand-activated nuclear receptors/xenosensors evolved: the Ah receptor (activated by aryl hydrocarbons and drugs such as @COMPOUND$) and type 2 steroid receptors such as @PROTEIN$ and CAR, activated by drugs such as rifampicin, carbamazepin and phenytoin.	0	18606396-239
Two major groups of ligand-activated nuclear receptors/xenosensors evolved: the @PROTEIN$ (activated by aryl hydrocarbons and drugs such as omeprazole) and type 2 steroid receptors such as PXR and CAR, activated by drugs such as rifampicin, carbamazepin and @COMPOUND$.	0	18606396-239
Two major groups of ligand-activated nuclear receptors/xenosensors evolved: the @PROTEIN$ (activated by aryl hydrocarbons and drugs such as @COMPOUND$) and type 2 steroid receptors such as PXR and CAR, activated by drugs such as rifampicin, carbamazepin and phenytoin.	1	18606396-239
The structure-activity relationship between @COMPOUND$ derivatives showing inhibitory effects on @PROTEIN$ in mouse macrophage RAW264.7 cells.	1	18607531-1203
We have investigated the structure-activity relationship between 63 natural @COMPOUND$ derivatives and their effects on the expression of inducible-nitric oxide synthase (@PROTEIN$) induced by lipopolysaccharide.	0	18607531-1204
We have investigated the structure-activity relationship between 63 natural oxycoumarin derivatives and their effects on the expression of inducible-nitric oxide synthase (@PROTEIN$) induced by @COMPOUND$.	1	18607531-1204
We have investigated the structure-activity relationship between 63 natural oxycoumarin derivatives and their effects on the expression of inducible-@PROTEIN$ (iNOS) induced by @COMPOUND$.	1	18607531-1204
We have investigated the structure-activity relationship between 63 natural @COMPOUND$ derivatives and their effects on the expression of inducible-@PROTEIN$ (iNOS) induced by lipopolysaccharide.	0	18607531-1204
Inhibition of protein synthesis by @COMPOUND$ reduces @PROTEIN$ expression in normoxic and hypoxic pancreatic cancer cells.	1	18607542-1212
Western blot analyses of @COMPOUND$-treated cells demonstrated that imexon reduces @PROTEIN$ protein levels in both normoxic and hypoxic conditions in a time- and concentration-dependant fashion.	1	18607542-1213
@COMPOUND$ did not similarly affect @PROTEIN$ levels.	0	18607542-1214
Concurrently, the half-life of existing @PROTEIN$ protein was increased by @COMPOUND$, in association with a marked inhibition of chymotryptic activity in the 20S proteasome.	1	18607542-1216
The inhibition of @PROTEIN$ translation was not specific, rather it was part of a general decrease in protein translation caused by @COMPOUND$.	1	18607542-1217
To determine whether a regimen of @COMPOUND$ pretreatment, bivalirudin during the procedure and clopidogrel (600 mg) immediately after percutaneous coronary intervention (PCI) was associated with platelet activation during and shortly after (1 and 2 h) PCI, we characterized platelet function in 10 patients with the use of flow cytometry in the absence of agonist and in response to @PROTEIN$ (10 nM), ADP (1 microM), the collagen-mimetic convulxin (5 ng/ml), and platelet activating factor (10 nM).	0	18607689-1312
To determine whether a regimen of aspirin pretreatment, bivalirudin during the procedure and clopidogrel (600 mg) immediately after percutaneous coronary intervention (PCI) was associated with platelet activation during and shortly after (1 and 2 h) PCI, we characterized platelet function in 10 patients with the use of flow cytometry in the absence of agonist and in response to @PROTEIN$ (10 nM), ADP (1 microM), the collagen-mimetic convulxin (5 ng/ml), and @COMPOUND$ (10 nM).	0	18607689-1312
To determine whether a regimen of aspirin pretreatment, bivalirudin during the procedure and @COMPOUND$ (600 mg) immediately after percutaneous coronary intervention (PCI) was associated with platelet activation during and shortly after (1 and 2 h) PCI, we characterized platelet function in 10 patients with the use of flow cytometry in the absence of agonist and in response to @PROTEIN$ (10 nM), ADP (1 microM), the collagen-mimetic convulxin (5 ng/ml), and platelet activating factor (10 nM).	0	18607689-1312
To determine whether a regimen of aspirin pretreatment, @COMPOUND$ during the procedure and clopidogrel (600 mg) immediately after percutaneous coronary intervention (PCI) was associated with platelet activation during and shortly after (1 and 2 h) PCI, we characterized platelet function in 10 patients with the use of flow cytometry in the absence of agonist and in response to @PROTEIN$ (10 nM), ADP (1 microM), the collagen-mimetic convulxin (5 ng/ml), and platelet activating factor (10 nM).	0	18607689-1312
Brainstem concentrations of @COMPOUND$ are not influenced by genetic ablation of the @PROTEIN$.	0	18607722-1326
The @PROTEIN$ (LDLr) mediates the uptake of LDL particles enriched with @COMPOUND$, into several tissues.	1	18607722-1327
Under the condition of delayed intervention (30 days after deafening) following @COMPOUND$+ furosemide deafening in rats, we conclude that chronic intracochlear electrical stimulation (ES) and continuous intracochlear administration of @PROTEIN$ (BDNF) enhance spiral ganglion cell (SGC) body and peripheral process survival and improve auditory sensitivity.	0	18607918-1505
Under the condition of delayed intervention (30 days after deafening) following @COMPOUND$+ furosemide deafening in rats, we conclude that chronic intracochlear electrical stimulation (ES) and continuous intracochlear administration of brain-derived neurotrophic factor (@PROTEIN$) enhance spiral ganglion cell (SGC) body and peripheral process survival and improve auditory sensitivity.	0	18607918-1505
Under the condition of delayed intervention (30 days after deafening) following gentamicin+ @COMPOUND$ deafening in rats, we conclude that chronic intracochlear electrical stimulation (ES) and continuous intracochlear administration of @PROTEIN$ (BDNF) enhance spiral ganglion cell (SGC) body and peripheral process survival and improve auditory sensitivity.	0	18607918-1505
Under the condition of delayed intervention (30 days after deafening) following gentamicin+ @COMPOUND$ deafening in rats, we conclude that chronic intracochlear electrical stimulation (ES) and continuous intracochlear administration of brain-derived neurotrophic factor (@PROTEIN$) enhance spiral ganglion cell (SGC) body and peripheral process survival and improve auditory sensitivity.	0	18607918-1505
For this purpose, human erythrocyte @PROTEIN$ was initially purified 2139-fold in a yield of 29% by using 2', 5'-ADP @COMPOUND$ 4B affinity gel and Sephadex G-200 gel filtration chromatography.	0	18608753-1365
The enzyme deoxyuridine 5'-triphosphate nucleotidohydrolase (@PROTEIN$) catalyses the hydrolysis of dUTP to dUMP and PPi thus controlling the incorporation of @COMPOUND$ into DNA genomes.	1	18608754-503
The enzyme @PROTEIN$ (dUTPase) catalyses the hydrolysis of dUTP to dUMP and PPi thus controlling the incorporation of @COMPOUND$ into DNA genomes.	1	18608754-503
In the present study we perform a kinetic analysis of Campylobacter @PROTEIN$ using the continuous spectrophotometric method and show that the enzyme is highly specific for @COMPOUND$ nucleotides.	1	18608754-504
@PROTEIN$ (tryptophan indole-lyase, Tnase, EC 4.1.99.1), a bacterial enzyme with no counterpart in eukaryotic cells, produces from L-tryptophan pyruvate, @COMPOUND$ and indole.	1	18608755-505
@PROTEIN$ (tryptophan indole-lyase, Tnase, EC 4.1.99.1), a bacterial enzyme with no counterpart in eukaryotic cells, produces from @COMPOUND$ pyruvate, ammonia and indole.	1	18608755-505
@PROTEIN$ (tryptophan indole-lyase, Tnase, EC 4.1.99.1), a bacterial enzyme with no counterpart in eukaryotic cells, produces from L-tryptophan @COMPOUND$, ammonia and indole.	1	18608755-505
@PROTEIN$ allows soil microorganisms to use @COMPOUND$ as a source of nitrogen and aid in the rapid break down of urea-based fertilizers resulting in phytopathicity.	1	18608766-514
@PROTEIN$ allows soil microorganisms to use urea as a source of @COMPOUND$ and aid in the rapid break down of urea-based fertilizers resulting in phytopathicity.	0	18608766-514
Adenosine deaminase (@PROTEIN$), an enzyme involved in purine metabolism, catalyzes the hydrolytic breakdown of @COMPOUND$ into inosine and free ammonia.	1	18608782-527
Adenosine deaminase (@PROTEIN$), an enzyme involved in purine metabolism, catalyzes the hydrolytic breakdown of adenosine into @COMPOUND$ and free ammonia.	1	18608782-527
Adenosine deaminase (@PROTEIN$), an enzyme involved in purine metabolism, catalyzes the hydrolytic breakdown of adenosine into inosine and free @COMPOUND$.	1	18608782-527
@PROTEIN$ (ADA), an enzyme involved in purine metabolism, catalyzes the hydrolytic breakdown of @COMPOUND$ into inosine and free ammonia.	1	18608782-527
@PROTEIN$ (ADA), an enzyme involved in purine metabolism, catalyzes the hydrolytic breakdown of adenosine into inosine and free @COMPOUND$.	1	18608782-527
@PROTEIN$ (ADA), an enzyme involved in purine metabolism, catalyzes the hydrolytic breakdown of adenosine into @COMPOUND$ and free ammonia.	1	18608782-527
Diastolic function and @PROTEIN$ changes during exercise predict @COMPOUND$ consumption in chronic heart failure patients.	1	18609042-761
Although incubation with prolactin (PRL) and/or adrenocorticotrophic hormone (@PROTEIN$) resulted in a dose-dependent increase of @COMPOUND$ and progesterone release by adrenal cells from both HAA and LAA male rats, the responses were markedly increased for adrenal cells from LAA rats as compared with HAA rats.	1	18609294-966
Although incubation with @PROTEIN$ (PRL) and/or adrenocorticotrophic hormone (ACTH) resulted in a dose-dependent increase of @COMPOUND$ and progesterone release by adrenal cells from both HAA and LAA male rats, the responses were markedly increased for adrenal cells from LAA rats as compared with HAA rats.	1	18609294-966
Although incubation with prolactin (PRL) and/or adrenocorticotrophic hormone (@PROTEIN$) resulted in a dose-dependent increase of corticosterone and @COMPOUND$ release by adrenal cells from both HAA and LAA male rats, the responses were markedly increased for adrenal cells from LAA rats as compared with HAA rats.	1	18609294-966
Although incubation with prolactin (@PROTEIN$) and/or adrenocorticotrophic hormone (ACTH) resulted in a dose-dependent increase of @COMPOUND$ and progesterone release by adrenal cells from both HAA and LAA male rats, the responses were markedly increased for adrenal cells from LAA rats as compared with HAA rats.	1	18609294-966
Although incubation with prolactin (@PROTEIN$) and/or adrenocorticotrophic hormone (ACTH) resulted in a dose-dependent increase of corticosterone and @COMPOUND$ release by adrenal cells from both HAA and LAA male rats, the responses were markedly increased for adrenal cells from LAA rats as compared with HAA rats.	1	18609294-966
Although incubation with @PROTEIN$ (PRL) and/or adrenocorticotrophic hormone (ACTH) resulted in a dose-dependent increase of corticosterone and @COMPOUND$ release by adrenal cells from both HAA and LAA male rats, the responses were markedly increased for adrenal cells from LAA rats as compared with HAA rats.	1	18609294-966
@COMPOUND$, a SSRI, is mainly metabolized by cytochrome P450 (@PROTEIN$) 2D6 and 1A2.	1	18609433-1079
@COMPOUND$, a SSRI, is mainly metabolized by @PROTEIN$ (CYP) 2D6 and 1A2.	1	18609433-1079
@PROTEIN$ is expressed in the rat DVC, where mRNA is localized to neurons that exhibit electrophysiological sensitivity to @COMPOUND$ imbalance.	0	18612599-292
Indoleamine 2,3-dioxygenase (@PROTEIN$) catalyzes the first and rate-limiting step of @COMPOUND$ pathway along the major route of Tryptophan catabolism.	1	18612775-1047
@PROTEIN$ (IDO) catalyzes the first and rate-limiting step of @COMPOUND$ pathway along the major route of Tryptophan catabolism.	1	18612775-1047
Type I @PROTEIN$ (TG1), an enzyme that catalyzes the formation of epsilon-(gamma-glutamyl) @COMPOUND$ bonds, is the key protein responsible for generation of the crosslinks.	1	18612777-425
@PROTEIN$-oncogene inactivating effect by @COMPOUND$ rich polypeptide (PRP-1) in chondrosarcoma JJ012 cells.	1	18612811-461
Like PSC, DSL6A cells secrete less @PROTEIN$ when cultured with @COMPOUND$.	1	18612819-471
Caspase inhibition with z-@COMPOUND$ was unable to prevent @PROTEIN$ localization to the nucleus and subsequently unable to prevent cell death.	0	18612824-1284
Purinergic receptor agonists @COMPOUND$ and UTP selectively activate certain @PROTEIN$ family tyrosine kinases and stimulate Na,K-ATPase activity.	1	18614168-1607
Purinergic receptor agonists ATP and @COMPOUND$ selectively activate certain @PROTEIN$ family tyrosine kinases and stimulate Na,K-ATPase activity.	1	18614168-1607
We measured the ability to increase GABA in eight healthy subjects by comparing the binding of ((11)C) @COMPOUND$, a positron emission tomography (PET) radiotracer specific for the benzodiazepine (BDZ) site, at baseline and in the presence of an acute elevation in GABA levels through the blockade of the GABA membrane transporter (@PROTEIN$).	0	18615011-597
@PROTEIN$ blockade resulted in significant increases in mean (+/-SD) ((11)C) @COMPOUND$-binding potential (BP(ND)) over baseline in brain regions representing the major functional domains of the cerebral cortex: association cortex+15.2+/-20.2% (p=0.05), sensory cortex+13.5+/-15.5% (p=0.03) and limbic (medial temporal lobe, MTL)+16.4+/-20.2% (p=0.03).	1	18615011-598
@PROTEIN$ inhibitory activity of @COMPOUND$ and synergistic effect with acarbose.	1	18615280-830
@PROTEIN$ inhibitory activity of cyanidin-3-galactoside and synergistic effect with @COMPOUND$.	1	18615280-830
Cyanidin-3-galactoside, a natural @COMPOUND$, was investigated for its @PROTEIN$ inhibitory activity.	0	18615280-831
@COMPOUND$, a natural anthocyanin, was investigated for its @PROTEIN$ inhibitory activity.	0	18615280-831
The susceptibilities to three organophosphate (OP) insecticides (malathion, chlorpyrifos, and phoxim), responses to three metabolic synergists (@COMPOUND$ (TPP), piperonyl butoxide (PBO), and diethyl maleate (DEM)), activities of major detoxification enzymes (general esterases (ESTs), glutathione S-transferases (GSTs), and cytochrome P450 monooxygenases (P450s)), and sensitivity of the target enzyme @PROTEIN$ (AChE) were compared between a laboratory-susceptible strain (LS) and a field-resistant population (FR) of the oriental migratory locust, Locusta migratoria manilensis (Meyen).	0	18615705-81
The susceptibilities to three organophosphate (OP) insecticides (malathion, chlorpyrifos, and @COMPOUND$), responses to three metabolic synergists (triphenyl phosphate (TPP), piperonyl butoxide (PBO), and diethyl maleate (DEM)), activities of major detoxification enzymes (general esterases (ESTs), glutathione S-transferases (GSTs), and cytochrome P450 monooxygenases (P450s)), and sensitivity of the target enzyme @PROTEIN$ (AChE) were compared between a laboratory-susceptible strain (LS) and a field-resistant population (FR) of the oriental migratory locust, Locusta migratoria manilensis (Meyen).	0	18615705-81
The susceptibilities to three organophosphate (OP) insecticides (malathion, chlorpyrifos, and @COMPOUND$), responses to three metabolic synergists (triphenyl phosphate (TPP), piperonyl butoxide (PBO), and diethyl maleate (DEM)), activities of major detoxification enzymes (general esterases (ESTs), glutathione S-transferases (GSTs), and cytochrome P450 monooxygenases (P450s)), and sensitivity of the target enzyme acetylcholinesterase (@PROTEIN$) were compared between a laboratory-susceptible strain (LS) and a field-resistant population (FR) of the oriental migratory locust, Locusta migratoria manilensis (Meyen).	0	18615705-81
The susceptibilities to three organophosphate (OP) insecticides (malathion, chlorpyrifos, and phoxim), responses to three metabolic synergists (@COMPOUND$ (TPP), piperonyl butoxide (PBO), and diethyl maleate (DEM)), activities of major detoxification enzymes (general esterases (ESTs), glutathione S-transferases (@PROTEIN$), and cytochrome P450 monooxygenases (P450s)), and sensitivity of the target enzyme acetylcholinesterase (AChE) were compared between a laboratory-susceptible strain (LS) and a field-resistant population (FR) of the oriental migratory locust, Locusta migratoria manilensis (Meyen).	0	18615705-81
The susceptibilities to three organophosphate (OP) insecticides (malathion, chlorpyrifos, and @COMPOUND$), responses to three metabolic synergists (triphenyl phosphate (TPP), piperonyl butoxide (PBO), and diethyl maleate (DEM)), activities of major detoxification enzymes (general @PROTEIN$ (ESTs), glutathione S-transferases (GSTs), and cytochrome P450 monooxygenases (P450s)), and sensitivity of the target enzyme acetylcholinesterase (AChE) were compared between a laboratory-susceptible strain (LS) and a field-resistant population (FR) of the oriental migratory locust, Locusta migratoria manilensis (Meyen).	0	18615705-81
The susceptibilities to three organophosphate (OP) insecticides (malathion, chlorpyrifos, and phoxim), responses to three metabolic synergists (triphenyl phosphate (TPP), @COMPOUND$ (PBO), and diethyl maleate (DEM)), activities of major detoxification enzymes (general esterases (ESTs), glutathione S-transferases (@PROTEIN$), and cytochrome P450 monooxygenases (P450s)), and sensitivity of the target enzyme acetylcholinesterase (AChE) were compared between a laboratory-susceptible strain (LS) and a field-resistant population (FR) of the oriental migratory locust, Locusta migratoria manilensis (Meyen).	0	18615705-81
The susceptibilities to three organophosphate (OP) insecticides (malathion, chlorpyrifos, and phoxim), responses to three metabolic synergists (@COMPOUND$ (TPP), piperonyl butoxide (PBO), and diethyl maleate (DEM)), activities of major detoxification enzymes (general esterases (ESTs), @PROTEIN$ (GSTs), and cytochrome P450 monooxygenases (P450s)), and sensitivity of the target enzyme acetylcholinesterase (AChE) were compared between a laboratory-susceptible strain (LS) and a field-resistant population (FR) of the oriental migratory locust, Locusta migratoria manilensis (Meyen).	0	18615705-81
The susceptibilities to three organophosphate (OP) insecticides (malathion, chlorpyrifos, and @COMPOUND$), responses to three metabolic synergists (triphenyl phosphate (TPP), piperonyl butoxide (PBO), and diethyl maleate (DEM)), activities of major detoxification enzymes (general esterases (ESTs), glutathione S-transferases (@PROTEIN$), and cytochrome P450 monooxygenases (P450s)), and sensitivity of the target enzyme acetylcholinesterase (AChE) were compared between a laboratory-susceptible strain (LS) and a field-resistant population (FR) of the oriental migratory locust, Locusta migratoria manilensis (Meyen).	0	18615705-81
The susceptibilities to three organophosphate (OP) insecticides (malathion, @COMPOUND$, and phoxim), responses to three metabolic synergists (triphenyl phosphate (TPP), piperonyl butoxide (PBO), and diethyl maleate (DEM)), activities of major detoxification enzymes (general esterases (ESTs), glutathione S-transferases (@PROTEIN$), and cytochrome P450 monooxygenases (P450s)), and sensitivity of the target enzyme acetylcholinesterase (AChE) were compared between a laboratory-susceptible strain (LS) and a field-resistant population (FR) of the oriental migratory locust, Locusta migratoria manilensis (Meyen).	0	18615705-81
The susceptibilities to three organophosphate (OP) insecticides (malathion, chlorpyrifos, and phoxim), responses to three metabolic synergists (triphenyl phosphate (TPP), @COMPOUND$ (PBO), and diethyl maleate (DEM)), activities of major detoxification enzymes (general esterases (ESTs), @PROTEIN$ (GSTs), and cytochrome P450 monooxygenases (P450s)), and sensitivity of the target enzyme acetylcholinesterase (AChE) were compared between a laboratory-susceptible strain (LS) and a field-resistant population (FR) of the oriental migratory locust, Locusta migratoria manilensis (Meyen).	0	18615705-81
The susceptibilities to three organophosphate (OP) insecticides (malathion, chlorpyrifos, and phoxim), responses to three metabolic synergists (triphenyl phosphate (TPP), @COMPOUND$ (PBO), and diethyl maleate (DEM)), activities of major detoxification enzymes (general @PROTEIN$ (ESTs), glutathione S-transferases (GSTs), and cytochrome P450 monooxygenases (P450s)), and sensitivity of the target enzyme acetylcholinesterase (AChE) were compared between a laboratory-susceptible strain (LS) and a field-resistant population (FR) of the oriental migratory locust, Locusta migratoria manilensis (Meyen).	0	18615705-81
The susceptibilities to three organophosphate (OP) insecticides (malathion, chlorpyrifos, and phoxim), responses to three metabolic synergists (triphenyl phosphate (TPP), piperonyl butoxide (PBO), and @COMPOUND$ (DEM)), activities of major detoxification enzymes (general esterases (ESTs), glutathione S-transferases (GSTs), and @PROTEIN$ monooxygenases (P450s)), and sensitivity of the target enzyme acetylcholinesterase (AChE) were compared between a laboratory-susceptible strain (LS) and a field-resistant population (FR) of the oriental migratory locust, Locusta migratoria manilensis (Meyen).	0	18615705-81
The susceptibilities to three organophosphate (OP) insecticides (malathion, chlorpyrifos, and phoxim), responses to three metabolic synergists (triphenyl phosphate (TPP), piperonyl butoxide (PBO), and @COMPOUND$ (DEM)), activities of major detoxification enzymes (general esterases (ESTs), glutathione S-transferases (GSTs), and cytochrome P450 monooxygenases (P450s)), and sensitivity of the target enzyme @PROTEIN$ (AChE) were compared between a laboratory-susceptible strain (LS) and a field-resistant population (FR) of the oriental migratory locust, Locusta migratoria manilensis (Meyen).	0	18615705-81
The susceptibilities to three organophosphate (OP) insecticides (@COMPOUND$, chlorpyrifos, and phoxim), responses to three metabolic synergists (triphenyl phosphate (TPP), piperonyl butoxide (PBO), and diethyl maleate (DEM)), activities of major detoxification enzymes (general esterases (ESTs), glutathione S-transferases (GSTs), and cytochrome P450 monooxygenases (P450s)), and sensitivity of the target enzyme @PROTEIN$ (AChE) were compared between a laboratory-susceptible strain (LS) and a field-resistant population (FR) of the oriental migratory locust, Locusta migratoria manilensis (Meyen).	0	18615705-81
The susceptibilities to three organophosphate (OP) insecticides (@COMPOUND$, chlorpyrifos, and phoxim), responses to three metabolic synergists (triphenyl phosphate (TPP), piperonyl butoxide (PBO), and diethyl maleate (DEM)), activities of major detoxification enzymes (general esterases (ESTs), glutathione S-transferases (@PROTEIN$), and cytochrome P450 monooxygenases (P450s)), and sensitivity of the target enzyme acetylcholinesterase (AChE) were compared between a laboratory-susceptible strain (LS) and a field-resistant population (FR) of the oriental migratory locust, Locusta migratoria manilensis (Meyen).	0	18615705-81
The susceptibilities to three organophosphate (OP) insecticides (malathion, @COMPOUND$, and phoxim), responses to three metabolic synergists (triphenyl phosphate (TPP), piperonyl butoxide (PBO), and diethyl maleate (DEM)), activities of major detoxification enzymes (general esterases (ESTs), glutathione S-transferases (GSTs), and @PROTEIN$ monooxygenases (P450s)), and sensitivity of the target enzyme acetylcholinesterase (AChE) were compared between a laboratory-susceptible strain (LS) and a field-resistant population (FR) of the oriental migratory locust, Locusta migratoria manilensis (Meyen).	0	18615705-81
The susceptibilities to three organophosphate (OP) insecticides (malathion, @COMPOUND$, and phoxim), responses to three metabolic synergists (triphenyl phosphate (TPP), piperonyl butoxide (PBO), and diethyl maleate (DEM)), activities of major detoxification enzymes (general @PROTEIN$ (ESTs), glutathione S-transferases (GSTs), and cytochrome P450 monooxygenases (P450s)), and sensitivity of the target enzyme acetylcholinesterase (AChE) were compared between a laboratory-susceptible strain (LS) and a field-resistant population (FR) of the oriental migratory locust, Locusta migratoria manilensis (Meyen).	0	18615705-81
The susceptibilities to three organophosphate (OP) insecticides (@COMPOUND$, chlorpyrifos, and phoxim), responses to three metabolic synergists (triphenyl phosphate (TPP), piperonyl butoxide (PBO), and diethyl maleate (DEM)), activities of major detoxification enzymes (general esterases (ESTs), glutathione S-transferases (GSTs), and @PROTEIN$ monooxygenases (P450s)), and sensitivity of the target enzyme acetylcholinesterase (AChE) were compared between a laboratory-susceptible strain (LS) and a field-resistant population (FR) of the oriental migratory locust, Locusta migratoria manilensis (Meyen).	0	18615705-81
The susceptibilities to three organophosphate (OP) insecticides (malathion, chlorpyrifos, and phoxim), responses to three metabolic synergists (triphenyl phosphate (TPP), @COMPOUND$ (PBO), and diethyl maleate (DEM)), activities of major detoxification enzymes (general esterases (ESTs), glutathione S-transferases (GSTs), and cytochrome P450 monooxygenases (P450s)), and sensitivity of the target enzyme @PROTEIN$ (AChE) were compared between a laboratory-susceptible strain (LS) and a field-resistant population (FR) of the oriental migratory locust, Locusta migratoria manilensis (Meyen).	0	18615705-81
The susceptibilities to three organophosphate (OP) insecticides (malathion, chlorpyrifos, and phoxim), responses to three metabolic synergists (@COMPOUND$ (TPP), piperonyl butoxide (PBO), and diethyl maleate (DEM)), activities of major detoxification enzymes (general @PROTEIN$ (ESTs), glutathione S-transferases (GSTs), and cytochrome P450 monooxygenases (P450s)), and sensitivity of the target enzyme acetylcholinesterase (AChE) were compared between a laboratory-susceptible strain (LS) and a field-resistant population (FR) of the oriental migratory locust, Locusta migratoria manilensis (Meyen).	0	18615705-81
The susceptibilities to three organophosphate (OP) insecticides (malathion, chlorpyrifos, and phoxim), responses to three metabolic synergists (triphenyl phosphate (TPP), @COMPOUND$ (PBO), and diethyl maleate (DEM)), activities of major detoxification enzymes (general esterases (ESTs), glutathione S-transferases (GSTs), and @PROTEIN$ monooxygenases (P450s)), and sensitivity of the target enzyme acetylcholinesterase (AChE) were compared between a laboratory-susceptible strain (LS) and a field-resistant population (FR) of the oriental migratory locust, Locusta migratoria manilensis (Meyen).	0	18615705-81
The susceptibilities to three organophosphate (OP) insecticides (malathion, chlorpyrifos, and phoxim), responses to three metabolic synergists (triphenyl phosphate (TPP), piperonyl butoxide (PBO), and @COMPOUND$ (DEM)), activities of major detoxification enzymes (general esterases (ESTs), glutathione S-transferases (GSTs), and cytochrome P450 monooxygenases (P450s)), and sensitivity of the target enzyme acetylcholinesterase (@PROTEIN$) were compared between a laboratory-susceptible strain (LS) and a field-resistant population (FR) of the oriental migratory locust, Locusta migratoria manilensis (Meyen).	0	18615705-81
The susceptibilities to three organophosphate (OP) insecticides (malathion, chlorpyrifos, and phoxim), responses to three metabolic synergists (triphenyl phosphate (TPP), piperonyl butoxide (PBO), and @COMPOUND$ (DEM)), activities of major detoxification enzymes (general esterases (ESTs), glutathione S-transferases (@PROTEIN$), and cytochrome P450 monooxygenases (P450s)), and sensitivity of the target enzyme acetylcholinesterase (AChE) were compared between a laboratory-susceptible strain (LS) and a field-resistant population (FR) of the oriental migratory locust, Locusta migratoria manilensis (Meyen).	0	18615705-81
The susceptibilities to three organophosphate (OP) insecticides (malathion, chlorpyrifos, and phoxim), responses to three metabolic synergists (triphenyl phosphate (TPP), @COMPOUND$ (PBO), and diethyl maleate (DEM)), activities of major detoxification enzymes (general esterases (ESTs), glutathione S-transferases (GSTs), and cytochrome P450 monooxygenases (P450s)), and sensitivity of the target enzyme acetylcholinesterase (@PROTEIN$) were compared between a laboratory-susceptible strain (LS) and a field-resistant population (FR) of the oriental migratory locust, Locusta migratoria manilensis (Meyen).	0	18615705-81
The susceptibilities to three organophosphate (OP) insecticides (malathion, @COMPOUND$, and phoxim), responses to three metabolic synergists (triphenyl phosphate (TPP), piperonyl butoxide (PBO), and diethyl maleate (DEM)), activities of major detoxification enzymes (general esterases (ESTs), glutathione S-transferases (GSTs), and cytochrome P450 monooxygenases (P450s)), and sensitivity of the target enzyme acetylcholinesterase (@PROTEIN$) were compared between a laboratory-susceptible strain (LS) and a field-resistant population (FR) of the oriental migratory locust, Locusta migratoria manilensis (Meyen).	0	18615705-81
The susceptibilities to three organophosphate (OP) insecticides (@COMPOUND$, chlorpyrifos, and phoxim), responses to three metabolic synergists (triphenyl phosphate (TPP), piperonyl butoxide (PBO), and diethyl maleate (DEM)), activities of major detoxification enzymes (general @PROTEIN$ (ESTs), glutathione S-transferases (GSTs), and cytochrome P450 monooxygenases (P450s)), and sensitivity of the target enzyme acetylcholinesterase (AChE) were compared between a laboratory-susceptible strain (LS) and a field-resistant population (FR) of the oriental migratory locust, Locusta migratoria manilensis (Meyen).	0	18615705-81
The susceptibilities to three organophosphate (OP) insecticides (malathion, chlorpyrifos, and phoxim), responses to three metabolic synergists (@COMPOUND$ (TPP), piperonyl butoxide (PBO), and diethyl maleate (DEM)), activities of major detoxification enzymes (general esterases (ESTs), glutathione S-transferases (GSTs), and cytochrome P450 monooxygenases (P450s)), and sensitivity of the target enzyme acetylcholinesterase (@PROTEIN$) were compared between a laboratory-susceptible strain (LS) and a field-resistant population (FR) of the oriental migratory locust, Locusta migratoria manilensis (Meyen).	0	18615705-81
The susceptibilities to three organophosphate (OP) insecticides (@COMPOUND$, chlorpyrifos, and phoxim), responses to three metabolic synergists (triphenyl phosphate (TPP), piperonyl butoxide (PBO), and diethyl maleate (DEM)), activities of major detoxification enzymes (general esterases (ESTs), glutathione S-transferases (GSTs), and cytochrome P450 monooxygenases (P450s)), and sensitivity of the target enzyme acetylcholinesterase (@PROTEIN$) were compared between a laboratory-susceptible strain (LS) and a field-resistant population (FR) of the oriental migratory locust, Locusta migratoria manilensis (Meyen).	0	18615705-81
The susceptibilities to three organophosphate (OP) insecticides (malathion, chlorpyrifos, and @COMPOUND$), responses to three metabolic synergists (triphenyl phosphate (TPP), piperonyl butoxide (PBO), and diethyl maleate (DEM)), activities of major detoxification enzymes (general esterases (ESTs), glutathione S-transferases (GSTs), and @PROTEIN$ monooxygenases (P450s)), and sensitivity of the target enzyme acetylcholinesterase (AChE) were compared between a laboratory-susceptible strain (LS) and a field-resistant population (FR) of the oriental migratory locust, Locusta migratoria manilensis (Meyen).	0	18615705-81
The susceptibilities to three organophosphate (OP) insecticides (malathion, @COMPOUND$, and phoxim), responses to three metabolic synergists (triphenyl phosphate (TPP), piperonyl butoxide (PBO), and diethyl maleate (DEM)), activities of major detoxification enzymes (general esterases (ESTs), glutathione S-transferases (GSTs), and cytochrome P450 monooxygenases (P450s)), and sensitivity of the target enzyme @PROTEIN$ (AChE) were compared between a laboratory-susceptible strain (LS) and a field-resistant population (FR) of the oriental migratory locust, Locusta migratoria manilensis (Meyen).	0	18615705-81
The susceptibilities to three organophosphate (OP) insecticides (malathion, chlorpyrifos, and phoxim), responses to three metabolic synergists (triphenyl phosphate (TPP), piperonyl butoxide (PBO), and @COMPOUND$ (DEM)), activities of major detoxification enzymes (general esterases (ESTs), @PROTEIN$ (GSTs), and cytochrome P450 monooxygenases (P450s)), and sensitivity of the target enzyme acetylcholinesterase (AChE) were compared between a laboratory-susceptible strain (LS) and a field-resistant population (FR) of the oriental migratory locust, Locusta migratoria manilensis (Meyen).	0	18615705-81
The susceptibilities to three organophosphate (OP) insecticides (malathion, chlorpyrifos, and phoxim), responses to three metabolic synergists (triphenyl phosphate (TPP), piperonyl butoxide (PBO), and @COMPOUND$ (DEM)), activities of major detoxification enzymes (general @PROTEIN$ (ESTs), glutathione S-transferases (GSTs), and cytochrome P450 monooxygenases (P450s)), and sensitivity of the target enzyme acetylcholinesterase (AChE) were compared between a laboratory-susceptible strain (LS) and a field-resistant population (FR) of the oriental migratory locust, Locusta migratoria manilensis (Meyen).	0	18615705-81
The susceptibilities to three organophosphate (OP) insecticides (malathion, chlorpyrifos, and @COMPOUND$), responses to three metabolic synergists (triphenyl phosphate (TPP), piperonyl butoxide (PBO), and diethyl maleate (DEM)), activities of major detoxification enzymes (general esterases (ESTs), @PROTEIN$ (GSTs), and cytochrome P450 monooxygenases (P450s)), and sensitivity of the target enzyme acetylcholinesterase (AChE) were compared between a laboratory-susceptible strain (LS) and a field-resistant population (FR) of the oriental migratory locust, Locusta migratoria manilensis (Meyen).	0	18615705-81
The susceptibilities to three organophosphate (OP) insecticides (@COMPOUND$, chlorpyrifos, and phoxim), responses to three metabolic synergists (triphenyl phosphate (TPP), piperonyl butoxide (PBO), and diethyl maleate (DEM)), activities of major detoxification enzymes (general esterases (ESTs), @PROTEIN$ (GSTs), and cytochrome P450 monooxygenases (P450s)), and sensitivity of the target enzyme acetylcholinesterase (AChE) were compared between a laboratory-susceptible strain (LS) and a field-resistant population (FR) of the oriental migratory locust, Locusta migratoria manilensis (Meyen).	0	18615705-81
The susceptibilities to three organophosphate (OP) insecticides (malathion, @COMPOUND$, and phoxim), responses to three metabolic synergists (triphenyl phosphate (TPP), piperonyl butoxide (PBO), and diethyl maleate (DEM)), activities of major detoxification enzymes (general esterases (ESTs), @PROTEIN$ (GSTs), and cytochrome P450 monooxygenases (P450s)), and sensitivity of the target enzyme acetylcholinesterase (AChE) were compared between a laboratory-susceptible strain (LS) and a field-resistant population (FR) of the oriental migratory locust, Locusta migratoria manilensis (Meyen).	0	18615705-81
The susceptibilities to three organophosphate (OP) insecticides (malathion, chlorpyrifos, and phoxim), responses to three metabolic synergists (@COMPOUND$ (TPP), piperonyl butoxide (PBO), and diethyl maleate (DEM)), activities of major detoxification enzymes (general esterases (ESTs), glutathione S-transferases (GSTs), and @PROTEIN$ monooxygenases (P450s)), and sensitivity of the target enzyme acetylcholinesterase (AChE) were compared between a laboratory-susceptible strain (LS) and a field-resistant population (FR) of the oriental migratory locust, Locusta migratoria manilensis (Meyen).	0	18615705-81
All these results clearly indicated that the observed @COMPOUND$ resistance in the FR was conferred by multiple mechanisms, including increased detoxification by ESTs and @PROTEIN$, and increased activity and reduced sensitivity of AChE to OP inhibition.	1	18615705-83
All these results clearly indicated that the observed @COMPOUND$ resistance in the FR was conferred by multiple mechanisms, including increased detoxification by ESTs and GSTs, and increased activity and reduced sensitivity of @PROTEIN$ to OP inhibition.	1	18615705-83
@PROTEIN$ act as crucial bacteriolytic enzymes in insect immune system by hydrolyzing the beta (1--&gt;4) bonds between @COMPOUND$ and N-acetylmuramic acid in the peptidoglycan of prokaryotic cell walls.	1	18615707-1194
@PROTEIN$ act as crucial bacteriolytic enzymes in insect immune system by hydrolyzing the beta (1--&gt;4) bonds between N-acetylglucosamine and @COMPOUND$ in the peptidoglycan of prokaryotic cell walls.	1	18615707-1194
@PROTEIN$ act as crucial bacteriolytic enzymes in insect immune system by hydrolyzing the beta (1--&gt;4) bonds between N-acetylglucosamine and N-acetylmuramic acid in the @COMPOUND$ of prokaryotic cell walls.	1	18615707-1194
"These mRNAs no longer encode the @PROTEIN$ homology (PH) domain of collybistin, which we now show binds @COMPOUND$ (PI3P/PtdIns-3-P), a phosphoinositide with an emerging role in membrane trafficking and signal transduction, rather than phosphatidylinositol 3,4,5-trisphosphate (PIP3/PtdIns-3,4,5-P) as previously suggested in the "" membrane activation model"" of gephyrin clustering."	1	18615734-449
"These mRNAs no longer encode the pleckstrin homology (PH) domain of @PROTEIN$, which we now show binds phosphatidylinositol-3-phosphate (PI3P/PtdIns-3-P), a @COMPOUND$ with an emerging role in membrane trafficking and signal transduction, rather than phosphatidylinositol 3,4,5-trisphosphate (PIP3/PtdIns-3,4,5-P) as previously suggested in the "" membrane activation model"" of gephyrin clustering."	1	18615734-449
"These mRNAs no longer encode the pleckstrin homology (PH) domain of @PROTEIN$, which we now show binds phosphatidylinositol-3-phosphate (PI3P/@COMPOUND$), a phosphoinositide with an emerging role in membrane trafficking and signal transduction, rather than phosphatidylinositol 3,4,5-trisphosphate (PIP3/PtdIns-3,4,5-P) as previously suggested in the "" membrane activation model"" of gephyrin clustering."	1	18615734-449
"These mRNAs no longer encode the pleckstrin homology (PH) domain of @PROTEIN$, which we now show binds phosphatidylinositol-3-phosphate (PI3P/PtdIns-3-P), a phosphoinositide with an emerging role in membrane trafficking and signal transduction, rather than @COMPOUND$ (PIP3/PtdIns-3,4,5-P) as previously suggested in the "" membrane activation model"" of gephyrin clustering."	1	18615734-449
"These mRNAs no longer encode the @PROTEIN$ homology (PH) domain of collybistin, which we now show binds phosphatidylinositol-3-phosphate (PI3P/PtdIns-3-P), a phosphoinositide with an emerging role in membrane trafficking and signal transduction, rather than @COMPOUND$ (PIP3/PtdIns-3,4,5-P) as previously suggested in the "" membrane activation model"" of gephyrin clustering."	1	18615734-449
"These mRNAs no longer encode the pleckstrin homology (PH) domain of @PROTEIN$, which we now show binds phosphatidylinositol-3-phosphate (PI3P/PtdIns-3-P), a phosphoinositide with an emerging role in membrane trafficking and signal transduction, rather than phosphatidylinositol 3,4,5-trisphosphate (PIP3/@COMPOUND$) as previously suggested in the "" membrane activation model"" of gephyrin clustering."	1	18615734-449
"These mRNAs no longer encode the @PROTEIN$ homology (PH) domain of collybistin, which we now show binds phosphatidylinositol-3-phosphate (PI3P/@COMPOUND$), a phosphoinositide with an emerging role in membrane trafficking and signal transduction, rather than phosphatidylinositol 3,4,5-trisphosphate (PIP3/PtdIns-3,4,5-P) as previously suggested in the "" membrane activation model"" of gephyrin clustering."	1	18615734-449
"These mRNAs no longer encode the @PROTEIN$ homology (PH) domain of collybistin, which we now show binds phosphatidylinositol-3-phosphate (PI3P/PtdIns-3-P), a phosphoinositide with an emerging role in membrane trafficking and signal transduction, rather than phosphatidylinositol 3,4,5-trisphosphate (PIP3/@COMPOUND$) as previously suggested in the "" membrane activation model"" of gephyrin clustering."	1	18615734-449
"These mRNAs no longer encode the pleckstrin homology (PH) domain of collybistin, which we now show binds phosphatidylinositol-3-phosphate (PI3P/PtdIns-3-P), a phosphoinositide with an emerging role in membrane trafficking and signal transduction, rather than phosphatidylinositol 3,4,5-trisphosphate (PIP3/@COMPOUND$) as previously suggested in the "" membrane activation model"" of @PROTEIN$ clustering."	0	18615734-449
"These mRNAs no longer encode the pleckstrin homology (PH) domain of @PROTEIN$, which we now show binds @COMPOUND$ (PI3P/PtdIns-3-P), a phosphoinositide with an emerging role in membrane trafficking and signal transduction, rather than phosphatidylinositol 3,4,5-trisphosphate (PIP3/PtdIns-3,4,5-P) as previously suggested in the "" membrane activation model"" of gephyrin clustering."	1	18615734-449
"These mRNAs no longer encode the @PROTEIN$ homology (PH) domain of collybistin, which we now show binds phosphatidylinositol-3-phosphate (PI3P/PtdIns-3-P), a @COMPOUND$ with an emerging role in membrane trafficking and signal transduction, rather than phosphatidylinositol 3,4,5-trisphosphate (PIP3/PtdIns-3,4,5-P) as previously suggested in the "" membrane activation model"" of gephyrin clustering."	1	18615734-449
"These mRNAs no longer encode the pleckstrin homology (PH) domain of collybistin, which we now show binds phosphatidylinositol-3-phosphate (PI3P/@COMPOUND$), a phosphoinositide with an emerging role in membrane trafficking and signal transduction, rather than phosphatidylinositol 3,4,5-trisphosphate (PIP3/PtdIns-3,4,5-P) as previously suggested in the "" membrane activation model"" of @PROTEIN$ clustering."	0	18615734-449
"These mRNAs no longer encode the pleckstrin homology (PH) domain of collybistin, which we now show binds @COMPOUND$ (PI3P/PtdIns-3-P), a phosphoinositide with an emerging role in membrane trafficking and signal transduction, rather than phosphatidylinositol 3,4,5-trisphosphate (PIP3/PtdIns-3,4,5-P) as previously suggested in the "" membrane activation model"" of @PROTEIN$ clustering."	0	18615734-449
"These mRNAs no longer encode the pleckstrin homology (PH) domain of collybistin, which we now show binds phosphatidylinositol-3-phosphate (PI3P/PtdIns-3-P), a @COMPOUND$ with an emerging role in membrane trafficking and signal transduction, rather than phosphatidylinositol 3,4,5-trisphosphate (PIP3/PtdIns-3,4,5-P) as previously suggested in the "" membrane activation model"" of @PROTEIN$ clustering."	0	18615734-449
"These mRNAs no longer encode the pleckstrin homology (PH) domain of collybistin, which we now show binds phosphatidylinositol-3-phosphate (PI3P/PtdIns-3-P), a phosphoinositide with an emerging role in membrane trafficking and signal transduction, rather than @COMPOUND$ (PIP3/PtdIns-3,4,5-P) as previously suggested in the "" membrane activation model"" of @PROTEIN$ clustering."	0	18615734-449
We investigated whether several different inflammatory markers including C-reactive protein (@PROTEIN$) and fibrinogen and white blood cells (WBCs) count, are associated with maximal @COMPOUND$ consumption (VO(2 max)) in women with polycystic ovary syndrome (PCOS).	0	18616717-310
We investigated whether several different inflammatory markers including C-reactive protein (CRP) and @PROTEIN$ and white blood cells (WBCs) count, are associated with maximal @COMPOUND$ consumption (VO(2 max)) in women with polycystic ovary syndrome (PCOS).	0	18616717-310
CSE activated the MMP-1 promoter, and this induction was prevented by @COMPOUND$ blockade of @PROTEIN$/2 phosphorylation.	1	18617682-1119
CSE activated the @PROTEIN$ promoter, and this induction was prevented by @COMPOUND$ blockade of ERK1/2 phosphorylation.	1	18617682-1119
Cotransfection, @COMPOUND$, and electrophoretic mobility shift assay studies identified activating and repressive roles for @PROTEIN$ and PEA3 transcription factors, respectively.	0	18617682-1120
We have previously demonstrated that @COMPOUND$, a stable prostacyclin (PGI (2)) analogue, induces angiogenesis in vivo, through a vascular endothelial growth factor (@PROTEIN$)-dependent mechanism.	1	18617751-1188
We have previously demonstrated that iloprost, a stable @COMPOUND$ (PGI (2)) analogue, induces angiogenesis in vivo, through a vascular endothelial growth factor (@PROTEIN$)-dependent mechanism.	0	18617751-1188
In this study, we demonstrate that @COMPOUND$-induced angiogenesis and @PROTEIN$ upregulation are modulated by peroxisome proliferator-activated receptor-alpha (PPARalpha), a ligand-inducible transcription factor that belongs to the nuclear hormone receptor superfamily and plays multiple biological activities in the vascular system.	1	18617751-1189
In this study, we demonstrate that @COMPOUND$-induced angiogenesis and VEGF upregulation are modulated by peroxisome proliferator-activated receptor-alpha (@PROTEIN$), a ligand-inducible transcription factor that belongs to the nuclear hormone receptor superfamily and plays multiple biological activities in the vascular system.	1	18617751-1189
In this study, we demonstrate that @COMPOUND$-induced angiogenesis and VEGF upregulation are modulated by @PROTEIN$ (PPARalpha), a ligand-inducible transcription factor that belongs to the nuclear hormone receptor superfamily and plays multiple biological activities in the vascular system.	1	18617751-1189
In contrast, @COMPOUND$ induces a robust angiogenic response in wild-type mice, along with local upregulation of @PROTEIN$.	1	18617751-1191
Importantly, mice lacking the PPARalpha gene exhibit a normal angiogenic response to @PROTEIN$, indicating that the absence of PPARalpha does not result in a general impairment of angiogenesis, but specifically affects the ability of @COMPOUND$ to induce angiogenesis.	1	18617751-1192
The proportion of @PROTEIN$ molecules that are directed to the novel cleavage pathway is regulated by the ratio of free @COMPOUND$ and cholesteryl esters in cells.	1	18618086-1425
In the hormone receptor-positive breast cancer cell line T47-D expression of @PROTEIN$ and its soluble isoforms was increased by treatment with estradiol and @COMPOUND$.	1	18618240-1582
In the hormone receptor-positive breast cancer cell line T47-D expression of @PROTEIN$ and its soluble isoforms was increased by treatment with @COMPOUND$ and tamoxifen.	1	18618240-1582
In contrast to the behavior in aqueous solution, lactose binding in @COMPOUND$ resulted in an increase of the @PROTEIN$'s radius of gyration from 49+/-1 to 55.5+/-1 A.	1	18618241-1584
@PROTEIN$-alpha (TNF-alpha) levels were also investigated in rat serum, but there was no statistically significant difference between the TNF-alpha levels of the @COMPOUND$-treated rats groups and the control rats.	0	18618243-1587
Tumor necrosis factor-alpha (@PROTEIN$) levels were also investigated in rat serum, but there was no statistically significant difference between the TNF-alpha levels of the @COMPOUND$-treated rats groups and the control rats.	0	18618243-1587
Our study indicates that brain @PROTEIN$ activity decreases after @COMPOUND$ administration at doses of 30 mg/kg and 100 mg/kg.	1	18618243-1588
Comparison of the PTM's of @PROTEIN$'s isolated from several vertebrate species reveals marked differences in their @COMPOUND$ content.	1	18618245-1590
Chicken @PROTEIN$ does not share any phosphorylated sites with dogfish MBP ; However, it does contain phosphorylated serine and @COMPOUND$ residues in common with mammalian MBP.	1	18618245-1591
Chicken @PROTEIN$ does not share any phosphorylated sites with dogfish MBP ; However, it does contain phosphorylated @COMPOUND$ and threonine residues in common with mammalian MBP.	1	18618245-1591
@COMPOUND$/NaPB administration increased acetylation at H4 and increased NF-kappaB @PROTEIN$ translocation to the nucleus in G93A mice, consistent with a therapeutic effect.	1	18618304-1646
Riluzole/@COMPOUND$ administration increased acetylation at H4 and increased NF-kappaB @PROTEIN$ translocation to the nucleus in G93A mice, consistent with a therapeutic effect.	1	18618304-1646
Due to the absence of hydrophobic solute-material interactions, which limit the scope of microstructures fabricated from poly(dimethylsiloxane) for biocatalytic applications, the new microreactor was fully compatible with the alternate enzyme substrate 2-nitro-phenyl-beta-D-galactoside and the @COMPOUND$ product resulting from its hydrolysis catalyzed by @PROTEIN$.	1	18618472-1060
These findings suggest that multiple variations in the @PROTEIN$ gene are associated with remission in white non-Hispanic depressed adults treated with @COMPOUND$.	1	18618621-1255
The planar angle between the carbamoyl phosphate and @COMPOUND$ domains of the catalytic chain is more open at pH 8.5 than in @PROTEIN$ structures determined at lower pH values.	1	18618694-248
The planar angle between the @COMPOUND$ and aspartate domains of the catalytic chain is more open at pH 8.5 than in @PROTEIN$ structures determined at lower pH values.	1	18618694-248
At 0.15 microM @COMPOUND$+), ((35)S) CaM bound to @PROTEIN$ with decreased affinity and binding enthalpy compared with RyR1.	0	18618700-254
At 0.15 microM @COMPOUND$+), ((35)S) @PROTEIN$ bound to RyR2 with decreased affinity and binding enthalpy compared with RyR1.	0	18618700-254
At 0.15 microM @COMPOUND$+), ((35)S) CaM bound to RyR2 with decreased affinity and binding enthalpy compared with @PROTEIN$.	0	18618700-254
The rates of ((35)S) CaM dissociation from RyR1 increased as the temperature was raised, whereas at 0.15 microM @COMPOUND$+) the rate from @PROTEIN$ was little affected.	0	18618700-255
The rates of ((35)S) CaM dissociation from @PROTEIN$ increased as the temperature was raised, whereas at 0.15 microM @COMPOUND$+) the rate from RyR2 was little affected.	0	18618700-255
The rates of ((35)S) @PROTEIN$ dissociation from RyR1 increased as the temperature was raised, whereas at 0.15 microM @COMPOUND$+) the rate from RyR2 was little affected.	0	18618700-255
In rats, infusion of angiotensin II increases @PROTEIN$ levels and arterial thickness which are reversed by treatment with the iron chelator @COMPOUND$.	1	18619522-636
Furthermore, @COMPOUND$ regulated endogenous survival signaling by up-regulating phosphorylated @PROTEIN$ that returned to its basal level later.	1	18619705-1094
Furthermore, @COMPOUND$ induced nucleus translocalization of p53 and @PROTEIN$ and recruitment of autophagosomes.	1	18619705-1095
Furthermore, @COMPOUND$ induced nucleus translocalization of @PROTEIN$ and Akt and recruitment of autophagosomes.	1	18619705-1095
The ubiquitous enzyme dUTP nucleotidohydrolase (@PROTEIN$) catalyses the hydrolysis of dUTP to dUMP and can be considered as the first line of defence against incorporation of @COMPOUND$ into DNA.	0	18619713-1104
Recent findings indicate that the polypyrimidine tract-binding protein (@PROTEIN$), also named hnRNP I, by binding to the 3'-UTR (untranslated region) of the preproinsulin mRNA molecule, stabilizes the messenger, thereby participating in the @COMPOUND$-induced increase in preproinsulin mRNA.	1	18621093-545
Recent findings indicate that the polypyrimidine tract-binding protein (PTB), also named @PROTEIN$, by binding to the 3'-UTR (untranslated region) of the preproinsulin mRNA molecule, stabilizes the messenger, thereby participating in the @COMPOUND$-induced increase in preproinsulin mRNA.	1	18621093-545
Pretreatment with extracellular signal-regulated kinase (ERK) and Jun N-terminal kinase (JNK) inhibitors, but not p38 mitogen-activated protein kinase (p38MAPK) significantly decreased @PROTEIN$-induced @COMPOUND$ anion release from macrophages in vivo.	1	18621373-794
Pretreatment with extracellular signal-regulated kinase (ERK) and Jun N-terminal kinase (JNK) inhibitors, but not p38 mitogen-activated protein kinase (@PROTEIN$) significantly decreased CRP-induced @COMPOUND$ anion release from macrophages in vivo.	0	18621373-794
The free radicals produced are thought to be generated during the production of @COMPOUND$, a reaction catalyzed by @PROTEIN$.	1	18621413-823
In the diabetic group, a decrease in the pancreatic @COMPOUND$ levels, glutathione peroxidase and superoxide dismutase activities and an increase in the pancreatic lipid peroxidation level and @PROTEIN$ activities were observed.	0	18621448-855
In the diabetic group, a decrease in the pancreatic @COMPOUND$ levels, glutathione peroxidase and @PROTEIN$ activities and an increase in the pancreatic lipid peroxidation level and catalase activities were observed.	0	18621448-855
In the diabetic group, a decrease in the pancreatic @COMPOUND$ levels, @PROTEIN$ and superoxide dismutase activities and an increase in the pancreatic lipid peroxidation level and catalase activities were observed.	0	18621448-855
The immunomodulatory effects of @COMPOUND$ are at least partially mediated through its ability to down-regulate the pathogenic over-production of tumor necrosis factor-alpha (@PROTEIN$).	1	18621563-947
The immunomodulatory effects of @COMPOUND$ are at least partially mediated through its ability to down-regulate the pathogenic over-production of @PROTEIN$-alpha (TNF-alpha).	1	18621563-947
In the central nervous system, @PROTEIN$ is involved in induction of a fever response and triggers the release of other cytokines, and may also influence transport of compounds into the brain, leading to cerebrospinal fluid leukocytosis, increased protein influx, and @COMPOUND$ accumulation.	1	18621563-948
@COMPOUND$ has been shown to down-regulate the production of @PROTEIN$.	1	18621563-949
Both cell types expressed estrogen and @PROTEIN$, although only the epithelial LM05-E cells were stimulated by @COMPOUND$ and inhibited by tamoxifen.	0	18622696-162
Both cell types expressed estrogen and @PROTEIN$, although only the epithelial LM05-E cells were stimulated by estradiol and inhibited by @COMPOUND$.	0	18622696-162
This study was performed to investigate the effect of combined treatment with @COMPOUND$ and chromium on vascular endothelial dysfunction, with the aim of gaining insight to the mechanisms by detecting the expression levels of ox-LDL and @PROTEIN$.	0	18622720-185
This study was performed to investigate the effect of combined treatment with niacin and @COMPOUND$ on vascular endothelial dysfunction, with the aim of gaining insight to the mechanisms by detecting the expression levels of ox-LDL and @PROTEIN$.	0	18622720-185
In HF group, the serum levels of total @COMPOUND$ (TC), low-density lipoprotein (LDL), oxidized low-density lipoprotein (ox-LDL) and endothelin (ET) were higher, whereas the levels of @PROTEIN$ (HDL), serum NO were lower than those in CG group.	0	18622720-186
These findings indicated that combined treatment with niacin and @COMPOUND$ has potential therapeutic protection of endothelial function by down-regulating ox-LDL/@PROTEIN$ signaling pathway.	1	18622720-187
These findings indicated that combined treatment with @COMPOUND$ and chromium has potential therapeutic protection of endothelial function by down-regulating ox-LDL/@PROTEIN$ signaling pathway.	1	18622720-187
The deduced amino acid sequence of Ai Lec was highly similar to those of the C-type @PROTEIN$ from other animals and contained a typical carbohydrate-recognition domain (CRD) of 131 residues, which has four conserved disulfide-bonded @COMPOUND$ residues that define the CRD and two additional cysteine residues at the amino terminus.	1	18622759-218
@PROTEIN$ kinases can be activated by trans-phosphorylation of a @COMPOUND$ located in the central activation loop of the catalytic domain.	1	18623061-1275
However, because the required exposure of this @COMPOUND$ is not observed in the down-regulated X-ray structures of @PROTEIN$ kinases, transient partial opening of the activation loop appears to be necessary for such processes.	0	18623061-1276
The growth of L. minor (as fresh weight) and @COMPOUND$ content were significantly reduced and @PROTEIN$ (SOD) activity was significantly decreased at microcystins concentration up to 0.5 mg/L.	0	18623078-486
The growth of L. minor (as fresh weight) and @COMPOUND$ content were significantly reduced and superoxide dismutase (@PROTEIN$) activity was significantly decreased at microcystins concentration up to 0.5 mg/L.	0	18623078-486
The experiment also indicated that catalase (@PROTEIN$) activity was not significantly influenced by @COMPOUND$ for both the two tested aquatic plants.	0	18623078-487
The experiment also indicated that @PROTEIN$ (CAT) activity was not significantly influenced by @COMPOUND$ for both the two tested aquatic plants.	0	18623078-487
The purpose of this study was to investigate the solid-state properties of lyophilized formulations of protein (@PROTEIN$) containing @COMPOUND$ or trehalose across a wide range of compositions, both in the presence or absence of hydroxyethylstarch (HES).	0	18623211-610
The purpose of this study was to investigate the solid-state properties of lyophilized formulations of protein (@PROTEIN$) containing sucrose or @COMPOUND$ across a wide range of compositions, both in the presence or absence of hydroxyethylstarch (HES).	0	18623211-610
The stimulatory effects of stearic, palmitic and palmitoleic acids on resistin secretion and the stimulatory effect of @COMPOUND$ on @PROTEIN$ secretion are mediated via TLR-4.	1	18624726-1067
The stimulatory effects of stearic, palmitic and palmitoleic acids on resistin secretion and the stimulatory effect of @COMPOUND$ on MCP-1 secretion are mediated via @PROTEIN$-4.	1	18624726-1067
@COMPOUND$ increased the levels of CD95 (@PROTEIN$), CD95-ligand and Fas-associated death domain.	1	18624760-178
Since lithium and @COMPOUND$-induced G(2)/M arrest we studied changes in the expression of proteins involved in this phase, specifically @PROTEIN$ B, cdc2 and the phosphorylated form of this protein (tyr15-cdc2).	0	18624766-181
Since @COMPOUND$ and SB-415286-induced G(2)/M arrest we studied changes in the expression of proteins involved in this phase, specifically cyclin B, @PROTEIN$ and the phosphorylated form of this protein (tyr15-cdc2).	0	18624766-181
Since lithium and @COMPOUND$-induced G(2)/M arrest we studied changes in the expression of proteins involved in this phase, specifically cyclin B, @PROTEIN$ and the phosphorylated form of this protein (tyr15-cdc2).	0	18624766-181
Since @COMPOUND$ and SB-415286-induced G(2)/M arrest we studied changes in the expression of proteins involved in this phase, specifically @PROTEIN$ B, cdc2 and the phosphorylated form of this protein (tyr15-cdc2).	0	18624766-181
On the other hand, @COMPOUND$ increased the expression of @PROTEIN$, involved in the regulation of proliferation.	1	18624766-182
We conclude that inhibitors of GSK-3 induced cell-cycle arrest, mediated by the phosphorylation of cdc2 and, in the case of @COMPOUND$, @PROTEIN$ expression, which induced apoptosis in a caspase-independent manner.	1	18624766-184
We conclude that inhibitors of GSK-3 induced cell-cycle arrest, mediated by the phosphorylation of @PROTEIN$ and, in the case of @COMPOUND$, SIRT2 expression, which induced apoptosis in a caspase-independent manner.	0	18624766-184
Reduction of intracellular @COMPOUND$+) levels abolished @PROTEIN$ reduction by HOG-LDL, as did pharmacological or genetic through calcium channel blockers or calcium chelator BAPTA or inhibition of NAD(P)H oxidase (with apocynin) or inhibition of calpain (calpain 1-specific siRNA).	1	18624772-192
Reduction of intracellular Ca(2+) levels abolished @PROTEIN$ reduction by HOG-LDL, as did pharmacological or genetic through calcium channel blockers or calcium chelator @COMPOUND$ or inhibition of NAD(P)H oxidase (with apocynin) or inhibition of calpain (calpain 1-specific siRNA).	1	18624772-192
Reduction of intracellular Ca(2+) levels abolished @PROTEIN$ reduction by HOG-LDL, as did pharmacological or genetic through calcium channel blockers or calcium chelator BAPTA or inhibition of NAD(P)H oxidase (with @COMPOUND$) or inhibition of calpain (calpain 1-specific siRNA).	0	18624772-192
In addition to transporting @COMPOUND$, @PROTEIN$ plays other roles in regulating GABA synthesis, reducing oxidative stress in neurons, and is important in supporting neuron viability.	1	18624794-206
In addition to transporting glutamate, @PROTEIN$ plays other roles in regulating @COMPOUND$ synthesis, reducing oxidative stress in neurons, and is important in supporting neuron viability.	1	18624794-206
Whereas both peptides @COMPOUND$ (17-30) and lactoferrampin (265-284) did not have bactericidal activity, 40 microM of @PROTEIN$ chimera (a fusion of the two peptides) inhibited the growth of all Vibrio tested to the same extent as the antibiotic gentamicin.	0	18625283-633
Whereas both peptides lactoferricin (17-30) and lactoferrampin (265-284) did not have bactericidal activity, 40 microM of @PROTEIN$ chimera (a fusion of the two peptides) inhibited the growth of all Vibrio tested to the same extent as the antibiotic @COMPOUND$.	0	18625283-633
We have recently shown that the antidepressant @COMPOUND$ enhances T cell proliferation and T(H)1 cytokine production in vivo, without changes on @PROTEIN$/CD8 subsets.	0	18625298-638
We found that @COMPOUND$ restored T cell proliferation and interleukin-2, @PROTEIN$ and tumor necrosis factor-alpha production by compensatory mechanisms.	1	18625298-639
We found that @COMPOUND$ restored T cell proliferation and interleukin-2, interferon-gamma and @PROTEIN$-alpha production by compensatory mechanisms.	1	18625298-639
Here we report a case of intragenic @PROTEIN$ microdeletion in renal cell carcinoma (RCC) associated with the effect of treatment by @COMPOUND$.	1	18625569-874
Taking advantage of this prostate cancer-specific property of PSMA (E/P), we successfully introduced bacterial @PROTEIN$ into LNCaP cells where the tumoricidal effect of 5-fluorouracil (@COMPOUND$) was significantly increased when compared with the cells without the exogenous UPRT.	1	18626508-1659
Taking advantage of this prostate cancer-specific property of PSMA (E/P), we successfully introduced bacterial @PROTEIN$ into LNCaP cells where the tumoricidal effect of @COMPOUND$ (5-FU) was significantly increased when compared with the cells without the exogenous UPRT.	1	18626508-1659
@PROTEIN$ is expressed in pancreatic beta cells where its postulated uncoupling activity will modulate @COMPOUND$-induced changes in ATP/ADP ratio and insulin secretion.	1	18626658-281
UCP2 is expressed in pancreatic beta cells where its postulated uncoupling activity will modulate @COMPOUND$-induced changes in ATP/ADP ratio and @PROTEIN$ secretion.	1	18626658-281
@PROTEIN$ is expressed in pancreatic beta cells where its postulated uncoupling activity will modulate glucose-induced changes in @COMPOUND$/ADP ratio and insulin secretion.	1	18626658-281
UCP2 is expressed in pancreatic beta cells where its postulated uncoupling activity will modulate glucose-induced changes in @COMPOUND$/ADP ratio and @PROTEIN$ secretion.	0	18626658-281
Neither @PROTEIN$ expression nor UCP2 overexpression modified basal or @COMPOUND$-stimulated metabolic changes.	0	18626658-283
Neither UCP1 expression nor @PROTEIN$ overexpression modified basal or @COMPOUND$-stimulated metabolic changes.	0	18626658-283
The @PROTEIN$ activity was increased by Mn(2+), @COMPOUND$+), and Mg(2+), while strongly inhibited by Fe(2+) and Ba(2+).	1	18626709-112
The @PROTEIN$ activity was increased by @COMPOUND$+), Cu(2+), and Mg(2+), while strongly inhibited by Fe(2+) and Ba(2+).	1	18626709-112
The @PROTEIN$ activity was increased by Mn(2+), Cu(2+), and Mg(2+), while strongly inhibited by Fe(2+) and @COMPOUND$+).	1	18626709-112
The @PROTEIN$ activity was increased by Mn(2+), Cu(2+), and Mg(2+), while strongly inhibited by @COMPOUND$+) and Ba(2+).	1	18626709-112
Meanwhile, SDS, ethyleneglycoltetraacetic acid, urea, and @COMPOUND$ were found to have significantly inhibitory effect on @PROTEIN$ activity.	1	18626709-113
Meanwhile, SDS, ethyleneglycoltetraacetic acid, @COMPOUND$, and ethylenediaminetetraacetic acid were found to have significantly inhibitory effect on @PROTEIN$ activity.	1	18626709-113
In the present study, we screened the inhibitory effect of the extract from 50 Thai medicinal plants on an inducible-nitric oxide synthase (@PROTEIN$) expression induced by @COMPOUND$ (LPS) in mouse macrophages RAW 264.7.	1	18626726-122
In the present study, we screened the inhibitory effect of the extract from 50 Thai medicinal plants on an inducible-@PROTEIN$ (iNOS) expression induced by @COMPOUND$ (LPS) in mouse macrophages RAW 264.7.	1	18626726-122
Following thermal denaturation, rabbit reticulocyte lysate and @COMPOUND$ were added and @PROTEIN$ activity measured.	0	18626791-1140
These results are in contrast to postmortem findings in schizophrenia and suggest that reduced @PROTEIN$ protein levels in schizophrenia patients' postmortem brain do not result from perinatal @COMPOUND$ deprivation.	0	18626794-227
We found that the acetylated @PROTEIN$ at @COMPOUND$ 9 and lysine 14 (H3K9/K14ac) is reduced in both the myelin basic protein (MBP) and proteolipid protein (PLP) genes of maturing oligodendroglial OL-1 cells, and furthermore, this temporally correlates with increases in MBP, PLP, and histone deacetylase (HDAC) 11 expression.	1	18627006-344
We found that the acetylated histone H3 at @COMPOUND$ 9 and lysine 14 (H3K9/K14ac) is reduced in both the myelin basic protein (@PROTEIN$) and proteolipid protein (PLP) genes of maturing oligodendroglial OL-1 cells, and furthermore, this temporally correlates with increases in MBP, PLP, and histone deacetylase (HDAC) 11 expression.	1	18627006-344
We found that the acetylated histone H3 at @COMPOUND$ 9 and lysine 14 (H3K9/K14ac) is reduced in both the myelin basic protein (MBP) and proteolipid protein (PLP) genes of maturing oligodendroglial OL-1 cells, and furthermore, this temporally correlates with increases in MBP, PLP, and @PROTEIN$ (HDAC) 11 expression.	0	18627006-344
We found that the acetylated histone H3 at @COMPOUND$ 9 and lysine 14 (H3K9/K14ac) is reduced in both the @PROTEIN$ (MBP) and proteolipid protein (PLP) genes of maturing oligodendroglial OL-1 cells, and furthermore, this temporally correlates with increases in MBP, PLP, and histone deacetylase (HDAC) 11 expression.	1	18627006-344
We found that the acetylated histone H3 at @COMPOUND$ 9 and lysine 14 (H3K9/K14ac) is reduced in both the myelin basic protein (MBP) and proteolipid protein (@PROTEIN$) genes of maturing oligodendroglial OL-1 cells, and furthermore, this temporally correlates with increases in MBP, PLP, and histone deacetylase (HDAC) 11 expression.	1	18627006-344
Although the current studies associating particular genes and their variants with seizure control or adverse events have inherent weaknesses and have not provided unifying conclusions, several results, for example that Asian patients with a particular HLA allele, @PROTEIN$ *1502, are at a higher risk for Stevens-Johnson syndrome when using @COMPOUND$, are helpful to increase our knowledge how genetic variation affects the treatment of epilepsy.	1	18627414-696
However, OPN-(/-) mice showed increased serum levels of tumour necrosis factor (@PROTEIN$)-alpha, which could be due to systemically present @COMPOUND$ translocated to the gut.	1	18627421-707
However, @PROTEIN$-(/-) mice showed increased serum levels of tumour necrosis factor (TNF)-alpha, which could be due to systemically present @COMPOUND$ translocated to the gut.	1	18627421-707
The expression of the ERG1, ERG3, ERG7, @PROTEIN$, ERG11 and ERG25 genes in response to incubation with @COMPOUND$ and biofilm formation was investigated using reverse-transcription PCR and real-time PCR in Candida albicans and Candida dubliniensis clinical isolates.	1	18627475-762
The expression of the ERG1, ERG3, ERG7, ERG9, @PROTEIN$ and ERG25 genes in response to incubation with @COMPOUND$ and biofilm formation was investigated using reverse-transcription PCR and real-time PCR in Candida albicans and Candida dubliniensis clinical isolates.	1	18627475-762
The expression of the ERG1, ERG3, ERG7, ERG9, ERG11 and @PROTEIN$ genes in response to incubation with @COMPOUND$ and biofilm formation was investigated using reverse-transcription PCR and real-time PCR in Candida albicans and Candida dubliniensis clinical isolates.	1	18627475-762
The expression of the ERG1, @PROTEIN$, ERG7, ERG9, ERG11 and ERG25 genes in response to incubation with @COMPOUND$ and biofilm formation was investigated using reverse-transcription PCR and real-time PCR in Candida albicans and Candida dubliniensis clinical isolates.	1	18627475-762
The expression of the @PROTEIN$, ERG3, ERG7, ERG9, ERG11 and ERG25 genes in response to incubation with @COMPOUND$ and biofilm formation was investigated using reverse-transcription PCR and real-time PCR in Candida albicans and Candida dubliniensis clinical isolates.	1	18627475-762
The expression of the ERG1, ERG3, @PROTEIN$, ERG9, ERG11 and ERG25 genes in response to incubation with @COMPOUND$ and biofilm formation was investigated using reverse-transcription PCR and real-time PCR in Candida albicans and Candida dubliniensis clinical isolates.	1	18627475-762
Expression of the @PROTEIN$ gene was found to be low or moderate and it was regulated by @COMPOUND$ addition more so than by biofilm formation.	1	18627475-763
The expression of the @PROTEIN$ increased in the presence of @COMPOUND$ in some isolates.	1	18627475-764
Concentrations of @COMPOUND$ 1000 and Na2SO4 were selected as independent variables to evaluate their impact on parameters of partitioning in aqueous two-phase system--the partition coefficient of @PROTEIN$, purification factor and pectinase yield.	0	18629545-780
Concentrations of polyethylene glycol 1000 and @COMPOUND$ were selected as independent variables to evaluate their impact on parameters of partitioning in aqueous two-phase system--the partition coefficient of @PROTEIN$, purification factor and pectinase yield.	0	18629545-780
In aged animals, administration of @COMPOUND$ for 21 days significantly decreased the levels of lipid peroxides and improved the activities of antioxidant enzymes like superoxide dismutase, @PROTEIN$, glutathione peroxidase and glutathione reductase.	1	18629605-1551
In aged animals, administration of @COMPOUND$ for 21 days significantly decreased the levels of lipid peroxides and improved the activities of antioxidant enzymes like superoxide dismutase, catalase, glutathione peroxidase and @PROTEIN$.	1	18629605-1551
In aged animals, administration of @COMPOUND$ for 21 days significantly decreased the levels of lipid peroxides and improved the activities of antioxidant enzymes like superoxide dismutase, catalase, @PROTEIN$ and glutathione reductase.	1	18629605-1551
In aged animals, administration of @COMPOUND$ for 21 days significantly decreased the levels of lipid peroxides and improved the activities of antioxidant enzymes like @PROTEIN$, catalase, glutathione peroxidase and glutathione reductase.	1	18629605-1551
L-Carnitine enhanced T-cell proliferative responses as evaluated by T-cell proliferation assay using (3H) @COMPOUND$ incorporation and also significantly reduced DNA damage, apoptosis and @PROTEIN$ level in lymphocytes of aged animals.	0	18629605-1552
@COMPOUND$ enhanced T-cell proliferative responses as evaluated by T-cell proliferation assay using (3H) thymidine incorporation and also significantly reduced DNA damage, apoptosis and @PROTEIN$ level in lymphocytes of aged animals.	1	18629605-1552
In our microarray analysis we observed that Seven-in-Absentia Homolog 2 (SIAH2) levels were low in @PROTEIN$ (ER) positive breast tumors of patients resistant to first-line @COMPOUND$ therapy.	1	18629630-845
In our microarray analysis we observed that @PROTEIN$ (SIAH2) levels were low in estrogen receptor (ER) positive breast tumors of patients resistant to first-line @COMPOUND$ therapy.	1	18629630-845
In our microarray analysis we observed that Seven-in-Absentia Homolog 2 (@PROTEIN$) levels were low in estrogen receptor (ER) positive breast tumors of patients resistant to first-line @COMPOUND$ therapy.	1	18629630-845
@COMPOUND$, an inhibitor of glial metabolism, inhibits the up-regulation of @PROTEIN$ expression, activity and NO production in the spinal cord induced by formalin test in rats.	1	18629637-851
In order to explore the involvement of glia in the NO-mediated nociceptive transmission, the present study was undertaken to investigate the effect of @COMPOUND$ (FC), an inhibitor of glial metabolism, on @PROTEIN$ expression and activity and NO production in the spinal cord during the process of peripheral inflammatory pain and hyperalgesia induced by formalin test in rats.	0	18629637-852
Oral administration of @COMPOUND$ remarkably prevented weight loss in the body and liver from DMN and inhibited the elevation of serum alanine transaminase (ALT), aspartate transaminase (@PROTEIN$), and total bilirubin levels.	1	18629640-41
Oral administration of morin remarkably prevented weight loss in the body and liver from DMN and inhibited the elevation of serum alanine transaminase (ALT), aspartate transaminase (@PROTEIN$), and total @COMPOUND$ levels.	0	18629640-41
@COMPOUND$ reduces induction of @PROTEIN$ and apoptosis in UVB-irradiated human skin independent of transcriptional controls.	1	18631247-468
We found that while OM24 treatment did not significantly affect UV-induced erythema and @COMPOUND$ dimer formation, OM24 treatment significantly reduced UV-induced @PROTEIN$ expression in keratinocytes.	0	18631247-469
Here we show that @PROTEIN$ selectively increases the power of @COMPOUND$-induced, but not carbachol-induced, gamma oscillations in acute hippocampal slices.	1	18632742-27
Here we show that @PROTEIN$ selectively increases the power of kainate-induced, but not @COMPOUND$-induced, gamma oscillations in acute hippocampal slices.	0	18632742-27
These effects of @PROTEIN$beta are blocked by @COMPOUND$, a pan-specific antagonist of ErbB receptors, and are mediated specifically via ErbB4 receptors, because mice harboring a targeted mutation of ErbB4 do not respond to NRG-1.	1	18632742-28
Of various agents tested in HaCaT cell cultures, only @COMPOUND$ (10(-6) M) and staurosporine (2.5 x 10(-8) M) upregulated @PROTEIN$ mRNA and protein expression, whereas tumor promoters, hormones, or dexamethasone were without effect.	1	18633436-86
Of various agents tested in HaCaT cell cultures, only retinoic acid (10(-6) M) and @COMPOUND$ (2.5 x 10(-8) M) upregulated @PROTEIN$ mRNA and protein expression, whereas tumor promoters, hormones, or dexamethasone were without effect.	1	18633436-86
Of various agents tested in HaCaT cell cultures, only retinoic acid (10(-6) M) and staurosporine (2.5 x 10(-8) M) upregulated @PROTEIN$ mRNA and protein expression, whereas tumor promoters, hormones, or @COMPOUND$ were without effect.	0	18633436-86
We have generated two novel chimeric @PROTEIN$-binding molecules, sFLT01 and sFLT02, which consist of the second immunoglobulin (IgG)-like domain of Flt-1 fused either to a human IgG1 Fc or solely to the CH3 domain of IgG1 Fc through a @COMPOUND$ linker 9Gly.	0	18633446-279
We have generated two novel chimeric VEGF-binding molecules, sFLT01 and sFLT02, which consist of the second immunoglobulin (IgG)-like domain of @PROTEIN$ fused either to a human IgG1 Fc or solely to the CH3 domain of IgG1 Fc through a @COMPOUND$ linker 9Gly.	1	18633446-279
By contrast, treatment of N2a cells with 1-10 microM @COMPOUND$ resulted in marked reductions in the expression of the axon growth-associated protein @PROTEIN$-43.	1	18633600-1063
@COMPOUND$-treated cells also showed an increased expression of the heat shock protein @PROTEIN$ compared to controls.	1	18633600-1064
We showed that in comparison to stage VI, stages I-V oocytes expressed higher levels of O-GlcNAc correlating changes in @PROTEIN$ expression, but not in @COMPOUND$ pools.	0	18633701-1577
We showed that in comparison to stage VI, stages I-V oocytes expressed higher levels of @PROTEIN$ correlating changes in OGT expression, but not in @COMPOUND$ pools.	0	18633701-1577
Upon @COMPOUND$ stimulation, an O-GlcNAc level burst occurred during meiotic resumption long before @PROTEIN$ and Mos-Erk2 pathways activations.	1	18633701-1578
Upon @COMPOUND$ stimulation, an O-GlcNAc level burst occurred during meiotic resumption long before MPF and @PROTEIN$-Erk2 pathways activations.	1	18633701-1578
Upon @COMPOUND$ stimulation, an O-GlcNAc level burst occurred during meiotic resumption long before MPF and Mos-@PROTEIN$ pathways activations.	1	18633701-1578
Upon @COMPOUND$ stimulation, an @PROTEIN$ level burst occurred during meiotic resumption long before MPF and Mos-Erk2 pathways activations.	1	18633701-1578
Mean plasma levels of folic acid, @COMPOUND$, and vitamin B12 did not change, but there was a significant decrease of @PROTEIN$ at T1, 0.36 mg dl(-1) on average (P = 0.01), which was maintained at T2.	0	18633707-828
Mean plasma levels of @COMPOUND$, homocysteine, and vitamin B12 did not change, but there was a significant decrease of @PROTEIN$ at T1, 0.36 mg dl(-1) on average (P = 0.01), which was maintained at T2.	0	18633707-828
Chondrocytes grown in monolayer were treated with interleukin-1alpha (@PROTEIN$), insulin-like growth factor-I (IGF-I), C3 Transferase, @COMPOUND$, or transfected with Rho wild type or two constitutively active mutants of Rho (Q63L and G14V).	0	18634065-1113
Chondrocytes grown in monolayer were treated with interleukin-1alpha (IL-1alpha), @PROTEIN$-like growth factor-I (IGF-I), C3 Transferase, @COMPOUND$, or transfected with Rho wild type or two constitutively active mutants of Rho (Q63L and G14V).	0	18634065-1113
Chondrocytes grown in monolayer were treated with interleukin-1alpha (IL-1alpha), insulin-like growth factor-I (@PROTEIN$), C3 Transferase, @COMPOUND$, or transfected with Rho wild type or two constitutively active mutants of Rho (Q63L and G14V).	0	18634065-1113
Affinity assays were performed to measure endogenous @COMPOUND$-bound @PROTEIN$, and confocal microscopy was used to assess changes in organization of the actin cytoskeleton.	1	18634065-1115
Affinity assays were performed to measure endogenous @COMPOUND$-bound Rho, and confocal microscopy was used to assess changes in organization of the @PROTEIN$ cytoskeleton.	0	18634065-1115
IL-1alpha and RhoG14V increased cytoplasmic @PROTEIN$ stress fiber formation, which was blocked by C3 Transferase, and @COMPOUND$.	1	18634065-1116
@PROTEIN$ and RhoG14V increased cytoplasmic actin stress fiber formation, which was blocked by C3 Transferase, and @COMPOUND$.	1	18634065-1116
Expression of RhoQ63L or RhoG14V resulted in increased MMP-13 expression; however, inhibition of Rho with @COMPOUND$ was unable to inhibit @PROTEIN$-induced MMP-13 expression.	0	18634065-1118
Expression of @PROTEIN$Q63L or RhoG14V resulted in increased MMP-13 expression; however, inhibition of Rho with @COMPOUND$ was unable to inhibit IL-1alpha-induced MMP-13 expression.	1	18634065-1118
Expression of RhoQ63L or RhoG14V resulted in increased @PROTEIN$ expression; however, inhibition of Rho with @COMPOUND$ was unable to inhibit IL-1alpha-induced MMP-13 expression.	0	18634065-1118
Plasma total @COMPOUND$, TAG, HDL, HDL2, HDL3, LDL, C-reactive protein, @PROTEIN$, IL-18, intercellular adhesion molecule-1, oxidised LDL, oxygen radical absorbance capacity using perchloric acid (ORACPCA), whole-blood fatty acids, bleeding time and blood pressure were measured at the beginning and end of each dietary period.	0	18634706-392
Plasma total @COMPOUND$, TAG, HDL, HDL2, HDL3, LDL, C-reactive protein, IL-6, @PROTEIN$, intercellular adhesion molecule-1, oxidised LDL, oxygen radical absorbance capacity using perchloric acid (ORACPCA), whole-blood fatty acids, bleeding time and blood pressure were measured at the beginning and end of each dietary period.	0	18634706-392
Plasma total cholesterol, @PROTEIN$, HDL, HDL2, HDL3, LDL, C-reactive protein, IL-6, IL-18, intercellular adhesion molecule-1, oxidised LDL, oxygen radical absorbance capacity using @COMPOUND$ (ORACPCA), whole-blood fatty acids, bleeding time and blood pressure were measured at the beginning and end of each dietary period.	0	18634706-392
Plasma total cholesterol, TAG, HDL, HDL2, HDL3, LDL, C-reactive protein, IL-6, @PROTEIN$, intercellular adhesion molecule-1, oxidised LDL, @COMPOUND$ radical absorbance capacity using perchloric acid (ORACPCA), whole-blood fatty acids, bleeding time and blood pressure were measured at the beginning and end of each dietary period.	0	18634706-392
Plasma total cholesterol, TAG, HDL, HDL2, HDL3, LDL, C-reactive protein, IL-6, @PROTEIN$, intercellular adhesion molecule-1, oxidised LDL, oxygen radical absorbance capacity using @COMPOUND$ (ORACPCA), whole-blood fatty acids, bleeding time and blood pressure were measured at the beginning and end of each dietary period.	0	18634706-392
Plasma total @COMPOUND$, @PROTEIN$, HDL, HDL2, HDL3, LDL, C-reactive protein, IL-6, IL-18, intercellular adhesion molecule-1, oxidised LDL, oxygen radical absorbance capacity using perchloric acid (ORACPCA), whole-blood fatty acids, bleeding time and blood pressure were measured at the beginning and end of each dietary period.	0	18634706-392
Plasma total cholesterol, TAG, HDL, HDL2, HDL3, LDL, C-reactive protein, @PROTEIN$, IL-18, intercellular adhesion molecule-1, oxidised LDL, oxygen radical absorbance capacity using @COMPOUND$ (ORACPCA), whole-blood fatty acids, bleeding time and blood pressure were measured at the beginning and end of each dietary period.	0	18634706-392
Plasma total cholesterol, TAG, HDL, HDL2, HDL3, LDL, C-reactive protein, @PROTEIN$, IL-18, intercellular adhesion molecule-1, oxidised LDL, @COMPOUND$ radical absorbance capacity using perchloric acid (ORACPCA), whole-blood fatty acids, bleeding time and blood pressure were measured at the beginning and end of each dietary period.	0	18634706-392
Plasma total cholesterol, @PROTEIN$, HDL, HDL2, HDL3, LDL, C-reactive protein, IL-6, IL-18, intercellular adhesion molecule-1, oxidised LDL, @COMPOUND$ radical absorbance capacity using perchloric acid (ORACPCA), whole-blood fatty acids, bleeding time and blood pressure were measured at the beginning and end of each dietary period.	0	18634706-392
The increase of mature @PROTEIN$ by macrophages was inhibited by @COMPOUND$ : caspase-1 is known to cleave the proform of IL-18 to produce active mature IL-18.	1	18634843-1147
In absence of stretch, we could activate @PROTEIN$ and deactivate GK1 by 1-oleoyl-2-acetyl-sn-glycerol (@COMPOUND$) and other amphipaths.	1	18635261-398
In absence of stretch, we could activate @PROTEIN$ and deactivate GK1 by @COMPOUND$ (OAG) and other amphipaths.	1	18635261-398
In absence of stretch, we could activate Gns and deactivate @PROTEIN$ by @COMPOUND$ (OAG) and other amphipaths.	1	18635261-398
In absence of stretch, we could activate Gns and deactivate @PROTEIN$ by 1-oleoyl-2-acetyl-sn-glycerol (@COMPOUND$) and other amphipaths.	1	18635261-398
Using enzyme-linked immunosorbent assays, we showed @COMPOUND$ to inhibit LPS-induced secretion of @PROTEIN$ and TNF-alpha.	1	18635336-453
Using enzyme-linked immunosorbent assays, we showed @COMPOUND$ to inhibit LPS-induced secretion of IL-6 and @PROTEIN$.	1	18635336-453
The inhibition of DMBA-carcinogenesis by GLN application was associated with increased arterial GLN and @COMPOUND$, elevated buccal mucosa GSH as well as induction of @PROTEIN$ and PARP, and inhibition of bcl-2.	0	18635390-1443
The inhibition of DMBA-carcinogenesis by GLN application was associated with increased arterial GLN and @COMPOUND$, elevated buccal mucosa GSH as well as induction of bax and PARP, and inhibition of @PROTEIN$.	0	18635390-1443
The inhibition of DMBA-carcinogenesis by GLN application was associated with increased arterial GLN and @COMPOUND$, elevated buccal mucosa GSH as well as induction of bax and @PROTEIN$, and inhibition of bcl-2.	0	18635390-1443
Dopamine release and direct stimulation of dopamine D2 and serotonin @PROTEIN$ receptors also contributes to the overall action of @COMPOUND$.	1	18635693-781
Our findings suggest that @COMPOUND$ differentially affects higher cognitive functions, but does not support the hypothesis from animal studies, that some of the MDMA effects are causally mediated through action at the @PROTEIN$ receptor system.	0	18635693-783
These results suggest that @PROTEIN$ does not play a significant role in clinical and functional manifestations in patients with schizophrenia who receive @COMPOUND$ treatment.	0	18635704-791
@COMPOUND$ is a chemical carcinogen found in tobacco smoke that causes activating mutations in @PROTEIN$ and induces lung tumors in mice.	1	18635814-879
In the present study, we measured plasma @PROTEIN$ levels by enzyme-linked immunosorbent assay in seven healthy volunteers after repeated experimental endotoxemia induced by 2 ng kg Escherichia coli @COMPOUND$ per day (to investigate inflammation-induced hepatic injury) and in 21 patients within 12 h after the occurrence of severe sepsis/septic shock (to investigate its ability to predict an increase of transaminases on day 7).	0	18636040-1068
Furthermore, @PROTEIN$ levels did not correlate with IL-6 levels but did with @COMPOUND$ infusion rate (Spearman r = 0.94; P = 0.02), suggesting that the extent of hemodynamic instability and not the degree of inflammation could be of importance for the occurrence of liver damage.	1	18636040-1069
Furthermore, GSTA1-1 levels did not correlate with @PROTEIN$ levels but did with @COMPOUND$ infusion rate (Spearman r = 0.94; P = 0.02), suggesting that the extent of hemodynamic instability and not the degree of inflammation could be of importance for the occurrence of liver damage.	0	18636040-1069
Heparin (H), @COMPOUND$ (A), anti@PROTEIN$ III (ATIII), and recombinant human activated protein C (rhAPC) with and without thrombin were added to cells suspended in septic plasma and normal plasma.	0	18636042-1310
Heparin (H), @COMPOUND$ (A), antithrombin III (ATIII), and recombinant human activated @PROTEIN$ (rhAPC) with and without thrombin were added to cells suspended in septic plasma and normal plasma.	0	18636042-1310
Heparin (H), @COMPOUND$ (A), antithrombin III (@PROTEIN$), and recombinant human activated protein C (rhAPC) with and without thrombin were added to cells suspended in septic plasma and normal plasma.	0	18636042-1310
Heparin (H), @COMPOUND$ (A), @PROTEIN$ (ATIII), and recombinant human activated protein C (rhAPC) with and without thrombin were added to cells suspended in septic plasma and normal plasma.	0	18636042-1310
@COMPOUND$ (H2S) is a novel gaseous mediator produced by @PROTEIN$ and cystathionine-gamma-lyase in the cardiovascular system, including the heart.	1	18636044-1070
Hydrogen sulfide (@COMPOUND$) is a novel gaseous mediator produced by @PROTEIN$ and cystathionine-gamma-lyase in the cardiovascular system, including the heart.	1	18636044-1070
@COMPOUND$ (H2S) is a novel gaseous mediator produced by cystathionine-beta-synthase and @PROTEIN$ in the cardiovascular system, including the heart.	1	18636044-1070
Hydrogen sulfide (@COMPOUND$) is a novel gaseous mediator produced by cystathionine-beta-synthase and @PROTEIN$ in the cardiovascular system, including the heart.	1	18636044-1070
Chemotaxis, @PROTEIN$ release and @COMPOUND$ anion production have been measured.	0	18636221-1488
According to @PROTEIN$-binding, arsenic trioxide (7 microM) within 48 h significantly increased @COMPOUND$ exposure of human erythrocytes without inducing hemolysis.	0	18636241-1243
Removal of extracellular Ca2+ or inhibition of the Ca2+-permeable cation channels with @COMPOUND$ blunted the effects of arsenic on @PROTEIN$-binding and cell shrinkage.	1	18636241-1244
In the present study, we investigated the inhibitory effect of the known oxycoumarins poncitrin (3), @COMPOUND$ (4), and xanthoxyletin (5), newly isolated from Clausena guillauminii (Rutaceae), together with the known carbazoles heptaphylline (1) and 7-methoxyheptaphylline (2) on inducible-nitric oxide synthase (@PROTEIN$) expression induced by lipopolysaccharide (LPS) and the NO generation in RAW 264.7 mouse macrophages.	0	18636311-1287
In the present study, we investigated the inhibitory effect of the known oxycoumarins poncitrin (3), osthol (4), and @COMPOUND$ (5), newly isolated from Clausena guillauminii (Rutaceae), together with the known carbazoles heptaphylline (1) and 7-methoxyheptaphylline (2) on inducible-nitric oxide synthase (@PROTEIN$) expression induced by lipopolysaccharide (LPS) and the NO generation in RAW 264.7 mouse macrophages.	0	18636311-1287
In the present study, we investigated the inhibitory effect of the known oxycoumarins poncitrin (3), osthol (4), and xanthoxyletin (5), newly isolated from Clausena guillauminii (Rutaceae), together with the known carbazoles @COMPOUND$ (1) and 7-methoxyheptaphylline (2) on inducible-nitric oxide synthase (@PROTEIN$) expression induced by lipopolysaccharide (LPS) and the NO generation in RAW 264.7 mouse macrophages.	0	18636311-1287
In the present study, we investigated the inhibitory effect of the known oxycoumarins poncitrin (3), @COMPOUND$ (4), and xanthoxyletin (5), newly isolated from Clausena guillauminii (Rutaceae), together with the known carbazoles heptaphylline (1) and 7-methoxyheptaphylline (2) on inducible-@PROTEIN$ (iNOS) expression induced by lipopolysaccharide (LPS) and the NO generation in RAW 264.7 mouse macrophages.	0	18636311-1287
In the present study, we investigated the inhibitory effect of the known oxycoumarins poncitrin (3), osthol (4), and xanthoxyletin (5), newly isolated from Clausena guillauminii (Rutaceae), together with the known carbazoles heptaphylline (1) and 7-methoxyheptaphylline (2) on inducible-@PROTEIN$ (iNOS) expression induced by @COMPOUND$ (LPS) and the NO generation in RAW 264.7 mouse macrophages.	0	18636311-1287
In the present study, we investigated the inhibitory effect of the known oxycoumarins poncitrin (3), osthol (4), and xanthoxyletin (5), newly isolated from Clausena guillauminii (Rutaceae), together with the known carbazoles heptaphylline (1) and 7-methoxyheptaphylline (2) on inducible-nitric oxide synthase (@PROTEIN$) expression induced by @COMPOUND$ (LPS) and the NO generation in RAW 264.7 mouse macrophages.	0	18636311-1287
In the present study, we investigated the inhibitory effect of the known oxycoumarins poncitrin (3), osthol (4), and xanthoxyletin (5), newly isolated from Clausena guillauminii (Rutaceae), together with the known carbazoles @COMPOUND$ (1) and 7-methoxyheptaphylline (2) on inducible-@PROTEIN$ (iNOS) expression induced by lipopolysaccharide (LPS) and the NO generation in RAW 264.7 mouse macrophages.	0	18636311-1287
In the present study, we investigated the inhibitory effect of the known oxycoumarins poncitrin (3), osthol (4), and @COMPOUND$ (5), newly isolated from Clausena guillauminii (Rutaceae), together with the known carbazoles heptaphylline (1) and 7-methoxyheptaphylline (2) on inducible-@PROTEIN$ (iNOS) expression induced by lipopolysaccharide (LPS) and the NO generation in RAW 264.7 mouse macrophages.	0	18636311-1287
Cell viability and reactive oxygen species concentration were determined, and the effects of pre-treatment with LA on these parameters were investigated together with the @PROTEIN$ and GPx activity as well as the concentration of @COMPOUND$.	0	18636399-1328
Cell viability and reactive @COMPOUND$ species concentration were determined, and the effects of pre-treatment with LA on these parameters were investigated together with the @PROTEIN$ and GPx activity as well as the concentration of reduced glutathione.	0	18636399-1328
Fibril growth was a second-order process with an enthalpy of activation (27+/-5 kcal mol(-1)), which is indistinguishable from that of tetramer formation by @PROTEIN$, which involves limited conformational changes including @COMPOUND$ trans to cis isomerization.	1	18636508-1410
Mutations in @PROTEIN$ are associated with severe psychomotor retardation, high serum T3 and low @COMPOUND$ (rT3) levels.	1	18636565-515
Mutations in @PROTEIN$ are associated with severe psychomotor retardation, high serum T3 and low 3,3',5'-triiodothyronine (@COMPOUND$) levels.	1	18636565-515
Results showed that MENT treatments increased @PROTEIN$ secretion and proliferation rate with a potency ranged between T and @COMPOUND$.	1	18637152-268
Results showed that @COMPOUND$ treatments increased @PROTEIN$ secretion and proliferation rate with a potency ranged between T and DHT.	1	18637152-268
The studies with @COMPOUND$ showed that in BPH and CaP cells, the conversion of T into DHT significantly contributes to its effect on the proliferation and @PROTEIN$ secretion, and corroborated the resistance of MENT to the 5-AR.	0	18637152-269
The studies with finasteride showed that in BPH and CaP cells, the conversion of T into DHT significantly contributes to its effect on the proliferation and @PROTEIN$ secretion, and corroborated the resistance of @COMPOUND$ to the 5-AR.	0	18637152-269
The studies with finasteride showed that in BPH and CaP cells, the conversion of T into @COMPOUND$ significantly contributes to its effect on the proliferation and @PROTEIN$ secretion, and corroborated the resistance of MENT to the 5-AR.	1	18637152-269
Pregnant Sprague-Dawley female rats were treated once with @COMPOUND$ (0, 0.3 or 1 microg/kg) by gavage on embryonic day (ED) 11 and the expression levels of androgen (AR) and @PROTEIN$ (ER), steroidogenic enzymes (P450scc and 3beta-HSD) and four regulatory factors (StAR, SF-1, GATA-4 and Insl-3) involved in foetal Leydig cell and adrenal function were analysed on ED 19.5.	0	18637154-273
Pregnant Sprague-Dawley female rats were treated once with @COMPOUND$ (0, 0.3 or 1 microg/kg) by gavage on embryonic day (ED) 11 and the expression levels of androgen (AR) and estrogen receptors (ER), steroidogenic enzymes (P450scc and 3beta-HSD) and four regulatory factors (StAR, @PROTEIN$, GATA-4 and Insl-3) involved in foetal Leydig cell and adrenal function were analysed on ED 19.5.	0	18637154-273
Pregnant Sprague-Dawley female rats were treated once with @COMPOUND$ (0, 0.3 or 1 microg/kg) by gavage on embryonic day (ED) 11 and the expression levels of androgen (AR) and estrogen receptors (ER), steroidogenic enzymes (P450scc and @PROTEIN$) and four regulatory factors (StAR, SF-1, GATA-4 and Insl-3) involved in foetal Leydig cell and adrenal function were analysed on ED 19.5.	0	18637154-273
Pregnant Sprague-Dawley female rats were treated once with @COMPOUND$ (0, 0.3 or 1 microg/kg) by gavage on embryonic day (ED) 11 and the expression levels of androgen (AR) and estrogen receptors (ER), steroidogenic enzymes (P450scc and 3beta-HSD) and four regulatory factors (StAR, SF-1, @PROTEIN$-4 and Insl-3) involved in foetal Leydig cell and adrenal function were analysed on ED 19.5.	0	18637154-273
Pregnant Sprague-Dawley female rats were treated once with @COMPOUND$ (0, 0.3 or 1 microg/kg) by gavage on embryonic day (ED) 11 and the expression levels of androgen (AR) and estrogen receptors (ER), steroidogenic enzymes (P450scc and 3beta-HSD) and four regulatory factors (@PROTEIN$, SF-1, GATA-4 and Insl-3) involved in foetal Leydig cell and adrenal function were analysed on ED 19.5.	0	18637154-273
In utero exposure to @COMPOUND$ reduced intratesticular T of foetal males (significant at 0.3 microg/kg TCDD) and tended to reduce the protein expression of @PROTEIN$ and AR of foetal male rat testis.	1	18637154-274
mRNA expression of developmental regulatory factors was not influenced by foetal @COMPOUND$ exposure, except for significantly reduced adrenal @PROTEIN$.	1	18637154-275
@COMPOUND$-containing bisphosphonates were found to inhibit @PROTEIN$-an essential enzyme in the cholesterol biosynthesis pathway, but their effect on cholesterol synthesis per se in the central nervous system (CNS) remains unknown.	0	18637708-746
Nitrogen-containing bisphosphonates were found to inhibit @PROTEIN$-an essential enzyme in the @COMPOUND$ biosynthesis pathway, but their effect on cholesterol synthesis per se in the central nervous system (CNS) remains unknown.	1	18637708-746
hsBAFF-upregulated intracellular free @COMPOUND$+) homeostasis regulates @PROTEIN$/2 activity and cell proliferation in B cells in vitro.	1	18637712-756
Using immunocytochemistry and Western blot analysis, we found that the activation of @PROTEIN$/2 due to hsBAFF was triggered by a (@COMPOUND$+))(i)-dependent pathway, leading to elevation of B cell proliferation.	1	18637712-757
This is supported by the findings that intracellular Ca(2+) chelator @COMPOUND$ attenuated phosphorylated @PROTEIN$/2 expression and cell proliferation in hsBAFF-stimulated B cells.	1	18637712-758
Taken together, the main finding of this study is that hsBAFF elicits higher but homeostatic (@COMPOUND$+))(i) levels, which regulates @PROTEIN$/2 activity and cell proliferation in in vitro B cells.	1	18637712-759
Surgical removal of pheochromocytoma significantly increased body weight, decreased both systolic and diastolic blood pressure, fasting blood @COMPOUND$ and glycated @PROTEIN$ levels.	0	18637714-1311
In this study we have investigated a long-term pattern of expression and production of spinal COX-1 and @PROTEIN$ in the model of osteoarthritis induced in rats by injection of @COMPOUND$ (MIA) into the knee joint.	0	18637715-1322
In this study we have investigated a long-term pattern of expression and production of spinal @PROTEIN$ and COX-2 in the model of osteoarthritis induced in rats by injection of @COMPOUND$ (MIA) into the knee joint.	0	18637715-1322
The enzyme @PROTEIN$ (IDO) converts @COMPOUND$ to kynurenine, blocking T-cell activation and inducing immunosuppression.	1	18639339-380
The enzyme indoleamine 2,3-dioxygenase (@PROTEIN$) converts tryptophan to @COMPOUND$, blocking T-cell activation and inducing immunosuppression.	1	18639339-380
The enzyme indoleamine 2,3-dioxygenase (@PROTEIN$) converts @COMPOUND$ to kynurenine, blocking T-cell activation and inducing immunosuppression.	1	18639339-380
The enzyme @PROTEIN$ (IDO) converts tryptophan to @COMPOUND$, blocking T-cell activation and inducing immunosuppression.	1	18639339-380
Serum l-@COMPOUND$ (l-KYN) concentrations, l-KYN/l-@PROTEIN$ ratio, and the level of IDO mRNA expression in ATLL cells were significantly increased in ATLL patients compared to those in healthy and HTLV-positive carrier subjects.	0	18639341-381
Serum l-kynurenine (l-@COMPOUND$) concentrations, l-KYN/l-@PROTEIN$ ratio, and the level of IDO mRNA expression in ATLL cells were significantly increased in ATLL patients compared to those in healthy and HTLV-positive carrier subjects.	0	18639341-381
Serum l-kynurenine (l-@COMPOUND$) concentrations, l-KYN/l-TRP ratio, and the level of @PROTEIN$ mRNA expression in ATLL cells were significantly increased in ATLL patients compared to those in healthy and HTLV-positive carrier subjects.	0	18639341-381
Serum l-@COMPOUND$ (l-KYN) concentrations, l-KYN/l-TRP ratio, and the level of @PROTEIN$ mRNA expression in ATLL cells were significantly increased in ATLL patients compared to those in healthy and HTLV-positive carrier subjects.	0	18639341-381
Peripheral administration of the acetylcholinesterase inhibitor @COMPOUND$ significantly reduced serum @PROTEIN$ levels through vagus nerve signaling, and protected against lethality during murine endotoxemia.	1	18639629-311
Administration of a centrally-acting muscarinic receptor antagonist abolished the suppression of TNF by @COMPOUND$, indicating that suppressing @PROTEIN$ activity, coupled with central muscarinic receptors, controls peripheral cytokine responses.	1	18639629-312
Administration of a centrally-acting muscarinic receptor antagonist abolished the suppression of @PROTEIN$ by @COMPOUND$, indicating that suppressing acetylcholinesterase activity, coupled with central muscarinic receptors, controls peripheral cytokine responses.	1	18639629-312
Administration of @COMPOUND$ to alpha7nAChR knockout mice failed to suppress @PROTEIN$ levels, indicating that the alpha7nAChR-mediated cholinergic anti-inflammatory pathway is required for the anti-inflammatory effect of galantamine.	0	18639629-313
The involvement of @COMPOUND$ and nitric oxide was verified by the block of @PROTEIN$ using specific scavengers (tiron and PTIO, respectively).	0	18639930-897
The involvement of superoxide and nitric oxide was verified by the block of @PROTEIN$ using specific scavengers (@COMPOUND$ and PTIO, respectively).	1	18639930-897
The involvement of superoxide and @COMPOUND$ was verified by the block of @PROTEIN$ using specific scavengers (tiron and PTIO, respectively).	0	18639930-897
Accordingly, @PROTEIN$ were blocked by the peroxynitrite scavenger @COMPOUND$ and could be mimicked by application of exogenous peroxynitrite.	1	18639930-898
This conclusion is supported by our findings that @PROTEIN$ were suppressed by inhibitors of phospholipases but could be mimicked by exogenous phospholipases or by amphipaths (oleic acid, @COMPOUND$).	1	18639930-899
This conclusion is supported by our findings that @PROTEIN$ were suppressed by inhibitors of phospholipases but could be mimicked by exogenous phospholipases or by amphipaths (@COMPOUND$, Triton X-100).	1	18639930-899
In the present study, therefore, the effect of FA/AD in presence or absence of p38MAPK inhibitor SB203580 on the proliferation, apoptosis, p38MAPK, caspase-3, location of p38MAPK and caspase-3, and interaction between p38MAPK and caspase-3 in Bel-7402 cell was investigated by @COMPOUND$ (MTT), @PROTEIN$-FITC/propidium iodide (PI) double staining, electron microscopy, immunoblot, immunofluorescence and immunoprecipitation/immunoblot assay, respectively.	0	18640003-956
In the present study, therefore, the effect of FA/AD in presence or absence of p38MAPK inhibitor SB203580 on the proliferation, apoptosis, p38MAPK, caspase-3, location of p38MAPK and caspase-3, and interaction between p38MAPK and caspase-3 in Bel-7402 cell was investigated by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide (MTT), @PROTEIN$-FITC/@COMPOUND$ (PI) double staining, electron microscopy, immunoblot, immunofluorescence and immunoprecipitation/immunoblot assay, respectively.	0	18640003-956
In the present study, therefore, the effect of FA/AD in presence or absence of p38MAPK inhibitor SB203580 on the proliferation, apoptosis, p38MAPK, caspase-3, location of p38MAPK and caspase-3, and interaction between p38MAPK and caspase-3 in Bel-7402 cell was investigated by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide (MTT), @PROTEIN$-@COMPOUND$/propidium iodide (PI) double staining, electron microscopy, immunoblot, immunofluorescence and immunoprecipitation/immunoblot assay, respectively.	0	18640003-956
To investigate the role of @COMPOUND$ analogs and electromagnetic field (EMF) stimulation on prostaglandin E(2) (@PROTEIN$ (2)) release and cyclooxygenase-2 (COX-2) expression in bovine synovial fibroblasts (SFs).	0	18640059-934
To investigate the role of @COMPOUND$ analogs and electromagnetic field (EMF) stimulation on prostaglandin E(2) (PGE (2)) release and cyclooxygenase-2 (@PROTEIN$) expression in bovine synovial fibroblasts (SFs).	0	18640059-934
To investigate the role of @COMPOUND$ analogs and electromagnetic field (EMF) stimulation on prostaglandin E(2) (PGE (2)) release and @PROTEIN$ (COX-2) expression in bovine synovial fibroblasts (SFs).	0	18640059-934
In this study, we compared the effects of @PROTEIN$-like growth factor-I (IGF-I), basic fibroblast growth factor (bFGF), transforming growth factor beta1 (TGF-beta1), and @COMPOUND$ on porcine TMJ condylar cartilage and ankle cartilage cells in monolayer culture.	0	18640663-1479
In this study, we compared the effects of insulin-like growth factor-I (IGF-I), basic fibroblast growth factor (bFGF), transforming growth factor beta1 (@PROTEIN$), and @COMPOUND$ on porcine TMJ condylar cartilage and ankle cartilage cells in monolayer culture.	0	18640663-1479
In this study, we compared the effects of insulin-like growth factor-I (@PROTEIN$), basic fibroblast growth factor (bFGF), transforming growth factor beta1 (TGF-beta1), and @COMPOUND$ on porcine TMJ condylar cartilage and ankle cartilage cells in monolayer culture.	0	18640663-1479
In this study, we compared the effects of insulin-like growth factor-I (IGF-I), @PROTEIN$ (bFGF), transforming growth factor beta1 (TGF-beta1), and @COMPOUND$ on porcine TMJ condylar cartilage and ankle cartilage cells in monolayer culture.	0	18640663-1479
Meanwhile, both the enhanced expression of @PROTEIN$ and increased activation of NF-kappaB induced by CRH in aortas of LDLr-/-mice were also largely suppressed by @COMPOUND$, whereas these inhibitory effects were not observed in anti-Svg-30 group.	1	18640679-288
Meanwhile, both the enhanced expression of VCAM-1 and increased activation of NF-kappaB induced by @PROTEIN$ in aortas of LDLr-/-mice were also largely suppressed by @COMPOUND$, whereas these inhibitory effects were not observed in anti-Svg-30 group.	0	18640679-288
@PROTEIN$/Akt activity, analyzed by phosphatidylinositol trisphosphate production and phosphorylated Akt (p-Akt) expression, was higher in the resistant cell lines than in the sensitive one and inhibition with @COMPOUND$ or LY294002 improved apoptosis in the resistant cell lines.	1	18640717-1523
@PROTEIN$/Akt activity, analyzed by phosphatidylinositol trisphosphate production and phosphorylated Akt (p-Akt) expression, was higher in the resistant cell lines than in the sensitive one and inhibition with wortmannin or @COMPOUND$ improved apoptosis in the resistant cell lines.	1	18640717-1523
@PROTEIN$/Akt activity, analyzed by @COMPOUND$ trisphosphate production and phosphorylated Akt (p-Akt) expression, was higher in the resistant cell lines than in the sensitive one and inhibition with wortmannin or LY294002 improved apoptosis in the resistant cell lines.	1	18640717-1523
Vincristine but not @COMPOUND$ increased p-@PROTEIN$ expression whereas co-treatment with PI3K inhibitors and vincristine increased apoptosis in the three cell lines.	0	18640717-1524
@COMPOUND$ but not doxorubicin increased p-@PROTEIN$ expression whereas co-treatment with PI3K inhibitors and vincristine increased apoptosis in the three cell lines.	1	18640717-1524
Vincristine but not doxorubicin increased p-@PROTEIN$ expression whereas co-treatment with PI3K inhibitors and @COMPOUND$ increased apoptosis in the three cell lines.	0	18640717-1524
Wortmannin and @COMPOUND$ inhibited P-@PROTEIN$ (Pgp) function and also increased NF-kappaB activity.	1	18640717-1525
@COMPOUND$ and LY294002 inhibited P-@PROTEIN$ (Pgp) function and also increased NF-kappaB activity.	1	18640717-1525
Namely, the results obtained for the most active compounds, 5-(chloroacetylamino) uracil (2) and its acyclic sugar analogue 18, suggest that formation of a covalent bond between reactive substituent and several possible targets within the @PROTEIN$ mechanism (sulphur of the @COMPOUND$ residue, basic part of the enzyme, N,N-methylene tetrahydrofolate or its reactive iminium forms) is the most probable mode of action.	1	18640746-1557
@COMPOUND$, a potent orally active angiogenesis inhibitor capable of inhibiting all known isoforms of Vascular Endothelial Growth Factor (@PROTEIN$) receptor, belongs to the class of aminophthalazines.	1	18641920-846
Recent evidence for toxic @COMPOUND$ (O(2)(-)) production by marine microalgae is afforded particular attention given that release of O(2)(-) anions can be exacerbated by the binding of @PROTEIN$ to the microalgal cell wall ; a novel model for grazing-activated chemical defence is proposed.	1	18642040-946
Activation of these receptors can inhibit @PROTEIN$-release in primary cultured corticotroph adenomas and compounds that target either sst (5) (@COMPOUND$, or SOM230) or D(2) (cabergoline) have shown significant efficacy in subsets of patients in recent clinical studies.	0	18642088-995
Activation of these receptors can inhibit @PROTEIN$-release in primary cultured corticotroph adenomas and compounds that target either sst (5) (pasireotide, or SOM230) or D(2) (@COMPOUND$) have shown significant efficacy in subsets of patients in recent clinical studies.	0	18642088-995
Activation of these receptors can inhibit @PROTEIN$-release in primary cultured corticotroph adenomas and compounds that target either sst (5) (pasireotide, or @COMPOUND$) or D(2) (cabergoline) have shown significant efficacy in subsets of patients in recent clinical studies.	0	18642088-995
The @COMPOUND$ induced chemotaxis was accompanied by polarization of the @PROTEIN$ cytoskeleton, and by polymerization of F-actin.	1	18642106-1330
@COMPOUND$ in anionic DSPG liposomes stimulated murine @PROTEIN$ production in RAW 264 cells at concentrations 25-to 30-fold lower than free drug.	1	18642386-611
To elucidate the mechanism by which @COMPOUND$ regulates adipose triglyceride @PROTEIN$ (ATGL).	1	18643838-993
@PROTEIN$ is one of the members of the G protein-coupled receptor family that can catalyze a GDP-@COMPOUND$ exchange reaction on the retinal G protein transducin (Gt) upon photon absorption.	1	18643908-800
Rhodopsin is one of the members of the G protein-coupled receptor family that can catalyze a @COMPOUND$-GTP exchange reaction on the retinal G protein @PROTEIN$ (Gt) upon photon absorption.	1	18643908-800
Rhodopsin is one of the members of the G protein-coupled receptor family that can catalyze a GDP-@COMPOUND$ exchange reaction on the retinal G protein @PROTEIN$ (Gt) upon photon absorption.	1	18643908-800
@PROTEIN$ is one of the members of the G protein-coupled receptor family that can catalyze a @COMPOUND$-GTP exchange reaction on the retinal G protein transducin (Gt) upon photon absorption.	1	18643908-800
@COMPOUND$ was associated with a lower frequency of extrapyramidal symptoms than other antipsychotics, fewer @PROTEIN$-related adverse events than risperidone and other atypical antipsychotics, but greater weight gain than typicals and risperidone.	1	18644606-1339
In our earlier method, glutathione disulfide (@COMPOUND$) was measured by first reducing it to GSH with @PROTEIN$ (GR) in the presence of NADPH.	1	18646192-1003
In our earlier method, @COMPOUND$ (GSSG) was measured by first reducing it to GSH with @PROTEIN$ (GR) in the presence of NADPH.	1	18646192-1003
In our earlier method, glutathione disulfide (GSSG) was measured by first reducing it to GSH with @PROTEIN$ (GR) in the presence of @COMPOUND$.	1	18646192-1003
In our earlier method, glutathione disulfide (GSSG) was measured by first reducing it to @COMPOUND$ with @PROTEIN$ (GR) in the presence of NADPH.	1	18646192-1003
The @PROTEIN$ insertion/deletion polymorphism is associated with phagocytic NADPH oxidase-dependent @COMPOUND$ generation: potential implication in hypertension.	1	18647135-78
Administration of @COMPOUND$ to DMH treated rats significantly decreased the tumor incidence, the number of aberrant crypt foci with simultaneous enhancement of tissue lipid peroxidation, GST, GPx, @PROTEIN$, and CAT activities.	1	18648748-1370
Administration of @COMPOUND$ to DMH treated rats significantly decreased the tumor incidence, the number of aberrant crypt foci with simultaneous enhancement of tissue lipid peroxidation, @PROTEIN$, GPx, SOD, and CAT activities.	1	18648748-1370
Administration of @COMPOUND$ to DMH treated rats significantly decreased the tumor incidence, the number of aberrant crypt foci with simultaneous enhancement of tissue lipid peroxidation, GST, GPx, SOD, and @PROTEIN$ activities.	1	18648748-1370
Culture of mid-segments of hair follicles in low calcium culture medium kept on @COMPOUND$ increased expression of filaggrin and Kdap, but downregulated expression of @PROTEIN$.	0	18648826-1446
Culture of mid-segments of hair follicles in low calcium culture medium kept on @COMPOUND$ increased expression of @PROTEIN$ and Kdap, but downregulated expression of involucrin.	0	18648826-1446
Culture of mid-segments of hair follicles in low calcium culture medium kept on @COMPOUND$ increased expression of filaggrin and @PROTEIN$, but downregulated expression of involucrin.	0	18648826-1446
The p-hydroxyphenylpyruvate produced by the Escherichia coli host was converted to @COMPOUND$ through the oxidation reaction of introduced @PROTEIN$.	1	18648877-1504
The @COMPOUND$ produced by the Escherichia coli host was converted to HGA through the oxidation reaction of introduced @PROTEIN$.	1	18648877-1504
The results showed that the intakes of dry matter (DM), organic matter (OM), nitrogen (N), the N-balance, urinary purine derivatives (PD) excretion, the ratios of allantoin to creatinine (CR), PD to CR, the plasma @COMPOUND$-N (PUN) and @PROTEIN$ increased in the animals, but the intake of neutral detergent fiber (NDF), the coefficient of whole tract, apparent digestibility of NDF, the transit time (TT) and the mean retention time (TMRT) decreased, when the proportion of concentrate in the diet increased.	0	18649000-1622
The results showed that the intakes of dry matter (DM), organic matter (OM), @COMPOUND$ (N), the N-balance, urinary purine derivatives (PD) excretion, the ratios of allantoin to creatinine (CR), PD to CR, the plasma urea-N (PUN) and @PROTEIN$ increased in the animals, but the intake of neutral detergent fiber (NDF), the coefficient of whole tract, apparent digestibility of NDF, the transit time (TT) and the mean retention time (TMRT) decreased, when the proportion of concentrate in the diet increased.	0	18649000-1622
The results showed that the intakes of dry matter (DM), organic matter (OM), nitrogen (N), the N-balance, urinary @COMPOUND$ derivatives (PD) excretion, the ratios of allantoin to creatinine (CR), PD to CR, the plasma urea-N (PUN) and @PROTEIN$ increased in the animals, but the intake of neutral detergent fiber (NDF), the coefficient of whole tract, apparent digestibility of NDF, the transit time (TT) and the mean retention time (TMRT) decreased, when the proportion of concentrate in the diet increased.	0	18649000-1622
The results showed that the intakes of dry matter (DM), organic matter (OM), nitrogen (N), the N-balance, urinary purine derivatives (PD) excretion, the ratios of allantoin to creatinine (@COMPOUND$), PD to CR, the plasma urea-N (PUN) and @PROTEIN$ increased in the animals, but the intake of neutral detergent fiber (NDF), the coefficient of whole tract, apparent digestibility of NDF, the transit time (TT) and the mean retention time (TMRT) decreased, when the proportion of concentrate in the diet increased.	0	18649000-1622
The results showed that the intakes of dry matter (DM), organic matter (OM), nitrogen (N), the N-balance, urinary purine derivatives (PD) excretion, the ratios of allantoin to @COMPOUND$ (CR), PD to CR, the plasma urea-N (PUN) and @PROTEIN$ increased in the animals, but the intake of neutral detergent fiber (NDF), the coefficient of whole tract, apparent digestibility of NDF, the transit time (TT) and the mean retention time (TMRT) decreased, when the proportion of concentrate in the diet increased.	0	18649000-1622
The results showed that the intakes of dry matter (DM), organic matter (OM), nitrogen (N), the N-balance, urinary purine derivatives (PD) excretion, the ratios of @COMPOUND$ to creatinine (CR), PD to CR, the plasma urea-N (PUN) and @PROTEIN$ increased in the animals, but the intake of neutral detergent fiber (NDF), the coefficient of whole tract, apparent digestibility of NDF, the transit time (TT) and the mean retention time (TMRT) decreased, when the proportion of concentrate in the diet increased.	0	18649000-1622
Activation of interleukin-6/@PROTEIN$ in rat cholangiocyte proliferation induced by @COMPOUND$.	1	18649135-39
Activation of @PROTEIN$/STAT3 in rat cholangiocyte proliferation induced by @COMPOUND$.	1	18649135-39
To investigate the activation pathways triggered by @PROTEIN$, ESR spin-trapping techniques using N-tert-butyl-alpha-phenylnitrone (PBN) as spin trap followed by @COMPOUND$ extraction were employed to identify and quantify the free radical intermediates.	0	18650080-816
Methylation of these @COMPOUND$ sites may lead to reduced @PROTEIN$ expression in the lymphocytes of these former heroin addicts.	1	18650805-1377
Two infants with elevated serum @PROTEIN$ had a decreased serum @COMPOUND$.	1	18651093-1447
Human bone marrow-derived mesenchymal stem cells and osteoblast differentiation on @COMPOUND$ with surface-grafted chitosan and immobilized bone @PROTEIN$-2.	0	18651113-1681
None of the compounds altered @PROTEIN$ gene expression, indicating that 3-@COMPOUND$ inhibits CYP11B1 activity on the protein level.	0	18651133-1703
None of the compounds altered Cyp11b1 gene expression, indicating that 3-@COMPOUND$ inhibits @PROTEIN$ activity on the protein level.	1	18651133-1703
Functional analysis demonstrated that elkj encoded a @PROTEIN$-elongase that mediated the elongation of EPA into @COMPOUND$ (22:5n-3), confirming the two-step conversion from EPA to DHA in marine microalga.	1	18651191-669
ANP (atrial natriuretic peptide) exerts its biological effects by binding to GC (guanylate @PROTEIN$)-A/NPR (natriuretic peptide receptor)-A, which generates the second messenger @COMPOUND$.	1	18651838-564
@PROTEIN$ (atrial natriuretic peptide) exerts its biological effects by binding to GC (guanylate cyclase)-A/NPR (natriuretic peptide receptor)-A, which generates the second messenger @COMPOUND$.	1	18651838-564
ANP (atrial natriuretic peptide) exerts its biological effects by binding to GC (guanylate cyclase)-A/@PROTEIN$ (natriuretic peptide receptor)-A, which generates the second messenger @COMPOUND$.	1	18651838-564
ANP (atrial @PROTEIN$) exerts its biological effects by binding to GC (guanylate cyclase)-A/NPR (natriuretic peptide receptor)-A, which generates the second messenger @COMPOUND$.	1	18651838-564
ANP (@PROTEIN$) exerts its biological effects by binding to GC (guanylate cyclase)-A/NPR (natriuretic peptide receptor)-A, which generates the second messenger @COMPOUND$.	1	18651838-564
Overexpression of Ets-1 enhanced significantly @PROTEIN$ mRNA levels, protein expression, GC activity and ANP-stimulated intracellular accumulation of @COMPOUND$ in transfected cells.	0	18651838-565
Overexpression of Ets-1 enhanced significantly Npr1 mRNA levels, protein expression, GC activity and @PROTEIN$-stimulated intracellular accumulation of @COMPOUND$ in transfected cells.	1	18651838-565
Overexpression of @PROTEIN$ enhanced significantly Npr1 mRNA levels, protein expression, GC activity and ANP-stimulated intracellular accumulation of @COMPOUND$ in transfected cells.	1	18651838-565
"In the current study, these cells were cultured with three different media: "" @PROTEIN$-plus"" medium containing @COMPOUND$ and 100 ng/mL of rhBMP-2, ""odontogenic"" medium containing dexamethasone, and ""control"" medium without supplements."	0	18652538-1158
The allatostatins (@PROTEIN$), with a Tyr/Phe-Xaa-Phe-Gly-Leu/Ile-amide C-terminus, are neuropeptides that occur in many orders of insects, but are known to inhibit @COMPOUND$ (JH) synthesis by corpora allata (CA) only in cockroaches, crickets, and termites.	1	18652864-1389
The @PROTEIN$ (ASTs), with a Tyr/Phe-Xaa-Phe-Gly-Leu/Ile-amide C-terminus, are neuropeptides that occur in many orders of insects, but are known to inhibit @COMPOUND$ (JH) synthesis by corpora allata (CA) only in cockroaches, crickets, and termites.	1	18652864-1389
The allatostatins (ASTs), with a Tyr/Phe-Xaa-Phe-Gly-Leu/Ile-amide C-terminus, are @PROTEIN$ that occur in many orders of insects, but are known to inhibit @COMPOUND$ (JH) synthesis by corpora allata (CA) only in cockroaches, crickets, and termites.	0	18652864-1389
Lecithin:retinol acyltransferase (@PROTEIN$) catalyzes the esterification of retinol (@COMPOUND$).	1	18652909-1018
@COMPOUND$ (RA) treatment increased this @PROTEIN$ promoter-luciferase activity in PrEC cells, but not in PC-3 cells.	1	18652909-1019
@COMPOUND$ (RA) treatment increased this LRAT promoter-@PROTEIN$ activity in PrEC cells, but not in PC-3 cells.	1	18652909-1019
As multidrug resistance (MDR) is a major problem in the chemotherapy of progressive breast cancer, the in vitro effects of Ad-REIC treatment were investigated in terms of the sensitivity of multidrug-resistant MCF7/ADR cells to @COMPOUND$ and of the P-@PROTEIN$ expression.	0	18654608-1184
As multidrug resistance (MDR) is a major problem in the chemotherapy of progressive breast cancer, the in vitro effects of Ad-@PROTEIN$ treatment were investigated in terms of the sensitivity of multidrug-resistant MCF7/ADR cells to @COMPOUND$ and of the P-glycoprotein expression.	0	18654608-1184
Ad-REIC treatment in MCF7/ADR cells also downregulated P-glycoprotein expresssion through @PROTEIN$ activation, and sensitized its drug resistance against @COMPOUND$.	0	18654608-1185
Ad-REIC treatment in MCF7/ADR cells also downregulated P-@PROTEIN$ expresssion through JNK activation, and sensitized its drug resistance against @COMPOUND$.	0	18654608-1185
Ad-@PROTEIN$ treatment in MCF7/ADR cells also downregulated P-glycoprotein expresssion through JNK activation, and sensitized its drug resistance against @COMPOUND$.	1	18654608-1185
@COMPOUND$, a homocamptothecin, targets @PROTEIN$.	1	18654747-1289
Both MudPIT and cDNA microarray analyses indicate that @COMPOUND$ treatment caused elevated levels of @PROTEIN$.	1	18654835-1331
Altogether these changes offer a straightforward explanation for how following the addition of Ca(2+), the @COMPOUND$ could escape and become available for bioluminescence on Renilla @PROTEIN$.	1	18655070-1550
Altogether these changes offer a straightforward explanation for how following the addition of @COMPOUND$+), the coelenterazine could escape and become available for bioluminescence on Renilla @PROTEIN$.	1	18655070-1550
The @COMPOUND$ functionalization was then used to immobilize bone @PROTEIN$ on the bioactive glasses.	1	18655138-1615
L-Kynurenine (KYN), a tryptophan metabolite, is metabolized to kynurenic acid (@COMPOUND$), which is an antagonist of N-methyl-D-aspartate and alpha7 nicotinic acetylcholine receptors, by kynurenine aminotransferase (@PROTEIN$) I and KAT II.	1	18655158-1630
L-Kynurenine (@COMPOUND$), a tryptophan metabolite, is metabolized to kynurenic acid (KYNA), which is an antagonist of N-methyl-D-aspartate and alpha7 nicotinic acetylcholine receptors, by kynurenine aminotransferase (@PROTEIN$) I and KAT II.	1	18655158-1630
L-@COMPOUND$ (KYN), a tryptophan metabolite, is metabolized to kynurenic acid (KYNA), which is an antagonist of N-methyl-D-aspartate and alpha7 nicotinic acetylcholine receptors, by kynurenine aminotransferase (@PROTEIN$) I and KAT II.	1	18655158-1630
L-Kynurenine (KYN), a tryptophan metabolite, is metabolized to @COMPOUND$ (KYNA), which is an antagonist of N-methyl-D-aspartate and alpha7 nicotinic acetylcholine receptors, by kynurenine aminotransferase (@PROTEIN$) I and KAT II.	1	18655158-1630
L-Kynurenine (KYN), a @COMPOUND$ metabolite, is metabolized to kynurenic acid (KYNA), which is an antagonist of N-methyl-D-aspartate and alpha7 nicotinic acetylcholine receptors, by kynurenine aminotransferase (@PROTEIN$) I and KAT II.	0	18655158-1630
L-Kynurenine (KYN), a tryptophan metabolite, is metabolized to kynurenic acid (KYNA), which is an antagonist of N-methyl-D-aspartate and alpha7 nicotinic acetylcholine receptors, by @COMPOUND$ aminotransferase (@PROTEIN$) I and KAT II.	1	18655158-1630
Exposure to @COMPOUND$ (BaP) by intraperitoneal injection increased biliary BaP metabolites and liver @PROTEIN$ gene expression.	1	18655176-1654
We examined the effect of several different doses of malathion (25, 75, 200 microM), or malathion in combination with vitamin C (VC; 10 microM) or @COMPOUND$ (VE; 30 microM), on the levels of malondialdehyde (MDA), and superoxide dismutase (SOD), catalase (@PROTEIN$), and glutathione peroxidase (GPx) activities in human erythrocytes in vitro.	0	18655177-1378
We examined the effect of several different doses of malathion (25, 75, 200 microM), or malathion in combination with vitamin C (VC; 10 microM) or vitamin E (VE; 30 microM), on the levels of @COMPOUND$ (MDA), and superoxide dismutase (SOD), @PROTEIN$ (CAT), and glutathione peroxidase (GPx) activities in human erythrocytes in vitro.	0	18655177-1378
We examined the effect of several different doses of malathion (25, 75, 200 microM), or malathion in combination with @COMPOUND$ (VC; 10 microM) or vitamin E (VE; 30 microM), on the levels of malondialdehyde (MDA), and superoxide dismutase (SOD), catalase (@PROTEIN$), and glutathione peroxidase (GPx) activities in human erythrocytes in vitro.	0	18655177-1378
We examined the effect of several different doses of @COMPOUND$ (25, 75, 200 microM), or malathion in combination with vitamin C (VC; 10 microM) or vitamin E (VE; 30 microM), on the levels of malondialdehyde (MDA), and superoxide dismutase (SOD), catalase (CAT), and @PROTEIN$ (GPx) activities in human erythrocytes in vitro.	0	18655177-1378
We examined the effect of several different doses of malathion (25, 75, 200 microM), or malathion in combination with vitamin C (VC; 10 microM) or @COMPOUND$ (VE; 30 microM), on the levels of malondialdehyde (MDA), and @PROTEIN$ (SOD), catalase (CAT), and glutathione peroxidase (GPx) activities in human erythrocytes in vitro.	0	18655177-1378
We examined the effect of several different doses of malathion (25, 75, 200 microM), or malathion in combination with vitamin C (VC; 10 microM) or @COMPOUND$ (VE; 30 microM), on the levels of malondialdehyde (MDA), and superoxide dismutase (SOD), @PROTEIN$ (CAT), and glutathione peroxidase (GPx) activities in human erythrocytes in vitro.	0	18655177-1378
We examined the effect of several different doses of malathion (25, 75, 200 microM), or malathion in combination with @COMPOUND$ (VC; 10 microM) or vitamin E (VE; 30 microM), on the levels of malondialdehyde (MDA), and superoxide dismutase (@PROTEIN$), catalase (CAT), and glutathione peroxidase (GPx) activities in human erythrocytes in vitro.	0	18655177-1378
We examined the effect of several different doses of malathion (25, 75, 200 microM), or malathion in combination with vitamin C (VC; 10 microM) or @COMPOUND$ (VE; 30 microM), on the levels of malondialdehyde (MDA), and superoxide dismutase (@PROTEIN$), catalase (CAT), and glutathione peroxidase (GPx) activities in human erythrocytes in vitro.	0	18655177-1378
We examined the effect of several different doses of @COMPOUND$ (25, 75, 200 microM), or malathion in combination with vitamin C (VC; 10 microM) or vitamin E (VE; 30 microM), on the levels of malondialdehyde (MDA), and @PROTEIN$ (SOD), catalase (CAT), and glutathione peroxidase (GPx) activities in human erythrocytes in vitro.	0	18655177-1378
We examined the effect of several different doses of malathion (25, 75, 200 microM), or malathion in combination with vitamin C (VC; 10 microM) or vitamin E (VE; 30 microM), on the levels of @COMPOUND$ (MDA), and superoxide dismutase (@PROTEIN$), catalase (CAT), and glutathione peroxidase (GPx) activities in human erythrocytes in vitro.	0	18655177-1378
We examined the effect of several different doses of malathion (25, 75, 200 microM), or malathion in combination with vitamin C (VC; 10 microM) or vitamin E (VE; 30 microM), on the levels of @COMPOUND$ (MDA), and superoxide dismutase (SOD), catalase (CAT), and @PROTEIN$ (GPx) activities in human erythrocytes in vitro.	0	18655177-1378
We examined the effect of several different doses of malathion (25, 75, 200 microM), or malathion in combination with @COMPOUND$ (VC; 10 microM) or vitamin E (VE; 30 microM), on the levels of malondialdehyde (MDA), and superoxide dismutase (SOD), @PROTEIN$ (CAT), and glutathione peroxidase (GPx) activities in human erythrocytes in vitro.	0	18655177-1378
We examined the effect of several different doses of @COMPOUND$ (25, 75, 200 microM), or malathion in combination with vitamin C (VC; 10 microM) or vitamin E (VE; 30 microM), on the levels of malondialdehyde (MDA), and superoxide dismutase (SOD), catalase (@PROTEIN$), and glutathione peroxidase (GPx) activities in human erythrocytes in vitro.	0	18655177-1378
We examined the effect of several different doses of @COMPOUND$ (25, 75, 200 microM), or malathion in combination with vitamin C (VC; 10 microM) or vitamin E (VE; 30 microM), on the levels of malondialdehyde (MDA), and superoxide dismutase (@PROTEIN$), catalase (CAT), and glutathione peroxidase (GPx) activities in human erythrocytes in vitro.	0	18655177-1378
We examined the effect of several different doses of malathion (25, 75, 200 microM), or malathion in combination with vitamin C (VC; 10 microM) or vitamin E (VE; 30 microM), on the levels of @COMPOUND$ (MDA), and superoxide dismutase (SOD), catalase (@PROTEIN$), and glutathione peroxidase (GPx) activities in human erythrocytes in vitro.	0	18655177-1378
We examined the effect of several different doses of @COMPOUND$ (25, 75, 200 microM), or malathion in combination with vitamin C (VC; 10 microM) or vitamin E (VE; 30 microM), on the levels of malondialdehyde (MDA), and superoxide dismutase (SOD), @PROTEIN$ (CAT), and glutathione peroxidase (GPx) activities in human erythrocytes in vitro.	0	18655177-1378
We examined the effect of several different doses of malathion (25, 75, 200 microM), or malathion in combination with vitamin C (VC; 10 microM) or vitamin E (VE; 30 microM), on the levels of @COMPOUND$ (MDA), and @PROTEIN$ (SOD), catalase (CAT), and glutathione peroxidase (GPx) activities in human erythrocytes in vitro.	0	18655177-1378
We examined the effect of several different doses of malathion (25, 75, 200 microM), or malathion in combination with @COMPOUND$ (VC; 10 microM) or vitamin E (VE; 30 microM), on the levels of malondialdehyde (MDA), and superoxide dismutase (SOD), catalase (CAT), and @PROTEIN$ (GPx) activities in human erythrocytes in vitro.	0	18655177-1378
We examined the effect of several different doses of malathion (25, 75, 200 microM), or malathion in combination with vitamin C (VC; 10 microM) or @COMPOUND$ (VE; 30 microM), on the levels of malondialdehyde (MDA), and superoxide dismutase (SOD), catalase (CAT), and @PROTEIN$ (GPx) activities in human erythrocytes in vitro.	0	18655177-1378
We examined the effect of several different doses of malathion (25, 75, 200 microM), or malathion in combination with @COMPOUND$ (VC; 10 microM) or vitamin E (VE; 30 microM), on the levels of malondialdehyde (MDA), and @PROTEIN$ (SOD), catalase (CAT), and glutathione peroxidase (GPx) activities in human erythrocytes in vitro.	0	18655177-1378
Erythrocytes were incubated under various treatment conditions (@COMPOUND$ alone, vitamins alone, or malathion plus vitamin) at 37 degrees C for 60 min, and the levels of MDA, and SOD, @PROTEIN$ and GPx activities, were determined.	1	18655177-1379
Erythrocytes were incubated under various treatment conditions (@COMPOUND$ alone, vitamins alone, or malathion plus vitamin) at 37 degrees C for 60 min, and the levels of MDA, and @PROTEIN$, CAT and GPx activities, were determined.	0	18655177-1379
Treatment with @COMPOUND$ alone increased the levels of MDA and decreased SOD, @PROTEIN$ 0.05).	1	18655177-1380
Treatment with @COMPOUND$ alone increased the levels of MDA and decreased @PROTEIN$, CAT 0.05).	1	18655177-1380
@PROTEIN$ reduces antioxidant defense system and enhances kidney tissue damage in @COMPOUND$ and lead exposed rats.	1	18655190-1668
In the present study, we investigated the effect of AdM, Pb+ AdM, and Cd+ AdM treatments on superoxide dismutase (@PROTEIN$), catalase (CAT), and glutathione peroxidase (@COMPOUND$-Px) activities as well as the level of malondialdehyde (MDA) in the kidney.	0	18655190-1669
In the present study, we investigated the effect of AdM, Pb+ AdM, and Cd+ AdM treatments on superoxide dismutase (SOD), catalase (CAT), and @PROTEIN$ (@COMPOUND$-Px) activities as well as the level of malondialdehyde (MDA) in the kidney.	0	18655190-1669
In the present study, we investigated the effect of AdM, Pb+ AdM, and Cd+ AdM treatments on @PROTEIN$ (SOD), catalase (CAT), and glutathione peroxidase (@COMPOUND$-Px) activities as well as the level of malondialdehyde (MDA) in the kidney.	0	18655190-1669
In the present study, we investigated the effect of AdM, Pb+ AdM, and Cd+ AdM treatments on superoxide dismutase (@PROTEIN$), catalase (CAT), and glutathione peroxidase (GSH-Px) activities as well as the level of @COMPOUND$ (MDA) in the kidney.	0	18655190-1669
In the present study, we investigated the effect of AdM, Pb+ AdM, and Cd+ AdM treatments on superoxide dismutase (SOD), catalase (CAT), and @PROTEIN$ (GSH-Px) activities as well as the level of @COMPOUND$ (MDA) in the kidney.	0	18655190-1669
In the present study, we investigated the effect of AdM, Pb+ AdM, and Cd+ AdM treatments on superoxide dismutase (SOD), catalase (@PROTEIN$), and glutathione peroxidase (@COMPOUND$-Px) activities as well as the level of malondialdehyde (MDA) in the kidney.	0	18655190-1669
In the present study, we investigated the effect of AdM, Pb+ AdM, and Cd+ AdM treatments on superoxide dismutase (SOD), catalase (@PROTEIN$), and glutathione peroxidase (GSH-Px) activities as well as the level of @COMPOUND$ (MDA) in the kidney.	0	18655190-1669
In the present study, we investigated the effect of AdM, Pb+ AdM, and Cd+ AdM treatments on superoxide dismutase (SOD), @PROTEIN$ (CAT), and glutathione peroxidase (@COMPOUND$-Px) activities as well as the level of malondialdehyde (MDA) in the kidney.	0	18655190-1669
In the present study, we investigated the effect of AdM, Pb+ AdM, and Cd+ AdM treatments on @PROTEIN$ (SOD), catalase (CAT), and glutathione peroxidase (GSH-Px) activities as well as the level of @COMPOUND$ (MDA) in the kidney.	0	18655190-1669
In the present study, we investigated the effect of AdM, Pb+ AdM, and Cd+ AdM treatments on superoxide dismutase (SOD), @PROTEIN$ (CAT), and glutathione peroxidase (GSH-Px) activities as well as the level of @COMPOUND$ (MDA) in the kidney.	0	18655190-1669
We found that @PROTEIN$ expression in LH orexin neurons varied in proportion to preference for morphine, @COMPOUND$ or food.	1	18655797-440
We found that @PROTEIN$ expression in LH orexin neurons varied in proportion to preference for @COMPOUND$, cocaine or food.	1	18655797-440
Recent studies showed that LH orexin neurons that project to ventral tegmental area (VTA) have greater @PROTEIN$ induction in association with elevated @COMPOUND$ preference during protracted withdrawal than non-VTA-projecting orexin neurons, indicating that the VTA is an important site of action for orexin's role in reward processing.	0	18655797-441
@PROTEIN$ are metalloproteins that function in electron transfer reactions and contain a @COMPOUND$ moiety covalently attached via thioether linkages between the co-factor and a CXXCH motif in the protein.	1	18655808-447
The antioxidant roles of @COMPOUND$ (Se) were evaluated in Brycon cephalus exposed to 2 mg L(-1) of Folisuper 600 BR (MP commercial formulation-MPc, 600 g L(-1)) for 96 h. Catalase (CAT), glutathione peroxidase (GPx), superoxide dismutase (SOD), @PROTEIN$ (GST), reduced glutathione (GSH) and lipid peroxidation (LPO) levels in the gills, white muscle and liver were evaluated in fish fed on diets containing 0 or 1.5 mg Se kg(-1) for 8 weeks.	0	18655848-489
The antioxidant roles of selenium (Se) were evaluated in Brycon cephalus exposed to 2 mg L(-1) of Folisuper 600 BR (MP commercial formulation-MPc, 600 g L(-1)) for 96 h. Catalase (CAT), glutathione peroxidase (GPx), superoxide dismutase (SOD), @PROTEIN$ (GST), reduced glutathione (@COMPOUND$) and lipid peroxidation (LPO) levels in the gills, white muscle and liver were evaluated in fish fed on diets containing 0 or 1.5 mg Se kg(-1) for 8 weeks.	0	18655848-489
The antioxidant roles of selenium (Se) were evaluated in Brycon cephalus exposed to 2 mg L(-1) of Folisuper 600 BR (MP commercial formulation-MPc, 600 g L(-1)) for 96 h. @PROTEIN$ (CAT), glutathione peroxidase (GPx), superoxide dismutase (SOD), glutathione S-transferase (GST), @COMPOUND$ (GSH) and lipid peroxidation (LPO) levels in the gills, white muscle and liver were evaluated in fish fed on diets containing 0 or 1.5 mg Se kg(-1) for 8 weeks.	0	18655848-489
The antioxidant roles of selenium (Se) were evaluated in Brycon cephalus exposed to 2 mg L(-1) of Folisuper 600 BR (MP commercial formulation-MPc, 600 g L(-1)) for 96 h. Catalase (CAT), glutathione peroxidase (GPx), superoxide dismutase (@PROTEIN$), glutathione S-transferase (GST), reduced glutathione (@COMPOUND$) and lipid peroxidation (LPO) levels in the gills, white muscle and liver were evaluated in fish fed on diets containing 0 or 1.5 mg Se kg(-1) for 8 weeks.	0	18655848-489
The antioxidant roles of selenium (Se) were evaluated in Brycon cephalus exposed to 2 mg L(-1) of Folisuper 600 BR (MP commercial formulation-MPc, 600 g L(-1)) for 96 h. Catalase (CAT), @PROTEIN$ (GPx), superoxide dismutase (SOD), glutathione S-transferase (GST), reduced glutathione (@COMPOUND$) and lipid peroxidation (LPO) levels in the gills, white muscle and liver were evaluated in fish fed on diets containing 0 or 1.5 mg Se kg(-1) for 8 weeks.	0	18655848-489
The antioxidant roles of @COMPOUND$ (Se) were evaluated in Brycon cephalus exposed to 2 mg L(-1) of Folisuper 600 BR (MP commercial formulation-MPc, 600 g L(-1)) for 96 h. @PROTEIN$ (CAT), glutathione peroxidase (GPx), superoxide dismutase (SOD), glutathione S-transferase (GST), reduced glutathione (GSH) and lipid peroxidation (LPO) levels in the gills, white muscle and liver were evaluated in fish fed on diets containing 0 or 1.5 mg Se kg(-1) for 8 weeks.	0	18655848-489
The antioxidant roles of selenium (Se) were evaluated in Brycon cephalus exposed to 2 mg L(-1) of Folisuper 600 BR (MP commercial formulation-MPc, 600 g L(-1)) for 96 h. Catalase (CAT), @PROTEIN$ (GPx), superoxide dismutase (SOD), glutathione S-transferase (GST), @COMPOUND$ (GSH) and lipid peroxidation (LPO) levels in the gills, white muscle and liver were evaluated in fish fed on diets containing 0 or 1.5 mg Se kg(-1) for 8 weeks.	0	18655848-489
The antioxidant roles of selenium (Se) were evaluated in Brycon cephalus exposed to 2 mg L(-1) of Folisuper 600 BR (MP commercial formulation-MPc, 600 g L(-1)) for 96 h. Catalase (CAT), glutathione peroxidase (GPx), superoxide dismutase (SOD), glutathione S-transferase (@PROTEIN$), @COMPOUND$ (GSH) and lipid peroxidation (LPO) levels in the gills, white muscle and liver were evaluated in fish fed on diets containing 0 or 1.5 mg Se kg(-1) for 8 weeks.	0	18655848-489
The antioxidant roles of @COMPOUND$ (Se) were evaluated in Brycon cephalus exposed to 2 mg L(-1) of Folisuper 600 BR (MP commercial formulation-MPc, 600 g L(-1)) for 96 h. Catalase (@PROTEIN$), glutathione peroxidase (GPx), superoxide dismutase (SOD), glutathione S-transferase (GST), reduced glutathione (GSH) and lipid peroxidation (LPO) levels in the gills, white muscle and liver were evaluated in fish fed on diets containing 0 or 1.5 mg Se kg(-1) for 8 weeks.	0	18655848-489
The antioxidant roles of selenium (Se) were evaluated in Brycon cephalus exposed to 2 mg L(-1) of Folisuper 600 BR (MP commercial formulation-MPc, 600 g L(-1)) for 96 h. Catalase (CAT), glutathione peroxidase (GPx), @PROTEIN$ (SOD), glutathione S-transferase (GST), reduced glutathione (@COMPOUND$) and lipid peroxidation (LPO) levels in the gills, white muscle and liver were evaluated in fish fed on diets containing 0 or 1.5 mg Se kg(-1) for 8 weeks.	0	18655848-489
The antioxidant roles of @COMPOUND$ (Se) were evaluated in Brycon cephalus exposed to 2 mg L(-1) of Folisuper 600 BR (MP commercial formulation-MPc, 600 g L(-1)) for 96 h. Catalase (CAT), glutathione peroxidase (GPx), superoxide dismutase (SOD), glutathione S-transferase (@PROTEIN$), reduced glutathione (GSH) and lipid peroxidation (LPO) levels in the gills, white muscle and liver were evaluated in fish fed on diets containing 0 or 1.5 mg Se kg(-1) for 8 weeks.	0	18655848-489
The antioxidant roles of selenium (Se) were evaluated in Brycon cephalus exposed to 2 mg L(-1) of Folisuper 600 BR (MP commercial formulation-MPc, 600 g L(-1)) for 96 h. Catalase (CAT), glutathione peroxidase (GPx), superoxide dismutase (@PROTEIN$), glutathione S-transferase (GST), @COMPOUND$ (GSH) and lipid peroxidation (LPO) levels in the gills, white muscle and liver were evaluated in fish fed on diets containing 0 or 1.5 mg Se kg(-1) for 8 weeks.	0	18655848-489
The antioxidant roles of selenium (Se) were evaluated in Brycon cephalus exposed to 2 mg L(-1) of Folisuper 600 BR (MP commercial formulation-MPc, 600 g L(-1)) for 96 h. Catalase (@PROTEIN$), glutathione peroxidase (GPx), superoxide dismutase (SOD), glutathione S-transferase (GST), reduced glutathione (@COMPOUND$) and lipid peroxidation (LPO) levels in the gills, white muscle and liver were evaluated in fish fed on diets containing 0 or 1.5 mg Se kg(-1) for 8 weeks.	0	18655848-489
The antioxidant roles of @COMPOUND$ (Se) were evaluated in Brycon cephalus exposed to 2 mg L(-1) of Folisuper 600 BR (MP commercial formulation-MPc, 600 g L(-1)) for 96 h. Catalase (CAT), @PROTEIN$ (GPx), superoxide dismutase (SOD), glutathione S-transferase (GST), reduced glutathione (GSH) and lipid peroxidation (LPO) levels in the gills, white muscle and liver were evaluated in fish fed on diets containing 0 or 1.5 mg Se kg(-1) for 8 weeks.	0	18655848-489
The antioxidant roles of selenium (Se) were evaluated in Brycon cephalus exposed to 2 mg L(-1) of Folisuper 600 BR (MP commercial formulation-MPc, 600 g L(-1)) for 96 h. Catalase (@PROTEIN$), glutathione peroxidase (GPx), superoxide dismutase (SOD), glutathione S-transferase (GST), @COMPOUND$ (GSH) and lipid peroxidation (LPO) levels in the gills, white muscle and liver were evaluated in fish fed on diets containing 0 or 1.5 mg Se kg(-1) for 8 weeks.	0	18655848-489
The antioxidant roles of selenium (Se) were evaluated in Brycon cephalus exposed to 2 mg L(-1) of Folisuper 600 BR (MP commercial formulation-MPc, 600 g L(-1)) for 96 h. @PROTEIN$ (CAT), glutathione peroxidase (GPx), superoxide dismutase (SOD), glutathione S-transferase (GST), reduced glutathione (@COMPOUND$) and lipid peroxidation (LPO) levels in the gills, white muscle and liver were evaluated in fish fed on diets containing 0 or 1.5 mg Se kg(-1) for 8 weeks.	0	18655848-489
The antioxidant roles of selenium (Se) were evaluated in Brycon cephalus exposed to 2 mg L(-1) of Folisuper 600 BR (MP commercial formulation-MPc, 600 g L(-1)) for 96 h. Catalase (CAT), glutathione peroxidase (GPx), superoxide dismutase (SOD), glutathione S-transferase (@PROTEIN$), reduced glutathione (@COMPOUND$) and lipid peroxidation (LPO) levels in the gills, white muscle and liver were evaluated in fish fed on diets containing 0 or 1.5 mg Se kg(-1) for 8 weeks.	0	18655848-489
The antioxidant roles of @COMPOUND$ (Se) were evaluated in Brycon cephalus exposed to 2 mg L(-1) of Folisuper 600 BR (MP commercial formulation-MPc, 600 g L(-1)) for 96 h. Catalase (CAT), glutathione peroxidase (GPx), @PROTEIN$ (SOD), glutathione S-transferase (GST), reduced glutathione (GSH) and lipid peroxidation (LPO) levels in the gills, white muscle and liver were evaluated in fish fed on diets containing 0 or 1.5 mg Se kg(-1) for 8 weeks.	0	18655848-489
The antioxidant roles of @COMPOUND$ (Se) were evaluated in Brycon cephalus exposed to 2 mg L(-1) of Folisuper 600 BR (MP commercial formulation-MPc, 600 g L(-1)) for 96 h. Catalase (CAT), glutathione peroxidase (GPx), superoxide dismutase (@PROTEIN$), glutathione S-transferase (GST), reduced glutathione (GSH) and lipid peroxidation (LPO) levels in the gills, white muscle and liver were evaluated in fish fed on diets containing 0 or 1.5 mg Se kg(-1) for 8 weeks.	0	18655848-489
The antioxidant roles of selenium (Se) were evaluated in Brycon cephalus exposed to 2 mg L(-1) of Folisuper 600 BR (MP commercial formulation-MPc, 600 g L(-1)) for 96 h. Catalase (CAT), glutathione peroxidase (GPx), superoxide dismutase (SOD), @PROTEIN$ (GST), @COMPOUND$ (GSH) and lipid peroxidation (LPO) levels in the gills, white muscle and liver were evaluated in fish fed on diets containing 0 or 1.5 mg Se kg(-1) for 8 weeks.	0	18655848-489
The antioxidant roles of selenium (Se) were evaluated in Brycon cephalus exposed to 2 mg L(-1) of Folisuper 600 BR (MP commercial formulation-MPc, 600 g L(-1)) for 96 h. Catalase (CAT), glutathione peroxidase (GPx), @PROTEIN$ (SOD), glutathione S-transferase (GST), @COMPOUND$ (GSH) and lipid peroxidation (LPO) levels in the gills, white muscle and liver were evaluated in fish fed on diets containing 0 or 1.5 mg Se kg(-1) for 8 weeks.	0	18655848-489
MPc also increased @PROTEIN$ activity in all tissues with a concurrent decrease in @COMPOUND$ levels.	0	18655848-490
@COMPOUND$ reverses ET-1-evoked mitogenic effects in human coronary arterial cells by activating the kinase-G to inhibit @PROTEIN$-enzymes.	1	18656273-863
@COMPOUND$ reverses @PROTEIN$-evoked mitogenic effects in human coronary arterial cells by activating the kinase-G to inhibit ERK-enzymes.	1	18656273-863
Pretreatment with the MEK-ERK inhibitor (@COMPOUND$) appreciably reversed the mitogenic effects of @PROTEIN$.	1	18656273-864
On the other hand, pretreatment with the polyphenolic @COMPOUND$ resveratrol (RSVL, 1-100 microM) triggered more prominent inhibition of ET-1-evoked cell proliferation and @PROTEIN$/2 activation.	0	18656273-865
On the other hand, pretreatment with the polyphenolic stilbene @COMPOUND$ (RSVL, 1-100 microM) triggered more prominent inhibition of ET-1-evoked cell proliferation and @PROTEIN$/2 activation.	1	18656273-865
Further, pretreatment with the specific cGMP-phosphodiesterase inhibitor, @COMPOUND$ (10 microM) appreciably augmented RSVL-evoked cGMP formation, @PROTEIN$ inhibition, and cytostatic response.	1	18656273-866
Moreover, the RSVL-induced @PROTEIN$-inhibitory effects were significantly reversed by the kinase-G inhibitor, KT-5823 (10 microM; 69%), but not by the kinase-A inhibitor (@COMPOUND$).	0	18656273-867
Moreover, the RSVL-induced @PROTEIN$-inhibitory effects were significantly reversed by the kinase-G inhibitor, @COMPOUND$ (10 microM; 69%), but not by the kinase-A inhibitor (KT-5720).	1	18656273-867
Adding @COMPOUND$ to the diet of the mice during the period of irradiation suppressed the activity and expression of @PROTEIN$ as well as the wrinkling and sagging formation.	1	18656335-913
Dietary @COMPOUND$ prevents the expression of @PROTEIN$, at least partly, by inhibiting photodynamic action involved in the formation of Chol-OOHs.	1	18656335-914
Exposure to @COMPOUND$ for 6 h induced expression of both caveolin-1 and cyclooxygenase (@PROTEIN$)-2.	1	18656337-916
Exposure to @COMPOUND$ for 6 h induced expression of both @PROTEIN$ and cyclooxygenase (COX)-2.	1	18656337-916
Pretreatment with @COMPOUND$ blocked fatty-acid-induced @PROTEIN$ and COX-2 expression in a time- and concentration-dependent manner.	1	18656337-917
Pretreatment with @COMPOUND$ blocked fatty-acid-induced caveolin-1 and @PROTEIN$ expression in a time- and concentration-dependent manner.	1	18656337-917
Exposure to @COMPOUND$ rapidly increased phosphorylation of several kinases, including @PROTEIN$, extracellular signal regulated kinase 1/2 (ERK1/2) and amino kinase terminal (Akt), with maximal induction at about 10 min.	1	18656337-918
Exposure to @COMPOUND$ rapidly increased phosphorylation of several kinases, including p38 MAPK, extracellular signal regulated kinase 1/2 (ERK1/2) and amino kinase terminal (@PROTEIN$), with maximal induction at about 10 min.	1	18656337-918
Exposure to @COMPOUND$ rapidly increased phosphorylation of several kinases, including p38 MAPK, @PROTEIN$/2 (ERK1/2) and amino kinase terminal (Akt), with maximal induction at about 10 min.	1	18656337-918
Exposure to @COMPOUND$ rapidly increased phosphorylation of several kinases, including p38 MAPK, extracellular signal regulated kinase 1/2 (@PROTEIN$/2) and amino kinase terminal (Akt), with maximal induction at about 10 min.	1	18656337-918
Inhibitors of ERK1/2 and Akt down-regulated the @COMPOUND$-induced increase in @PROTEIN$ protein, which also occurred after pretreatment with EGCG.	1	18656337-919
Inhibitors of ERK1/2 and Akt down-regulated the linoleic-acid-induced increase in @PROTEIN$ protein, which also occurred after pretreatment with @COMPOUND$.	1	18656337-919
Caveolin-1 silencing blocked @COMPOUND$-induced phosphorylation of @PROTEIN$/2 and protein expression of COX-2, suggesting that specific MAPK signaling is caveolae dependent.	1	18656337-920
@PROTEIN$ silencing blocked @COMPOUND$-induced phosphorylation of ERK1/2 and protein expression of COX-2, suggesting that specific MAPK signaling is caveolae dependent.	0	18656337-920
Caveolin-1 silencing blocked @COMPOUND$-induced phosphorylation of ERK1/2 and protein expression of COX-2, suggesting that specific @PROTEIN$ signaling is caveolae dependent.	1	18656337-920
Caveolin-1 silencing blocked @COMPOUND$-induced phosphorylation of ERK1/2 and protein expression of @PROTEIN$, suggesting that specific MAPK signaling is caveolae dependent.	1	18656337-920
@COMPOUND$ causes G(2)/M arrest associated with the modulation of p21 (Cip1) and @PROTEIN$ and activates p53-dependent apoptosis pathway in human breast cancer SK-BR-3 cells.	1	18656338-921
@COMPOUND$ causes G(2)/M arrest associated with the modulation of p21 (Cip1) and Cdc2 and activates @PROTEIN$-dependent apoptosis pathway in human breast cancer SK-BR-3 cells.	1	18656338-921
@COMPOUND$ causes G(2)/M arrest associated with the modulation of @PROTEIN$ (Cip1) and Cdc2 and activates p53-dependent apoptosis pathway in human breast cancer SK-BR-3 cells.	1	18656338-921
@COMPOUND$ causes G(2)/M arrest associated with the modulation of p21 (@PROTEIN$) and Cdc2 and activates p53-dependent apoptosis pathway in human breast cancer SK-BR-3 cells.	1	18656338-921
To investigate the regulatory proteins of cell cycle arrest affected by @COMPOUND$, we treated cells with 50 and 100 microM apigenin for 72 h. Apigenin caused a slight decrease in @PROTEIN$ and cyclin E expression, with no change in CDK2 and CDK4.	1	18656338-922
To investigate the regulatory proteins of cell cycle arrest affected by apigenin, we treated cells with 50 and 100 microM apigenin for 72 h. @COMPOUND$ caused a slight decrease in cyclin D and cyclin E expression, with no change in @PROTEIN$ and CDK4.	0	18656338-922
To investigate the regulatory proteins of cell cycle arrest affected by @COMPOUND$, we treated cells with 50 and 100 microM apigenin for 72 h. Apigenin caused a slight decrease in cyclin D and cyclin E expression, with no change in CDK2 and @PROTEIN$.	0	18656338-922
To investigate the regulatory proteins of cell cycle arrest affected by apigenin, we treated cells with 50 and 100 microM apigenin for 72 h. @COMPOUND$ caused a slight decrease in @PROTEIN$ and cyclin E expression, with no change in CDK2 and CDK4.	1	18656338-922
To investigate the regulatory proteins of cell cycle arrest affected by @COMPOUND$, we treated cells with 50 and 100 microM apigenin for 72 h. Apigenin caused a slight decrease in cyclin D and cyclin E expression, with no change in @PROTEIN$ and CDK4.	0	18656338-922
To investigate the regulatory proteins of cell cycle arrest affected by apigenin, we treated cells with 50 and 100 microM apigenin for 72 h. @COMPOUND$ caused a slight decrease in cyclin D and cyclin E expression, with no change in CDK2 and @PROTEIN$.	0	18656338-922
In addition, the @COMPOUND$-induced accumulation of the cell population in the G(2)/M phase resulted in a decrease in CDK1 together with @PROTEIN$ and cyclin B.	1	18656338-923
In addition, the @COMPOUND$-induced accumulation of the cell population in the G(2)/M phase resulted in a decrease in @PROTEIN$ together with cyclin A and cyclin B.	1	18656338-923
In an additional study, @COMPOUND$ also increased the accumulation of p53 and further enhanced the level of @PROTEIN$ (Cip1), with no change in p27 (Kip1).	1	18656338-924
In an additional study, @COMPOUND$ also increased the accumulation of p53 and further enhanced the level of p21 (@PROTEIN$), with no change in p27 (Kip1).	1	18656338-924
In an additional study, @COMPOUND$ also increased the accumulation of p53 and further enhanced the level of p21 (Cip1), with no change in @PROTEIN$ (Kip1).	0	18656338-924
In an additional study, @COMPOUND$ also increased the accumulation of @PROTEIN$ and further enhanced the level of p21 (Cip1), with no change in p27 (Kip1).	1	18656338-924
The expression of Bax and @PROTEIN$ of p53 downstream target was increased markedly at high concentration treatment over 50 microM @COMPOUND$.	1	18656338-925
The expression of Bax and cytochrome c of @PROTEIN$ downstream target was increased markedly at high concentration treatment over 50 microM @COMPOUND$.	1	18656338-925
The expression of @PROTEIN$ and cytochrome c of p53 downstream target was increased markedly at high concentration treatment over 50 microM @COMPOUND$.	1	18656338-925
Therefore, we next examined whether @PROTEIN$ and 5-HT2C receptors are involved, and from where 5-HT is released in the @COMPOUND$ test.	0	18656400-711
Therefore, we next examined whether @COMPOUND$2A and @PROTEIN$ receptors are involved, and from where 5-HT is released in the formalin test.	0	18656400-711
Therefore, we next examined whether 5-HT2A and @PROTEIN$ receptors are involved, and from where 5-HT is released in the @COMPOUND$ test.	0	18656400-711
These results indicate that @COMPOUND$ released into peripheral tissue and its receptors, @PROTEIN$ as well as 5-HT2C, at the periphery have an important role in pain-related behaviors during acute peripheral inflammation.	1	18656400-713
These results indicate that @COMPOUND$ released into peripheral tissue and its receptors, 5-HT2A as well as @PROTEIN$, at the periphery have an important role in pain-related behaviors during acute peripheral inflammation.	1	18656400-713
@COMPOUND$ strongly decreased the expression of @PROTEIN$ 0.01).	1	18656896-1449
In contrast, the administration of @COMPOUND$ significantly attenuated the immobilization stress-induced decrease in @PROTEIN$ 0.01).	1	18656896-1450
@COMPOUND$ exhibited differential effects on @PROTEIN$ mRNA expression in the rat hippocampus and neocortex.	1	18656896-1451
These results suggest that @COMPOUND$ might have a neuroprotective effect by recovering stress-induced decreases in @PROTEIN$ mRNA expression.	1	18656896-1452
In conclusion, @COMPOUND$ overload in rats induced hypertriglyceridemia and @PROTEIN$ resistance associated with an enhanced oxidative stress.	1	18657000-1427
Clinical and biochemical parameters including @COMPOUND$ (FAM), glycated hemoglobin (HbA1c) and serum @PROTEIN$ were investigated in children and adolescents with 1 type diabetes with (+DC) and without (-DC) complications.	0	18657005-297
Clinical and biochemical parameters including @COMPOUND$ (FAM), glycated @PROTEIN$ (HbA1c) and serum AGEs were investigated in children and adolescents with 1 type diabetes with (+DC) and without (-DC) complications.	0	18657005-297
Leptin and soluble @PROTEIN$ receptor changes after pulmonary endarterectomy: relations to @COMPOUND$ and cytokine network.	1	18657007-1437
@PROTEIN$ and soluble leptin receptor changes after pulmonary endarterectomy: relations to @COMPOUND$ and cytokine network.	1	18657007-1437
Leptin and soluble @PROTEIN$ receptor (SLR) were compared with evolution of @COMPOUND$ and inflammatory cytokines in twenty-two patients with chronic thromboembolic pulmonary hypertension treated with pulmonary endarterectomy using cardiopulmonary bypass (CBP) and deep hypothermic circulatory arrest (DHCA).	0	18657007-1438
@PROTEIN$ and soluble leptin receptor (SLR) were compared with evolution of @COMPOUND$ and inflammatory cytokines in twenty-two patients with chronic thromboembolic pulmonary hypertension treated with pulmonary endarterectomy using cardiopulmonary bypass (CBP) and deep hypothermic circulatory arrest (DHCA).	0	18657007-1438
Using this method, we also determined whether streptozotocin-induced DM in rats (4-week duration) leads to changes in renal subcellular targeting of @PROTEIN$, and evaluated the effects of tight metabolic control (insulin, 12 IU/day) and angiotensin receptor blocker, @COMPOUND$ (4 weeks, 20 mg/kg/day).	0	18657009-1440
Using this method, we also determined whether streptozotocin-induced DM in rats (4-week duration) leads to changes in renal subcellular targeting of CAV-1, and evaluated the effects of tight metabolic control (@PROTEIN$, 12 IU/day) and angiotensin receptor blocker, @COMPOUND$ (4 weeks, 20 mg/kg/day).	0	18657009-1440
Androgenic action correlates inversely with a polymorphic CAG repeat region in the AR gene encoding for glutamine residues the length of which appears to influence @PROTEIN$ (HDL) @COMPOUND$ levels.	1	18657194-724
Androgenic action correlates inversely with a polymorphic CAG repeat region in the AR gene encoding for @COMPOUND$ residues the length of which appears to influence @PROTEIN$ (HDL) cholesterol levels.	1	18657194-724
These vessels are formed by proliferating cells that incorporate @COMPOUND$ and express the endothelial cell markers vegfr2/@PROTEIN$ and fli1.	0	18657228-1396
These vessels are formed by proliferating cells that incorporate @COMPOUND$ and express the endothelial cell markers vegfr2/kdr and @PROTEIN$.	0	18657228-1396
Moreover, similar to rFGF2, injection of the zebrafish form of @PROTEIN$ (VEGF-A) induces a significant angiogenic response in the ZFYM assay that is suppressed by the VEGF receptor-2/KDR TK inhibitor @COMPOUND$.	1	18657228-1398
Moreover, similar to rFGF2, injection of the zebrafish form of vascular endothelial growth factor-A (@PROTEIN$) induces a significant angiogenic response in the ZFYM assay that is suppressed by the VEGF receptor-2/KDR TK inhibitor @COMPOUND$.	1	18657228-1398
In this study, we examined @COMPOUND$ for its ability to suppress redox-sensitive, proinflammatory NF-kappaB activation via NF-kappaB-inducing kinase (NIK)/@PROTEIN$ (IKK) and mitogen-activated protein kinases (MAPKs) by reducing oxidative stress in aged rats.	1	18657961-1695
In this study, we examined @COMPOUND$ for its ability to suppress redox-sensitive, proinflammatory NF-kappaB activation via NF-kappaB-inducing kinase (NIK)/IkappaB kinase (IKK) and @PROTEIN$ (MAPKs) by reducing oxidative stress in aged rats.	1	18657961-1695
In this study, we examined @COMPOUND$ for its ability to suppress redox-sensitive, proinflammatory NF-kappaB activation via NF-kappaB-inducing kinase (NIK)/IkappaB kinase (IKK) and mitogen-activated protein kinases (@PROTEIN$) by reducing oxidative stress in aged rats.	1	18657961-1695
In this study, we examined @COMPOUND$ for its ability to suppress redox-sensitive, proinflammatory NF-kappaB activation via NF-kappaB-inducing kinase (@PROTEIN$)/IkappaB kinase (IKK) and mitogen-activated protein kinases (MAPKs) by reducing oxidative stress in aged rats.	1	18657961-1695
Data show that in aged kidney tissue, @COMPOUND$ exhibited its antioxidative action by maintaining redox regulation, suppressing NF-kappaB activation and modulating the expression of NF-kappaB-induced, proinflammatory @PROTEIN$, iNOS, VCAM-1 and ICAM-1.	1	18657961-1696
Data show that in aged kidney tissue, @COMPOUND$ exhibited its antioxidative action by maintaining redox regulation, suppressing NF-kappaB activation and modulating the expression of NF-kappaB-induced, proinflammatory COX-2, iNOS, @PROTEIN$ and ICAM-1.	1	18657961-1696
Data show that in aged kidney tissue, @COMPOUND$ exhibited its antioxidative action by maintaining redox regulation, suppressing NF-kappaB activation and modulating the expression of NF-kappaB-induced, proinflammatory COX-2, @PROTEIN$, VCAM-1 and ICAM-1.	1	18657961-1696
Data show that in aged kidney tissue, @COMPOUND$ exhibited its antioxidative action by maintaining redox regulation, suppressing NF-kappaB activation and modulating the expression of NF-kappaB-induced, proinflammatory COX-2, iNOS, VCAM-1 and @PROTEIN$.	1	18657961-1696
The molecular modulation of NF-kappaB by @COMPOUND$ was further revealed in endothelial YPEN-1 cells through ferulate's ability to suppress the activation of @PROTEIN$/IKK and MAPKs.	1	18657961-1698
The molecular modulation of NF-kappaB by @COMPOUND$ was further revealed in endothelial YPEN-1 cells through ferulate's ability to suppress the activation of NIK/IKK and @PROTEIN$.	1	18657961-1698
Based on these results, we conclude that @COMPOUND$'s antioxidative capacity suppressed the age-related increase in NF-kappaB activity through inhibition of @PROTEIN$/IKK and MAPKs in vivo.	1	18657961-1699
Based on these results, we conclude that @COMPOUND$'s antioxidative capacity suppressed the age-related increase in NF-kappaB activity through inhibition of NIK/IKK and @PROTEIN$ in vivo.	1	18657961-1699
Previous studies have shown that wounding of human corneal epithelial cells (HCECs) results in the release of G-protein-coupled receptor ligands such as @COMPOUND$ and lysophosphatidic acid (LPA), which in turn transactivate epidermal growth factor (EGF) receptor (@PROTEIN$) through ectodomain shedding of heparin-binding EGF-like growth factor (HB-EGF).	1	18658095-656
Previous studies have shown that wounding of human corneal epithelial cells (HCECs) results in the release of G-protein-coupled receptor ligands such as ATP and @COMPOUND$ (LPA), which in turn transactivate epidermal growth factor (EGF) receptor (EGFR) through ectodomain shedding of heparin-binding EGF-like growth factor (@PROTEIN$).	1	18658095-656
Previous studies have shown that wounding of human corneal epithelial cells (HCECs) results in the release of G-protein-coupled receptor ligands such as @COMPOUND$ and lysophosphatidic acid (LPA), which in turn transactivate @PROTEIN$ (EGF) receptor (EGFR) through ectodomain shedding of heparin-binding EGF-like growth factor (HB-EGF).	1	18658095-656
Previous studies have shown that wounding of human corneal epithelial cells (HCECs) results in the release of G-protein-coupled receptor ligands such as ATP and @COMPOUND$ (LPA), which in turn transactivate epidermal growth factor (EGF) receptor (@PROTEIN$) through ectodomain shedding of heparin-binding EGF-like growth factor (HB-EGF).	1	18658095-656
Previous studies have shown that wounding of human corneal epithelial cells (HCECs) results in the release of G-protein-coupled receptor ligands such as ATP and @COMPOUND$ (LPA), which in turn transactivate epidermal growth factor (@PROTEIN$) receptor (EGFR) through ectodomain shedding of heparin-binding EGF-like growth factor (HB-EGF).	1	18658095-656
Previous studies have shown that wounding of human corneal epithelial cells (HCECs) results in the release of G-protein-coupled receptor ligands such as ATP and @COMPOUND$ (LPA), which in turn transactivate @PROTEIN$ (EGF) receptor (EGFR) through ectodomain shedding of heparin-binding EGF-like growth factor (HB-EGF).	1	18658095-656
Previous studies have shown that wounding of human corneal epithelial cells (HCECs) results in the release of G-protein-coupled receptor ligands such as @COMPOUND$ and lysophosphatidic acid (LPA), which in turn transactivate epidermal growth factor (@PROTEIN$) receptor (EGFR) through ectodomain shedding of heparin-binding EGF-like growth factor (HB-EGF).	1	18658095-656
Previous studies have shown that wounding of human corneal epithelial cells (HCECs) results in the release of G-protein-coupled receptor ligands such as @COMPOUND$ and lysophosphatidic acid (LPA), which in turn transactivate epidermal growth factor (EGF) receptor (EGFR) through ectodomain shedding of heparin-binding EGF-like growth factor (@PROTEIN$).	1	18658095-656
@COMPOUND$ is a free radical molecule synthesized from L-arginine by @PROTEIN$ that plays a critical role in various physiological and pathological processes, including tumor growth and angiogenesis.	1	18660796-396
Nitric oxide is a free radical molecule synthesized from @COMPOUND$ by @PROTEIN$ that plays a critical role in various physiological and pathological processes, including tumor growth and angiogenesis.	1	18660796-396
Furthermore, restoration of KSR1 expression in KSR (-/-) MEFs following stable transduction of cells with a KSR1 expression vector, enhanced sensitivity of cells to tunicamycin and @COMPOUND$ and decreased @PROTEIN$/2 activation following exposure to these drugs.	0	18661133-1463
Furthermore, restoration of @PROTEIN$ expression in KSR (-/-) MEFs following stable transduction of cells with a KSR1 expression vector, enhanced sensitivity of cells to tunicamycin and @COMPOUND$ and decreased ERK1/2 activation following exposure to these drugs.	1	18661133-1463
We demonstrated the increase in the levels of p53, Bax, and @PROTEIN$ and decrease in the level of Bcl-2, which are associated with the induction of apoptotic cell death after 24 h treatment with @COMPOUND$ in N18 cells.	1	18661233-1568
We demonstrated the increase in the levels of p53, Bax, and cytochrome c and decrease in the level of @PROTEIN$, which are associated with the induction of apoptotic cell death after 24 h treatment with @COMPOUND$ in N18 cells.	1	18661233-1568
We demonstrated the increase in the levels of p53, @PROTEIN$, and cytochrome c and decrease in the level of Bcl-2, which are associated with the induction of apoptotic cell death after 24 h treatment with @COMPOUND$ in N18 cells.	1	18661233-1568
We demonstrated the increase in the levels of @PROTEIN$, Bax, and cytochrome c and decrease in the level of Bcl-2, which are associated with the induction of apoptotic cell death after 24 h treatment with @COMPOUND$ in N18 cells.	1	18661233-1568
GFP-fluorescent cells were slowly cycling, as shown by their long-term retention of @COMPOUND$, and less than 10% expressed the proliferative markers Ki67 and @PROTEIN$.	0	18661547-124
@PROTEIN$ gene polymorphisms and high levels of @COMPOUND$ are associated with a high degree of steatosis and fibrosis, conditions associated with a low sustained virological response (SVR) rate.	0	18662278-741
@COMPOUND$ inhibits expression of ADAMTS4 (@PROTEIN$) in human osteoarthritic chondrocytes.	1	18662930-1285
@COMPOUND$ inhibits expression of @PROTEIN$ (aggrecanase-1) in human osteoarthritic chondrocytes.	1	18662930-1285
The discovery that a common polymorphism (@COMPOUND$TLPR, short variant) in the human serotonin transporter gene (@PROTEIN$) can influence personality traits and increase the risk for depression in adulthood has led to the hypothesis that a relative increase in the extracellular levels of serotonin (5-HT) during development could be critical for the establishment of brain circuits.	0	18663366-1650
Besides the biogenesis of lysosome-related organelles complex 1 and dystrophin-associated protein complex, several molecules in the DTNBP1 network likely provide insight into the role of DTNBP1 in biological systems: @COMPOUND$, beta-estradiol, @PROTEIN$ and tumour necrosis factor.	0	18663367-1653
Besides the biogenesis of lysosome-related organelles complex 1 and dystrophin-associated protein complex, several molecules in the @PROTEIN$ network likely provide insight into the role of DTNBP1 in biological systems: @COMPOUND$, beta-estradiol, calmodulin and tumour necrosis factor.	1	18663367-1653
Besides the biogenesis of lysosome-related organelles complex 1 and dystrophin-associated protein complex, several molecules in the DTNBP1 network likely provide insight into the role of DTNBP1 in biological systems: retinoic acid, @COMPOUND$, @PROTEIN$ and tumour necrosis factor.	0	18663367-1653
Besides the biogenesis of lysosome-related organelles complex 1 and dystrophin-associated protein complex, several molecules in the @PROTEIN$ network likely provide insight into the role of DTNBP1 in biological systems: retinoic acid, @COMPOUND$, calmodulin and tumour necrosis factor.	1	18663367-1653
Prior to the first dose of @COMPOUND$, serum concentrations of studied chemokines correlated with marker of RA activity such as the erythrocyte sedimentation rate and @PROTEIN$ level with DAS.	0	18663553-101
Hypothetically, @PROTEIN$ influences the transport of @COMPOUND$ across the blood-brain barrier.	1	18663559-103
Most genes involved in lipid metabolism and especially in ergosterol biosynthesis were up-regulated in response to @COMPOUND$, including ERG6, @PROTEIN$, ERG11, ERG24, ERG25 and ERG26.	1	18663659-168
Most genes involved in lipid metabolism and especially in ergosterol biosynthesis were up-regulated in response to @COMPOUND$, including ERG6, ERG7, @PROTEIN$, ERG24, ERG25 and ERG26.	1	18663659-168
Most genes involved in lipid metabolism and especially in ergosterol biosynthesis were up-regulated in response to @COMPOUND$, including @PROTEIN$, ERG7, ERG11, ERG24, ERG25 and ERG26.	1	18663659-168
Most genes involved in lipid metabolism and especially in ergosterol biosynthesis were up-regulated in response to @COMPOUND$, including ERG6, ERG7, ERG11, ERG24, @PROTEIN$ and ERG26.	1	18663659-168
Most genes involved in lipid metabolism and especially in ergosterol biosynthesis were up-regulated in response to @COMPOUND$, including ERG6, ERG7, ERG11, ERG24, ERG25 and @PROTEIN$.	1	18663659-168
Most genes involved in lipid metabolism and especially in ergosterol biosynthesis were up-regulated in response to @COMPOUND$, including ERG6, ERG7, ERG11, @PROTEIN$, ERG25 and ERG26.	1	18663659-168
In prolonged OJ with LPS administration, hepatocyte apoptosis depending on @PROTEIN$ expression significantly increased in association with a decrease in @COMPOUND$ contents, thus resulting in liver necrapoptosis.	0	18665046-1318
Administration of @COMPOUND$ to inhibit HMGB1 or anti-RAGE antibody could significantly decrease expression levels of CTLA-4, @PROTEIN$ on Tregs, and IL-10 production after burns.	1	18665051-1321
Administration of @COMPOUND$ to inhibit HMGB1 or anti-RAGE antibody could significantly decrease expression levels of CTLA-4, Foxp3 on Tregs, and @PROTEIN$ production after burns.	1	18665051-1321
Administration of @COMPOUND$ to inhibit HMGB1 or anti-RAGE antibody could significantly decrease expression levels of @PROTEIN$, Foxp3 on Tregs, and IL-10 production after burns.	1	18665051-1321
In contrast, the degree of (1) spinal cord inflammation and tissue injury (histological score), (2) nitrotyrosine and poly(@COMPOUND$ (ADP) ribose) formation, (3) @PROTEIN$ expression, (4) nuclear factor-kappaB activation, and (5) apoptosis (terminal deoxynucleotidyltransferase-mediated dUTP-biotin end labeling, Bax, and Bcl-2) was markedly reduced in spinal cord tissue obtained from mice treated with glycyrrhizin extract (10 mg/kg, i.p., 30 min before and 1 and 6 h after SCI).	0	18665052-290
In contrast, the degree of (1) spinal cord inflammation and tissue injury (histological score), (2) nitrotyrosine and poly(adenosine diphosphate (ADP) ribose) formation, (3) iNOS expression, (4) nuclear factor-kappaB activation, and (5) apoptosis (terminal deoxynucleotidyltransferase-mediated dUTP-biotin end labeling, @PROTEIN$, and Bcl-2) was markedly reduced in spinal cord tissue obtained from mice treated with @COMPOUND$ extract (10 mg/kg, i.p., 30 min before and 1 and 6 h after SCI).	1	18665052-290
In contrast, the degree of (1) spinal cord inflammation and tissue injury (histological score), (2) nitrotyrosine and poly(@COMPOUND$ (ADP) ribose) formation, (3) iNOS expression, (4) nuclear factor-kappaB activation, and (5) apoptosis (terminal deoxynucleotidyltransferase-mediated dUTP-biotin end labeling, Bax, and @PROTEIN$) was markedly reduced in spinal cord tissue obtained from mice treated with glycyrrhizin extract (10 mg/kg, i.p., 30 min before and 1 and 6 h after SCI).	0	18665052-290
In contrast, the degree of (1) spinal cord inflammation and tissue injury (histological score), (2) nitrotyrosine and poly(adenosine diphosphate (ADP) ribose) formation, (3) @PROTEIN$ expression, (4) nuclear factor-kappaB activation, and (5) apoptosis (terminal deoxynucleotidyltransferase-mediated dUTP-biotin end labeling, Bax, and Bcl-2) was markedly reduced in spinal cord tissue obtained from mice treated with @COMPOUND$ extract (10 mg/kg, i.p., 30 min before and 1 and 6 h after SCI).	1	18665052-290
In contrast, the degree of (1) spinal cord inflammation and tissue injury (histological score), (2) nitrotyrosine and poly(@COMPOUND$ (ADP) ribose) formation, (3) iNOS expression, (4) nuclear factor-kappaB activation, and (5) apoptosis (terminal deoxynucleotidyltransferase-mediated dUTP-biotin end labeling, @PROTEIN$, and Bcl-2) was markedly reduced in spinal cord tissue obtained from mice treated with glycyrrhizin extract (10 mg/kg, i.p., 30 min before and 1 and 6 h after SCI).	0	18665052-290
In contrast, the degree of (1) spinal cord inflammation and tissue injury (histological score), (2) nitrotyrosine and poly(@COMPOUND$ (ADP) ribose) formation, (3) iNOS expression, (4) nuclear factor-kappaB activation, and (5) apoptosis (@PROTEIN$-mediated dUTP-biotin end labeling, Bax, and Bcl-2) was markedly reduced in spinal cord tissue obtained from mice treated with glycyrrhizin extract (10 mg/kg, i.p., 30 min before and 1 and 6 h after SCI).	0	18665052-290
In contrast, the degree of (1) spinal cord inflammation and tissue injury (histological score), (2) nitrotyrosine and poly(adenosine diphosphate (ADP) ribose) formation, (3) iNOS expression, (4) nuclear factor-kappaB activation, and (5) apoptosis (@PROTEIN$-mediated dUTP-biotin end labeling, Bax, and Bcl-2) was markedly reduced in spinal cord tissue obtained from mice treated with @COMPOUND$ extract (10 mg/kg, i.p., 30 min before and 1 and 6 h after SCI).	1	18665052-290
In contrast, the degree of (1) spinal cord inflammation and tissue injury (histological score), (2) nitrotyrosine and poly(adenosine diphosphate (ADP) ribose) formation, (3) iNOS expression, (4) nuclear factor-kappaB activation, and (5) apoptosis (terminal deoxynucleotidyltransferase-mediated dUTP-biotin end labeling, Bax, and @PROTEIN$) was markedly reduced in spinal cord tissue obtained from mice treated with @COMPOUND$ extract (10 mg/kg, i.p., 30 min before and 1 and 6 h after SCI).	1	18665052-290
@COMPOUND$ attenuated mast cell recruitment thereby decreased the expressions of @PROTEIN$ and 9 in rat liver carcinogenesis.	1	18665326-1562
@COMPOUND$ administered rats showed increased MCD as revealed by toluidine blue staining along with upregulated expressions of MMP-2 and @PROTEIN$.	1	18665326-1563
@COMPOUND$ administered rats showed increased MCD as revealed by toluidine blue staining along with upregulated expressions of @PROTEIN$ and MMP-9.	1	18665326-1563
@COMPOUND$ treatment inhibited this increase in MCD and downregulated the expressions of @PROTEIN$ and MMP-9 as revealed by Western blotting and immunohistochemistry.	1	18665326-1564
@COMPOUND$ treatment inhibited this increase in MCD and downregulated the expressions of MMP-2 and @PROTEIN$ as revealed by Western blotting and immunohistochemistry.	1	18665326-1564
In conclusion, @COMPOUND$ exerted beneficial effects on liver carcinogenesis by attenuating the recruitment of mast cells and thereby decreased the expressions of @PROTEIN$ and MMP-9.	1	18665326-1565
In conclusion, @COMPOUND$ exerted beneficial effects on liver carcinogenesis by attenuating the recruitment of mast cells and thereby decreased the expressions of MMP-2 and @PROTEIN$.	1	18665326-1565
As a result, combined @COMPOUND$ and @PROTEIN$ infusion significantly decreased plasma K+ concentration despite a significant decrease of urinary K+ excretion in sgk1+/+ but not in sgk1-/-mice.	0	18665390-1624
While it is clearly demonstrated that members of the @PROTEIN$/6/7 subfamily are activated by @COMPOUND$, the mechanism by which phospholipase C activates members of the TRPC1/4/5 subfamily remains a mystery.	1	18665391-1625
While it is clearly demonstrated that members of the TRPC3/6/7 subfamily are activated by @COMPOUND$, the mechanism by which phospholipase C activates members of the @PROTEIN$/4/5 subfamily remains a mystery.	0	18665391-1625
Depletion of polyphosphatidylinositol 4-phosphate and @COMPOUND$ (PIP2) through inhibition of @PROTEIN$ activates calcium entry and membrane currents in TRPC5-expressing but not in TRPC3-or TRPC7-expressing cells.	1	18665391-1626
Depletion of polyphosphatidylinositol 4-phosphate and @COMPOUND$ (PIP2) through inhibition of phosphatidylinositol 4-kinase activates calcium entry and membrane currents in TRPC5-expressing but not in @PROTEIN$-or TRPC7-expressing cells.	0	18665391-1626
Depletion of polyphosphatidylinositol 4-phosphate and @COMPOUND$ (PIP2) through inhibition of phosphatidylinositol 4-kinase activates calcium entry and membrane currents in TRPC5-expressing but not in TRPC3-or @PROTEIN$-expressing cells.	0	18665391-1626
Depletion of polyphosphatidylinositol 4-phosphate and @COMPOUND$ (PIP2) through inhibition of phosphatidylinositol 4-kinase activates calcium entry and membrane currents in @PROTEIN$-expressing but not in TRPC3-or TRPC7-expressing cells.	0	18665391-1626
Inclusion of polyphosphatidylinositol 4-phosphate or PIP2, but not @COMPOUND$, in the patch pipette inhibited @PROTEIN$ currents.	0	18665391-1627
Osteogenic differentiation was enhanced after treatment with @COMPOUND$ as confirmed by Alizarin Red S staining, elevated alkaline phosphatase activity and @PROTEIN$ mRNA expression, a greater calcium peak by energy-dispersive xray spectrophotometry, and by immunofluorescence staining against CD44 by flow cytometric analysis.	1	18665432-1672
Osteogenic differentiation was enhanced after treatment with @COMPOUND$ as confirmed by Alizarin Red S staining, elevated @PROTEIN$ activity and osteocalcin mRNA expression, a greater calcium peak by energy-dispersive xray spectrophotometry, and by immunofluorescence staining against CD44 by flow cytometric analysis.	1	18665432-1672
Osteogenic differentiation was enhanced after treatment with @COMPOUND$ as confirmed by Alizarin Red S staining, elevated alkaline phosphatase activity and osteocalcin mRNA expression, a greater calcium peak by energy-dispersive xray spectrophotometry, and by immunofluorescence staining against @PROTEIN$ by flow cytometric analysis.	1	18665432-1672
@PROTEIN$ inhibits contraction and proliferation of human aortic smooth muscle cells by @COMPOUND$/PKA pathway activation.	1	18667202-1391
@PROTEIN$ was able to inhibit angiotensin II-induced proliferation and contraction in a dose-response fashion via the @COMPOUND$/PKA pathway.	1	18667202-1393
The results indicated that the backbone of @PROTEIN$ was composed of (1--&gt;6)-linked-alpha-D-galactopyranosyl and (1--&gt;2,6)-linked-alpha-D-galactopyranosyl residues, which were terminated with a single terminal (1--&gt;)-@COMPOUND$ residue at the O-2 position of galactosyl along the main chain in the ratio of 1:1:1.	1	18667302-1496
The results indicated that the backbone of @PROTEIN$ was composed of (1--&gt;6)-linked-alpha-@COMPOUND$ and (1--&gt;2,6)-linked-alpha-D-galactopyranosyl residues, which were terminated with a single terminal (1--&gt;)-beta-D-glucose residue at the O-2 position of galactosyl along the main chain in the ratio of 1:1:1.	1	18667302-1496
Preliminary tests in vitro showed POP is capable of enhancing concanavalin A (@PROTEIN$)-or @COMPOUND$ (LPS)-induced lymphocyte proliferation, which suggested that POP could be a potential immunostimulating agent for use in functional foods or medicine against both pathogens and cancer.	0	18667302-1497
Preliminary tests in vitro showed @PROTEIN$ is capable of enhancing concanavalin A (ConA)-or @COMPOUND$ (LPS)-induced lymphocyte proliferation, which suggested that POP could be a potential immunostimulating agent for use in functional foods or medicine against both pathogens and cancer.	1	18667302-1497
Preliminary tests in vitro showed POP is capable of enhancing @PROTEIN$ (ConA)-or @COMPOUND$ (LPS)-induced lymphocyte proliferation, which suggested that POP could be a potential immunostimulating agent for use in functional foods or medicine against both pathogens and cancer.	0	18667302-1497
Inhibition of the phosphatidyl-inositol-3 kinase/Akt pathway by @COMPOUND$ and specific abrogation of Akt1 protein using small-interfering RNA revealed a regulatory function of Akt1 in @PROTEIN$-mediated VEGF biosynthesis in keratinocytes.	0	18668138-492
Inhibition of the phosphatidyl-inositol-3 kinase/Akt pathway by @COMPOUND$ and specific abrogation of Akt1 protein using small-interfering RNA revealed a regulatory function of Akt1 in insulin-mediated @PROTEIN$ biosynthesis in keratinocytes.	0	18668138-492
Inhibition of the phosphatidyl-inositol-3 kinase/Akt pathway by @COMPOUND$ and specific abrogation of @PROTEIN$ protein using small-interfering RNA revealed a regulatory function of Akt1 in insulin-mediated VEGF biosynthesis in keratinocytes.	0	18668138-492
Cross-linked hydrogels showed increased resistance to digestion by testicular @PROTEIN$ and hyaluronidase SD with increasing @COMPOUND$ concentration.	1	18668211-556
@COMPOUND$ (CPF), a commonly used organophosphorus insecticide, induces @PROTEIN$ inhibition and cholinergic toxicity.	1	18668222-95
Role of @PROTEIN$ in apoptosis induced by @COMPOUND$.	1	18668243-580
It was observed that administration of the PKC inhibitor @COMPOUND$ (5 mg/kg) suppressed the activation of three exercise-induced PKC isoforms (PKCalpha, @PROTEIN$, and PKCepsilon) and attenuated the exercise-mediated reduction of myocardial infarct size during ischemia-reperfusion injury.	1	18668351-55
It was observed that administration of the PKC inhibitor @COMPOUND$ (5 mg/kg) suppressed the activation of three exercise-induced PKC isoforms (@PROTEIN$, PKCdelta, and PKCepsilon) and attenuated the exercise-mediated reduction of myocardial infarct size during ischemia-reperfusion injury.	1	18668351-55
@COMPOUND$ is known to have regulatory effects on gastrointestinal functions via the vanilloid receptor (@PROTEIN$).	1	18668366-689
Cholesteryl ester transfer protein (@PROTEIN$) is a plasma glycoprotein that facilitates the transfer of neutral lipids and phospholipids between lipoproteins and contributes to the regulation of the plasma concentration of high density lipoprotein @COMPOUND$ (HDL-C).	1	18670196-1382
Cholesteryl ester transfer protein (CETP) is a plasma glycoprotein that facilitates the transfer of neutral lipids and phospholipids between lipoproteins and contributes to the regulation of the plasma concentration of @PROTEIN$ @COMPOUND$ (HDL-C).	1	18670196-1382
Cholesteryl ester transfer protein (CETP) is a plasma @PROTEIN$ that facilitates the transfer of neutral lipids and phospholipids between lipoproteins and contributes to the regulation of the plasma concentration of high density lipoprotein @COMPOUND$ (HDL-C).	1	18670196-1382
@PROTEIN$ (CETP) is a plasma glycoprotein that facilitates the transfer of neutral lipids and phospholipids between lipoproteins and contributes to the regulation of the plasma concentration of high density lipoprotein @COMPOUND$ (HDL-C).	1	18670196-1382
These studies frequently showed that erythropoietic stimulating agents (ESA) with oral or IV iron often resulted in improvement in left ventricular systolic and diastolic function, dilation, and hypertrophy, stabilization or improvement in renal function, reduced hospitalizations, diuretic dose, mitral regurgitation, pulmonary artery pressure, plasma volume, heart rate, serum brain natriuretic peptide levels, and the inflammatory markers C reactive protein and @PROTEIN$, and an improvement in New York Heart Association class, exercise capacity, @COMPOUND$ utilization during exercise, sleep apnea, caloric intake, depression, and quality of life.	0	18670732-960
These studies frequently showed that erythropoietic stimulating agents (ESA) with oral or IV iron often resulted in improvement in left ventricular systolic and diastolic function, dilation, and hypertrophy, stabilization or improvement in renal function, reduced hospitalizations, diuretic dose, mitral regurgitation, pulmonary artery pressure, plasma volume, heart rate, serum @PROTEIN$ levels, and the inflammatory markers C reactive protein and Interleukin 6, and an improvement in New York Heart Association class, exercise capacity, @COMPOUND$ utilization during exercise, sleep apnea, caloric intake, depression, and quality of life.	0	18670732-960
DNA sequences of a calmodulin (@PROTEIN$)-encoding gene region containing three exons, two introns and a 411-bp mt intergenic spacer (IGS) spanning the cytochrome b (cytb) and @COMPOUND$ 2 genes, were obtained from 49 Acropora species.	0	18670809-1037
DNA sequences of a calmodulin (CaM)-encoding gene region containing three exons, two introns and a 411-bp mt intergenic spacer (IGS) spanning the @PROTEIN$ (cytb) and @COMPOUND$ 2 genes, were obtained from 49 Acropora species.	0	18670809-1037
DNA sequences of a calmodulin (CaM)-encoding gene region containing three exons, two introns and a 411-bp mt intergenic spacer (IGS) spanning the cytochrome b (@PROTEIN$) and @COMPOUND$ 2 genes, were obtained from 49 Acropora species.	0	18670809-1037
DNA sequences of a @PROTEIN$ (CaM)-encoding gene region containing three exons, two introns and a 411-bp mt intergenic spacer (IGS) spanning the cytochrome b (cytb) and @COMPOUND$ 2 genes, were obtained from 49 Acropora species.	0	18670809-1037
Both expression of tac and @PROTEIN$ were induced by 2% @COMPOUND$.	1	18670810-1039
Contaminants of current high use in the LRGV, such as atrazine, and some of the highly persistent organochlorines, such as @COMPOUND$ and DDE, could be potentially associated with modulation of @PROTEIN$ activity in avian tissues.	1	18670880-1082
Contaminants of current high use in the LRGV, such as @COMPOUND$, and some of the highly persistent organochlorines, such as toxaphene and DDE, could be potentially associated with modulation of @PROTEIN$ activity in avian tissues.	1	18670880-1082
Contaminants of current high use in the LRGV, such as atrazine, and some of the highly persistent organochlorines, such as toxaphene and @COMPOUND$, could be potentially associated with modulation of @PROTEIN$ activity in avian tissues.	1	18670880-1082
In this view, this study aimed at the investigating the use of a crude @PROTEIN$ preparation from onion solid by-products for oxidising @COMPOUND$, a widespread o-diphenol, whose various derivatives may occur in food industry wastes, such as olive mill waste waters.	1	18670892-1460
@COMPOUND$ exposures that caused a loss of binding function were examined for effects on expression of key NK cell-@PROTEIN$ needed for binding to targets.	0	18670896-1090
Here, we have investigated how the post-synthetic acetylation of @PROTEIN$ affects its interaction with negatively supercoiled DNA by employing monoacetylated at Lys2 protein, isolated from @COMPOUND$-treated cells.	0	18670905-814
@PROTEIN$ protein contains high glycine and @COMPOUND$, which concerns regulation and function of the matrix structure fiber.	1	18670906-1096
@PROTEIN$ protein contains high @COMPOUND$ and tyrosine, which concerns regulation and function of the matrix structure fiber.	1	18670906-1096
@COMPOUND$ inhibited MIH induced Mos expression and its phosphorylation, which in turn reduced @PROTEIN$ phosphorylation and GVBD.	1	18671273-1368
@COMPOUND$ inhibited MIH induced @PROTEIN$ expression and its phosphorylation, which in turn reduced Myt1 phosphorylation and GVBD.	1	18671273-1368
@COMPOUND$ inhibited @PROTEIN$ induced Mos expression and its phosphorylation, which in turn reduced Myt1 phosphorylation and GVBD.	1	18671273-1368
@COMPOUND$ levels were found to increase approximately 20-fold 24 h after macrophage activation with Escherichia coli lipopolysaccharide plus @PROTEIN$ ; this response was concurrent with an increase in the expression of NOS2 (inducible nitric oxide synthase) and was inhibited by the (*)NO (nitric oxide) inhibitor L-NAME (N(G)-nitro-L-arginine methyl ester).	1	18671672-48
CLNO2 levels were found to increase approximately 20-fold 24 h after macrophage activation with Escherichia coli lipopolysaccharide plus @PROTEIN$ ; this response was concurrent with an increase in the expression of NOS2 (inducible nitric oxide synthase) and was inhibited by the (*)NO (nitric oxide) inhibitor L-NAME (@COMPOUND$).	0	18671672-48
@COMPOUND$ levels were found to increase approximately 20-fold 24 h after macrophage activation with Escherichia coli lipopolysaccharide plus interferon-gamma ; this response was concurrent with an increase in the expression of NOS2 (inducible @PROTEIN$) and was inhibited by the (*)NO (nitric oxide) inhibitor L-NAME (N(G)-nitro-L-arginine methyl ester).	1	18671672-48
CLNO2 levels were found to increase approximately 20-fold 24 h after macrophage activation with Escherichia coli @COMPOUND$ plus interferon-gamma ; this response was concurrent with an increase in the expression of @PROTEIN$ (inducible nitric oxide synthase) and was inhibited by the (*)NO (nitric oxide) inhibitor L-NAME (N(G)-nitro-L-arginine methyl ester).	1	18671672-48
CLNO2 levels were found to increase approximately 20-fold 24 h after macrophage activation with Escherichia coli lipopolysaccharide plus interferon-gamma ; this response was concurrent with an increase in the expression of @PROTEIN$ (inducible nitric oxide synthase) and was inhibited by the (*)NO (nitric oxide) inhibitor L-NAME (@COMPOUND$).	0	18671672-48
CLNO2 levels were found to increase approximately 20-fold 24 h after macrophage activation with Escherichia coli @COMPOUND$ plus interferon-gamma ; this response was concurrent with an increase in the expression of NOS2 (inducible @PROTEIN$) and was inhibited by the (*)NO (nitric oxide) inhibitor L-NAME (N(G)-nitro-L-arginine methyl ester).	0	18671672-48
@COMPOUND$ levels were found to increase approximately 20-fold 24 h after macrophage activation with Escherichia coli lipopolysaccharide plus interferon-gamma ; this response was concurrent with an increase in the expression of @PROTEIN$ (inducible nitric oxide synthase) and was inhibited by the (*)NO (nitric oxide) inhibitor L-NAME (N(G)-nitro-L-arginine methyl ester).	1	18671672-48
CLNO2 levels were found to increase approximately 20-fold 24 h after macrophage activation with Escherichia coli @COMPOUND$ plus @PROTEIN$ ; this response was concurrent with an increase in the expression of NOS2 (inducible nitric oxide synthase) and was inhibited by the (*)NO (nitric oxide) inhibitor L-NAME (N(G)-nitro-L-arginine methyl ester).	0	18671672-48
CLNO2 levels were found to increase approximately 20-fold 24 h after macrophage activation with Escherichia coli lipopolysaccharide plus interferon-gamma ; this response was concurrent with an increase in the expression of NOS2 (inducible @PROTEIN$) and was inhibited by the (*)NO (nitric oxide) inhibitor L-NAME (@COMPOUND$).	0	18671672-48
@COMPOUND$-mediated ubiquitination regulates @PROTEIN$.	1	18671761-109
Short-acting @PROTEIN$ analogues, in comparison with regular human insulin (HRI), provide a greater control of postprandial @COMPOUND$, while their superiority on haemoglobin A1c (HbA1c) is controversial.	1	18671795-129
Short-acting insulin analogues, in comparison with regular human insulin (@PROTEIN$), provide a greater control of postprandial @COMPOUND$, while their superiority on haemoglobin A1c (HbA1c) is controversial.	1	18671795-129
Western blotting showed that @COMPOUND$ down-regulated @PROTEIN$ protein expression in the BA, which in the SAH-only group was significantly higher than that of the normal group.	1	18671897-205
Hepatocytes exposed to resistin, but only in the presence of @PROTEIN$, show a decrease in insulin-stimulated @COMPOUND$ content.	1	18672341-581
Differentiated EBD cells in both monolayer and three-dimensional in vitro culture demonstrated fat granules by light microscopy, stained positive for lipids with @COMPOUND$, and expressed adipocyte-specific genes (lipoprotein @PROTEIN$ (LPL), peroxisome proliferator activated receptor gamma2, and adipocyte-specific fatty acid binding protein (alphaP2)).	0	18673089-1229
Differentiated EBD cells in both monolayer and three-dimensional in vitro culture demonstrated fat granules by light microscopy, stained positive for lipids with @COMPOUND$, and expressed adipocyte-specific genes (lipoprotein lipase (LPL), peroxisome proliferator activated receptor gamma2, and adipocyte-specific @PROTEIN$ (alphaP2)).	0	18673089-1229
Differentiated EBD cells in both monolayer and three-dimensional in vitro culture demonstrated fat granules by light microscopy, stained positive for lipids with @COMPOUND$, and expressed adipocyte-specific genes (lipoprotein lipase (@PROTEIN$), peroxisome proliferator activated receptor gamma2, and adipocyte-specific fatty acid binding protein (alphaP2)).	0	18673089-1229
Differentiated EBD cells in both monolayer and three-dimensional in vitro culture demonstrated fat granules by light microscopy, stained positive for lipids with @COMPOUND$, and expressed adipocyte-specific genes (lipoprotein lipase (LPL), peroxisome proliferator activated receptor @PROTEIN$, and adipocyte-specific fatty acid binding protein (alphaP2)).	0	18673089-1229
In addition, AIT induced a more favourable regulation of blood @COMPOUND$ and @PROTEIN$ compared with MTG.	0	18673303-1358
Beta1,4-@PROTEIN$-I (B4GALT1), one of seven beta1,4-galactosyltransferases, is an enzyme commonly found in the trans-Golgi complex that adds @COMPOUND$ to oligosaccharides.	1	18673333-52
Beta1,4-galactosyltransferase-I (@PROTEIN$), one of seven beta1,4-galactosyltransferases, is an enzyme commonly found in the trans-Golgi complex that adds @COMPOUND$ to oligosaccharides.	1	18673333-52
Beta1,4-galactosyltransferase-I (B4GALT1), one of seven beta1,4-@PROTEIN$, is an enzyme commonly found in the trans-Golgi complex that adds @COMPOUND$ to oligosaccharides.	1	18673333-52
When compared to the other mammalian @PROTEIN$ genes, the porcine coding sequence contained a single @COMPOUND$ codon inserted into the region encoding the cytoplasmic domain.	1	18673333-53
@COMPOUND$ inhibited the levels of the anti-apoptotic proteins @PROTEIN$ and Bcl-xl, but promoted the levels of the pro-apoptotic protein Bax.	1	18674953-1307
@COMPOUND$ inhibited the levels of the anti-apoptotic proteins Bcl-2 and Bcl-xl, but promoted the levels of the pro-apoptotic @PROTEIN$.	1	18674953-1307
In conclusion, Gyp induced ER stress and production of reactive @COMPOUND$ species and Ca(2+), change the ratio of @PROTEIN$ and Bax, followed by the dysfunction of mitochondria, caused cytochrome c release, activation of caspase-3 before leading to apoptosis.	0	18674953-1308
In conclusion, Gyp induced ER stress and production of reactive oxygen species and @COMPOUND$+), change the ratio of Bcl-2 and @PROTEIN$, followed by the dysfunction of mitochondria, caused cytochrome c release, activation of caspase-3 before leading to apoptosis.	0	18674953-1308
In conclusion, Gyp induced ER stress and production of reactive oxygen species and @COMPOUND$+), change the ratio of @PROTEIN$ and Bax, followed by the dysfunction of mitochondria, caused cytochrome c release, activation of caspase-3 before leading to apoptosis.	0	18674953-1308
In conclusion, Gyp induced ER stress and production of reactive @COMPOUND$ species and Ca(2+), change the ratio of Bcl-2 and Bax, followed by the dysfunction of mitochondria, caused @PROTEIN$ release, activation of caspase-3 before leading to apoptosis.	0	18674953-1308
In conclusion, @COMPOUND$ induced ER stress and production of reactive oxygen species and Ca(2+), change the ratio of @PROTEIN$ and Bax, followed by the dysfunction of mitochondria, caused cytochrome c release, activation of caspase-3 before leading to apoptosis.	1	18674953-1308
In conclusion, Gyp induced ER stress and production of reactive oxygen species and @COMPOUND$+), change the ratio of Bcl-2 and Bax, followed by the dysfunction of mitochondria, caused @PROTEIN$ release, activation of caspase-3 before leading to apoptosis.	0	18674953-1308
In conclusion, @COMPOUND$ induced ER stress and production of reactive oxygen species and Ca(2+), change the ratio of Bcl-2 and Bax, followed by the dysfunction of mitochondria, caused @PROTEIN$ release, activation of caspase-3 before leading to apoptosis.	1	18674953-1308
In conclusion, Gyp induced ER stress and production of reactive @COMPOUND$ species and Ca(2+), change the ratio of Bcl-2 and @PROTEIN$, followed by the dysfunction of mitochondria, caused cytochrome c release, activation of caspase-3 before leading to apoptosis.	0	18674953-1308
In conclusion, @COMPOUND$ induced ER stress and production of reactive oxygen species and Ca(2+), change the ratio of Bcl-2 and @PROTEIN$, followed by the dysfunction of mitochondria, caused cytochrome c release, activation of caspase-3 before leading to apoptosis.	1	18674953-1308
To compare expression of endometrial estrogen (ER) and progesterone (PR) receptors, beta(3)-integrin subunit, leukemia inhibitory factor (LIF), interleukin-6 (@PROTEIN$), and pinopodes in Indian women using @COMPOUND$ as a contraceptive with fertile and infertile subjects during the window of implantation.	1	18675966-641
To compare expression of endometrial estrogen (ER) and progesterone (PR) receptors, beta(3)-integrin subunit, leukemia inhibitory factor (LIF), @PROTEIN$ (IL-6), and pinopodes in Indian women using @COMPOUND$ as a contraceptive with fertile and infertile subjects during the window of implantation.	1	18675966-641
To compare expression of endometrial estrogen (ER) and progesterone (PR) receptors, beta(3)-integrin subunit, leukemia inhibitory factor (@PROTEIN$), interleukin-6 (IL-6), and pinopodes in Indian women using @COMPOUND$ as a contraceptive with fertile and infertile subjects during the window of implantation.	1	18675966-641
We have also observed that the reduction of transition at 95+/-3 degrees C in thermal scans of nuclear preparations isolated from blood of B-CLL randomized patients who showed response to @COMPOUND$ or fludarabine combined with cyclophosphamide, i.e., CC and FC, respectively, corresponded with the decrease or disappearance of anti-apoptotic proteins @PROTEIN$ and/or Mcl 1.	0	18676014-229
We have also observed that the reduction of transition at 95+/-3 degrees C in thermal scans of nuclear preparations isolated from blood of B-CLL randomized patients who showed response to cladribine or fludarabine combined with @COMPOUND$, i.e., CC and FC, respectively, corresponded with the decrease or disappearance of anti-apoptotic proteins @PROTEIN$ and/or Mcl 1.	0	18676014-229
We have also observed that the reduction of transition at 95+/-3 degrees C in thermal scans of nuclear preparations isolated from blood of B-CLL randomized patients who showed response to cladribine or @COMPOUND$ combined with cyclophosphamide, i.e., CC and FC, respectively, corresponded with the decrease or disappearance of anti-apoptotic proteins Bcl-2 and/or @PROTEIN$ 1.	0	18676014-229
We have also observed that the reduction of transition at 95+/-3 degrees C in thermal scans of nuclear preparations isolated from blood of B-CLL randomized patients who showed response to cladribine or fludarabine combined with @COMPOUND$, i.e., CC and FC, respectively, corresponded with the decrease or disappearance of anti-apoptotic proteins Bcl-2 and/or @PROTEIN$ 1.	0	18676014-229
We have also observed that the reduction of transition at 95+/-3 degrees C in thermal scans of nuclear preparations isolated from blood of B-CLL randomized patients who showed response to cladribine or @COMPOUND$ combined with cyclophosphamide, i.e., CC and FC, respectively, corresponded with the decrease or disappearance of anti-apoptotic proteins @PROTEIN$ and/or Mcl 1.	0	18676014-229
We have also observed that the reduction of transition at 95+/-3 degrees C in thermal scans of nuclear preparations isolated from blood of B-CLL randomized patients who showed response to @COMPOUND$ or fludarabine combined with cyclophosphamide, i.e., CC and FC, respectively, corresponded with the decrease or disappearance of anti-apoptotic proteins Bcl-2 and/or @PROTEIN$ 1.	0	18676014-229
Exposure of erythrocytes to PGNs increased cytosolic Ca(2+) concentration, increased ceramide formation, enhanced the percentage of @PROTEIN$-binding erythrocytes, decreased erythrocyte forward scatter, and lowered the intracellular @COMPOUND$ concentration.	0	18676199-799
Exposure of erythrocytes to @PROTEIN$ increased cytosolic Ca(2+) concentration, increased ceramide formation, enhanced the percentage of annexin V-binding erythrocytes, decreased erythrocyte forward scatter, and lowered the intracellular @COMPOUND$ concentration.	1	18676199-799
Exposure of erythrocytes to PGNs increased cytosolic @COMPOUND$+) concentration, increased ceramide formation, enhanced the percentage of @PROTEIN$-binding erythrocytes, decreased erythrocyte forward scatter, and lowered the intracellular ATP concentration.	0	18676199-799
Exposure of erythrocytes to @PROTEIN$ increased cytosolic @COMPOUND$+) concentration, increased ceramide formation, enhanced the percentage of annexin V-binding erythrocytes, decreased erythrocyte forward scatter, and lowered the intracellular ATP concentration.	1	18676199-799
Inhibition of mitogen-activated protein kinase (MAPK) and @PROTEIN$ prevented the antiapoptotic effects of @COMPOUND$ and decreased chemotherapy-induced apoptosis.	1	18676776-233
Inhibition of mitogen-activated protein kinase (@PROTEIN$) and Akt prevented the antiapoptotic effects of @COMPOUND$ and decreased chemotherapy-induced apoptosis.	1	18676776-233
Inhibition of @PROTEIN$ (MAPK) and Akt prevented the antiapoptotic effects of @COMPOUND$ and decreased chemotherapy-induced apoptosis.	1	18676776-233
@COMPOUND$ up-regulated Akt-mediated antiapoptotic X-linked inhibitor of apoptosis protein and phosphorylated proapoptotic @PROTEIN$.	1	18676776-235
Induction of NY-ESO-1 expression on tumor targets using the demethylating agent 5-aza-2'-deoxycytidine (alone or in combination with the histone deacetylase inhibitor @COMPOUND$) resulted in enhanced @PROTEIN$ secretion by the TCR-transduced PBL on culture with treated targets.	1	18677478-391
Induction of NY-ESO-1 expression on tumor targets using the demethylating agent @COMPOUND$ (alone or in combination with the histone deacetylase inhibitor depsipeptide) resulted in enhanced @PROTEIN$ secretion by the TCR-transduced PBL on culture with treated targets.	1	18677478-391
In the absence of @PROTEIN$, cells lost the ability to reduce soluble or insoluble @COMPOUND$).	1	18677521-1468
DNA sequences of upstream regions of coregulated operons in the adapted mutant are divergent, suggesting the presence of recognition sites for different @PROTEIN$ and indicating that adaptation of the omcB mutant to growth on soluble @COMPOUND$) has shifted the relevant expression networks involved to a more diverse molecular basis.	0	18677521-1470
Elevated beta1,4-@PROTEIN$-I induced by the intraspinal injection of @COMPOUND$.	1	18677561-697
E-selectin, which ligand was modified by beta1,4-@PROTEIN$-I, was correlated with @COMPOUND$-containing glycans following injecting LPS into spinal cord.	0	18677561-698
Effects of @PROTEIN$ on amino acid transporters were examined using their substrates: (3)H-@COMPOUND$, (3)H-lysine, and (3)H-methylaminoisobutyric acid, respectively.	0	18677571-1520
Effects of @PROTEIN$ on amino acid transporters were examined using their substrates: (3)H-phenylalanine, (3)H-@COMPOUND$, and (3)H-methylaminoisobutyric acid, respectively.	0	18677571-1520
@COMPOUND$, an anticonvulsant and mood stabilizer, up-regulates @PROTEIN$, a neurotrophic/neuroprotective protein.	1	18677583-1526
In this study, we investigated the molecular mechanism through which @PROTEIN$ is up-regulated by @COMPOUND$ using cultured human neuron-like cells.	1	18677583-1527
@COMPOUND$, within therapeutically relevant ranges, induced time- and concentration-dependent up-regulations of both @PROTEIN$ messenger RNA and protein implicating an underlying gene transcriptional-mediated mechanism.	1	18677583-1528
@COMPOUND$ increased transcriptional activity of a human @PROTEIN$ promoter-reporter gene construct.	1	18677583-1529
ERK and/or PI3K pathway inhibitors and RSK1 small hairpin RNA knockdown reduced, but did not abolish, baseline and @COMPOUND$-induced promoter activities and lowered @PROTEIN$ protein levels.	0	18677583-1530
These data collectively suggest that @COMPOUND$ induces Bcl-2 regulation partially through activations of the ERK and @PROTEIN$ cascades and their convergent kinase, RSK, although other unknown mechanism(s) are likely involved.	1	18677583-1531
These data collectively suggest that @COMPOUND$ induces Bcl-2 regulation partially through activations of the ERK and PI3K cascades and their convergent kinase, @PROTEIN$, although other unknown mechanism(s) are likely involved.	1	18677583-1531
These data collectively suggest that @COMPOUND$ induces @PROTEIN$ regulation partially through activations of the ERK and PI3K cascades and their convergent kinase, RSK, although other unknown mechanism(s) are likely involved.	1	18677583-1531
These data collectively suggest that @COMPOUND$ induces Bcl-2 regulation partially through activations of the @PROTEIN$ and PI3K cascades and their convergent kinase, RSK, although other unknown mechanism(s) are likely involved.	1	18677583-1531
Given the known roles of @PROTEIN$ in the central nervous system, the current findings offer a partial yet complex molecular mechanistic explanation for the known neurobiological effects of @COMPOUND$ including neurite growth, neuronal survival, and neurogenesis.	0	18677583-1532
With covalent method, @COMPOUND$ was introduced to immobilize @PROTEIN$.	1	18679593-620
As metabolic flux for the operation of the @COMPOUND$ pathway is maintained through the activities of @PROTEIN$ and C4H, thus, catechins biosynthesis in tea is critically dependent on the products of these enzymes.	1	18679731-726
As metabolic flux for the operation of the @COMPOUND$ pathway is maintained through the activities of PAL and @PROTEIN$, thus, catechins biosynthesis in tea is critically dependent on the products of these enzymes.	1	18679731-726
Activities of antioxidant enzymes (@PROTEIN$, catalase, glutathione peroxidase, glutathione reductase, glutatione-S-transferase, and @COMPOUND$) in liver also decreased in carcinogen-administered rats, which were significantly elevated in bacoside A-pretreated rats.	0	18679812-4
Activities of antioxidant enzymes (superoxide dismutase, catalase, @PROTEIN$, glutathione reductase, glutatione-S-transferase, and @COMPOUND$) in liver also decreased in carcinogen-administered rats, which were significantly elevated in bacoside A-pretreated rats.	0	18679812-4
Activities of antioxidant enzymes (superoxide dismutase, @PROTEIN$, glutathione peroxidase, glutathione reductase, glutatione-S-transferase, and @COMPOUND$) in liver also decreased in carcinogen-administered rats, which were significantly elevated in bacoside A-pretreated rats.	0	18679812-4
Activities of antioxidant enzymes (superoxide dismutase, catalase, glutathione peroxidase, @PROTEIN$, glutatione-S-transferase, and @COMPOUND$) in liver also decreased in carcinogen-administered rats, which were significantly elevated in bacoside A-pretreated rats.	0	18679812-4
In this study, we report that AR-@COMPOUND$, a non-GalR1 agonist, inhibited plasma extravasation induced by substance P and @PROTEIN$ in a manner similar to galanin, confirming a non-GalR1-mediated effect.	0	18679831-20
In this study, we report that AR-@COMPOUND$, a non-GalR1 agonist, inhibited plasma extravasation induced by substance P and calcitonin gene-related peptide in a manner similar to @PROTEIN$, confirming a non-GalR1-mediated effect.	0	18679831-20
In this study, we report that AR-@COMPOUND$, a non-GalR1 agonist, inhibited plasma extravasation induced by @PROTEIN$ and calcitonin gene-related peptide in a manner similar to galanin, confirming a non-GalR1-mediated effect.	0	18679831-20
Inhibition of non-small cell lung cancer cell migration by grape seed @COMPOUND$ is mediated through the inhibition of nitric oxide, guanylate cyclase, and @PROTEIN$/2.	1	18680102-211
Inhibition of non-small cell lung cancer cell migration by grape seed @COMPOUND$ is mediated through the inhibition of nitric oxide, guanylate @PROTEIN$, and ERK1/2.	1	18680102-211
Additionally, UO126 and @COMPOUND$ inhibited the migration restoring effects of L-arginine in L-NAME-treated cells, suggesting the involvement of cGMP and @PROTEIN$ pathways in NO-mediated migration.	1	18680102-215
Additionally, UO126 and ODQ inhibited the migration restoring effects of @COMPOUND$ in L-NAME-treated cells, suggesting the involvement of cGMP and @PROTEIN$ pathways in NO-mediated migration.	1	18680102-215
Additionally, UO126 and ODQ inhibited the migration restoring effects of L-arginine in L-NAME-treated cells, suggesting the involvement of @COMPOUND$ and @PROTEIN$ pathways in NO-mediated migration.	0	18680102-215
GSPs inhibited @COMPOUND$ and 8-Br-cGMP-induced activation of @PROTEIN$/2 in A549 cells.	1	18680102-216
GSPs inhibited L-arginine and @COMPOUND$-induced activation of @PROTEIN$/2 in A549 cells.	1	18680102-216
Enhancement of p53 expression in keratinocytes by the @COMPOUND$ apigenin is associated with RNA-binding protein @PROTEIN$.	0	18680106-970
Enhancement of @PROTEIN$ expression in keratinocytes by the @COMPOUND$ apigenin is associated with RNA-binding protein HuR.	0	18680106-970
Enhancement of p53 expression in keratinocytes by the bioflavonoid @COMPOUND$ is associated with @PROTEIN$ HuR.	0	18680106-970
Enhancement of p53 expression in keratinocytes by the bioflavonoid @COMPOUND$ is associated with RNA-binding protein @PROTEIN$.	1	18680106-970
Enhancement of @PROTEIN$ expression in keratinocytes by the bioflavonoid @COMPOUND$ is associated with RNA-binding protein HuR.	1	18680106-970
Enhancement of p53 expression in keratinocytes by the @COMPOUND$ apigenin is associated with @PROTEIN$ HuR.	0	18680106-970
We have reported previously that @COMPOUND$, a naturally occurring nonmutagenic flavonoid, increased wild-type @PROTEIN$ protein expression in the mouse keratinocyte 308 cell line by a mechanism involving p53 protein stabilization.	1	18680106-971
We have reported previously that apigenin, a naturally occurring nonmutagenic @COMPOUND$, increased wild-type @PROTEIN$ protein expression in the mouse keratinocyte 308 cell line by a mechanism involving p53 protein stabilization.	0	18680106-971
Instead, biosynthetic labeling showed that @COMPOUND$ increased nascent @PROTEIN$ protein synthesis by enhancing p53 translation.	1	18680106-973
Furthermore, @COMPOUND$ treatment increased the level of association of the RNA binding protein HuR with endogenous @PROTEIN$ mRNA.	1	18680106-975
Furthermore, @COMPOUND$ treatment increased the level of association of the RNA binding protein @PROTEIN$ with endogenous p53 mRNA.	1	18680106-975
Furthermore, @COMPOUND$ treatment increased the level of association of the @PROTEIN$ HuR with endogenous p53 mRNA.	0	18680106-975
@COMPOUND$ treatment also augmented @PROTEIN$ translocation into the cytoplasm.	1	18680106-976
Overall, these findings indicate that, in addition to modulating @PROTEIN$ protein stability, one of the mechanisms by which @COMPOUND$ induces p53 protein expression is enhancement of translation through the RNA binding protein HuR.	1	18680106-979
Overall, these findings indicate that, in addition to modulating p53 protein stability, one of the mechanisms by which @COMPOUND$ induces p53 protein expression is enhancement of translation through the RNA binding protein @PROTEIN$.	1	18680106-979
Overall, these findings indicate that, in addition to modulating p53 protein stability, one of the mechanisms by which @COMPOUND$ induces p53 protein expression is enhancement of translation through the @PROTEIN$ HuR.	0	18680106-979
Immunoblot analysis of signaling molecules, including cyclic-AMP response element binding protein (@PROTEIN$), mitogen-activated protein kinases (MAPKp44/42; ERK1/2), in area CA1 revealed that @COMPOUND$ treatment reversed hypothyroidism-induced reduction of signaling molecules essential for learning and memory, and L-LTP.	1	18680156-264
Immunoblot analysis of signaling molecules, including cyclic-AMP response element binding protein (CREB), mitogen-activated protein kinases (MAPKp44/42; @PROTEIN$/2), in area CA1 revealed that @COMPOUND$ treatment reversed hypothyroidism-induced reduction of signaling molecules essential for learning and memory, and L-LTP.	1	18680156-264
Immunoblot analysis of signaling molecules, including cyclic-AMP response element binding protein (CREB), @PROTEIN$ (MAPKp44/42; ERK1/2), in area CA1 revealed that @COMPOUND$ treatment reversed hypothyroidism-induced reduction of signaling molecules essential for learning and memory, and L-LTP.	1	18680156-264
Immunoblot analysis of signaling molecules, including cyclic-@PROTEIN$ response element binding protein (CREB), mitogen-activated protein kinases (MAPKp44/42; ERK1/2), in area CA1 revealed that @COMPOUND$ treatment reversed hypothyroidism-induced reduction of signaling molecules essential for learning and memory, and L-LTP.	0	18680156-264
@PROTEIN$ resistance is a major determinant of sustained virological response in genotype 1 chronic hepatitis C patients receiving peginterferon alpha-2b plus @COMPOUND$.	1	18680550-1533
Aim To investigate retrospectively the impact of @PROTEIN$ resistance on treatment response in Chinese genotype 1 CHC patients receiving a 24-week course therapy with peginterferon alpha-2b/@COMPOUND$.	1	18680550-1535
We hypothesised that @PROTEIN$ could be a limiting step in @COMPOUND$-arginine interconversion.	1	18680626-658
We hypothesised that @PROTEIN$ could be a limiting step in glutamine-@COMPOUND$ interconversion.	1	18680626-658
@PROTEIN$ overexpression decreased plasma and liver @COMPOUND$ concentrations but did not affect glutamine or arginine homeostasis.	1	18680626-659
@PROTEIN$ overexpression decreased plasma and liver ornithine concentrations but did not affect @COMPOUND$ or arginine homeostasis.	0	18680626-659
@PROTEIN$ overexpression decreased plasma and liver ornithine concentrations but did not affect glutamine or @COMPOUND$ homeostasis.	0	18680626-659
There was an inverse relationship between @COMPOUND$ levels and @PROTEIN$ activity.	1	18680626-660
In men there is a large interindividual variation of @PROTEIN$ levels and consequently of @COMPOUND$ (T) and E(2) levels.	1	18681858-1
Bone marrow cells were obtained from 5-day-old Muscovy ducks and cultured with (Group A) No added factors, (B) 30ng/mL soluble @PROTEIN$ (sRANKL), (C) 30ng/mL sRANKL and 10ng/mL OPG, (D) 10ng/mL OPG, (E) 50ng/mL OPG, (F) 100ng/mL OPG and (G) 30ng/mL sRANKL, 6mmol/@COMPOUND$ and 3mmol/L P. sRANKL promoted the survival of OCs on day 2, whereas the number of OCs decreased with addition of OPG in a dose-dependent manner.	0	18682334-364
Bone marrow cells were obtained from 5-day-old Muscovy ducks and cultured with (Group A) No added factors, (B) 30ng/mL soluble RANKL (sRANKL), (C) 30ng/mL sRANKL and 10ng/mL @PROTEIN$, (D) 10ng/mL OPG, (E) 50ng/mL OPG, (F) 100ng/mL OPG and (G) 30ng/mL sRANKL, 6mmol/@COMPOUND$ and 3mmol/L P. sRANKL promoted the survival of OCs on day 2, whereas the number of OCs decreased with addition of OPG in a dose-dependent manner.	0	18682334-364
Over-expression of @PROTEIN$ decreased the yield of ethanol and 2,3-butanediol, meanwhile it increased the concentration of @COMPOUND$.	1	18682988-518
Over-expression of @PROTEIN$ decreased the yield of @COMPOUND$ and 2,3-butanediol, meanwhile it increased the concentration of acetic acid.	1	18682988-518
Over-expression of @PROTEIN$ decreased the yield of ethanol and @COMPOUND$, meanwhile it increased the concentration of acetic acid.	1	18682988-518
@COMPOUND$ prevents acute liver damage after massive hepatectomy in rats through suppression of a CXC chemokine @PROTEIN$ and induction of heat shock proteins.	1	18683011-1547
Furthermore, HA induced dose-dependent elevation of reactive @COMPOUND$ species (ROS) level in SMCs, and antioxidant vitamin C and Trolox effectively suppressed HA-induced DNA damage and dysregulation of @PROTEIN$/Bax.	0	18683188-1093
Furthermore, HA induced dose-dependent elevation of reactive oxygen species (ROS) level in SMCs, and antioxidant vitamin C and @COMPOUND$ effectively suppressed HA-induced DNA damage and dysregulation of Bcl-2/@PROTEIN$.	1	18683188-1093
Furthermore, HA induced dose-dependent elevation of reactive oxygen species (ROS) level in SMCs, and antioxidant vitamin C and @COMPOUND$ effectively suppressed HA-induced DNA damage and dysregulation of @PROTEIN$/Bax.	1	18683188-1093
Furthermore, HA induced dose-dependent elevation of reactive oxygen species (ROS) level in SMCs, and antioxidant @COMPOUND$ and Trolox effectively suppressed HA-induced DNA damage and dysregulation of @PROTEIN$/Bax.	1	18683188-1093
Furthermore, HA induced dose-dependent elevation of reactive oxygen species (ROS) level in SMCs, and antioxidant @COMPOUND$ and Trolox effectively suppressed HA-induced DNA damage and dysregulation of Bcl-2/@PROTEIN$.	1	18683188-1093
Furthermore, HA induced dose-dependent elevation of reactive @COMPOUND$ species (ROS) level in SMCs, and antioxidant vitamin C and Trolox effectively suppressed HA-induced DNA damage and dysregulation of Bcl-2/@PROTEIN$.	0	18683188-1093
The adsorption of ovine @PROTEIN$ onto @COMPOUND$-modified surfaces was reduced relative to unmodified surfaces, and in vitro ovine blood contact through a rocking test revealed marked reductions in platelet deposition and bulk phase platelet activation relative to unmodified TiAl6V4 and polystyrene controls.	1	18683221-1122
When the @PROTEIN$ concentration was higher than 15 U/mL, the gelation could be finished within 1 min and yielded a composite with evenly suspended and distributed @COMPOUND$ microspheres.	1	18683225-1127
The culture tests using MSCs show that the level of alkaline phosphatase (@PROTEIN$) activity in the cells cultured on SPV-H increased during the 21-day culture in a medium without Dex and @COMPOUND$.	1	18683233-58
The culture tests using MSCs show that the level of @PROTEIN$ (ALP) activity in the cells cultured on SPV-H increased during the 21-day culture in a medium without Dex and @COMPOUND$.	1	18683233-58
The level was unchanged in MSCs cultured on PV-H. In the case of supplementing Dex and @COMPOUND$ to the medium, the level of @PROTEIN$ activity in MSCs cultured on SPV-H was higher than that on PV-H at all time points during the 21-day culture.	1	18683233-59
The combined treatment strategy not only decreased @PROTEIN$-positive aggregation in striatum, alleviated @COMPOUND$ aggregation formation, and reduced striatal volume, but also extended life span in the R6/2 animal model.	0	18683244-106
@PROTEIN$ inhibits toll-like receptor 3-induced @COMPOUND$ production in Schwann cells and subsequent sensory neuronal cell death in vitro.	1	18683246-1143
The @PROTEIN$ and LUC genes were chosen because they can be used as markers for the easy detection of transgenic plants, while @COMPOUND$ tail better enables the isolation of protein expressed in plant tissue.	0	18683252-1154
Expression was performed in fusion to @COMPOUND$ binding protein using chemically defined minimal medium, followed by a single-step affinity capture and enzymatic cleavage using tobacco etch virus @PROTEIN$.	0	18683262-1162
The amplification of gltA gene encoding @PROTEIN$ of TCA cycle was required for the efficient conversion of acetyl-CoA, generated during vanillin production from @COMPOUND$, to CoA, which is essential for vanillin production.	1	18683263-1164
The amplification of @PROTEIN$ gene encoding citrate synthase of TCA cycle was required for the efficient conversion of acetyl-CoA, generated during vanillin production from @COMPOUND$, to CoA, which is essential for vanillin production.	1	18683263-1164
The amplification of gltA gene encoding @PROTEIN$ of TCA cycle was required for the efficient conversion of acetyl-CoA, generated during @COMPOUND$ production from ferulic acid, to CoA, which is essential for vanillin production.	1	18683263-1164
The amplification of @PROTEIN$ gene encoding citrate synthase of TCA cycle was required for the efficient conversion of acetyl-CoA, generated during @COMPOUND$ production from ferulic acid, to CoA, which is essential for vanillin production.	1	18683263-1164
The @PROTEIN$ amplification of the glyoxylate bypass in the icdA null mutant remarkably increased the production rate of @COMPOUND$ with a little increase in the amount of vanillin production.	1	18683263-1167
The real synergistic effect of @PROTEIN$ amplification and icdA deletion was observed with use of XAD-2 resin reducing the toxicity of @COMPOUND$ produced during culture.	1	18683263-1168
The real synergistic effect of gltA amplification and @PROTEIN$ deletion was observed with use of XAD-2 resin reducing the toxicity of @COMPOUND$ produced during culture.	1	18683263-1168
Treatment of dermal fibroblasts with @COMPOUND$) induced expression of @PROTEIN$ (1.2+/-0.2, 1.7+/-0.2, and 1.8+/-0.2 relative fold increase) and BMP-6 (9.1+/-0.3, 23.3+/-2.1, and 30.4+/-3.0 relative fold increase) at 3, 14, and 21 days, respectively.	1	18683889-1688
Treatment of dermal fibroblasts with @COMPOUND$) induced expression of BMP-4 (1.2+/-0.2, 1.7+/-0.2, and 1.8+/-0.2 relative fold increase) and @PROTEIN$ (9.1+/-0.3, 23.3+/-2.1, and 30.4+/-3.0 relative fold increase) at 3, 14, and 21 days, respectively.	1	18683889-1688
@COMPOUND$) was also shown to induce the expression of the osteoblast-specific markers, @PROTEIN$ and osteocalcin, in a dose-dependent manner in human dermal fibroblasts.	1	18683889-1689
@COMPOUND$) was also shown to induce the expression of the osteoblast-specific markers, alkaline phosphatase and @PROTEIN$, in a dose-dependent manner in human dermal fibroblasts.	1	18683889-1689
The aims of this study were: (i) to characterize the basal circadian rhythm of adrenocorticotropin hormone (@PROTEIN$) and cortisol in IBS vs healthy controls; (ii) to compare stimulated ACTH, cortisol and @COMPOUND$ responses to a pelvic visceral stressor (sigmoidoscopy) in IBS and controls; and (iii) to correlate neuroendocrine responses with colonic mucosal cytokine expression and symptoms in IBS.	0	18684212-1656
The aims of this study were: (i) to characterize the basal circadian rhythm of adrenocorticotropin hormone (@PROTEIN$) and @COMPOUND$ in IBS vs healthy controls; (ii) to compare stimulated ACTH, cortisol and noradrenaline responses to a pelvic visceral stressor (sigmoidoscopy) in IBS and controls; and (iii) to correlate neuroendocrine responses with colonic mucosal cytokine expression and symptoms in IBS.	0	18684212-1656
In Study 1, basal @COMPOUND$ levels were analysed in 41 IBS and 25 controls using 24-h collections of plasma @PROTEIN$ and cortisol (q10 min sampling).	0	18684212-1657
Basal @PROTEIN$ 0.05), while basal and stimulated plasma @COMPOUND$ levels were higher in patients.	0	18684212-1658
A 3-fold increase in the expression of the @PROTEIN$ gene was associated with decreased @COMPOUND$ methylation of the analysed promoter region in the vegetarian group compared with the age-matched omnivores group.	0	18684339-438
ALK2 (R206H) with @PROTEIN$ or Smad5 induced osteoblastic differentiation that could be inhibited by Smad7 or @COMPOUND$.	1	18684712-650
ALK2 (R206H) with Smad1 or Smad5 induced osteoblastic differentiation that could be inhibited by @PROTEIN$ or @COMPOUND$.	0	18684712-650
ALK2 (R206H) with Smad1 or @PROTEIN$ induced osteoblastic differentiation that could be inhibited by Smad7 or @COMPOUND$.	1	18684712-650
@PROTEIN$ (R206H) with Smad1 or Smad5 induced osteoblastic differentiation that could be inhibited by Smad7 or @COMPOUND$.	1	18684712-650
Combustion products of @COMPOUND$ inhibit @PROTEIN$ activity and induce expression of oxidative DNA damage repair enzymes in human bronchial epithelial cells.	0	18685817-1575
The aim of the present study was to examine whether increased serum Hsp70 levels are related to clinical characteristics and standard laboratory parameters of preeclamptic patients, as well as to markers of inflammation (C-reactive protein), endothelial activation (von Willebrand factor antigen) or endothelial injury (@PROTEIN$), trophoblast debris (cell-free fetal DNA) and oxidative stress (@COMPOUND$).	0	18686014-49
The aim of the present study was to examine whether increased serum @PROTEIN$ levels are related to clinical characteristics and standard laboratory parameters of preeclamptic patients, as well as to markers of inflammation (C-reactive protein), endothelial activation (von Willebrand factor antigen) or endothelial injury (fibronectin), trophoblast debris (cell-free fetal DNA) and oxidative stress (@COMPOUND$).	0	18686014-49
Furthermore, serum levels of blood urea nitrogen, @COMPOUND$, bilirubin and CRP, serum alanine aminotransferase and lactate dehydrogenase (LDH) activities, as well as plasma levels of VWF :Ag, @PROTEIN$, cell-free fetal DNA and malondialdehyde were also significantly higher in preeclamptic patients than in normotensive, healthy pregnant women.	0	18686014-50
Furthermore, serum levels of blood urea nitrogen, creatinine, bilirubin and CRP, serum alanine aminotransferase and lactate dehydrogenase (LDH) activities, as well as plasma levels of @PROTEIN$ :Ag, fibronectin, cell-free fetal DNA and @COMPOUND$ were also significantly higher in preeclamptic patients than in normotensive, healthy pregnant women.	0	18686014-50
Furthermore, serum levels of blood urea nitrogen, creatinine, @COMPOUND$ and CRP, serum alanine aminotransferase and lactate dehydrogenase (LDH) activities, as well as plasma levels of @PROTEIN$ :Ag, fibronectin, cell-free fetal DNA and malondialdehyde were also significantly higher in preeclamptic patients than in normotensive, healthy pregnant women.	0	18686014-50
Furthermore, serum levels of blood urea @COMPOUND$, creatinine, bilirubin and @PROTEIN$, serum alanine aminotransferase and lactate dehydrogenase (LDH) activities, as well as plasma levels of VWF :Ag, fibronectin, cell-free fetal DNA and malondialdehyde were also significantly higher in preeclamptic patients than in normotensive, healthy pregnant women.	0	18686014-50
Furthermore, serum levels of blood urea nitrogen, @COMPOUND$, bilirubin and @PROTEIN$, serum alanine aminotransferase and lactate dehydrogenase (LDH) activities, as well as plasma levels of VWF :Ag, fibronectin, cell-free fetal DNA and malondialdehyde were also significantly higher in preeclamptic patients than in normotensive, healthy pregnant women.	0	18686014-50
Furthermore, serum levels of blood urea @COMPOUND$, creatinine, bilirubin and CRP, serum alanine aminotransferase and lactate dehydrogenase (@PROTEIN$) activities, as well as plasma levels of VWF :Ag, fibronectin, cell-free fetal DNA and malondialdehyde were also significantly higher in preeclamptic patients than in normotensive, healthy pregnant women.	0	18686014-50
Furthermore, serum levels of blood @COMPOUND$ nitrogen, creatinine, bilirubin and CRP, serum alanine aminotransferase and lactate dehydrogenase (LDH) activities, as well as plasma levels of VWF :Ag, @PROTEIN$, cell-free fetal DNA and malondialdehyde were also significantly higher in preeclamptic patients than in normotensive, healthy pregnant women.	0	18686014-50
Furthermore, serum levels of blood @COMPOUND$ nitrogen, creatinine, bilirubin and @PROTEIN$, serum alanine aminotransferase and lactate dehydrogenase (LDH) activities, as well as plasma levels of VWF :Ag, fibronectin, cell-free fetal DNA and malondialdehyde were also significantly higher in preeclamptic patients than in normotensive, healthy pregnant women.	0	18686014-50
Furthermore, serum levels of blood urea nitrogen, creatinine, @COMPOUND$ and CRP, serum alanine aminotransferase and lactate dehydrogenase (@PROTEIN$) activities, as well as plasma levels of VWF :Ag, fibronectin, cell-free fetal DNA and malondialdehyde were also significantly higher in preeclamptic patients than in normotensive, healthy pregnant women.	0	18686014-50
Furthermore, serum levels of blood urea nitrogen, creatinine, bilirubin and @PROTEIN$, serum alanine aminotransferase and lactate dehydrogenase (LDH) activities, as well as plasma levels of VWF :Ag, fibronectin, cell-free fetal DNA and @COMPOUND$ were also significantly higher in preeclamptic patients than in normotensive, healthy pregnant women.	0	18686014-50
Furthermore, serum levels of blood @COMPOUND$ nitrogen, creatinine, bilirubin and CRP, serum alanine aminotransferase and lactate dehydrogenase (LDH) activities, as well as plasma levels of @PROTEIN$ :Ag, fibronectin, cell-free fetal DNA and malondialdehyde were also significantly higher in preeclamptic patients than in normotensive, healthy pregnant women.	0	18686014-50
Furthermore, serum levels of blood urea nitrogen, @COMPOUND$, bilirubin and CRP, serum alanine aminotransferase and lactate dehydrogenase (LDH) activities, as well as plasma levels of @PROTEIN$ :Ag, fibronectin, cell-free fetal DNA and malondialdehyde were also significantly higher in preeclamptic patients than in normotensive, healthy pregnant women.	0	18686014-50
Furthermore, serum levels of blood urea nitrogen, creatinine, @COMPOUND$ and CRP, serum alanine aminotransferase and lactate dehydrogenase (LDH) activities, as well as plasma levels of VWF :Ag, @PROTEIN$, cell-free fetal DNA and malondialdehyde were also significantly higher in preeclamptic patients than in normotensive, healthy pregnant women.	0	18686014-50
Furthermore, serum levels of blood urea @COMPOUND$, creatinine, bilirubin and CRP, serum alanine aminotransferase and lactate dehydrogenase (LDH) activities, as well as plasma levels of @PROTEIN$ :Ag, fibronectin, cell-free fetal DNA and malondialdehyde were also significantly higher in preeclamptic patients than in normotensive, healthy pregnant women.	0	18686014-50
Furthermore, serum levels of blood urea @COMPOUND$, creatinine, bilirubin and CRP, serum alanine aminotransferase and lactate dehydrogenase (LDH) activities, as well as plasma levels of VWF :Ag, @PROTEIN$, cell-free fetal DNA and malondialdehyde were also significantly higher in preeclamptic patients than in normotensive, healthy pregnant women.	0	18686014-50
Furthermore, serum levels of blood urea nitrogen, creatinine, @COMPOUND$ and @PROTEIN$, serum alanine aminotransferase and lactate dehydrogenase (LDH) activities, as well as plasma levels of VWF :Ag, fibronectin, cell-free fetal DNA and malondialdehyde were also significantly higher in preeclamptic patients than in normotensive, healthy pregnant women.	0	18686014-50
Furthermore, serum levels of blood @COMPOUND$ nitrogen, creatinine, bilirubin and CRP, serum alanine aminotransferase and lactate dehydrogenase (@PROTEIN$) activities, as well as plasma levels of VWF :Ag, fibronectin, cell-free fetal DNA and malondialdehyde were also significantly higher in preeclamptic patients than in normotensive, healthy pregnant women.	0	18686014-50
Furthermore, serum levels of blood urea nitrogen, creatinine, bilirubin and CRP, serum alanine aminotransferase and lactate dehydrogenase (@PROTEIN$) activities, as well as plasma levels of VWF :Ag, fibronectin, cell-free fetal DNA and @COMPOUND$ were also significantly higher in preeclamptic patients than in normotensive, healthy pregnant women.	0	18686014-50
Furthermore, serum levels of blood urea nitrogen, creatinine, bilirubin and CRP, serum alanine aminotransferase and lactate dehydrogenase (LDH) activities, as well as plasma levels of VWF :Ag, @PROTEIN$, cell-free fetal DNA and @COMPOUND$ were also significantly higher in preeclamptic patients than in normotensive, healthy pregnant women.	0	18686014-50
Furthermore, serum levels of blood urea nitrogen, @COMPOUND$, bilirubin and CRP, serum alanine aminotransferase and lactate dehydrogenase (@PROTEIN$) activities, as well as plasma levels of VWF :Ag, fibronectin, cell-free fetal DNA and malondialdehyde were also significantly higher in preeclamptic patients than in normotensive, healthy pregnant women.	0	18686014-50
In preeclamptic patients, serum Hsp70 levels showed significant correlations with serum @PROTEIN$ levels (Spearman R = 0.32, p = 0.010), serum aspartate aminotransferase (R = 0.32, p = 0.008) and LDH (0.001), as well as with plasma @COMPOUND$ levels (R = 0.25, p = 0.043).	0	18686014-51
In preeclamptic patients, serum @PROTEIN$ levels showed significant correlations with serum CRP levels (Spearman R = 0.32, p = 0.010), serum aspartate aminotransferase (R = 0.32, p = 0.008) and LDH (0.001), as well as with plasma @COMPOUND$ levels (R = 0.25, p = 0.043).	1	18686014-51
In preeclamptic patients, serum Hsp70 levels showed significant correlations with serum CRP levels (Spearman R = 0.32, p = 0.010), serum @PROTEIN$ (R = 0.32, p = 0.008) and LDH (0.001), as well as with plasma @COMPOUND$ levels (R = 0.25, p = 0.043).	0	18686014-51
In preeclamptic patients, serum Hsp70 levels showed significant correlations with serum CRP levels (Spearman R = 0.32, p = 0.010), serum aspartate aminotransferase (R = 0.32, p = 0.008) and @PROTEIN$ (0.001), as well as with plasma @COMPOUND$ levels (R = 0.25, p = 0.043).	0	18686014-51
In an effort to identify agents which enhance the activity of oligos and which possess less toxicity than traditionally employed chemotherapeutics, @COMPOUND$, an immunosuppressive agent known to regulate tumor growth and signal transduction mediated by the @PROTEIN$ receptor, is compared to paclitaxel in combination therapy employing monospecific or bispecific oligos.	1	18686047-887
In an effort to identify agents which enhance the activity of oligos and which possess less toxicity than traditionally employed chemotherapeutics, Rapamycin, an immunosuppressive agent known to regulate tumor growth and signal transduction mediated by the @PROTEIN$ receptor, is compared to @COMPOUND$ in combination therapy employing monospecific or bispecific oligos.	0	18686047-887
In this study we investigated the superoxide radicals scavenging effect and @PROTEIN$ inhibitory activity by @COMPOUND$, which was originally isolated from the roots of Salvia miltiorrhiza (also named Danshen or Dansham), an important herb in Oriental medicine.	1	18686136-131
In this study we investigated the @COMPOUND$ radicals scavenging effect and @PROTEIN$ inhibitory activity by magnesium lithospermate B, which was originally isolated from the roots of Salvia miltiorrhiza (also named Danshen or Dansham), an important herb in Oriental medicine.	0	18686136-131
Superoxide radicals were generated both in beta-NADH/@COMPOUND$ system and xanthine/@PROTEIN$ system.	0	18686136-132
Superoxide radicals were generated both in @COMPOUND$/PMS system and xanthine/@PROTEIN$ system.	0	18686136-132
Superoxide radicals were generated both in beta-NADH/PMS system and @COMPOUND$/@PROTEIN$ system.	1	18686136-132
@COMPOUND$ radicals were generated both in beta-NADH/PMS system and xanthine/@PROTEIN$ system.	1	18686136-132
Further study suggested that @COMPOUND$ can directly inhibit @PROTEIN$ and exhibits competitive inhibition.	1	18686136-133
In addition, @COMPOUND$ significantly protected HL-60 cells from superoxide radicals-induced apoptosis in the xanthine/@PROTEIN$ reactions.	1	18686136-134
In addition, magnesium lithospermate B significantly protected HL-60 cells from superoxide radicals-induced apoptosis in the @COMPOUND$/@PROTEIN$ reactions.	1	18686136-134
Four different molecules contain galactofuranose in A. fumigatus: (i) the @COMPOUND$ present in the alkali soluble and insoluble fraction of the cell wall (ii) N- and O glycan moieties of secreted @PROTEIN$ (iii) a GPI-anchored lipophosphogalactomannan and (iv) several sphingolipids also anchored to the membrane by an inositol phosphoceramide.	0	18686165-403
Four different molecules contain galactofuranose in A. fumigatus: (i) the galactomannan present in the alkali soluble and insoluble fraction of the cell wall (ii) N- and O glycan moieties of secreted @PROTEIN$ (iii) a GPI-anchored lipophosphogalactomannan and (iv) several sphingolipids also anchored to the membrane by an @COMPOUND$.	0	18686165-403
Four different molecules contain galactofuranose in A. fumigatus: (i) the @COMPOUND$ present in the alkali soluble and insoluble fraction of the cell wall (ii) N- and O glycan moieties of secreted glycoproteins (iii) a @PROTEIN$-anchored lipophosphogalactomannan and (iv) several sphingolipids also anchored to the membrane by an inositol phosphoceramide.	0	18686165-403
Four different molecules contain galactofuranose in A. fumigatus: (i) the galactomannan present in the alkali soluble and insoluble fraction of the cell wall (ii) N- and O @COMPOUND$ moieties of secreted @PROTEIN$ (iii) a GPI-anchored lipophosphogalactomannan and (iv) several sphingolipids also anchored to the membrane by an inositol phosphoceramide.	1	18686165-403
Four different molecules contain galactofuranose in A. fumigatus: (i) the galactomannan present in the alkali soluble and insoluble fraction of the cell wall (ii) N- and O glycan moieties of secreted glycoproteins (iii) a @PROTEIN$-anchored lipophosphogalactomannan and (iv) several sphingolipids also anchored to the membrane by an @COMPOUND$.	0	18686165-403
Four different molecules contain galactofuranose in A. fumigatus: (i) the galactomannan present in the alkali soluble and insoluble fraction of the cell wall (ii) N- and O @COMPOUND$ moieties of secreted glycoproteins (iii) a @PROTEIN$-anchored lipophosphogalactomannan and (iv) several sphingolipids also anchored to the membrane by an inositol phosphoceramide.	0	18686165-403
The estimated @PROTEIN$ level and the IMCL content in these patients were correlated with body mass index, percentage of body fat, other measures of abdominal obesity, serum lipoproteins, fasting and post-oral @COMPOUND$ load serum insulin levels and other surrogate markers of insulin resistance.	0	18687549-1315
The estimated CRP level and the IMCL content in these patients were correlated with body mass index, percentage of body fat, other measures of abdominal obesity, serum lipoproteins, fasting and post-oral @COMPOUND$ load serum @PROTEIN$ levels and other surrogate markers of insulin resistance.	1	18687549-1315
Studies suggest that @PROTEIN$ activation in osteoblasts is the underlying cause of glucocorticoid- and estrogen deficiency-mediated osteoporosis, and at least partially underlies the teratogenic effects of @COMPOUND$ on limb development.	1	18687985-1621
The @PROTEIN$-induced up-regulation of RhoA was inhibited by @COMPOUND$, an inhibitor of signal transducer and activator of transcription 6 (STAT6).	0	18688040-30
The IL-13-induced up-regulation of @PROTEIN$ was inhibited by @COMPOUND$, an inhibitor of signal transducer and activator of transcription 6 (STAT6).	1	18688040-30
The IL-13-induced up-regulation of RhoA was inhibited by @COMPOUND$, an inhibitor of signal transducer and activator of transcription 6 (@PROTEIN$).	1	18688040-30
The goal of this study was to determine the mechanisms by which @COMPOUND$ induces @PROTEIN$ gene expression in airway epithelial cells.	1	18688042-1313
Pretreatment with ER antagonist @COMPOUND$ blocked both E2-induced @PROTEIN$/2-MAPK activation and MUC5B gene expression.	1	18688042-1314
Pretreatment with ER antagonist @COMPOUND$ blocked both E2-induced ERK1/2-@PROTEIN$ activation and MUC5B gene expression.	1	18688042-1314
Pretreatment with ER antagonist @COMPOUND$ blocked both E2-induced ERK1/2-MAPK activation and @PROTEIN$ gene expression.	1	18688042-1314
We here show that calumenin in the presence of @COMPOUND$+) binds to @PROTEIN$ with a dissociation constant K (d) around 0.4 muM.	1	18688696-558
It represents transition in @COMPOUND$-deprived conditions, known to lead to H2 production in Chlamydomonas reinhardtii, and the two main processes then induced which are an over-accumulation of intracellular starch and a progressive reduction of @PROTEIN$ activity for anoxia achievement.	1	18688816-657
We examined whether @COMPOUND$ produced locally in the brain may contribute to the activation of @PROTEIN$ in the CNS.	1	18689429-1187
Macrophages isolated from iron deficient rats, or pregnant rats at day 21 of gestation, either supplemented with a single dose of @COMPOUND$, 10 mg, at the commencement of pregnancy, or not, showed significant increases of macrophage ferroportin mRNA expression, which was paralleled by significant decreases in hepatic @PROTEIN$ mRNA expression.	1	18690415-286
Rat dicarboxylate transporter (@PROTEIN$), expressed in renal tubular epithelial cells, plays a key role in regulating blood and urinary @COMPOUND$ level by reabsorbing citrate from the lumen.	1	18690549-796
However, as opposed to exogenous @COMPOUND$, the continuous use of @PROTEIN$ during in vitro differentiation completely blocked rMSC mineralization.	0	18690792-145
We show that the effects of both @PROTEIN$-2 and @COMPOUND$ are mediated through FGF receptor 1 (FGFR1) and that inhibition of signaling through this receptor arrests cell growth, resulting in the cells being unable to reach the critical density necessary to induce differentiation.	0	18690792-146
We show that the effects of both @PROTEIN$ and @COMPOUND$ are mediated through FGF receptor 1 (FGFR1) and that inhibition of signaling through this receptor arrests cell growth, resulting in the cells being unable to reach the critical density necessary to induce differentiation.	0	18690792-146
We show that the effects of both FGF-2 and @COMPOUND$ are mediated through FGF receptor 1 (@PROTEIN$) and that inhibition of signaling through this receptor arrests cell growth, resulting in the cells being unable to reach the critical density necessary to induce differentiation.	1	18690792-146
Two related polytopic @PROTEIN$ of the major facilitator family, NarK and NarU, catalyse @COMPOUND$ uptake, nitrite export and nitrite uptake across the Escherichia coli cytoplasmic membrane by an unknown mechanism.	0	18691156-926
Two related polytopic membrane proteins of the major facilitator family, NarK and @PROTEIN$, catalyse @COMPOUND$ uptake, nitrite export and nitrite uptake across the Escherichia coli cytoplasmic membrane by an unknown mechanism.	1	18691156-926
Two related polytopic membrane proteins of the major facilitator family, @PROTEIN$ and NarU, catalyse @COMPOUND$ uptake, nitrite export and nitrite uptake across the Escherichia coli cytoplasmic membrane by an unknown mechanism.	1	18691156-926
Intracellular interleukin-4 (Th2 cytokine) and @PROTEIN$ (Th1 cytokine) production was assessed in CD4+ T lymphocytes activated by phorbol 12-myristate 13-acetate and @COMPOUND$ using flow cytometry.	1	18691343-1073
Intracellular interleukin-4 (Th2 cytokine) and interferon-gamma (@PROTEIN$ cytokine) production was assessed in CD4+ T lymphocytes activated by @COMPOUND$ and ionomycin using flow cytometry.	1	18691343-1073
Intracellular interleukin-4 (Th2 cytokine) and @PROTEIN$ (Th1 cytokine) production was assessed in CD4+ T lymphocytes activated by @COMPOUND$ and ionomycin using flow cytometry.	1	18691343-1073
Intracellular interleukin-4 (Th2 cytokine) and interferon-gamma (@PROTEIN$ cytokine) production was assessed in CD4+ T lymphocytes activated by phorbol 12-myristate 13-acetate and @COMPOUND$ using flow cytometry.	1	18691343-1073
This signaling system is engaged by the active component of cannabis, Delta9-tetrahydrocannabinol (@COMPOUND$), which exerts its pharmacological effects by activation of G protein-coupled type-1 (CB1) and type-2 (@PROTEIN$) cannabinoid receptors.	1	18691603-1685
This signaling system is engaged by the active component of cannabis, @COMPOUND$ (Delta9-THC), which exerts its pharmacological effects by activation of G protein-coupled type-1 (CB1) and type-2 (@PROTEIN$) cannabinoid receptors.	1	18691603-1685
This signaling system is engaged by the active component of cannabis, @COMPOUND$ (Delta9-THC), which exerts its pharmacological effects by activation of G protein-coupled type-1 (@PROTEIN$) and type-2 (CB2) cannabinoid receptors.	1	18691603-1685
This signaling system is engaged by the active component of cannabis, Delta9-tetrahydrocannabinol (@COMPOUND$), which exerts its pharmacological effects by activation of G protein-coupled type-1 (@PROTEIN$) and type-2 (CB2) cannabinoid receptors.	1	18691603-1685
@COMPOUND$ stimulates antioxidant response element-mediated expression of @PROTEIN$ in mouse macrophages.	1	18691715-1342
The current study investigated whether @COMPOUND$ induces transcription of @PROTEIN$ (Gcl), via ARE driven gene expression in mouse macrophages.	0	18691715-1343
The current study investigated whether @COMPOUND$ induces transcription of glutamate-cysteine ligase (@PROTEIN$), via ARE driven gene expression in mouse macrophages.	0	18691715-1343
Treatment of mouse macrophages with d-/l-@COMPOUND$ (50microM) induced depletion of intracellular glutathione and a compensatory increase in @PROTEIN$ activity.	1	18691715-1344
Treatment of mouse macrophages with d-/l-homocysteine (50microM) induced depletion of intracellular @COMPOUND$ and a compensatory increase in @PROTEIN$ activity.	0	18691715-1344
Real-time RT-PCR revealed increased mRNA-expression of the catalytic subunit of Gcl (Gclc) after treatment with @COMPOUND$, and this occurred via increased transcription as demonstrated with @PROTEIN$ promoter reporter constructs for Gclc.	0	18691715-1345
Ligand-induced @PROTEIN$-downregulation modulates cell death associated proteins and enhances chemosensitivity to @COMPOUND$ in THP-1 acute myeloid leukemia cells.	1	18691757-12
Only EGF activated @PROTEIN$ signaling and up-regulated early gene expression, while @COMPOUND$ triggered the expression of classical AR-responsive genes with the exception of the EGF-induced PSA transcript in A549 cells.	0	18692155-570
Only EGF activated ERK signaling and up-regulated early gene expression, while @COMPOUND$ triggered the expression of classical AR-responsive genes with the exception of the EGF-induced @PROTEIN$ transcript in A549 cells.	0	18692155-570
Only @PROTEIN$ activated ERK signaling and up-regulated early gene expression, while @COMPOUND$ triggered the expression of classical AR-responsive genes with the exception of the EGF-induced PSA transcript in A549 cells.	0	18692155-570
@COMPOUND$ and @PROTEIN$ up-regulated cyclinD1 (CD1) at both mRNA and protein levels in A549 cells, while in LNCaP cells each mitogen increased only CD1 protein expression.	0	18692155-571
@COMPOUND$ and EGF up-regulated cyclinD1 (@PROTEIN$) at both mRNA and protein levels in A549 cells, while in LNCaP cells each mitogen increased only CD1 protein expression.	1	18692155-571
High @COMPOUND$ induced endothelial cell growth inhibition is associated with an increase in @PROTEIN$ secretion and inhibition of Ras prenylation via suppression of the mevalonate pathway.	1	18692592-835
High @COMPOUND$ induced endothelial cell growth inhibition is associated with an increase in TGFbeta1 secretion and inhibition of @PROTEIN$ prenylation via suppression of the mevalonate pathway.	1	18692592-835
The influence of the prenylation status of @PROTEIN$ on the observed changes in endothelial cell growth under high @COMPOUND$ conditions has not previously been examined.	0	18692592-836
Calcineurin inhibitors (CsA, @COMPOUND$ and pimecrolimus) inhibited NO production and @PROTEIN$ expression in a concentration-dependent manner, CsA being more potent than FK-506 and pimecrolimus.	1	18692599-393
Calcineurin inhibitors (CsA, FK-506 and @COMPOUND$) inhibited NO production and @PROTEIN$ expression in a concentration-dependent manner, CsA being more potent than FK-506 and pimecrolimus.	1	18692599-393
In conclusion, the results suggest that calcineurin inhibitors cyclosporin A, tacrolimus (FK-506) and @COMPOUND$ inhibit @PROTEIN$ expression and NO production in response to inflammatory stimuli by enhancing the decay of iNOS mRNA by a 3'UTR-dependent manner.	1	18692599-395
In conclusion, the results suggest that calcineurin inhibitors @COMPOUND$, tacrolimus (FK-506) and pimecrolimus inhibit @PROTEIN$ expression and NO production in response to inflammatory stimuli by enhancing the decay of iNOS mRNA by a 3'UTR-dependent manner.	1	18692599-395
In conclusion, the results suggest that calcineurin inhibitors cyclosporin A, @COMPOUND$ (FK-506) and pimecrolimus inhibit @PROTEIN$ expression and NO production in response to inflammatory stimuli by enhancing the decay of iNOS mRNA by a 3'UTR-dependent manner.	1	18692599-395
In conclusion, the results suggest that calcineurin inhibitors cyclosporin A, tacrolimus (@COMPOUND$) and pimecrolimus inhibit @PROTEIN$ expression and NO production in response to inflammatory stimuli by enhancing the decay of iNOS mRNA by a 3'UTR-dependent manner.	1	18692599-395
An increased activity of ATP-binding cassette transporter A1 (@PROTEIN$) and ABCG5/G8 heterodimer has been proposed as a mechanism underlying the hypocholesterolaemic effect of @COMPOUND$.	1	18692849-615
An increased activity of ATP-binding cassette transporter A1 (ABCA1) and @PROTEIN$/G8 heterodimer has been proposed as a mechanism underlying the hypocholesterolaemic effect of @COMPOUND$.	1	18692849-615
In sum, @COMPOUND$ exposure lowered TOSC, a result that at least in part can be related to lowering of antioxidant enzymes like @PROTEIN$.	1	18692896-648
Accumulation of @COMPOUND$ in PA was increased by @PROTEIN$ at 10nM and by IGF-I at 1 nM and 10nM.	1	18693051-793
Accumulation of @COMPOUND$ in PA was increased by insulin at 10nM and by @PROTEIN$ at 1 nM and 10nM.	1	18693051-793
@PROTEIN$ is important to this response because it increases @COMPOUND$ uptake.	1	18693094-1555
It was shown that PAR significantly increased serum ALT, @PROTEIN$, ALP, liver MDA levels and significantly decreased liver @COMPOUND$-Px activity, when compared to the control group (Group 1).	0	18693095-825
It was shown that PAR significantly increased serum ALT, AST, @PROTEIN$, liver MDA levels and significantly decreased liver @COMPOUND$-Px activity, when compared to the control group (Group 1).	0	18693095-825
Biological testing of the compound demonstrated a significant antidiabetic activity by reducing the elevated blood glucose levels and restoring the @PROTEIN$ levels in @COMPOUND$-induced diabetic rats.	0	18693100-829
Biological testing of the compound demonstrated a significant antidiabetic activity by reducing the elevated blood @COMPOUND$ levels and restoring the @PROTEIN$ levels in streptozotocin-induced diabetic rats.	0	18693100-829
The activity of guanylyl @PROTEIN$ was determined by the amount of @COMPOUND$ generated in responses to sodium nitroprusside (SNP) or ANP.	1	18693294-868
Both SAHA and @COMPOUND$ induced an arrest in the cell cycle along with the induction of apoptotic pathways as evidenced by flow cytometry, annexin assay, detection of activated caspase 9, and molecular analysis of @PROTEIN$/Bcl-2 expression.	1	18694296-116
Both @COMPOUND$ and MS-275 induced an arrest in the cell cycle along with the induction of apoptotic pathways as evidenced by flow cytometry, annexin assay, detection of activated caspase 9, and molecular analysis of @PROTEIN$/Bcl-2 expression.	1	18694296-116
Both SAHA and @COMPOUND$ induced an arrest in the cell cycle along with the induction of apoptotic pathways as evidenced by flow cytometry, annexin assay, detection of activated caspase 9, and molecular analysis of Bax/@PROTEIN$ expression.	1	18694296-116
Both @COMPOUND$ and MS-275 induced an arrest in the cell cycle along with the induction of apoptotic pathways as evidenced by flow cytometry, annexin assay, detection of activated caspase 9, and molecular analysis of Bax/@PROTEIN$ expression.	1	18694296-116
Immunolocalization of @PROTEIN$ in the boar epididymis: the effect of GnRH agonist @COMPOUND$.	0	18694429-208
E(2) increased the expression of @PROTEIN$ and caveolin-2 mRNA and proteins, but pre-treatment with @COMPOUND$ (an estrogen receptor (ER) antagonist) inhibited E(2)-induced increase in caveolin-1 and caveolin-2 proteins expression.	1	18694845-560
E(2) increased the expression of caveolin-1 and @PROTEIN$ mRNA and proteins, but pre-treatment with @COMPOUND$ (an estrogen receptor (ER) antagonist) inhibited E(2)-induced increase in caveolin-1 and caveolin-2 proteins expression.	1	18694845-560
Phospho-@PROTEIN$ was significantly blocked by @COMPOUND$ or pyrazolopyrimidine 2 (PP2 ; a Src-kinase inhibitor).	1	18694845-561
Phospho-@PROTEIN$ was significantly blocked by ICI 182,780 or @COMPOUND$ 2 (PP2 ; a Src-kinase inhibitor).	1	18694845-561
LY 294002 (a PI3K inhibitor) or PD 98059 (an ERK1/2 inhibitor) prevented E(2)-induced increase in @PROTEIN$ expression and the accompanying ((3)H)-@COMPOUND$ incorporation.	1	18694845-562
LY 294002 (a PI3K inhibitor) or @COMPOUND$ (an ERK1/2 inhibitor) prevented E(2)-induced increase in @PROTEIN$ expression and the accompanying ((3)H)-thymidine incorporation.	1	18694845-562
@COMPOUND$ (a PI3K inhibitor) or PD 98059 (an ERK1/2 inhibitor) prevented E(2)-induced increase in @PROTEIN$ expression and the accompanying ((3)H)-thymidine incorporation.	1	18694845-562
Furthermore, inhibition of caveolin-1 expression using a caveolin-1 siRNA significantly attenuated E(2)-induced up-regulation of proto-oncogenes, @PROTEIN$, ((3)H)-@COMPOUND$ incorporation, overall cell number, and percent of the cell population in S phase, while mediating a concomitant increase in the G0/G1 population.	0	18694845-563
Almost all @PROTEIN$ kinase that translocates to the nucleus shows a marked phosphorylation on @COMPOUND$ 473.	1	18694847-1230
During the early response in AR, @COMPOUND$ has been found to be the most abundant mediator and it is associated with many symptoms of this disease mediated through the @PROTEIN$.	1	18695846-1364
During the incubation of @COMPOUND$ with para-hydroquinones using @PROTEIN$ as biocatalyst, one or two main products were formed.	1	18695937-929
The effect on activation voltage but not that on amplitude was absent when expressing a cAMP-insensitive mutant (@PROTEIN$R/E), while a C-terminal truncated form of HCN2 (HCN2DeltaCx) exhibited only the voltage dependent but not the amplitude effect of @COMPOUND$.	1	18696104-1256
Thus, the action of erbstatin on the activation relation and current amplitude are distinct and separable in newborn myocytes, and the effect on activation voltage depends on the @COMPOUND$ status of @PROTEIN$ channels.	1	18696104-1257
Thus, the action of @COMPOUND$ on the activation relation and current amplitude are distinct and separable in newborn myocytes, and the effect on activation voltage depends on the cAMP status of @PROTEIN$ channels.	1	18696104-1257
In contrast to newborn myocytes, @COMPOUND$ had no effect on @PROTEIN$ under control conditions in adult myocytes but induced a negative shift with no change in amplitude when saturated cAMP was added to the pipette solution.	0	18696104-1258
In contrast to newborn myocytes, erbstatin had no effect on @PROTEIN$ under control conditions in adult myocytes but induced a negative shift with no change in amplitude when saturated @COMPOUND$ was added to the pipette solution.	0	18696104-1258
Arginine-specific @PROTEIN$ (Art) catalyzes the mono-ADP-ribosylation, in which it transfers a single ADP-ribose moiety of NAD to the @COMPOUND$ residue(s) of target proteins, and may regulate the function of the proteins or peptides in cellular processes.	1	18696216-140
@COMPOUND$-specific @PROTEIN$ (Art) catalyzes the mono-ADP-ribosylation, in which it transfers a single ADP-ribose moiety of NAD to the arginine residue(s) of target proteins, and may regulate the function of the proteins or peptides in cellular processes.	1	18696216-140
Arginine-specific @PROTEIN$ (Art) catalyzes the mono-ADP-ribosylation, in which it transfers a single ADP-ribose moiety of @COMPOUND$ to the arginine residue(s) of target proteins, and may regulate the function of the proteins or peptides in cellular processes.	1	18696216-140
A D-amino acid oxidase gene (dao) was ligated with the P(Hase) and cloned into pGEMKT to constitutively express protein of @PROTEIN$ without the use of any inducer such as @COMPOUND$ which is poisonous to the cells and environment.	1	18696261-327
A D-amino acid oxidase gene (@PROTEIN$) was ligated with the P(Hase) and cloned into pGEMKT to constitutively express protein of DAAO without the use of any inducer such as @COMPOUND$ which is poisonous to the cells and environment.	1	18696261-327
In response to a @COMPOUND$-containing atherogenic diet, C57BL/6J mice significantly increased expression of @PROTEIN$ in the aorta, while mice lacking UCP2, in the absence of any other genetic modification, displayed significant endothelial dysfunction following the atherogenic diet.	1	18698091-1558
These data establish that in the vasculature @PROTEIN$ functions as an adaptive antioxidant defense to protect against the development of atherosclerosis in response to a fat and @COMPOUND$ diet.	1	18698091-1559
To confirm that mouse @PROTEIN$-PG possesses a single GAG chain attached to Ser (89), we substituted Ser (89) by @COMPOUND$ (89).	1	18698130-1197
PC-1 is the primary generator of @COMPOUND$ in osteoblastic cells; therefore, regulated expression of PC-1 by @PROTEIN$s may be a principal mechanism by which FGF signaling affects bone mineralization.	1	18698132-1603
PC-1 is the primary generator of @COMPOUND$ in osteoblastic cells; therefore, regulated expression of PC-1 by @PROTEIN$ may be a principal mechanism by which FGF signaling affects bone mineralization.	1	18698132-1603
In analogy to the reduction of @COMPOUND$+) oscillation frequency, the blockers impaired HCEC contraction, NF-kappaB activation, and @PROTEIN$ expression.	1	18698333-75
Cisternal SAH-CSF induces cytosolic @COMPOUND$+) oscillations in HCEC that results in cellular constriction, NF-kappaB activation, and @PROTEIN$ expression.	1	18698333-76
For proof of principle, we use L-lactate and @COMPOUND$ as representative pair of enantiomers, L-@PROTEIN$ as stereospecific signal generator, and cascade blue hydrazide as reactive signal amplifier to capture the produced pyruvate.	0	18698636-309
For proof of principle, we use @COMPOUND$ and D-lactate as representative pair of enantiomers, L-@PROTEIN$ as stereospecific signal generator, and cascade blue hydrazide as reactive signal amplifier to capture the produced pyruvate.	0	18698636-309
For proof of principle, we use L-lactate and D-lactate as representative pair of enantiomers, L-@PROTEIN$ as stereospecific signal generator, and cascade blue hydrazide as reactive signal amplifier to capture the produced @COMPOUND$.	0	18698636-309
Escherichia coli strain PC09 (DeltaxylB, cAMP-independent CRP (crp *) mutant) expressing an NADPH-dependent @PROTEIN$ from Candida boidinii (CbXR) was previously reported to produce @COMPOUND$ from xylose while metabolizing glucose (Cirino et al.	1	18698648-318
Escherichia coli strain PC09 (DeltaxylB, cAMP-independent CRP (crp *) mutant) expressing an NADPH-dependent @PROTEIN$ from Candida boidinii (CbXR) was previously reported to produce xylitol from xylose while metabolizing @COMPOUND$ (Cirino et al.	1	18698648-318
Studies in which the expression of CbXR or a @PROTEIN$ was increased suggest that enzyme activity and xylose transport are not limiting @COMPOUND$ production in PC09.	1	18698648-319
For the case of xylose-proton symport, omitting the @PROTEIN$ (glucose-6-phosphate dehydrogenase) or PntAB (membrane-bound transhydrogenase) reactions or TCA cycle activity from the model reduces the theoretical maximum yield from 9.2 to 8.8, 3.6, and 8.0 mol @COMPOUND$ (mol glucose)(-1), respectively.	1	18698648-321
For the case of xylose-proton symport, omitting the Zwf (glucose-6-phosphate dehydrogenase) or @PROTEIN$ (membrane-bound transhydrogenase) reactions or TCA cycle activity from the model reduces the theoretical maximum yield from 9.2 to 8.8, 3.6, and 8.0 mol @COMPOUND$ (mol glucose)(-1), respectively.	1	18698648-321
Experimentally, deleting pgi (encoding @PROTEIN$) from strain PC09 improves the yield from 3.4 to 4.0 mol @COMPOUND$ (mol glucose)(-1), while deleting either or both E. coli transhydrogenases (sthA and pntA) has no significant effect on the measured yield.	1	18698648-322
Experimentally, deleting @PROTEIN$ (encoding phosphoglucose isomerase) from strain PC09 improves the yield from 3.4 to 4.0 mol @COMPOUND$ (mol glucose)(-1), while deleting either or both E. coli transhydrogenases (sthA and pntA) has no significant effect on the measured yield.	1	18698648-322
Experimentally, deleting pgi (encoding phosphoglucose isomerase) from strain PC09 improves the yield from 3.4 to 4.0 mol @COMPOUND$ (mol glucose)(-1), while deleting either or both E. coli transhydrogenases (@PROTEIN$ and pntA) has no significant effect on the measured yield.	0	18698648-322
Experimentally, deleting pgi (encoding phosphoglucose isomerase) from strain PC09 improves the yield from 3.4 to 4.0 mol @COMPOUND$ (mol glucose)(-1), while deleting either or both E. coli transhydrogenases (sthA and @PROTEIN$) has no significant effect on the measured yield.	0	18698648-322
Deleting either @PROTEIN$ or sucC (TCA cycle) significantly reduces the yield from 3.4 to 2.0 and 2.3 mol xylitol (mol @COMPOUND$)(-1), respectively.	1	18698648-323
Deleting either zwf or @PROTEIN$ (TCA cycle) significantly reduces the yield from 3.4 to 2.0 and 2.3 mol @COMPOUND$ (mol glucose)(-1), respectively.	1	18698648-323
Deleting either zwf or @PROTEIN$ (TCA cycle) significantly reduces the yield from 3.4 to 2.0 and 2.3 mol xylitol (mol @COMPOUND$)(-1), respectively.	1	18698648-323
Deleting either @PROTEIN$ or sucC (TCA cycle) significantly reduces the yield from 3.4 to 2.0 and 2.3 mol @COMPOUND$ (mol glucose)(-1), respectively.	1	18698648-323
In the process studied, the enzyme cellobiose dehydrogenase (@PROTEIN$) oxidizes lactose at the C-1 position of the reducing sugar moiety to lactobionolactone, which spontaneously hydrolyzes to @COMPOUND$.	1	18698649-324
In the process studied, the enzyme cellobiose dehydrogenase (@PROTEIN$) oxidizes @COMPOUND$ at the C-1 position of the reducing sugar moiety to lactobionolactone, which spontaneously hydrolyzes to lactobionic acid.	1	18698649-324
@COMPOUND$ served as the terminal electron acceptor of the reaction and was fully reduced to water by @PROTEIN$.	1	18698649-326
Immunocytochemical localization of cell surface markers like SSEA-3, SSEA-4, @COMPOUND$-1-60, and TRA-1-81, staining for alkaline phosphatase and @PROTEIN$ polymerase chain reaction (RT-PCR) analysis of pluripotency state markers viz.	0	18699724-117
Immunocytochemical localization of cell surface markers like @COMPOUND$, SSEA-4, TRA-1-60, and TRA-1-81, staining for alkaline phosphatase and @PROTEIN$ polymerase chain reaction (RT-PCR) analysis of pluripotency state markers viz.	0	18699724-117
Immunocytochemical localization of cell surface markers like SSEA-3, SSEA-4, @COMPOUND$-1-60, and TRA-1-81, staining for @PROTEIN$ and reverse transcriptase polymerase chain reaction (RT-PCR) analysis of pluripotency state markers viz.	0	18699724-117
Immunocytochemical localization of cell surface markers like SSEA-3, SSEA-4, @COMPOUND$-1-60, and TRA-1-81, staining for alkaline phosphatase and reverse transcriptase polymerase chain reaction (RT-@PROTEIN$) analysis of pluripotency state markers viz.	0	18699724-117
Immunocytochemical localization of cell surface markers like @COMPOUND$, SSEA-4, TRA-1-60, and TRA-1-81, staining for alkaline phosphatase and reverse transcriptase polymerase chain reaction (RT-@PROTEIN$) analysis of pluripotency state markers viz.	0	18699724-117
Immunocytochemical localization of cell surface markers like @COMPOUND$, SSEA-4, TRA-1-60, and TRA-1-81, staining for @PROTEIN$ and reverse transcriptase polymerase chain reaction (RT-PCR) analysis of pluripotency state markers viz.	0	18699724-117
Solamargine induces apoptosis and enhances susceptibility to trastuzumab and @COMPOUND$ in breast cancer cells with low or high expression levels of HER2/@PROTEIN$.	0	18699774-1334
@COMPOUND$ induces apoptosis and enhances susceptibility to trastuzumab and epirubicin in breast cancer cells with low or high expression levels of @PROTEIN$/neu.	0	18699774-1334
Solamargine induces apoptosis and enhances susceptibility to trastuzumab and @COMPOUND$ in breast cancer cells with low or high expression levels of @PROTEIN$/neu.	0	18699774-1334
@COMPOUND$ induces apoptosis and enhances susceptibility to trastuzumab and epirubicin in breast cancer cells with low or high expression levels of HER2/@PROTEIN$.	0	18699774-1334
SM (@COMPOUND$), a major steroidal alkaloid glycoside purified from Solanum incanum, triggered apoptosis of breast cancer cells (MCF-7 and SK-BR-3 cells) and non-cancerous breast epithelial cells (HBL-100 cells) within 3 h. To extend the application of trastuzumab in breast cancer patients, the regulation of @PROTEIN$/neu expression by SM was investigated.	0	18699774-1335
SM (solamargine), a major @COMPOUND$ glycoside purified from Solanum incanum, triggered apoptosis of breast cancer cells (MCF-7 and SK-BR-3 cells) and non-cancerous breast epithelial cells (HBL-100 cells) within 3 h. To extend the application of trastuzumab in breast cancer patients, the regulation of HER2/@PROTEIN$ expression by SM was investigated.	0	18699774-1335
SM (@COMPOUND$), a major steroidal alkaloid glycoside purified from Solanum incanum, triggered apoptosis of breast cancer cells (MCF-7 and SK-BR-3 cells) and non-cancerous breast epithelial cells (HBL-100 cells) within 3 h. To extend the application of trastuzumab in breast cancer patients, the regulation of HER2/@PROTEIN$ expression by SM was investigated.	0	18699774-1335
SM (solamargine), a major @COMPOUND$ glycoside purified from Solanum incanum, triggered apoptosis of breast cancer cells (MCF-7 and SK-BR-3 cells) and non-cancerous breast epithelial cells (HBL-100 cells) within 3 h. To extend the application of trastuzumab in breast cancer patients, the regulation of @PROTEIN$/neu expression by SM was investigated.	0	18699774-1335
Since ondansetron completely reversed the effects of @COMPOUND$ on DA neuronal activity, the effects of MAOA inhibition appeared to be mediated by @PROTEIN$ receptors.	0	18700056-1486
Since ondansetron completely reversed the effects of @COMPOUND$ on DA neuronal activity, the effects of @PROTEIN$ inhibition appeared to be mediated by 5-HT3 receptors.	0	18700056-1486
Since @COMPOUND$ completely reversed the effects of clorgyline on DA neuronal activity, the effects of MAOA inhibition appeared to be mediated by @PROTEIN$ receptors.	0	18700056-1486
Since @COMPOUND$ completely reversed the effects of clorgyline on DA neuronal activity, the effects of @PROTEIN$ inhibition appeared to be mediated by 5-HT3 receptors.	0	18700056-1486
The effects of @PROTEIN$ were reversed by the mitochondrial KATP blocker, @COMPOUND$, indicating that mitochondrial KATP channels participate in the regulation of astrocyte activation.	1	18700057-534
The cell proliferation, the up-regulation of pS2, and the down-regulation of @PROTEIN$ and ERbeta gene expressions induced by the racemate and enantiomers of o,p'-DDT were all reversed by cotreatment with 10(-6) mol/L @COMPOUND$.	1	18700809-895
The cell proliferation, the up-regulation of pS2, and the down-regulation of ERalpha and @PROTEIN$ gene expressions induced by the racemate and enantiomers of o,p'-DDT were all reversed by cotreatment with 10(-6) mol/L @COMPOUND$.	1	18700809-895
While bass in all @COMPOUND$ treatment groups had significantly inhibited brain @PROTEIN$ activity, only the medium and high treatment groups showed a dose- and time-dependent increase in time to capture prey.	1	18700818-411
The aim of this phase 0 study was to investigate whether @COMPOUND$ passes the blood-tumor barrier, and is phosphorylated in the tumor by @PROTEIN$ (dCK) to gemcitabine nucleotides in order to enable radiosensitization, and whether it is deaminated by deoxycytidine deaminase (dCDA) to dFdU.	1	18701427-85
The aim of this phase 0 study was to investigate whether @COMPOUND$ passes the blood-tumor barrier, and is phosphorylated in the tumor by deoxycytidine kinase (@PROTEIN$) to gemcitabine nucleotides in order to enable radiosensitization, and whether it is deaminated by deoxycytidine deaminase (dCDA) to dFdU.	1	18701427-85
The @COMPOUND$ mutation at amino acid location 164 significantly reduced the initial hydrolysis of either the @PROTEIN$ in solution or the proteins bound on HAP, which was confirmed by amelogenin oligopeptide assays.	1	18701806-1254
In conclusion, dentin mineralization in a corrected @COMPOUND$ and vitamin D environment compensates the adverse effect of @PROTEIN$ mutation.	0	18701809-777
In conclusion, dentin mineralization in a corrected phosphate and @COMPOUND$ environment compensates the adverse effect of @PROTEIN$ mutation.	0	18701809-777
The considered biological model system consisted of a coating antibody (goat IgG), bovine serum albumin (@PROTEIN$) as blocking agent, and a complementary antibody labelled with @COMPOUND$ (anti-goat IgG).	0	18702173-1549
The considered biological model system consisted of a coating antibody (goat IgG), bovine @PROTEIN$ (BSA) as blocking agent, and a complementary antibody labelled with @COMPOUND$ (anti-goat IgG).	0	18702173-1549
Prolonged L-alanine exposure induces changes in metabolism, @COMPOUND$+) handling and desensitization of @PROTEIN$ secretion in clonal pancreatic beta-cells.	0	18702613-201
Prolonged L-@COMPOUND$ exposure induces changes in metabolism, Ca(2+) handling and desensitization of @PROTEIN$ secretion in clonal pancreatic beta-cells.	1	18702613-201
Collectively, these results illustrate the phenomenon of beta-cell desensitization by amino acids, indicating that prolonged exposure to alanine can induce reversible alterations to metabolic flux, @COMPOUND$+) handling and @PROTEIN$ secretion.	0	18702613-203
Collectively, these results illustrate the phenomenon of beta-cell desensitization by amino acids, indicating that prolonged exposure to @COMPOUND$ can induce reversible alterations to metabolic flux, Ca(2+) handling and @PROTEIN$ secretion.	1	18702613-203
Acylation-stimulating protein (@PROTEIN$) has been shown to positively stimulate fatty acid esterification and @COMPOUND$ uptake in adipocytes.	1	18702682-263
Using a set of experiments aimed at manipulate a putative @COMPOUND$/NMDA/NO signal transduction pathway, we have demonstrated, by quantitative real-time PCR, that NMDA enhances the expression of @PROTEIN$ mRNA in a dose-response manner.	1	18703100-623
Using a set of experiments aimed at manipulate a putative l-glutamate/@COMPOUND$/NO signal transduction pathway, we have demonstrated, by quantitative real-time PCR, that NMDA enhances the expression of @PROTEIN$ mRNA in a dose-response manner.	1	18703100-623
Reaction parameters for the production of XOS from corncob using @PROTEIN$ from Aspergillus oryzae MTCC 5154 were optimized and an XOS yield of 10.2+/-0.14 mg ml(-1) corresponding to 81+/-3.9% with 73.5% @COMPOUND$ was obtained.	0	18703333-1701
@COMPOUND$ inhibits cytokine-induced nuclear factor-kappaB activation via AMP-activated @PROTEIN$ activation in vascular endothelial cells.	1	18703532-1538
Cilostazol is a selective inhibitor of phosphodiesterase 3 that increases intracellular cyclic AMP (@COMPOUND$) levels and activates @PROTEIN$, thereby inhibiting platelet aggregation and inducing peripheral vasodilation.	0	18703532-1539
@COMPOUND$ is a selective inhibitor of phosphodiesterase 3 that increases intracellular cyclic AMP (cAMP) levels and activates @PROTEIN$, thereby inhibiting platelet aggregation and inducing peripheral vasodilation.	1	18703532-1539
We hypothesized that @COMPOUND$ may prevent inflammatory cytokine induced-nuclear factor (NF)-kappaB activation by activating AMP-activated protein kinase (@PROTEIN$) in vascular endothelial cells.	1	18703532-1540
We hypothesized that @COMPOUND$ may prevent inflammatory cytokine induced-nuclear factor (NF)-kappaB activation by activating AMP-activated @PROTEIN$ (AMPK) in vascular endothelial cells.	1	18703532-1540
Serum @COMPOUND$ (E2) levels were not altered at any time point after @PROTEIN$, demonstrating that the increased KiSS-1 expression observed was not caused by an elevation in E2.	0	18703622-1294
A2aR stimulation inhibits HA fragment-induced pro-fibrotic genes @PROTEIN$, keratinocyte chemoattractant (KC), macrophage inflammatory protein (MIP)-2, and MIP-1alpha while simultaneously synergizing with @COMPOUND$ fragments to up-regulate the TH1 cytokine IL-12.	0	18703794-1209
A2aR stimulation inhibits HA fragment-induced pro-fibrotic genes TNF-alpha, keratinocyte chemoattractant (KC), macrophage inflammatory protein (@PROTEIN$)-2, and MIP-1alpha while simultaneously synergizing with @COMPOUND$ fragments to up-regulate the TH1 cytokine IL-12.	0	18703794-1209
A2aR stimulation inhibits HA fragment-induced pro-fibrotic genes TNF-alpha, keratinocyte chemoattractant (KC), macrophage inflammatory protein (MIP)-2, and @PROTEIN$ while simultaneously synergizing with @COMPOUND$ fragments to up-regulate the TH1 cytokine IL-12.	0	18703794-1209
In addition, treatment of primary mouse lung fibroblasts with @COMPOUND$ stimulated @PROTEIN$ activity and collagen formation in vitro.	1	18703795-1210
These data support the idea that @COMPOUND$ may play a role in airway diseases, including asthma and pulmonary fibrosis, through NOS inhibition and enhancement of @PROTEIN$ activity.	1	18703795-1211
These data support the idea that @COMPOUND$ may play a role in airway diseases, including asthma and pulmonary fibrosis, through @PROTEIN$ inhibition and enhancement of arginase activity.	1	18703795-1211
Osteopontin (@PROTEIN$) inhibits the growth of @COMPOUND$ (COM) and other crystal phases in a phosphorylation-dependent manner.	1	18703867-1272
Prostaglandins D2, E2, and F2alpha were increased in the tissues from mouse pups exposed to &gt;95% @COMPOUND$ at 7 d indicating a differential expression of @PROTEIN$ products.	1	18703992-1333
@COMPOUND$ replacement to euglycemia causes hypoxia, acidosis, and decreased @PROTEIN$ secretion in fetal sheep with intrauterine growth restriction.	1	18704001-1340
@COMPOUND$ stimulated @PROTEIN$ secretion (GSIS) was lower in the Glu group.	1	18704001-1341
These data confirm that endogenous miR-34a regulates @PROTEIN$ levels and supports the notion that miR-34a contributes to the effects of @COMPOUND$ and VPA on GRM7.	1	18704095-238
These results confirm the therapeutic potential of @PROTEIN$ blockade on motor symptoms induced by reduced striatal @COMPOUND$ function.	1	18704096-1413
Further, they demonstrate that @PROTEIN$ blockade may also have beneficial effects on cognitive deficits induced by @COMPOUND$ depletion.	1	18704096-1414
Here, we found that the addition of glucocorticoids, such as dexamethasone and @COMPOUND$, to cultured human keratinocytes increased their @PROTEIN$ gene expression.	1	18704103-600
Here, we found that the addition of glucocorticoids, such as @COMPOUND$ and cortisol, to cultured human keratinocytes increased their @PROTEIN$ gene expression.	1	18704103-600
Gene expression of mitogen-activated protein kinase (@PROTEIN$) phosphatase-1 was also increased by the addition of @COMPOUND$.	1	18704103-601
Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (@PROTEIN$), catalase (CAT), glutathione peroxidase (GPx), reduced glutathione (@COMPOUND$), vitamin E and vitamin C.	0	18704264-1595
Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (@PROTEIN$), catalase (CAT), glutathione peroxidase (GPx), @COMPOUND$ (GSH), vitamin E and vitamin C.	0	18704264-1595
Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (@PROTEIN$) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), reduced glutathione (GSH), vitamin E and @COMPOUND$.	0	18704264-1595
Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), catalase (@PROTEIN$), glutathione peroxidase (GPx), reduced glutathione (GSH), vitamin E and @COMPOUND$.	0	18704264-1595
Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (@PROTEIN$), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), reduced glutathione (@COMPOUND$), vitamin E and vitamin C.	0	18704264-1595
Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (@PROTEIN$) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), @COMPOUND$ (GSH), vitamin E and vitamin C.	0	18704264-1595
Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), @PROTEIN$ (CAT), glutathione peroxidase (GPx), reduced glutathione (GSH), vitamin E and @COMPOUND$.	0	18704264-1595
Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (@PROTEIN$), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), @COMPOUND$ (GSH), vitamin E and vitamin C.	0	18704264-1595
Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (@PROTEIN$) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), reduced glutathione (GSH), @COMPOUND$ and vitamin C.	0	18704264-1595
Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), catalase (@PROTEIN$), glutathione peroxidase (GPx), reduced glutathione (GSH), @COMPOUND$ and vitamin C.	0	18704264-1595
Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (@PROTEIN$) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), reduced glutathione (@COMPOUND$), vitamin E and vitamin C.	0	18704264-1595
Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (@PROTEIN$), catalase (CAT), glutathione peroxidase (GPx), reduced glutathione (GSH), @COMPOUND$ and vitamin C.	0	18704264-1595
Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), @PROTEIN$ (CAT), glutathione peroxidase (GPx), reduced glutathione (GSH), @COMPOUND$ and vitamin C.	0	18704264-1595
Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker @PROTEIN$ (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), reduced glutathione (@COMPOUND$), vitamin E and vitamin C.	0	18704264-1595
Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (@PROTEIN$), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), reduced glutathione (GSH), @COMPOUND$ and vitamin C.	0	18704264-1595
Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), catalase (@PROTEIN$), glutathione peroxidase (GPx), reduced glutathione (@COMPOUND$), vitamin E and vitamin C.	0	18704264-1595
Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), catalase (@PROTEIN$), glutathione peroxidase (GPx), @COMPOUND$ (GSH), vitamin E and vitamin C.	0	18704264-1595
Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker @PROTEIN$ (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), reduced glutathione (GSH), @COMPOUND$ and vitamin C.	0	18704264-1595
Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker @PROTEIN$ (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), reduced glutathione (GSH), vitamin E and @COMPOUND$.	0	18704264-1595
Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), @PROTEIN$ (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), reduced glutathione (GSH), @COMPOUND$ and vitamin C.	0	18704264-1595
Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (@PROTEIN$), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), reduced glutathione (GSH), vitamin E and @COMPOUND$.	0	18704264-1595
Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), catalase (CAT), @PROTEIN$ (GPx), reduced glutathione (@COMPOUND$), vitamin E and vitamin C.	0	18704264-1595
Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), @PROTEIN$ (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), @COMPOUND$ (GSH), vitamin E and vitamin C.	0	18704264-1595
Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like @PROTEIN$ (SOD), catalase (CAT), glutathione peroxidase (GPx), @COMPOUND$ (GSH), vitamin E and vitamin C.	0	18704264-1595
Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like @PROTEIN$ (SOD), catalase (CAT), glutathione peroxidase (GPx), reduced glutathione (@COMPOUND$), vitamin E and vitamin C.	0	18704264-1595
Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), catalase (CAT), @PROTEIN$ (GPx), reduced glutathione (GSH), @COMPOUND$ and vitamin C.	0	18704264-1595
Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like @PROTEIN$ (SOD), catalase (CAT), glutathione peroxidase (GPx), reduced glutathione (GSH), @COMPOUND$ and vitamin C.	0	18704264-1595
Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (@PROTEIN$) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), reduced glutathione (@COMPOUND$), vitamin E and vitamin C.	0	18704264-1595
Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (@PROTEIN$) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), @COMPOUND$ (GSH), vitamin E and vitamin C.	0	18704264-1595
Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), catalase (CAT), @PROTEIN$ (GPx), @COMPOUND$ (GSH), vitamin E and vitamin C.	0	18704264-1595
Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), @PROTEIN$ (CAT), glutathione peroxidase (GPx), @COMPOUND$ (GSH), vitamin E and vitamin C.	0	18704264-1595
Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), @PROTEIN$ (CAT), glutathione peroxidase (GPx), reduced glutathione (@COMPOUND$), vitamin E and vitamin C.	0	18704264-1595
Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), @PROTEIN$ (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), reduced glutathione (@COMPOUND$), vitamin E and vitamin C.	0	18704264-1595
Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like @PROTEIN$ (SOD), catalase (CAT), glutathione peroxidase (GPx), reduced glutathione (GSH), vitamin E and @COMPOUND$.	0	18704264-1595
Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), catalase (CAT), @PROTEIN$ (GPx), reduced glutathione (GSH), vitamin E and @COMPOUND$.	0	18704264-1595
Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (@PROTEIN$) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), reduced glutathione (GSH), vitamin E and @COMPOUND$.	0	18704264-1595
Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), @PROTEIN$ (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), reduced glutathione (GSH), vitamin E and @COMPOUND$.	0	18704264-1595
Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (@PROTEIN$), catalase (CAT), glutathione peroxidase (GPx), reduced glutathione (GSH), vitamin E and @COMPOUND$.	0	18704264-1595
Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker @PROTEIN$ (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), @COMPOUND$ (GSH), vitamin E and vitamin C.	0	18704264-1595
Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (@PROTEIN$) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), reduced glutathione (GSH), @COMPOUND$ and vitamin C.	0	18704264-1595
Achieving CCgR within 12 months and maintaining it without an increase in @PROTEIN$-ABL transcripts might indicate that low-dose @COMPOUND$ therapy can produce acceptable outcomes without excess toxicity.	1	18704417-141
Achieving CCgR within 12 months and maintaining it without an increase in BCR-@PROTEIN$ transcripts might indicate that low-dose @COMPOUND$ therapy can produce acceptable outcomes without excess toxicity.	1	18704417-141
Rac1 (-/-) platelets displayed defective thrombus formation on collagen under flow conditions which could be fully restored by co-infusion of ADP and the @COMPOUND$) analog U46619, indicating that impaired @PROTEIN$-, but not G-protein signaling, was responsible for the observed defect.	0	18704487-89
@PROTEIN$ (-/-) platelets displayed defective thrombus formation on collagen under flow conditions which could be fully restored by co-infusion of ADP and the @COMPOUND$) analog U46619, indicating that impaired GPVI-, but not G-protein signaling, was responsible for the observed defect.	0	18704487-89
@PROTEIN$ 13910 CC genotype is associated with @COMPOUND$ intolerance, a condition often resulting in reduced milk intake.	1	18704543-120
Osteointegration of @COMPOUND$ or its alloy with bone can be greatly improved by calcium phosphate coatings, and further enhanced by an extracellular @PROTEIN$ layer such as collagen.	1	18704651-196
Osteointegration of titanium or its alloy with bone can be greatly improved by @COMPOUND$ coatings, and further enhanced by an extracellular @PROTEIN$ layer such as collagen.	0	18704651-196
Use of @PROTEIN$ and fibronectin to influence osteoblast responses to @COMPOUND$ scaffolds.	1	18704653-197
Use of tissue transglutaminase and @PROTEIN$ to influence osteoblast responses to @COMPOUND$ scaffolds.	1	18704653-197
To explore the possibility of controlling cell interaction with biomaterials, @COMPOUND$ scaffolds were modified using the enzyme @PROTEIN$ (tTgase) in conjunction with fibronectin.	1	18704653-198
To explore the possibility of controlling cell interaction with biomaterials, @COMPOUND$ scaffolds were modified using the enzyme tissue transglutaminase (tTgase) in conjunction with @PROTEIN$.	1	18704653-198
Four MPTP monkeys received L-DOPA/@COMPOUND$ plus CI-1041 an NMDA antagonist selective for @PROTEIN$/NR2B and four were treated with L-DOPA/Benserazide plus a small dose of cabergoline ; one monkey of each group developed mild dyskinesias at the end of treatment.	0	18704766-300
Four MPTP monkeys received L-DOPA/Benserazide plus CI-1041 an NMDA antagonist selective for @PROTEIN$/NR2B and four were treated with L-DOPA/Benserazide plus a small dose of @COMPOUND$ ; one monkey of each group developed mild dyskinesias at the end of treatment.	0	18704766-300
Four MPTP monkeys received L-DOPA/@COMPOUND$ plus CI-1041 an NMDA antagonist selective for NR1/@PROTEIN$ and four were treated with L-DOPA/Benserazide plus a small dose of cabergoline ; one monkey of each group developed mild dyskinesias at the end of treatment.	0	18704766-300
Four MPTP monkeys received @COMPOUND$/Benserazide plus CI-1041 an NMDA antagonist selective for @PROTEIN$/NR2B and four were treated with L-DOPA/Benserazide plus a small dose of cabergoline ; one monkey of each group developed mild dyskinesias at the end of treatment.	0	18704766-300
Four MPTP monkeys received L-DOPA/Benserazide plus CI-1041 an NMDA antagonist selective for NR1/@PROTEIN$ and four were treated with L-DOPA/Benserazide plus a small dose of @COMPOUND$ ; one monkey of each group developed mild dyskinesias at the end of treatment.	0	18704766-300
Four MPTP monkeys received @COMPOUND$/Benserazide plus CI-1041 an NMDA antagonist selective for NR1/@PROTEIN$ and four were treated with L-DOPA/Benserazide plus a small dose of cabergoline ; one monkey of each group developed mild dyskinesias at the end of treatment.	0	18704766-300
Hence, MPTP lesion, L-DOPA treatment and prevention of LID with CI-1041 and cabergoline, or reduction with @COMPOUND$ were associated with modulation of @PROTEIN$/NMDA glutamate receptors.	1	18704766-304
Hence, MPTP lesion, @COMPOUND$ treatment and prevention of LID with CI-1041 and cabergoline, or reduction with Ro 61-8048 were associated with modulation of @PROTEIN$/NMDA glutamate receptors.	1	18704766-304
Hence, MPTP lesion, L-DOPA treatment and prevention of LID with CI-1041 and @COMPOUND$, or reduction with Ro 61-8048 were associated with modulation of @PROTEIN$/NMDA glutamate receptors.	1	18704766-304
@PROTEIN$ (UDP-N-acetylmuramoyl-L-alanine:D-glutamate ligase), a three-domain bacterial protein, catalyses a highly specific incorporation of D-glutamate to the cytoplasmic intermediate UDP-N-acetyl-muramoyl-L-alanine (@COMPOUND$) utilizing ATP hydrolysis to ADP and P(i).	1	18704940-430
On the basis of structural studies of @PROTEIN$ complexes, a stepwise catalytic mechanism was proposed that commences with a formation of the acyl-phosphate intermediate, followed by a nucleophilic attack of @COMPOUND$ that, through the formation of a tetrahedral reaction intermediate and subsequent phosphate dissociation, affords the final product, UDP-N-acetyl-muramoyl-L-alanine-D-glutamate (UMAG).	1	18704940-431
Although the overall amino acid identity between @PROTEIN$ and the LeuT(Aa) is only 17%, it increases to above 50% in the first shell of the putative 5-HT binding site, allowing de novo computational docking of @COMPOUND$ derivatives in atomic detail.	0	18704946-1065
Mal-@PROTEIN$, prepared by conjugating sCT via thio-ether bonds with aqueous-soluble palmitic acid derivative at Cys 1 and Cys 7, was reacted with mPEG-@COMPOUND$ (mPEG-Suc, 5 kDa).	1	18704953-1278
Mal-@PROTEIN$, prepared by conjugating sCT via thio-ether bonds with aqueous-soluble @COMPOUND$ derivative at Cys 1 and Cys 7, was reacted with mPEG-succinimide (mPEG-Suc, 5 kDa).	1	18704953-1278
Mal-@PROTEIN$, prepared by conjugating sCT via thio-ether bonds with aqueous-soluble palmitic acid derivative at Cys 1 and Cys 7, was reacted with @COMPOUND$-succinimide (mPEG-Suc, 5 kDa).	1	18704953-1278
Our findings suggest that @PROTEIN$ substituted with a PEG of an appropriate Mw at Lys (34) could be used as a promising type 2 anti-diabetic agent to timely control postprandial @COMPOUND$ levels.	1	18704955-1137
The antidepressant @COMPOUND$ blocks the adverse effects of stress on memory and enables spatial learning to rapidly increase neural cell adhesion molecule (@PROTEIN$) expression in the hippocampus of rats.	1	18706130-1404
@PROTEIN$ activity was also inhibited for all the soils treated with @COMPOUND$ (from 0.1 to 50mg/kg dry soil), but a declining inhibition was observed after 2 days of incubation.	1	18706695-1298
The magnitude of autophagosome formation is tightly regulated by intracellular and extracellular amino acid concentrations and @COMPOUND$ levels via signaling pathways that include the nutrient sensing kinase @PROTEIN$.	1	18706940-826
Normoglycemic (4.72 mmol/L), moderate (11.1 mmol/L) or high grade (16.7 mmol/@COMPOUND$ clamps were maintained for 6 hours by infusion of glucose, @PROTEIN$ and somatostatin.	0	18707755-1088
Normoglycemic (4.72 mmol/L), moderate (11.1 mmol/L) or high grade (16.7 mmol/L) @COMPOUND$ clamps were maintained for 6 hours by infusion of glucose, @PROTEIN$ and somatostatin.	0	18707755-1088
Normoglycemic (4.72 mmol/L), moderate (11.1 mmol/L) or high grade (16.7 mmol/L) glucose clamps were maintained for 6 hours by infusion of glucose, @PROTEIN$ and @COMPOUND$.	0	18707755-1088
or=6 ng/ml) was associated with increased expression of mrp-1 and @PROTEIN$ and decreased @COMPOUND$, while higher level resistance (10 ng/ml) was primarily associated with the increased expression of P-glycoproteins.	0	18708066-1324
or=6 ng/ml) was associated with increased expression of mrp-1 and pgp-1 and decreased @COMPOUND$, while higher level resistance (10 ng/ml) was primarily associated with the increased expression of P-@PROTEIN$.	0	18708066-1324
or=6 ng/ml) was associated with increased expression of @PROTEIN$-1 and pgp-1 and decreased @COMPOUND$, while higher level resistance (10 ng/ml) was primarily associated with the increased expression of P-glycoproteins.	0	18708066-1324
@COMPOUND$+) also induces the release of the pro-apoptotic factors, @PROTEIN$ and AIF.	1	18708157-1383
@COMPOUND$+) also induces the release of the pro-apoptotic factors, cytochrome c and @PROTEIN$.	1	18708157-1383
Incubation of rat hepatocyte primary cultures with @COMPOUND$+) results in apoptosis induction with caspase activation and increased level of expression of @PROTEIN$.	1	18708157-1384
@COMPOUND$ reduced amounts of the caspase inhibitor XIAP, and API-2 increased amounts of the BH3-only protein @PROTEIN$.	0	18708158-1385
@PROTEIN$ accumulated in mitochondria in response to API-2, whereas release of cytochrome c from mitochondria required both API-2 and @COMPOUND$.	0	18708158-1386
Bax accumulated in mitochondria in response to API-2, whereas release of @PROTEIN$ from mitochondria required both API-2 and @COMPOUND$.	1	18708158-1386
We suggest that @COMPOUND$ elicits events that activate Bax once it translocates to mitochondria and that inactivation of @PROTEIN$ signals these events and the down-regulation of XIAP.	1	18708158-1387
We suggest that @COMPOUND$ elicits events that activate @PROTEIN$ once it translocates to mitochondria and that inactivation of cdk9 signals these events and the down-regulation of XIAP.	1	18708158-1387
Intravenous @COMPOUND$ enhances @PROTEIN$ activity giving cardioprotection.	1	18708191-1226
We investigated whether acute intravenous @COMPOUND$, through an effect on cyclooxygenase (COX)-2 and heat shock protein (@PROTEIN$) 72, might induce preconditioning.	1	18708191-1227
We investigated whether acute intravenous @COMPOUND$, through an effect on cyclooxygenase (@PROTEIN$)-2 and heat shock protein (HSP) 72, might induce preconditioning.	1	18708191-1227
Islets from @COMPOUND$-supplemented mice had: (i) significantly higher @PROTEIN$ content, (ii) increased insulin secretion at stimulatory glucose concentrations, (iii) significantly displaced the dose-response curve for glucose-induced insulin release to the left, (iv) increased glucose metabolism at 5.6 and 11.1-mmol/L concentrations; (v) slowed cytosolic Ca2+ concentration ((Ca2+)i) oscillations in response to stimulatory glucose concentrations; (vi) increased insulin, sulfonylurea receptor-1, glucokinase, Glut-2, proconvertase and pancreas duodenum homeobox-1 (PDX-1) gene expression and (vii) increased PDX-1 expression in the nucleus.	1	18708284-1027
Islets from @COMPOUND$-supplemented mice had: (i) significantly higher insulin content, (ii) increased insulin secretion at stimulatory glucose concentrations, (iii) significantly displaced the dose-response curve for glucose-induced insulin release to the left, (iv) increased glucose metabolism at 5.6 and 11.1-mmol/L concentrations; (v) slowed cytosolic Ca2+ concentration ((Ca2+)i) oscillations in response to stimulatory glucose concentrations; (vi) increased insulin, sulfonylurea receptor-1, glucokinase, @PROTEIN$, proconvertase and pancreas duodenum homeobox-1 (PDX-1) gene expression and (vii) increased PDX-1 expression in the nucleus.	1	18708284-1027
Islets from @COMPOUND$-supplemented mice had: (i) significantly higher insulin content, (ii) increased insulin secretion at stimulatory glucose concentrations, (iii) significantly displaced the dose-response curve for glucose-induced insulin release to the left, (iv) increased glucose metabolism at 5.6 and 11.1-mmol/L concentrations; (v) slowed cytosolic Ca2+ concentration ((Ca2+)i) oscillations in response to stimulatory glucose concentrations; (vi) increased insulin, sulfonylurea receptor-1, glucokinase, Glut-2, proconvertase and @PROTEIN$ (PDX-1) gene expression and (vii) increased PDX-1 expression in the nucleus.	1	18708284-1027
Islets from @COMPOUND$-supplemented mice had: (i) significantly higher insulin content, (ii) increased insulin secretion at stimulatory glucose concentrations, (iii) significantly displaced the dose-response curve for glucose-induced insulin release to the left, (iv) increased glucose metabolism at 5.6 and 11.1-mmol/L concentrations; (v) slowed cytosolic Ca2+ concentration ((Ca2+)i) oscillations in response to stimulatory glucose concentrations; (vi) increased insulin, sulfonylurea receptor-1, @PROTEIN$, Glut-2, proconvertase and pancreas duodenum homeobox-1 (PDX-1) gene expression and (vii) increased PDX-1 expression in the nucleus.	1	18708284-1027
Islets from @COMPOUND$-supplemented mice had: (i) significantly higher insulin content, (ii) increased insulin secretion at stimulatory glucose concentrations, (iii) significantly displaced the dose-response curve for glucose-induced insulin release to the left, (iv) increased glucose metabolism at 5.6 and 11.1-mmol/L concentrations; (v) slowed cytosolic Ca2+ concentration ((Ca2+)i) oscillations in response to stimulatory glucose concentrations; (vi) increased insulin, sulfonylurea receptor-1, glucokinase, Glut-2, proconvertase and pancreas duodenum homeobox-1 (@PROTEIN$) gene expression and (vii) increased PDX-1 expression in the nucleus.	1	18708284-1027
Islets from @COMPOUND$-supplemented mice had: (i) significantly higher insulin content, (ii) increased insulin secretion at stimulatory glucose concentrations, (iii) significantly displaced the dose-response curve for glucose-induced insulin release to the left, (iv) increased glucose metabolism at 5.6 and 11.1-mmol/L concentrations; (v) slowed cytosolic Ca2+ concentration ((Ca2+)i) oscillations in response to stimulatory glucose concentrations; (vi) increased insulin, @PROTEIN$, glucokinase, Glut-2, proconvertase and pancreas duodenum homeobox-1 (PDX-1) gene expression and (vii) increased PDX-1 expression in the nucleus.	1	18708284-1027
Moreover, @COMPOUND$ supplementation significantly increased both basal and @PROTEIN$ stimulated tyrosine phosphorylation of the insulin receptor in skeletal muscle and liver tissues.	0	18708284-1028
Moreover, @COMPOUND$ supplementation significantly increased both basal and insulin stimulated tyrosine phosphorylation of the @PROTEIN$ in skeletal muscle and liver tissues.	1	18708284-1028
Moreover, taurine supplementation significantly increased both basal and insulin stimulated @COMPOUND$ phosphorylation of the @PROTEIN$ in skeletal muscle and liver tissues.	1	18708284-1028
Moreover, taurine supplementation significantly increased both basal and @PROTEIN$ stimulated @COMPOUND$ phosphorylation of the insulin receptor in skeletal muscle and liver tissues.	1	18708284-1028
These results indicate that @COMPOUND$ controls glucose homeostasis by regulating the expression of genes required for glucose-stimulated @PROTEIN$ secretion.	1	18708284-1029
These results indicate that taurine controls @COMPOUND$ homeostasis by regulating the expression of genes required for glucose-stimulated @PROTEIN$ secretion.	1	18708284-1029
In addition, @COMPOUND$ enhances peripheral @PROTEIN$ sensitivity.	1	18708284-1030
Furthermore, treatment of @COMPOUND$ and EPA also synergistically blocked the activation of downstream @PROTEIN$ molecule.	1	18708285-1040
Immunocytochemical staining results revealed that @COMPOUND$ and EPA could also up-regulate the expression of apoptotic proteins such as @PROTEIN$ and Fas ligand to suppress cell survival.	1	18708285-1041
Immunocytochemical staining results revealed that @COMPOUND$ and EPA could also up-regulate the expression of apoptotic proteins such as Bax and @PROTEIN$ to suppress cell survival.	1	18708285-1041
Amino acids (@COMPOUND$, aspartic acid, glutamic acid) and @PROTEIN$ (GOx) were adsorbed on CNF and the results were compared with those obtained when activated carbon (AC) was used as support.	0	18709446-802
Amino acids (alanine, aspartic acid, glutamic acid) and @PROTEIN$ (GOx) were adsorbed on CNF and the results were compared with those obtained when @COMPOUND$ (AC) was used as support.	0	18709446-802
Amino acids (alanine, @COMPOUND$, glutamic acid) and @PROTEIN$ (GOx) were adsorbed on CNF and the results were compared with those obtained when activated carbon (AC) was used as support.	0	18709446-802
The NSCs and neuroblasts had epidermal growth factor receptor (EGFR) and platelet-derived growth factor receptor alpha (@PROTEIN$) expressed on the ciliary apparatus and were the only cell types incorporating the proliferation marker @COMPOUND$.	0	18709646-694
The NSCs and neuroblasts had @PROTEIN$ (EGFR) and platelet-derived growth factor receptor alpha (PDGFRalpha) expressed on the ciliary apparatus and were the only cell types incorporating the proliferation marker @COMPOUND$.	0	18709646-694
The NSCs and neuroblasts had epidermal growth factor receptor (@PROTEIN$) and platelet-derived growth factor receptor alpha (PDGFRalpha) expressed on the ciliary apparatus and were the only cell types incorporating the proliferation marker @COMPOUND$.	0	18709646-694
Ependymal and displaced ependymal cells also expressed EGFR and @PROTEIN$ on their cilia but did not incorporate @COMPOUND$.	0	18709646-695
Ependymal and displaced ependymal cells also expressed @PROTEIN$ and PDGFRalpha on their cilia but did not incorporate @COMPOUND$.	0	18709646-695
Both 17alpha- and @COMPOUND$ elicited rapid phosphorylation of p42/44MAPK, @PROTEIN$, and GSK-3beta within 8 min.	1	18709647-968
Both 17alpha- and @COMPOUND$ elicited rapid phosphorylation of p42/44MAPK, Akt, and @PROTEIN$ within 8 min.	1	18709647-968
Both 17alpha- and @COMPOUND$ elicited rapid phosphorylation of @PROTEIN$/44MAPK, Akt, and GSK-3beta within 8 min.	1	18709647-968
Whereas Zn2+-dependent upregulation of @PROTEIN$ may help to counteract excessive astrocyte swelling and production of reactive oxygen and @COMPOUND$ species, stimulation of PBR expression may augment HE development.	1	18709649-718
Whereas Zn2+-dependent upregulation of metallothionein may help to counteract excessive astrocyte swelling and production of reactive oxygen and @COMPOUND$ species, stimulation of @PROTEIN$ expression may augment HE development.	0	18709649-718
Whereas @COMPOUND$+-dependent upregulation of metallothionein may help to counteract excessive astrocyte swelling and production of reactive oxygen and nitrogen oxide species, stimulation of @PROTEIN$ expression may augment HE development.	0	18709649-718
Whereas Zn2+-dependent upregulation of @PROTEIN$ may help to counteract excessive astrocyte swelling and production of reactive @COMPOUND$ and nitrogen oxide species, stimulation of PBR expression may augment HE development.	1	18709649-718
Whereas Zn2+-dependent upregulation of metallothionein may help to counteract excessive astrocyte swelling and production of reactive @COMPOUND$ and nitrogen oxide species, stimulation of @PROTEIN$ expression may augment HE development.	0	18709649-718
Whereas @COMPOUND$+-dependent upregulation of @PROTEIN$ may help to counteract excessive astrocyte swelling and production of reactive oxygen and nitrogen oxide species, stimulation of PBR expression may augment HE development.	1	18709649-718
Accordingly, the TLR3 agonist @COMPOUND$) (PIC) induced higher release of @PROTEIN$ in primary and purified astroglia than in microglia.	1	18709661-989
Accordingly, the TLR3 agonist poly(I:C) (@COMPOUND$) induced higher release of @PROTEIN$ in primary and purified astroglia than in microglia.	1	18709661-989
As siRNA, @COMPOUND$ induced @PROTEIN$, Stat1, VCAM-1, and Cox-2 and increased TLR3 mRNA expression.	1	18709661-990
As siRNA, @COMPOUND$ induced IP-10, Stat1, @PROTEIN$, and Cox-2 and increased TLR3 mRNA expression.	1	18709661-990
As siRNA, @COMPOUND$ induced IP-10, @PROTEIN$, VCAM-1, and Cox-2 and increased TLR3 mRNA expression.	1	18709661-990
As siRNA, @COMPOUND$ induced IP-10, Stat1, VCAM-1, and Cox-2 and increased @PROTEIN$ mRNA expression.	1	18709661-990
As siRNA, @COMPOUND$ induced IP-10, Stat1, VCAM-1, and @PROTEIN$ and increased TLR3 mRNA expression.	1	18709661-990
Intracellular concentrations of @COMPOUND$+) modulate the strength of signal and alter the outcomes of cytotoxic T-lymphocyte antigen-4 (CD152)-@PROTEIN$/CD86 interactions in CD4 (+) T lymphocytes.	1	18710402-1097
Intracellular concentrations of @COMPOUND$+) modulate the strength of signal and alter the outcomes of cytotoxic T-lymphocyte antigen-4 (CD152)-CD80/@PROTEIN$ interactions in CD4 (+) T lymphocytes.	1	18710402-1097
Intracellular concentrations of @COMPOUND$+) modulate the strength of signal and alter the outcomes of cytotoxic T-lymphocyte @PROTEIN$ (CD152)-CD80/CD86 interactions in CD4 (+) T lymphocytes.	1	18710402-1097
Intracellular concentrations of @COMPOUND$+) modulate the strength of signal and alter the outcomes of cytotoxic T-lymphocyte antigen-4 (@PROTEIN$)-CD80/CD86 interactions in CD4 (+) T lymphocytes.	1	18710402-1097
During activation with @COMPOUND$ and low amounts of I, intracellular concentrations of calcium ((Ca(2+))(i)) were greatly reduced upon CTLA-4-@PROTEIN$/CD86 blockade.	1	18710402-1099
During activation with PMA and low amounts of I, intracellular concentrations of calcium ((@COMPOUND$+))(i)) were greatly reduced upon CTLA-4-CD80/@PROTEIN$ blockade.	1	18710402-1099
During activation with @COMPOUND$ and low amounts of I, intracellular concentrations of calcium ((Ca(2+))(i)) were greatly reduced upon CTLA-4-CD80/@PROTEIN$ blockade.	1	18710402-1099
During activation with @COMPOUND$ and low amounts of I, intracellular concentrations of calcium ((Ca(2+))(i)) were greatly reduced upon @PROTEIN$-CD80/CD86 blockade.	1	18710402-1099
During activation with PMA and low amounts of I, intracellular concentrations of calcium ((@COMPOUND$+))(i)) were greatly reduced upon CTLA-4-@PROTEIN$/CD86 blockade.	1	18710402-1099
During activation with PMA and low amounts of I, intracellular concentrations of calcium ((@COMPOUND$+))(i)) were greatly reduced upon @PROTEIN$-CD80/CD86 blockade.	1	18710402-1099
Further experiments demonstrated that CTLA-4-@PROTEIN$/CD86 interactions reduced cell cycling upon activation with @COMPOUND$ and high amounts of I or TG (high SOS) but the opposite occurred with PMA and low amounts of I or TG (low SOS).	1	18710402-1100
Further experiments demonstrated that CTLA-4-@PROTEIN$/CD86 interactions reduced cell cycling upon activation with PMA and high amounts of I or TG (high @COMPOUND$) but the opposite occurred with PMA and low amounts of I or TG (low SOS).	1	18710402-1100
Further experiments demonstrated that @PROTEIN$-CD80/CD86 interactions reduced cell cycling upon activation with PMA and high amounts of I or TG (high @COMPOUND$) but the opposite occurred with PMA and low amounts of I or TG (low SOS).	1	18710402-1100
Further experiments demonstrated that CTLA-4-CD80/@PROTEIN$ interactions reduced cell cycling upon activation with @COMPOUND$ and high amounts of I or TG (high SOS) but the opposite occurred with PMA and low amounts of I or TG (low SOS).	1	18710402-1100
Further experiments demonstrated that @PROTEIN$-CD80/CD86 interactions reduced cell cycling upon activation with @COMPOUND$ and high amounts of I or TG (high SOS) but the opposite occurred with PMA and low amounts of I or TG (low SOS).	1	18710402-1100
Further experiments demonstrated that CTLA-4-CD80/@PROTEIN$ interactions reduced cell cycling upon activation with PMA and high amounts of I or TG (high @COMPOUND$) but the opposite occurred with PMA and low amounts of I or TG (low SOS).	1	18710402-1100
@COMPOUND$ decreased fasting glucose by 20 % and liver weights by 37 % compared with those in the CLA group; it maintained circulating @PROTEIN$, HOMA1-IR and HOMA1 for beta cell function at levels found in the control group.	1	18710604-62
FSO decreased fasting @COMPOUND$ by 20 % and liver weights by 37 % compared with those in the CLA group; it maintained circulating @PROTEIN$, HOMA1-IR and HOMA1 for beta cell function at levels found in the control group.	0	18710604-62
Animal evidence indicates that green tea may modulate @PROTEIN$ sensitivity, with epigallocatechin-3-gallate (@COMPOUND$) proposed as a likely health-promoting component.	0	18710606-240
Animal evidence indicates that green tea may modulate @PROTEIN$ sensitivity, with @COMPOUND$ (EGCG) proposed as a likely health-promoting component.	0	18710606-240
Animal evidence indicates that @COMPOUND$ may modulate @PROTEIN$ sensitivity, with epigallocatechin-3-gallate (EGCG) proposed as a likely health-promoting component.	0	18710606-240
The purpose of this study was to investigate the effect of dietary supplementation with @COMPOUND$ on @PROTEIN$ resistance and associated metabolic risk factors in man.	1	18710606-241
@COMPOUND$ treatment had no effect on @PROTEIN$ sensitivity, insulin secretion or glucose tolerance but did reduce diastolic blood pressure (mean change: placebo-0.058 (se 0.75) mmHg; EGCG-2.68 (se 0.72) mmHg; P = 0.014).	0	18710606-242
EGCG treatment had no effect on @PROTEIN$ sensitivity, insulin secretion or @COMPOUND$ tolerance but did reduce diastolic blood pressure (mean change: placebo-0.058 (se 0.75) mmHg; EGCG-2.68 (se 0.72) mmHg; P = 0.014).	0	18710606-242
In conclusion, regular intake of @COMPOUND$ had no effect on @PROTEIN$ resistance but did result in a modest reduction in diastolic blood pressure.	0	18710606-243
We found that postovulatory administration of 1.5 mg of @COMPOUND$ to women with a subsequent or existing early pregnancy did not affect the immunohistochemical expressions of @PROTEIN$ (ER (alpha), ER (beta)), P receptors (PR(B), PR(A+B)), androgen receptor (AR), or proliferation index Ki67 in the first-trimester decidua and chorionic villi.	0	18710702-125
We found that postovulatory administration of 1.5 mg of @COMPOUND$ to women with a subsequent or existing early pregnancy did not affect the immunohistochemical expressions of estrogen receptors (ER (alpha), ER (beta)), P receptors (PR(B), PR(A+B)), @PROTEIN$ (AR), or proliferation index Ki67 in the first-trimester decidua and chorionic villi.	0	18710702-125
@COMPOUND$ effect on HS cell viability was markedly reduced in hypoxic condition without an induction of chemoresistant related protein, P-@PROTEIN$.	0	18710819-1300
High-level toxin production occurred after detectable spore germination in all experiments except those with C. difficile PCR ribotype 027 and @COMPOUND$, in which marked @PROTEIN$ production preceded detectable germination, which coincided with isolate recovery on fluoroquinolone-containing medium.	0	18710908-298
Furthermore, @PROTEIN$ overexpression reduced @COMPOUND$ anion generation after H/R, whereas glutathione levels were significantly improved compared with WT controls.	1	18711728-143
Furthermore, @PROTEIN$ overexpression reduced superoxide anion generation after H/R, whereas @COMPOUND$ levels were significantly improved compared with WT controls.	1	18711728-143
Our previous studies have shown that @COMPOUND$ (5-HT) altered under diabetic condition was accompanied by alterations of protein kinase C-alpha (@PROTEIN$) and CaMKII, and those alterations were reversed after insulin administration.	1	18711746-961
Our previous studies have shown that @COMPOUND$ (5-HT) altered under diabetic condition was accompanied by alterations of protein kinase C-alpha (PKC-alpha) and CaMKII, and those alterations were reversed after @PROTEIN$ administration.	1	18711746-961
Our previous studies have shown that serotonin (@COMPOUND$) altered under diabetic condition was accompanied by alterations of protein kinase C-alpha (@PROTEIN$) and CaMKII, and those alterations were reversed after insulin administration.	1	18711746-961
Our previous studies have shown that serotonin (@COMPOUND$) altered under diabetic condition was accompanied by alterations of protein kinase C-alpha (PKC-alpha) and @PROTEIN$, and those alterations were reversed after insulin administration.	1	18711746-961
Our previous studies have shown that serotonin (@COMPOUND$) altered under diabetic condition was accompanied by alterations of @PROTEIN$-alpha (PKC-alpha) and CaMKII, and those alterations were reversed after insulin administration.	1	18711746-961
Our previous studies have shown that serotonin (@COMPOUND$) altered under diabetic condition was accompanied by alterations of protein kinase C-alpha (PKC-alpha) and CaMKII, and those alterations were reversed after @PROTEIN$ administration.	1	18711746-961
Our previous studies have shown that @COMPOUND$ (5-HT) altered under diabetic condition was accompanied by alterations of @PROTEIN$-alpha (PKC-alpha) and CaMKII, and those alterations were reversed after insulin administration.	1	18711746-961
Our previous studies have shown that @COMPOUND$ (5-HT) altered under diabetic condition was accompanied by alterations of protein kinase C-alpha (PKC-alpha) and @PROTEIN$, and those alterations were reversed after insulin administration.	1	18711746-961
The current study showed that alloxan-induced diabetic animals revealed hyperglycemia and was associated with an increase in the content of @COMPOUND$, @PROTEIN$ expression and PKC 0.05) simultaneously in striatum (ST), midbrain (MB), pons medulla (PM), cerebellum (CB), and cerebral cortex (CCX) from 7 days to 60 days.	0	18711746-962
The current study showed that @COMPOUND$-induced diabetic animals revealed hyperglycemia and was associated with an increase in the content of 5-HT, PKC-alpha expression and PKC 0.05) simultaneously in striatum (ST), midbrain (MB), @PROTEIN$ medulla (PM), cerebellum (CB), and cerebral cortex (CCX) from 7 days to 60 days.	0	18711746-962
The current study showed that alloxan-induced diabetic animals revealed hyperglycemia and was associated with an increase in the content of @COMPOUND$, @PROTEIN$-alpha expression and PKC 0.05) simultaneously in striatum (ST), midbrain (MB), pons medulla (PM), cerebellum (CB), and cerebral cortex (CCX) from 7 days to 60 days.	0	18711746-962
The current study showed that alloxan-induced diabetic animals revealed hyperglycemia and was associated with an increase in the content of @COMPOUND$, PKC-alpha expression and PKC 0.05) simultaneously in striatum (ST), midbrain (MB), @PROTEIN$ medulla (PM), cerebellum (CB), and cerebral cortex (CCX) from 7 days to 60 days.	0	18711746-962
The current study showed that @COMPOUND$-induced diabetic animals revealed hyperglycemia and was associated with an increase in the content of 5-HT, @PROTEIN$ expression and PKC 0.05) simultaneously in striatum (ST), midbrain (MB), pons medulla (PM), cerebellum (CB), and cerebral cortex (CCX) from 7 days to 60 days.	1	18711746-962
The current study showed that @COMPOUND$-induced diabetic animals revealed hyperglycemia and was associated with an increase in the content of 5-HT, @PROTEIN$-alpha expression and PKC 0.05) simultaneously in striatum (ST), midbrain (MB), pons medulla (PM), cerebellum (CB), and cerebral cortex (CCX) from 7 days to 60 days.	1	18711746-962
Although the @COMPOUND$ levels in hippocampus (HC) and hypothalamus (HT) were not altered, the @PROTEIN$ expression and PKC 0.05) in level in HC.	0	18711746-963
Although the @COMPOUND$ levels in hippocampus (HC) and hypothalamus (HT) were not altered, the @PROTEIN$-alpha expression and PKC 0.05) in level in HC.	0	18711746-963
We tested the hypothesis that a nitric oxide donor, @COMPOUND$, up-regulates stromal cell-derived factor-1 (SDF1) and angiopoietin 1 (Ang1) in the ischemic brain and their respective receptors chemokine CXC motif receptor 4 (@PROTEIN$) and Tie2 in the subventricular zone (SVZ) and thereby promote SVZ neuroblast cell migration after stroke.	1	18711749-1020
We tested the hypothesis that a nitric oxide donor, @COMPOUND$, up-regulates stromal cell-derived factor-1 (@PROTEIN$) and angiopoietin 1 (Ang1) in the ischemic brain and their respective receptors chemokine CXC motif receptor 4 (CXCR4) and Tie2 in the subventricular zone (SVZ) and thereby promote SVZ neuroblast cell migration after stroke.	1	18711749-1020
We tested the hypothesis that a @COMPOUND$ donor, DETA-NONOate, up-regulates stromal cell-derived factor-1 (SDF1) and angiopoietin 1 (Ang1) in the ischemic brain and their respective receptors chemokine CXC motif receptor 4 (CXCR4) and @PROTEIN$ in the subventricular zone (SVZ) and thereby promote SVZ neuroblast cell migration after stroke.	1	18711749-1020
We tested the hypothesis that a @COMPOUND$ donor, DETA-NONOate, up-regulates stromal cell-derived factor-1 (@PROTEIN$) and angiopoietin 1 (Ang1) in the ischemic brain and their respective receptors chemokine CXC motif receptor 4 (CXCR4) and Tie2 in the subventricular zone (SVZ) and thereby promote SVZ neuroblast cell migration after stroke.	1	18711749-1020
We tested the hypothesis that a @COMPOUND$ donor, DETA-NONOate, up-regulates stromal cell-derived factor-1 (SDF1) and angiopoietin 1 (@PROTEIN$) in the ischemic brain and their respective receptors chemokine CXC motif receptor 4 (CXCR4) and Tie2 in the subventricular zone (SVZ) and thereby promote SVZ neuroblast cell migration after stroke.	1	18711749-1020
We tested the hypothesis that a nitric oxide donor, @COMPOUND$, up-regulates stromal cell-derived factor-1 (SDF1) and angiopoietin 1 (Ang1) in the ischemic brain and their respective receptors chemokine CXC motif receptor 4 (CXCR4) and @PROTEIN$ in the subventricular zone (SVZ) and thereby promote SVZ neuroblast cell migration after stroke.	1	18711749-1020
We tested the hypothesis that a nitric oxide donor, @COMPOUND$, up-regulates stromal cell-derived factor-1 (SDF1) and angiopoietin 1 (@PROTEIN$) in the ischemic brain and their respective receptors chemokine CXC motif receptor 4 (CXCR4) and Tie2 in the subventricular zone (SVZ) and thereby promote SVZ neuroblast cell migration after stroke.	1	18711749-1020
We tested the hypothesis that a @COMPOUND$ donor, DETA-NONOate, up-regulates stromal cell-derived factor-1 (SDF1) and angiopoietin 1 (Ang1) in the ischemic brain and their respective receptors chemokine CXC motif receptor 4 (@PROTEIN$) and Tie2 in the subventricular zone (SVZ) and thereby promote SVZ neuroblast cell migration after stroke.	1	18711749-1020
To elucidate whether @PROTEIN$/CXCR4 and Ang1/Tie2 pathways mediate DETA-NONOate-induced SVZ migration after stroke, SDF1alpha, Ang1 peptide, a specific antagonist of CXCR4 (@COMPOUND$), and a neutralizing antibody of Tie2 (anti-Tie2) were used in vitro.	1	18711749-1021
To elucidate whether @PROTEIN$/CXCR4 and Ang1/Tie2 pathways mediate @COMPOUND$-induced SVZ migration after stroke, SDF1alpha, Ang1 peptide, a specific antagonist of CXCR4 (AMD3100), and a neutralizing antibody of Tie2 (anti-Tie2) were used in vitro.	1	18711749-1021
To elucidate whether @PROTEIN$/CXCR4 and Ang1/Tie2 pathways mediate DETA-NONOate-induced SVZ migration after stroke, SDF1alpha, Ang1 @COMPOUND$ specific antagonist of CXCR4 (AMD3100), and a neutralizing antibody of Tie2 (anti-Tie2) were used in vitro.	1	18711749-1021
@COMPOUND$ significantly increased the expression of SDF1 and Ang1 in the ischemic border and up-regulated @PROTEIN$ and Tie2 in the SVZ compared with MCAo control.	1	18711749-1023
@COMPOUND$ significantly increased the expression of SDF1 and Ang1 in the ischemic border and up-regulated CXCR4 and @PROTEIN$ in the SVZ compared with MCAo control.	1	18711749-1023
@COMPOUND$ significantly increased the expression of @PROTEIN$ and Ang1 in the ischemic border and up-regulated CXCR4 and Tie2 in the SVZ compared with MCAo control.	1	18711749-1023
@COMPOUND$ significantly increased the expression of SDF1 and @PROTEIN$ in the ischemic border and up-regulated CXCR4 and Tie2 in the SVZ compared with MCAo control.	1	18711749-1023
Our data indicate that treatment of stroke with a @COMPOUND$ donor up-regulates SDF1/CXCR4 and Ang1/@PROTEIN$ pathways and thereby likely increases SVZ neuroblast cell migration.	1	18711749-1025
Our data indicate that treatment of stroke with a @COMPOUND$ donor up-regulates SDF1/CXCR4 and @PROTEIN$/Tie2 pathways and thereby likely increases SVZ neuroblast cell migration.	1	18711749-1025
Our data indicate that treatment of stroke with a @COMPOUND$ donor up-regulates @PROTEIN$/CXCR4 and Ang1/Tie2 pathways and thereby likely increases SVZ neuroblast cell migration.	1	18711749-1025
Our data indicate that treatment of stroke with a @COMPOUND$ donor up-regulates SDF1/@PROTEIN$ and Ang1/Tie2 pathways and thereby likely increases SVZ neuroblast cell migration.	1	18711749-1025
The MEK inhibitor @COMPOUND$ did not inhibit neurite outgrowth, and Y-27632 and staurosporine did not induce @PROTEIN$ phosphorylation, suggesting that the inhibitory effect of ODQ on neurite outgrowth is independent of the ERK signaling pathway.	0	18711750-1026
The MEK inhibitor PD98059 did not inhibit neurite outgrowth, and Y-27632 and staurosporine did not induce @PROTEIN$ phosphorylation, suggesting that the inhibitory effect of @COMPOUND$ on neurite outgrowth is independent of the ERK signaling pathway.	0	18711750-1026
The MEK inhibitor PD98059 did not inhibit neurite outgrowth, and Y-27632 and @COMPOUND$ did not induce @PROTEIN$ phosphorylation, suggesting that the inhibitory effect of ODQ on neurite outgrowth is independent of the ERK signaling pathway.	0	18711750-1026
We used this model to identify a potent competitive inhibitor, N1,N7-dihexyl-1,7-diamino-4-azaheptane, and to develop an affinity column, 1,16-diamino4,13-diazahexadecane-linked @COMPOUND$, which was useful for the purification of @PROTEIN$.	1	18712272-1403
Rapid determination of @COMPOUND$ using engineered Escherichia coli overexpressing @PROTEIN$.	1	18712288-246
Purification, characterization, and preliminary X-ray diffraction analysis of a @COMPOUND$-specific @PROTEIN$ from Cymbosema roseum seeds.	1	18712290-619
Here, we report the purification, partial primary structure, carbohydrate affinity characterization, crystallization, and preliminary X-ray diffraction analysis of a @COMPOUND$-specific @PROTEIN$ from Cymbosema roseum seeds (CRLII).	1	18712290-620
Effects on haemolytic activity of single @COMPOUND$ substitutions in the Bordetella pertussis @PROTEIN$ pore-forming fragment.	1	18712361-637
Associations between the uptake of 111In-@COMPOUND$-trastuzumab, @PROTEIN$ density and response to trastuzumab (Herceptin) in athymic mice bearing subcutaneous human tumour xenografts.	1	18712381-639
The purpose of the study was to investigate the associations between uptake of (111)In-@COMPOUND$-trastuzumab, tumour @PROTEIN$ density and response to trastuzumab (Herceptin) of human breast cancer (BC) xenografts in athymic mice.	1	18712381-640
The @COMPOUND$ (the final product of ATP hydrolysis by @PROTEIN$), have a recognized neuroprotective actions in the central nervous system (CNS) in pathological conditions.	1	18712598-674
To this end, the cultured fibroblasts were analyzed for very @COMPOUND$ (VLCFA) concentrations, peroxisomal beta- and alpha-oxidation, @PROTEIN$ (DHAPAT) activity, peroxisomal thiolase, and catalase immunofluorescence.	0	18712838-744
To this end, the cultured fibroblasts were analyzed for very @COMPOUND$ (VLCFA) concentrations, peroxisomal beta- and alpha-oxidation, dihydroxyacetone-phosphate acyltransferase (DHAPAT) activity, peroxisomal thiolase, and @PROTEIN$ immunofluorescence.	0	18712838-744
To this end, the cultured fibroblasts were analyzed for very @COMPOUND$ (VLCFA) concentrations, peroxisomal beta- and alpha-oxidation, dihydroxyacetone-phosphate acyltransferase (@PROTEIN$) activity, peroxisomal thiolase, and catalase immunofluorescence.	0	18712838-744
To this end, the cultured fibroblasts were analyzed for very @COMPOUND$ (VLCFA) concentrations, peroxisomal beta- and alpha-oxidation, dihydroxyacetone-phosphate acyltransferase (DHAPAT) activity, peroxisomal @PROTEIN$, and catalase immunofluorescence.	0	18712838-744
Also, @PROTEIN$ induction and concomitant @COMPOUND$ generation appear to participate in the cytotoxicity of excessive portal pressure after extended hepatectomy.	1	18713274-881
Superoxide dismutase (SOD), @PROTEIN$ (GSH-Px), catalase (CAT) enzyme activities, antioxidant potential (AOP) value, malondialdehyde (MDA), @COMPOUND$ and triglyceride levels in the liver tissues and total cholesterol and triglyceride levels in serum samples were measured.	0	18713277-882
Superoxide dismutase (SOD), glutathione peroxidase (GSH-Px), @PROTEIN$ (CAT) enzyme activities, antioxidant potential (AOP) value, malondialdehyde (MDA), @COMPOUND$ and triglyceride levels in the liver tissues and total cholesterol and triglyceride levels in serum samples were measured.	0	18713277-882
Superoxide dismutase (SOD), glutathione peroxidase (GSH-Px), catalase (@PROTEIN$) enzyme activities, antioxidant potential (AOP) value, malondialdehyde (MDA), @COMPOUND$ and triglyceride levels in the liver tissues and total cholesterol and triglyceride levels in serum samples were measured.	0	18713277-882
Superoxide dismutase (@PROTEIN$), glutathione peroxidase (GSH-Px), catalase (CAT) enzyme activities, antioxidant potential (AOP) value, @COMPOUND$ (MDA), cholesterol and triglyceride levels in the liver tissues and total cholesterol and triglyceride levels in serum samples were measured.	0	18713277-882
Superoxide dismutase (SOD), @PROTEIN$ (GSH-Px), catalase (CAT) enzyme activities, antioxidant potential (AOP) value, @COMPOUND$ (MDA), cholesterol and triglyceride levels in the liver tissues and total cholesterol and triglyceride levels in serum samples were measured.	0	18713277-882
@PROTEIN$ (SOD), glutathione peroxidase (GSH-Px), catalase (CAT) enzyme activities, antioxidant potential (AOP) value, malondialdehyde (MDA), @COMPOUND$ and triglyceride levels in the liver tissues and total cholesterol and triglyceride levels in serum samples were measured.	0	18713277-882
Superoxide dismutase (SOD), glutathione peroxidase (GSH-Px), catalase (@PROTEIN$) enzyme activities, antioxidant potential (AOP) value, @COMPOUND$ (MDA), cholesterol and triglyceride levels in the liver tissues and total cholesterol and triglyceride levels in serum samples were measured.	0	18713277-882
@PROTEIN$ (SOD), glutathione peroxidase (GSH-Px), catalase (CAT) enzyme activities, antioxidant potential (AOP) value, @COMPOUND$ (MDA), cholesterol and triglyceride levels in the liver tissues and total cholesterol and triglyceride levels in serum samples were measured.	0	18713277-882
Superoxide dismutase (@PROTEIN$), glutathione peroxidase (GSH-Px), catalase (CAT) enzyme activities, antioxidant potential (AOP) value, malondialdehyde (MDA), @COMPOUND$ and triglyceride levels in the liver tissues and total cholesterol and triglyceride levels in serum samples were measured.	0	18713277-882
Superoxide dismutase (SOD), glutathione peroxidase (GSH-Px), @PROTEIN$ (CAT) enzyme activities, antioxidant potential (AOP) value, @COMPOUND$ (MDA), cholesterol and triglyceride levels in the liver tissues and total cholesterol and triglyceride levels in serum samples were measured.	0	18713277-882
Inhibition of apoptotic signaling and neointimal hyperplasia by @COMPOUND$ and @PROTEIN$ following vascular injury.	1	18714161-1109
Forced cytoplasmic overexpression of APE1 profoundly attenuated the upregulation of HMGB1-mediated reactive @COMPOUND$ species generation, cytokine secretion, and @PROTEIN$ expression by primary monocytes and macrophage-like THP-1 cell lines.	0	18715145-1378
Forced cytoplasmic overexpression of @PROTEIN$ profoundly attenuated the upregulation of HMGB1-mediated reactive @COMPOUND$ species generation, cytokine secretion, and cyclooxygenase-2 expression by primary monocytes and macrophage-like THP-1 cell lines.	1	18715145-1378
Forced cytoplasmic overexpression of APE1 profoundly attenuated the upregulation of @PROTEIN$-mediated reactive @COMPOUND$ species generation, cytokine secretion, and cyclooxygenase-2 expression by primary monocytes and macrophage-like THP-1 cell lines.	1	18715145-1378
NO, a gas, is produced from L-@COMPOUND$ by different isoforms of @PROTEIN$ (NOS) and serves many normal physiologic purposes, such as promoting vasodilation of blood vessels and mediating communication between nervous system cells.	1	18715148-1380
NO, a gas, is produced from L-@COMPOUND$ by different isoforms of nitric oxide synthase (@PROTEIN$) and serves many normal physiologic purposes, such as promoting vasodilation of blood vessels and mediating communication between nervous system cells.	1	18715148-1380
As one of the very few repair systems for oxidized proteins, @PROTEIN$ and MsrB enzymes play a major role in protein homeostasis during aging and have also been involved in cellular defenses against oxidative stress, by scavenging reactive @COMPOUND$ species.	1	18715149-1381
As one of the very few repair systems for oxidized proteins, MsrA and @PROTEIN$ enzymes play a major role in protein homeostasis during aging and have also been involved in cellular defenses against oxidative stress, by scavenging reactive @COMPOUND$ species.	1	18715149-1381
@PROTEIN$-@COMPOUND$ levels increase with age in American women but not in Hong Kong Chinese women.	1	18715284-1402
@PROTEIN$ (HDL) @COMPOUND$ is a powerful cardiovascular risk factor.	1	18715284-1403
Repeated injections of arsenic trioxide induced oxidative stress and hepatotoxicity in mice as revealed from elevated levels of glutamate oxaloacetate transaminases, glutamate pyruvate transaminases, acid and alkaline phosphatases, lipid peroxidation along with reduction of @PROTEIN$, catalase, @COMPOUND$ content, glutathione reductase and succinate dehydrogenase activities.	0	18715643-1517
Repeated injections of arsenic trioxide induced oxidative stress and hepatotoxicity in mice as revealed from elevated levels of glutamate oxaloacetate transaminases, glutamate pyruvate transaminases, acid and @PROTEIN$, lipid peroxidation along with reduction of superoxide dismutase, catalase, @COMPOUND$ content, glutathione reductase and succinate dehydrogenase activities.	0	18715643-1517
Repeated injections of arsenic trioxide induced oxidative stress and hepatotoxicity in mice as revealed from elevated levels of glutamate oxaloacetate transaminases, glutamate pyruvate transaminases, acid and alkaline phosphatases, lipid peroxidation along with reduction of superoxide dismutase, @PROTEIN$, @COMPOUND$ content, glutathione reductase and succinate dehydrogenase activities.	0	18715643-1517
Repeated injections of arsenic trioxide induced oxidative stress and hepatotoxicity in mice as revealed from elevated levels of glutamate oxaloacetate transaminases, glutamate pyruvate transaminases, acid and alkaline phosphatases, lipid peroxidation along with reduction of superoxide dismutase, catalase, @COMPOUND$ content, @PROTEIN$ and succinate dehydrogenase activities.	0	18715643-1517
Hepatoprotective potential of vitamin C was indicated by its ability to restore @COMPOUND$, SOD, @PROTEIN$, AcP, AlkP and GRD levels towards near normal.	0	18715643-1518
Hepatoprotective potential of vitamin C was indicated by its ability to restore @COMPOUND$, @PROTEIN$, CAT, AcP, AlkP and GRD levels towards near normal.	0	18715643-1518
Hepatoprotective potential of vitamin C was indicated by its ability to restore @COMPOUND$, SOD, CAT, @PROTEIN$, AlkP and GRD levels towards near normal.	0	18715643-1518
Hepatoprotective potential of vitamin C was indicated by its ability to restore @COMPOUND$, SOD, CAT, AcP, AlkP and @PROTEIN$ levels towards near normal.	0	18715643-1518
The interaction of quercetin, which is a @COMPOUND$, with bovine @PROTEIN$ (BSA) was investigated under pseudo-physiological conditions by the application of UV-vis spectrometry, spectrofluorimetry and cyclic voltammetry (CV).	1	18715823-1582
The interaction of @COMPOUND$, which is a bioflavonoid, with bovine @PROTEIN$ (BSA) was investigated under pseudo-physiological conditions by the application of UV-vis spectrometry, spectrofluorimetry and cyclic voltammetry (CV).	1	18715823-1582
The interaction of quercetin, which is a @COMPOUND$, with bovine serum albumin (@PROTEIN$) was investigated under pseudo-physiological conditions by the application of UV-vis spectrometry, spectrofluorimetry and cyclic voltammetry (CV).	1	18715823-1582
The interaction of @COMPOUND$, which is a bioflavonoid, with bovine serum albumin (@PROTEIN$) was investigated under pseudo-physiological conditions by the application of UV-vis spectrometry, spectrofluorimetry and cyclic voltammetry (CV).	1	18715823-1582
1x10(-5) mol L(-1)), most of the site marker reacted with the quercetin-@PROTEIN$, but free @COMPOUND$ was present at higher concentrations.	0	18715823-1585
Under optimum conditions, the fluorescence intensity of @PROTEIN$-GNPs is linearly proportional to @COMPOUND$ concentration from 6.0x10(-8)mol/L to 8.0x10(-6)mol/L with a detection limit of 1.0x10(-8)mol/L.	1	18715824-1587
C18 and C20Gb(3) were, in mixtures without @COMPOUND$ :1Gb(3), dominant negative for @PROTEIN$ vesicle binding.	0	18716315-1771
@PROTEIN$/VT1bound C18 and @COMPOUND$ :1Gb(3) mixtures, although neither isoform bound alone.	1	18716315-1772
Monolayer surface pressure measurement showed VT1, but not VT2, bound @COMPOUND$) at cellular DRM surface pressures, and confirmed loss of VT1 and @PROTEIN$ (but not VT2) specific C18Gb(3) binding.	0	18716315-1773
@PROTEIN$ inhibition in chlorpyrifos workers: Characterization of biomarkers of exposure and response in relation to urinary @COMPOUND$.	0	18716607-1835
The objective of this study was to evaluate the quantitative relation between measured red blood cell @PROTEIN$ (RBC AChE) and plasma butyrylcholinesterase (BuChE) activities with exposure to @COMPOUND$ (CPF) as assessed by measurement of urinary 3,5,6-trichloro-2-pyridinol (TCPy) in a study group of workers occupationally exposed in the manufacture of CPF and a referent group of chemical manufacturing workers.	1	18716607-1836
The objective of this study was to evaluate the quantitative relation between measured red blood cell @PROTEIN$ (RBC AChE) and plasma butyrylcholinesterase (BuChE) activities with exposure to chlorpyrifos (CPF) as assessed by measurement of urinary 3,5,6-trichloro-2-pyridinol (@COMPOUND$) in a study group of workers occupationally exposed in the manufacture of CPF and a referent group of chemical manufacturing workers.	1	18716607-1836
The objective of this study was to evaluate the quantitative relation between measured red blood cell @PROTEIN$ (RBC AChE) and plasma butyrylcholinesterase (BuChE) activities with exposure to chlorpyrifos (CPF) as assessed by measurement of urinary @COMPOUND$ (TCPy) in a study group of workers occupationally exposed in the manufacture of CPF and a referent group of chemical manufacturing workers.	1	18716607-1836
Immunofluorescence analysis revealed that two known virulence-associated surface proteins featuring @COMPOUND$-X-Thr-Gly motif, @PROTEIN$-released protein and surface antigen one, were absent in the DeltasrtA.	0	18716756-1877
Immunofluorescence analysis revealed that two known virulence-associated @PROTEIN$ featuring @COMPOUND$-X-Thr-Gly motif, muramidase-released protein and surface antigen one, were absent in the DeltasrtA.	1	18716756-1877
Immunofluorescence analysis revealed that two known virulence-associated @PROTEIN$ featuring Leu-Pro-X-Thr-@COMPOUND$ motif, muramidase-released protein and surface antigen one, were absent in the DeltasrtA.	1	18716756-1877
Immunofluorescence analysis revealed that two known virulence-associated surface proteins featuring Leu-Pro-X-Thr-@COMPOUND$ motif, @PROTEIN$-released protein and surface antigen one, were absent in the DeltasrtA.	0	18716756-1877
In addition, neuronal @PROTEIN$, another component of the NMDA/@COMPOUND$/cGMP intracellular pathway, has been reported to be dysregulated in schizophrenia patients.	1	18716761-1880
In addition, neuronal @PROTEIN$, another component of the NMDA/nitric oxide/@COMPOUND$ intracellular pathway, has been reported to be dysregulated in schizophrenia patients.	1	18716761-1880
A role for @PROTEIN$ in @COMPOUND$-induced fever in Pekin ducks (Anas platyrhynchos): is natriuretic peptide an endogenous antipyretic in birds.	0	18716782-1887
We induced fever in Pekin ducks with @COMPOUND$ and, at the same time, treated the animals with @PROTEIN$ antiserum at a dose that effectively inhibited the known renal actions of endogenously secreted natriuretic peptide.	0	18716782-1888
Among the Gram-negative bacteria, 100% of the Escherichia coli isolates (including extended spectrum @PROTEIN$ (ESBL)-producers) were @COMPOUND$-susceptible, while about 10% of the Enterobacter cloacae and Klebsiella pneumoniae isolates were resistant.	1	18716808-1894
The data presented here show that NH4Cl (5 mM) mediates astroglial cell swelling, and that treatment with NH4Cl or @COMPOUND$ (25 mM) causes rearrangements of @PROTEIN$ filaments and reduces astroglial glutamate uptake capacity.	1	18716864-1923
Here, we proposed that @PROTEIN$, a vacuolar amino peptidase, is involved in glutathione catabolism under @COMPOUND$ stress.	1	18716881-1940
Thus, under cadmium stress, @PROTEIN$ and gamma-glutamyl transferase seem to work together to assure an efficient @COMPOUND$ turnover stored in the vacuole.	1	18716881-1942
Thus, under @COMPOUND$ stress, @PROTEIN$ and gamma-glutamyl transferase seem to work together to assure an efficient glutathione turnover stored in the vacuole.	1	18716881-1942
In this research, the effects of pH, temperature, and @COMPOUND$ on growth kinetics of a newly isolated strain of Bacillus circulans from the Amazon and their correlations with @PROTEIN$ (TGase) production and cell sporulation were investigated.	1	18716920-1959
In this research, the effects of pH, temperature, and @COMPOUND$ on growth kinetics of a newly isolated strain of Bacillus circulans from the Amazon and their correlations with transglutaminase (@PROTEIN$) production and cell sporulation were investigated.	1	18716920-1959
No relationships were observed among mercury, selenium, and several other neurochemical biomarkers (dopamine-2, @COMPOUND$ type A, muscarinic cholinergic, and nicotinic cholinergic receptors; @PROTEIN$ and monoamine oxidase enzymes).	0	18717617-2177
No relationships were observed among mercury, @COMPOUND$, and several other neurochemical biomarkers (dopamine-2, gamma-aminobutyric acid type A, muscarinic cholinergic, and nicotinic cholinergic receptors; @PROTEIN$ and monoamine oxidase enzymes).	0	18717617-2177
No relationships were observed among mercury, selenium, and several other neurochemical biomarkers (@COMPOUND$-2, gamma-aminobutyric acid type A, muscarinic cholinergic, and nicotinic cholinergic receptors; @PROTEIN$ and monoamine oxidase enzymes).	0	18717617-2177
No relationships were observed among mercury, @COMPOUND$, and several other neurochemical biomarkers (dopamine-2, gamma-aminobutyric acid type A, muscarinic cholinergic, and nicotinic cholinergic receptors; cholinesterase and @PROTEIN$ enzymes).	0	18717617-2177
No relationships were observed among mercury, selenium, and several other neurochemical biomarkers (@COMPOUND$-2, gamma-aminobutyric acid type A, muscarinic cholinergic, and nicotinic cholinergic receptors; cholinesterase and @PROTEIN$ enzymes).	0	18717617-2177
No relationships were observed among mercury, selenium, and several other neurochemical biomarkers (dopamine-2, @COMPOUND$ type A, muscarinic cholinergic, and nicotinic cholinergic receptors; cholinesterase and @PROTEIN$ enzymes).	0	18717617-2177
No relationships were observed among @COMPOUND$, selenium, and several other neurochemical biomarkers (dopamine-2, gamma-aminobutyric acid type A, muscarinic cholinergic, and nicotinic cholinergic receptors; cholinesterase and @PROTEIN$ enzymes).	0	18717617-2177
No relationships were observed among @COMPOUND$, selenium, and several other neurochemical biomarkers (dopamine-2, gamma-aminobutyric acid type A, muscarinic cholinergic, and nicotinic cholinergic receptors; @PROTEIN$ and monoamine oxidase enzymes).	0	18717617-2177
Despite responsive antioxidative defense (increased activities of superoxide dismutase, ascorbate @PROTEIN$, and pyrogallol peroxidase), @COMPOUND$+ caused oxidative damage to lipids and proteins as evaluated by malondialdehyde and carbonyl group levels, and induced DNA strand breaks.	0	18717625-2181
Despite responsive antioxidative defense (increased activities of @PROTEIN$, ascorbate peroxidase, and pyrogallol peroxidase), @COMPOUND$+ caused oxidative damage to lipids and proteins as evaluated by malondialdehyde and carbonyl group levels, and induced DNA strand breaks.	0	18717625-2181
However, Ref-1 inhibition followed by H2O2 treatment extensively induced the level of intracellular reactive @COMPOUND$ species (ROS) through activation of the components of NADPH oxidase, like p22 (phox), @PROTEIN$ (phox), and Nox4.	1	18717627-2182
However, Ref-1 inhibition followed by H2O2 treatment extensively induced the level of intracellular reactive @COMPOUND$ species (ROS) through activation of the components of NADPH oxidase, like @PROTEIN$ (phox), p47 (phox), and Nox4.	1	18717627-2182
However, Ref-1 inhibition followed by H2O2 treatment extensively induced the level of intracellular reactive @COMPOUND$ species (ROS) through activation of the components of NADPH oxidase, like p22 (phox), p47 (phox), and @PROTEIN$.	1	18717627-2182
We conclude that mitochondrial dysfunction can induce @PROTEIN$ oligomerization via @COMPOUND$ depletion-driven microtubule depolymerization and via ROS increase-driven protein oxidation.	1	18717628-2183
Decreased expression of @PROTEIN$, the binding site for @COMPOUND$, during epileptogenesis and chronic epilepsy.	1	18717715-2195
We previously showed that gene expression of @PROTEIN$ (SV2A), the binding site for the antiepileptic drug @COMPOUND$, is reduced during epileptogenesis in the rat.	1	18717715-2196
We previously showed that gene expression of synaptic vesicle protein 2A (@PROTEIN$), the binding site for the antiepileptic drug @COMPOUND$, is reduced during epileptogenesis in the rat.	1	18717715-2196
We also demonstrated that the deletion of the @PROTEIN$ gene doubled ATP-driven @COMPOUND$ synthesis and increased cellular ATP synthetic activity.	1	18718549-2503
Selenocystine induces caspase-independent apoptosis in MCF-7 human breast carcinoma cells with involvement of @PROTEIN$ phosphorylation and reactive @COMPOUND$ species generation.	0	18718551-2505
In the present study, we showed that selenocystine (SeC), a naturally occurring selenoamino acid, induced caspase-independent apoptosis in MCF-7 breast carcinoma cells, which was accompanied by poly(ADP-ribose) polymerase (@PROTEIN$) cleavage, caspase activation, DNA fragmentation, @COMPOUND$ exposure and nuclear condensation.	0	18718551-2506
In the present study, we showed that selenocystine (SeC), a naturally occurring selenoamino acid, induced caspase-independent apoptosis in MCF-7 breast carcinoma cells, which was accompanied by poly(@PROTEIN$-ribose) polymerase (PARP) cleavage, caspase activation, DNA fragmentation, @COMPOUND$ exposure and nuclear condensation.	0	18718551-2506
Silencing and attenuating of @PROTEIN$ activation with RNA interference and @COMPOUND$ treatment, respectively, partially suppressed SeC-induced cell apoptosis.	1	18718551-2507
Activation of c-@PROTEIN$ N-terminal kinase is essential for oxidative stress-induced Jurkat cell apoptosis by @COMPOUND$.	1	18718660-2524
Within 10min of NH(2) Cl treatment, c-Jun N-terminal kinase (@PROTEIN$) activation and elevation of cytosolic @COMPOUND$+) were observed.	0	18718660-2525
Within 10min of NH(2) @COMPOUND$ treatment, c-Jun N-terminal kinase (@PROTEIN$) activation and elevation of cytosolic Ca(2+) were observed.	0	18718660-2525
Within 10min of NH(2) Cl treatment, c-@PROTEIN$ N-terminal kinase (JNK) activation and elevation of cytosolic @COMPOUND$+) were observed.	0	18718660-2525
Within 10min of NH(2) @COMPOUND$ treatment, c-@PROTEIN$ N-terminal kinase (JNK) activation and elevation of cytosolic Ca(2+) were observed.	0	18718660-2525
Induction in the activity of @PROTEIN$ and azoreductase was observed during decolorization of @COMPOUND$ in the batch culture, which represented their role in degradation.	1	18718713-2535
Induction in the activity of lignin peroxidase and @PROTEIN$ was observed during decolorization of @COMPOUND$ in the batch culture, which represented their role in degradation.	1	18718713-2535
Treatment with @COMPOUND$ resulted in dose- and time-dependent inhibition of growth of BeWo cells with IC(50) values of 2.01 and 1.19 microM for 7 and 24 h respectively, accompanied by downregulation of @PROTEIN$.	1	18719855-2110
In all cases, the phenotype of SVQ524 was nearly overcome by the addition of @COMPOUND$ or cobalamin to the plant growth media or by the presence of a copy of the @PROTEIN$ gene in cosmid pMUS756.	0	18719891-434
In all cases, the phenotype of SVQ524 was nearly overcome by the addition of methionine or @COMPOUND$ to the plant growth media or by the presence of a copy of the @PROTEIN$ gene in cosmid pMUS756.	0	18719891-434
Obesity increases @PROTEIN$ resistance and @COMPOUND$ intolerance and also exacerbates metabolic abnormalities present in type 2 diabetes.	0	18719969-461
Inhibition of @PROTEIN$ kinase by @COMPOUND$ : Investigation by simulated molecular docking and subsequent in vitro/in vivo evaluation.	1	18720192-531
The investigation included simulated docking experiments to fit @COMPOUND$ within the binding pocket of @PROTEIN$ followed by experimental in vitro and in vivo validations.	1	18720192-532
@COMPOUND$ was found to optimally fit within the binding pocket of @PROTEIN$ via several attractive interactions with key amino acids.	1	18720192-533
A sample preparation protocol applying a binary matrix-assisted laser desorption/ionization(MALDI) matrix containing alpha-cyano-4-hydroxy cinnamic acid (CHCA) and 2,5-dihydroxy @COMPOUND$ (DHB) on trifluoro acetic acid (TFA) etched latex glove surfaces allowed the direct determination (exact molecular weight) of Hevein, @PROTEIN$ and a truncated form of REF (tREF) within nine different brands of natural latex gloves by means of MALDI-TOF-MS in the linear mode.	0	18720446-603
A sample preparation protocol applying a binary matrix-assisted laser desorption/ionization(MALDI) matrix containing alpha-cyano-4-hydroxy cinnamic acid (CHCA) and 2,5-dihydroxy benzoic acid (DHB) on @COMPOUND$ (TFA) etched latex glove surfaces allowed the direct determination (exact molecular weight) of Hevein, @PROTEIN$ and a truncated form of REF (tREF) within nine different brands of natural latex gloves by means of MALDI-TOF-MS in the linear mode.	0	18720446-603
A sample preparation protocol applying a binary matrix-assisted laser desorption/ionization(MALDI) matrix containing alpha-cyano-4-hydroxy cinnamic acid (CHCA) and 2,5-dihydroxy benzoic acid (DHB) on @COMPOUND$ (TFA) etched latex glove surfaces allowed the direct determination (exact molecular weight) of @PROTEIN$, REF and a truncated form of REF (tREF) within nine different brands of natural latex gloves by means of MALDI-TOF-MS in the linear mode.	0	18720446-603
A sample preparation protocol applying a binary matrix-assisted laser desorption/ionization(MALDI) matrix containing alpha-cyano-4-hydroxy cinnamic acid (CHCA) and 2,5-dihydroxy benzoic acid (@COMPOUND$) on trifluoro acetic acid (@PROTEIN$) etched latex glove surfaces allowed the direct determination (exact molecular weight) of Hevein, REF and a truncated form of REF (tREF) within nine different brands of natural latex gloves by means of MALDI-TOF-MS in the linear mode.	0	18720446-603
A sample preparation protocol applying a binary matrix-assisted laser desorption/ionization(MALDI) matrix containing alpha-cyano-4-hydroxy cinnamic acid (@COMPOUND$) and 2,5-dihydroxy benzoic acid (DHB) on trifluoro acetic acid (TFA) etched latex glove surfaces allowed the direct determination (exact molecular weight) of Hevein, @PROTEIN$ and a truncated form of REF (tREF) within nine different brands of natural latex gloves by means of MALDI-TOF-MS in the linear mode.	0	18720446-603
A sample preparation protocol applying a binary matrix-assisted laser desorption/ionization(MALDI) matrix containing alpha-cyano-4-hydroxy cinnamic acid (@COMPOUND$) and 2,5-dihydroxy benzoic acid (DHB) on trifluoro acetic acid (TFA) etched latex glove surfaces allowed the direct determination (exact molecular weight) of @PROTEIN$, REF and a truncated form of REF (tREF) within nine different brands of natural latex gloves by means of MALDI-TOF-MS in the linear mode.	0	18720446-603
A sample preparation protocol applying a binary matrix-assisted laser desorption/ionization(MALDI) matrix containing alpha-cyano-4-hydroxy cinnamic acid (CHCA) and 2,5-dihydroxy @COMPOUND$ (DHB) on trifluoro acetic acid (TFA) etched latex glove surfaces allowed the direct determination (exact molecular weight) of @PROTEIN$, REF and a truncated form of REF (tREF) within nine different brands of natural latex gloves by means of MALDI-TOF-MS in the linear mode.	0	18720446-603
A sample preparation protocol applying a binary matrix-assisted laser desorption/ionization(MALDI) matrix containing alpha-cyano-4-hydroxy cinnamic acid (CHCA) and 2,5-dihydroxy benzoic acid (DHB) on @COMPOUND$ (@PROTEIN$) etched latex glove surfaces allowed the direct determination (exact molecular weight) of Hevein, REF and a truncated form of REF (tREF) within nine different brands of natural latex gloves by means of MALDI-TOF-MS in the linear mode.	0	18720446-603
A sample preparation protocol applying a binary matrix-assisted laser desorption/ionization(MALDI) matrix containing alpha-cyano-4-hydroxy cinnamic acid (@COMPOUND$) and 2,5-dihydroxy benzoic acid (DHB) on trifluoro acetic acid (@PROTEIN$) etched latex glove surfaces allowed the direct determination (exact molecular weight) of Hevein, REF and a truncated form of REF (tREF) within nine different brands of natural latex gloves by means of MALDI-TOF-MS in the linear mode.	0	18720446-603
A sample preparation protocol applying a binary matrix-assisted laser desorption/ionization(MALDI) matrix containing alpha-cyano-4-hydroxy cinnamic acid (CHCA) and 2,5-dihydroxy @COMPOUND$ (DHB) on trifluoro acetic acid (@PROTEIN$) etched latex glove surfaces allowed the direct determination (exact molecular weight) of Hevein, REF and a truncated form of REF (tREF) within nine different brands of natural latex gloves by means of MALDI-TOF-MS in the linear mode.	0	18720446-603
A sample preparation protocol applying a binary matrix-assisted laser desorption/ionization(MALDI) matrix containing alpha-cyano-4-hydroxy cinnamic acid (CHCA) and 2,5-dihydroxy benzoic acid (@COMPOUND$) on trifluoro acetic acid (TFA) etched latex glove surfaces allowed the direct determination (exact molecular weight) of Hevein, @PROTEIN$ and a truncated form of REF (tREF) within nine different brands of natural latex gloves by means of MALDI-TOF-MS in the linear mode.	0	18720446-603
A sample preparation protocol applying a binary matrix-assisted laser desorption/ionization(MALDI) matrix containing alpha-cyano-4-hydroxy cinnamic acid (CHCA) and 2,5-dihydroxy benzoic acid (@COMPOUND$) on trifluoro acetic acid (TFA) etched latex glove surfaces allowed the direct determination (exact molecular weight) of @PROTEIN$, REF and a truncated form of REF (tREF) within nine different brands of natural latex gloves by means of MALDI-TOF-MS in the linear mode.	0	18720446-603
Pathological role of @PROTEIN$ on NKT cells in @COMPOUND$-mediated liver injury.	1	18721153-786
Methods: We injected @PROTEIN$ knock out (KO) or wild type mice with @COMPOUND$ (CCl(4)) and examined the difference of liver injury by immunological or histological analysis.	1	18721153-787
Studies using 1-@COMPOUND$ (1-MT), the specific inhibitor of IDO, showed that this enzyme is important in @PROTEIN$ (IFN-gamma)-dependent inhibition of allergic inflammation in the respiratory airway during immunotherapy.	0	18721245-809
Studies using 1-methyl-tryptophan (@COMPOUND$), the specific inhibitor of IDO, showed that this enzyme is important in interferon-gamma (@PROTEIN$)-dependent inhibition of allergic inflammation in the respiratory airway during immunotherapy.	1	18721245-809
Studies using 1-@COMPOUND$ (1-MT), the specific inhibitor of IDO, showed that this enzyme is important in interferon-gamma (@PROTEIN$)-dependent inhibition of allergic inflammation in the respiratory airway during immunotherapy.	1	18721245-809
Studies using 1-methyl-tryptophan (@COMPOUND$), the specific inhibitor of IDO, showed that this enzyme is important in @PROTEIN$ (IFN-gamma)-dependent inhibition of allergic inflammation in the respiratory airway during immunotherapy.	1	18721245-809
We examined the substrates of cannabinoid-mediated inhibition of both the emetic phases via immunolabeling for @COMPOUND$, Substance P, cannabinoid receptors 1 and 2 (CB(1), CB(2)), and the neuronal activation marker @PROTEIN$ in the least shrew (Cryptotis parva).	0	18721829-966
We examined the substrates of cannabinoid-mediated inhibition of both the emetic phases via immunolabeling for @COMPOUND$, @PROTEIN$, cannabinoid receptors 1 and 2 (CB(1), CB(2)), and the neuronal activation marker Fos in the least shrew (Cryptotis parva).	0	18721829-966
We examined the substrates of cannabinoid-mediated inhibition of both the emetic phases via immunolabeling for @COMPOUND$, Substance P, @PROTEIN$ and 2 (CB(1), CB(2)), and the neuronal activation marker Fos in the least shrew (Cryptotis parva).	0	18721829-966
To observe the inhibitory effects of TSP-1 functional fragments, critical for @PROTEIN$ binding, on the activation of L-TGF-beta1, we isolated alveolar macrophages from Wistar rat lungs 7 days after @COMPOUND$ administration (5mg/kg body weight) and cultured the cells with or without TSP-1 functional or control fragments.	0	18722097-1040
To observe the inhibitory effects of @PROTEIN$ functional fragments, critical for CD36 binding, on the activation of L-TGF-beta1, we isolated alveolar macrophages from Wistar rat lungs 7 days after @COMPOUND$ administration (5mg/kg body weight) and cultured the cells with or without TSP-1 functional or control fragments.	0	18722097-1040
To observe the inhibitory effects of TSP-1 functional fragments, critical for CD36 binding, on the activation of L-@PROTEIN$, we isolated alveolar macrophages from Wistar rat lungs 7 days after @COMPOUND$ administration (5mg/kg body weight) and cultured the cells with or without TSP-1 functional or control fragments.	0	18722097-1040
The pERE@PROTEIN$9 vector was delivered to a single MCF-7 using a nanoneedle and the effect of @COMPOUND$, which is an antagonist of estrogen, was observed using the GFP expression level.	0	18722104-1045
By @COMPOUND$ treatment, the fluorescence intensity of the @PROTEIN$ was decreased by 30-50% within 24h.	1	18722104-1046
Effect of different @PROTEIN$ dosages on cell viability and @COMPOUND$ production by Kluyveromyces marxianus in SSF processes.	1	18722114-1051
This study was aimed to study the effect of commercial @PROTEIN$ (Celluclast 1.5 LFG) on Kluyveromyces marxianus CECT 10875 growth and @COMPOUND$ production in SSF processes.	1	18722114-1052
Crustacean hyperglycemic hormone (@PROTEIN$) not only plays an important role in the modulation of hemolymph @COMPOUND$ level but also functions in other biological events including molting, reproduction and stress response.	1	18722490-1167
@PROTEIN$ (CHH) not only plays an important role in the modulation of hemolymph @COMPOUND$ level but also functions in other biological events including molting, reproduction and stress response.	1	18722490-1167
As a proof-of-concept, @PROTEIN$-coated QDs (ConA-QDs) and @COMPOUND$-coated AuNPs (Dex-AuNPs) were used to detect the mannosylated proteins.	0	18722763-1249
As a proof-of-concept, Concanavalin A-coated QDs (@PROTEIN$-QDs) and @COMPOUND$-coated AuNPs (Dex-AuNPs) were used to detect the mannosylated proteins.	0	18722763-1249
As a result, the PL intensity of QDs was found to be linearly correlated with the concentration and the number of @COMPOUND$ moiety of the @PROTEIN$.	1	18722763-1250
We demonstrate for the first time that several developmental stages of the human parasite Schistosoma mansoni express @PROTEIN$, which is responsible for the hydrolysis of l-@COMPOUND$ to l-ornithine and urea.	1	18723022-1306
We demonstrate for the first time that several developmental stages of the human parasite Schistosoma mansoni express @PROTEIN$, which is responsible for the hydrolysis of l-arginine to l-ornithine and @COMPOUND$.	1	18723022-1306
We demonstrate for the first time that several developmental stages of the human parasite Schistosoma mansoni express @PROTEIN$, which is responsible for the hydrolysis of l-arginine to @COMPOUND$ and urea.	1	18723022-1306
To overcome this limitation we turned to the yeast Pichia stipitis, which naturally produces @COMPOUND$, as a source of @PROTEIN$ (Xyl3).	1	18723107-1332
We examined the effects of plasmid-based expression of Xyl3 versus @PROTEIN$ on growth and @COMPOUND$ production by engineered E. coli strains.	0	18723107-1333
Behavioral and biochemical responses including filtering rates, key phase I, II and antioxidant enzymes and levels of @PROTEIN$, @COMPOUND$, lipid peroxidation and DNA strand breaks were determined in digestive glands of mussels after being exposed to sublethal levels of mercury chloride, methyl mercury, cadmium and Aroclor 1260 during 5 days.	0	18723121-1340
In this study, a representative FRET system (@PROTEIN$ donor and YFP acceptor) is compared with the BRET(2) system (Renilla luciferase donor, green fluorescent protein (2) (GFP (2)) acceptor and @COMPOUND$ substrate).	0	18723336-870
In this study, a representative FRET system (CFP donor and YFP acceptor) is compared with the BRET(2) system (Renilla luciferase donor, green fluorescent protein (2) (@PROTEIN$ (2)) acceptor and @COMPOUND$ substrate).	0	18723336-870
In this study, a representative FRET system (CFP donor and YFP acceptor) is compared with the BRET(2) system (Renilla @PROTEIN$ donor, green fluorescent protein (2) (GFP (2)) acceptor and @COMPOUND$ substrate).	0	18723336-870
In this study, a representative FRET system (CFP donor and @PROTEIN$ acceptor) is compared with the BRET(2) system (Renilla luciferase donor, green fluorescent protein (2) (GFP (2)) acceptor and @COMPOUND$ substrate).	0	18723336-870
In this study, a representative FRET system (CFP donor and YFP acceptor) is compared with the BRET(2) system (Renilla luciferase donor, @PROTEIN$ (2) (GFP (2)) acceptor and @COMPOUND$ substrate).	0	18723336-870
If no pretreatment applied, hydrolyses of the textiles by cellulase and @PROTEIN$ for 24 h followed by simultaneous saccharification and fermentation (SSF) in 4 days, resulted in 0.140-0.145 g @COMPOUND$/g textiles, which was 25-26% of the corresponding theoretical yield.	1	18723342-981
If no pretreatment applied, hydrolyses of the textiles by @PROTEIN$ and beta-glucosidase for 24 h followed by simultaneous saccharification and fermentation (SSF) in 4 days, resulted in 0.140-0.145 g @COMPOUND$/g textiles, which was 25-26% of the corresponding theoretical yield.	1	18723342-981
In cystic fibrosis, this equilibrium is disrupted by mutations in the cystic fibrosis transmembrane conductance regulator (@PROTEIN$) gene resulting in the absence of functional CFTR protein, which in turn results in deficient cAMP-dependent Cl (-) secretion and predominant @COMPOUND$ (+) absorption.	1	18723440-1394
In cystic fibrosis, this equilibrium is disrupted by mutations in the cystic fibrosis transmembrane conductance regulator (@PROTEIN$) gene resulting in the absence of functional CFTR protein, which in turn results in deficient @COMPOUND$-dependent Cl (-) secretion and predominant Na (+) absorption.	1	18723440-1394
In cystic fibrosis, this equilibrium is disrupted by mutations in the @PROTEIN$ (CFTR) gene resulting in the absence of functional CFTR protein, which in turn results in deficient cAMP-dependent Cl (-) secretion and predominant @COMPOUND$ (+) absorption.	1	18723440-1394
In cystic fibrosis, this equilibrium is disrupted by mutations in the @PROTEIN$ (CFTR) gene resulting in the absence of functional CFTR protein, which in turn results in deficient @COMPOUND$-dependent Cl (-) secretion and predominant Na (+) absorption.	1	18723440-1394
In cystic fibrosis, this equilibrium is disrupted by mutations in the cystic fibrosis transmembrane conductance regulator (@PROTEIN$) gene resulting in the absence of functional CFTR protein, which in turn results in deficient cAMP-dependent @COMPOUND$ (-) secretion and predominant Na (+) absorption.	1	18723440-1394
In cystic fibrosis, this equilibrium is disrupted by mutations in the @PROTEIN$ (CFTR) gene resulting in the absence of functional CFTR protein, which in turn results in deficient cAMP-dependent @COMPOUND$ (-) secretion and predominant Na (+) absorption.	1	18723440-1394
Two patients presented a heterozygous T-to-G transversion in exon 2 (c.518T&gt;G) of the @PROTEIN$, which results in a leucine-to-@COMPOUND$ substitution at codon 173.	1	18723471-1399
Two patients presented a heterozygous T-to-G transversion in exon 2 (c.518T&gt;G) of the @PROTEIN$, which results in a @COMPOUND$-to-arginine substitution at codon 173.	1	18723471-1399
@COMPOUND$ inhibits the autocrine PDGF-B synthesis and PDGF-BB-induced mRNA expression of @PROTEIN$ in rat mesangial cells.	1	18723570-1420
Angiotensin II (@PROTEIN$) stimulation of water and @COMPOUND$ intake is a classic model of the behavioural effects of hormones.	1	18723579-1422
@PROTEIN$ (AngII) stimulation of water and @COMPOUND$ intake is a classic model of the behavioural effects of hormones.	1	18723579-1422
Previous studies support the hypotheses that @PROTEIN$ is involved in AngII-induced water, but not @COMPOUND$ intake and that MAP kinase plays a role in NaCl consumption, but not water intake, after injection of AngII.	0	18723579-1423
Pretreatment with the PKC inhibitor chelerythrine attenuated @PROTEIN$-induced water intake, but @COMPOUND$ intake was unaffected.	0	18723579-1424
Pretreatment with the PKC inhibitor @COMPOUND$ attenuated @PROTEIN$-induced water intake, but NaCl intake was unaffected.	1	18723579-1424
In contrast, pretreatment with U0126, a MAP kinase inhibitor, had no effect on @PROTEIN$-induced water intake, but attenuated @COMPOUND$ intake.	0	18723579-1425
The prevalence rates of elevated blood pressure and hypertriglyceridemia were significantly higher among HCT recipients than among controls, but the prevalence rates of abdominal obesity, elevated blood @COMPOUND$ and low @PROTEIN$ cholesterol were not.	0	18724397-1741
The prevalence rates of elevated blood pressure and hypertriglyceridemia were significantly higher among HCT recipients than among controls, but the prevalence rates of abdominal obesity, elevated blood glucose and low @PROTEIN$ @COMPOUND$ were not.	1	18724397-1741
Specific neurochemical elements in these structures include not only decreases in reward neurotransmission, such as decreases in @COMPOUND$ and opioid peptide function in the ventral striatum, but also recruitment of brain stress systems, such as corticotropin-releasing factor (@PROTEIN$), in the extended amygdala.	1	18725236-2014
Specific neurochemical elements in these structures include not only decreases in reward neurotransmission, such as decreases in @COMPOUND$ and opioid peptide function in the ventral striatum, but also recruitment of brain stress systems, such as @PROTEIN$ (CRF), in the extended amygdala.	1	18725236-2014
Neither enzymatic activity of transaminases (@PROTEIN$ and ALT) nor @COMPOUND$ levels were significantly altered.	0	18726068-972
On other hand, @PROTEIN$ gene mutations at kinase domain in non-small cell lung cancer (NSCLC) have been examined for their ability to predict sensitivity to @COMPOUND$ or erlotinib.	1	18726117-2302
On other hand, @PROTEIN$ gene mutations at kinase domain in non-small cell lung cancer (NSCLC) have been examined for their ability to predict sensitivity to gefitinib or @COMPOUND$.	1	18726117-2302
Although the TO2 hamster heart exhibits normal function at 1 month of age (presymptomatic stage), elevated levels of myeloperoxidase, monocyte chemotactic protein-1, @COMPOUND$, osteopontin, and @PROTEIN$ were evident, indicating the presence of inflammation, oxidative stress, and osteogenic phenotype.	0	18726675-2476
Although the TO2 hamster heart exhibits normal function at 1 month of age (presymptomatic stage), elevated levels of myeloperoxidase, @PROTEIN$, @COMPOUND$, osteopontin, and alkaline phosphatase were evident, indicating the presence of inflammation, oxidative stress, and osteogenic phenotype.	0	18726675-2476
Transitions in the @COMPOUND$ microenvironment and secondary structure of two monocot @PROTEIN$ from Sauromatum guttatum and Arisaema tortuosum under different denaturing conditions were studied by steady state and time resolved fluorescence and CD spectroscopy.	0	18726677-2477
The @PROTEIN$ exist as tetramers with a single @COMPOUND$ residue estimated per monomer, present in a polar environment.	1	18726677-2478
Similarly, both the @PROTEIN$ showed a drastic loss of secondary structure in 5 M Gdn-@COMPOUND$ or 6 M Urea or at pH 2.0 and below.	1	18726677-2479
Similarly, both the @PROTEIN$ showed a drastic loss of secondary structure in 5 M Gdn-HCl or 6 M @COMPOUND$ or at pH 2.0 and below.	1	18726677-2479
Similarly, both the @PROTEIN$ showed a drastic loss of secondary structure in 5 M @COMPOUND$-HCl or 6 M Urea or at pH 2.0 and below.	1	18726677-2479
In order to determine the possible effects of hemolysate on brain microvascular endothelial cells (BMECs), we examined the effects of hemolysate on the expression of intercellular adhesion molecule-1 (ICAM-1) and @PROTEIN$ (MCP-1), generation of reactive @COMPOUND$ species (ROS), and NF-kappaB activation in rat BMECs.	0	18726687-2490
In order to determine the possible effects of hemolysate on brain microvascular endothelial cells (BMECs), we examined the effects of hemolysate on the expression of intercellular adhesion molecule-1 (@PROTEIN$) and monocyte chemoattractant protein-1 (MCP-1), generation of reactive @COMPOUND$ species (ROS), and NF-kappaB activation in rat BMECs.	0	18726687-2490
In order to determine the possible effects of hemolysate on brain microvascular endothelial cells (BMECs), we examined the effects of hemolysate on the expression of intercellular adhesion molecule-1 (ICAM-1) and monocyte chemoattractant protein-1 (@PROTEIN$), generation of reactive @COMPOUND$ species (ROS), and NF-kappaB activation in rat BMECs.	0	18726687-2490
We examined @COMPOUND$ (1,25(OH)(2)D(3))-induced expression of 25-hydroxyvitamin D(3) 24-hydroxylase (CYP24) and apical calcium channel (@PROTEIN$) mRNA levels in 2-, 9-, and 15-day cultures Caco-2 cells that model proliferating, post-proliferative, and differentiated enterocytes.	1	18726998-19
We examined @COMPOUND$ (1,25(OH)(2)D(3))-induced expression of 25-hydroxyvitamin D(3) 24-hydroxylase (@PROTEIN$) and apical calcium channel (TRPV6) mRNA levels in 2-, 9-, and 15-day cultures Caco-2 cells that model proliferating, post-proliferative, and differentiated enterocytes.	1	18726998-19
Here, we tested the hypothesis that interactions with @PROTEIN$ play a role in the DNA-damaging properties of @COMPOUND$.	0	18727009-26
Next, we selected @COMPOUND$ as the most DNA-damaging Alternaria metabolite for further studies of interactions with @PROTEIN$.	0	18727009-27
Stabilisation of covalent @PROTEIN$ II-DNA intermediates by @COMPOUND$ was also detectable in cell culture, and here, the IIalpha isoform was preferentially targeted.	1	18727009-28
Bone formation and maturation processes were evaluated by double staining for alkaline @PROTEIN$ and tartrate-resistant acid phosphatase, immunohistochemistry for bone matrix proteins, vital staining with @COMPOUND$, and elemental mapping with an electron probe microanalyzer.	0	18727113-70
Bone formation and maturation processes were evaluated by double staining for alkaline phosphatase and tartrate-resistant acid phosphatase, immunohistochemistry for bone @PROTEIN$, vital staining with @COMPOUND$, and elemental mapping with an electron probe microanalyzer.	0	18727113-70
Bone formation and maturation processes were evaluated by double staining for @PROTEIN$ and tartrate-resistant acid phosphatase, immunohistochemistry for bone matrix proteins, vital staining with @COMPOUND$, and elemental mapping with an electron probe microanalyzer.	0	18727113-70
Phosphorylation of insulin receptor substrate (@PROTEIN$) proteins on @COMPOUND$ residues has emerged as a key step in these control processes under both physiological and pathological conditions.	1	18728222-493
Phosphorylation of @PROTEIN$ substrate (IRS) proteins on @COMPOUND$ residues has emerged as a key step in these control processes under both physiological and pathological conditions.	1	18728222-493
In contrast, SKI-1 (@PROTEIN$ or site-1) is a membrane-bound serine protease inhibitable by @COMPOUND$.	1	18728345-519
In contrast, @PROTEIN$ (S1P or site-1) is a membrane-bound serine protease inhibitable by @COMPOUND$.	1	18728345-519
In contrast, SKI-1 (S1P or site-1) is a membrane-bound @PROTEIN$ inhibitable by @COMPOUND$.	1	18728345-519
The progressive ankylosis gene (ank) is a @PROTEIN$ that transports intracellular @COMPOUND$ to the extracellular milieu.	1	18728347-520
@PROTEIN$ receptor-1 is essential for LPS-induced sensitization and tolerance to @COMPOUND$-glucose deprivation in murine neonatal organotypic hippocampal slices.	1	18728678-624
@PROTEIN$ receptor-1 is essential for LPS-induced sensitization and tolerance to oxygen-@COMPOUND$ deprivation in murine neonatal organotypic hippocampal slices.	1	18728678-624
The role of tumor necrosis factor (@PROTEIN$) receptors 1 and 2 in @COMPOUND$ (LPS)-induced sensitization and tolerance to oxygen-glucose deprivation (OGD) was evaluated in neonatal murine hippocampal organotypic slices.	1	18728678-625
The role of @PROTEIN$ (TNF) receptors 1 and 2 in @COMPOUND$ (LPS)-induced sensitization and tolerance to oxygen-glucose deprivation (OGD) was evaluated in neonatal murine hippocampal organotypic slices.	1	18728678-625
The immunoblot, ELISA and EMSA analysis demonstrated that the treatment of HCT116 cells with @COMPOUND$ resulted in the inhibition of (i) IKKalpha, (ii) phosphorylation and degradation of IkappaBalpha, (iii) phosphorylation of NF-kappaB/@PROTEIN$ at Ser (536), (iv) nuclear translocation of NF-kappaB/p65, (v) NF-kappaB/p65 DNA binding activity, and (vi) transcriptional activation of NF-kappaB.	1	18729103-711
The immunoblot, ELISA and EMSA analysis demonstrated that the treatment of HCT116 cells with @COMPOUND$ resulted in the inhibition of (i) @PROTEIN$, (ii) phosphorylation and degradation of IkappaBalpha, (iii) phosphorylation of NF-kappaB/p65 at Ser (536), (iv) nuclear translocation of NF-kappaB/p65, (v) NF-kappaB/p65 DNA binding activity, and (vi) transcriptional activation of NF-kappaB.	1	18729103-711
The immunoblot, ELISA and EMSA analysis demonstrated that the treatment of HCT116 cells with @COMPOUND$ resulted in the inhibition of (i) IKKalpha, (ii) phosphorylation and degradation of @PROTEIN$, (iii) phosphorylation of NF-kappaB/p65 at Ser (536), (iv) nuclear translocation of NF-kappaB/p65, (v) NF-kappaB/p65 DNA binding activity, and (vi) transcriptional activation of NF-kappaB.	1	18729103-711
Accommodation of @COMPOUND$ and its analogues by @PROTEIN$ is dominated by hydrophobic interactions.	1	18729824-936
The role of the functional architecture of the HuAChE (human @PROTEIN$) in reactivity toward the carbamates pyridostigmine, @COMPOUND$ and several analogues of physostigmine, that are currently used or considered for use as drugs for Alzheimer's disease, was analysed using over 20 mutants of residues that constitute the interaction subsites in the active centre.	1	18729824-937
The role of the functional architecture of the HuAChE (human @PROTEIN$) in reactivity toward the carbamates pyridostigmine, rivastigmine and several analogues of @COMPOUND$, that are currently used or considered for use as drugs for Alzheimer's disease, was analysed using over 20 mutants of residues that constitute the interaction subsites in the active centre.	1	18729824-937
The role of the functional architecture of the HuAChE (human @PROTEIN$) in reactivity toward the carbamates @COMPOUND$, rivastigmine and several analogues of physostigmine, that are currently used or considered for use as drugs for Alzheimer's disease, was analysed using over 20 mutants of residues that constitute the interaction subsites in the active centre.	1	18729824-937
Cells were grown for 24 h with APAP in the presence or absence of 4-methylpyrazole (4MP), L-arginine methyl ester (L-NAME), @PROTEIN$ (SOD), or @COMPOUND$ red (RuR).	0	18751681-68
Cells were grown for 24 h with APAP in the presence or absence of 4-methylpyrazole (4MP), L-arginine methyl ester (L-NAME), superoxide dismutase (@PROTEIN$), or @COMPOUND$ red (RuR).	0	18751681-68
Cells were grown for 24 h with APAP in the presence or absence of 4-methylpyrazole (4MP), L-arginine methyl ester (L-NAME), @PROTEIN$ (SOD), or ruthenium red (@COMPOUND$).	0	18751681-68
Cells were grown for 24 h with APAP in the presence or absence of 4-methylpyrazole (4MP), @COMPOUND$ (L-NAME), superoxide dismutase (@PROTEIN$), or ruthenium red (RuR).	0	18751681-68
Cells were grown for 24 h with APAP in the presence or absence of 4-methylpyrazole (4MP), L-arginine methyl ester (L-NAME), superoxide dismutase (@PROTEIN$), or ruthenium red (@COMPOUND$).	0	18751681-68
Cells were grown for 24 h with @COMPOUND$ in the presence or absence of 4-methylpyrazole (4MP), L-arginine methyl ester (L-NAME), @PROTEIN$ (SOD), or ruthenium red (RuR).	0	18751681-68
Cells were grown for 24 h with APAP in the presence or absence of 4-methylpyrazole (4MP), @COMPOUND$ (L-NAME), @PROTEIN$ (SOD), or ruthenium red (RuR).	0	18751681-68
Cells were grown for 24 h with @COMPOUND$ in the presence or absence of 4-methylpyrazole (4MP), L-arginine methyl ester (L-NAME), superoxide dismutase (@PROTEIN$), or ruthenium red (RuR).	0	18751681-68
Synaptic vesicle-bound @PROTEIN$ can support vesicular @COMPOUND$ uptake.	1	18751889-128
We present evidence that ATP generated by synaptic vesicle-associated @PROTEIN$ is harnessed to transport @COMPOUND$ into synaptic vesicles.	1	18751889-129
We examined the expression of @PROTEIN$ and ASCT1 in @COMPOUND$ (KA)-induced neurodegeneration of the mouse hippocampus using immunohistochemistry and Western blots.	1	18751891-135
We examined the expression of Phgdh and @PROTEIN$ in @COMPOUND$ (KA)-induced neurodegeneration of the mouse hippocampus using immunohistochemistry and Western blots.	1	18751891-135
In the present study the effect of the convulsant drug @COMPOUND$ (MP) repetitive administration (4-7 days) on the hippocampal @PROTEIN$ subunit was studied.	1	18751892-136
A significant decrease in @PROTEIN$ in the whole hippocampus was observed after MP4 with a tendency to recover to normal values in @COMPOUND$ by western blot assay.	1	18751892-137
Heart glycogen represents a store of glucosyl residues which are mobilized by the catalysis of @PROTEIN$ (GP) and are mainly destined to serve as substrates for the generation of @COMPOUND$.	0	18751894-139
However, @COMPOUND$ was equally effective in @PROTEIN$alpha1(-/-) and wild-type animals, suggesting additional AMPK-independent action of phenformin.	0	18752001-187
The relationship between prolactin (@PROTEIN$), leptin, @COMPOUND$ (NO), and cytokines in patients with hyperprolactinemia.	0	18752070-205
The relationship between @PROTEIN$ (PRL), leptin, @COMPOUND$ (NO), and cytokines in patients with hyperprolactinemia.	0	18752070-205
The relationship between prolactin (PRL), @PROTEIN$, @COMPOUND$ (NO), and cytokines in patients with hyperprolactinemia.	0	18752070-205
The aim of this study was to determine the changes in serum @PROTEIN$, tumor necrosis factor-alpha (TNF-alpha), interleukin-6 (IL-6), @COMPOUND$ (NO) levels in patients with hyperprolactinemia.	0	18752070-206
The aim of this study was to determine the changes in serum leptin, tumor necrosis factor-alpha (TNF-alpha), interleukin-6 (@PROTEIN$), @COMPOUND$ (NO) levels in patients with hyperprolactinemia.	0	18752070-206
The aim of this study was to determine the changes in serum leptin, @PROTEIN$-alpha (TNF-alpha), interleukin-6 (IL-6), @COMPOUND$ (NO) levels in patients with hyperprolactinemia.	0	18752070-206
The aim of this study was to determine the changes in serum leptin, tumor necrosis factor-alpha (@PROTEIN$), interleukin-6 (IL-6), @COMPOUND$ (NO) levels in patients with hyperprolactinemia.	0	18752070-206
The aim of this study was to determine the changes in serum leptin, tumor necrosis factor-alpha (TNF-alpha), @PROTEIN$ (IL-6), @COMPOUND$ (NO) levels in patients with hyperprolactinemia.	0	18752070-206
Joint analysis of individual participants' data from 17 studies on the association of the IL6 variant-174G&gt;C with circulating @COMPOUND$ levels, @PROTEIN$ levels, and body mass index.	0	18752089-210
Joint analysis of individual participants' data from 17 studies on the association of the @PROTEIN$ variant-174G&gt;C with circulating @COMPOUND$ levels, interleukin-6 levels, and body mass index.	0	18752089-210
Effect of @PROTEIN$ *3 genotype on the stereoselective pharmacokinetics of @COMPOUND$ in healthy subjects.	1	18752284-283
In conclusion, the present study showed that despite the evidence that @COMPOUND$ is stereoselectively metabolized, @PROTEIN$ *3 genotype did not affect stereoselective disposition of amlodipine.	0	18752284-286
It provides the evidence that @PROTEIN$ *3genotype plays a minor role in the interindividual variability of stereoselective disposition of @COMPOUND$ in humans.	1	18752284-287
Tissues were stained for BrdU, @PROTEIN$, vimentin, and @COMPOUND$ and eosin staining.	0	18752291-293
Tissues were stained for @COMPOUND$, @PROTEIN$, vimentin, and haematoxylin and eosin staining.	0	18752291-293
Tissues were stained for @COMPOUND$, Pax-7, @PROTEIN$, and haematoxylin and eosin staining.	0	18752291-293
Tissues were stained for BrdU, Pax-7, @PROTEIN$, and @COMPOUND$ and eosin staining.	0	18752291-293
Differences in the expression of inwardly rectifying potassium channels (Kir4.1), glial fibrillary @PROTEIN$ (GFAP), and @COMPOUND$ levels in cortical astrocytes were detected using immunohistochemical methods.	0	18752295-295
Differences in the expression of inwardly rectifying potassium channels (@PROTEIN$), glial fibrillary acidic protein (GFAP), and @COMPOUND$ levels in cortical astrocytes were detected using immunohistochemical methods.	0	18752295-295
Differences in the expression of inwardly rectifying potassium channels (Kir4.1), glial fibrillary acidic protein (@PROTEIN$), and @COMPOUND$ levels in cortical astrocytes were detected using immunohistochemical methods.	0	18752295-295
Immunohistochemical analysis suggests that the diverse expression of @PROTEIN$ channels and GFAP as well as differences in the accumulation of @COMPOUND$ might contribute to the distinct ability of astrocytes to regulate their volume.	0	18752295-296
Immunohistochemical analysis suggests that the diverse expression of Kir4.1 channels and @PROTEIN$ as well as differences in the accumulation of @COMPOUND$ might contribute to the distinct ability of astrocytes to regulate their volume.	0	18752295-296
These evoked expressions at both molecular and cellular levels were significantly inhibited after TRPV(1) receptors were blocked by 5'-iodoresiniferatoxin (5 microg) or @PROTEIN$ was inhibited by @COMPOUND$ chloride (5 microg).	1	18752301-300
These evoked expressions at both molecular and cellular levels were significantly inhibited after TRPV(1) receptors were blocked by @COMPOUND$ (5 microg) or @PROTEIN$ was inhibited by chelerythrine chloride (5 microg).	0	18752301-300
These evoked expressions at both molecular and cellular levels were significantly inhibited after TRPV(1) receptors were blocked by 5'-iodoresiniferatoxin (5 microg) or @PROTEIN$ was inhibited by chelerythrine @COMPOUND$ (5 microg).	1	18752301-300
Regulation of the phosphoinositide-3 kinase and @PROTEIN$ signaling pathways by @COMPOUND$ and its reduced metabolites in the rat brain.	1	18752305-1438
Several growth factors, such as vascular endothelial growth factor, @PROTEIN$, and insulin-like growth factor-I are involved in the actions of @COMPOUND$ in the central nervous system.	1	18752305-1439
Several growth factors, such as vascular endothelial growth factor, brain-derived neurotrophic factor, and @PROTEIN$-like growth factor-I are involved in the actions of @COMPOUND$ in the central nervous system.	1	18752305-1439
Significant increases in the phosphorylation of @PROTEIN$, in the expression of the catalytic (p110) and the regulatory (p85) subunits of PI3K and in the phosphorylation of Akt were observed in the hypothalamus, the hippocampus, and the cerebellum 24 hr after @COMPOUND$ administration.	1	18752305-1440
Significant increases in the phosphorylation of ERK, in the expression of the catalytic (p110) and the regulatory (@PROTEIN$) subunits of PI3K and in the phosphorylation of Akt were observed in the hypothalamus, the hippocampus, and the cerebellum 24 hr after @COMPOUND$ administration.	1	18752305-1440
Significant increases in the phosphorylation of ERK, in the expression of the catalytic (@PROTEIN$) and the regulatory (p85) subunits of PI3K and in the phosphorylation of Akt were observed in the hypothalamus, the hippocampus, and the cerebellum 24 hr after @COMPOUND$ administration.	1	18752305-1440
Significant increases in the phosphorylation of ERK, in the expression of the catalytic (p110) and the regulatory (p85) subunits of PI3K and in the phosphorylation of @PROTEIN$ were observed in the hypothalamus, the hippocampus, and the cerebellum 24 hr after @COMPOUND$ administration.	1	18752305-1440
Significant increases in the phosphorylation of ERK, in the expression of the catalytic (p110) and the regulatory (p85) subunits of @PROTEIN$ and in the phosphorylation of Akt were observed in the hypothalamus, the hippocampus, and the cerebellum 24 hr after @COMPOUND$ administration.	1	18752305-1440
In addition, we used PET to evaluate the striatal dopamine transporter availability (@PROTEIN$) with ((11)C)d-threo-@COMPOUND$ in the patient group.	1	18752414-337
Associated with the mitochondrial permeabilization, PdC also induced the release of @PROTEIN$, which is sensitive to inhibition by @COMPOUND$.	1	18752468-361
Toll-like receptor 4 (@PROTEIN$-4)/myeloid differentiation protein-2 complex ligation by @COMPOUND$ induces production of pro-inflammatory cytokines and co-stimulatory molecules on antigen presenting cells.	1	18752565-399
Toll-like receptor 4 (TLR-4)/myeloid differentiation @PROTEIN$ complex ligation by @COMPOUND$ induces production of pro-inflammatory cytokines and co-stimulatory molecules on antigen presenting cells.	1	18752565-399
Immunohistochemistry was performed on paraffin-embedded sections, using anti-@COMPOUND$ (5mc) and anti-Acetyl-@PROTEIN$ (Lys 9).	0	18752633-420
Here, the @PROTEIN$-mediated (45)Ca(2+) uptake was compared in @COMPOUND$ (+)-loaded pig coronary artery smooth muscle and endothelial cells.	0	18752635-423
The concept of a linkage between NCX and SERCA in smooth muscle was also confirmed by similar distribution of NCX and @PROTEIN$ proteins when detergent-treated microsomes were fractionated by flotation on @COMPOUND$ density gradients.	0	18752635-425
The concept of a linkage between @PROTEIN$ and SERCA in smooth muscle was also confirmed by similar distribution of NCX and SERCA2 proteins when detergent-treated microsomes were fractionated by flotation on @COMPOUND$ density gradients.	0	18752635-425
The recent approval of sunitinib, sorafenib, @COMPOUND$ and bevacizumab in combination with @PROTEIN$ has revolutionized the management of renal cell carcinoma.	0	18752971-536
The recent approval of sunitinib, @COMPOUND$, temsirolimus and bevacizumab in combination with @PROTEIN$ has revolutionized the management of renal cell carcinoma.	0	18752971-536
The recent approval of @COMPOUND$, sorafenib, temsirolimus and bevacizumab in combination with @PROTEIN$ has revolutionized the management of renal cell carcinoma.	0	18752971-536
Here we report identification of the first three in vivo non-histone protein substrates of @COMPOUND$ propionylation in eukaryotic cells: p53, p300, and @PROTEIN$.	1	18753126-578
Here we report identification of the first three in vivo non-histone protein substrates of @COMPOUND$ propionylation in eukaryotic cells: @PROTEIN$, p300, and CREB-binding protein.	1	18753126-578
Here we report identification of the first three in vivo non-histone protein substrates of @COMPOUND$ propionylation in eukaryotic cells: p53, @PROTEIN$, and CREB-binding protein.	1	18753126-578
@PROTEIN$ was able to perform autopropionylation on @COMPOUND$ residues in cells.	1	18753126-580
This study determined the effects of the estrous cycle, pregnancy, @COMPOUND$ (P4), and interferon tau (IFNT) on expression of both facilitative (@PROTEIN$, SLC2A3, and SLC2A4) and sodium-dependent (SLC5A1 and SLC5A11) glucose transporters in ovine uterine endometria from Days 10 to 16 of the estrous cycle and Days 10 to 20 of pregnancy, as well as in conceptuses from Days 10 to 20 of pregnancy.	1	18753604-688
This study determined the effects of the estrous cycle, pregnancy, @COMPOUND$ (P4), and interferon tau (IFNT) on expression of both facilitative (SLC2A1, @PROTEIN$, and SLC2A4) and sodium-dependent (SLC5A1 and SLC5A11) glucose transporters in ovine uterine endometria from Days 10 to 16 of the estrous cycle and Days 10 to 20 of pregnancy, as well as in conceptuses from Days 10 to 20 of pregnancy.	1	18753604-688
This study determined the effects of the estrous cycle, pregnancy, @COMPOUND$ (P4), and interferon tau (IFNT) on expression of both facilitative (SLC2A1, SLC2A3, and SLC2A4) and sodium-dependent (@PROTEIN$ and SLC5A11) glucose transporters in ovine uterine endometria from Days 10 to 16 of the estrous cycle and Days 10 to 20 of pregnancy, as well as in conceptuses from Days 10 to 20 of pregnancy.	1	18753604-688
This study determined the effects of the estrous cycle, pregnancy, @COMPOUND$ (P4), and interferon tau (IFNT) on expression of both facilitative (SLC2A1, SLC2A3, and SLC2A4) and sodium-dependent (SLC5A1 and SLC5A11) @PROTEIN$ in ovine uterine endometria from Days 10 to 16 of the estrous cycle and Days 10 to 20 of pregnancy, as well as in conceptuses from Days 10 to 20 of pregnancy.	1	18753604-688
This study determined the effects of the estrous cycle, pregnancy, @COMPOUND$ (P4), and interferon tau (IFNT) on expression of both facilitative (SLC2A1, SLC2A3, and @PROTEIN$) and sodium-dependent (SLC5A1 and SLC5A11) glucose transporters in ovine uterine endometria from Days 10 to 16 of the estrous cycle and Days 10 to 20 of pregnancy, as well as in conceptuses from Days 10 to 20 of pregnancy.	1	18753604-688
This study determined the effects of the estrous cycle, pregnancy, @COMPOUND$ (P4), and interferon tau (@PROTEIN$) on expression of both facilitative (SLC2A1, SLC2A3, and SLC2A4) and sodium-dependent (SLC5A1 and SLC5A11) glucose transporters in ovine uterine endometria from Days 10 to 16 of the estrous cycle and Days 10 to 20 of pregnancy, as well as in conceptuses from Days 10 to 20 of pregnancy.	0	18753604-688
This study determined the effects of the estrous cycle, pregnancy, @COMPOUND$ (P4), and interferon @PROTEIN$ (IFNT) on expression of both facilitative (SLC2A1, SLC2A3, and SLC2A4) and sodium-dependent (SLC5A1 and SLC5A11) glucose transporters in ovine uterine endometria from Days 10 to 16 of the estrous cycle and Days 10 to 20 of pregnancy, as well as in conceptuses from Days 10 to 20 of pregnancy.	0	18753604-688
In @PROTEIN$-D patients, plasma triglycerides, apolipoprotein B-48 (apoB-48), free fatty acids (FFAs), and free @COMPOUND$ levels were much higher after OFL than those of controls, along with increases in chylomicron (CM) remnants and small dense low-density lipoprotein (sdLDL) particles.	0	18753675-708
In CD36-D patients, plasma triglycerides, apolipoprotein B-48 (@PROTEIN$), free fatty acids (FFAs), and free @COMPOUND$ levels were much higher after OFL than those of controls, along with increases in chylomicron (CM) remnants and small dense low-density lipoprotein (sdLDL) particles.	0	18753675-708
In CD36-D patients, plasma triglycerides, @PROTEIN$ (apoB-48), free fatty acids (FFAs), and free @COMPOUND$ levels were much higher after OFL than those of controls, along with increases in chylomicron (CM) remnants and small dense low-density lipoprotein (sdLDL) particles.	0	18753675-708
Identification of @PROTEIN$ as a candidate gene for regulation of responsiveness to dietary @COMPOUND$ in rats.	1	18753676-709
Here we narrowed Dihc2 to a region including 33 genes and predicted transcripts and identified RGD1309450_predicted, a homologous gene of @PROTEIN$, as a strong candidate for responsiveness to dietary @COMPOUND$.	1	18753676-710
@COMPOUND$ is a strong correlate of @PROTEIN$ levels in men and postmenopausal women.	1	18753737-733
Up to 72% hexose yield and 94% pentose yield were obtained using modified steam explosion with 2% @COMPOUND$ at 140 degrees C for 30 min and enzymatic hydrolysis with cellulase (15 filter per unit (FPU)/g cellulose) and @PROTEIN$ (50 cellobiose units (CBU)/g cellulose).	0	18754081-829
Up to 72% hexose yield and 94% pentose yield were obtained using modified steam explosion with 2% @COMPOUND$ at 140 degrees C for 30 min and enzymatic hydrolysis with @PROTEIN$ (15 filter per unit (FPU)/g cellulose) and beta-glucosidase (50 cellobiose units (CBU)/g cellulose).	0	18754081-829
@COMPOUND$ (GSH), catalase (@PROTEIN$), and malondialdehyde (MDA) activities in blood were measured.	0	18754092-832
Glutathione (@COMPOUND$), catalase (@PROTEIN$), and malondialdehyde (MDA) activities in blood were measured.	0	18754092-832
Glutathione (GSH), catalase (@PROTEIN$), and @COMPOUND$ (MDA) activities in blood were measured.	0	18754092-832
Glutathione (@COMPOUND$), @PROTEIN$ (CAT), and malondialdehyde (MDA) activities in blood were measured.	0	18754092-832
Glutathione (GSH), @PROTEIN$ (CAT), and @COMPOUND$ (MDA) activities in blood were measured.	0	18754092-832
@COMPOUND$ (GSH), @PROTEIN$ (CAT), and malondialdehyde (MDA) activities in blood were measured.	0	18754092-832
Catalase, myeloperoxidase (@PROTEIN$), glutathione peroxidase (GSH-Px), glutathione reductase (GR), @COMPOUND$, and nitric oxide (NO) activities were measured from tissue samples.	0	18754092-833
Catalase, myeloperoxidase (MPO), glutathione peroxidase (GSH-Px), @PROTEIN$ (GR), malondialdehyde, and @COMPOUND$ (NO) activities were measured from tissue samples.	0	18754092-833
@PROTEIN$, myeloperoxidase (MPO), glutathione peroxidase (GSH-Px), glutathione reductase (GR), malondialdehyde, and @COMPOUND$ (NO) activities were measured from tissue samples.	0	18754092-833
Catalase, myeloperoxidase (MPO), @PROTEIN$ (GSH-Px), glutathione reductase (GR), @COMPOUND$, and nitric oxide (NO) activities were measured from tissue samples.	0	18754092-833
Catalase, myeloperoxidase (MPO), @PROTEIN$ (GSH-Px), glutathione reductase (GR), malondialdehyde, and @COMPOUND$ (NO) activities were measured from tissue samples.	0	18754092-833
@PROTEIN$, myeloperoxidase (MPO), glutathione peroxidase (GSH-Px), glutathione reductase (GR), @COMPOUND$, and nitric oxide (NO) activities were measured from tissue samples.	0	18754092-833
Catalase, myeloperoxidase (MPO), glutathione peroxidase (GSH-Px), @PROTEIN$ (GR), @COMPOUND$, and nitric oxide (NO) activities were measured from tissue samples.	0	18754092-833
Catalase, myeloperoxidase (@PROTEIN$), glutathione peroxidase (GSH-Px), glutathione reductase (GR), malondialdehyde, and @COMPOUND$ (NO) activities were measured from tissue samples.	0	18754092-833
In this study we examined the possible antigenotoxic effect of selenium (Se) in rats chronically exposed to low levels of @COMPOUND$ (MeHg) and the association between @PROTEIN$ (GSH-Px) activity and DNA lesions (via comet assay) in the same exposed animals.	0	18754101-836
In this study we examined the possible antigenotoxic effect of selenium (Se) in rats chronically exposed to low levels of methylmercury (@COMPOUND$) and the association between @PROTEIN$ (GSH-Px) activity and DNA lesions (via comet assay) in the same exposed animals.	0	18754101-836
To investigate any similarities in the inhibition of @PROTEIN$ by quinacrine and @COMPOUND$, molecular modeling techniques were adopted and revealed that quinacrine molecule anchors inside the same binding pocket of the protein where disulfiram is also attached.	1	18754103-838
administered during 7 days at 20 mg/kg per day (subacute treatment), @COMPOUND$ abrogated LPS-induced erythrocytes lipoperoxidation and catalase (@PROTEIN$) activity depression to control levels.	1	18754105-839
administered during 7 days at 20 mg/kg per day (subacute treatment), @COMPOUND$ abrogated LPS-induced erythrocytes lipoperoxidation and @PROTEIN$ (CAT) activity depression to control levels.	1	18754105-839
H2S can be produced from @COMPOUND$ by enzymes such as @PROTEIN$.	1	18754702-986
The influence of carbon sources on rhGH (recombinant human @PROTEIN$) production by two Pichia pastoris strains having different @COMPOUND$ utilization phenotypes (P. pastoris-hGH-Mut (+) and P. pastoris-hGH-Mut (s)) was investigated using batch bioreactors.	0	18754757-1000
The present study was undertaken to test the hypothesis that PPARalpha activator @COMPOUND$ plays a key role in left ventricular hypertrophic remodelling via the formation of c-@PROTEIN$/c-jun heterodimers in spontaneous hypertensive rats (SHRs).	1	18754816-1023
The present study was undertaken to test the hypothesis that PPARalpha activator @COMPOUND$ plays a key role in left ventricular hypertrophic remodelling via the formation of c-fos/c-@PROTEIN$ heterodimers in spontaneous hypertensive rats (SHRs).	1	18754816-1023
Effects of @COMPOUND$ ethyl ester on @PROTEIN$ and apelin in lean and overweight (cafeteria diet-fed) rats.	0	18755047-1448
Effects of eicosapentaenoic acid @COMPOUND$ on @PROTEIN$ and apelin in lean and overweight (cafeteria diet-fed) rats.	0	18755047-1448
Effects of eicosapentaenoic acid ethyl ester on @PROTEIN$ and @COMPOUND$ in lean and overweight (cafeteria diet-fed) rats.	0	18755047-1448
In the presence of AA (Fe:AA molar ratio of 1:20), significantly more Fe was absorbed from FeSO4 (about 303 %), @PROTEIN$ (about 454 %) and P-HSF (about 371 %) when compared with ferrous @COMPOUND$ or ferritin without AA.	0	18755051-1093
In the presence of AA (Fe:AA molar ratio of 1:20), significantly more Fe was absorbed from FeSO4 (about 303 %), HSF (about 454 %) and P-HSF (about 371 %) when compared with ferrous @COMPOUND$ or @PROTEIN$ without AA.	0	18755051-1093
Insulin-like growth factor-I (@PROTEIN$) is neuroprotective against @COMPOUND$-related toxicity and promotes white matter production following a number of insults.	1	18755266-1173
@PROTEIN$-like growth factor-I (IGF-I) is neuroprotective against @COMPOUND$-related toxicity and promotes white matter production following a number of insults.	1	18755266-1173
These data indicate that @PROTEIN$ may be a potential treatment for some of @COMPOUND$'s damaging effects, a finding that has important implications for children of women who drink alcohol during pregnancy.	1	18755266-1174
This study is aimed to investigate the effects of @COMPOUND$ (TEGDMA) and 2-hydroxyethyl methacrylate (HEMA) on expression of @PROTEIN$ (COX-2) and inducible nitric oxide synthase (iNOS) in cultured murine macrophage cell line RAW 264.7.	1	18755506-1246
This study is aimed to investigate the effects of @COMPOUND$ (TEGDMA) and 2-hydroxyethyl methacrylate (HEMA) on expression of cyclooxygenase-2 (@PROTEIN$) and inducible nitric oxide synthase (iNOS) in cultured murine macrophage cell line RAW 264.7.	1	18755506-1246
This study is aimed to investigate the effects of @COMPOUND$ (TEGDMA) and 2-hydroxyethyl methacrylate (HEMA) on expression of cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (@PROTEIN$) in cultured murine macrophage cell line RAW 264.7.	1	18755506-1246
This study is aimed to investigate the effects of triethyleneglycol dimethacrylate (TEGDMA) and @COMPOUND$ (HEMA) on expression of cyclooxygenase-2 (COX-2) and inducible @PROTEIN$ (iNOS) in cultured murine macrophage cell line RAW 264.7.	1	18755506-1246
This study is aimed to investigate the effects of triethyleneglycol dimethacrylate (TEGDMA) and @COMPOUND$ (HEMA) on expression of cyclooxygenase-2 (@PROTEIN$) and inducible nitric oxide synthase (iNOS) in cultured murine macrophage cell line RAW 264.7.	1	18755506-1246
This study is aimed to investigate the effects of triethyleneglycol dimethacrylate (TEGDMA) and @COMPOUND$ (HEMA) on expression of cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (@PROTEIN$) in cultured murine macrophage cell line RAW 264.7.	1	18755506-1246
This study is aimed to investigate the effects of @COMPOUND$ (TEGDMA) and 2-hydroxyethyl methacrylate (HEMA) on expression of cyclooxygenase-2 (COX-2) and inducible @PROTEIN$ (iNOS) in cultured murine macrophage cell line RAW 264.7.	1	18755506-1246
This study is aimed to investigate the effects of triethyleneglycol dimethacrylate (TEGDMA) and @COMPOUND$ (HEMA) on expression of @PROTEIN$ (COX-2) and inducible nitric oxide synthase (iNOS) in cultured murine macrophage cell line RAW 264.7.	1	18755506-1246
SWCNT coatings were thus functionalized with poly(@COMPOUND$-pyrrole) and applied to the anchoring of glucose oxidase (@PROTEIN$), modified with beta-cyclodextrin.	1	18755582-1265
SWCNT coatings were thus functionalized with poly(@COMPOUND$-pyrrole) and applied to the anchoring of @PROTEIN$ (GOX), modified with beta-cyclodextrin.	1	18755582-1265
This allows the immobilization of @COMPOUND$-tagged @PROTEIN$.	1	18755582-1266
@COMPOUND$-induced bone @PROTEIN$ (BMP) 2 expression during bone regeneration: an immunohistochemical study.	1	18755616-1270
@COMPOUND$-induced bone morphogenetic protein (@PROTEIN$) 2 expression during bone regeneration: an immunohistochemical study.	1	18755616-1270
The purpose of this study was to investigate bone morphogenetic protein (BMP) 2 expression after implantation of a @COMPOUND$ and recombinant human @PROTEIN$ (rhBMP-2) and to compare the bone regeneration capability of these substances in the rabbit nasal bone using immunohistologic methods.	1	18755616-1271
The purpose of this study was to investigate bone @PROTEIN$ (BMP) 2 expression after implantation of a @COMPOUND$ and recombinant human BMP-2 (rhBMP-2) and to compare the bone regeneration capability of these substances in the rabbit nasal bone using immunohistologic methods.	1	18755616-1271
The purpose of this study was to investigate bone morphogenetic protein (@PROTEIN$) 2 expression after implantation of a @COMPOUND$ and recombinant human BMP-2 (rhBMP-2) and to compare the bone regeneration capability of these substances in the rabbit nasal bone using immunohistologic methods.	1	18755616-1271
@COMPOUND$, a second messenger in LH signaling, was identified as a factor in hCG-dependent regulation of Cdk5/@PROTEIN$.	1	18755796-1307
@COMPOUND$, a second messenger in LH signaling, was identified as a factor in hCG-dependent regulation of @PROTEIN$/p35.	1	18755796-1307
Intracellular production of @PROTEIN$ and IL-2 after stimulation with phorbol myristate/@COMPOUND$ was flowcytometrically measured in CD4 (+) T cells from peripheral blood (PB) and cerebrospinal fluid (CSF) of 29 patients with multiple sclerosis (MS), and 16 with other inflammatory and 41 with other non-inflammatory neurological diseases.	1	18755820-1310
Intracellular production of TNFalpha and @PROTEIN$ after stimulation with @COMPOUND$ myristate/ionomycin was flowcytometrically measured in CD4 (+) T cells from peripheral blood (PB) and cerebrospinal fluid (CSF) of 29 patients with multiple sclerosis (MS), and 16 with other inflammatory and 41 with other non-inflammatory neurological diseases.	1	18755820-1310
Intracellular production of @PROTEIN$ and IL-2 after stimulation with @COMPOUND$ myristate/ionomycin was flowcytometrically measured in CD4 (+) T cells from peripheral blood (PB) and cerebrospinal fluid (CSF) of 29 patients with multiple sclerosis (MS), and 16 with other inflammatory and 41 with other non-inflammatory neurological diseases.	1	18755820-1310
Intracellular production of TNFalpha and @PROTEIN$ after stimulation with phorbol myristate/@COMPOUND$ was flowcytometrically measured in CD4 (+) T cells from peripheral blood (PB) and cerebrospinal fluid (CSF) of 29 patients with multiple sclerosis (MS), and 16 with other inflammatory and 41 with other non-inflammatory neurological diseases.	1	18755820-1310
Intracellular production of @PROTEIN$ and IL-2 after stimulation with phorbol @COMPOUND$/ionomycin was flowcytometrically measured in CD4 (+) T cells from peripheral blood (PB) and cerebrospinal fluid (CSF) of 29 patients with multiple sclerosis (MS), and 16 with other inflammatory and 41 with other non-inflammatory neurological diseases.	1	18755820-1310
Intracellular production of TNFalpha and @PROTEIN$ after stimulation with phorbol @COMPOUND$/ionomycin was flowcytometrically measured in CD4 (+) T cells from peripheral blood (PB) and cerebrospinal fluid (CSF) of 29 patients with multiple sclerosis (MS), and 16 with other inflammatory and 41 with other non-inflammatory neurological diseases.	1	18755820-1310
Although we reported that 8-Cl-cAMP induces growth inhibition via p38 mitogen-activated protein kinase (@PROTEIN$) and a metabolite of 8-Cl-cAMP, 8-Cl-@COMPOUND$ mediates this process, the action mechanism of 8-Cl-cAMP is still uncertain.	1	18756496-1463
Certain non-steroidal anti-inflammatory drugs, e.g., the @PROTEIN$-specific nonsteroidal anti-inflammatory drugs, @COMPOUND$, raise Abeta(42) levels.	1	18756527-1486
This was significantly in accordance with intracellular oxidative stress levels measured by glutathione depletion, @COMPOUND$ production, @PROTEIN$ inhibition as well as reactive oxygen species generation.	0	18756589-1515
This was significantly in accordance with intracellular oxidative stress levels measured by glutathione depletion, malondialdehyde production, @PROTEIN$ inhibition as well as reactive @COMPOUND$ species generation.	0	18756589-1515
This was significantly in accordance with intracellular oxidative stress levels measured by @COMPOUND$ depletion, malondialdehyde production, @PROTEIN$ inhibition as well as reactive oxygen species generation.	0	18756589-1515
@COMPOUND$, @PROTEIN$ and CRP as markers of silent brain infarction.	0	18757054-1690
@COMPOUND$, IL-6 and @PROTEIN$ as markers of silent brain infarction.	0	18757054-1690
We found previously that increased levels of polyamine oxidase (PAO) (acetylpolyamine oxidase (AcPAO) plus spermine oxidase (@PROTEIN$)), and @COMPOUND$ (CH(2)CHCHO) are good markers of stroke.	0	18757054-1691
We found previously that increased levels of polyamine oxidase (@PROTEIN$) (acetylpolyamine oxidase (AcPAO) plus spermine oxidase (SMO)), and @COMPOUND$ (CH(2)CHCHO) are good markers of stroke.	0	18757054-1691
We found previously that increased levels of @PROTEIN$ (PAO) (acetylpolyamine oxidase (AcPAO) plus spermine oxidase (SMO)), and @COMPOUND$ (CH(2)CHCHO) are good markers of stroke.	0	18757054-1691
We found previously that increased levels of polyamine oxidase (PAO) (acetylpolyamine oxidase (AcPAO) plus @PROTEIN$ (SMO)), and @COMPOUND$ (CH(2)CHCHO) are good markers of stroke.	0	18757054-1691
We then investigated whether silent brain infarction (SBI) can be detected by measuring @COMPOUND$, @PROTEIN$, or other biomarkers.	0	18757054-1692
It was found that the levels of protein-conjugated @COMPOUND$ (PC-Acro), @PROTEIN$ (IL-6) and C-reactive protein (CRP) were significantly higher in SBI than in normal subjects.	0	18757054-1693
It was found that the levels of protein-conjugated @COMPOUND$ (PC-Acro), interleukin-6 (@PROTEIN$) and C-reactive protein (CRP) were significantly higher in SBI than in normal subjects.	0	18757054-1693
It was found that the levels of protein-conjugated @COMPOUND$ (PC-Acro), interleukin-6 (IL-6) and C-reactive protein (@PROTEIN$) were significantly higher in SBI than in normal subjects.	0	18757054-1693
Human skin keratinocytes HaCat attacked by Staphylococcus aureus @PROTEIN$ showed a transient drop of cellular @COMPOUND$ levels whereas in toxin-perforated bovine mammary epithelial cells (BMEC), the ATP levels dropped more slowly.	1	18757097-1716
Catalepsy, serum @PROTEIN$, receptor binding profile and cortical (PFC), hippocampal (Hip) and @COMPOUND$ (DA) levels were determined.	0	18757185-1747
Estrogenic effect was determined by the change of uterine weight, and oxidant effects were determined by the content of SOD, @COMPOUND$-Px, @PROTEIN$ and MDA.	0	18757188-1748
Estrogenic effect was determined by the change of uterine weight, and oxidant effects were determined by the content of @PROTEIN$, @COMPOUND$-Px, CAT and MDA.	0	18757188-1748
The intake of formononetin increased the uterine weight of the mice significantly as well as the content of SOD, @COMPOUND$-Px, @PROTEIN$, and reduced MDA in body.	0	18757188-1749
The intake of formononetin increased the uterine weight of the mice significantly as well as the content of @PROTEIN$, @COMPOUND$-Px, CAT, and reduced MDA in body.	0	18757188-1749
A novel @COMPOUND$-specific @PROTEIN$ from Phaseolus coccineus seeds with potent antineoplastic and antifungal activities.	1	18757189-1750
A novel @PROTEIN$ (PCL) with specificity towards @COMPOUND$ was purified from Phaseolus coccineus L. (P. multiflorus willd) seeds using ion exchange chromatography on CM and DEAE-Sepharose, and gel filtration on Sephacryl S-200 column.	1	18757189-1751
The characterization for the binding of calcium and @COMPOUND$ to Euplotes octocarinatus @PROTEIN$.	1	18757233-1762
We have previously shown that ROS-induced MUC5AC expression in NHBE cells is dependent on @COMPOUND$ depolymerization and epidermal growth factor receptor (EGFR)/mitogen-activated protein kinase (@PROTEIN$) activation.	0	18757307-1779
We have previously shown that ROS-induced MUC5AC expression in NHBE cells is dependent on @COMPOUND$ depolymerization and epidermal growth factor receptor (EGFR)/@PROTEIN$ (MAPK) activation.	0	18757307-1779
We have previously shown that ROS-induced @PROTEIN$ expression in NHBE cells is dependent on @COMPOUND$ depolymerization and epidermal growth factor receptor (EGFR)/mitogen-activated protein kinase (MAPK) activation.	1	18757307-1779
We have previously shown that ROS-induced MUC5AC expression in NHBE cells is dependent on @COMPOUND$ depolymerization and @PROTEIN$ (EGFR)/mitogen-activated protein kinase (MAPK) activation.	0	18757307-1779
We have previously shown that ROS-induced MUC5AC expression in NHBE cells is dependent on @COMPOUND$ depolymerization and epidermal growth factor receptor (@PROTEIN$)/mitogen-activated protein kinase (MAPK) activation.	0	18757307-1779
Alkaline phosphatase activity and @PROTEIN$ expression of the osteoblasts cultured on the @COMPOUND$ scaffolds remained stable over three weeks, whilst expression of collagen type I and osteopontin decreased.	0	18757495-1808
@PROTEIN$ activity and osteonectin expression of the osteoblasts cultured on the @COMPOUND$ scaffolds remained stable over three weeks, whilst expression of collagen type I and osteopontin decreased.	0	18757495-1808
The @PROTEIN$ activity of osteoblasts cultured on @COMPOUND$ scaffolds is comparable with that from two commercially-available scaffolds-OPLA and collagen scaffolds (Becton-Dickinson (BD) Inc., Franklin Lakes, NJ, USA).	0	18757495-1809
The vasodilating effect of @COMPOUND$ and dorzolamide involves mechanisms other than @PROTEIN$ inhibition.	0	18757514-1816
The vasodilating effect of acetazolamide and @COMPOUND$ involves mechanisms other than @PROTEIN$ inhibition.	0	18757514-1816
The objective of the present study was to investigate the effects of a high-@COMPOUND$ diet on @PROTEIN$ expression and IR localization and activity in the rat liver.	1	18757837-1932
@PROTEIN$ and P53 play important roles in the signal transduction leading to neointimal growth inhibition and induction of apoptosis of smooth muscle cells due to rapamycin and @COMPOUND$.	1	18758183-2073
P27 and @PROTEIN$ play important roles in the signal transduction leading to neointimal growth inhibition and induction of apoptosis of smooth muscle cells due to @COMPOUND$ and paclitaxel.	1	18758183-2073
@PROTEIN$ and P53 play important roles in the signal transduction leading to neointimal growth inhibition and induction of apoptosis of smooth muscle cells due to @COMPOUND$ and paclitaxel.	1	18758183-2073
P27 and @PROTEIN$ play important roles in the signal transduction leading to neointimal growth inhibition and induction of apoptosis of smooth muscle cells due to rapamycin and @COMPOUND$.	1	18758183-2073
Immobilization of @PROTEIN$ on the @COMPOUND$ modified pretreated glassy carbon electrode for preparing a novel hydrogen peroxide biosensor.	1	18758695-2200
A novel hydrogen peroxide (H2O2) biosensor was developed by immobilizing @PROTEIN$ on the @COMPOUND$ modified electrochemical pretreated glassy carbon electrode (PGCE) via the bridging of an ethylenediamine monolayer.	1	18758695-2201
Involvement of @PROTEIN$ in TPA-potentiated apoptosis induction during @COMPOUND$-mediated erythroid differentiation in K562 cells.	0	18758751-2238
To better understand the mechanisms underlying differentiation-mediated regulation of apoptosis, we have studied the effects of @PROTEIN$ pathway with an activator of the protein kinase C, 12-O-tetradecanoylphorbol-13-acetate (TPA), during @COMPOUND$-induced erythroid differentiation of K562 erythroleukemia cells.	0	18758751-2239
To better understand the mechanisms underlying differentiation-mediated regulation of apoptosis, we have studied the effects of @PROTEIN$ pathway with an activator of the protein kinase C, @COMPOUND$ (TPA), during hemin-induced erythroid differentiation of K562 erythroleukemia cells.	1	18758751-2239
Taken together, our results suggested the involvement of @PROTEIN$ in TPA-potentiated apoptosis induction during @COMPOUND$-mediated erythroid differentiation in K562 cells.	0	18758751-2244
At glutamatergic synapses, increased binding to the @COMPOUND$-B site located in the @PROTEIN$ (NMDAR) can enhance neurotransmission via NMDARs.	1	18758757-2247
The most common adverse events were mild and transient gastrointestinal disturbances, skin rash, nonprogressive transient increases in serum @COMPOUND$ and urine @PROTEIN$, and a temporary reduction of the creatinine clearance.	0	18758781-2256
In vitro effect of radiation, antibody to epidermal growth factor receptor and @COMPOUND$ in human head and neck squamous carcinoma cells with mutant @PROTEIN$ and over-expressed EGFR.	1	18758819-2275
In vitro effect of radiation, antibody to epidermal growth factor receptor and @COMPOUND$ in human head and neck squamous carcinoma cells with mutant P53 and over-expressed @PROTEIN$.	1	18758819-2275
In vitro effect of radiation, antibody to @PROTEIN$ and @COMPOUND$ in human head and neck squamous carcinoma cells with mutant P53 and over-expressed EGFR.	0	18758819-2275
The optimal condition for the labeling of cypate to @PROTEIN$ was 4 h reaction duration at 4 degrees C and pH 8.5 under catalysis by HOBt/@COMPOUND$.	1	18758925-2312
The optimal condition for the labeling of cypate to @PROTEIN$ was 4 h reaction duration at 4 degrees C and pH 8.5 under catalysis by @COMPOUND$/HBTU.	1	18758925-2312
Effects of insulin and @COMPOUND$ on expression of @PROTEIN$ family proteins and caspase-3 activity in hippocampus of diabetic rats were evaluated in this study.	1	18758938-2315
Effects of @PROTEIN$ and @COMPOUND$ on expression of Bcl-2 family proteins and caspase-3 activity in hippocampus of diabetic rats were evaluated in this study.	0	18758938-2315
Chemo-enzymatic synthesis of poly-N-acetyllactosamine (poly-@COMPOUND$) structures and their characterization for @PROTEIN$-galectin-mediated binding of ECM glycoproteins to biomaterial surfaces.	1	18758940-2316
Chemo-enzymatic synthesis of @COMPOUND$ (poly-LacNAc) structures and their characterization for CGL2-@PROTEIN$-mediated binding of ECM glycoproteins to biomaterial surfaces.	1	18758940-2316
Chemo-enzymatic synthesis of poly-N-acetyllactosamine (poly-@COMPOUND$) structures and their characterization for CGL2-@PROTEIN$-mediated binding of ECM glycoproteins to biomaterial surfaces.	1	18758940-2316
Chemo-enzymatic synthesis of @COMPOUND$ (poly-LacNAc) structures and their characterization for @PROTEIN$-galectin-mediated binding of ECM glycoproteins to biomaterial surfaces.	1	18758940-2316
Chemo-enzymatic synthesis of poly-N-acetyllactosamine (poly-@COMPOUND$) structures and their characterization for CGL2-galectin-mediated binding of ECM @PROTEIN$ to biomaterial surfaces.	1	18758940-2316
Chemo-enzymatic synthesis of @COMPOUND$ (poly-LacNAc) structures and their characterization for CGL2-galectin-mediated binding of ECM @PROTEIN$ to biomaterial surfaces.	1	18758940-2316
@COMPOUND$ (poly-LacNAc) structures have been identified as important ligands for @PROTEIN$-mediated cell adhesion to extra-cellular matrix (ECM) proteins.	1	18758940-2317
Poly-N-acetyllactosamine (poly-@COMPOUND$) structures have been identified as important ligands for @PROTEIN$-mediated cell adhesion to extra-cellular matrix (ECM) proteins.	1	18758940-2317
We here present the biofunctionalization of surfaces with poly-@COMPOUND$ structures and subsequent binding of ECM @PROTEIN$.	1	18758940-2318
A mixture of poly-@COMPOUND$-structures covalently coupled to functionalized microtiter plates were identified for best binding to our model galectin His(6) @PROTEIN$.	1	18758940-2319
A mixture of poly-@COMPOUND$-structures covalently coupled to functionalized microtiter plates were identified for best binding to our model @PROTEIN$ His(6) CGL2.	1	18758940-2319
We further demonstrate for the first time that these poly-@COMPOUND$ surfaces are suitable for further @PROTEIN$-mediated binding of the ECM glycoproteins laminin and fibronectin.	1	18758940-2320
We further demonstrate for the first time that these poly-@COMPOUND$ surfaces are suitable for further galectin-mediated binding of the ECM glycoproteins laminin and @PROTEIN$.	1	18758940-2320
We further demonstrate for the first time that these poly-@COMPOUND$ surfaces are suitable for further galectin-mediated binding of the ECM @PROTEIN$ laminin and fibronectin.	1	18758940-2320
We further demonstrate for the first time that these poly-@COMPOUND$ surfaces are suitable for further galectin-mediated binding of the @PROTEIN$ glycoproteins laminin and fibronectin.	1	18758940-2320
Seasonal variation of the metal (Zn, Fe, @COMPOUND$) and @PROTEIN$ concentrations in the liver cytosol of the European chub (Squalius cephalus L.).	0	18758978-2339
The specimens caught in the spring period had higher biometric (liver mass, condition and hepatosomatic indices) and some biochemical parameters (@PROTEIN$ (MT) and @COMPOUND$) that are characteristic for the reproductive period.	0	18758978-2340
@PROTEIN$ (GAD) is the rate-limiting enzyme in the synthesis of gamma-aminobutyric acid (@COMPOUND$), the most important inhibitory neurotransmitter in central nervous system (CNS).	1	18758993-2343
Glutamate decarboxylase (@PROTEIN$) is the rate-limiting enzyme in the synthesis of @COMPOUND$ (GABA), the most important inhibitory neurotransmitter in central nervous system (CNS).	1	18758993-2343
Glutamate decarboxylase (@PROTEIN$) is the rate-limiting enzyme in the synthesis of gamma-aminobutyric acid (@COMPOUND$), the most important inhibitory neurotransmitter in central nervous system (CNS).	1	18758993-2343
@PROTEIN$ (GAD) is the rate-limiting enzyme in the synthesis of @COMPOUND$ (GABA), the most important inhibitory neurotransmitter in central nervous system (CNS).	1	18758993-2343
These transcripts were predicted to synthesis of @PROTEIN$ proteins truncated of the binding site for @COMPOUND$, an essential cofactor, therefore cannot function as a decarboxylase.	1	18758993-2344
Loss-of-expression of @PROTEIN$ in tumor tissues has been suggested to correlate with tumor progression and to the relatively poorer outcomes of @COMPOUND$ analog treatment in some clinical trials.	1	18759148-2382
@COMPOUND$ (CVF) is a structural and functional analog of @PROTEIN$ isolated from cobra venom.	1	18760301-213
Activities of malate- and succinate-dehydrogenases (MDH, @PROTEIN$) and NADH- and succinate-cytochrome c reductases (NCCR, SCCR) were rapidly inhibited, while cytochrome c oxidase (CCO) was unaltered by @COMPOUND$ treatment.	1	18760497-301
Activities of malate- and succinate-dehydrogenases (@PROTEIN$, SDH) and NADH- and succinate-cytochrome c reductases (NCCR, SCCR) were rapidly inhibited, while cytochrome c oxidase (CCO) was unaltered by @COMPOUND$ treatment.	1	18760497-301
However, this stimulated the NADPH-generating enzyme activities of the @COMPOUND$ phosphate pathway, glucose-6-phosphate- and 6-phosphogluconate-dehydrogenases (G6PDH, 6PGDH), as well as enzyme activity of fermentation, @PROTEIN$ (ADH), with concomitant inhibition in the capacity of enzyme inactivator (INADH).	0	18760497-302
However, this stimulated the NADPH-generating enzyme activities of the @COMPOUND$ phosphate pathway, glucose-6-phosphate- and 6-phosphogluconate-dehydrogenases (@PROTEIN$, 6PGDH), as well as enzyme activity of fermentation, alcohol dehydrogenase (ADH), with concomitant inhibition in the capacity of enzyme inactivator (INADH).	0	18760497-302
However, this stimulated the NADPH-generating enzyme activities of the @COMPOUND$ phosphate pathway, glucose-6-phosphate- and 6-phosphogluconate-dehydrogenases (G6PDH, 6PGDH), as well as enzyme activity of fermentation, alcohol dehydrogenase (@PROTEIN$), with concomitant inhibition in the capacity of enzyme inactivator (INADH).	0	18760497-302
We also examined cellular impedance responsiveness of PC 12 cells in response to phenotypic alteration especially with regard to modulation of ion fluxes using nerve growth factor (@PROTEIN$), dexamethasone and @COMPOUND$.	0	18760912-456
We also examined cellular impedance responsiveness of PC 12 cells in response to phenotypic alteration especially with regard to modulation of ion fluxes using nerve growth factor (@PROTEIN$), @COMPOUND$ and forskolin.	0	18760912-456
This paper investigates the effect of sterilisation by gamma irradiation (dose 2.5Mrad) on the following properties of @COMPOUND$ (PCL): (1) degradation rate (catalysed by @PROTEIN$), (2) mechanical properties, (3) the ability of cells to attach and subsequently grow on its surface.	1	18760952-480
Specifically, animals were exposed to one of five dipsetic stimuli: (1) 24-h water deprivation, (2) replacement of drinking water with 2.5% @COMPOUND$, (3) peripheral administration of hypertonic saline, (4) ICV injection of angiotensin II (@PROTEIN$), or (5) the combination of peripheral hypertonic saline and central AngII.	0	18761029-495
Specifically, animals were exposed to one of five dipsetic stimuli: (1) 24-h water deprivation, (2) replacement of drinking water with 2.5% @COMPOUND$, (3) peripheral administration of hypertonic saline, (4) ICV injection of @PROTEIN$ (AngII), or (5) the combination of peripheral hypertonic saline and central AngII.	0	18761029-495
We therefore propose @COMPOUND$-dependent homodimerization to be an essential step in the regulation of @PROTEIN$-dependent transcription.	1	18761103-512
In order to investigate the role of spinal @PROTEIN$ in the phenomenon of @COMPOUND$-precipitated withdrawal we examined the effect of herpes simplex virus vector-mediated overexpression of proenkephalin in lumbar dorsal root ganglia in rats with neuropathic pain treated with morphine.	1	18761380-599
The @PROTEIN$ were isolated by @COMPOUND$ treatment of crude extracts followed by chromatography on chitin.	1	18761426-612
One hundred and forty-four HCV-2- and HCV-3-infected patients initiated Peg-@PROTEIN$-2a (180 microg/week) and @COMPOUND$ (1000 or 1200 mg/day); those with viral clearance at week 4 were randomized to either Peg-IFN alpha-2a monotherapy (n = 59) or continuing combination therapy (n = 61) until week 12.	0	18761603-651
Thus in HCV-2- and HCV-3-infected patients, withdrawal of @COMPOUND$ and continuation of Peg-@PROTEIN$-2a monotherapy may be appropriate to attain an SVR, providing viraemia is cleared early during therapy and associated with low baseline viral load.	0	18761603-652
The @PROTEIN$-deficient mouse, which develops atherosclerotic lesions rapidly when fed @COMPOUND$, was used to determine the ability of dried plums to reduce atherosclerosis.	0	18761779-682
Urinary @COMPOUND$-reactive substances (TBARS) excretion and serum amyloid P-component (@PROTEIN$) were measured as indicators of oxidative stress and inflammation, respectively.	0	18761779-683
Urinary @COMPOUND$-reactive substances (TBARS) excretion and @PROTEIN$ (SAP) were measured as indicators of oxidative stress and inflammation, respectively.	0	18761779-683
Inhibition in the brain is dominated by the neurotransmitter @COMPOUND$ (GABA); operating through @PROTEIN$.	1	18762200-801
Inhibition in the brain is dominated by the neurotransmitter gamma-aminobutyric acid (@COMPOUND$); operating through @PROTEIN$.	1	18762200-801
Thus, in keeping with the ability of neurosteroids to potentiate @COMPOUND$ currents via a broad variety of @PROTEIN$ isoforms in neurons, the potentiation site is structurally highly conserved on this important neurotransmitter receptor family.	1	18762201-805
The 5-HT2AR response dominated the @PROTEIN$ signaling pathway when co-expressed with 5-HT1AR, and diminution of the response by the 5-HT2AR antagonist @COMPOUND$ could not be rescued by the 5-HT1AR agonist.	1	18762202-807
The inhibitors include mitogen-inducible gene-6 (@PROTEIN$)/receptor-associated late transducer (RALT)/Gene 33, fibroblast growth factor receptor substrate 2beta (FRS2beta)/suc1-associated neurotrophic factor target-2 (SNT-2)/FRS3, suppressor of cytokine signaling 3 (SOCS3)/SOCS4/SOCS5, and @COMPOUND$-rich repeats and immunoglobulin-like domains 1 (LRIG1).	0	18762271-826
The inhibitors include mitogen-inducible gene-6 (Mig-6)/receptor-associated late transducer (RALT)/Gene 33, fibroblast growth factor receptor substrate 2beta (FRS2beta)/suc1-associated neurotrophic factor target-2 (SNT-2)/FRS3, suppressor of cytokine signaling 3 (SOCS3)/SOCS4/SOCS5, and @COMPOUND$-rich repeats and immunoglobulin-like domains 1 (@PROTEIN$).	0	18762271-826
The inhibitors include mitogen-inducible gene-6 (Mig-6)/receptor-associated late transducer (RALT)/Gene 33, fibroblast growth factor receptor substrate 2beta (FRS2beta)/suc1-associated neurotrophic factor target-2 (SNT-2)/FRS3, suppressor of cytokine signaling 3 (SOCS3)/@PROTEIN$/SOCS5, and @COMPOUND$-rich repeats and immunoglobulin-like domains 1 (LRIG1).	0	18762271-826
The inhibitors include mitogen-inducible gene-6 (Mig-6)/receptor-associated late transducer (RALT)/Gene 33, fibroblast growth factor receptor substrate 2beta (FRS2beta)/suc1-associated neurotrophic factor target-2 (SNT-2)/FRS3, suppressor of cytokine signaling 3 (SOCS3)/SOCS4/@PROTEIN$, and @COMPOUND$-rich repeats and immunoglobulin-like domains 1 (LRIG1).	0	18762271-826
The inhibitors include mitogen-inducible gene-6 (Mig-6)/receptor-associated late transducer (RALT)/Gene 33, fibroblast growth factor receptor substrate 2beta (FRS2beta)/suc1-associated neurotrophic factor target-2 (SNT-2)/FRS3, @PROTEIN$ (SOCS3)/SOCS4/SOCS5, and @COMPOUND$-rich repeats and immunoglobulin-like domains 1 (LRIG1).	0	18762271-826
The inhibitors include mitogen-inducible gene-6 (Mig-6)/receptor-associated late transducer (RALT)/Gene 33, fibroblast growth factor receptor substrate 2beta (FRS2beta)/suc1-associated neurotrophic factor target-2 (@PROTEIN$)/FRS3, suppressor of cytokine signaling 3 (SOCS3)/SOCS4/SOCS5, and @COMPOUND$-rich repeats and immunoglobulin-like domains 1 (LRIG1).	0	18762271-826
The inhibitors include mitogen-inducible gene-6 (Mig-6)/receptor-associated late transducer (RALT)/Gene 33, fibroblast growth factor receptor substrate 2beta (FRS2beta)/suc1-associated neurotrophic factor target-2 (SNT-2)/@PROTEIN$, suppressor of cytokine signaling 3 (SOCS3)/SOCS4/SOCS5, and @COMPOUND$-rich repeats and immunoglobulin-like domains 1 (LRIG1).	0	18762271-826
The inhibitors include mitogen-inducible gene-6 (Mig-6)/receptor-associated late transducer (RALT)/Gene 33, fibroblast growth factor receptor substrate 2beta (FRS2beta)/@PROTEIN$ (SNT-2)/FRS3, suppressor of cytokine signaling 3 (SOCS3)/SOCS4/SOCS5, and @COMPOUND$-rich repeats and immunoglobulin-like domains 1 (LRIG1).	0	18762271-826
The inhibitors include mitogen-inducible gene-6 (Mig-6)/receptor-associated late transducer (RALT)/Gene 33, fibroblast growth factor receptor substrate 2beta (FRS2beta)/suc1-associated neurotrophic factor target-2 (SNT-2)/FRS3, suppressor of cytokine signaling 3 (@PROTEIN$)/SOCS4/SOCS5, and @COMPOUND$-rich repeats and immunoglobulin-like domains 1 (LRIG1).	0	18762271-826
The inhibitors include mitogen-inducible gene-6 (Mig-6)/receptor-associated late transducer (RALT)/Gene 33, fibroblast growth factor receptor substrate 2beta (@PROTEIN$)/suc1-associated neurotrophic factor target-2 (SNT-2)/FRS3, suppressor of cytokine signaling 3 (SOCS3)/SOCS4/SOCS5, and @COMPOUND$-rich repeats and immunoglobulin-like domains 1 (LRIG1).	0	18762271-826
Novel homo- and hetero-nuclear @COMPOUND$ (II) complexes of tetradentate Schiff bases: synthesis, characterization, solvent-extraction and @PROTEIN$-like activity studies.	1	18762369-869
In streptozotocin-nicotinamide-induced diabetic mice, ASP8497 was administered orally for 3 weeks at 1, 3, or 10 mg/kg once daily, which improved the hemoglobin A (1c), non-fasting plasma @PROTEIN$, fasting blood @COMPOUND$ levels, glucose intolerance, and lipid profiles (plasma triglyceride, non-esterified fatty acid and total cholesterol) with neutral effect on body weight.	0	18762913-991
In streptozotocin-nicotinamide-induced diabetic mice, ASP8497 was administered orally for 3 weeks at 1, 3, or 10 mg/kg once daily, which improved the @PROTEIN$ (1c), non-fasting plasma insulin, fasting blood @COMPOUND$ levels, glucose intolerance, and lipid profiles (plasma triglyceride, non-esterified fatty acid and total cholesterol) with neutral effect on body weight.	0	18762913-991
In streptozotocin-nicotinamide-induced diabetic mice, ASP8497 was administered orally for 3 weeks at 1, 3, or 10 mg/kg once daily, which improved the @PROTEIN$ (1c), non-fasting plasma insulin, fasting blood glucose levels, glucose intolerance, and lipid profiles (plasma triglyceride, non-esterified fatty acid and total @COMPOUND$) with neutral effect on body weight.	0	18762913-991
In streptozotocin-nicotinamide-induced diabetic mice, ASP8497 was administered orally for 3 weeks at 1, 3, or 10 mg/kg once daily, which improved the hemoglobin A (1c), non-fasting plasma @PROTEIN$, fasting blood glucose levels, glucose intolerance, and lipid profiles (plasma triglyceride, non-esterified fatty acid and total @COMPOUND$) with neutral effect on body weight.	0	18762913-991
The laboratory findings of the cases were compatible with VDDR; serum calcium (Ca) 7.5+/-1.9 mg/dL, PO4 4.4+/-1.3 mg/dL, alkaline phosphatase (@PROTEIN$) 1,341+/-823, @COMPOUND$ (25 (OH) D) 5.8+/-2.9 ng/mL, intact parathyroid hormone (iPTH) 240+/-106 pg/mL.	0	18762977-1011
The laboratory findings of the cases were compatible with VDDR; serum calcium (Ca) 7.5+/-1.9 mg/dL, PO4 4.4+/-1.3 mg/dL, @PROTEIN$ (ALP) 1,341+/-823, @COMPOUND$ (25 (OH) D) 5.8+/-2.9 ng/mL, intact parathyroid hormone (iPTH) 240+/-106 pg/mL.	0	18762977-1011
The laboratory findings of the cases were compatible with VDDR; serum calcium (Ca) 7.5+/-1.9 mg/dL, @COMPOUND$ 4.4+/-1.3 mg/dL, alkaline phosphatase (@PROTEIN$) 1,341+/-823, 25-hydroxyvitamin D (25 (OH) D) 5.8+/-2.9 ng/mL, intact parathyroid hormone (iPTH) 240+/-106 pg/mL.	0	18762977-1011
The laboratory findings of the cases were compatible with VDDR; serum calcium (Ca) 7.5+/-1.9 mg/dL, @COMPOUND$ 4.4+/-1.3 mg/dL, @PROTEIN$ (ALP) 1,341+/-823, 25-hydroxyvitamin D (25 (OH) D) 5.8+/-2.9 ng/mL, intact parathyroid hormone (iPTH) 240+/-106 pg/mL.	0	18762977-1011
There are no controlled trials comparing @PROTEIN$ and @COMPOUND$ efficacy and therapeutic mechanisms in psoriasis.	0	18763027-1031
Oral immunogenicity and protective efficacy in mice of transgenic rice plants producing a vaccine candidate antigen (@COMPOUND$) of Ascaris suum fused with cholera @PROTEIN$ subunit.	0	18763047-1035
Inhibition of human poly(A)-specific @PROTEIN$ (PARN) by @COMPOUND$ nucleotides: kinetic analysis.	1	18763168-1076
Inhibition of human poly(A)-specific ribonuclease (@PROTEIN$) by @COMPOUND$ nucleotides: kinetic analysis.	1	18763168-1076
The aqueous extract was found to be more effective than @COMPOUND$, a classical anticarcinogenic drug, with respect to its action on antioxidant enzymes and @PROTEIN$ in the liver of mice with developing lymphomas.	1	18764779-1509
Cu,Zn-@PROTEIN$-driven free radical modifications: @COMPOUND$- and carbonate radical anion-initiated protein radical chemistry.	0	18764780-1510
The understanding of the mechanism, oxidant(s) involved and how and what protein radicals are produced during the reaction of wild-type @PROTEIN$ (Cu,Zn-superoxide dismutase) with @COMPOUND$ and their fate is incomplete, but a better understanding of the role of this reaction is needed.	1	18764780-1511
The understanding of the mechanism, oxidant(s) involved and how and what protein radicals are produced during the reaction of wild-type SOD1 (Cu,Zn-@PROTEIN$) with @COMPOUND$ and their fate is incomplete, but a better understanding of the role of this reaction is needed.	1	18764780-1511
In the absence of (bi)carbonate, site-specific radical-mediated fragmentation is produced by @PROTEIN$ active-site @COMPOUND$.	1	18764780-1512
Finally, we propose a biochemical mechanism to explain CO(*-) production from CO2, enhanced protein radical formation and protection by (bi)carbonate against @COMPOUND$-induced fragmentation of the @PROTEIN$ active site.	1	18764780-1513
Furthermore, lysosomal integrity was disrupted after addition of clioquinol and zinc to the cells, as shown by redistribution of both Acridine Orange and cathepsin D. @COMPOUND$ plus zinc resulted in a cleavage of Bid (@PROTEIN$), a hallmark of lysosome-mediated apoptotic cell death.	1	18764784-1516
Furthermore, lysosomal integrity was disrupted after addition of @COMPOUND$ and zinc to the cells, as shown by redistribution of both Acridine Orange and cathepsin D. Clioquinol plus zinc resulted in a cleavage of Bid (@PROTEIN$), a hallmark of lysosome-mediated apoptotic cell death.	1	18764784-1516
Furthermore, lysosomal integrity was disrupted after addition of clioquinol and zinc to the cells, as shown by redistribution of both @COMPOUND$ and cathepsin D. Clioquinol plus zinc resulted in a cleavage of Bid (@PROTEIN$), a hallmark of lysosome-mediated apoptotic cell death.	0	18764784-1516
Imidazoline-induced amplification of glucose- and @COMPOUND$-stimulated @PROTEIN$ release includes a marked suppression of islet nitric oxide generation in the mouse.	1	18764864-1538
Imidazoline-induced amplification of @COMPOUND$- and carbachol-stimulated @PROTEIN$ release includes a marked suppression of islet nitric oxide generation in the mouse.	1	18764864-1538
@COMPOUND$-induced amplification of glucose- and carbachol-stimulated @PROTEIN$ release includes a marked suppression of islet nitric oxide generation in the mouse.	1	18764864-1538
The picture of signalling mechanisms underlying the wound-regulated FAD7 expression, and potential roles of @PROTEIN$ proteins as attenuators of wound-induced @COMPOUND$ biosynthesis, are discussed.	0	18764923-1564
The picture of signalling mechanisms underlying the wound-regulated @PROTEIN$ expression, and potential roles of CPL proteins as attenuators of wound-induced @COMPOUND$ biosynthesis, are discussed.	0	18764923-1564
KiSS-1 mRNA was significantly increased by seizure activity in rats and when neuronal activity in organotypic hippocampal slice cultures was enhanced by kainate or @COMPOUND$, while mRNA for @PROTEIN$ remained essentially unchanged.	0	18765263-1705
KiSS-1 mRNA was significantly increased by seizure activity in rats and when neuronal activity in organotypic hippocampal slice cultures was enhanced by @COMPOUND$ or picrotoxin, while mRNA for @PROTEIN$ remained essentially unchanged.	0	18765263-1705
In permeabilized muscle fibers, we observed, a strong inhibition of both state 3 mitochondrial respiration and functionally isolated maximal cytochrome c oxidase (@PROTEIN$) activity after 49 days of @COMPOUND$ exposure.	1	18765295-1718
In permeabilized muscle fibers, we observed, a strong inhibition of both state 3 mitochondrial respiration and functionally isolated maximal @PROTEIN$ oxidase (COX) activity after 49 days of @COMPOUND$ exposure.	1	18765295-1718
The dominant positive regulator of mTORC1 is the @COMPOUND$-charged form of the @PROTEIN$-like GTPase Rheb.	1	18765678-1803
The dominant positive regulator of mTORC1 is the @COMPOUND$-charged form of the ras-like GTPase @PROTEIN$.	1	18765678-1803
In contrast, amino acids, especially leucine, regulate mTORC1 by controlling the ability of @PROTEIN$-@COMPOUND$ to activate mTORC1.	1	18765678-1804
@COMPOUND$, hematocrit, blood urea nitrogen, total protein, albumin, @PROTEIN$ 0.05) after transport regardless of space allowance.	0	18765850-1867
At 2 h in suspension, keratinocytes that had become committed to terminal differentiation had increased side scatter, were @COMPOUND$ (7-@PROTEIN$) positive and annexin V negative; they exhibited loss of mitochondrial membrane potential and increased cardiolipin oxidation, but with no increase in reactive oxygen species.	0	18766172-2008
At 2 h in suspension, keratinocytes that had become committed to terminal differentiation had increased side scatter, were @COMPOUND$ (7-AAD) positive and @PROTEIN$ negative; they exhibited loss of mitochondrial membrane potential and increased cardiolipin oxidation, but with no increase in reactive oxygen species.	0	18766172-2008
"Iron uptake by the ubiquitous iron-storage protein ferritin involves the oxidation of two @COMPOUND$) ions located at the highly conserved dinuclear "" @PROTEIN$ centre"" in individual subunits."	1	18766385-2075
"Iron uptake by the ubiquitous iron-storage protein @PROTEIN$ involves the oxidation of two @COMPOUND$) ions located at the highly conserved dinuclear "" ferroxidase centre"" in individual subunits."	1	18766385-2075
We have measured X-ray absorption spectra of four mutants (K86Q, K86Q/E27D, K86Q/E107D, and K86Q/E27D/E107D, involving variations of Glu to Asp on either or both sides of the dinuclear ferroxidase site) of recombinant human H-chain @PROTEIN$ (rHuHF) in their complexes with reactive Fe(II) and redox-inactive @COMPOUND$).	1	18766385-2076
We have measured X-ray absorption spectra of four mutants (K86Q, K86Q/E27D, K86Q/E107D, and K86Q/E27D/E107D, involving variations of Glu to Asp on either or both sides of the dinuclear @PROTEIN$ site) of recombinant human H-chain ferritin (rHuHF) in their complexes with reactive @COMPOUND$) and redox-inactive Zn(II).	1	18766385-2076
We have measured X-ray absorption spectra of four mutants (K86Q, K86Q/E27D, K86Q/E107D, and K86Q/E27D/E107D, involving variations of Glu to Asp on either or both sides of the dinuclear @PROTEIN$ site) of recombinant human H-chain ferritin (rHuHF) in their complexes with reactive Fe(II) and redox-inactive @COMPOUND$).	1	18766385-2076
We have measured X-ray absorption spectra of four mutants (K86Q, K86Q/E27D, K86Q/E107D, and K86Q/E27D/E107D, involving variations of Glu to Asp on either or both sides of the dinuclear ferroxidase site) of recombinant human H-chain @PROTEIN$ (rHuHF) in their complexes with reactive @COMPOUND$) and redox-inactive Zn(II).	1	18766385-2076
The aim of this study was to determine the effect of @COMPOUND$ on endothelial function in anti-tumour necrosis factor (@PROTEIN$)-naive RA patients.	1	18766955-2250
Compared with nonperfused constructs, flow perfused constructs demonstrated improved cells proliferation and differentiation according to cell viability, @COMPOUND$ consumption, @PROTEIN$ activity, and osteopontin.	0	18767058-2287
Behavior of rat periodontal ligament cells on @PROTEIN$-immobilized @COMPOUND$ surfaces treated by plasma modification.	1	18767059-2288
The aim of this study was to investigate the behavior of rat periodontal ligament (PDL) cells cultured on fibroblast growth factor-2 (@PROTEIN$)-immobilized titanium surfaces treated by @COMPOUND$ (O2) plasma.	1	18767059-2289
The aim of this study was to investigate the behavior of rat periodontal ligament (PDL) cells cultured on fibroblast growth factor-2 (@PROTEIN$)-immobilized titanium surfaces treated by oxygen (@COMPOUND$) plasma.	1	18767059-2289
The aim of this study was to investigate the behavior of rat periodontal ligament (PDL) cells cultured on @PROTEIN$ (FGF-2)-immobilized titanium surfaces treated by @COMPOUND$ (O2) plasma.	1	18767059-2289
The aim of this study was to investigate the behavior of rat periodontal ligament (PDL) cells cultured on fibroblast growth factor-2 (@PROTEIN$)-immobilized @COMPOUND$ surfaces treated by oxygen (O2) plasma.	1	18767059-2289
The aim of this study was to investigate the behavior of rat periodontal ligament (PDL) cells cultured on @PROTEIN$ (FGF-2)-immobilized titanium surfaces treated by oxygen (@COMPOUND$) plasma.	1	18767059-2289
The aim of this study was to investigate the behavior of rat periodontal ligament (PDL) cells cultured on @PROTEIN$ (FGF-2)-immobilized @COMPOUND$ surfaces treated by oxygen (O2) plasma.	1	18767059-2289
These were treated with @COMPOUND$ plasma and dipped in @PROTEIN$ solution.	0	18767059-2290
Cells from fourth subculture were seeded onto the @PROTEIN$-immobilized @COMPOUND$ surface.	1	18767059-2291
These findings suggest that @COMPOUND$ plasma modification can immobilize @PROTEIN$ onto a titanium surface.	1	18767059-2292
These findings suggest that oxygen plasma modification can immobilize @PROTEIN$ onto a @COMPOUND$ surface.	1	18767059-2292
One of the best triads for bone engineering is bone marrow stromal cells, @COMPOUND$ ceramics, and bone @PROTEIN$ (BMP).	0	18767063-2297
One of the best triads for bone engineering is bone marrow stromal cells, @COMPOUND$ ceramics, and bone morphogenetic protein (@PROTEIN$).	0	18767063-2297
The cells were mixed with @COMPOUND$ (beta-TCP) granules followed by osteoblast induction with recombinant human @PROTEIN$ (rhBMP-2) (first mixture), or were first induced with rhBMP-2 on plastic dishes and then mixed with the beta-TCP granules (last mixture) just prior to the operation.	0	18767063-2298
Effect of short-time exposures to @COMPOUND$ and lead on brain @PROTEIN$ from Danio rerio and Poecilia reticulata.	1	18767136-1171
The aim of this work was to verify, in two small size freshwater teleosts Danio rerio and Poecilia reticulata, the effects of short-time exposures (24 and 72 h) to a sublethal dose (500 microg/L) of @COMPOUND$ and lead, on brain monoamine oxidase (@PROTEIN$), an important neural enzyme.	1	18767136-1172
The aim of this work was to verify, in two small size freshwater teleosts Danio rerio and Poecilia reticulata, the effects of short-time exposures (24 and 72 h) to a sublethal dose (500 microg/L) of @COMPOUND$ and lead, on brain @PROTEIN$ (MAO), an important neural enzyme.	1	18767136-1172
Methylene@COMPOUND$ dehydrogenase) @PROTEIN$) formyltetrahydrofolate synthetase (MTHFD1) is a trifunctional enzyme that interconverts tetrahydrofolate (THF) derivatives for nucleotide synthesis.	1	18767138-2325
Methylene@COMPOUND$ dehydrogenase) methenyltetrahydrofolate cyclohydrolase) formyltetrahydrofolate synthetase (@PROTEIN$) is a trifunctional enzyme that interconverts tetrahydrofolate (THF) derivatives for nucleotide synthesis.	1	18767138-2325
Methylene@COMPOUND$ dehydrogenase) methenyltetrahydrofolate cyclohydrolase) @PROTEIN$ (MTHFD1) is a trifunctional enzyme that interconverts tetrahydrofolate (THF) derivatives for nucleotide synthesis.	1	18767138-2325
An oncogenetic tree model was built using data on mutations of TP53, KRAS2, APC, and @PROTEIN$ genes, methylation at @COMPOUND$ sites of MLH1 and TP16 genes, methylation in tumor (MINT) markers, and microsatellite instability (MSI) for 971 colon tumors from a population-based series.	0	18767147-1187
An oncogenetic tree model was built using data on mutations of TP53, KRAS2, @PROTEIN$, and BRAF genes, methylation at @COMPOUND$ sites of MLH1 and TP16 genes, methylation in tumor (MINT) markers, and microsatellite instability (MSI) for 971 colon tumors from a population-based series.	0	18767147-1187
An oncogenetic tree model was built using data on mutations of TP53, KRAS2, APC, and BRAF genes, methylation at @COMPOUND$ sites of @PROTEIN$ and TP16 genes, methylation in tumor (MINT) markers, and microsatellite instability (MSI) for 971 colon tumors from a population-based series.	1	18767147-1187
An oncogenetic tree model was built using data on mutations of TP53, @PROTEIN$, APC, and BRAF genes, methylation at @COMPOUND$ sites of MLH1 and TP16 genes, methylation in tumor (MINT) markers, and microsatellite instability (MSI) for 971 colon tumors from a population-based series.	0	18767147-1187
An oncogenetic tree model was built using data on mutations of @PROTEIN$, KRAS2, APC, and BRAF genes, methylation at @COMPOUND$ sites of MLH1 and TP16 genes, methylation in tumor (MINT) markers, and microsatellite instability (MSI) for 971 colon tumors from a population-based series.	0	18767147-1187
We characterized this selenoprotein @PROTEIN$ which had a single Sec residue at the catalytic site but no @COMPOUND$ (Cys) residues in the protein sequence.	0	18767149-2331
Zn2+-linked dimerization of @PROTEIN$ from Helicobacter pylori, a chaperone involved in @COMPOUND$ trafficking and urease activation.	1	18767150-2332
Zn2+-linked dimerization of UreG from Helicobacter pylori, a chaperone involved in @COMPOUND$ trafficking and @PROTEIN$ activation.	0	18767150-2332
The biosynthesis of the active metal-bound form of the nickel-dependent enzyme @PROTEIN$ involves the formation of a @COMPOUND$-carbamate functional group concomitantly with the delivery of two Ni(2+) ions into the precast active site of the apoenzyme and with GTP hydrolysis.	1	18767150-2333
The biosynthesis of the active metal-bound form of the nickel-dependent enzyme @PROTEIN$ involves the formation of a lysine-carbamate functional group concomitantly with the delivery of two @COMPOUND$+) ions into the precast active site of the apoenzyme and with GTP hydrolysis.	1	18767150-2333
The biosynthesis of the active metal-bound form of the nickel-dependent enzyme @PROTEIN$ involves the formation of a lysine-@COMPOUND$ functional group concomitantly with the delivery of two Ni(2+) ions into the precast active site of the apoenzyme and with GTP hydrolysis.	1	18767150-2333
Residue-wise conformational stability of @PROTEIN$ dimer from native-state @COMPOUND$ exchange.	1	18767155-2335
Whereas the role of locally produced 1, @COMPOUND$ is not yet clear, it is possible that it contributes importantly to vitamin D-mediated inhibition of parathyroid cell growth, so @PROTEIN$ can be considered a candidate parathyroid tumor suppressor gene in that its acquired inactivation in a parathyroid cell could confer a tumorigenic growth advantage.	0	18767934-15
Whereas the role of locally produced 1, 25-dihydroxy@COMPOUND$ is not yet clear, it is possible that it contributes importantly to vitamin D-mediated inhibition of parathyroid cell growth, so @PROTEIN$ can be considered a candidate parathyroid tumor suppressor gene in that its acquired inactivation in a parathyroid cell could confer a tumorigenic growth advantage.	0	18767934-15
Mechanistically, we showed EphA2 knockdown suppressed @PROTEIN$-induced @COMPOUND$ 536 phosphorylation of NFkappaB, an event critical of ICAM-1 transcriptional upregulation.	1	18768213-91
Mechanistically, we showed EphA2 knockdown suppressed thrombin-induced @COMPOUND$ 536 phosphorylation of NFkappaB, an event critical of @PROTEIN$ transcriptional upregulation.	1	18768213-91
Total antioxidant capacity, catalase, @COMPOUND$-reactive substances, hemoglobin, transferrin saturation and @PROTEIN$ did not change significantly.	0	18768362-173
Total antioxidant capacity, catalase, @COMPOUND$-reactive substances, hemoglobin, @PROTEIN$ saturation and ferritin did not change significantly.	0	18768362-173
Total antioxidant capacity, @PROTEIN$, @COMPOUND$-reactive substances, hemoglobin, transferrin saturation and ferritin did not change significantly.	0	18768362-173
Total antioxidant capacity, catalase, @COMPOUND$-reactive substances, @PROTEIN$, transferrin saturation and ferritin did not change significantly.	0	18768362-173
Considering the post-cAMP sites of HA action, it is shown herein that HA markedly inhibited db-cAMP-stimulated steroidogenic acute regulatory (STAR) protein expression, as well as steps catalyzed by P450-dependent enzymes, mainly the conversion of cholesterol to @COMPOUND$ by cholesterol side-chain cleavage enzyme (@PROTEIN$).	1	18768916-385
Considering the post-cAMP sites of HA action, it is shown herein that HA markedly inhibited db-cAMP-stimulated steroidogenic acute regulatory (STAR) protein expression, as well as steps catalyzed by P450-dependent enzymes, mainly the conversion of @COMPOUND$ to pregnenolone by @PROTEIN$ (CYP11A).	1	18768916-385
Considering the post-cAMP sites of HA action, it is shown herein that HA markedly inhibited db-cAMP-stimulated steroidogenic acute regulatory (STAR) protein expression, as well as steps catalyzed by P450-dependent enzymes, mainly the conversion of @COMPOUND$ to pregnenolone by cholesterol side-chain cleavage enzyme (@PROTEIN$).	1	18768916-385
Considering the post-cAMP sites of HA action, it is shown herein that HA markedly inhibited db-cAMP-stimulated steroidogenic acute regulatory (STAR) protein expression, as well as steps catalyzed by P450-dependent enzymes, mainly the conversion of cholesterol to @COMPOUND$ by @PROTEIN$ (CYP11A).	1	18768916-385
Finally, HA increased @PROTEIN$ (NOS) activity, and the NOS inhibitor NG-nitro-@COMPOUND$ (L-NAME) markedly attenuated the effect of the amine on steroid synthesis.	0	18768916-386
LH, FSH, 17 @COMPOUND$, progesterone, aldosterone and @PROTEIN$ were assayed at the seventh, fourteenth, twenty-first and twenty-eighth days of the cycle after 30 min of recumbency.	0	18769443-565
LH, FSH, 17 beta-estradiol, @COMPOUND$, aldosterone and @PROTEIN$ were assayed at the seventh, fourteenth, twenty-first and twenty-eighth days of the cycle after 30 min of recumbency.	0	18769443-565
Aldosterone was positively related to @PROTEIN$ and @COMPOUND$.	0	18769443-566
@PROTEIN$ activity and @COMPOUND$ levels may therefore be altered in 22q11DS individuals.	0	18769474-571
@PROTEIN$ (158) genotype and plasma @COMPOUND$ levels were determined in the 22q11DS children.	0	18769474-572
We have investigated its antibacterial activity and binding activity to pathogenic whole cell antigens, @COMPOUND$ (LPS) and staphylococcal @PROTEIN$.	0	18769875-666
Quinone formation is closely linked to other representative hypotheses such as mitochondrial dysfunction, inflammation, oxidative stress, and dysfunction of the @PROTEIN$-proteasome system, in the pathogenesis of neurodegenerative diseases such as Parkinson's disease and @COMPOUND$-induced neurotoxicity.	0	18770028-698
The effect of @COMPOUND$ exposure on birds was examined by measuring aerobic metabolism, blood hemoglobin content, plasma @PROTEIN$, and body weight for up to 21 d postdose.	1	18771337-1073
The effect of @COMPOUND$ exposure on birds was examined by measuring aerobic metabolism, blood @PROTEIN$ content, plasma cholinesterases, and body weight for up to 21 d postdose.	1	18771337-1073
Of the 37 E. coli isolated from diarrhoeic calves, @COMPOUND$ (18.9%), F41 (18.9%), heat-stable enterotoxin a (STa) (18.9%), Shiga @PROTEIN$ (Stx1; 13.5%) and Shiga toxin 2 (Stx2 ; 5.4%) and intimin (8.1%) genes were identified by multiplex PCR.	0	18771515-1111
Of the 37 E. coli isolated from diarrhoeic calves, @COMPOUND$ (18.9%), F41 (18.9%), heat-stable enterotoxin a (STa) (18.9%), Shiga toxin 1 (Stx1; 13.5%) and Shiga toxin 2 (@PROTEIN$ ; 5.4%) and intimin (8.1%) genes were identified by multiplex PCR.	0	18771515-1111
Of the 37 E. coli isolated from diarrhoeic calves, K99 (18.9%), @COMPOUND$ (18.9%), heat-stable enterotoxin a (STa) (18.9%), Shiga toxin 1 (Stx1; 13.5%) and Shiga toxin 2 (Stx2 ; 5.4%) and @PROTEIN$ (8.1%) genes were identified by multiplex PCR.	0	18771515-1111
Of the 37 E. coli isolated from diarrhoeic calves, K99 (18.9%), @COMPOUND$ (18.9%), heat-stable enterotoxin a (STa) (18.9%), Shiga @PROTEIN$ (Stx1; 13.5%) and Shiga toxin 2 (Stx2 ; 5.4%) and intimin (8.1%) genes were identified by multiplex PCR.	0	18771515-1111
Of the 37 E. coli isolated from diarrhoeic calves, @COMPOUND$ (18.9%), F41 (18.9%), heat-stable @PROTEIN$ a (STa) (18.9%), Shiga toxin 1 (Stx1; 13.5%) and Shiga toxin 2 (Stx2 ; 5.4%) and intimin (8.1%) genes were identified by multiplex PCR.	0	18771515-1111
Of the 37 E. coli isolated from diarrhoeic calves, K99 (18.9%), @COMPOUND$ (18.9%), heat-stable enterotoxin a (STa) (18.9%), Shiga toxin 1 (Stx1; 13.5%) and Shiga toxin 2 (Stx2 ; 5.4%) and intimin (8.1%) genes were identified by multiplex @PROTEIN$.	0	18771515-1111
Of the 37 E. coli isolated from diarrhoeic calves, @COMPOUND$ (18.9%), F41 (18.9%), heat-stable enterotoxin a (STa) (18.9%), Shiga toxin 1 (Stx1; 13.5%) and Shiga toxin 2 (Stx2 ; 5.4%) and intimin (8.1%) genes were identified by multiplex @PROTEIN$.	0	18771515-1111
Of the 37 E. coli isolated from diarrhoeic calves, K99 (18.9%), @COMPOUND$ (18.9%), heat-stable @PROTEIN$ a (STa) (18.9%), Shiga toxin 1 (Stx1; 13.5%) and Shiga toxin 2 (Stx2 ; 5.4%) and intimin (8.1%) genes were identified by multiplex PCR.	0	18771515-1111
Of the 37 E. coli isolated from diarrhoeic calves, K99 (18.9%), @COMPOUND$ (18.9%), heat-stable enterotoxin a (STa) (18.9%), Shiga toxin 1 (Stx1; 13.5%) and Shiga toxin 2 (@PROTEIN$ ; 5.4%) and intimin (8.1%) genes were identified by multiplex PCR.	0	18771515-1111
Of the 37 E. coli isolated from diarrhoeic calves, @COMPOUND$ (18.9%), F41 (18.9%), heat-stable enterotoxin a (STa) (18.9%), Shiga toxin 1 (Stx1; 13.5%) and Shiga toxin 2 (Stx2 ; 5.4%) and @PROTEIN$ (8.1%) genes were identified by multiplex PCR.	0	18771515-1111
Of the 18 E. coli isolated from healthy calves, @COMPOUND$ (16.6%) and intimin (55.5%) genes were identified by @PROTEIN$.	0	18771515-1112
Of the 18 E. coli isolated from healthy calves, @COMPOUND$ (16.6%) and @PROTEIN$ (55.5%) genes were identified by PCR.	0	18771515-1112
@COMPOUND$, F41, STa, Stx1 and @PROTEIN$ were found as the most common virulence gene markers of E. coli strains isolated from calves with diarrhoea.	0	18771515-1113
K99, @COMPOUND$, STa, Stx1 and @PROTEIN$ were found as the most common virulence gene markers of E. coli strains isolated from calves with diarrhoea.	0	18771515-1113
These agents possess a range of physiological effects that are associated with improved glycaemic control in diabetes including stimulation of @COMPOUND$-dependent @PROTEIN$ secretion, suppression of glucagon secretion, slowing of gastric emptying, and reduction of food intake.	1	18771570-1136
These agents possess a range of physiological effects that are associated with improved glycaemic control in diabetes including stimulation of @COMPOUND$-dependent insulin secretion, suppression of @PROTEIN$ secretion, slowing of gastric emptying, and reduction of food intake.	0	18771570-1136
Induction of the spliced form of @PROTEIN$ as well as total XBP1 by @COMPOUND$ was significantly attenuated in patients with BD.	1	18771604-1158
Induction of @PROTEIN$ by @COMPOUND$ was also decreased in the BD group.	1	18771604-1159
Efforts in the field of synthetic vaccine carriers are focussing on decorating the particle surface with ligands for DC receptors such as heparan @COMPOUND$ glycosaminoglycan structures, integrins, Siglecs, ga@PROTEIN$, C-type lectins and toll-like receptors.	0	18771683-1179
Efforts in the field of synthetic vaccine carriers are focussing on decorating the particle surface with ligands for DC receptors such as heparan @COMPOUND$ glycosaminoglycan structures, integrins, Siglecs, @PROTEIN$, C-type lectins and toll-like receptors.	0	18771683-1179
Reversal of the inhibitory effect of @COMPOUND$ on @PROTEIN$ generation by rFVIIa, aPCC and PCC.	1	18771795-1211
Reversal of the inhibitory effect of fondaparinux on @PROTEIN$ generation by rFVIIa, a@COMPOUND$ and PCC.	1	18771795-1211
It appears that GSTM1 null and GSTT1 null have a clear association with longer overall survival in patients with different malignancies who are treated with substrates for these @PROTEIN$ (mostly alkylating agents and @COMPOUND$).	1	18771857-1234
It appears that GSTM1 null and @PROTEIN$ null have a clear association with longer overall survival in patients with different malignancies who are treated with substrates for these GSTs (mostly alkylating agents and @COMPOUND$).	1	18771857-1234
It appears that @PROTEIN$ null and GSTT1 null have a clear association with longer overall survival in patients with different malignancies who are treated with substrates for these GSTs (mostly alkylating agents and @COMPOUND$).	1	18771857-1234
@COMPOUND$ attenuates antigen-specific IgE production through the modulation of @PROTEIN$/Th2 balance in ovalbumin-sensitized BALB/c mice.	1	18771904-1247
BALB/c mice were either left untreated or administered daily with vehicle (VH; saline) and/or @COMPOUND$ (200 or 400 mg/kg) by gavage for 3 consecutive days prior to sensitization with @PROTEIN$ (OVA).	0	18771904-1248
Treatment with @COMPOUND$, but not equimolar mannitol or 3-O-methyl glucose, resulted in phosphorylation and activation of TNF-alpha converting enzyme (TACE) (@PROTEIN$), which were attenuated by sorbinil or AR-specific small interference RNA.	1	18772236-1315
Treatment with HG, but not equimolar @COMPOUND$ or 3-O-methyl glucose, resulted in phosphorylation and activation of @PROTEIN$ (TACE) (ADAM17), which were attenuated by sorbinil or AR-specific small interference RNA.	0	18772236-1315
Treatment with HG, but not equimolar mannitol or 3-O-methyl @COMPOUND$, resulted in phosphorylation and activation of TNF-alpha converting enzyme (@PROTEIN$) (ADAM17), which were attenuated by sorbinil or AR-specific small interference RNA.	0	18772236-1315
Treatment with HG, but not equimolar mannitol or 3-O-methyl glucose, resulted in phosphorylation and activation of @PROTEIN$ (TACE) (ADAM17), which were attenuated by @COMPOUND$ or AR-specific small interference RNA.	1	18772236-1315
Treatment with @COMPOUND$, but not equimolar mannitol or 3-O-methyl glucose, resulted in phosphorylation and activation of @PROTEIN$ (TACE) (ADAM17), which were attenuated by sorbinil or AR-specific small interference RNA.	1	18772236-1315
Treatment with HG, but not equimolar @COMPOUND$ or 3-O-methyl glucose, resulted in phosphorylation and activation of TNF-alpha converting enzyme (TACE) (@PROTEIN$), which were attenuated by sorbinil or AR-specific small interference RNA.	0	18772236-1315
Treatment with HG, but not equimolar mannitol or 3-O-methyl glucose, resulted in phosphorylation and activation of TNF-alpha converting enzyme (TACE) (@PROTEIN$), which were attenuated by @COMPOUND$ or AR-specific small interference RNA.	1	18772236-1315
Treatment with HG, but not equimolar mannitol or 3-O-methyl @COMPOUND$, resulted in phosphorylation and activation of @PROTEIN$ (TACE) (ADAM17), which were attenuated by sorbinil or AR-specific small interference RNA.	0	18772236-1315
Treatment with @COMPOUND$, but not equimolar mannitol or 3-O-methyl glucose, resulted in phosphorylation and activation of TNF-alpha converting enzyme (@PROTEIN$) (ADAM17), which were attenuated by sorbinil or AR-specific small interference RNA.	1	18772236-1315
Treatment with HG, but not equimolar mannitol or 3-O-methyl glucose, resulted in phosphorylation and activation of TNF-alpha converting enzyme (@PROTEIN$) (ADAM17), which were attenuated by @COMPOUND$ or AR-specific small interference RNA.	1	18772236-1315
Treatment with HG, but not equimolar mannitol or 3-O-methyl @COMPOUND$, resulted in phosphorylation and activation of TNF-alpha converting enzyme (TACE) (@PROTEIN$), which were attenuated by sorbinil or AR-specific small interference RNA.	0	18772236-1315
Treatment with HG, but not equimolar @COMPOUND$ or 3-O-methyl glucose, resulted in phosphorylation and activation of TNF-alpha converting enzyme (@PROTEIN$) (ADAM17), which were attenuated by sorbinil or AR-specific small interference RNA.	0	18772236-1315
These results indicate that @COMPOUND$-induced TNF-alpha shedding could be attributed to @PROTEIN$ activation, which is regulated, in part, by PKC-delta and AR.	1	18772236-1316
These results indicate that @COMPOUND$-induced @PROTEIN$ shedding could be attributed to TACE activation, which is regulated, in part, by PKC-delta and AR.	1	18772236-1316
These results indicate that @COMPOUND$-induced TNF-alpha shedding could be attributed to TACE activation, which is regulated, in part, by @PROTEIN$ and AR.	0	18772236-1316
We conclude that gastrocnemius, heart, and liver mitochondria of streptozotocin diabetic rats are not irrevocably altered toward excess @COMPOUND$ production either by @PROTEIN$ or complex III.	1	18772240-1321
Consequently, the primary mechanism of resistance to @COMPOUND$ is a function of the activity of the DNA repair enzyme O(6)-methylguanine DNA @PROTEIN$ (MGMT).	1	18772354-1356
Consequently, the primary mechanism of resistance to @COMPOUND$ is a function of the activity of the DNA repair enzyme O(6)-methylguanine DNA methyltransferase (@PROTEIN$).	1	18772354-1356
Despite their inhibitory effects on inflammatory gene expression, loss of @PROTEIN$ or LXRs in macrophages did not exert major effects on obesity or @COMPOUND$ tolerance induced by a high-fat diet.	0	18772483-962
Our results do not exclude a contribution of macrophage @PROTEIN$ and LXR expression to systemic metabolism in certain contexts, but these factors do not appear to be dominant contributors to @COMPOUND$ tolerance in a high-fat-fed Th1-biased bone marrow transplant model.	0	18772483-964
The dark side of @COMPOUND$ deficiency: II. Type 2 diabetes and @PROTEIN$ resistance.	1	18772488-1372
A considerable body of evidence exists suggesting a link among reduced @COMPOUND$ plasma levels, type 2 diabetes (T2D), and @PROTEIN$ resistance (IR).	1	18772488-1373
Androgen therapy of hypogonadal men improves @PROTEIN$ sensitivity, fasting @COMPOUND$, and HbA1c levels.	0	18772488-1376
Effects of conjugated linoleic acid plus n-3 @COMPOUND$ on @PROTEIN$ secretion and estimated insulin sensitivity in men.	1	18772894-1473
Effects of @COMPOUND$ plus n-3 polyunsaturated fatty acids on @PROTEIN$ secretion and estimated insulin sensitivity in men.	1	18772894-1473
A mechanism for the bioreduction of H2PtCl6 and PtCl2 into @COMPOUND$ nanoparticles by a @PROTEIN$ enzyme from Fusarium oxysporum is proposed.	1	18773149-1572
Responses of limbic and extrapyramidal @PROTEIN$ systems to @COMPOUND$ treatment.	1	18773198-1602
Radioisotopic localization of (90) @COMPOUND$-ibritumomab tiuxetan in patients with @PROTEIN$+ non-Hodgkin's lymphoma.	1	18773247-1624
We solved the crystal structures of Aquifex aeolicus @PROTEIN$ and its complex with adenosine 5 '-(alpha,beta-methylene) triphosphate (@COMPOUND$).	1	18773910-1819
We solved the crystal structures of Aquifex aeolicus @PROTEIN$ and its complex with adenosine 5 '-(alpha,beta-@COMPOUND$) triphosphate (AMPCPP).	1	18773910-1819
To identify the amino-acid residues that contribute to @PROTEIN$ activity, we prepared six mutants of SPS and examined their @COMPOUND$-dependent ATP consumption.	1	18773910-1820
"In @PROTEIN$. @COMPOUND$, the N-terminal loop, including the two residues, assumes different conformations (""open"" and ""closed"") between the two subunits."	1	18773910-1821
The results indicated that @PROTEIN$ receptors within the nucleus accumbens are involved in the acquisition and expression of @COMPOUND$-induced CPP in sensitized rats.	1	18773925-1827
Effect of obestatin on insulin, @PROTEIN$ and @COMPOUND$ secretion in the perfused rat pancreas.	0	18773927-1828
Effect of @PROTEIN$ on insulin, glucagon and @COMPOUND$ secretion in the perfused rat pancreas.	1	18773927-1828
Effect of obestatin on @PROTEIN$, glucagon and @COMPOUND$ secretion in the perfused rat pancreas.	0	18773927-1828
The potentiated effect of obestatin on @COMPOUND$-induced @PROTEIN$ output was not observed in the presence of diazoxide, an agent that activates ATP-dependent K(+) channels, thus suggesting that these channels might be sensitive to this peptide.	1	18773927-1829
The potentiated effect of @PROTEIN$ on @COMPOUND$-induced insulin output was not observed in the presence of diazoxide, an agent that activates ATP-dependent K(+) channels, thus suggesting that these channels might be sensitive to this peptide.	1	18773927-1829
The potentiated effect of obestatin on glucose-induced @PROTEIN$ output was not observed in the presence of @COMPOUND$, an agent that activates ATP-dependent K(+) channels, thus suggesting that these channels might be sensitive to this peptide.	1	18773927-1829
The potentiated effect of @PROTEIN$ on glucose-induced insulin output was not observed in the presence of @COMPOUND$, an agent that activates ATP-dependent K(+) channels, thus suggesting that these channels might be sensitive to this peptide.	1	18773927-1829
Four brain areas (cortex, hippocampus, thalamus and hypothalamus) were analyzed for EB extravasation, water and electrolyte (@COMPOUND$ (+), K(+), Cl (-)) contents, immunostained for albumin and glial fibrillary @PROTEIN$ (GFAP), and examined for neuronal, glial and axonal alterations using standard light and electron microscopy.	0	18773954-1841
Four brain areas (cortex, hippocampus, thalamus and hypothalamus) were analyzed for EB extravasation, water and electrolyte (@COMPOUND$ (+), K(+), Cl (-)) contents, immunostained for albumin and glial fibrillary acidic protein (@PROTEIN$), and examined for neuronal, glial and axonal alterations using standard light and electron microscopy.	0	18773954-1841
Four brain areas (cortex, hippocampus, thalamus and hypothalamus) were analyzed for EB extravasation, water and electrolyte (Na (+), K(+), @COMPOUND$ (-)) contents, immunostained for albumin and glial fibrillary acidic protein (@PROTEIN$), and examined for neuronal, glial and axonal alterations using standard light and electron microscopy.	0	18773954-1841
Four brain areas (cortex, hippocampus, thalamus and hypothalamus) were analyzed for EB extravasation, water and electrolyte (Na (+), K(+), @COMPOUND$ (-)) contents, immunostained for albumin and glial fibrillary @PROTEIN$ (GFAP), and examined for neuronal, glial and axonal alterations using standard light and electron microscopy.	0	18773954-1841
We administered @COMPOUND$ to newborn rats on postnatal days (PN) 1-4 at doses spanning the threshold for detectable @PROTEIN$ inhibition (0.1 mg/kg/day) and the first signs of loss of viability (0.2 mg/kg/day).	1	18773955-1842
The Arg105 in @PROTEIN$ is highly conserved across species and its replacement with @COMPOUND$ is predicted to be pathogenic.	1	18774132-1889
We also assess prostaglandin (PGE (2)) and thromboxane (@COMPOUND$ (2)) inhibition to establish the correlation between behavioural measures and the degree of selectivity for COX-1 and @PROTEIN$.	0	18774319-1994
We also assess prostaglandin (PGE (2)) and thromboxane (@COMPOUND$ (2)) inhibition to establish the correlation between behavioural measures and the degree of selectivity for @PROTEIN$ and COX-2.	0	18774319-1994
We also assess prostaglandin (PGE (2)) and @COMPOUND$ (TXB (2)) inhibition to establish the correlation between behavioural measures and the degree of selectivity for COX-1 and @PROTEIN$.	0	18774319-1994
We also assess prostaglandin (PGE (2)) and @COMPOUND$ (TXB (2)) inhibition to establish the correlation between behavioural measures and the degree of selectivity for @PROTEIN$ and COX-2.	0	18774319-1994
We also assess prostaglandin (@PROTEIN$ (2)) and thromboxane (@COMPOUND$ (2)) inhibition to establish the correlation between behavioural measures and the degree of selectivity for COX-1 and COX-2.	0	18774319-1994
We also assess prostaglandin (@PROTEIN$ (2)) and @COMPOUND$ (TXB (2)) inhibition to establish the correlation between behavioural measures and the degree of selectivity for COX-1 and COX-2.	0	18774319-1994
High-dose steroid therapy for the former symptoms of AHS, and immunoglobulin, @PROTEIN$, and @COMPOUND$ for the latter agranulocytosis were successfully performed.	0	18774664-2104
0.05 vs. aortic IR) plasma levels of @COMPOUND$, P-selectin, intercellular adhesion molecule-1 (ICAM-I), and tissue levels of malondialdehyde and @PROTEIN$.	0	18774689-2116
Niemann-Pick C disease (NPC) is an autosomal recessive neurodegenerative disorder caused by the abnormal function of @PROTEIN$ or NPC2 proteins, leading to an accumulation of unesterified @COMPOUND$ and glycosphingolipids (GSLs) in the lysosomes.	1	18774957-2175
Niemann-Pick C disease (NPC) is an autosomal recessive neurodegenerative disorder caused by the abnormal function of NPC1 or @PROTEIN$ proteins, leading to an accumulation of unesterified @COMPOUND$ and glycosphingolipids (GSLs) in the lysosomes.	1	18774957-2175
@PROTEIN$-diminished arginine and indolamine 2,3-dioxygenase-diminished tryptophan) or @COMPOUND$ (NO) production.	0	18775028-2185
@PROTEIN$-diminished @COMPOUND$ and indolamine 2,3-dioxygenase-diminished tryptophan) or nitric oxide (NO) production.	1	18775028-2185
@PROTEIN$-diminished arginine and indolamine 2,3-dioxygenase-diminished @COMPOUND$) or nitric oxide (NO) production.	0	18775028-2185
Memory impairment in young women at increased risk of depression: influence of @COMPOUND$ and 5-@PROTEIN$ genotype.	0	18775088-2206
The aim of the present study was to determine whether memory impairments were present in young women at increased familial risk of depression and whether memory performance was related either to @COMPOUND$ secretion or to allelic variation in the promoter region of the serotonin transporter gene (5-@PROTEIN$).	0	18775088-2207
The relative gene expression of @PROTEIN$ 0.05) in-@COMPOUND$ calves compared with+ Cu or-Cu+Mn calves.	1	18775090-2208
Effects of a flaxseed-derived @COMPOUND$ supplement on C-reactive protein, @PROTEIN$ and retinol-binding protein 4 in type 2 diabetic patients.	1	18775100-2213
Effects of a flaxseed-derived @COMPOUND$ supplement on C-reactive protein, IL-6 and retinol-binding @PROTEIN$ in type 2 diabetic patients.	1	18775100-2213
The present study explored the effects of flaxseed-derived @COMPOUND$ on inflammatory factors and @PROTEIN$ concentrations in type 2 diabetics, who have higher levels of these biomarkers.	1	18775100-2214
No between-treatment differences were found with regard to IL-6 or @PROTEIN$ ; though IL-6 0.001 following @COMPOUND$ and placebo treatments, respectively).	0	18775100-2215
No between-treatment differences were found with regard to @PROTEIN$ or RBP4 ; though IL-6 0.001 following @COMPOUND$ and placebo treatments, respectively).	0	18775100-2215
These include typical G-protein (Galphaq/11)-coupled cascades, such as activation of phospholipase C (PLC), and subsequent accumulation of inositol-(1,4,5)-triphosphate (IP3), intracellular @COMPOUND$+) mobilization, and activation of @PROTEIN$.	0	18775460-2359
Here we report the discovery of a series of novel adamantyl @COMPOUND$ as selective inhibitors of human 11beta-HSD1 in HEK-293 cells transfected with the @PROTEIN$ gene.	1	18775471-2362
Polymorphism in the @PROTEIN$ gene, plasma lipoprotein(a), cardiovascular disease, and low-dose @COMPOUND$ therapy.	0	18775538-2383
We investigated whether this allele was associated with elevated @PROTEIN$ and cardiovascular risk in the Women's Health Study, a randomized trial of low-dose @COMPOUND$, and whether aspirin reduced cardiovascular risk in minor allele carriers.	0	18775538-2384
The study was prompted to characterize the B-type @PROTEIN$ activities in the terrestrial snail Xeropicta derbentina and to evaluate its sensitivity to organophosphorus and @COMPOUND$ pesticides.	1	18775593-2403
Specific @PROTEIN$ and carboxylesterase activities were mainly obtained with @COMPOUND$ (K(m)=77.2 mM; V(max)=38.2 mU/mg protein) and 1-naphthyl acetate (K(m)=222 mM, V(max)=1095 mU/mg protein) substrates, respectively.	1	18775593-2404
Specific @PROTEIN$ and carboxylesterase activities were mainly obtained with acetylthiocholine (K(m)=77.2 mM; V(max)=38.2 mU/mg protein) and @COMPOUND$ (K(m)=222 mM, V(max)=1095 mU/mg protein) substrates, respectively.	1	18775593-2404
To distinguish between isoform-specific and context-dependent modulation as possible explanations for this selectivity, the effects of @COMPOUND$ were evaluated on recombinant @PROTEIN$ expressed in HEK293T cells.	1	18775733-2451
Drosophila responds to detection of diamonopimelic-type microbial @COMPOUND$ through activation of the immune deficiency (Imd) pathway, a signaling pathway with numerous similarities to the mammalian pro-inflammatory @PROTEIN$ pathway.	1	18775745-2455
We measured serum high-sensitivity C-reactive protein (hs-@PROTEIN$), fetuin-A, IL-6, IL-18, IL-10 (ELISA) and others (haemoglobin level, white blood cell count, serum calcium, phosphate, calcium-phosphate product, albumin, fibrinogen, @COMPOUND$, high-density lipoprotein (HDL), triglycerides and parathormone).	0	18775894-2504
We measured serum high-sensitivity C-reactive protein (hs-CRP), fetuin-A, @PROTEIN$, IL-18, IL-10 (ELISA) and others (haemoglobin level, white blood cell count, serum calcium, phosphate, @COMPOUND$ product, albumin, fibrinogen, cholesterol, high-density lipoprotein (HDL), triglycerides and parathormone).	0	18775894-2504
We measured serum high-sensitivity C-reactive protein (hs-CRP), fetuin-A, IL-6, IL-18, IL-10 (ELISA) and others (haemoglobin level, white blood cell count, serum calcium, phosphate, calcium-phosphate product, albumin, @PROTEIN$, @COMPOUND$, high-density lipoprotein (HDL), triglycerides and parathormone).	0	18775894-2504
We measured serum high-sensitivity C-reactive protein (hs-CRP), fetuin-A, @PROTEIN$, IL-18, IL-10 (ELISA) and others (haemoglobin level, white blood cell count, serum @COMPOUND$, calcium-phosphate product, albumin, fibrinogen, cholesterol, high-density lipoprotein (HDL), triglycerides and parathormone).	0	18775894-2504
We measured serum high-sensitivity C-reactive protein (hs-CRP), @PROTEIN$, IL-6, IL-18, IL-10 (ELISA) and others (haemoglobin level, white blood cell count, serum calcium, phosphate, calcium-phosphate product, albumin, fibrinogen, @COMPOUND$, high-density lipoprotein (HDL), triglycerides and parathormone).	0	18775894-2504
We measured serum high-sensitivity C-reactive protein (hs-@PROTEIN$), fetuin-A, IL-6, IL-18, IL-10 (ELISA) and others (haemoglobin level, white blood cell count, serum calcium, phosphate, @COMPOUND$ product, albumin, fibrinogen, cholesterol, high-density lipoprotein (HDL), triglycerides and parathormone).	0	18775894-2504
We measured serum high-sensitivity C-reactive protein (hs-CRP), @PROTEIN$, IL-6, IL-18, IL-10 (ELISA) and others (haemoglobin level, white blood cell count, serum @COMPOUND$, calcium-phosphate product, albumin, fibrinogen, cholesterol, high-density lipoprotein (HDL), triglycerides and parathormone).	0	18775894-2504
We measured serum high-sensitivity C-reactive protein (hs-CRP), fetuin-A, IL-6, @PROTEIN$, IL-10 (ELISA) and others (haemoglobin level, white blood cell count, serum calcium, phosphate, calcium-phosphate product, albumin, fibrinogen, @COMPOUND$, high-density lipoprotein (HDL), triglycerides and parathormone).	0	18775894-2504
We measured serum high-sensitivity C-reactive protein (hs-CRP), fetuin-A, @PROTEIN$, IL-18, IL-10 (ELISA) and others (haemoglobin level, white blood cell count, serum calcium, phosphate, calcium-phosphate product, albumin, fibrinogen, @COMPOUND$, high-density lipoprotein (HDL), triglycerides and parathormone).	0	18775894-2504
We measured serum high-sensitivity C-reactive protein (hs-CRP), fetuin-A, IL-6, IL-18, IL-10 (ELISA) and others (haemoglobin level, white blood cell count, serum @COMPOUND$, calcium-phosphate product, albumin, fibrinogen, cholesterol, @PROTEIN$ (HDL), triglycerides and parathormone).	0	18775894-2504
We measured serum high-sensitivity C-reactive protein (hs-CRP), fetuin-A, IL-6, IL-18, IL-10 (ELISA) and others (haemoglobin level, white blood cell count, serum calcium, phosphate, calcium-phosphate product, albumin, fibrinogen, @COMPOUND$, @PROTEIN$ (HDL), triglycerides and parathormone).	0	18775894-2504
We measured serum high-sensitivity C-reactive protein (hs-CRP), fetuin-A, IL-6, @PROTEIN$, IL-10 (ELISA) and others (haemoglobin level, white blood cell count, serum @COMPOUND$, calcium-phosphate product, albumin, fibrinogen, cholesterol, high-density lipoprotein (HDL), triglycerides and parathormone).	0	18775894-2504
We measured serum high-sensitivity C-reactive protein (hs-CRP), fetuin-A, IL-6, IL-18, IL-10 (ELISA) and others (haemoglobin level, white blood cell count, serum calcium, phosphate, @COMPOUND$ product, albumin, @PROTEIN$, cholesterol, high-density lipoprotein (HDL), triglycerides and parathormone).	0	18775894-2504
We measured serum high-sensitivity C-reactive protein (hs-CRP), fetuin-A, IL-6, IL-18, IL-10 (ELISA) and others (haemoglobin level, white blood cell count, serum calcium, phosphate, @COMPOUND$ product, albumin, fibrinogen, cholesterol, high-density lipoprotein (HDL), triglycerides and @PROTEIN$).	0	18775894-2504
We measured serum high-sensitivity C-reactive protein (hs-CRP), fetuin-A, IL-6, IL-18, @PROTEIN$ (ELISA) and others (haemoglobin level, white blood cell count, serum calcium, phosphate, @COMPOUND$ product, albumin, fibrinogen, cholesterol, high-density lipoprotein (HDL), triglycerides and parathormone).	0	18775894-2504
We measured serum high-sensitivity C-reactive protein (hs-CRP), fetuin-A, IL-6, IL-18, @PROTEIN$ (ELISA) and others (haemoglobin level, white blood cell count, serum calcium, phosphate, calcium-phosphate product, albumin, fibrinogen, @COMPOUND$, high-density lipoprotein (HDL), triglycerides and parathormone).	0	18775894-2504
We measured serum high-sensitivity C-reactive protein (hs-CRP), fetuin-A, IL-6, @PROTEIN$, IL-10 (ELISA) and others (haemoglobin level, white blood cell count, serum calcium, phosphate, @COMPOUND$ product, albumin, fibrinogen, cholesterol, high-density lipoprotein (HDL), triglycerides and parathormone).	0	18775894-2504
We measured serum high-sensitivity C-reactive protein (hs-CRP), fetuin-A, IL-6, IL-18, IL-10 (ELISA) and others (haemoglobin level, white blood cell count, serum calcium, phosphate, @COMPOUND$ product, albumin, fibrinogen, cholesterol, @PROTEIN$ (HDL), triglycerides and parathormone).	0	18775894-2504
We measured serum high-sensitivity C-reactive protein (hs-CRP), fetuin-A, IL-6, IL-18, IL-10 (ELISA) and others (haemoglobin level, white blood cell count, serum calcium, phosphate, calcium-phosphate product, albumin, fibrinogen, @COMPOUND$, high-density lipoprotein (HDL), triglycerides and @PROTEIN$).	0	18775894-2504
We measured serum high-sensitivity C-reactive protein (hs-CRP), fetuin-A, IL-6, IL-18, @PROTEIN$ (ELISA) and others (haemoglobin level, white blood cell count, serum @COMPOUND$, calcium-phosphate product, albumin, fibrinogen, cholesterol, high-density lipoprotein (HDL), triglycerides and parathormone).	0	18775894-2504
We measured serum high-sensitivity C-reactive protein (hs-CRP), fetuin-A, IL-6, IL-18, IL-10 (ELISA) and others (haemoglobin level, white blood cell count, serum @COMPOUND$, calcium-phosphate product, albumin, @PROTEIN$, cholesterol, high-density lipoprotein (HDL), triglycerides and parathormone).	0	18775894-2504
We measured serum high-sensitivity C-reactive protein (hs-CRP), fetuin-A, IL-6, IL-18, IL-10 (ELISA) and others (haemoglobin level, white blood cell count, serum @COMPOUND$, calcium-phosphate product, albumin, fibrinogen, cholesterol, high-density lipoprotein (HDL), triglycerides and @PROTEIN$).	0	18775894-2504
We measured serum high-sensitivity C-reactive protein (hs-@PROTEIN$), fetuin-A, IL-6, IL-18, IL-10 (ELISA) and others (haemoglobin level, white blood cell count, serum @COMPOUND$, calcium-phosphate product, albumin, fibrinogen, cholesterol, high-density lipoprotein (HDL), triglycerides and parathormone).	0	18775894-2504
We measured serum high-sensitivity C-reactive protein (hs-CRP), @PROTEIN$, IL-6, IL-18, IL-10 (ELISA) and others (haemoglobin level, white blood cell count, serum calcium, phosphate, @COMPOUND$ product, albumin, fibrinogen, cholesterol, high-density lipoprotein (HDL), triglycerides and parathormone).	0	18775894-2504
Serum @COMPOUND$ (25-OHD), calcium, @PROTEIN$ and phosphorus were measured.	0	18775944-2518
Serum 25-hydroxyvitamin D (25-OHD), calcium, @PROTEIN$ and @COMPOUND$ were measured.	0	18775944-2518
In the current study, we found that treatment of peripheral blood mononuclear cells with combination IL-2/IL-4 for 48 hours, but not with IL-2 or IL-4 alone, abrogated @COMPOUND$ (DEX)-induced @PROTEIN$ (GCR)-alpha nuclear translocation in both CD4 (+) and CD8(+) T cells.	1	18776133-17
In the current study, we found that treatment of peripheral blood mononuclear cells with combination IL-2/IL-4 for 48 hours, but not with IL-2 or IL-4 alone, abrogated @COMPOUND$ (DEX)-induced glucocorticoid receptor (GCR)-alpha nuclear translocation in both @PROTEIN$ (+) and CD8(+) T cells.	1	18776133-17
Linear regression analyses showed that @COMPOUND$ and phospholipid efflux and cellular apoA-I binding correlated significantly with the ability of @PROTEIN$ to form cell surface lipid domains.	1	18776170-42
Linear regression analyses showed that @COMPOUND$ and phospholipid efflux and cellular @PROTEIN$ binding correlated significantly with the ability of ABCA1 to form cell surface lipid domains.	0	18776170-42
@COMPOUND$-mediated inflammation and @PROTEIN$ resistance in human adipocytes are attenuated by resveratrol.	0	18776171-43
Conjugated linoleic acid-mediated inflammation and @PROTEIN$ resistance in human adipocytes are attenuated by @COMPOUND$.	1	18776171-43
Inflammation plays a role in trans-10, cis-12 (10,12)-@COMPOUND$ (CLA)-mediated delipidation and @PROTEIN$ resistance in adipocytes.	0	18776171-44
Given the anti-inflammatory role of @COMPOUND$ (RSV), we hypothesized that RSV would attenuate inflammation and @PROTEIN$ resistance caused by 10,12 CLA in human adipocytes.	1	18776171-45
Near-infrared fluorescence detection of @COMPOUND$-biotin-mediated @PROTEIN$ labeling.	1	18777013-349
Near-infrared fluorescence detection of ATP-@COMPOUND$-mediated @PROTEIN$ labeling.	1	18777013-349
Wheat germ @PROTEIN$ had a high activity and enantioselectivity only in n-hexane with a high initial water activity (alpha(w) = 0.97), especially with @COMPOUND$ (C 32%, E &gt; 200).	1	18777014-352
We determined effects of the vasopeptidase inhibitor (VPI) omapatrilat and angiotensin II type 1 receptor (AT(1)R) blocker (ARB) @COMPOUND$ in rats during healing between day-2 and day-21 after reperfused myocardial infarction (RMI) on left ventricular (LV) remodeling and function, and regional matrix metalloproteinase (MMP)-9, tissue inhibitor of MMP (TIMP)-3, inducible-nitric-oxide-synthase (iNOS), oxidant-generating myeloperoxidase (MPO), and cytokines @PROTEIN$ (TNF)-alpha, interleukin (IL)-6 and IL-10, and transforming-growth-factor (TGF)-beta(1), and collagens.	0	18777087-373
We determined effects of the vasopeptidase inhibitor (VPI) @COMPOUND$ and angiotensin II type 1 receptor (AT(1)R) blocker (ARB) candesartan in rats during healing between day-2 and day-21 after reperfused myocardial infarction (RMI) on left ventricular (LV) remodeling and function, and regional matrix metalloproteinase (MMP)-9, tissue inhibitor of MMP (TIMP)-3, inducible-nitric-oxide-synthase (iNOS), oxidant-generating myeloperoxidase (MPO), and cytokines @PROTEIN$ (TNF)-alpha, interleukin (IL)-6 and IL-10, and transforming-growth-factor (TGF)-beta(1), and collagens.	0	18777087-373
We determined effects of the vasopeptidase inhibitor (VPI) @COMPOUND$ and angiotensin II type 1 receptor (AT(1)R) blocker (ARB) candesartan in rats during healing between day-2 and day-21 after reperfused myocardial infarction (RMI) on left ventricular (LV) remodeling and function, and regional matrix metalloproteinase (MMP)-9, tissue inhibitor of MMP (TIMP)-3, inducible-@PROTEIN$ (iNOS), oxidant-generating myeloperoxidase (MPO), and cytokines tumor-necrosis-factor (TNF)-alpha, interleukin (IL)-6 and IL-10, and transforming-growth-factor (TGF)-beta(1), and collagens.	0	18777087-373
We determined effects of the vasopeptidase inhibitor (VPI) @COMPOUND$ and angiotensin II type 1 receptor (AT(1)R) blocker (ARB) candesartan in rats during healing between day-2 and day-21 after reperfused myocardial infarction (RMI) on left ventricular (LV) remodeling and function, and regional matrix metalloproteinase (MMP)-9, tissue inhibitor of MMP (TIMP)-3, inducible-nitric-oxide-synthase (@PROTEIN$), oxidant-generating myeloperoxidase (MPO), and cytokines tumor-necrosis-factor (TNF)-alpha, interleukin (IL)-6 and IL-10, and transforming-growth-factor (TGF)-beta(1), and collagens.	0	18777087-373
We determined effects of the vasopeptidase inhibitor (VPI) omapatrilat and angiotensin II type 1 receptor (AT(1)R) blocker (ARB) @COMPOUND$ in rats during healing between day-2 and day-21 after reperfused myocardial infarction (RMI) on left ventricular (LV) remodeling and function, and regional matrix metalloproteinase (MMP)-9, tissue inhibitor of MMP (TIMP)-3, inducible-nitric-oxide-synthase (iNOS), oxidant-generating myeloperoxidase (@PROTEIN$), and cytokines tumor-necrosis-factor (TNF)-alpha, interleukin (IL)-6 and IL-10, and transforming-growth-factor (TGF)-beta(1), and collagens.	0	18777087-373
We determined effects of the vasopeptidase inhibitor (VPI) @COMPOUND$ and angiotensin II type 1 receptor (AT(1)R) blocker (ARB) candesartan in rats during healing between day-2 and day-21 after reperfused myocardial infarction (RMI) on left ventricular (LV) remodeling and function, and regional matrix metalloproteinase (MMP)-9, tissue inhibitor of MMP (@PROTEIN$)-3, inducible-nitric-oxide-synthase (iNOS), oxidant-generating myeloperoxidase (MPO), and cytokines tumor-necrosis-factor (TNF)-alpha, interleukin (IL)-6 and IL-10, and transforming-growth-factor (TGF)-beta(1), and collagens.	0	18777087-373
We determined effects of the vasopeptidase inhibitor (VPI) omapatrilat and angiotensin II type 1 receptor (AT(1)R) blocker (ARB) @COMPOUND$ in rats during healing between day-2 and day-21 after reperfused myocardial infarction (RMI) on left ventricular (LV) remodeling and function, and regional matrix metalloproteinase (MMP)-9, tissue inhibitor of MMP (TIMP)-3, inducible-nitric-oxide-synthase (iNOS), oxidant-generating myeloperoxidase (MPO), and cytokines tumor-necrosis-factor (@PROTEIN$)-alpha, interleukin (IL)-6 and IL-10, and transforming-growth-factor (TGF)-beta(1), and collagens.	0	18777087-373
We determined effects of the vasopeptidase inhibitor (VPI) omapatrilat and angiotensin II type 1 receptor (AT(1)R) blocker (ARB) @COMPOUND$ in rats during healing between day-2 and day-21 after reperfused myocardial infarction (RMI) on left ventricular (LV) remodeling and function, and regional matrix metalloproteinase (MMP)-9, tissue inhibitor of MMP (TIMP)-3, inducible-nitric-oxide-synthase (@PROTEIN$), oxidant-generating myeloperoxidase (MPO), and cytokines tumor-necrosis-factor (TNF)-alpha, interleukin (IL)-6 and IL-10, and transforming-growth-factor (TGF)-beta(1), and collagens.	0	18777087-373
We determined effects of the vasopeptidase inhibitor (VPI) @COMPOUND$ and angiotensin II type 1 receptor (AT(1)R) blocker (ARB) candesartan in rats during healing between day-2 and day-21 after reperfused myocardial infarction (RMI) on left ventricular (LV) remodeling and function, and regional matrix metalloproteinase (MMP)-9, tissue inhibitor of MMP (TIMP)-3, inducible-nitric-oxide-synthase (iNOS), oxidant-generating myeloperoxidase (MPO), and cytokines tumor-necrosis-factor (TNF)-alpha, interleukin (IL)-6 and @PROTEIN$, and transforming-growth-factor (TGF)-beta(1), and collagens.	0	18777087-373
We determined effects of the vasopeptidase inhibitor (VPI) @COMPOUND$ and angiotensin II type 1 receptor (AT(1)R) blocker (ARB) candesartan in rats during healing between day-2 and day-21 after reperfused myocardial infarction (RMI) on left ventricular (LV) remodeling and function, and regional matrix metalloproteinase (MMP)-9, tissue inhibitor of MMP (TIMP)-3, inducible-nitric-oxide-synthase (iNOS), oxidant-generating myeloperoxidase (@PROTEIN$), and cytokines tumor-necrosis-factor (TNF)-alpha, interleukin (IL)-6 and IL-10, and transforming-growth-factor (TGF)-beta(1), and collagens.	0	18777087-373
We determined effects of the vasopeptidase inhibitor (VPI) @COMPOUND$ and angiotensin II type 1 receptor (AT(1)R) blocker (ARB) candesartan in rats during healing between day-2 and day-21 after reperfused myocardial infarction (RMI) on left ventricular (LV) remodeling and function, and regional matrix metalloproteinase (MMP)-9, tissue inhibitor of MMP (TIMP)-3, inducible-nitric-oxide-synthase (iNOS), oxidant-generating myeloperoxidase (MPO), and cytokines tumor-necrosis-factor (@PROTEIN$)-alpha, interleukin (IL)-6 and IL-10, and transforming-growth-factor (TGF)-beta(1), and collagens.	0	18777087-373
We determined effects of the vasopeptidase inhibitor (VPI) omapatrilat and angiotensin II type 1 receptor (AT(1)R) blocker (ARB) @COMPOUND$ in rats during healing between day-2 and day-21 after reperfused myocardial infarction (RMI) on left ventricular (LV) remodeling and function, and regional matrix metalloproteinase (MMP)-9, tissue inhibitor of MMP (@PROTEIN$)-3, inducible-nitric-oxide-synthase (iNOS), oxidant-generating myeloperoxidase (MPO), and cytokines tumor-necrosis-factor (TNF)-alpha, interleukin (IL)-6 and IL-10, and transforming-growth-factor (TGF)-beta(1), and collagens.	0	18777087-373
We determined effects of the vasopeptidase inhibitor (VPI) omapatrilat and angiotensin II type 1 receptor (AT(1)R) blocker (ARB) @COMPOUND$ in rats during healing between day-2 and day-21 after reperfused myocardial infarction (RMI) on left ventricular (LV) remodeling and function, and regional matrix metalloproteinase (MMP)-9, tissue inhibitor of MMP (TIMP)-3, inducible-nitric-oxide-synthase (iNOS), oxidant-generating myeloperoxidase (MPO), and cytokines tumor-necrosis-factor (TNF)-alpha, interleukin (IL)-6 and @PROTEIN$, and transforming-growth-factor (TGF)-beta(1), and collagens.	0	18777087-373
We determined effects of the vasopeptidase inhibitor (VPI) omapatrilat and angiotensin II type 1 receptor (AT(1)R) blocker (ARB) @COMPOUND$ in rats during healing between day-2 and day-21 after reperfused myocardial infarction (RMI) on left ventricular (LV) remodeling and function, and regional matrix metalloproteinase (MMP)-9, tissue inhibitor of MMP (TIMP)-3, inducible-@PROTEIN$ (iNOS), oxidant-generating myeloperoxidase (MPO), and cytokines tumor-necrosis-factor (TNF)-alpha, interleukin (IL)-6 and IL-10, and transforming-growth-factor (TGF)-beta(1), and collagens.	0	18777087-373
The results suggest that modulation of matrix @PROTEIN$, oxidants, cytokines, and NOSs with omapatrilat and @COMPOUND$ contribute to reversal of adverse collagen and LV remodeling and attenuation of LV dysfunction during healing after RMI.	1	18777087-374
The results suggest that modulation of matrix @PROTEIN$, oxidants, cytokines, and NOSs with @COMPOUND$ and candesartan contribute to reversal of adverse collagen and LV remodeling and attenuation of LV dysfunction during healing after RMI.	1	18777087-374
We recently reported @COMPOUND$ (Hcy)-induced @PROTEIN$-phosphorylation was suppressed by pertussis toxin (PTX), which suggested the involvement of GPCRs in initiating signal transduction.	1	18777088-375
Other factors prognostic for inferior survival were @PROTEIN$ 37 g/L (HR 3.22, 95% CI 1.11-13.22, p = 0.034) and treatment with non-cyclophosphamide, @COMPOUND$, vincristine, and prednisolone chemotherapy (HR 4.89, 95% CI 1.67-14.36, p = 0.004).	0	18777110-388
Other factors prognostic for inferior survival were @PROTEIN$ 37 g/L (HR 3.22, 95% CI 1.11-13.22, p = 0.034) and treatment with non-@COMPOUND$, doxorubicin, vincristine, and prednisolone chemotherapy (HR 4.89, 95% CI 1.67-14.36, p = 0.004).	0	18777110-388
Other factors prognostic for inferior survival were @PROTEIN$ 37 g/L (HR 3.22, 95% CI 1.11-13.22, p = 0.034) and treatment with non-cyclophosphamide, doxorubicin, @COMPOUND$, and prednisolone chemotherapy (HR 4.89, 95% CI 1.67-14.36, p = 0.004).	0	18777110-388
Other factors prognostic for inferior survival were @PROTEIN$ 37 g/L (HR 3.22, 95% CI 1.11-13.22, p = 0.034) and treatment with non-cyclophosphamide, doxorubicin, vincristine, and @COMPOUND$ chemotherapy (HR 4.89, 95% CI 1.67-14.36, p = 0.004).	0	18777110-388
Association between @COMPOUND$ (247) polymorphism of @PROTEIN$ and cerebral infarction in a Chinese population.	1	18777117-392
The purpose of this study was to identify associations between the @COMPOUND$ (247) polymorphism of @PROTEIN$ gene and CI in a Chinese cohort.	1	18777117-393
We have discovered multiple genetic and biochemical differences between humans and these other hominids, in relation to @COMPOUND$ and in Siglecs (Sia-recognizing Ig superfamily @PROTEIN$).	0	18777136-397
Possible binding site for the substrate, prostaglandin H(2) (@COMPOUND$)), was identified by systematically probing the refined molecular structure of @PROTEIN$.	1	18777160-404
We cloned the zGCAP4 gene, purified non-myristoylated and myristoylated forms of the protein after heterologous expression in Escherichia coli and studied its properties: zGCAP4 was a strong activator of membrane-bound guanylate @PROTEIN$ from bovine and zebrafish retina, showing half-maximal activation at 520-570 nM free @COMPOUND$+) concentration.	0	18777180-406
Thus, expression and biochemical properties of zGCAP4 are in agreement with its function as an efficient @COMPOUND$+)-sensitive regulator of guanylate @PROTEIN$ activity in cone vision.	0	18777180-408
The results of the present work show that this replacement does not considerably affect the DNA modifications by this drug, recognition of these modifications by @PROTEIN$ protein, their repair, and reactivity of the @COMPOUND$ with GSH.	0	18777181-411
The results of the present work show that this replacement does not considerably affect the DNA modifications by this drug, recognition of these modifications by @PROTEIN$ protein, their repair, and reactivity of the platinum complex with @COMPOUND$.	0	18777181-411
However, in addition to @PROTEIN$ activity, we discovered that EGST also possesses @COMPOUND$ : disulfide oxidoreductase activity, for which the residue Cys (10) plays an essential role.	0	18778244-705
However, in addition to GST activity, we discovered that EGST also possesses @COMPOUND$ : @PROTEIN$ activity, for which the residue Cys (10) plays an essential role.	0	18778244-705
Anti-P mAb promoted @PROTEIN$ overproduction in a dose- and time-dependent manner in both @COMPOUND$ (LPS)-activated RAW 264.7 cells and primary human macrophages.	0	18778281-720
Increased secretion of hyperimmune antibodies following @COMPOUND$ stimulation of @PROTEIN$-activated human B cells in vitro.	1	18778289-732
The addition of a bisecting @COMPOUND$ residue by beta(1,4)-@PROTEIN$ (GnTIII) is known to control the processing of N-linked glycans in mammals, for example by preventing alpha(1,6)-fucosylation of the core glycan.	1	18778316-735
Both CTSs targeted enhanced @PROTEIN$ (eYFP) to a @COMPOUND$-sensitive compartment, indicative of Golgi localization.	0	18778316-736
We have investigated the pre-receptor metabolism of @COMPOUND$ in primary hOSE cells and an immortalised hOSE cell line, OSE-C2, focusing on transcriptional regulation of 3beta-hydroxysteroid dehydrogenase (@PROTEIN$) by inflammatory, anti-inflammatory and apoptotic factors.	0	18778748-865
We have investigated the pre-receptor metabolism of @COMPOUND$ in primary hOSE cells and an immortalised hOSE cell line, OSE-C2, focusing on transcriptional regulation of @PROTEIN$ (3beta-HSD) by inflammatory, anti-inflammatory and apoptotic factors.	0	18778748-865
Coexpression with H6PDH potentiated @PROTEIN$ reductase activity at high @COMPOUND$.	1	18778749-866
@PROTEIN$ dehydrogenase activity was observed in H4IIE cells only at subphysiological @COMPOUND$ levels, indicating a highly efficient supply of substrate for H6PDH and NADPH generation in the ER-lumen.	1	18778749-867
There are data to suggest that psychological intervention can influence neuroendocrine (e.g., @COMPOUND$) and immune function indicators, especially lymphocyte proliferation and @PROTEIN$ cytokine production.	0	18778768-874
The proteins identified belong to the photosynthesis, carbohydrate and @COMPOUND$ metabolism, and @PROTEIN$ functional categories.	0	18778874-903
In the present study, we investigated whether CD147/basigin is involved, via its association with @PROTEIN$ and 4 to transport @COMPOUND$, in glycolysis and then contributes to the progression of A375 melanoma cells.	1	18778892-914
In the present study, we investigated whether CD147/@PROTEIN$ is involved, via its association with MCT1 and 4 to transport @COMPOUND$, in glycolysis and then contributes to the progression of A375 melanoma cells.	1	18778892-914
TCblR belongs to the @PROTEIN$ family, with 2 low-density lipoprotein receptor type A domains separated by a complement-like @COMPOUND$-rich region.	1	18779389-1017
TCblR belongs to the low-density lipoprotein receptor family, with 2 low-density lipoprotein receptor @PROTEIN$ domains separated by a complement-like @COMPOUND$-rich region.	1	18779389-1017
Variability of AChE, BChE, and @PROTEIN$ genes in the late-onset form of Alzheimer's disease and relationships with response to treatment with @COMPOUND$ and Rivastigmine.	1	18780301-1284
Variability of AChE, BChE, and @PROTEIN$ genes in the late-onset form of Alzheimer's disease and relationships with response to treatment with Donepezil and @COMPOUND$.	1	18780301-1284
Variability of @PROTEIN$, BChE, and ChAT genes in the late-onset form of Alzheimer's disease and relationships with response to treatment with Donepezil and @COMPOUND$.	1	18780301-1284
Variability of @PROTEIN$, BChE, and ChAT genes in the late-onset form of Alzheimer's disease and relationships with response to treatment with @COMPOUND$ and Rivastigmine.	1	18780301-1284
Extended-release PEG-@COMPOUND$ allows for long-term imaging of firefly @PROTEIN$ activity in vivo.	1	18780328-1293
Spectrofluorimetric determination of vitamin B(1) using horseradish @PROTEIN$ as catalyst in the presence of @COMPOUND$.	1	18780332-1296
In this work a new spectrofluorimetric method for the determination of vitamin B(1), based on the catalytic activity of horseradish peroxidase (@PROTEIN$) in the presence of hydrogen peroxide (@COMPOUND$), has been developed.	1	18780332-1297
In this work a new spectrofluorimetric method for the determination of vitamin B(1), based on the catalytic activity of horseradish @PROTEIN$ (HRP) in the presence of hydrogen peroxide (@COMPOUND$), has been developed.	1	18780332-1297
In this work a new spectrofluorimetric method for the determination of vitamin B(1), based on the catalytic activity of horseradish peroxidase (@PROTEIN$) in the presence of @COMPOUND$ (H2O2), has been developed.	1	18780332-1297
In this work a new spectrofluorimetric method for the determination of vitamin B(1), based on the catalytic activity of horseradish @PROTEIN$ (HRP) in the presence of @COMPOUND$ (H2O2), has been developed.	1	18780332-1297
Electrospun polyglyconate (@COMPOUND$) and its blends with proteins such as gelatin and @PROTEIN$, with a spatially designed layer structure, were prepared as potential scaffolds for vascular tissue engineering.	1	18780360-1305
Electrospun @COMPOUND$ (Maxon) and its blends with proteins such as gelatin and @PROTEIN$, with a spatially designed layer structure, were prepared as potential scaffolds for vascular tissue engineering.	1	18780360-1305
So far, in maize, three classes of mutants involved in @COMPOUND$ biosynthesis have been isolated: @PROTEIN$, lpa2 and lpa3.	1	18781168-1823
So far, in maize, three classes of mutants involved in @COMPOUND$ biosynthesis have been isolated: lpa1, @PROTEIN$ and lpa3.	1	18781168-1823
So far, in maize, three classes of mutants involved in @COMPOUND$ biosynthesis have been isolated: lpa1, lpa2 and @PROTEIN$.	1	18781168-1823
Bevacizumab (Avastin), ranibizumab (Lucentis) and pegaptanib sodium (@COMPOUND$) are anti-@PROTEIN$ medications that have been used in the treatment of CNV.	1	18781316-1566
Bevacizumab (Avastin), ranibizumab (Lucentis) and @COMPOUND$ (Macugen) are anti-@PROTEIN$ medications that have been used in the treatment of CNV.	1	18781316-1566
Blood samples were collected to assay for biomarkers of oxidative stress (malondialdehyde and carbonyl groups) and antioxidants (@PROTEIN$, @COMPOUND$, alpha-tocopherol, and beta-carotene).	0	18781338-1571
Blood samples were collected to assay for biomarkers of oxidative stress (@COMPOUND$ and carbonyl groups) and antioxidants (@PROTEIN$, reduced glutathione, alpha-tocopherol, and beta-carotene).	0	18781338-1571
The low content of sphingomyelin, sulfatide and @COMPOUND$ is consistent with the immunohistochemical results showing that in the grey-lethal brain significant depletion and disorganization of the myelinated fibres is present, thus supporting the hypothesis that loss of function of the @PROTEIN$ causes neuronal impairment and myelin deficit.	0	18781385-1599
Finally and most importantly, our data indicate that a decrease in AKT activity followed by a total decrease in p70 (@PROTEIN$) phosphorylation reflecting a decrease in mTOR activity occurs during high @COMPOUND$ consumption, resulting from high cell density.	1	18781596-1677
Finally and most importantly, our data indicate that a decrease in AKT activity followed by a total decrease in @PROTEIN$ (S6K) phosphorylation reflecting a decrease in mTOR activity occurs during high @COMPOUND$ consumption, resulting from high cell density.	1	18781596-1677
Finally and most importantly, our data indicate that a decrease in AKT activity followed by a total decrease in p70 (S6K) phosphorylation reflecting a decrease in @PROTEIN$ activity occurs during high @COMPOUND$ consumption, resulting from high cell density.	1	18781596-1677
Some of the peptide derivatives inhibited @PROTEIN$-mediated uptake of ((3)H) @COMPOUND$-Sar.	1	18781650-1708
Effect of enzyme supplementation at moderate @PROTEIN$ loadings on initial @COMPOUND$ and xylose release from corn stover solids pretreated by leading technologies.	0	18781688-1721
For a combined mass loading of cellulase and @PROTEIN$ of 16.1 mg/g original @COMPOUND$ (about 7.5 FPU/g), glucose release from pretreated solids ranged from 50% to75% of the theoretical maximum and was greater for all pretreatments at all protein loadings compared to pure Avicel cellulose except for solids from controlled pH pretreatment and from dilute acid pretreatment by the Sunds pilot unit.	1	18781688-1722
For a combined mass loading of cellulase and @PROTEIN$ of 16.1 mg/g original glucan (about 7.5 FPU/g), @COMPOUND$ release from pretreated solids ranged from 50% to75% of the theoretical maximum and was greater for all pretreatments at all protein loadings compared to pure Avicel cellulose except for solids from controlled pH pretreatment and from dilute acid pretreatment by the Sunds pilot unit.	1	18781688-1722
For a combined mass loading of @PROTEIN$ and beta-glucosidase of 16.1 mg/g original @COMPOUND$ (about 7.5 FPU/g), glucose release from pretreated solids ranged from 50% to75% of the theoretical maximum and was greater for all pretreatments at all protein loadings compared to pure Avicel cellulose except for solids from controlled pH pretreatment and from dilute acid pretreatment by the Sunds pilot unit.	1	18781688-1722
For a combined mass loading of @PROTEIN$ and beta-glucosidase of 16.1 mg/g original glucan (about 7.5 FPU/g), @COMPOUND$ release from pretreated solids ranged from 50% to75% of the theoretical maximum and was greater for all pretreatments at all protein loadings compared to pure Avicel cellulose except for solids from controlled pH pretreatment and from dilute acid pretreatment by the Sunds pilot unit.	1	18781688-1722
PCFT/@PROTEIN$ could therefore play a physiological role in Fe nutrition and the data highlight the potential for the interaction of @COMPOUND$ and haem at the level of intestinal absorption.	1	18782461-1964
Following an oral @COMPOUND$ challenge, there was a weak trend for glucose-stimulated @PROTEIN$ release to be increased in the offspring of dams fed the folate-deficient diet.	1	18782463-1965
Association between serum retinol-binding @PROTEIN$ and small dense low-density lipoprotein @COMPOUND$ levels in young adult women.	1	18782570-2009
Adult female X. laevis were injected three times at weekly intervals with the hapten-carrier complex, trinitrophenylated bovine @PROTEIN$ (@COMPOUND$-BSA).	1	18782588-2018
Adult female X. laevis were injected three times at weekly intervals with the hapten-carrier complex, trinitrophenylated bovine serum albumin (@COMPOUND$-@PROTEIN$).	1	18782588-2018
By using the system, we obtained four event timing data sets (stimulation by @PROTEIN$ with and without @COMPOUND$ at the concentrations of 0.01, 0.1, and 1 microM).	0	18782661-2054
First, R-state, or allosteric, autocatalysis of nitrite reduction increases the rate of NO generation by deoxy@PROTEIN$ and results in maximal NO production at approximately 50% hemoglobin @COMPOUND$ saturation, which is physiologically associated with greatest NO-dependent vasodilation.	1	18783254-2198
Role of @PROTEIN$ and Nox2 in hyperoxia-induced reactive @COMPOUND$ species generation and migration of human lung endothelial cells.	1	18783311-2231
Downregulation of @PROTEIN$, or pretreatment with @COMPOUND$, attenuated hyperoxia-induced cell migration and capillary tube formation, suggesting that ROS generated by Nox4 regulate endothelial cell motility.	0	18783311-2234
Using newly designed degenerate primers targeting the @PROTEIN$ gene we analysed the potential for @COMPOUND$ utilization in DNA and cDNA libraries constructed from a phytoplankton bloom in the Western English Channel during July 2006.	1	18783384-2267
Low-density lipoprotein @COMPOUND$ and non-@PROTEIN$ cholesterol and the incidence of cardiovascular disease in an urban Japanese cohort study: The Suita study.	0	18783774-2396
Only a small number of population-based cohort studies have directly compared the predictive value of low-density lipoprotein @COMPOUND$ (LDL-C) and non-@PROTEIN$ cholesterol (non-HDLC) for coronary artery disease in Asian populations, such as Japan.	0	18783774-2397
Finally, we show that Vcx1 helps return cytosolic @COMPOUND$+) toward resting levels after shock with high extracellular Ca(2+) much more effectively than @PROTEIN$ and that calcineurin, a protein phosphatase regulator of Vcx1 and Pmc1, had no detectable effects on these factors within the first few minutes of its activation.	0	18783827-2422
It is a serious problem that effective treatment choices to T315I, in the @PROTEIN$ kinase domain that shows a strong tolerance in @COMPOUND$ do not exist clinically.	1	18783828-2424
Moreover, diacylgycerol-dependent protein kinase C isoenzymes and activation of extracellular signal-regulated protein kinase (@PROTEIN$) are required for glucose-, @COMPOUND$- and KCl-induced Egr-1 expression.	1	18783846-2433
Moreover, diacylgycerol-dependent @PROTEIN$ isoenzymes and activation of extracellular signal-regulated protein kinase (ERK) are required for @COMPOUND$-, tolbutamide- and KCl-induced Egr-1 expression.	1	18783846-2433
Moreover, diacylgycerol-dependent @PROTEIN$ isoenzymes and activation of extracellular signal-regulated protein kinase (ERK) are required for glucose-, @COMPOUND$- and KCl-induced Egr-1 expression.	1	18783846-2433
Moreover, diacylgycerol-dependent protein kinase C isoenzymes and activation of extracellular signal-regulated protein kinase (ERK) are required for glucose-, @COMPOUND$- and KCl-induced @PROTEIN$ expression.	1	18783846-2433
Moreover, diacylgycerol-dependent protein kinase C isoenzymes and activation of extracellular signal-regulated protein kinase (ERK) are required for @COMPOUND$-, tolbutamide- and KCl-induced @PROTEIN$ expression.	1	18783846-2433
Moreover, diacylgycerol-dependent protein kinase C isoenzymes and activation of extracellular signal-regulated protein kinase (@PROTEIN$) are required for @COMPOUND$-, tolbutamide- and KCl-induced Egr-1 expression.	1	18783846-2433
Moreover, diacylgycerol-dependent @PROTEIN$ C isoenzymes and activation of extracellular signal-regulated protein kinase (ERK) are required for @COMPOUND$-, tolbutamide- and KCl-induced Egr-1 expression.	1	18783846-2433
Moreover, diacylgycerol-dependent @PROTEIN$ C isoenzymes and activation of extracellular signal-regulated protein kinase (ERK) are required for glucose-, @COMPOUND$- and KCl-induced Egr-1 expression.	1	18783846-2433
Long-term blinded placebo-controlled study of SNT-MC17/@COMPOUND$ in the @PROTEIN$ deficient mdx mouse: cardiac protection and improved exercise performance.	1	18784063-2498
Long-term blinded placebo-controlled study of @COMPOUND$/idebenone in the @PROTEIN$ deficient mdx mouse: cardiac protection and improved exercise performance.	1	18784063-2498
@PROTEIN$ blockade normalizes hippocampal alterations and cognitive impairment in @COMPOUND$-induced type 1 diabetes mice.	1	18784648-124
The study aim was to determine whether urine albumin/@COMPOUND$ ratio (UACR), high-sensitivity C-reactive protein (hsCRP) or N-terminal pro-@PROTEIN$ (Nt-proBNP) added to risk prediction based on HeartScore and history of diabetes or cardiovascular disease.	0	18784734-168
Transgene optimization significantly improves SIN vector titers, @PROTEIN$ expression and reconstitution of @COMPOUND$ production in X-CGD cells.	0	18784749-176
Quantitative evaluation of @PROTEIN$ contribution to oral absorption of @COMPOUND$ in rats.	1	18784906-222
@COMPOUND$ concentration in the liver and in plasma alanine aminotransferase (ALT) and aspartate transaminase (@PROTEIN$) activities were determined.	1	18784908-224
In brain tissue, Cu concentration, superoxide dismutase (@PROTEIN$) activities, @COMPOUND$ (MDA) levels and glutathione (GSH) concentrations were determined.	0	18784908-225
In brain tissue, Cu concentration, @PROTEIN$ (SOD) activities, @COMPOUND$ (MDA) levels and glutathione (GSH) concentrations were determined.	0	18784908-225
In brain tissue, @COMPOUND$ concentration, @PROTEIN$ (SOD) activities, malondialdehyde (MDA) levels and glutathione (GSH) concentrations were determined.	0	18784908-225
In brain tissue, @COMPOUND$ concentration, superoxide dismutase (@PROTEIN$) activities, malondialdehyde (MDA) levels and glutathione (GSH) concentrations were determined.	0	18784908-225
We previously reported that inhibition of @PROTEIN$-kinase (ROCK) by hydroxyl @COMPOUND$ improves cognitive deficit and neuronal damage in rats with chronic cerebral ischemia (Huang et al., Cell Mol Neurobiol 28:757-768, 2008).	1	18785000-243
Finally, in the presence of OGD and @COMPOUND$ mesylate, superoxide dismutase (@PROTEIN$) activity was increased by 50% for cortex and by 58% for hippocampus, compared to OGD only group.	1	18785000-244
Finally, in the presence of OGD and @COMPOUND$ mesylate, @PROTEIN$ (SOD) activity was increased by 50% for cortex and by 58% for hippocampus, compared to OGD only group.	1	18785000-244
Na+/H+ exchanger isoform 3 (@PROTEIN$) is responsible for net uptake of @COMPOUND$ and water from the gastrointestinal (GI) tract.	1	18785066-298
@PROTEIN$ is also important in the regulation of @COMPOUND$ signaling, a second messenger implicated in learning, memory, and mood.	1	18785206-418
Elevated amounts of @PROTEIN$, one of the @COMPOUND$-generating reactions of glycolysis, in wood frog brain during freezing would enhance the glycolytic capacity of the organ and support the maintenance of cellular energetics under the ischemic conditions of the frozen state.	1	18785212-354
SNs and SMs were exposed to macrophages with and without addition of @COMPOUND$ (LPS), a positive inducer of tumor necrosis factor-alpha (TNF-alpha), interleukin 6 (@PROTEIN$), and nitric oxide (NO).	1	18785685-518
SNs and SMs were exposed to macrophages with and without addition of endotoxin lipopolysaccharide (LPS), a positive inducer of tumor necrosis factor-alpha (TNF-alpha), @PROTEIN$ (IL-6), and @COMPOUND$ (NO).	0	18785685-518
SNs and SMs were exposed to macrophages with and without addition of endotoxin lipopolysaccharide (LPS), a positive inducer of @PROTEIN$-alpha (TNF-alpha), interleukin 6 (IL-6), and @COMPOUND$ (NO).	0	18785685-518
SNs and SMs were exposed to macrophages with and without addition of endotoxin lipopolysaccharide (LPS), a positive inducer of tumor necrosis factor-alpha (@PROTEIN$), interleukin 6 (IL-6), and @COMPOUND$ (NO).	0	18785685-518
SNs and SMs were exposed to macrophages with and without addition of @COMPOUND$ (LPS), a positive inducer of tumor necrosis factor-alpha (@PROTEIN$), interleukin 6 (IL-6), and nitric oxide (NO).	1	18785685-518
SNs and SMs were exposed to macrophages with and without addition of @COMPOUND$ (LPS), a positive inducer of tumor necrosis factor-alpha (TNF-alpha), @PROTEIN$ (IL-6), and nitric oxide (NO).	1	18785685-518
SNs and SMs were exposed to macrophages with and without addition of endotoxin lipopolysaccharide (LPS), a positive inducer of tumor necrosis factor-alpha (TNF-alpha), interleukin 6 (@PROTEIN$), and @COMPOUND$ (NO).	0	18785685-518
SNs and SMs were exposed to macrophages with and without addition of @COMPOUND$ (LPS), a positive inducer of @PROTEIN$-alpha (TNF-alpha), interleukin 6 (IL-6), and nitric oxide (NO).	1	18785685-518
We therefore hypothesized that a diffusible product of the @PROTEIN$ enzyme reaction (possibly DAG (@COMPOUND$)) mediated the biological effects of the protein.	1	18785878-575
Silencing of @PROTEIN$, the key entry-point enzyme for @COMPOUND$ biosynthesis led to flavonoid-deficient roots.	1	18786000-610
@PROTEIN$ enzymes have been characterised in plants, bacteria and fungi and are thought to be important in detoxification of nitriles, utilisation of @COMPOUND$ and synthesis of plant hormones.	1	18786181-656
In plants cyanide is converted to beta-cyano-L-alanine, which is subsequently detoxified to aspartic acid and @COMPOUND$ by @PROTEIN$.	1	18786181-657
In plants cyanide is converted to beta-cyano-L-alanine, which is subsequently detoxified to @COMPOUND$ and ammonia by @PROTEIN$.	1	18786181-657
The mitochondrial membrane potential (Delta psi (mit)) was also tested with @COMPOUND$ 30 min after SI challenge, and was shown to have collapsed in the incompatible pollen tubes after exposure to @PROTEIN$.	1	18786182-658
In conclusion, female rats undernourished in utero had normophagic obesity as adults but had an absence of @COMPOUND$-induced hypophagia and low hypothalamic levels of the @PROTEIN$ receptor.	0	18786279-668
Compensatory adaptations for the functional serotonergic impairment were evidenced, such as an enhanced release of @COMPOUND$ in response to a meal allied to up-regulated hypothalamic @PROTEIN$ and transporter expression.	1	18786279-669
The proliferation of the parental cell line was most efficiently stimulated by @COMPOUND$ (DHT), but the LNCaP(@PROTEIN$) cells were equally stimulated by Adione, indicating that 17beta-HSD3 efficiently converts Adione to T in this model.	0	18786604-753
The proliferation of the parental cell line was most efficiently stimulated by 5alpha-dihydrotestosterone (@COMPOUND$), but the LNCaP(@PROTEIN$) cells were equally stimulated by Adione, indicating that 17beta-HSD3 efficiently converts Adione to T in this model.	0	18786604-753
They potentiate @COMPOUND$-induced @PROTEIN$ secretion and may be responsible for up to 70% of postprandial insulin secretion.	1	18786605-754
However, in supraphysiological doses, @PROTEIN$ administration may completely normalize beta as well as alpha cell sensitivity to @COMPOUND$.	1	18786605-755
The induction of signal transduction by serum and growth factors significantly increases the level of @PROTEIN$ ubiquitination, while the treatment of cells with UV and @COMPOUND$ has the opposite effect.	1	18786649-767
Interaction of @COMPOUND$ with bovine @PROTEIN$ : determination of the binding mechanism and binding site by spectroscopic methods.	1	18786760-796
The interaction between @COMPOUND$ (MG) and bovine @PROTEIN$ (BSA) under simulative physiological conditions was investigated by the methods of fluorescence spectroscopy, UV-vis absorption and circular dichroism (CD) spectroscopy.	1	18786760-797
The interaction between @COMPOUND$ (MG) and bovine serum albumin (@PROTEIN$) under simulative physiological conditions was investigated by the methods of fluorescence spectroscopy, UV-vis absorption and circular dichroism (CD) spectroscopy.	1	18786760-797
The binding distance (r) between MG and the @COMPOUND$ residue of @PROTEIN$ was obtained to be 4.79 nm according to Frster theory of non-radioactive energy transfer.	1	18786760-798
Unlike @COMPOUND$, Cystatin C (@PROTEIN$) is believed to be independent of body composition in both adults and children.	0	18786974-878
Unlike @COMPOUND$, @PROTEIN$ C (CysC) is believed to be independent of body composition in both adults and children.	0	18786974-878
Levels of endothelial @PROTEIN$ and inducible nitric oxide synthase did not differ among the groups, nor did total nitrite plus @COMPOUND$ levels.	0	18787021-886
@COMPOUND$ controls cytosolic Ca2+ and @PROTEIN$ secretion in mouse islets lacking adenosine triphosphate-sensitive K+ channels owing to a knockout of the pore-forming subunit Kir6.2.	1	18787024-887
Glucose controls cytosolic Ca2+ and @PROTEIN$ secretion in mouse islets lacking @COMPOUND$-sensitive K+ channels owing to a knockout of the pore-forming subunit Kir6.2.	1	18787024-887
Thereafter we determined that hCG effect could be partially blocked by pharmacologic inhibition of @PROTEIN$ pathway with 50 microM @COMPOUND$ but not by the inhibition of the phosphatidylinositol 3-kinase pathway with 0.1 microm wortmannin.	1	18787032-890
Thereafter we determined that hCG effect could be partially blocked by pharmacologic inhibition of @PROTEIN$ pathway with 50 microM PD98059 but not by the inhibition of the phosphatidylinositol 3-kinase pathway with 0.1 microm @COMPOUND$.	0	18787032-890
Lung injury was assessed by measuring vascular permeability (via @COMPOUND$), edema, neutrophil infiltration (via myeloperoxidase (@PROTEIN$), and expression of proinflammatory cytokines.	0	18787174-941
Cholesterol efflux from ((3)H) @COMPOUND$-acetyl-LDL-loaded monocyte-derived macrophages to standard apolipoprotein A-I (@PROTEIN$), HDL(2), and serum was measured.	1	18787236-950
@COMPOUND$ efflux from ((3)H) cholesterol-oleate-acetyl-LDL-loaded monocyte-derived macrophages to standard apolipoprotein A-I (@PROTEIN$), HDL(2), and serum was measured.	1	18787236-950
Cholesterol efflux from ((3)H) @COMPOUND$-acetyl-LDL-loaded monocyte-derived macrophages to standard @PROTEIN$ (apoA-I), HDL(2), and serum was measured.	1	18787236-950
@COMPOUND$ efflux from ((3)H) cholesterol-oleate-acetyl-LDL-loaded monocyte-derived macrophages to standard @PROTEIN$ (apoA-I), HDL(2), and serum was measured.	1	18787236-950
@COMPOUND$ efflux to @PROTEIN$, HDL(2), and serum from macrophage foam cells derived from low- and high-HDL subjects was similar.	0	18787236-952
@COMPOUND$ efflux from THP-1 macrophages to serum from study subjects correlated with serum apoB (P = 0.033), @PROTEIN$ (P = 0.004), apoA-II 0.0001), and the percentage of apoA-I present in the form of prebeta-HDL (P = 0.0001).	1	18787236-954
@COMPOUND$ efflux from THP-1 macrophages to serum from study subjects correlated with serum apoB (P = 0.033), apoA-I (P = 0.004), @PROTEIN$ 0.0001), and the percentage of apoA-I present in the form of prebeta-HDL (P = 0.0001).	1	18787236-954
In this study, the degradation of @PROTEIN$- and R-@COMPOUND$ under anaerobic conditions was studied.	0	18787748-1079
Regulation of muscle protein degradation, not synthesis, by dietary @COMPOUND$ in rats fed @PROTEIN$-deficient diet.	0	18787757-1084
Studies of HeLa cells and serum- and glucocorticoid-regulated kinase 1 (SGK1) knockout mice identified @COMPOUND$ residues in the @PROTEIN$ (NDRG1-Thr (346/356/366)) that are phosphorylated by SGK1 but not by related kinases (Murray et al., Biochem J 385:1-12, 2005).	1	18787837-1099
Studies of HeLa cells and serum- and glucocorticoid-regulated kinase 1 (SGK1) knockout mice identified @COMPOUND$ residues in the n-myc downstream-regulated gene 1 protein (@PROTEIN$-Thr (346/356/366)) that are phosphorylated by SGK1 but not by related kinases (Murray et al., Biochem J 385:1-12, 2005).	1	18787837-1099
Although G (Na) is negligible in hormone-deprived cells, these cells displayed basal @PROTEIN$ activity that was sensitive to @COMPOUND$, an inhibitor of 3-phosphatidylinositol phosphate kinase (PI3K).	1	18787837-1100
@PROTEIN$ expression analysis in chemotherapy-naive patients with advanced non-small-cell lung cancer treated with gefitinib or placebo in combination with @COMPOUND$-based chemotherapy.	1	18787840-1103
The present investigation was carried out to assess the erythrocytic oxidative stress indices such as lipid peroxides level and activities of antioxidant enzymes such as @PROTEIN$ and catalase, and some hematological parameters after treatment of subclinically ketotic lactating cows with antioxidants, @COMPOUND$ and selenium, incorporated in conventional treatment regimen.	0	18787967-1145
The present investigation was carried out to assess the erythrocytic oxidative stress indices such as lipid peroxides level and activities of antioxidant enzymes such as superoxide dismutase and @PROTEIN$, and some hematological parameters after treatment of subclinically ketotic lactating cows with antioxidants, @COMPOUND$ and selenium, incorporated in conventional treatment regimen.	0	18787967-1145
The present investigation was carried out to assess the erythrocytic oxidative stress indices such as lipid peroxides level and activities of antioxidant enzymes such as @PROTEIN$ and catalase, and some hematological parameters after treatment of subclinically ketotic lactating cows with antioxidants, vitamin E and @COMPOUND$, incorporated in conventional treatment regimen.	0	18787967-1145
The present investigation was carried out to assess the erythrocytic oxidative stress indices such as lipid peroxides level and activities of antioxidant enzymes such as superoxide dismutase and @PROTEIN$, and some hematological parameters after treatment of subclinically ketotic lactating cows with antioxidants, vitamin E and @COMPOUND$, incorporated in conventional treatment regimen.	0	18787967-1145
This study was designed to determine the effect of molsidomine (MO), a precursor of @COMPOUND$ (NO) donor, on hypoxia inducible factor alpha (@PROTEIN$) and Sonic hedgehog (Shh) levels considered to be involved in the development of testes ischemia/reperfusion (I-R) injury.	1	18787973-1149
This study was designed to determine the effect of @COMPOUND$ (MO), a precursor of nitric oxide (NO) donor, on hypoxia inducible factor alpha (@PROTEIN$) and Sonic hedgehog (Shh) levels considered to be involved in the development of testes ischemia/reperfusion (I-R) injury.	1	18787973-1149
Candida albicans and C. tropicalis obtained from whole saliva of patients presenting signs of oral candidosis were assayed for quantification of colony forming units, exoenzyme activity (phospholipase and @PROTEIN$) and antifungal drug sensitivity (@COMPOUND$, fluconazole and itraconazole) by the reference method of the Clinical and Laboratory Standards Institute.	0	18787978-1152
Candida albicans and C. tropicalis obtained from whole saliva of patients presenting signs of oral candidosis were assayed for quantification of colony forming units, exoenzyme activity (phospholipase and @PROTEIN$) and antifungal drug sensitivity (amphotericin B, @COMPOUND$ and itraconazole) by the reference method of the Clinical and Laboratory Standards Institute.	0	18787978-1152
Candida albicans and C. tropicalis obtained from whole saliva of patients presenting signs of oral candidosis were assayed for quantification of colony forming units, exoenzyme activity (phospholipase and @PROTEIN$) and antifungal drug sensitivity (amphotericin B, fluconazole and @COMPOUND$) by the reference method of the Clinical and Laboratory Standards Institute.	0	18787978-1152
To achieve sustained delivery of a novel bone-induced growth factor, chitosan microspheres loaded with synthetic oligopeptide (S((@COMPOUND$))KIPKASSVPTELSAISTLYLDDD, P24) were prepared by an emulsion-ionic cross-linking method in the presence of tripolyphosphate, with bovine serum albumin (@PROTEIN$) as a control.	0	18788036-1175
To achieve sustained delivery of a novel bone-induced growth factor, chitosan microspheres loaded with synthetic oligopeptide (S((@COMPOUND$))KIPKASSVPTELSAISTLYLDDD, P24) were prepared by an emulsion-ionic cross-linking method in the presence of tripolyphosphate, with bovine @PROTEIN$ (BSA) as a control.	0	18788036-1175
Colon cancer cells maintain low levels of @COMPOUND$ to avoid cell death caused by inhibition of @PROTEIN$/HDAC3.	0	18789002-1201
Colon cancer cells maintain low levels of @COMPOUND$ to avoid cell death caused by inhibition of HDAC1/@PROTEIN$.	0	18789002-1201
This process is associated with an increase in intracellular levels of @COMPOUND$, increase in the acetylation status of @PROTEIN$, and enhanced cell death.	0	18789002-1204
The @COMPOUND$/@PROTEIN$ (PKA) signaling cascade is crucial for synaptic plasticity in a wide variety of species.	1	18789341-1500
Epigenetic reprogramming of breast cancer cells by @COMPOUND$ occurs regardless of @PROTEIN$ status.	0	18789398-1523
In the present study, we have investigated the effect of @PROTEIN$ on ABCA1 expression and @COMPOUND$ efflux in THP-1 macrophage-derived foam cells.	1	18789440-1646
In the present study, we have investigated the effect of IFN-gamma on @PROTEIN$ expression and @COMPOUND$ efflux in THP-1 macrophage-derived foam cells.	0	18789440-1646
Every 12 weeks intestinal permeability (@COMPOUND$/mannitol ratio), haemoglobin, plasma albumin, alpha-1-acid @PROTEIN$, IgG and Giardia-specific IgM (GSIgM) and eggs of the three common geohelminths and G. intestinalis cysts were determined.	0	18789466-1548
Every 12 weeks intestinal permeability (lactulose/@COMPOUND$ ratio), haemoglobin, plasma albumin, @PROTEIN$-acid glycoprotein, IgG and Giardia-specific IgM (GSIgM) and eggs of the three common geohelminths and G. intestinalis cysts were determined.	0	18789466-1548
Every 12 weeks intestinal permeability (@COMPOUND$/mannitol ratio), haemoglobin, plasma albumin, @PROTEIN$-acid glycoprotein, IgG and Giardia-specific IgM (GSIgM) and eggs of the three common geohelminths and G. intestinalis cysts were determined.	0	18789466-1548
Every 12 weeks intestinal permeability (lactulose/@COMPOUND$ ratio), haemoglobin, plasma albumin, alpha-1-acid @PROTEIN$, IgG and Giardia-specific IgM (GSIgM) and eggs of the three common geohelminths and G. intestinalis cysts were determined.	0	18789466-1548
As such, the aim of the present study was to investigate whether @PROTEIN$-inhibition with @COMPOUND$, a molecule distinctly different from torcetrapib, impacts on vascular function, a well-established surrogate of atherosclerotic vascular disease, as well as markers of inflammation and oxidative stress in patients with type II hyperlipidemia.	1	18789492-1558
In this review we discuss the @PROTEIN$ that transport arsenic and @COMPOUND$ into cells, from bacteria to humans, as well as some of the efflux proteins involved in detoxification.	1	18789529-1570
Pathways involved in the hydrolysis of nitrile pollutants (aliphatic nitriles, @COMPOUND$ analogues) and the corresponding enzymes (@PROTEIN$, nitrile hydratase) are described in detail.	1	18789530-2169
Since stellate cells have been found to express the beta but not the alpha isoform of the @PROTEIN$, it can be predicted that nutritional intakes of the soy isoflavone @COMPOUND$-a selective agonist for ERbeta in the low nanomolar plasma concentrations achievable with these intakes-have potential for suppressing hepatic fibrosis, in both men and women.	0	18789597-659
Since stellate cells have been found to express the beta but not the alpha isoform of the @PROTEIN$, it can be predicted that nutritional intakes of the soy @COMPOUND$ genistein-a selective agonist for ERbeta in the low nanomolar plasma concentrations achievable with these intakes-have potential for suppressing hepatic fibrosis, in both men and women.	1	18789597-659
We report that the PP inhibition of proteolysis in young rats was mediated by the increased @PROTEIN$ secretion and resulted from a down-regulation of both lysosomal and @COMPOUND$+)-dependent proteolysis.	0	18789664-1638
Aqueous extract of cumin was tested for its antiglycating ability against @COMPOUND$-induced glycation of goat lens total soluble protein (TSP), alpha-crystallin from goat lens and a nonlenticular protein bovine @PROTEIN$ (BSA).	1	18789666-1639
Aqueous extract of cumin was tested for its antiglycating ability against @COMPOUND$-induced glycation of goat lens total soluble protein (@PROTEIN$), alpha-crystallin from goat lens and a nonlenticular protein bovine serum albumin (BSA).	1	18789666-1639
Aqueous extract of cumin was tested for its antiglycating ability against @COMPOUND$-induced glycation of goat lens total soluble protein (TSP), alpha-crystallin from goat lens and a nonlenticular protein bovine serum albumin (@PROTEIN$).	1	18789666-1639
To investigate the effects of selenium on mRNA expressions of proinflammatory cytokines and inducible nitric oxide synthase (@PROTEIN$) in the pancreas of streptozotocin-induced diabetic mice, the animals were divided into three groups in this study: a normal control group, an untreated diabetes mellitus group and a @COMPOUND$-treated diabetes mellitus group.	0	18789669-1641
To investigate the effects of selenium on mRNA expressions of proinflammatory cytokines and inducible @PROTEIN$ (iNOS) in the pancreas of streptozotocin-induced diabetic mice, the animals were divided into three groups in this study: a normal control group, an untreated diabetes mellitus group and a @COMPOUND$-treated diabetes mellitus group.	0	18789669-1641
To investigate the effects of @COMPOUND$ on mRNA expressions of proinflammatory cytokines and inducible @PROTEIN$ (iNOS) in the pancreas of streptozotocin-induced diabetic mice, the animals were divided into three groups in this study: a normal control group, an untreated diabetes mellitus group and a selenite-treated diabetes mellitus group.	1	18789669-1641
To investigate the effects of @COMPOUND$ on mRNA expressions of proinflammatory cytokines and inducible nitric oxide synthase (@PROTEIN$) in the pancreas of streptozotocin-induced diabetic mice, the animals were divided into three groups in this study: a normal control group, an untreated diabetes mellitus group and a selenite-treated diabetes mellitus group.	1	18789669-1641
The results showed that pancreatic @COMPOUND$ content and @PROTEIN$.05), respectively, in selenite-treated diabetes mellitus group compared with untreated diabetes mellitus group.	0	18789669-1642
The results showed that pancreatic selenium content and @PROTEIN$.05), respectively, in @COMPOUND$-treated diabetes mellitus group compared with untreated diabetes mellitus group.	0	18789669-1642
Meanwhile, pancreatic mRNA expressions of proinflammatory cytokines interleukin-1beta, @PROTEIN$-alpha and interferon-gamma ; mRNA expression and activity of iNOS.05), respectively, in @COMPOUND$-treated diabetes mellitus group compared with untreated diabetes mellitus group.	1	18789669-1643
Meanwhile, pancreatic mRNA expressions of proinflammatory cytokines interleukin-1beta, tumor necrosis factor-alpha and interferon-gamma ; mRNA expression and activity of @PROTEIN$.05), respectively, in @COMPOUND$-treated diabetes mellitus group compared with untreated diabetes mellitus group.	1	18789669-1643
Meanwhile, pancreatic mRNA expressions of proinflammatory cytokines interleukin-1beta, tumor necrosis factor-alpha and @PROTEIN$ ; mRNA expression and activity of iNOS.05), respectively, in @COMPOUND$-treated diabetes mellitus group compared with untreated diabetes mellitus group.	1	18789669-1643
Decreases in PNNs, aggrecan and @COMPOUND$ were observed only in the terminal stages and correlated with the distribution of @PROTEIN$ (BSE) and activated glial cells.	1	18789733-21
This study suggests that the loss of PNNs, aggrecan and @COMPOUND$ is a consequence of @PROTEIN$ (BSE) accumulation.	0	18789733-22
This study suggests that the loss of @PROTEIN$, aggrecan and @COMPOUND$ is a consequence of PrP (BSE) accumulation.	0	18789733-22
Cells were exposed to native low-density lipoprotein (LDL), acetylated LDL, and LDL that had been modified by oxidation with @COMPOUND$ or ferrous ions or by exposure to auto-oxidation products of arachidonic acid for 16h, and @PROTEIN$ was then assayed in medium.	0	18789802-1681
Cells were exposed to native low-density lipoprotein (LDL), acetylated LDL, and LDL that had been modified by oxidation with copper or ferrous ions or by exposure to auto-oxidation products of @COMPOUND$ for 16h, and @PROTEIN$ was then assayed in medium.	0	18789802-1681
Cells were exposed to native low-density lipoprotein (LDL), acetylated LDL, and LDL that had been modified by oxidation with copper or @COMPOUND$ or by exposure to auto-oxidation products of arachidonic acid for 16h, and @PROTEIN$ was then assayed in medium.	0	18789802-1681
In hypersensitive alpha4L9'A mice, injections of a low dose of @COMPOUND$ (0.1 mg/kg) led to strong c-@PROTEIN$ expression in only the ventrolateral region of the MHb, but not in the MHb of wild-type (WT) mice.	1	18789953-507
To address this issue, we have examined the effects of excitotoxic lesion of CM/Pf and of @COMPOUND$-induced lesion of nigral dopamine neurons, separately or in association, on gene expression of markers of neuronal activity in the rat basal ganglia (striatal @PROTEIN$ precursors, GAD67, cytochrome oxidase subunit I) by quantitative in situ hybridization histochemistry.	1	18790021-1764
To address this issue, we have examined the effects of excitotoxic lesion of CM/Pf and of @COMPOUND$-induced lesion of nigral dopamine neurons, separately or in association, on gene expression of markers of neuronal activity in the rat basal ganglia (striatal neuropeptide precursors, GAD67, @PROTEIN$) by quantitative in situ hybridization histochemistry.	1	18790021-1764
To address this issue, we have examined the effects of excitotoxic lesion of CM/Pf and of @COMPOUND$-induced lesion of nigral dopamine neurons, separately or in association, on gene expression of markers of neuronal activity in the rat basal ganglia (striatal neuropeptide precursors, @PROTEIN$, cytochrome oxidase subunit I) by quantitative in situ hybridization histochemistry.	1	18790021-1764
"Participating in a significant fraction of the fundamental paths connecting the ligands to the phenotypes, cofactor @COMPOUND$ and complex Gbeta/Ggamma were identified as ""housekeeping"" molecules, through which all pathways of @PROTEIN$ network are cross-talking."	1	18790083-1786
These effects were probably associated with the increase of intracellular @COMPOUND$ in mitochondrial signaling pathway which attributed to the down-regulation of @PROTEIN$ (SOD).	1	18790533-1437
These effects were probably associated with the increase of intracellular @COMPOUND$ in mitochondrial signaling pathway which attributed to the down-regulation of superoxide dismutase (@PROTEIN$).	1	18790533-1437
This initiates a @COMPOUND$ signalling cascade resulting in the translocation of @PROTEIN$-bearing vesicles to the apical membrane.	1	18790812-2041
The formation and trafficking of autophagic vesicles are directed in part by associated conjugation cascades that couple the AUTOPHAGY-RELATED8 (@PROTEIN$) and ATG12 proteins to their respective targets, @COMPOUND$ and the ATG5 protein.	1	18790996-2085
The formation and trafficking of autophagic vesicles are directed in part by associated conjugation cascades that couple the AUTOPHAGY-RELATED8 (ATG8) and @PROTEIN$ proteins to their respective targets, @COMPOUND$ and the ATG5 protein.	1	18790996-2085
The formation and trafficking of autophagic vesicles are directed in part by associated conjugation cascades that couple the AUTOPHAGY-RELATED8 (ATG8) and ATG12 proteins to their respective targets, @COMPOUND$ and the @PROTEIN$ protein.	0	18790996-2085
Levels of Atg transcripts and/or the @PROTEIN$-@COMPOUND$ adduct increase during leaf senescence and nitrogen and fixed-carbon limitations, indicating that autophagy plays a key role in nutrient remobilization.	1	18790996-2086
This study confirmed QTL previously identified for pH except those on @PROTEIN$, 11, 12, and X, and found 11 new 5% genome-wise significant QTL for @COMPOUND$-related traits.	0	18791141-99
The objective of this study was to examine the effect of level and duration of feeding of an n-3 PUFA-enriched fish oil (@COMPOUND$) supplement in combination with soybean oil (SO) on the transcriptional regulation of @PROTEIN$ gene expression in bovine muscle.	1	18791145-109
Whole blood and plasma were analyzed for total Se, @PROTEIN$ activity in whole blood (GPX-1) and plasma, and thyroid hormones (thyroxine and @COMPOUND$) in plasma.	0	18791154-2132
Whole blood and plasma were analyzed for total Se, @PROTEIN$ activity in whole blood (GPX-1) and plasma, and thyroid hormones (@COMPOUND$ and triiodothyronine) in plasma.	0	18791154-2132
Whole blood and plasma were analyzed for total Se, glutathione peroxidase activity in whole blood (@PROTEIN$) and plasma, and thyroid hormones (thyroxine and @COMPOUND$) in plasma.	0	18791154-2132
Whole blood and plasma were analyzed for total Se, glutathione peroxidase activity in whole blood (@PROTEIN$) and plasma, and thyroid hormones (@COMPOUND$ and triiodothyronine) in plasma.	0	18791154-2132
Studies have shown that administration of @COMPOUND$ (estrogen) after trauma-hemorrhage normalized cardiac @PROTEIN$ levels and restored cardiac functions under those conditions.	1	18791496-2222
Chemopreventive potential of @COMPOUND$ in mouse skin tumors through regulation of mitochondrial and @PROTEIN$/AKT signaling pathways.	1	18791811-2349
@COMPOUND$ plus low-dose trastuzumab in @PROTEIN$ positive metastatic breast cancer.	0	18791821-2351
This phase II study, evaluated the activity and cardiotoxicity of first-line @COMPOUND$ plus low-dose trastuzumab (LD-T) in patients with @PROTEIN$ positive MBC.	0	18791821-2352
The DEP-induced increases in peribronchial eosinophils and mucous goblet cells in the lung tissues, and of @PROTEIN$ and IL-13 in the BAL fluid, were significantly attenuated by the antioxidant @COMPOUND$.	1	18791914-2380
The DEP-induced increases in peribronchial eosinophils and mucous goblet cells in the lung tissues, and of IL-5 and @PROTEIN$ in the BAL fluid, were significantly attenuated by the antioxidant @COMPOUND$.	1	18791914-2380
Each of the developed consortium has a phosphate solubilizer, @COMPOUND$ fixer, @PROTEIN$ producer, heterotrophic member and an antagonist.	0	18792056-2438
Each of the developed consortium has a @COMPOUND$ solubilizer, nitrogen fixer, @PROTEIN$ producer, heterotrophic member and an antagonist.	0	18792056-2438
Using cannabinoid receptor antagonists and cannabinoid receptor gene deficient mice (CB(1) (-/-) and CB(2) (-/-)), we showed that both CB(1) and CB(2) receptors were involved in the @COMPOUND$-induced attenuation of serum IL-12 and @PROTEIN$.	0	18792785-89
Promoter analysis of the @PROTEIN$, 4, and 11 genes in HeLa cells did not reveal a cis-regulatory element responsive to @COMPOUND$ in their 5'-flanking sequences.	0	18792801-694
@PROTEIN$- and caspase-3-mediated superoxide-induced apoptosis of rat hepatic stellate cells: reversal by @COMPOUND$.	1	18792915-162
In vivo administration of a synthetic phospholipid, named hereafter phospho-ceramide analogue-1 (PCERA-1), was previously found to suppress @COMPOUND$ (LPS)-induced @PROTEIN$ blood levels.	1	18793216-256
In conclusion, the anti-inflammatory activity of PCERA-1 seems to be mediated by a cell membrane receptor, upstream of @COMPOUND$ production, and eventually TNF-alpha suppression and @PROTEIN$ induction.	0	18793216-258
In conclusion, the anti-inflammatory activity of PCERA-1 seems to be mediated by a cell membrane receptor, upstream of @COMPOUND$ production, and eventually @PROTEIN$ suppression and IL-10 induction.	0	18793216-258
Acylated ghrelin and TNF , @PROTEIN$ , IL-1 and IL-6 were measured with @COMPOUND$.	0	18793341-327
Acylated ghrelin and @PROTEIN$ , IFN , IL-1 and IL-6 were measured with @COMPOUND$.	0	18793341-327
Acylated @PROTEIN$ and TNF , IFN , IL-1 and IL-6 were measured with @COMPOUND$.	0	18793341-327
Acylated ghrelin and TNF , IFN , IL-1 and @PROTEIN$ were measured with @COMPOUND$.	0	18793341-327
Pre-gravid physical activity and reduced risk of @COMPOUND$ intolerance in pregnancy : the role of @PROTEIN$ sensitivity.	1	18793347-2512
Thus, we sought to study the relationships between types of pre-gravid physical activity and metabolic parameters in pregnancy, including @COMPOUND$ tolerance, @PROTEIN$ sensitivity and beta-cell function.	0	18793347-2513
Inhibition of autophagy by treating rats with @COMPOUND$ (15 microg/kg; intraperitoneally) abolished the ischaemic adaptation-induced induction of @PROTEIN$-II, Beclin-1, BAG-1 and cardioprotection.	1	18793351-330
Inhibition of autophagy by treating rats with @COMPOUND$ (15 microg/kg; intraperitoneally) abolished the ischaemic adaptation-induced induction of LC3-II, Beclin-1, @PROTEIN$ and cardioprotection.	1	18793351-330
Inhibition of autophagy by treating rats with @COMPOUND$ (15 microg/kg; intraperitoneally) abolished the ischaemic adaptation-induced induction of LC3-II, @PROTEIN$, BAG-1 and cardioprotection.	1	18793351-330
When myosin molecules work as an aggregate, the sliding movement of a myosin filament driven by the power strokes of some myosin heads makes other myosin heads that have completed their power strokes detach from the @PROTEIN$ without consuming @COMPOUND$.	0	18793694-459
A critical requirement for this mechanism is that @COMPOUND$ must preferentially facilitate the detachment of myosins that have completed their power strokes, but are still strongly attached to the @PROTEIN$.	0	18793694-460
Efficacy, safety and patient-reported outcomes of combination @PROTEIN$ and @COMPOUND$ versus etanercept alone in patients with rheumatoid arthritis: a double-blind randomised 2-year study.	0	18794178-604
To determine the efficacy and safety of @PROTEIN$ and etanercept plus @COMPOUND$ versus sulfasalazine in patients with rheumatoid arthritis (RA) despite sulfasalazine therapy.	0	18794178-605
A randomized trial of @COMPOUND$ and @PROTEIN$ with or without rituximab for PBSC mobilization in B-cell non-Hodgkin's lymphoma.	0	18794865-1914
Twenty seven patients were mobilized with @COMPOUND$ and @PROTEIN$ and 28 with etoposide, G-CSF and rituximab.	0	18794865-1915
Aberrant methylation of the @PROTEIN$ (O6-methylguanine-DNA methyltransferase) DNA-repair gene is a predictive marker for the response to chemotherapy with alkylating agents (e.g., @COMPOUND$) in malignant gliomas.	1	18795231-893
This work describes the influence of two polar lipids, Sn-1/3 and Sn-@COMPOUND$, on the activity of @PROTEIN$ in biphasic systems and in microemulsions.	1	18795240-896
In previous communications, we have shown that Sn-@COMPOUND$ can replace Sn-1,3 regiospecific @PROTEIN$ at the oil-water interface, causing a drastically reduced rate of lipolysis.	1	18795240-897
Depletion of tungsten and/or molybdenum, however, did not affect the growth of the pure culture of S. fumaroxidans on @COMPOUND$ plus fumarate significantly, although the specific activities of @PROTEIN$ and especially formate dehydrogenase were influenced by the absence of Mo and W. This indicates that the organism has a low W or Mo requirement under these conditions.	0	18795263-905
Depletion of tungsten and/or molybdenum, however, did not affect the growth of the pure culture of S. fumaroxidans on @COMPOUND$ plus fumarate significantly, although the specific activities of hydrogenase and especially @PROTEIN$ were influenced by the absence of Mo and W. This indicates that the organism has a low W or Mo requirement under these conditions.	0	18795263-905
Depletion of tungsten and/or molybdenum, however, did not affect the growth of the pure culture of S. fumaroxidans on propionate plus @COMPOUND$ significantly, although the specific activities of @PROTEIN$ and especially formate dehydrogenase were influenced by the absence of Mo and W. This indicates that the organism has a low W or Mo requirement under these conditions.	0	18795263-905
Depletion of tungsten and/or molybdenum, however, did not affect the growth of the pure culture of S. fumaroxidans on propionate plus @COMPOUND$ significantly, although the specific activities of hydrogenase and especially @PROTEIN$ were influenced by the absence of Mo and W. This indicates that the organism has a low W or Mo requirement under these conditions.	0	18795263-905
Our results suggest a more prominent role for H2 as electron carrier in the syntrophic conversion of @COMPOUND$, when the essential trace metals W and Mo for the functioning of @PROTEIN$ are depleted.	1	18795263-906
Previous studies have demonstrated an association between genetic polymorphisms of the mu opioid receptor gene (@PROTEIN$) and response to @COMPOUND$ treatment.	1	18795264-907
Based on the preclinical evidence of @PROTEIN$ I (Topo-1) upregulation by @COMPOUND$ (MMC) and decreased NF-kappaB activation by celecoxib, we evaluated combinations of irinotecan/MMC and irinotecan/MMC/celecoxib in patients with advanced solid malignancies.	1	18795290-925
The cells expressed @PROTEIN$ sensitive to @COMPOUND$ (2) and decreased by siRNA, which both reduced fast volume changes.	1	18795320-932
Two conserved @COMPOUND$ repeats within the COMM domain were found to be critically required for @PROTEIN$ binding.	1	18795889-1063
Functional analysis of rat liver @PROTEIN$ promoter: differential responsiveness to @COMPOUND$.	1	18795892-1064
Wet-wrap treatment using dilutions of @COMPOUND$ ointment and fluticasone propionate cream in human @PROTEIN$ (+/+) mice with atopic dermatitis.	0	18795918-1074
Wet-wrap treatment using dilutions of tacrolimus ointment and @COMPOUND$ cream in human @PROTEIN$ (+/+) mice with atopic dermatitis.	0	18795918-1074
The use of low-dose COCs is preferable in PCOS, especially among patients with @COMPOUND$ intolerance, @PROTEIN$ resistance and uncomplicated diabetes mellitus.	0	18795969-1090
Due to its faculty to protect @PROTEIN$ (ChE) activity against irreversible inactivation by OP, @COMPOUND$ (PB) was used as a prophylaxis treatment during the first Persian Gulf War.	1	18796314-1192
Mice lacking Niemann-Pick C1-Like 1 (@PROTEIN$) (NPC1L1 (-/-)mice) exhibit a defect in intestinal absorption of cholesterol and @COMPOUND$.	1	18796403-1220
In this study, we examined the role of @PROTEIN$ in @COMPOUND$ and cholesterol trafficking in mice lacking ATP-binding cassette (ABC) transporters G5 and G8 (G5/G8(-/-) mice).	0	18796403-1222
We found that mice lacking ABCG5/G8 and @PROTEIN$ (triple knockout (TKO) mice) did not accumulate @COMPOUND$ in plasma and the liver.	0	18796403-1223
We found that mice lacking @PROTEIN$/G8 and NPC1L1 (triple knockout (TKO) mice) did not accumulate @COMPOUND$ in plasma and the liver.	0	18796403-1223
In conclusion, @PROTEIN$ is essential for @COMPOUND$ to enter the body in mice.	1	18796403-1224
The slow BSO-induced @COMPOUND$ depletion allows separation of two redox-related phases, namely, early thiol disequilibrium and late frank oxidative stress; each phase contributes to the progressive activation of a @PROTEIN$-p50 homodimer.	0	18796561-1268
In contrast, Notch-signaling inhibition by the @COMPOUND$ (GSI ; z-Leu-Leu-Nle-CHO) and the specific @PROTEIN$ down-regulation by small-interfering RNA accelerate spontaneous B-CLL cell apoptosis.	0	18796623-1276
Effects of exhaustion and calcium supplementation on @PROTEIN$ and @COMPOUND$ levels in athletes.	0	18797825-1625
The present study was performed to investigate the effects of strenuous exercise and calcium supplementation on @COMPOUND$ and @PROTEIN$ levels in athletes at rest and exhaustion.	0	18797825-1626
One-month supplementation with calcium does not influence the @COMPOUND$ and @PROTEIN$ 0.05).	0	18797825-1627
Effects of nonspecific targeting of @PROTEIN$ were evaluated with addition of imatinib (@COMPOUND$) to cell cultures.	0	18797870-1649
In the pericentral necrotic zone after @COMPOUND$-treatment, no induction of @PROTEIN$ was found.	0	18797914-1664
Sixty-one percent of the isolates were @PROTEIN$ producers, which explains the poor activity of @COMPOUND$.	1	18797943-1672
In contrast, chelating intracellular calcium ((Ca(2+))(i)) by @COMPOUND$ abolished @PROTEIN$-mediated Arc up-regulation.	0	18798281-1790
In contrast, chelating intracellular calcium ((@COMPOUND$+))(i)) by BAPTA-AM abolished @PROTEIN$-mediated Arc up-regulation.	0	18798281-1790
These data suggested novel functions of (@COMPOUND$+))(i) and CaM in @PROTEIN$ signaling.	1	18798281-1791
These data suggested novel functions of (@COMPOUND$+))(i) and @PROTEIN$ in BDNF signaling.	0	18798281-1791
Comparison of the Arc transcription profiles between @COMPOUND$+)-stimulated and @PROTEIN$-stimulated neurons demonstrated that the regulatory mechanisms were distinctively tailored to the complex features of neuronal activity.	0	18798281-1792
Bark of elderberry (Sambucus nigra) contains a galactose (Gal)/N-acetylgalactosamine (@COMPOUND$)-specific @PROTEIN$ (SNA-II) corresponding to slightly truncated B-chains of a genuine Type-II ribosome-inactivating protein (Type-II RIPs, SNA-V), found in the same species.	1	18798567-1853
Bark of elderberry (Sambucus nigra) contains a galactose (Gal)/N-acetylgalactosamine (@COMPOUND$)-specific lectin (SNA-II) corresponding to slightly truncated B-chains of a genuine Type-II @PROTEIN$ (Type-II RIPs, SNA-V), found in the same species.	0	18798567-1853
Bark of elderberry (Sambucus nigra) contains a galactose (Gal)/N-acetylgalactosamine (@COMPOUND$)-specific lectin (SNA-II) corresponding to slightly truncated B-chains of a genuine Type-II ribosome-inactivating protein (Type-II @PROTEIN$, SNA-V), found in the same species.	0	18798567-1853
Infusion of each receptor antagonist alone similarly reduced basal unstressed volume and blood flow in @PROTEIN$-treated CHF patients, but not in healthy volunteers or @COMPOUND$-treated CHF patients.	0	18798730-1896
In @COMPOUND$-treated heart failure, venous responses to @PROTEIN$ are preserved but arterial responses are reduced compared with healthy controls.	0	18798730-1897
Later-onset congenital central hypoventilation syndrome due to a heterozygous 24-@COMPOUND$ repeat expansion mutation in the @PROTEIN$ gene.	1	18798833-1679
to describe a family with later onset congenital central hypoventilation syndrome (LO-CCHS) and heterozygosity for a 24-@COMPOUND$ repeat expansion mutation in the @PROTEIN$ gene, rendered phenotypically apparent with exposure to anesthetics.	1	18798833-1680
Effects of @COMPOUND$ on breast cancer cell migration and invasion through the @PROTEIN$ cytoskeleton.	1	18798864-1974
High @COMPOUND$ attenuates VEGF expression in rat multipotent adult progenitor cells in association with inhibition of JAK2/@PROTEIN$ signalling.	0	18798867-1982
High @COMPOUND$ attenuates VEGF expression in rat multipotent adult progenitor cells in association with inhibition of @PROTEIN$/STAT3 signalling.	0	18798867-1982
High @COMPOUND$ attenuates @PROTEIN$ expression in rat multipotent adult progenitor cells in association with inhibition of JAK2/STAT3 signalling.	1	18798867-1982
This study was to investigate the effect of high @COMPOUND$ (HG) on vascular endothelial growth factor (VEGF) expression in bone marrow stem cells and JAK2/@PROTEIN$-3 signalling.	0	18798867-1983
This study was to investigate the effect of high @COMPOUND$ (HG) on vascular endothelial growth factor (VEGF) expression in bone marrow stem cells and @PROTEIN$/STAT-3 signalling.	0	18798867-1983
This study was to investigate the effect of high glucose (@COMPOUND$) on vascular endothelial growth factor (@PROTEIN$) expression in bone marrow stem cells and JAK2/STAT-3 signalling.	0	18798867-1983
This study was to investigate the effect of high glucose (@COMPOUND$) on vascular endothelial growth factor (VEGF) expression in bone marrow stem cells and @PROTEIN$/STAT-3 signalling.	0	18798867-1983
This study was to investigate the effect of high glucose (@COMPOUND$) on vascular endothelial growth factor (VEGF) expression in bone marrow stem cells and JAK2/@PROTEIN$-3 signalling.	0	18798867-1983
This study was to investigate the effect of high @COMPOUND$ (HG) on vascular endothelial growth factor (@PROTEIN$) expression in bone marrow stem cells and JAK2/STAT-3 signalling.	0	18798867-1983
Hepatic stellate cell activation in focal nodular hyperplasia with a central scar was accompanied by the expression of @COMPOUND$ and inducible @PROTEIN$ in the liver.	0	18799187-2083
Expression of @COMPOUND$ and inducible @PROTEIN$ was rarely seen in focal nodular hyperplasia without a central scar, focal nodular hyperplasia-like nodules, or nodular regenerative hyperplasia.	0	18799187-2084
The main purpose of this study was to evaluate the regional distribution pattern and relative frequency of some endocrine cells in the three portions of the gastrointestinal tract (GIT)--the proventriculus, gizzard and duodenum-of the rufous-collared sparrow (Zonotrichia capensis subtorquata), by immunohistochemical methods using six types of polyclonal antisera, specific for serotonin (5-HT), @COMPOUND$ (D cells), glucagon, motilin, polypeptide YY (@PROTEIN$) and insulin.	0	18799201-2087
The main purpose of this study was to evaluate the regional distribution pattern and relative frequency of some endocrine cells in the three portions of the gastrointestinal tract (GIT)--the proventriculus, gizzard and duodenum-of the rufous-collared sparrow (Zonotrichia capensis subtorquata), by immunohistochemical methods using six types of polyclonal antisera, specific for @COMPOUND$ (5-HT), somatostatin (D cells), @PROTEIN$, motilin, polypeptide YY (PYY) and insulin.	0	18799201-2087
The main purpose of this study was to evaluate the regional distribution pattern and relative frequency of some endocrine cells in the three portions of the gastrointestinal tract (GIT)--the proventriculus, gizzard and duodenum-of the rufous-collared sparrow (Zonotrichia capensis subtorquata), by immunohistochemical methods using six types of polyclonal antisera, specific for serotonin (@COMPOUND$), somatostatin (D cells), glucagon, motilin, polypeptide YY (PYY) and @PROTEIN$.	0	18799201-2087
The main purpose of this study was to evaluate the regional distribution pattern and relative frequency of some endocrine cells in the three portions of the gastrointestinal tract (GIT)--the proventriculus, gizzard and duodenum-of the rufous-collared sparrow (Zonotrichia capensis subtorquata), by immunohistochemical methods using six types of polyclonal antisera, specific for @COMPOUND$ (5-HT), somatostatin (D cells), glucagon, @PROTEIN$, polypeptide YY (PYY) and insulin.	0	18799201-2087
The main purpose of this study was to evaluate the regional distribution pattern and relative frequency of some endocrine cells in the three portions of the gastrointestinal tract (GIT)--the proventriculus, gizzard and duodenum-of the rufous-collared sparrow (Zonotrichia capensis subtorquata), by immunohistochemical methods using six types of polyclonal antisera, specific for serotonin (@COMPOUND$), somatostatin (D cells), glucagon, @PROTEIN$, polypeptide YY (PYY) and insulin.	0	18799201-2087
The main purpose of this study was to evaluate the regional distribution pattern and relative frequency of some endocrine cells in the three portions of the gastrointestinal tract (GIT)--the proventriculus, gizzard and duodenum-of the rufous-collared sparrow (Zonotrichia capensis subtorquata), by immunohistochemical methods using six types of polyclonal antisera, specific for serotonin (5-HT), @COMPOUND$ (D cells), @PROTEIN$, motilin, polypeptide YY (PYY) and insulin.	0	18799201-2087
The main purpose of this study was to evaluate the regional distribution pattern and relative frequency of some endocrine cells in the three portions of the gastrointestinal tract (GIT)--the proventriculus, gizzard and duodenum-of the rufous-collared sparrow (Zonotrichia capensis subtorquata), by immunohistochemical methods using six types of polyclonal antisera, specific for @COMPOUND$ (5-HT), somatostatin (D cells), glucagon, motilin, polypeptide YY (PYY) and @PROTEIN$.	0	18799201-2087
The main purpose of this study was to evaluate the regional distribution pattern and relative frequency of some endocrine cells in the three portions of the gastrointestinal tract (GIT)--the proventriculus, gizzard and duodenum-of the rufous-collared sparrow (Zonotrichia capensis subtorquata), by immunohistochemical methods using six types of polyclonal antisera, specific for @COMPOUND$ (5-HT), somatostatin (D cells), glucagon, motilin, polypeptide YY (@PROTEIN$) and insulin.	0	18799201-2087
The main purpose of this study was to evaluate the regional distribution pattern and relative frequency of some endocrine cells in the three portions of the gastrointestinal tract (GIT)--the proventriculus, gizzard and duodenum-of the rufous-collared sparrow (Zonotrichia capensis subtorquata), by immunohistochemical methods using six types of polyclonal antisera, specific for serotonin (@COMPOUND$), somatostatin (D cells), @PROTEIN$, motilin, polypeptide YY (PYY) and insulin.	0	18799201-2087
The main purpose of this study was to evaluate the regional distribution pattern and relative frequency of some endocrine cells in the three portions of the gastrointestinal tract (GIT)--the proventriculus, gizzard and duodenum-of the rufous-collared sparrow (Zonotrichia capensis subtorquata), by immunohistochemical methods using six types of polyclonal antisera, specific for serotonin (5-HT), @COMPOUND$ (D cells), glucagon, motilin, polypeptide YY (PYY) and @PROTEIN$.	0	18799201-2087
The main purpose of this study was to evaluate the regional distribution pattern and relative frequency of some endocrine cells in the three portions of the gastrointestinal tract (GIT)--the proventriculus, gizzard and duodenum-of the rufous-collared sparrow (Zonotrichia capensis subtorquata), by immunohistochemical methods using six types of polyclonal antisera, specific for serotonin (@COMPOUND$), somatostatin (D cells), glucagon, motilin, polypeptide YY (@PROTEIN$) and insulin.	0	18799201-2087
The main purpose of this study was to evaluate the regional distribution pattern and relative frequency of some endocrine cells in the three portions of the gastrointestinal tract (GIT)--the proventriculus, gizzard and duodenum-of the rufous-collared sparrow (Zonotrichia capensis subtorquata), by immunohistochemical methods using six types of polyclonal antisera, specific for serotonin (5-HT), @COMPOUND$ (D cells), glucagon, @PROTEIN$, polypeptide YY (PYY) and insulin.	0	18799201-2087
In the gizzard, endocrine cells secreting @COMPOUND$, 5-HT and @PROTEIN$ were detected, while those secreting glucagon and insulin were not.	0	18799201-2088
In the gizzard, endocrine cells secreting somatostatin, @COMPOUND$ and PYY were detected, while those secreting glucagon and @PROTEIN$ were not.	0	18799201-2088
In the gizzard, endocrine cells secreting @COMPOUND$, 5-HT and PYY were detected, while those secreting @PROTEIN$ and insulin were not.	0	18799201-2088
In the gizzard, endocrine cells secreting somatostatin, @COMPOUND$ and PYY were detected, while those secreting @PROTEIN$ and insulin were not.	0	18799201-2088
In the gizzard, endocrine cells secreting somatostatin, @COMPOUND$ and @PROTEIN$ were detected, while those secreting glucagon and insulin were not.	0	18799201-2088
In the gizzard, endocrine cells secreting @COMPOUND$, 5-HT and PYY were detected, while those secreting glucagon and @PROTEIN$ were not.	0	18799201-2088
In the final part of the gizzard, endocrine cells secreting @COMPOUND$ were more frequent, and cells secreting somatostatin and @PROTEIN$ were not detected.	0	18799201-2089
In the final part of the gizzard, endocrine cells secreting 5-HT were more frequent, and cells secreting @COMPOUND$ and @PROTEIN$ were not detected.	0	18799201-2089
Cell fractionation by @COMPOUND$ gradient and differential centrifugation demonstrated that in bradykinin-stimulated cells, @PROTEIN$ localized in fractions corresponding to caveolae.	0	18799634-2193
However, there are conflicting data regarding the role of Gpr30 as an @PROTEIN$ (ER): several laboratories were unable to demonstrate @COMPOUND$ binding to GPR30 or estradiol-activated signal transduction in Gpr30-expressing cells.	0	18799753-2260
Our data demonstrate that in vivo @PROTEIN$ is dispensable for the mediation of @COMPOUND$ effects in reproductive organs.	0	18799753-2261
Sorbitol can fuel mouse sperm motility and protein @COMPOUND$ phosphorylation via @PROTEIN$.	0	18799757-2262
@COMPOUND$ can fuel mouse sperm motility and protein tyrosine phosphorylation via @PROTEIN$.	1	18799757-2262
Here we characterize @PROTEIN$ mRNA and SORD expression during mouse spermatogenesis and examine the ability of @COMPOUND$ to support epididymal sperm motility and tyrosine phosphorylation.	0	18799757-2263
Here we characterize Sord mRNA and @PROTEIN$ expression during mouse spermatogenesis and examine the ability of @COMPOUND$ to support epididymal sperm motility and tyrosine phosphorylation.	0	18799757-2263
Here we characterize Sord mRNA and @PROTEIN$ expression during mouse spermatogenesis and examine the ability of sorbitol to support epididymal sperm motility and @COMPOUND$ phosphorylation.	0	18799757-2263
Here we characterize @PROTEIN$ mRNA and SORD expression during mouse spermatogenesis and examine the ability of sorbitol to support epididymal sperm motility and @COMPOUND$ phosphorylation.	0	18799757-2263
Increase in @COMPOUND$ clearance in the early postnatal period likely reflects maturation of @PROTEIN$-mediated N-demethylation.	1	18800037-1366
@COMPOUND$ modulation of alpha-, @PROTEIN$, and the norepinephrine transporter in an animal model of depression.	1	18800064-2365
@COMPOUND$ modulation of alpha-, gamma-synuclein, and the @PROTEIN$ in an animal model of depression.	1	18800064-2365
The @PROTEIN$-selective antidepressant @COMPOUND$ (DMI) was chronically administered for 14 days to WKY rats and the strain from which it was outbred that does not show depressive-like behavior, the Wistar rat.	1	18800064-2366
The present study was designed to evaluate the impact of zinc status before burn on the recovery of injury with focus on plasma @PROTEIN$ and @COMPOUND$ levels.	0	18800198-2413
Blood and tissue samples were collected 3, 6, and 24 h after injury in order to study biochemical parameters and the @COMPOUND$/@PROTEIN$ response in relation with the zinc status.	0	18800198-2414
In addition, the burn-induced insulin resistance, leading to protein catabolism, was emphasized, with higher plasma insulin, @COMPOUND$, and @PROTEIN$ levels in zinc-deficient animals versus normal-fed rats.	0	18800198-2415
In addition, the burn-induced @PROTEIN$ resistance, leading to protein catabolism, was emphasized, with higher plasma insulin, @COMPOUND$, and leptin levels in zinc-deficient animals versus normal-fed rats.	0	18800198-2415
methoxyphenoxy)benzyl) @COMPOUND$) is a positron emission tomography (PET) radioligand recently applied in clinical studies of norepinephrine transporters (@PROTEIN$) in the human brain in vivo.	1	18800204-2418
methoxyphenoxy)benzyl) @COMPOUND$) is a positron emission tomography (PET) radioligand recently applied in clinical studies of @PROTEIN$ (NETs) in the human brain in vivo.	1	18800204-2418
The most predictive model of @PROTEIN$ response for the pediatric cohort had, as the major variables, @COMPOUND$ clearance x dialysis duration/total body water (Kt/V), urea reduction ratio (URR), intact parathyroid hormone (iPTH), blood loss, normalized protein catabolic rates (nPCR) and indices of malnutrition and inflammation, whereas adults had iron and folate deficiencies as the dominant variables.	1	18800231-631
The most predictive model of @PROTEIN$ response for the pediatric cohort had, as the major variables, urea clearance x dialysis duration/total body water (Kt/V), urea reduction ratio (URR), intact parathyroid hormone (iPTH), blood loss, normalized protein catabolic rates (nPCR) and indices of malnutrition and inflammation, whereas adults had iron and @COMPOUND$ deficiencies as the dominant variables.	1	18800231-631
In summary @PROTEIN$ resistance in the pediatric dialysis cohort was predicted by nutritional deficits, inflammation, poor dialysis, and hyperparathyroidism, while iron and @COMPOUND$ deficits were the major determinants in adults.	1	18800231-632
@COMPOUND$ selectively causes Bax- and @PROTEIN$-mediated apoptosis in human lung cancer cells.	1	18800351-2001
@COMPOUND$ selectively causes @PROTEIN$- and Bak-mediated apoptosis in human lung cancer cells.	1	18800351-2001
The @COMPOUND$-mediated G2-M phase cell cycle arrest was explained by down-regulation of cyclin-dependent kinase 1 (@PROTEIN$) and cell division cycle 25C protein expression leading to accumulation of Tyr15 phosphorylated (inactive) Cdk1.	1	18800351-2002
The @COMPOUND$-mediated G2-M phase cell cycle arrest was explained by down-regulation of @PROTEIN$ (Cdk1) and cell division cycle 25C protein expression leading to accumulation of Tyr15 phosphorylated (inactive) Cdk1.	1	18800351-2002
Knockdown of Bax and @PROTEIN$ proteins conferred significant protection against @COMPOUND$-induced apoptotic cytoplasmic histone-associated DNA fragmentation.	0	18800351-2003
Knockdown of @PROTEIN$ and Bak proteins conferred significant protection against @COMPOUND$-induced apoptotic cytoplasmic histone-associated DNA fragmentation.	0	18800351-2003
In the present work, we showed for the first time that synthetic oligodeoxynucleotides containing unmethylated cytosine guanine motifs (@COMPOUND$) are able to stimulate, in the presence of interferon-gamma (@PROTEIN$), both arginase and inducible nitric oxide synthase (iNOS) in murine Mphi.	0	18800985-2514
In the present work, we showed for the first time that synthetic oligodeoxynucleotides containing unmethylated cytosine guanine motifs (@COMPOUND$) are able to stimulate, in the presence of interferon-gamma (IFN-gamma), both @PROTEIN$ and inducible nitric oxide synthase (iNOS) in murine Mphi.	1	18800985-2514
In the present work, we showed for the first time that synthetic oligodeoxynucleotides containing unmethylated cytosine guanine motifs (@COMPOUND$) are able to stimulate, in the presence of @PROTEIN$ (IFN-gamma), both arginase and inducible nitric oxide synthase (iNOS) in murine Mphi.	0	18800985-2514
In the present work, we showed for the first time that synthetic oligodeoxynucleotides containing unmethylated cytosine guanine motifs (@COMPOUND$) are able to stimulate, in the presence of interferon-gamma (IFN-gamma), both arginase and inducible @PROTEIN$ (iNOS) in murine Mphi.	1	18800985-2514
In the present work, we showed for the first time that synthetic oligodeoxynucleotides containing unmethylated cytosine guanine motifs (@COMPOUND$) are able to stimulate, in the presence of interferon-gamma (IFN-gamma), both arginase and inducible nitric oxide synthase (@PROTEIN$) in murine Mphi.	1	18800985-2514
A significant increase in @PROTEIN$ activity was observed upon a short pre-incubation (1 hr) with IFN-gamma and subsequent @COMPOUND$ stimulation.	1	18800985-2515
A significant increase in arginase activity was observed upon a short pre-incubation (1 hr) with @PROTEIN$ and subsequent @COMPOUND$ stimulation.	0	18800985-2515
Therefore, a very interesting observation of this study was that the @COMPOUND$-mediated arginase activity is dependent on @PROTEIN$ priming.	1	18800985-2516
Therefore, a very interesting observation of this study was that the @COMPOUND$-mediated @PROTEIN$ activity is dependent on IFN-gamma priming.	1	18800985-2516
This report reveals a singular effect of the combination of @COMPOUND$ and @PROTEIN$, one of the mayor cytokines produced in response to CpG administration in vivo.	1	18800985-2517
@COMPOUND$ has a three-fold higher binding affinity for ERalpha than for @PROTEIN$.	1	18801207-197
@COMPOUND$ has a three-fold higher binding affinity for @PROTEIN$ than for ERbeta.	1	18801207-197
In the present study, we examined the effect of gliclazide, a second generation @COMPOUND$ with antioxidant properties, on LOX-1 expression and LOX-1-mediated @PROTEIN$ expression and apoptosis in oxLDL-treated human aortic endothelial cells (HAECs).	0	18801483-309
In the present study, we examined the effect of @COMPOUND$, a second generation sulfonylurea with antioxidant properties, on LOX-1 expression and LOX-1-mediated @PROTEIN$ expression and apoptosis in oxLDL-treated human aortic endothelial cells (HAECs).	1	18801483-309
In the present study, we examined the effect of @COMPOUND$, a second generation sulfonylurea with antioxidant properties, on @PROTEIN$ expression and LOX-1-mediated MMP-9 expression and apoptosis in oxLDL-treated human aortic endothelial cells (HAECs).	1	18801483-309
In the present study, we examined the effect of gliclazide, a second generation @COMPOUND$ with antioxidant properties, on @PROTEIN$ expression and LOX-1-mediated MMP-9 expression and apoptosis in oxLDL-treated human aortic endothelial cells (HAECs).	0	18801483-309
The phenolics: @COMPOUND$ (ATH), sinapoyl esters and activity of antioxidant enzymes: superoxide dismutase (SOD), catalase (CAT), guaiacol peroxidase (@PROTEIN$), ascorbate peroxidase (APX), glutathione peroxidase (GPX) and glutathione reductase (GR), in red cabbage seedlings subjected to Cu2+ stress were investigated.	0	18801573-338
The phenolics: @COMPOUND$ (ATH), sinapoyl esters and activity of antioxidant enzymes: superoxide dismutase (SOD), @PROTEIN$ (CAT), guaiacol peroxidase (POX), ascorbate peroxidase (APX), glutathione peroxidase (GPX) and glutathione reductase (GR), in red cabbage seedlings subjected to Cu2+ stress were investigated.	0	18801573-338
The phenolics: @COMPOUND$ (ATH), sinapoyl esters and activity of antioxidant enzymes: superoxide dismutase (SOD), catalase (@PROTEIN$), guaiacol peroxidase (POX), ascorbate peroxidase (APX), glutathione peroxidase (GPX) and glutathione reductase (GR), in red cabbage seedlings subjected to Cu2+ stress were investigated.	0	18801573-338
The phenolics: @COMPOUND$ (ATH), sinapoyl esters and activity of antioxidant enzymes: superoxide dismutase (SOD), catalase (CAT), guaiacol peroxidase (POX), ascorbate peroxidase (APX), glutathione peroxidase (@PROTEIN$) and glutathione reductase (GR), in red cabbage seedlings subjected to Cu2+ stress were investigated.	0	18801573-338
The phenolics: @COMPOUND$ (ATH), sinapoyl esters and activity of antioxidant enzymes: superoxide dismutase (SOD), catalase (CAT), guaiacol peroxidase (POX), ascorbate peroxidase (APX), glutathione peroxidase (GPX) and @PROTEIN$ (GR), in red cabbage seedlings subjected to Cu2+ stress were investigated.	0	18801573-338
The phenolics: @COMPOUND$ (ATH), sinapoyl esters and activity of antioxidant enzymes: superoxide dismutase (SOD), catalase (CAT), guaiacol peroxidase (POX), ascorbate peroxidase (APX), @PROTEIN$ (GPX) and glutathione reductase (GR), in red cabbage seedlings subjected to Cu2+ stress were investigated.	0	18801573-338
The phenolics: @COMPOUND$ (ATH), sinapoyl esters and activity of antioxidant enzymes: superoxide dismutase (@PROTEIN$), catalase (CAT), guaiacol peroxidase (POX), ascorbate peroxidase (APX), glutathione peroxidase (GPX) and glutathione reductase (GR), in red cabbage seedlings subjected to Cu2+ stress were investigated.	0	18801573-338
The phenolics: @COMPOUND$ (ATH), sinapoyl esters and activity of antioxidant enzymes: superoxide dismutase (SOD), catalase (CAT), guaiacol peroxidase (POX), ascorbate peroxidase (@PROTEIN$), glutathione peroxidase (GPX) and glutathione reductase (GR), in red cabbage seedlings subjected to Cu2+ stress were investigated.	0	18801573-338
The phenolics: @COMPOUND$ (ATH), sinapoyl esters and activity of antioxidant enzymes: @PROTEIN$ (SOD), catalase (CAT), guaiacol peroxidase (POX), ascorbate peroxidase (APX), glutathione peroxidase (GPX) and glutathione reductase (GR), in red cabbage seedlings subjected to Cu2+ stress were investigated.	0	18801573-338
The phenolics: @COMPOUND$ (ATH), sinapoyl esters and activity of antioxidant enzymes: superoxide dismutase (SOD), catalase (CAT), guaiacol @PROTEIN$ (POX), ascorbate peroxidase (APX), glutathione peroxidase (GPX) and glutathione reductase (GR), in red cabbage seedlings subjected to Cu2+ stress were investigated.	0	18801573-338
It could results from the fact that phenolic compounds (@COMPOUND$), which could be also substrates for different @PROTEIN$, were the first line of defence against metal stress.	1	18801573-339
The affinity characteristics of developed immunosensors were investigated in reaction with @COMPOUND$, and @PROTEIN$.	1	18801652-367
The detection limit for @COMPOUND$ was 10 ngmL(-1) and for @PROTEIN$ 0.01 ngmL(-1).	0	18801652-368
This was achieved by (1) direct comparison of the sensitivity of ASIC1, ASIC2, @PROTEIN$ and TRPV1 knockout mice versus wildtype littermates to acute thermal and mechanical noxious stimuli and (2) studying the behavioural responses of each transgenic strain to hind paw inflammation with either complete Freund's adjuvant (CFA) or @COMPOUND$.	0	18801682-382
This was achieved by (1) direct comparison of the sensitivity of ASIC1, @PROTEIN$, ASIC3 and TRPV1 knockout mice versus wildtype littermates to acute thermal and mechanical noxious stimuli and (2) studying the behavioural responses of each transgenic strain to hind paw inflammation with either complete Freund's adjuvant (CFA) or @COMPOUND$.	0	18801682-382
This was achieved by (1) direct comparison of the sensitivity of @PROTEIN$, ASIC2, ASIC3 and TRPV1 knockout mice versus wildtype littermates to acute thermal and mechanical noxious stimuli and (2) studying the behavioural responses of each transgenic strain to hind paw inflammation with either complete Freund's adjuvant (CFA) or @COMPOUND$.	0	18801682-382
This was achieved by (1) direct comparison of the sensitivity of ASIC1, ASIC2, ASIC3 and @PROTEIN$ knockout mice versus wildtype littermates to acute thermal and mechanical noxious stimuli and (2) studying the behavioural responses of each transgenic strain to hind paw inflammation with either complete Freund's adjuvant (CFA) or @COMPOUND$.	0	18801682-382
Following @COMPOUND$ injection, ASIC1 (-/-) and ASIC2 (-/-), but not @PROTEIN$ (-/-) or TRPV1 (-/-), mice showed enhanced pain behaviour, predominantly in the second phase of the test.	0	18801682-383
Following @COMPOUND$ injection, ASIC1 (-/-) and @PROTEIN$ (-/-), but not ASIC3 (-/-) or TRPV1 (-/-), mice showed enhanced pain behaviour, predominantly in the second phase of the test.	1	18801682-383
Following @COMPOUND$ injection, ASIC1 (-/-) and ASIC2 (-/-), but not ASIC3 (-/-) or @PROTEIN$ (-/-), mice showed enhanced pain behaviour, predominantly in the second phase of the test.	0	18801682-383
Following @COMPOUND$ injection, @PROTEIN$ (-/-) and ASIC2 (-/-), but not ASIC3 (-/-) or TRPV1 (-/-), mice showed enhanced pain behaviour, predominantly in the second phase of the test.	1	18801682-383
The biochemical parameters studied are: albumin (ALB), alanine aminotransferase (ALT), amylase (@PROTEIN$), total @COMPOUND$ (TBI), blood urea nitrogen (BUN), creatinine (CRE), glucose, globulin, total proteins (TP), and the ions calcium, phosphorus, sodium, and potassium.	0	18801894-463
The biochemical parameters studied are: albumin (ALB), alanine aminotransferase (ALT), amylase (@PROTEIN$), total bilirubin (TBI), blood urea nitrogen (BUN), creatinine (CRE), glucose, globulin, total proteins (TP), and the ions calcium, @COMPOUND$, sodium, and potassium.	0	18801894-463
The biochemical parameters studied are: albumin (@PROTEIN$), alanine aminotransferase (ALT), amylase (AMY), total @COMPOUND$ (TBI), blood urea nitrogen (BUN), creatinine (CRE), glucose, globulin, total proteins (TP), and the ions calcium, phosphorus, sodium, and potassium.	0	18801894-463
The biochemical parameters studied are: albumin (@PROTEIN$), alanine aminotransferase (ALT), amylase (AMY), total bilirubin (TBI), blood urea nitrogen (BUN), creatinine (CRE), glucose, globulin, total proteins (TP), and the ions calcium, @COMPOUND$, sodium, and potassium.	0	18801894-463
The biochemical parameters studied are: albumin (ALB), alanine aminotransferase (ALT), amylase (@PROTEIN$), total bilirubin (TBI), blood urea nitrogen (BUN), @COMPOUND$ (CRE), glucose, globulin, total proteins (TP), and the ions calcium, phosphorus, sodium, and potassium.	0	18801894-463
The biochemical parameters studied are: albumin (@PROTEIN$), alanine aminotransferase (ALT), amylase (AMY), total bilirubin (TBI), blood urea nitrogen (BUN), creatinine (CRE), @COMPOUND$, globulin, total proteins (TP), and the ions calcium, phosphorus, sodium, and potassium.	0	18801894-463
The biochemical parameters studied are: albumin (@PROTEIN$), alanine aminotransferase (ALT), amylase (AMY), total bilirubin (TBI), blood urea nitrogen (BUN), @COMPOUND$ (CRE), glucose, globulin, total proteins (TP), and the ions calcium, phosphorus, sodium, and potassium.	0	18801894-463
The biochemical parameters studied are: albumin (ALB), alanine aminotransferase (ALT), amylase (@PROTEIN$), total bilirubin (TBI), blood urea nitrogen (BUN), creatinine (CRE), @COMPOUND$, globulin, total proteins (TP), and the ions calcium, phosphorus, sodium, and potassium.	0	18801894-463
In addition, serum levels of @COMPOUND$, adiponectin, and @PROTEIN$ were measured.	0	18801899-465
In addition, @COMPOUND$-activated @PROTEIN$ levels were high during fasting and low during HF diet.	1	18801899-466
This action of @PROTEIN$ was abolished by SB 212090 but not by @COMPOUND$.	0	18801901-901
After 7 d central @PROTEIN$ treatment, the total content of @COMPOUND$ was analyzed by quantitative shotgun lipidomics mass spectrometry.	0	18801905-473
Previously we have shown that @COMPOUND$ has antiinflammatory actions not explicable by activation of @PROTEIN$,but possibly by the glucocorticoid receptor (GR).	0	18801908-476
Previously we have shown that @COMPOUND$ has antiinflammatory actions not explicable by activation of PPARgamma,but possibly by the @PROTEIN$ (GR).	1	18801908-476
@COMPOUND$ drives @PROTEIN$ expression from a simple glucocorticoid-response element containing reporter gene in a GR-dependent manner (EC50 4 microm), with a similar amplitude response to the partial GR agonist RU486.	1	18801908-477
To begin to understand the mechanisms for the development of acute insulin resistance, @COMPOUND$ phosphorylation of insulin receptor substrate (@PROTEIN$)-1 and c-Jun N-terminal kinase phosphorylation/activation was investigated.	1	18801909-478
To begin to understand the mechanisms for the development of acute @PROTEIN$ resistance, @COMPOUND$ phosphorylation of insulin receptor substrate (IRS)-1 and c-Jun N-terminal kinase phosphorylation/activation was investigated.	0	18801909-478
To begin to understand the mechanisms for the development of acute insulin resistance, @COMPOUND$ phosphorylation of insulin receptor substrate (IRS)-1 and c-@PROTEIN$ N-terminal kinase phosphorylation/activation was investigated.	0	18801909-478
Circulating oxidized LDL (oxLDL) levels are strongly correlated to LDL-@COMPOUND$ (LDL-c) and apolipoprotein-B100 (@PROTEIN$), making it difficult to disentangle their independent contributions to cardiovascular risk.	0	18802196-558
FMD of the brachial artery and plasma concentrations of oxLDL, LDL-@COMPOUND$, and @PROTEIN$ were measured in 624 men and women (age range 50 to 87 years), participating in a population-based cohort study.	0	18802196-559
After adjustment for age, sex, @COMPOUND$ tolerance status, and Framingham risk score, the oxLDL/@PROTEIN$ ratio was negatively related to FMD (P = 0.017).	0	18802196-560
The @PROTEIN$ isolated from the youngest group had the highest capacity to form @COMPOUND$ and AGEs under glycation in vitro.	1	18802325-593
The patterns of nerves immunoreactive (IR) to antibodies towards serotonin (@COMPOUND$) and the invertebrate @PROTEIN$ FMRFamide are described in relation to the musculature.	0	18802724-681
The patterns of nerves immunoreactive (IR) to antibodies towards @COMPOUND$ (5-HT) and the invertebrate neuropeptide @PROTEIN$ are described in relation to the musculature.	0	18802724-681
The patterns of nerves immunoreactive (IR) to antibodies towards @COMPOUND$ (5-HT) and the invertebrate @PROTEIN$ FMRFamide are described in relation to the musculature.	0	18802724-681
The patterns of nerves immunoreactive (IR) to antibodies towards serotonin (@COMPOUND$) and the invertebrate neuropeptide @PROTEIN$ are described in relation to the musculature.	0	18802724-681
Based on these results we analyzed the expression of either M1 receptors or @PROTEIN$ following @COMPOUND$ treatment of retinal cell cultures.	0	18802750-687
Immunotoxicity of perfluorooctanoic acid and perfluorooctane @COMPOUND$ and the role of @PROTEIN$.	0	18802816-701
Inhibitory activities of Cassia tora and its @COMPOUND$ constituents on @PROTEIN$.	1	18803227-822
The results obtained from the Fluo-3 image experiments showed that @PROTEIN$ pretreatment of cultured neurons at a final concentration of 50, 100, or 200 ng/ml acutely and dose dependently attenuated the @COMPOUND$+) influx induced by application of KCl (60 mM) or glutamate (50 microM).	1	18803284-847
The results obtained from the @COMPOUND$ image experiments showed that @PROTEIN$ pretreatment of cultured neurons at a final concentration of 50, 100, or 200 ng/ml acutely and dose dependently attenuated the Ca(2+) influx induced by application of KCl (60 mM) or glutamate (50 microM).	0	18803284-847
@COMPOUND$) was injected into pregnant mice 3 hr after the @PROTEIN$ administration to label the neural progenitor cells.	0	18803286-849
A vitreous fraction showing @PROTEIN$ 1000 Da, consistent with @COMPOUND$.	0	18803297-852
The secretion of endorphins, @COMPOUND$ (P(4)), human chorionic gonadotropin, 17beta-estradiol, and @PROTEIN$ by trophoblasts that lie adjacent to the embryoblast in the blastocyst suggests that these pregnancy-associated factors may directly signal the growth and development of the embryoblast.	0	18803462-1385
The secretion of endorphins, progesterone (P(4)), human chorionic gonadotropin, @COMPOUND$, and @PROTEIN$ by trophoblasts that lie adjacent to the embryoblast in the blastocyst suggests that these pregnancy-associated factors may directly signal the growth and development of the embryoblast.	0	18803462-1385
A specific @COMPOUND$-labelled probe, obtained by PCR amplification of a 270-bp fragment of the gene coding the LCDV @PROTEIN$, was used for ISH.	1	18803582-1273
In particular, a Cimicifuga heracleifolia extract (CHE) was reported to inhibit the formation of @COMPOUND$ and the @PROTEIN$ activity in cultured rat islet.	0	18803655-955
No differences in estradiol, @COMPOUND$, or @PROTEIN$ plasma concentrations were observed in exposed males or females compared to controls.	0	18804292-1116
No differences in @COMPOUND$, testosterone, or @PROTEIN$ plasma concentrations were observed in exposed males or females compared to controls.	0	18804292-1116
Macrophages located in the media differentiate into giant cells and/or produce reactive oxygen species, @COMPOUND$ and matrix metallo-@PROTEIN$.	0	18804314-557
Macrophages located in the media differentiate into giant cells and/or produce reactive @COMPOUND$ species, nitric oxide and matrix metallo-@PROTEIN$.	0	18804314-557
Having compared four kinds of antibody immobilizations on Au surface, an optimized mAb 8G3 was immobilized onto the Au electrode with @PROTEIN$ on a mixed self-assembled monolayer (SAM) of @COMPOUND$ (11-MUA) and 6-mercaptohexan-1-ol (6-MHO) as adhesive layer.	0	18804365-1156
Having compared four kinds of antibody immobilizations on Au surface, an optimized mAb 8G3 was immobilized onto the Au electrode with @PROTEIN$ on a mixed self-assembled monolayer (SAM) of 11-mercaptoundecanoic acid (11-@COMPOUND$) and 6-mercaptohexan-1-ol (6-MHO) as adhesive layer.	0	18804365-1156
Having compared four kinds of antibody immobilizations on Au surface, an optimized mAb 8G3 was immobilized onto the Au electrode with @PROTEIN$ on a mixed self-assembled monolayer (SAM) of 11-mercaptoundecanoic acid (11-MUA) and 6-mercaptohexan-1-ol (6-@COMPOUND$) as adhesive layer.	0	18804365-1156
Having compared four kinds of antibody immobilizations on Au surface, an optimized mAb 8G3 was immobilized onto the Au electrode with @PROTEIN$ on a mixed self-assembled monolayer (SAM) of 11-mercaptoundecanoic acid (11-MUA) and @COMPOUND$ (6-MHO) as adhesive layer.	0	18804365-1156
@COMPOUND$ is a potent glucocorticoid with high affinity for the @PROTEIN$, which is now used for the treatment of inflammatory bowel diseases.	1	18804521-2419
Studies on the antioxidant effect and interaction of @COMPOUND$ and dicholesteroyl diselenide with hepatic @PROTEIN$ and isoforms of lactate dehydrogenase.	0	18804525-2139
Studies on the interaction of dicholesteroyl diselenide (DCDS) and @COMPOUND$ (DPDS) with hepatic @PROTEIN$ (ALA-D) and different isoforms of lactate dehydrogenase (LDH) from different tissues were investigated.	0	18804525-2140
Studies on the interaction of dicholesteroyl diselenide (DCDS) and @COMPOUND$ (DPDS) with hepatic delta-aminolevulinic acid dehydratase (ALA-D) and different isoforms of lactate dehydrogenase (@PROTEIN$) from different tissues were investigated.	0	18804525-2140
A single @COMPOUND$ insertion/deletion (4G/5G) polymorphism in the promoter region of the @PROTEIN$ gene, may play an important role in the regulation of PAI-1 expression.	1	18804848-1280
A single guanosine insertion/deletion (4G/@COMPOUND$) polymorphism in the promoter region of the @PROTEIN$ gene, may play an important role in the regulation of PAI-1 expression.	1	18804848-1280
@COMPOUND$ is an effective chemo-sensitizer via @PROTEIN$ inhibition.	1	18804908-377
@COMPOUND$ also recovered the depletion of I-kappaBalpha via @PROTEIN$ 2 inhibition, which resulted in a decrease of NF-kappaB activity in EcR293/TG cells.	1	18804908-379
@COMPOUND$ also recovered the depletion of @PROTEIN$ via TGase 2 inhibition, which resulted in a decrease of NF-kappaB activity in EcR293/TG cells.	1	18804908-379
Influence of @PROTEIN$ on buffalo (Bubalus bubalis) spermatozoa motility, membrane integrity, lipid peroxidation and @COMPOUND$ uptake in vitro.	0	18804927-1300
The objective of the present experiment was to examine the influence of mean physiological concentration of insulin-like growth factor-I (@PROTEIN$) on frozen-thawed Surti buffalo (Bubalus bubalis) spermatozoa functional parameters, i.e., motility, plasmalemma integrity, acrosomal integrity, functional membrane integrity, lipid peroxidation and @COMPOUND$ uptake in vitro.	1	18804927-1301
Frozen-thawed semen samples (n=6) were washed in @COMPOUND$ and divided into two equal parts (control and @PROTEIN$ groups).	0	18804927-1302
@COMPOUND$ utilization was significantly higher in @PROTEIN$ 0.01) of incubation.	0	18804927-1303
This diagnosis was confirmed by genetic testing, which revealed a novel point mutation in the @PROTEIN$ gene, c.2545G--&gt;C, leading to a codon encoding for @COMPOUND$ instead of glycine (p.Gly849Arg).	1	18804950-1309
This diagnosis was confirmed by genetic testing, which revealed a novel point mutation in the @PROTEIN$ gene, c.2545G--&gt;C, leading to a codon encoding for arginine instead of @COMPOUND$ (p.Gly849Arg).	1	18804950-1309
Animal studies show that ecosapentaenoic acid (EPA) and @COMPOUND$ (DHA) are effective for the prevention and treatment of @PROTEIN$ resistance (IR).	1	18804984-1311
Signaling involving @COMPOUND$ is organized in subcellular compartments and a distinct cAMP compartment might be required for proper @PROTEIN$ mobility and function.	1	18805402-1407
We also found an inhibitory effect of @COMPOUND$ on the associations between cadherin 5, @PROTEIN$ and CD31, adherens junction proteins whose interaction is critical for endothelial cell cord formation.	1	18805433-1411
We also found a strong inhibitory effect of @COMPOUND$ on hypoxia-induced endothelial cell formation of cords and @PROTEIN$ expression, the main mediator of hypoxia-mediated effects and a key driver of angiogenesis and metastasis.	1	18805433-1412
Differential effects of @PROTEIN$ receptor activation by WAY 161503 on @COMPOUND$-induced place conditioning and locomotor activity in rats.	0	18805442-1416
Control @COMPOUND$-loaded @PROTEIN$ nanoparticles with IgG2a antibodies yielded only marginal effects.	1	18805484-1419
Engineered @COMPOUND$-containing glutaredoxin displays strong @PROTEIN$ activity rivaling natural enzyme.	0	18805505-1370
Engineered @COMPOUND$-containing @PROTEIN$ displays strong glutathione peroxidase activity rivaling natural enzyme.	1	18805505-1370
The use of a common thioredoxin fold with a high affinity for @COMPOUND$ in glutaredoxin (Grx) and @PROTEIN$ (GPx) suggests a possibility of engineering Grx into GPx and vice versa.	1	18805505-1371
The use of a common thioredoxin fold with a high affinity for @COMPOUND$ in @PROTEIN$ (Grx) and glutathione peroxidase (GPx) suggests a possibility of engineering Grx into GPx and vice versa.	1	18805505-1371
The potassium channels blockade by either @COMPOUND$ or @PROTEIN$ also resulted in a potent inhibition of HEDS-induced aortic relaxation, whereas apamine only slightly reduced it.	0	18805508-1434
The potassium channels blockade by either tetraethylammonium or @PROTEIN$ also resulted in a potent inhibition of HEDS-induced aortic relaxation, whereas @COMPOUND$ only slightly reduced it.	0	18805508-1434
ROS activated almost immediately in a time- and concentration-dependent manner the MAPK pathways p38, ERK and @PROTEIN$ (their activation was abrogated by the antioxidant @COMPOUND$).	1	18805632-1457
ROS activated almost immediately in a time- and concentration-dependent manner the MAPK pathways p38, @PROTEIN$ and JNK (their activation was abrogated by the antioxidant @COMPOUND$).	1	18805632-1457
ROS activated almost immediately in a time- and concentration-dependent manner the @PROTEIN$ pathways p38, ERK and JNK (their activation was abrogated by the antioxidant @COMPOUND$).	1	18805632-1457
ROS activated almost immediately in a time- and concentration-dependent manner the MAPK pathways @PROTEIN$, ERK and JNK (their activation was abrogated by the antioxidant @COMPOUND$).	1	18805632-1457
Multiple linear regression (MLR), radial basis network (RB), and multilayer perceptron (MLP) neural network (NN) models have been explored for the estimation of toxicity of ammonium, imidazolium, morpholinium, phosphonium, piperidinium, @COMPOUND$, pyrrolidinium and quinolinium ionic liquid salts in the Leukemia Rat Cell Line (IPC-81) and Acetylcholinesterase (@PROTEIN$) using only their empirical formulas (elemental composition) and molecular weights.	0	18805639-1461
Multiple linear regression (MLR), radial basis network (RB), and multilayer perceptron (MLP) neural network (NN) models have been explored for the estimation of toxicity of @COMPOUND$, imidazolium, morpholinium, phosphonium, piperidinium, pyridinium, pyrrolidinium and quinolinium ionic liquid salts in the Leukemia Rat Cell Line (IPC-81) and Acetylcholinesterase (@PROTEIN$) using only their empirical formulas (elemental composition) and molecular weights.	0	18805639-1461
Multiple linear regression (MLR), radial basis network (RB), and multilayer perceptron (MLP) neural network (NN) models have been explored for the estimation of toxicity of ammonium, imidazolium, morpholinium, phosphonium, piperidinium, pyridinium, @COMPOUND$ and quinolinium ionic liquid salts in the Leukemia Rat Cell Line (IPC-81) and @PROTEIN$ (AChE) using only their empirical formulas (elemental composition) and molecular weights.	0	18805639-1461
Multiple linear regression (MLR), radial basis network (RB), and multilayer perceptron (MLP) neural network (NN) models have been explored for the estimation of toxicity of ammonium, imidazolium, morpholinium, @COMPOUND$, piperidinium, pyridinium, pyrrolidinium and quinolinium ionic liquid salts in the Leukemia Rat Cell Line (IPC-81) and @PROTEIN$ (AChE) using only their empirical formulas (elemental composition) and molecular weights.	0	18805639-1461
Multiple linear regression (MLR), radial basis network (RB), and multilayer perceptron (MLP) neural network (NN) models have been explored for the estimation of toxicity of ammonium, imidazolium, morpholinium, @COMPOUND$, piperidinium, pyridinium, pyrrolidinium and quinolinium ionic liquid salts in the Leukemia Rat Cell Line (IPC-81) and Acetylcholinesterase (@PROTEIN$) using only their empirical formulas (elemental composition) and molecular weights.	0	18805639-1461
Multiple linear regression (MLR), radial basis network (RB), and multilayer perceptron (MLP) neural network (NN) models have been explored for the estimation of toxicity of ammonium, imidazolium, morpholinium, phosphonium, @COMPOUND$, pyridinium, pyrrolidinium and quinolinium ionic liquid salts in the Leukemia Rat Cell Line (IPC-81) and Acetylcholinesterase (@PROTEIN$) using only their empirical formulas (elemental composition) and molecular weights.	0	18805639-1461
Multiple linear regression (MLR), radial basis network (RB), and multilayer perceptron (MLP) neural network (NN) models have been explored for the estimation of toxicity of ammonium, imidazolium, morpholinium, phosphonium, @COMPOUND$, pyridinium, pyrrolidinium and quinolinium ionic liquid salts in the Leukemia Rat Cell Line (IPC-81) and @PROTEIN$ (AChE) using only their empirical formulas (elemental composition) and molecular weights.	0	18805639-1461
Multiple linear regression (MLR), radial basis network (RB), and multilayer perceptron (MLP) neural network (NN) models have been explored for the estimation of toxicity of ammonium, @COMPOUND$, morpholinium, phosphonium, piperidinium, pyridinium, pyrrolidinium and quinolinium ionic liquid salts in the Leukemia Rat Cell Line (IPC-81) and @PROTEIN$ (AChE) using only their empirical formulas (elemental composition) and molecular weights.	0	18805639-1461
Multiple linear regression (MLR), radial basis network (RB), and multilayer perceptron (MLP) neural network (NN) models have been explored for the estimation of toxicity of ammonium, imidazolium, morpholinium, phosphonium, piperidinium, pyridinium, pyrrolidinium and @COMPOUND$ ionic liquid salts in the Leukemia Rat Cell Line (IPC-81) and @PROTEIN$ (AChE) using only their empirical formulas (elemental composition) and molecular weights.	0	18805639-1461
Multiple linear regression (MLR), radial basis network (RB), and multilayer perceptron (MLP) neural network (NN) models have been explored for the estimation of toxicity of @COMPOUND$, imidazolium, morpholinium, phosphonium, piperidinium, pyridinium, pyrrolidinium and quinolinium ionic liquid salts in the Leukemia Rat Cell Line (IPC-81) and @PROTEIN$ (AChE) using only their empirical formulas (elemental composition) and molecular weights.	0	18805639-1461
Multiple linear regression (MLR), radial basis network (RB), and multilayer perceptron (MLP) neural network (NN) models have been explored for the estimation of toxicity of ammonium, imidazolium, @COMPOUND$, phosphonium, piperidinium, pyridinium, pyrrolidinium and quinolinium ionic liquid salts in the Leukemia Rat Cell Line (IPC-81) and Acetylcholinesterase (@PROTEIN$) using only their empirical formulas (elemental composition) and molecular weights.	0	18805639-1461
Multiple linear regression (MLR), radial basis network (RB), and multilayer perceptron (MLP) neural network (NN) models have been explored for the estimation of toxicity of ammonium, imidazolium, morpholinium, phosphonium, piperidinium, pyridinium, @COMPOUND$ and quinolinium ionic liquid salts in the Leukemia Rat Cell Line (IPC-81) and Acetylcholinesterase (@PROTEIN$) using only their empirical formulas (elemental composition) and molecular weights.	0	18805639-1461
Multiple linear regression (MLR), radial basis network (RB), and multilayer perceptron (MLP) neural network (NN) models have been explored for the estimation of toxicity of ammonium, imidazolium, @COMPOUND$, phosphonium, piperidinium, pyridinium, pyrrolidinium and quinolinium ionic liquid salts in the Leukemia Rat Cell Line (IPC-81) and @PROTEIN$ (AChE) using only their empirical formulas (elemental composition) and molecular weights.	0	18805639-1461
Multiple linear regression (MLR), radial basis network (RB), and multilayer perceptron (MLP) neural network (NN) models have been explored for the estimation of toxicity of ammonium, imidazolium, morpholinium, phosphonium, piperidinium, @COMPOUND$, pyrrolidinium and quinolinium ionic liquid salts in the Leukemia Rat Cell Line (IPC-81) and @PROTEIN$ (AChE) using only their empirical formulas (elemental composition) and molecular weights.	0	18805639-1461
Multiple linear regression (MLR), radial basis network (RB), and multilayer perceptron (MLP) neural network (NN) models have been explored for the estimation of toxicity of ammonium, imidazolium, morpholinium, phosphonium, piperidinium, pyridinium, pyrrolidinium and @COMPOUND$ ionic liquid salts in the Leukemia Rat Cell Line (IPC-81) and Acetylcholinesterase (@PROTEIN$) using only their empirical formulas (elemental composition) and molecular weights.	0	18805639-1461
Multiple linear regression (MLR), radial basis network (RB), and multilayer perceptron (MLP) neural network (NN) models have been explored for the estimation of toxicity of ammonium, @COMPOUND$, morpholinium, phosphonium, piperidinium, pyridinium, pyrrolidinium and quinolinium ionic liquid salts in the Leukemia Rat Cell Line (IPC-81) and Acetylcholinesterase (@PROTEIN$) using only their empirical formulas (elemental composition) and molecular weights.	0	18805639-1461
The beneficial effect of DHA on the treatment groups was accompanied by decreases in blood-brain barrier disruption, brain edema, @COMPOUND$ (MDA) production, inflammatory cell infiltration, interleukin-6 (@PROTEIN$) expression and caspase-3 activity.	0	18805685-1489
The beneficial effect of DHA on the treatment groups was accompanied by decreases in blood-brain barrier disruption, brain edema, @COMPOUND$ (MDA) production, inflammatory cell infiltration, @PROTEIN$ (IL-6) expression and caspase-3 activity.	0	18805685-1489
Elevation of antioxidative capacity, as evidenced by decreased MDA level and increased @PROTEIN$ activity and @COMPOUND$ level, was detected only in the chronic daily-administration group.	0	18805685-1490
@PROTEIN$ secretion is highly sensitive to desorption of plasma membrane @COMPOUND$.	1	18806218-232
Suppression of retinal @PROTEIN$ in experimental diabetes and @COMPOUND$-induced retinopathy: role of NADPH oxidase.	0	18806296-1733
TKTL 1 was highest expressed in cell lines derived from more invasive tumors but the expression level was not strongly correlated to proliferation rate, to @PROTEIN$ expression or to the response to @COMPOUND$.	0	18806930-1949
Magnesium (Mg), @PROTEIN$ (IL-8), and @COMPOUND$ levels were analyzed in blood, while edema, neutrophil infiltration, eosinophilia, loss of striation, and nucleolization were evaluated in histopathological examination.	0	18806932-1906
Magnesium (Mg), interleukin 8 (@PROTEIN$), and @COMPOUND$ levels were analyzed in blood, while edema, neutrophil infiltration, eosinophilia, loss of striation, and nucleolization were evaluated in histopathological examination.	0	18806932-1906
@COMPOUND$ (Mg), @PROTEIN$ (IL-8), and malondialdehyde levels were analyzed in blood, while edema, neutrophil infiltration, eosinophilia, loss of striation, and nucleolization were evaluated in histopathological examination.	0	18806932-1906
@COMPOUND$ (Mg), interleukin 8 (@PROTEIN$), and malondialdehyde levels were analyzed in blood, while edema, neutrophil infiltration, eosinophilia, loss of striation, and nucleolization were evaluated in histopathological examination.	0	18806932-1906
Study of multiple binding constants of @COMPOUND$ with human @PROTEIN$ by capillary electrophoresis-frontal analysis and multivariate regression.	1	18807018-1954
In this paper, to evaluate the pharmacokinetic and pharmacodynamic properties of @COMPOUND$ (DXM), the interaction between DXM and @PROTEIN$ was studied by capillary electrophoresis-frontal analysis (CE-FA).	1	18807018-1955
Arthropod @PROTEIN$ transport and store @COMPOUND$ and are composed of six subunits, or multiples thereof depending on the species.	0	18807050-1745
The protein is insensitive to lactate, but affected by urate which markedly increased @PROTEIN$-@COMPOUND$ affinity, acting as the physiological major positive effector.	1	18807050-1746
The estrogen-induced increase in @PROTEIN$ protein in MCF-7-HER2 cells was abrogated by the antiestrogen ICI 182780 and by gefitinib (@COMPOUND$ ; a phospho-tyrosine kinase inhibitor), indicating an ER-mediated effect and confirming involvement of receptor tyrosine kinases, respectively.	1	18807177-2028
The estrogen-induced increase in @PROTEIN$ protein in MCF-7-HER2 cells was abrogated by the antiestrogen ICI 182780 and by @COMPOUND$ (Iressa ; a phospho-tyrosine kinase inhibitor), indicating an ER-mediated effect and confirming involvement of receptor tyrosine kinases, respectively.	1	18807177-2028
The estrogen-induced increase in @PROTEIN$ protein in MCF-7-HER2 cells was abrogated by the antiestrogen @COMPOUND$ and by gefitinib (Iressa ; a phospho-tyrosine kinase inhibitor), indicating an ER-mediated effect and confirming involvement of receptor tyrosine kinases, respectively.	1	18807177-2028
Enzymatic activities of an H(2)O(2) independent oxidase along with @PROTEIN$ and an azoreductase suggest their prominent role during the decolorization of reactive yellow @COMPOUND$.	1	18807200-2046
Enzymatic activities of an H(2)O(2) independent oxidase along with laccase and an @PROTEIN$ suggest their prominent role during the decolorization of reactive yellow @COMPOUND$.	1	18807200-2046
@PROTEIN$ activity was prominent in presence of cofactors @COMPOUND$ and NADP in mineral salt medium.	1	18807200-2047
@PROTEIN$ activity was prominent in presence of cofactors NADH and @COMPOUND$ in mineral salt medium.	1	18807200-2047
The increase of @COMPOUND$ availability caused the induction of the antioxidant enzyme @PROTEIN$, which indicates that the defensive mechanisms of the cells against oxidative stress were effective and cells could cope with increased pressure.	1	18807214-2051
Concentrations of aqueous-phase perfluorooctanoic acid (PFOA), a representative perfluorinated aliphatic (PFA) compound, are shown to be reduced effectively via reaction with horseradish peroxidase (@PROTEIN$), hydrogen peroxide, and a phenolic cosubstrate (@COMPOUND$).	1	18808217-2356
Concentrations of aqueous-phase perfluorooctanoic acid (PFOA), a representative perfluorinated aliphatic (PFA) compound, are shown to be reduced effectively via reaction with horseradish @PROTEIN$ (HRP), hydrogen peroxide, and a phenolic cosubstrate (@COMPOUND$).	1	18808217-2356
Concentrations of aqueous-phase perfluorooctanoic acid (PFOA), a representative perfluorinated aliphatic (PFA) compound, are shown to be reduced effectively via reaction with horseradish @PROTEIN$ (HRP), @COMPOUND$, and a phenolic cosubstrate (4-methoxyphenol).	1	18808217-2356
Concentrations of aqueous-phase perfluorooctanoic acid (PFOA), a representative perfluorinated aliphatic (PFA) compound, are shown to be reduced effectively via reaction with horseradish peroxidase (@PROTEIN$), @COMPOUND$, and a phenolic cosubstrate (4-methoxyphenol).	1	18808217-2356
Approximately 68% depletion of the parent compound and 98% depletion of its related acute aquatic toxicity are achieved in 6 h. Because no PFOA removal is observed in the absence of cosubstrate and/or following consumption thereof, we conclude that radical intermediate species generated during reaction between @PROTEIN$ and @COMPOUND$ mediate nonspecific depletion of PFOA and that these intermediates may be sufficiently reactive to sever the extremely stable C-F bonds of PFOA.	1	18808217-2357
In the present study, the mRNA expression and promoter @COMPOUND$ methylation of @PROTEIN$ isoforms (i.e.	0	18808365-2406
The present study is the first report that demonstrates selective inactivation of @PROTEIN$ isoforms through the promoter @COMPOUND$ methylation pathway in leukaemias.	1	18808365-2407
@PROTEIN$ monogalactosyldiacylglycerol synthases are involved in @COMPOUND$ starvation-induced lipid remodeling, and are crucial for low-phosphate adaptation.	1	18808455-2441
This study was performed to evaluate the effects of @COMPOUND$ on breast cancer cell lines with respect to the activity of @PROTEIN$ and Akt : a downstream modulator of cell growth and survival.	1	18809244-141
This study was performed to evaluate the effects of @COMPOUND$ on breast cancer cell lines with respect to the activity of PDGFR beta and @PROTEIN$ : a downstream modulator of cell growth and survival.	1	18809244-141
The mechanisms may include the recently revealed anti-inflammatory effects of @PROTEIN$ as well as its conventional @COMPOUND$ and free fatty acids lowering effects, and possibly may also include changes in body fat distribution and plasma adiponectin level.	1	18809262-150
Recently, we reported stimulatory effect of ghrelin alone and in combination with growth hormone (GH) on @COMPOUND$ secretion, @PROTEIN$ activity in parallel with inhibitory effect on cell apoptosis.	0	18809347-188
Recently, we reported stimulatory effect of ghrelin alone and in combination with @PROTEIN$ (GH) on @COMPOUND$ secretion, aromatase activity in parallel with inhibitory effect on cell apoptosis.	1	18809347-188
Recently, we reported stimulatory effect of @PROTEIN$ alone and in combination with growth hormone (GH) on @COMPOUND$ secretion, aromatase activity in parallel with inhibitory effect on cell apoptosis.	1	18809347-188
In cultures treated together ghrelin and (D-Lys-3)-GHRP-6, @COMPOUND$ secretion, @PROTEIN$ activity and cell proliferation returned to control levels.	0	18809347-189
In cultures treated together @PROTEIN$ and (D-Lys-3)-GHRP-6, @COMPOUND$ secretion, aromatase activity and cell proliferation returned to control levels.	1	18809347-189
Expression levels of the functional activities (albumin secretion and @COMPOUND$ removal) and the cell-cell adhesion molecules (cadherin and @PROTEIN$) were higher in the hepatocytes that formed spheroids compared to those which assumed a monolayer configuration, and these levels were maintained for at least 10 days.	0	18809364-192
Nevertheless, certain clinical cases manifest themselves with the onset of acute renal failure bought upon by the administration of blockers of the rennin-@PROTEIN$-@COMPOUND$ system, or by some other causes responsible for a sudden drop in renal plasma flow (e.g., thrombosis of the renal artery).	1	18809367-193
The function of rhamnose-binding @PROTEIN$ in innate immunity by restricted binding to @COMPOUND$.	1	18809432-1105
This is the first finding that @COMPOUND$ plays a role in innate immunity by cooperating with natural ligands, @PROTEIN$.	1	18809432-1106
Effect of polyols on the solubility of bovine serum albumin (@PROTEIN$) in the presence of @COMPOUND$ glycols (PEGs) was investigated in order to strengthen the understanding of the observed effects of polyols and PEGs on protein properties in solution.	0	18809481-220
Effect of polyols on the solubility of bovine @PROTEIN$ (BSA) in the presence of @COMPOUND$ glycols (PEGs) was investigated in order to strengthen the understanding of the observed effects of polyols and PEGs on protein properties in solution.	0	18809481-220
After 2 and 6 weeks of treatment, parotid gland was removed and total protein and @COMPOUND$ (free and total) concentration and amylase and @PROTEIN$ activities were determined.	0	18810331-544
At week 2 of the study, parotid gland of diabetic rats presented a reduction of total protein concentration (55%) and an increase of amylase (120%) and @PROTEIN$ (160%) activities, free (150%) and total (170%) @COMPOUND$ concentration.	0	18810331-545
To investigate the change pattern of @PROTEIN$ (SP) and @COMPOUND$ (NO) in the portal vein during the recto-anal inhibitory reflex (RAIR), and its physiological significance; the influence of external splanchnic nerve (ESN) of rectum and anus to the RAIR.	0	18810466-577
Considering the common metabolic pathway and synergism between dopamine and @COMPOUND$, the role of dopamine transporter (SLC6A3, DAT) and @PROTEIN$ A (MAOA) genes in SIDS and stillbirth (sudden intrauterine unexplained death, SIUD) was investigated.	0	18810510-591
Considering the common metabolic pathway and synergism between dopamine and @COMPOUND$, the role of dopamine transporter (SLC6A3, DAT) and monoamine oxidase A (@PROTEIN$) genes in SIDS and stillbirth (sudden intrauterine unexplained death, SIUD) was investigated.	0	18810510-591
Considering the common metabolic pathway and synergism between dopamine and @COMPOUND$, the role of dopamine transporter (@PROTEIN$, DAT) and monoamine oxidase A (MAOA) genes in SIDS and stillbirth (sudden intrauterine unexplained death, SIUD) was investigated.	0	18810510-591
Considering the common metabolic pathway and synergism between dopamine and @COMPOUND$, the role of dopamine transporter (SLC6A3, @PROTEIN$) and monoamine oxidase A (MAOA) genes in SIDS and stillbirth (sudden intrauterine unexplained death, SIUD) was investigated.	0	18810510-591
A @PROTEIN$ (F2) and lipase-like materials (F1) were purified from the culture supernatant of P. monteilii TKU009 with soybean powder as the sole carbon/@COMPOUND$ source.	0	18810517-648
DHEA, DHEA-S, @COMPOUND$, total testosterone, free testosterone, sex hormone-binding globulin, estrone, estradiol, cortisol, insulin, @PROTEIN$, IGFBP-1, IGFBP-3, and adiponectin in plasma or serum were measured.	0	18810712-643
DHEA, DHEA-S, dihydrotestosterone, total testosterone, free testosterone, sex hormone-binding globulin, @COMPOUND$, estradiol, cortisol, insulin, @PROTEIN$, IGFBP-1, IGFBP-3, and adiponectin in plasma or serum were measured.	0	18810712-643
DHEA, DHEA-S, dihydrotestosterone, total testosterone, free testosterone, sex hormone-binding globulin, estrone, estradiol, @COMPOUND$, insulin, IGF-1, IGFBP-1, @PROTEIN$, and adiponectin in plasma or serum were measured.	0	18810712-643
DHEA, DHEA-S, dihydro@COMPOUND$, total testosterone, free testosterone, sex hormone-binding globulin, estrone, estradiol, cortisol, insulin, IGF-1, IGFBP-1, @PROTEIN$, and adiponectin in plasma or serum were measured.	0	18810712-643
DHEA, @COMPOUND$, dihydrotestosterone, total testosterone, free testosterone, sex hormone-binding globulin, estrone, estradiol, cortisol, insulin, @PROTEIN$, IGFBP-1, IGFBP-3, and adiponectin in plasma or serum were measured.	0	18810712-643
DHEA, @COMPOUND$, dihydrotestosterone, total testosterone, free testosterone, sex hormone-binding globulin, estrone, estradiol, cortisol, @PROTEIN$, IGF-1, IGFBP-1, IGFBP-3, and adiponectin in plasma or serum were measured.	0	18810712-643
DHEA, DHEA-S, @COMPOUND$, total testosterone, free testosterone, sex hormone-binding globulin, estrone, estradiol, cortisol, @PROTEIN$, IGF-1, IGFBP-1, IGFBP-3, and adiponectin in plasma or serum were measured.	0	18810712-643
DHEA, DHEA-S, dihydrotestosterone, total testosterone, free testosterone, sex hormone-binding globulin, estrone, estradiol, @COMPOUND$, @PROTEIN$, IGF-1, IGFBP-1, IGFBP-3, and adiponectin in plasma or serum were measured.	0	18810712-643
DHEA, DHEA-S, dihydrotestosterone, total testosterone, free testosterone, sex hormone-binding globulin, estrone, @COMPOUND$, cortisol, insulin, IGF-1, @PROTEIN$, IGFBP-3, and adiponectin in plasma or serum were measured.	0	18810712-643
DHEA, DHEA-S, dihydro@COMPOUND$, total testosterone, free testosterone, sex hormone-binding globulin, estrone, estradiol, cortisol, insulin, @PROTEIN$, IGFBP-1, IGFBP-3, and adiponectin in plasma or serum were measured.	0	18810712-643
DHEA, @COMPOUND$, dihydrotestosterone, total testosterone, free testosterone, sex hormone-binding globulin, estrone, estradiol, cortisol, insulin, IGF-1, IGFBP-1, @PROTEIN$, and adiponectin in plasma or serum were measured.	0	18810712-643
DHEA, DHEA-S, dihydrotestosterone, total testosterone, free testosterone, sex hormone-binding globulin, estrone, @COMPOUND$, cortisol, @PROTEIN$, IGF-1, IGFBP-1, IGFBP-3, and adiponectin in plasma or serum were measured.	0	18810712-643
DHEA, DHEA-S, dihydrotestosterone, total testosterone, free testosterone, sex hormone-binding globulin, estrone, @COMPOUND$, cortisol, insulin, @PROTEIN$, IGFBP-1, IGFBP-3, and adiponectin in plasma or serum were measured.	0	18810712-643
DHEA, @COMPOUND$, dihydrotestosterone, total testosterone, free testosterone, sex hormone-binding globulin, estrone, estradiol, cortisol, insulin, IGF-1, @PROTEIN$, IGFBP-3, and adiponectin in plasma or serum were measured.	0	18810712-643
DHEA, DHEA-S, dihydrotestosterone, total testosterone, free testosterone, sex hormone-binding globulin, estrone, estradiol, @COMPOUND$, insulin, IGF-1, @PROTEIN$, IGFBP-3, and adiponectin in plasma or serum were measured.	0	18810712-643
DHEA, DHEA-S, dihydrotestosterone, total testosterone, free testosterone, sex hormone-binding globulin, @COMPOUND$, estradiol, cortisol, @PROTEIN$, IGF-1, IGFBP-1, IGFBP-3, and adiponectin in plasma or serum were measured.	0	18810712-643
DHEA, DHEA-S, @COMPOUND$, total testosterone, free testosterone, sex hormone-binding globulin, estrone, estradiol, cortisol, insulin, IGF-1, @PROTEIN$, IGFBP-3, and adiponectin in plasma or serum were measured.	0	18810712-643
DHEA, DHEA-S, dihydro@COMPOUND$, total testosterone, free testosterone, sex hormone-binding globulin, estrone, estradiol, cortisol, @PROTEIN$, IGF-1, IGFBP-1, IGFBP-3, and adiponectin in plasma or serum were measured.	0	18810712-643
DHEA, DHEA-S, @COMPOUND$, total testosterone, free testosterone, sex hormone-binding globulin, estrone, estradiol, cortisol, insulin, IGF-1, IGFBP-1, @PROTEIN$, and adiponectin in plasma or serum were measured.	0	18810712-643
DHEA, DHEA-S, dihydro@COMPOUND$, total testosterone, free testosterone, sex hormone-binding globulin, estrone, estradiol, cortisol, insulin, IGF-1, @PROTEIN$, IGFBP-3, and adiponectin in plasma or serum were measured.	0	18810712-643
DHEA, DHEA-S, dihydrotestosterone, total testosterone, free testosterone, sex hormone-binding globulin, @COMPOUND$, estradiol, cortisol, insulin, IGF-1, @PROTEIN$, IGFBP-3, and adiponectin in plasma or serum were measured.	0	18810712-643
DHEA, DHEA-S, dihydrotestosterone, total testosterone, free testosterone, sex hormone-binding globulin, estrone, estradiol, @COMPOUND$, insulin, @PROTEIN$, IGFBP-1, IGFBP-3, and adiponectin in plasma or serum were measured.	0	18810712-643
DHEA, DHEA-S, dihydrotestosterone, total testosterone, free testosterone, sex hormone-binding globulin, estrone, @COMPOUND$, cortisol, insulin, IGF-1, IGFBP-1, @PROTEIN$, and adiponectin in plasma or serum were measured.	0	18810712-643
DHEA, DHEA-S, dihydrotestosterone, total testosterone, free testosterone, sex hormone-binding globulin, @COMPOUND$, estradiol, cortisol, insulin, IGF-1, IGFBP-1, @PROTEIN$, and adiponectin in plasma or serum were measured.	0	18810712-643
Our data indicate that genetic differences in @PROTEIN$ gene expression may predispose individual differences in the responsivity to repeated intake of @COMPOUND$.	1	18812013-984
Angiotensin II (@PROTEIN$) is the key peptide hormone in the renin-angiotensin-@COMPOUND$ system (RAAS).	1	18812209-396
Angiotensin II (Ang II) is the key @PROTEIN$ in the renin-angiotensin-@COMPOUND$ system (RAAS).	1	18812209-396
Angiotensin II (Ang II) is the key peptide hormone in the renin-@PROTEIN$-@COMPOUND$ system (RAAS).	1	18812209-396
@PROTEIN$ (Ang II) is the key peptide hormone in the renin-angiotensin-@COMPOUND$ system (RAAS).	1	18812209-396
The enzyme responsible for D-@COMPOUND$ biosynthesis, @PROTEIN$ (SR), is therefore a promising target for treatment of neuropathologies related to glutamate receptor excitotoxicity, such as stroke or Alzheimer's disease.	1	18812225-1232
Hepatocyte apoptosis was estimated morphologically using @PROTEIN$ combined with @COMPOUND$, or toluidine blue staining.	0	18812229-1054
Hepatocyte apoptosis was estimated morphologically using @PROTEIN$ combined with propidium iodide, or @COMPOUND$ staining.	0	18812229-1054
To investigate the metabolism of @COMPOUND$ through the @PROTEIN$ (CYP450) metabolic pathway, we studied the in vitro rat liver microsomal production of hydroxylated metabolites and their activity at recombinant human TRPV(1) receptors.	1	18812233-1056
The FFA fractions elicited pro-inflammatory responses inducing @PROTEIN$ and intracellular adhesion molecule expression and reactive @COMPOUND$ species (ROS) production in human aortic endothelial cells (HAECs).	0	18812596-1164
@PROTEIN$ single nucleotide polymorphism G2677T/A and haplotype are correlated with response to @COMPOUND$-cisplatin chemotherapy in patients with non-small-cell lung cancer.	1	18812689-1190
Functional expression of @PROTEIN$ responsible for protection against oxidative stress through promotion of @COMPOUND$ synthesis after Nrf2 upregulation in undifferentiated mesenchymal C3H10T1/2 stem cells.	1	18814142-2252
Functional expression of beta2 adrenergic receptors responsible for protection against oxidative stress through promotion of @COMPOUND$ synthesis after @PROTEIN$ upregulation in undifferentiated mesenchymal C3H10T1/2 stem cells.	0	18814142-2252
Exposure to adrenaline not only increased cAMP formation, phosphorylation of cAMP responsive element (CRE) binding protein (@PROTEIN$) on serine133 and CRE reporter activity in a manner sensitive to @COMPOUND$, but also rendered C3H10T1/2 cells resistant to the cytotoxicity of hydrogen peroxide, but not of either 2,4-dinitirophenol or tunicamycin.	1	18814142-2253
Exposure to adrenaline not only increased cAMP formation, phosphorylation of cAMP responsive element (CRE) binding protein (@PROTEIN$) on serine133 and CRE reporter activity in a manner sensitive to propranolol, but also rendered C3H10T1/2 cells resistant to the cytotoxicity of @COMPOUND$, but not of either 2,4-dinitirophenol or tunicamycin.	1	18814142-2253
These results suggest that adrenaline may selectively protect mesenchymal C3H10T1/2 cells from oxidative stress through a mechanism related to the promoted biosynthesis of @COMPOUND$ in association with transient @PROTEIN$ expression after activation of beta(2)AdR.	1	18814142-2254
Two principal signaling pathways that regulate proliferation are PI3K/@COMPOUND$/Akt and @PROTEIN$/Ras/ERK1/2.	0	18814181-1610
Two principal signaling pathways that regulate proliferation are PI3K/@COMPOUND$/Akt and Shc/@PROTEIN$/ERK1/2.	0	18814181-1610
Two principal signaling pathways that regulate proliferation are @PROTEIN$/@COMPOUND$/Akt and Shc/Ras/ERK1/2.	1	18814181-1610
Two principal signaling pathways that regulate proliferation are PI3K/@COMPOUND$/@PROTEIN$ and Shc/Ras/ERK1/2.	1	18814181-1610
Two principal signaling pathways that regulate proliferation are PI3K/@COMPOUND$/Akt and Shc/Ras/@PROTEIN$/2.	0	18814181-1610
However, @COMPOUND$ treatment resulted in intracellular accumulation of @PROTEIN$ and prevented its translocation to the cell surface.	1	18814266-2509
@COMPOUND$ (imatinib) is a potent and selective inhibitor of the tyrosine kinases, Bcr-Abl, @PROTEIN$ and platelet-derived growth factor receptors (PDGFRs).	1	18814279-1660
Imatinib mesylate (@COMPOUND$) is a potent and selective inhibitor of the tyrosine kinases, Bcr-@PROTEIN$, c-Kit and platelet-derived growth factor receptors (PDGFRs).	1	18814279-1660
@COMPOUND$ (imatinib) is a potent and selective inhibitor of the tyrosine kinases, @PROTEIN$-Abl, c-Kit and platelet-derived growth factor receptors (PDGFRs).	1	18814279-1660
Imatinib mesylate (@COMPOUND$) is a potent and selective inhibitor of the tyrosine kinases, Bcr-Abl, @PROTEIN$ and platelet-derived growth factor receptors (PDGFRs).	1	18814279-1660
Imatinib mesylate (@COMPOUND$) is a potent and selective inhibitor of the tyrosine kinases, @PROTEIN$-Abl, c-Kit and platelet-derived growth factor receptors (PDGFRs).	1	18814279-1660
@COMPOUND$ (imatinib) is a potent and selective inhibitor of the tyrosine kinases, Bcr-@PROTEIN$, c-Kit and platelet-derived growth factor receptors (PDGFRs).	1	18814279-1660
The large and diverse family of @PROTEIN$ monooxygenases (CYPs) was systematically analyzed to identify selectivity- and specificity-determining residues in the substrate recognition site 5, which is located in close vicinity to the @COMPOUND$ center.	1	18814300-1665
The large and diverse family of cytochrome P450 monooxygenases (@PROTEIN$) was systematically analyzed to identify selectivity- and specificity-determining residues in the substrate recognition site 5, which is located in close vicinity to the @COMPOUND$ center.	0	18814300-1665
In 98.4% of all @PROTEIN$ sequences a preferentially hydrophobic residue is located at position 5 after the ExxR motif that is predicted to point close to the @COMPOUND$ center.	0	18814300-1666
We report the interaction of a potent synthetic derivative of @COMPOUND$, isoxazolcurcumin (IOC) with human serum albumin (@PROTEIN$) using various biophysical methods.	1	18814316-53
We report the interaction of a potent synthetic derivative of curcumin, isoxazolcurcumin (@COMPOUND$) with human @PROTEIN$ (HSA) using various biophysical methods.	1	18814316-53
We report the interaction of a potent synthetic derivative of @COMPOUND$, isoxazolcurcumin (IOC) with human @PROTEIN$ (HSA) using various biophysical methods.	1	18814316-53
We report the interaction of a potent synthetic derivative of curcumin, isoxazolcurcumin (@COMPOUND$) with human serum albumin (@PROTEIN$) using various biophysical methods.	1	18814316-53
The observed fluorescence quenching of @PROTEIN$ by @COMPOUND$ is due to a complex formation by a static quenching process with a quenching constant of the order of 10(5) M(-1).	1	18814316-54
From the observed Frster-type fluorescence resonance energy transfer (FRET), the donor (Trp 214 in @PROTEIN$) to acceptor (@COMPOUND$) distance is calculated to be 3.2 nm.	1	18814316-55
The preferred binding site of IOC was analyzed by ligand displacement experiments with 1-anilino-8-naphthalenesulfonate (ANS) and @COMPOUND$-bound @PROTEIN$.	1	18814316-56
The preferred binding site of IOC was analyzed by ligand displacement experiments with @COMPOUND$ (ANS) and warfarin-bound @PROTEIN$.	1	18814316-56
The preferred binding site of @COMPOUND$ was analyzed by ligand displacement experiments with 1-anilino-8-naphthalenesulfonate (ANS) and warfarin-bound @PROTEIN$.	1	18814316-56
A number of site-specific modifications of the nucleosome core histones-including the trimethylated forms of @PROTEIN$ lysines K4, K9, and @COMPOUND$-are of particular interest for postmortem research, because these marks differentiate between active and inactive chromatin and seem to remain relatively stable during tissue autolysis.	1	18814864-1818
We here demonstrate that @PROTEIN$ confers a sensitivity towards near ultraviolet (UVA) light, which rapidly causes @COMPOUND$+) entry.	1	18814910-1833
In the presence of the photosensitising agents @COMPOUND$ (100 nM) or hypericin (10 nM), the sensitivity of light-induced @PROTEIN$ activation was increased and extended towards the visible spectrum.	1	18814910-1834
In the presence of the photosensitising agents acridine orange (100 nM) or @COMPOUND$ (10 nM), the sensitivity of light-induced @PROTEIN$ activation was increased and extended towards the visible spectrum.	1	18814910-1834
To verify the possible involvement of lipids and several other compounds including @COMPOUND$ (H(2)O(2)) and glyceraldehyde-3-phosphate dehydrogenase (@PROTEIN$) in the response of Hordeum vulgare to early potassium deprivation, plants were grown in hydroponic conditions for 30d with a modified Hewitt nutrient solution containing 3mM K(+).	0	18814934-1845
To verify the possible involvement of lipids and several other compounds including @COMPOUND$ (H(2)O(2)) and @PROTEIN$ (G3PDH) in the response of Hordeum vulgare to early potassium deprivation, plants were grown in hydroponic conditions for 30d with a modified Hewitt nutrient solution containing 3mM K(+).	0	18814934-1845
A new biosensor for trehalose determination has been realized by means of a flow system, based on a reactor in which the trehalase enzyme catalyses its hydrolysis into two @COMPOUND$ molecules, and a GOD (@PROTEIN$) amperometric biosensor is employed for the glucose determination.	0	18815024-1868
A new biosensor for trehalose determination has been realized by means of a flow system, based on a reactor in which the trehalase enzyme catalyses its hydrolysis into two @COMPOUND$ molecules, and a @PROTEIN$ (glucose oxidase) amperometric biosensor is employed for the glucose determination.	1	18815024-1868
The angiogenic potential of vascular endothelial growth factor (@PROTEIN$) and its @COMPOUND$ pressure-dependent regulation suggest a strong connection between this growth factor and the 'delay phenomenon'.	1	18815084-1886
Quantitative proteomics analysis of macrophage rafts reveals compartmentalized activation of the proteasome and of proteasome-mediated @PROTEIN$ activation in response to @COMPOUND$.	1	18815123-1901
@COMPOUND$ toxicity and @PROTEIN$-dependent detoxification in astrocytes.	1	18815141-1912
After serum @COMPOUND$ reached a stable nadir in the transplant recipients, @PROTEIN$ and its hemodynamic determinants were evaluated and the whole allograft K(f) was computed.	0	18815243-1973
Lower expression of IGFBP1 and @PROTEIN$ mRNA and protein was observed in hESF from women with vs. those without endometriosis in response to @COMPOUND$, but not P4, suggesting a blunted response of these decidual biomarkers to activation of the PKA pathway in eutopic endometrium in women with disease.	1	18815356-1953
Lower expression of @PROTEIN$ and prolactin mRNA and protein was observed in hESF from women with vs. those without endometriosis in response to @COMPOUND$, but not P4, suggesting a blunted response of these decidual biomarkers to activation of the PKA pathway in eutopic endometrium in women with disease.	1	18815356-1953
Furthermore, constitutive expression of an @COMPOUND$-insensitive, active form of @PROTEIN$ protein mimicked the effects of low oxygen, inhibiting the differentiation of trophoblast giant cells.	0	18815358-2022
Finally, the results showed that the @PROTEIN$ covalently attached onto @COMPOUND$ exhibited the highest enantioselectivity and operational stability.	1	18815782-2147
Effect of the inoculum size on carbapenem susceptibilities of @PROTEIN$-negative, @COMPOUND$-resistant Haemophilus influenzae.	0	18815831-2150
However, the effect of inoculum size of @PROTEIN$-negative, @COMPOUND$-resistant H. influenzae (BLNAR) on MICs for carbapenems has not been investigated.	0	18815831-2151
It has been proposed that there is improvement in @COMPOUND$ and @PROTEIN$ metabolism after weight loss in patients who underwent diet restriction and bariatric surgery.	0	18815849-2155
@COMPOUND$ deficiency due to the methylenetetrahydrofolate reductase (@PROTEIN$) and methionine synthase (MS) variants leads to carcinogenesis by affecting DNA synthesis, repair, and methylation.	1	18815869-2158
@COMPOUND$ deficiency due to the methylenetetrahydrofolate reductase (MTHFR) and @PROTEIN$ (MS) variants leads to carcinogenesis by affecting DNA synthesis, repair, and methylation.	1	18815869-2158
@COMPOUND$ deficiency due to the @PROTEIN$ (MTHFR) and methionine synthase (MS) variants leads to carcinogenesis by affecting DNA synthesis, repair, and methylation.	1	18815869-2158
@COMPOUND$ has been the mainstay of endocrine therapy for @PROTEIN$-positive breast cancer.	1	18815881-2160
The bifunctional enzyme @PROTEIN$/N-acetylmannosamine kinase (GNE) is the key enzyme for the biosynthesis of @COMPOUND$, terminal components of glycoconjugates associated with a variety of physiological and pathological processes.	1	18815882-2164
The bifunctional enzyme UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase (@PROTEIN$) is the key enzyme for the biosynthesis of @COMPOUND$, terminal components of glycoconjugates associated with a variety of physiological and pathological processes.	1	18815882-2164
A subthreshold stimulation by acute pathological threatening conditions (e.g., global ischemia subthreshold for cell death) enhances neuronal @PROTEIN$ and glial Cx43 hemichannel activity, favoring @COMPOUND$ release and generation of preconditioning.	1	18816186-2283
A subthreshold stimulation by acute pathological threatening conditions (e.g., global ischemia subthreshold for cell death) enhances neuronal Cx36 and glial @PROTEIN$ hemichannel activity, favoring @COMPOUND$ release and generation of preconditioning.	1	18816186-2283
A study of rituximab and ifosfamide, carboplatin, and @COMPOUND$ chemotherapy in children with recurrent/refractory B-cell (@PROTEIN$+) non-Hodgkin lymphoma and mature B-cell acute lymphoblastic leukemia: a report from the Children's Oncology Group.	1	18816698-2452
A study of rituximab and ifosfamide, @COMPOUND$, and etoposide chemotherapy in children with recurrent/refractory B-cell (@PROTEIN$+) non-Hodgkin lymphoma and mature B-cell acute lymphoblastic leukemia: a report from the Children's Oncology Group.	1	18816698-2452
A study of rituximab and @COMPOUND$, carboplatin, and etoposide chemotherapy in children with recurrent/refractory B-cell (@PROTEIN$+) non-Hodgkin lymphoma and mature B-cell acute lymphoblastic leukemia: a report from the Children's Oncology Group.	1	18816698-2452
4) PKA regulates neurotransmission without @PROTEIN$ involvement because, after @COMPOUND$ or CaC modulation of the PKC activity, coupling to the ACh release of PKA can normally be stimulated with Sp-8-BrcAMP or inhibited with H-89.	0	18816790-2482
5) After PKA inhibition with H-89, @PROTEIN$ stimulation with @COMPOUND$ (or inhibition with CaC) does not lead to any change in evoked ACh release.	1	18816790-2483
In contrast, PKA inhibition prevent @PROTEIN$ stimulation (with the @COMPOUND$) and coupling to ACh output.	1	18816790-2484
The inhibition of female rabbit sexual behavior by @COMPOUND$ : @PROTEIN$-dependent and-independent effects.	1	18817778-252
Reproductive experience alters @COMPOUND$ and @PROTEIN$ levels in the rat dam.	0	18817795-259
The present study investigated whether the levels of circulating @COMPOUND$ and its binding protein, @PROTEIN$ (CBG), are altered with reproductive experience and pup-exposure during late pregnancy and the postpartum.	1	18817795-260
The present study investigated whether the levels of circulating @COMPOUND$ and its binding protein, corticosteroid binding globulin (@PROTEIN$), are altered with reproductive experience and pup-exposure during late pregnancy and the postpartum.	1	18817795-260
Total serum @COMPOUND$ and @PROTEIN$ were assayed from five groups; multiparous, primiparous, nulliparous, primip-no-pups, and sensitized rats during gestation (days 14 and 19) and the postpartum period (days 1, 5, 14, 21, and 35).	0	18817795-261
The influence of @COMPOUND$, atorvastatin and high-cholesterol diet on @PROTEIN$ activity, amyloid beta and cholesterol synthesis in rat brain.	0	18817797-263
The influence of simvastatin, @COMPOUND$ and high-cholesterol diet on @PROTEIN$ activity, amyloid beta and cholesterol synthesis in rat brain.	0	18817797-263
The expressions of serotonin receptors (5-hydroxytryptamine receptor), corticotropin-releasing hormone (@PROTEIN$) and @COMPOUND$ (AVP) mRNA in the hypothalamus were detected by real time PCR.	0	18817816-1059
The expressions of serotonin receptors (5-hydroxytryptamine receptor), @PROTEIN$ (CRH) and @COMPOUND$ (AVP) mRNA in the hypothalamus were detected by real time PCR.	0	18817816-1059
The expressions of serotonin receptors (@PROTEIN$), corticotropin-releasing hormone (CRH) and @COMPOUND$ (AVP) mRNA in the hypothalamus were detected by real time PCR.	0	18817816-1059
The expressions of @PROTEIN$ (5-hydroxytryptamine receptor), corticotropin-releasing hormone (CRH) and @COMPOUND$ (AVP) mRNA in the hypothalamus were detected by real time PCR.	0	18817816-1059
After incubation with 4- androstene-3,17-dione (4-dione), there are no estrogens, estrone (E1) and @COMPOUND$ (E2), detected suggesting that the pathway of @PROTEIN$ is not important in these cell lines.	0	18817841-391
After incubation with 4- androstene-3,17-dione (4-dione), there are no estrogens, @COMPOUND$ (E1) and estradiol (E2), detected suggesting that the pathway of @PROTEIN$ is not important in these cell lines.	0	18817841-391
The aim of this study was to investigate the effects of acute and chronic exercise on @COMPOUND$ reactive substances, as an indicator of lipid peroxidation, in the hippocampus, which has a high concentration of @PROTEIN$, and prefrontal cortex and striatum, which have high dopamine content.	0	18817845-305
The aim of this study was to investigate the effects of acute and chronic exercise on thiobarbituric acid reactive substances, as an indicator of lipid peroxidation, in the hippocampus, which has a high concentration of @PROTEIN$, and prefrontal cortex and striatum, which have high @COMPOUND$ content.	0	18817845-305
Additionally we examined antioxidant enzyme activities, @PROTEIN$ and glutathione peroxidase and nitrite-@COMPOUND$ levels to assess the effects of reactive oxygen and nitrogen species.	0	18817845-306
Additionally we examined antioxidant enzyme activities, superoxide dismutase and @PROTEIN$ and nitrite-@COMPOUND$ levels to assess the effects of reactive oxygen and nitrogen species.	0	18817845-306
Oral administration of (PhSe)(2) in rats did not change plasma alanine and @PROTEIN$ activities (AST and ALT) as well as @COMPOUND$ and creatinine levels.	0	18818063-283
Oral administration of (PhSe)(2) in rats did not change plasma alanine and aspartate aminotransferase activities (@PROTEIN$ and ALT) as well as @COMPOUND$ and creatinine levels.	0	18818063-283
Oral administration of (PhSe)(2) in rats did not change plasma alanine and @PROTEIN$ activities (AST and ALT) as well as urea and @COMPOUND$ levels.	0	18818063-283
Oral administration of (PhSe)(2) in rats did not change plasma alanine and aspartate aminotransferase activities (@PROTEIN$ and ALT) as well as urea and @COMPOUND$ levels.	0	18818063-283
Total plasma @COMPOUND$ level, @PROTEIN$ C677T polymorphism, inherited abnormalities of the natural anticoagulant system as well as plasma folate and cobalamin levels were determined.	0	18818229-311
Total plasma homocysteine level, @PROTEIN$ C677T polymorphism, inherited abnormalities of the natural anticoagulant system as well as plasma folate and @COMPOUND$ levels were determined.	0	18818229-311
Total plasma homocysteine level, @PROTEIN$ C677T polymorphism, inherited abnormalities of the natural anticoagulant system as well as plasma @COMPOUND$ and cobalamin levels were determined.	0	18818229-311
Immunohistochemical colabeling for nesfatin-1 and @PROTEIN$, histidine decarboxylase, or @COMPOUND$ revealed two subtypes of nesfatin-1-positive endocrine cells.	0	18818289-2648
Immunohistochemical colabeling for nesfatin-1 and ghrelin, @PROTEIN$, or @COMPOUND$ revealed two subtypes of nesfatin-1-positive endocrine cells.	0	18818289-2648
Cells in the midportion of the glands coexpressed nesfatin-1 and @PROTEIN$, whereas few cells in the glandular base coexpressed nesfatin-1 and @COMPOUND$ or histidine decarboxylase.	0	18818289-2649
Cells in the midportion of the glands coexpressed nesfatin-1 and ghrelin, whereas few cells in the glandular base coexpressed nesfatin-1 and @COMPOUND$ or @PROTEIN$.	0	18818289-2649
Importantly, @PROTEIN$ and PAI-1 proteins and tPA activity were low/nondetectable in granulosa cells obtained after treatment with hCG and the PG synthesis inhibitor @COMPOUND$.	1	18818294-345
Importantly, tPA and @PROTEIN$ proteins and tPA activity were low/nondetectable in granulosa cells obtained after treatment with hCG and the PG synthesis inhibitor @COMPOUND$.	1	18818294-345
To determine whether hCG stimulation of tPA and @PROTEIN$ requires PGE2, granulosa cells obtained at 0 h were cultured with hCG plus @COMPOUND$ to inhibit PG production; some cells also received PGE2 or an agonist selective for one PGE2 receptor (EP).	0	18818294-346
To determine whether hCG stimulation of @PROTEIN$ and PAI-1 requires PGE2, granulosa cells obtained at 0 h were cultured with hCG plus @COMPOUND$ to inhibit PG production; some cells also received PGE2 or an agonist selective for one PGE2 receptor (EP).	0	18818294-346
The role of @COMPOUND$ in the treatment of obesity through @PROTEIN$ antagonism.	1	18818299-354
In conclusion, the enhanced H(2)O(2) contraction in resistance arteries from SHRs seems to be mediated by increased TXA(2) release from @PROTEIN$ followed by elevations in vascular smooth muscle (@COMPOUND$+))(i) levels and O(2)(.	0	18818375-367
The @PROTEIN$ proto-oncogene and microRNA-@COMPOUND$ comprise an active autoregulatory feedback loop in human hematopoietic cells.	1	18818396-379
Herein we show that @PROTEIN$ expression is subject to posttranscriptional regulation by microRNA (miRNA)-@COMPOUND$.	1	18818396-380
Exogenous expression of @PROTEIN$ mRNA lacking the 3'-UTR partially rescued the miR-@COMPOUND$ induced cell-cycle block.	1	18818396-381
Occupancy of one canonical @PROTEIN$ binding site was demonstrated by chromatin immunoprecipitation analysis and shown to be required for miR-@COMPOUND$ expression in K562 cells.	1	18818396-382
In aggregate, these findings suggest the presence of a @PROTEIN$-miR-@COMPOUND$ autoregulatory feedback loop of potential importance in human hematopoiesis.	1	18818396-384
The central homeostasis is characterized by increased cerebrocortical synaptosomal T(3) content, deiodinase type II (@PROTEIN$) activity, and @COMPOUND$ content.	0	18818486-396
This review provides an introduction to epigenetic concepts for renal investigators and an overview of our work detailing an epigenetic pathway for @COMPOUND$ signaling and the control of epithelial @PROTEIN$-alpha (ENaCalpha) subunit gene expression in the collecting duct.	0	18818687-454
We aim to evaluate whether an E1A, E1B double-restricted oncolytic adenovirus, AxdAdB-3, can improve the efficacy for gallbladder cancers (GBCs) of the replication-deficient adenovirus-based herpes simplex virus thymidine kinase (HSVtk)/@COMPOUND$ (GCV) therapy directed by the @PROTEIN$ (CEA) promoter.	1	18818710-2729
We aim to evaluate whether an E1A, E1B double-restricted oncolytic adenovirus, AxdAdB-3, can improve the efficacy for gallbladder cancers (GBCs) of the replication-deficient adenovirus-based herpes simplex virus thymidine kinase (HSVtk)/ganciclovir (@COMPOUND$) therapy directed by the carcinoembryonic antigen (@PROTEIN$) promoter.	1	18818710-2729
We aim to evaluate whether an E1A, E1B double-restricted oncolytic adenovirus, AxdAdB-3, can improve the efficacy for gallbladder cancers (GBCs) of the replication-deficient adenovirus-based herpes simplex virus thymidine kinase (HSVtk)/@COMPOUND$ (GCV) therapy directed by the carcinoembryonic antigen (@PROTEIN$) promoter.	1	18818710-2729
We aim to evaluate whether an E1A, E1B double-restricted oncolytic adenovirus, AxdAdB-3, can improve the efficacy for gallbladder cancers (GBCs) of the replication-deficient adenovirus-based herpes simplex virus thymidine kinase (HSVtk)/ganciclovir (@COMPOUND$) therapy directed by the @PROTEIN$ (CEA) promoter.	1	18818710-2729
Cytopathic effects of AxdAdB-3 plus AxCEAprTK (an adenovirus expressing HSVtk directed by CEA promoter) or AxCAHSVtk (an adenovirus expressing HSVtk directed by a nonspecific @PROTEIN$ promoter) with @COMPOUND$ administration were examined in several GBC lines and normal cells.	0	18818710-2730
This mutation in the @PROTEIN$ gene replaces a @COMPOUND$ encoding codon with a stop signal.	1	18818946-557
Cyclophilin A (CypA), a receptor for the immunosuppressive agent @COMPOUND$ (CsA), is a cis-trans peptidyl-prolyl isomerase (@PROTEIN$) which accelerates the cis-trans isomerization of prolyl-peptide bonds, interacts with a variety of proteins and therefore regulates their activities.	0	18819019-595
Cyclophilin A (@PROTEIN$), a receptor for the immunosuppressive agent @COMPOUND$ (CsA), is a cis-trans peptidyl-prolyl isomerase (PPIase) which accelerates the cis-trans isomerization of prolyl-peptide bonds, interacts with a variety of proteins and therefore regulates their activities.	1	18819019-595
@PROTEIN$ (CypA), a receptor for the immunosuppressive agent @COMPOUND$ (CsA), is a cis-trans peptidyl-prolyl isomerase (PPIase) which accelerates the cis-trans isomerization of prolyl-peptide bonds, interacts with a variety of proteins and therefore regulates their activities.	1	18819019-595
While studies have shown that @COMPOUND$ does not exhibit nonspecific actions on @PROTEIN$, its effects on steroid hormone production have not been reported.	0	18819053-613
New treatments for type 2 diabetes mellitus are needed to retain @PROTEIN$-@COMPOUND$ coupling and lower the risk of weight gain and hypoglycaemia.	1	18819705-825
The parameters measured in E. albidus whole body were: lipid peroxidation (LPO), total @COMPOUND$ (TG), as well as the enzymatic activities of superoxide dismutase (SOD), catalase (@PROTEIN$), glutathione reductase (GR), glutathione peroxidase (GPx) and glutathione S-transferase (GST).	0	18819713-827
The parameters measured in E. albidus whole body were: lipid peroxidation (LPO), total @COMPOUND$ (TG), as well as the enzymatic activities of superoxide dismutase (SOD), catalase (CAT), glutathione reductase (GR), glutathione peroxidase (GPx) and glutathione S-transferase (@PROTEIN$).	0	18819713-827
The parameters measured in E. albidus whole body were: lipid peroxidation (LPO), total @COMPOUND$ (TG), as well as the enzymatic activities of superoxide dismutase (@PROTEIN$), catalase (CAT), glutathione reductase (GR), glutathione peroxidase (GPx) and glutathione S-transferase (GST).	0	18819713-827
The parameters measured in E. albidus whole body were: lipid peroxidation (LPO), total @COMPOUND$ (TG), as well as the enzymatic activities of superoxide dismutase (SOD), catalase (CAT), glutathione reductase (GR), glutathione peroxidase (GPx) and @PROTEIN$ (GST).	0	18819713-827
The parameters measured in E. albidus whole body were: lipid peroxidation (LPO), total @COMPOUND$ (TG), as well as the enzymatic activities of @PROTEIN$ (SOD), catalase (CAT), glutathione reductase (GR), glutathione peroxidase (GPx) and glutathione S-transferase (GST).	0	18819713-827
The parameters measured in E. albidus whole body were: lipid peroxidation (LPO), total @COMPOUND$ (TG), as well as the enzymatic activities of superoxide dismutase (SOD), catalase (CAT), @PROTEIN$ (GR), glutathione peroxidase (GPx) and glutathione S-transferase (GST).	0	18819713-827
The parameters measured in E. albidus whole body were: lipid peroxidation (LPO), total @COMPOUND$ (TG), as well as the enzymatic activities of superoxide dismutase (SOD), catalase (CAT), glutathione reductase (GR), @PROTEIN$ (GPx) and glutathione S-transferase (GST).	0	18819713-827
The parameters measured in E. albidus whole body were: lipid peroxidation (LPO), total @COMPOUND$ (TG), as well as the enzymatic activities of superoxide dismutase (SOD), @PROTEIN$ (CAT), glutathione reductase (GR), glutathione peroxidase (GPx) and glutathione S-transferase (GST).	0	18819713-827
Augmentation of antibody responses by @COMPOUND$ and @PROTEIN$.	0	18819820-872
In accord with published results, we could show that treatment with @COMPOUND$ resulted in depletion of @PROTEIN$, a known Hsp90 client protein.	1	18820127-944
In accord with published results, we could show that treatment with @COMPOUND$ resulted in depletion of Chk1, a known @PROTEIN$ client protein.	0	18820127-944
In addition, we observed a time- and dose-dependent decrease in @PROTEIN$ kinase level, a negative regulator of mitosis, after @COMPOUND$ treatment in gastrointestinal cancer cells.	1	18820127-945
@PROTEIN$ alpha is a proximal mediator of synergistic hepatotoxicity from @COMPOUND$/lipopolysaccharide coexposure.	1	18820134-953
A small cytoplasmic protein, @PROTEIN$, has been identified in human hepatic tissue, but its role in @COMPOUND$ metabolism is unknown.	0	18820153-959
As with @PROTEIN$, they are involved in making @COMPOUND$ available to apo-enzymes inside the cell.	1	18820153-962
BrdU proliferation assays showed that in vivo proliferation of CD8+ T cells was reduced in @COMPOUND$-fed mice, and @PROTEIN$-dependent in vitro proliferation of naive CD8+ T cells was also reduced.	0	18820175-973
Multiple studies suggest increased conversion of @COMPOUND$ to bile acids by @PROTEIN$ (CYP7A1) protects against dyslipidemia and atherosclerosis.	1	18820241-987
Multiple studies suggest increased conversion of @COMPOUND$ to bile acids by cholesterol 7alpha-hydroxylase (@PROTEIN$) protects against dyslipidemia and atherosclerosis.	1	18820241-987
Therefore, we queried whether @COMPOUND$ is prosurvival in podocytes through a @PROTEIN$-dependent pathway.	0	18820279-997
Treatment with pioglitazone, associated with @COMPOUND$, showed a reduction of @PROTEIN$ monocyte production after their in vitro activation with LPS.	1	18820825-2189
Regulation of T-type @PROTEIN$.1 channels expression by synthetic glucocorticoid @COMPOUND$ in neonatal cardiac myocytes.	1	18820838-1229
The supernatant of the majority of the strains did not release the aglycone from @COMPOUND$, suggesting that cell-associated beta-glucosidases (beta-@PROTEIN$) are mainly responsible for the metabolism of soybean glyco-conjugates.	0	18820905-1243
The supernatant of the majority of the strains did not release the aglycone from @COMPOUND$, suggesting that cell-associated @PROTEIN$ (beta-Glu) are mainly responsible for the metabolism of soybean glyco-conjugates.	0	18820905-1243
Role of @PROTEIN$ as a biomarker for predicting resistance to @COMPOUND$ in breast cancer.	1	18820913-1250
Acute regulation is mediated by the @PROTEIN$ (StAR), which facilitates the rapid influx of @COMPOUND$ into mitochondria, where P450scc resides.	1	18821018-1286
Acute regulation is mediated by the steroidogenic acute regulatory protein (@PROTEIN$), which facilitates the rapid influx of @COMPOUND$ into mitochondria, where P450scc resides.	1	18821018-1286
In the absence of @PROTEIN$ in the zona glomerulosa, C21 deoxy steroids are produced, leading to the mineralocorticoid, @COMPOUND$.	0	18821018-1287
In the presence of the 17alpha-hydroxylase but not the 17,20 lyase activity of @PROTEIN$ in the zona fasciculata, C21, 17-hydroxy steroids are produced, leading to the glucocorticoid, @COMPOUND$.	0	18821018-1288
When both the 17alpha-hydroxylase and 17,20 lyase activities of @PROTEIN$ are present in the zona reticularis, the androgen precursor @COMPOUND$ is produced.	1	18821018-1289
In the adrenal zona reticularis, the abundant expression of P450 oxidoreductase and cytochrome b5, and the low expression of @PROTEIN$ (HSD3B2) result in the production of the large amounts of @COMPOUND$ that characterize adrenarche.	1	18821018-1291
In the adrenal zona reticularis, the abundant expression of P450 oxidoreductase and @PROTEIN$, and the low expression of 3beta-hydroxysteroid dehydrogenase (HSD3B2) result in the production of the large amounts of @COMPOUND$ that characterize adrenarche.	1	18821018-1291
In the adrenal zona reticularis, the abundant expression of P450 oxidoreductase and cytochrome b5, and the low expression of 3beta-hydroxysteroid dehydrogenase (@PROTEIN$) result in the production of the large amounts of @COMPOUND$ that characterize adrenarche.	1	18821018-1291
These were mutated in onion @PROTEIN$ (acINV) according to the residue in festuca @COMPOUND$ : sucrose 1-fructosyltransferase (saSST) and vice versa.	0	18821058-2709
These were mutated in onion vacuolar invertase (acINV) according to the residue in festuca @COMPOUND$ : @PROTEIN$-fructosyltransferase (saSST) and vice versa.	0	18821058-2709
Optimization of chitosan succinate and chitosan @COMPOUND$ microspheres for oral delivery of @PROTEIN$ using response surface methodology.	0	18821127-1366
The relative pharmacological efficacy for chitosan @COMPOUND$ and chitosan succinate microspheres (18.66+/-3.84%, 16.24+/-4%) was almost three-fold higher than the efficacy of the oral @PROTEIN$ administration (4.68+/-1.52%).	0	18821127-1367
Induction of autophagy in malignant rhabdoid tumor cells by the histone deacetylase inhibitor @COMPOUND$ through @PROTEIN$ translocation.	1	18821579-1511
@COMPOUND$ converted unconjugated @PROTEIN$ (LC3-I) to conjugated light chain 3 (LC3-II) and induced localization of LC3 to autophagosomes.	1	18821579-1513
@COMPOUND$ converted unconjugated microtubule-associated protein light chain 3 (@PROTEIN$) to conjugated light chain 3 (LC3-II) and induced localization of LC3 to autophagosomes.	1	18821579-1513
@COMPOUND$ converted unconjugated microtubule-associated protein light chain 3 (LC3-I) to conjugated light chain 3 (@PROTEIN$) and induced localization of LC3 to autophagosomes.	1	18821579-1513
@COMPOUND$ converted unconjugated microtubule-associated protein light chain 3 (LC3-I) to conjugated light chain 3 (LC3-II) and induced localization of @PROTEIN$ to autophagosomes.	1	18821579-1513
@PROTEIN$ (AIF), which plays a role in caspase-independent cell death, translocated to the nucleus in response to @COMPOUND$ treatment.	1	18821579-1514
Apoptosis inducing factor (@PROTEIN$), which plays a role in caspase-independent cell death, translocated to the nucleus in response to @COMPOUND$ treatment.	1	18821579-1514
Furthermore, the effect of @COMPOUND$ on @PROTEIN$ has not been reported previously.	1	18821853-1612
In the present study, we investigated the cellular and molecular mechanisms of @PROTEIN$ regulation by @COMPOUND$ in VSMCs (vascular SMCs).	1	18821853-1613
The objective of this study was to examine the impact of polymorphisms in the acyl-CoA:diacylglycerol acyltransferase (DGAT1), @PROTEIN$ and growth hormone receptor genes on body energy (body condition score, total body energy content and cumulative effective energy balance) and blood metabolic traits (levels of @COMPOUND$, glucose and non-esterified fatty acids), measured once before the first calving and then repeatedly throughout first lactation in 497 Holstein cows.	0	18822099-1671
The objective of this study was to examine the impact of polymorphisms in the acyl-CoA:diacylglycerol acyltransferase (@PROTEIN$), leptin and growth hormone receptor genes on body energy (body condition score, total body energy content and cumulative effective energy balance) and blood metabolic traits (levels of @COMPOUND$, glucose and non-esterified fatty acids), measured once before the first calving and then repeatedly throughout first lactation in 497 Holstein cows.	0	18822099-1671
The objective of this study was to examine the impact of polymorphisms in the acyl-CoA:diacylglycerol acyltransferase (DGAT1), leptin and @PROTEIN$ receptor genes on body energy (body condition score, total body energy content and cumulative effective energy balance) and blood metabolic traits (levels of beta-hydroxybutyrate, @COMPOUND$ and non-esterified fatty acids), measured once before the first calving and then repeatedly throughout first lactation in 497 Holstein cows.	0	18822099-1671
The objective of this study was to examine the impact of polymorphisms in the acyl-CoA:diacylglycerol acyltransferase (DGAT1), @PROTEIN$ and growth hormone receptor genes on body energy (body condition score, total body energy content and cumulative effective energy balance) and blood metabolic traits (levels of beta-hydroxybutyrate, @COMPOUND$ and non-esterified fatty acids), measured once before the first calving and then repeatedly throughout first lactation in 497 Holstein cows.	0	18822099-1671
The objective of this study was to examine the impact of polymorphisms in the acyl-CoA:diacylglycerol acyltransferase (@PROTEIN$), leptin and growth hormone receptor genes on body energy (body condition score, total body energy content and cumulative effective energy balance) and blood metabolic traits (levels of beta-hydroxybutyrate, @COMPOUND$ and non-esterified fatty acids), measured once before the first calving and then repeatedly throughout first lactation in 497 Holstein cows.	0	18822099-1671
The objective of this study was to examine the impact of polymorphisms in the acyl-CoA:diacylglycerol acyltransferase (DGAT1), leptin and @PROTEIN$ receptor genes on body energy (body condition score, total body energy content and cumulative effective energy balance) and blood metabolic traits (levels of @COMPOUND$, glucose and non-esterified fatty acids), measured once before the first calving and then repeatedly throughout first lactation in 497 Holstein cows.	0	18822099-1671
Pretransplant conditioning consisted of @COMPOUND$, l-@PROTEIN$ and TBI (2 Gy).	0	18822105-1672
Despite pre- and post-operative PP and immunosuppressive treatment consisting of steroids, CycA, daclizumab, and @PROTEIN$, daily protein excretion and serum @COMPOUND$ increased.	0	18822107-1673
Despite pre- and post-operative PP and immunosuppressive treatment consisting of steroids, @PROTEIN$, daclizumab, and MMF, daily protein excretion and serum @COMPOUND$ increased.	0	18822107-1673
Inhibition of @PROTEIN$ by @COMPOUND$ analogues: Implications for anticancer activity.	1	18822278-1745
@PROTEIN$-@COMPOUND$ (HDL-C) is invertedly related to the incidence of cardiovascular events.	1	18822413-1812
An isocratic fluorescence HPLC assay for the monitoring of @PROTEIN$ activity and l-@COMPOUND$ depletion in children receiving E. colil-asparaginase for the treatment of acute lymphoblastic leukaemia.	0	18823071-2096
Effects of CYP2C19 and @PROTEIN$ genotype on the eradication rate of Helicobacter pylori infection by triple therapy with pantoprazole, amoxycillin and @COMPOUND$.	0	18823430-2181
Effects of @PROTEIN$ and MDR1 genotype on the eradication rate of Helicobacter pylori infection by triple therapy with pantoprazole, amoxycillin and @COMPOUND$.	0	18823430-2181
Anti-gastric cancer effects of @COMPOUND$, a selective COX-2 inhibitor, through inhibition of @PROTEIN$ signaling.	1	18823436-2183
Effect of renin-angiotensin-@COMPOUND$ system inhibition, dietary sodium restriction, and/or diuretics on urinary @PROTEIN$ excretion in nondiabetic proteinuric kidney disease: a post hoc analysis of a randomized controlled trial.	0	18823687-2243
Among the R-Nx strains, a substitution of @COMPOUND$ to Cys at position 81 (Gly81 Cys) of the @PROTEIN$ gene in 10 strains isolated from wild birds and ovine foetuses, and of Asp to Tyr at position 87 (Asp87 Tyr) in one strain isolated from ewe faeces, were revealed by sequencing the gene.	1	18823722-2255
Expansion of the first @COMPOUND$ tract of the @PROTEIN$ gene in a boy presenting with generalized dystonia in the absence of infantile spasms.	1	18823727-2261
Gene sequencing detected an additional seven GCG repeats in the first @COMPOUND$ tract of the @PROTEIN$ gene, a mutation which leads to an expansion of the normal 16 alanine residues to 23.	1	18823727-2262
Emerging evidence that both @PROTEIN$ (BDNF) and @COMPOUND$ suppress FoxO activity suggests a potential role of FoxOs in regulating mood-relevant behavior.	0	18823877-2298
Emerging evidence that both brain-derived neurotrophic factor (@PROTEIN$) and @COMPOUND$ suppress FoxO activity suggests a potential role of FoxOs in regulating mood-relevant behavior.	0	18823877-2298
We determined the plasma concentrations of tryptophan (TRP), @COMPOUND$, 3-hydroxykynurenine (3-HKYN); two distinct SOX markers: Cu/Zn @PROTEIN$ (Cu/Zn SOD) and total peroxide ; and high sensitivity C-reactive protein (hs CRP) as a indicator of inflammation in 146 ESRD patients and healthy controls.	0	18823890-2301
We determined the plasma concentrations of @COMPOUND$ (TRP), KYN, 3-hydroxykynurenine (3-HKYN); two distinct SOX markers: Cu/Zn superoxide dismutase (Cu/Zn @PROTEIN$) and total peroxide ; and high sensitivity C-reactive protein (hs CRP) as a indicator of inflammation in 146 ESRD patients and healthy controls.	0	18823890-2301
We determined the plasma concentrations of @COMPOUND$ (TRP), KYN, 3-hydroxykynurenine (3-HKYN); two distinct SOX markers: Cu/Zn @PROTEIN$ (Cu/Zn SOD) and total peroxide ; and high sensitivity C-reactive protein (hs CRP) as a indicator of inflammation in 146 ESRD patients and healthy controls.	0	18823890-2301
We determined the plasma concentrations of tryptophan (TRP), @COMPOUND$, 3-hydroxykynurenine (3-HKYN); two distinct SOX markers: Cu/Zn superoxide dismutase (Cu/Zn SOD) and total peroxide ; and high sensitivity C-reactive protein (hs @PROTEIN$) as a indicator of inflammation in 146 ESRD patients and healthy controls.	0	18823890-2301
We determined the plasma concentrations of tryptophan (TRP), KYN, 3-hydroxykynurenine (3-HKYN); two distinct SOX markers: Cu/Zn su@COMPOUND$ dismutase (Cu/Zn SOD) and total peroxide ; and high sensitivity C-reactive protein (hs @PROTEIN$) as a indicator of inflammation in 146 ESRD patients and healthy controls.	0	18823890-2301
We determined the plasma concentrations of tryptophan (TRP), KYN, @COMPOUND$ (3-HKYN); two distinct SOX markers: Cu/Zn superoxide dismutase (Cu/Zn @PROTEIN$) and total peroxide ; and high sensitivity C-reactive protein (hs CRP) as a indicator of inflammation in 146 ESRD patients and healthy controls.	0	18823890-2301
We determined the plasma concentrations of tryptophan (TRP), @COMPOUND$, 3-hydroxykynurenine (3-HKYN); two distinct SOX markers: Cu/Zn superoxide dismutase (Cu/Zn @PROTEIN$) and total peroxide ; and high sensitivity C-reactive protein (hs CRP) as a indicator of inflammation in 146 ESRD patients and healthy controls.	0	18823890-2301
We determined the plasma concentrations of tryptophan (TRP), KYN, @COMPOUND$ (3-HKYN); two distinct SOX markers: Cu/Zn @PROTEIN$ (Cu/Zn SOD) and total peroxide ; and high sensitivity C-reactive protein (hs CRP) as a indicator of inflammation in 146 ESRD patients and healthy controls.	0	18823890-2301
We determined the plasma concentrations of @COMPOUND$ (TRP), KYN, 3-hydroxykynurenine (3-HKYN); two distinct SOX markers: Cu/Zn superoxide dismutase (Cu/Zn SOD) and total peroxide ; and high sensitivity C-reactive protein (hs @PROTEIN$) as a indicator of inflammation in 146 ESRD patients and healthy controls.	0	18823890-2301
We determined the plasma concentrations of tryptophan (TRP), KYN, 3-hydroxykynurenine (3-HKYN); two distinct SOX markers: Cu/Zn su@COMPOUND$ dismutase (Cu/Zn @PROTEIN$) and total peroxide ; and high sensitivity C-reactive protein (hs CRP) as a indicator of inflammation in 146 ESRD patients and healthy controls.	0	18823890-2301
We determined the plasma concentrations of tryptophan (TRP), KYN, @COMPOUND$ (3-HKYN); two distinct SOX markers: Cu/Zn superoxide dismutase (Cu/Zn SOD) and total peroxide ; and high sensitivity C-reactive protein (hs @PROTEIN$) as a indicator of inflammation in 146 ESRD patients and healthy controls.	0	18823890-2301
ESRD patients showed a significant increase in Cu/Zn @PROTEIN$, total @COMPOUND$ and hs CRP levels between controls and all patients group.	0	18823890-2304
ESRD patients showed a significant increase in Cu/Zn SOD, total @COMPOUND$ and hs @PROTEIN$ levels between controls and all patients group.	0	18823890-2304
Diabetes is characterized by elevated fasting blood @COMPOUND$ (FBG) resulting from improper @PROTEIN$ regulation and/or insulin resistance.	1	18823964-2330
THII significantly diminished these changes in @COMPOUND$ and @PROTEIN$.	0	18823964-2332
Using HPLC techniques we evaluated the electrical field stimulation-evoked overflow of noradrenaline (NA), adenosine 5 '-triphosphate (ATP), and @COMPOUND$ (beta-NAD) in the presence of low nanomolar concentrations of omega-conotoxin GVIA or @PROTEIN$ in the canine mesenteric arteries and veins.	0	18824011-260
Using HPLC techniques we evaluated the electrical field stimulation-evoked overflow of noradrenaline (@COMPOUND$), adenosine 5 '-triphosphate (ATP), and beta-nicotinamide adenine dinucleotide (beta-NAD) in the presence of low nanomolar concentrations of omega-@PROTEIN$ GVIA or omega-agatoxin IVA in the canine mesenteric arteries and veins.	0	18824011-260
Using HPLC techniques we evaluated the electrical field stimulation-evoked overflow of noradrenaline (NA), adenosine 5 '-triphosphate (ATP), and beta-nicotinamide adenine dinucleotide (@COMPOUND$) in the presence of low nanomolar concentrations of omega-@PROTEIN$ GVIA or omega-agatoxin IVA in the canine mesenteric arteries and veins.	0	18824011-260
Using HPLC techniques we evaluated the electrical field stimulation-evoked overflow of noradrenaline (@COMPOUND$), adenosine 5 '-triphosphate (ATP), and beta-nicotinamide adenine dinucleotide (beta-NAD) in the presence of low nanomolar concentrations of omega-conotoxin GVIA or @PROTEIN$ in the canine mesenteric arteries and veins.	0	18824011-260
Using HPLC techniques we evaluated the electrical field stimulation-evoked overflow of noradrenaline (NA), adenosine 5 '-triphosphate (ATP), and @COMPOUND$ (beta-NAD) in the presence of low nanomolar concentrations of omega-@PROTEIN$ GVIA or omega-agatoxin IVA in the canine mesenteric arteries and veins.	0	18824011-260
Using HPLC techniques we evaluated the electrical field stimulation-evoked overflow of @COMPOUND$ (NA), adenosine 5 '-triphosphate (ATP), and beta-nicotinamide adenine dinucleotide (beta-NAD) in the presence of low nanomolar concentrations of omega-@PROTEIN$ GVIA or omega-agatoxin IVA in the canine mesenteric arteries and veins.	0	18824011-260
Using HPLC techniques we evaluated the electrical field stimulation-evoked overflow of @COMPOUND$ (NA), adenosine 5 '-triphosphate (ATP), and beta-nicotinamide adenine dinucleotide (beta-NAD) in the presence of low nanomolar concentrations of omega-conotoxin GVIA or @PROTEIN$ in the canine mesenteric arteries and veins.	0	18824011-260
Using HPLC techniques we evaluated the electrical field stimulation-evoked overflow of noradrenaline (NA), adenosine 5 '-triphosphate (ATP), and beta-nicotinamide adenine dinucleotide (@COMPOUND$) in the presence of low nanomolar concentrations of omega-conotoxin GVIA or @PROTEIN$ in the canine mesenteric arteries and veins.	0	18824011-260
An extensive kinetic profile towards a plethora of purines and mutational analyses have established models on how @PROTEIN$ recognizes the @COMPOUND$ and revealed specific amino acid residues involved in proper folding, topogenesis, function and specificity.	1	18824106-2403
The present work describes for the first time the purification of the @PROTEIN$ transporter of A. nidulans through overexpression via the strong, @COMPOUND$-inducible, glucose-repressible, alcA promoter.	1	18824106-2404
The present work describes for the first time the purification of the @PROTEIN$ transporter of A. nidulans through overexpression via the strong, ethanol-inducible, @COMPOUND$-repressible, alcA promoter.	1	18824106-2404
The present work describes for the first time the purification of the UapA transporter of A. nidulans through overexpression via the strong, @COMPOUND$-inducible, glucose-repressible, @PROTEIN$ promoter.	1	18824106-2404
The present work describes for the first time the purification of the UapA transporter of A. nidulans through overexpression via the strong, ethanol-inducible, @COMPOUND$-repressible, @PROTEIN$ promoter.	1	18824106-2404
Three enzymes function in biosynthesis of GDP-mannose from the glycolytic intermediate @COMPOUND$ : phosphomannose isomerase (PMI), phosphomannomutase (PMM) and @PROTEIN$ (GMPP).	1	18824121-2411
Three enzymes function in biosynthesis of GDP-mannose from the glycolytic intermediate @COMPOUND$ : phosphomannose isomerase (PMI), @PROTEIN$ (PMM) and GDP-mannose pyrophosphorylase (GMPP).	1	18824121-2411
Three enzymes function in biosynthesis of GDP-mannose from the glycolytic intermediate @COMPOUND$ : @PROTEIN$ (PMI), phosphomannomutase (PMM) and GDP-mannose pyrophosphorylase (GMPP).	1	18824121-2411
Three enzymes function in biosynthesis of GDP-@COMPOUND$ from the glycolytic intermediate fructose 6-phosphate : @PROTEIN$ (PMI), phosphomannomutase (PMM) and GDP-mannose pyrophosphorylase (GMPP).	1	18824121-2411
Three enzymes function in biosynthesis of GDP-@COMPOUND$ from the glycolytic intermediate fructose 6-phosphate : phosphomannose isomerase (PMI), phosphomannomutase (@PROTEIN$) and GDP-mannose pyrophosphorylase (GMPP).	1	18824121-2411
Three enzymes function in biosynthesis of GDP-@COMPOUND$ from the glycolytic intermediate fructose 6-phosphate : phosphomannose isomerase (PMI), phosphomannomutase (PMM) and @PROTEIN$ (GMPP).	1	18824121-2411
Three enzymes function in biosynthesis of GDP-mannose from the glycolytic intermediate @COMPOUND$ : phosphomannose isomerase (@PROTEIN$), phosphomannomutase (PMM) and GDP-mannose pyrophosphorylase (GMPP).	1	18824121-2411
Three enzymes function in biosynthesis of GDP-mannose from the glycolytic intermediate @COMPOUND$ : phosphomannose isomerase (PMI), phosphomannomutase (@PROTEIN$) and GDP-mannose pyrophosphorylase (GMPP).	1	18824121-2411
Three enzymes function in biosynthesis of GDP-@COMPOUND$ from the glycolytic intermediate fructose 6-phosphate : phosphomannose isomerase (@PROTEIN$), phosphomannomutase (PMM) and GDP-mannose pyrophosphorylase (GMPP).	1	18824121-2411
Three enzymes function in biosynthesis of GDP-@COMPOUND$ from the glycolytic intermediate fructose 6-phosphate : phosphomannose isomerase (PMI), @PROTEIN$ (PMM) and GDP-mannose pyrophosphorylase (GMPP).	1	18824121-2411
Synthesis of GDP-@COMPOUND$ from exogenous mannose requires @PROTEIN$ or phosphotransferase enzymes together with PMM and GMPP.	1	18824121-2412
Synthesis of GDP-@COMPOUND$ from exogenous mannose requires hexokinase or phosphotransferase enzymes together with @PROTEIN$ and GMPP.	1	18824121-2412
Preincubation of airway epithelial cells with @COMPOUND$ (dissolved in tetrahydrofuran) delivered lycopene into the cells and resulted in a 24% reduction in interleukin-6 after rhinovirus-1B infection, 31% reduction in @PROTEIN$ after rhinovirus-43 infection and 85% reduction in rhinovirus-1B replication.	1	18824341-1648
Preincubation of airway epithelial cells with lycopene (dissolved in @COMPOUND$) delivered lycopene into the cells and resulted in a 24% reduction in interleukin-6 after rhinovirus-1B infection, 31% reduction in @PROTEIN$ after rhinovirus-43 infection and 85% reduction in rhinovirus-1B replication.	0	18824341-1648
Preincubation of airway epithelial cells with @COMPOUND$ (dissolved in tetrahydrofuran) delivered lycopene into the cells and resulted in a 24% reduction in @PROTEIN$ after rhinovirus-1B infection, 31% reduction in IP-10 after rhinovirus-43 infection and 85% reduction in rhinovirus-1B replication.	1	18824341-1648
Preincubation of airway epithelial cells with lycopene (dissolved in @COMPOUND$) delivered lycopene into the cells and resulted in a 24% reduction in @PROTEIN$ after rhinovirus-1B infection, 31% reduction in IP-10 after rhinovirus-43 infection and 85% reduction in rhinovirus-1B replication.	0	18824341-1648
@PROTEIN$, vascular endothelial growth factor, and @COMPOUND$ increased EC permeability, disrupted cell junctions, and induced stress fiber formation.	0	18824415-2564
Clarified glycomic and protemic information combined with publicly available microarray data sets allowed us to identify @PROTEIN$ as a receptor of @COMPOUND$ epitope.	1	18824476-2583
Spinal and bulbar muscular atrophy (SBMA) is a motor neuron disease caused by @COMPOUND$ expansion mutation in the @PROTEIN$ (AR).	1	18824496-2592
Also, our previous studies implicated the SphK1/@PROTEIN$ pathway in the induction of the @COMPOUND$ cascade, a major inflammatory pathway involved in colon carcinogenesis.	1	18824518-2598
In the azoxymethane (@COMPOUND$) murine model of colon cancer, SphK1 and @PROTEIN$ were significantly elevated in colon cancer tissues compared to normal mucosa.	1	18824518-2599
In the @COMPOUND$ (AOM) murine model of colon cancer, SphK1 and @PROTEIN$ were significantly elevated in colon cancer tissues compared to normal mucosa.	1	18824518-2599
Uptake of @COMPOUND$, losartan, and cefadroxil was quantified in HeLa cells after heterologous expression of human @PROTEIN$ (hPEPT1).	0	18824524-2604
Uptake of valsartan, @COMPOUND$, and cefadroxil was quantified in HeLa cells after heterologous expression of human @PROTEIN$ (hPEPT1).	0	18824524-2604
Uptake of valsartan, losartan, and @COMPOUND$ was quantified in HeLa cells after heterologous expression of human @PROTEIN$ (hPEPT1).	0	18824524-2604
In contrast to cefadroxil, no @PROTEIN$-specific uptake of @COMPOUND$ and losartan was found.	0	18824524-2605
In contrast to cefadroxil, no @PROTEIN$-specific uptake of valsartan and @COMPOUND$ was found.	0	18824524-2605
In contrast to @COMPOUND$, no @PROTEIN$-specific uptake of valsartan and losartan was found.	1	18824524-2605
The 2-(acylamino)-3-thiophenecarboxylates suppressed @PROTEIN$-mediated @COMPOUND$ (-) current in T84 colonic cells in response to cholera and Escherichia coli (STa) toxins, and prevented intestinal fluid accumulation in a closed-loop mouse model of secretory diarrhea.	1	18824527-2607
We investigated the hypothesis that modulation of EPC biology and attenuation of allograft vasculopathy by increased @PROTEIN$ @COMPOUND$ after human apo A-I (AdA-I) transfer requires scavenger receptor (SR)-BI expression in bone marrow-derived EPCs.	1	18824596-2638
Hormone-sensitive lipase (@PROTEIN$) is a key regulator of @COMPOUND$ esters metabolism.	1	18824635-2654
@PROTEIN$ (HSL) is a key regulator of @COMPOUND$ esters metabolism.	1	18824635-2654
We found associations between the @COMPOUND$ phenotype and age, diagnosis of hypertension and one htSNP (141689) located upstream of @PROTEIN$.	0	18825162-2817
@PROTEIN$ and free @COMPOUND$ are independent risk factors for benign prostatic hyperplasia.	0	18825163-2818
The objective of the present study was to test the @PROTEIN$, @COMPOUND$ and metabolic syndrome hypotheses as promoters of BPH.	0	18825163-2819
Using a multivariate analysis, BPH as measured by the total prostate gland volume correlated statistically significantly with fasting serum @PROTEIN$ (beta=0.200, P=0.028), free @COMPOUND$ (beta=0.233, P=0.008) and lean body mass (beta=0.257, P=0.034).	0	18825163-2820
@PROTEIN$ and free @COMPOUND$ appear to be independent risk factors for BPH, confirming both the insulin and the oestradiol hypotheses.	0	18825163-2821
Insulin and free @COMPOUND$ appear to be independent risk factors for BPH, confirming both the @PROTEIN$ and the oestradiol hypotheses.	0	18825163-2821
@COMPOUND$ plus single-dose @PROTEIN$ glargine: a safe regimen for low-risk type 2 diabetic patients who insist on fasting in Ramadan.	0	18825302-18
Much interest has been directed to the study of the @PROTEIN$, because @COMPOUND$ has been instrumental in discovering the unique role of a subset of primary sensory neurons in causing nociceptive responses, in activating reflex pathways including cough, and in producing neurogenic inflammation.	0	18825335-25
To evaluate @COMPOUND$ (AVP) and @PROTEIN$ plasma concentrations in patients with vasodilatory shock after cardiac surgery.	0	18825368-41
In this study, we report a novel @PROTEIN$ defect in a Tunisian family, in which @COMPOUND$ 23 is substituted by a Stop codon causing a premature termination of translation.	1	18825380-47
Eight newly synthesized carbacylamidophosphates with the general formula RC(O) NHP (O) Cl2 with R = pCl-C6H4 1a, pBr-C6H4 2a, C6H5 3a, and pMe-C6H4 4a and RC(O) NHP (O)(NC4H8O)2 R = pCl-C6H4 1b, pBr-C6H4 2b, C6H5 3b, pMe-C6H4 4b, were selected to compare the inhibition kinetic parameters, IC50, Ki, kp and KD, on human erythrocyte @PROTEIN$ (hAChE) and bovine serum butyrylcholinesterase (BuChE), Also, the in vivo inhibition potency of @COMPOUND$, 2b and 3a, were studied.	0	18825527-114
Eight newly synthesized carbacylamidophosphates with the general formula RC(O) @COMPOUND$ (O) Cl2 with R = pCl-C6H4 1a, pBr-C6H4 2a, C6H5 3a, and pMe-C6H4 4a and RC(O) NHP (O)(NC4H8O)2 R = pCl-C6H4 1b, pBr-C6H4 2b, C6H5 3b, pMe-C6H4 4b, were selected to compare the inhibition kinetic parameters, IC50, Ki, kp and KD, on human erythrocyte @PROTEIN$ (hAChE) and bovine serum butyrylcholinesterase (BuChE), Also, the in vivo inhibition potency of compound 2a, 2b and 3a, were studied.	0	18825527-114
Eight newly synthesized carbacylamidophosphates with the general formula RC(O) NHP (O) Cl2 with R = pCl-C6H4 1a, @COMPOUND$-C6H4 2a, C6H5 3a, and pMe-C6H4 4a and RC(O) NHP (O)(NC4H8O)2 R = pCl-C6H4 1b, pBr-C6H4 2b, C6H5 3b, pMe-C6H4 4b, were selected to compare the inhibition kinetic parameters, IC50, Ki, kp and KD, on human erythrocyte @PROTEIN$ (hAChE) and bovine serum butyrylcholinesterase (BuChE), Also, the in vivo inhibition potency of compound 2a, 2b and 3a, were studied.	0	18825527-114
Eight newly synthesized carbacylamidophosphates with the general formula RC(O) NHP (O) Cl2 with R = pCl-C6H4 1a, pBr-C6H4 2a, C6H5 3a, and @COMPOUND$-C6H4 4a and RC(O) NHP (O)(NC4H8O)2 R = pCl-C6H4 1b, pBr-C6H4 2b, C6H5 3b, pMe-C6H4 4b, were selected to compare the inhibition kinetic parameters, IC50, Ki, kp and KD, on human erythrocyte @PROTEIN$ (hAChE) and bovine serum butyrylcholinesterase (BuChE), Also, the in vivo inhibition potency of compound 2a, 2b and 3a, were studied.	0	18825527-114
The presented study is aimed at reactivation of @COMPOUND$-inhibited butyrylcholinesterase since this enzyme play an important role in Alzheimer's disease as deputy for @PROTEIN$ and furthermore it could be applied as a scavenger in case of overdosing.	0	18825528-117
Among them, @COMPOUND$ and 5 had significant @PROTEIN$ inhibitory activities.	1	18825531-118
Here we report the docking study of four @COMPOUND$ catechins and four alkylating anticancer drugs into the @PROTEIN$ model, as GSTs were found to be affected by tea catechins.	1	18825537-122
Here we report the docking study of four @COMPOUND$ catechins and four alkylating anticancer drugs into the GST P1-1 model, as @PROTEIN$ were found to be affected by tea catechins.	1	18825537-122
The protein glycation inhibitory activity of ethanolic extract of Lawsonia inermis (henna) plant tissues was evaluated in vitro using the model system of bovine @PROTEIN$ and @COMPOUND$.	0	18825553-139
In vitro effects of @COMPOUND$ treatment on fish liver @PROTEIN$ activity.	1	18825555-141
The effect of @COMPOUND$ (PN), a highly toxic agent, on @PROTEIN$ (CAT) activity in fish liver microsomal homogenates was determined.	1	18825555-142
The effect of @COMPOUND$ (PN), a highly toxic agent, on catalase (@PROTEIN$) activity in fish liver microsomal homogenates was determined.	1	18825555-142
NMR-derived @COMPOUND$-bound structure of @PROTEIN$ from the halophile Haloferax volcanii.	1	18825778-209
@COMPOUND$-regulated activity of @PROTEIN$.	1	18826375-301
The biological roles of the @COMPOUND$-regulated conformational equilibrium of @PROTEIN$ are discussed in terms of the self and non-self discrimination mechanism.	1	18826375-305
The Iowa Gambling Task (IGT) was used to examine (i) social decision-making in women with borderline personality disorder (BPD), and (ii) the relationship between impaired decision-making and the tryptophan hydroxylase-1 (@PROTEIN$) gene, involved in @COMPOUND$ synthesis.	1	18826425-314
These results underscore the differential regulation of GPX expression in response to cadmium, aluminium and @COMPOUND$, and strongly support a role for @PROTEIN$ and possibly other GPX genes in stress and/or metabolic signalling.	1	18826485-2656
These results underscore the differential regulation of @PROTEIN$ expression in response to cadmium, @COMPOUND$ and nitric oxide, and strongly support a role for GPX6 and possibly other GPX genes in stress and/or metabolic signalling.	1	18826485-2656
These results underscore the differential regulation of GPX expression in response to cadmium, @COMPOUND$ and nitric oxide, and strongly support a role for @PROTEIN$ and possibly other GPX genes in stress and/or metabolic signalling.	1	18826485-2656
These results underscore the differential regulation of @PROTEIN$ expression in response to cadmium, aluminium and @COMPOUND$, and strongly support a role for GPX6 and possibly other GPX genes in stress and/or metabolic signalling.	1	18826485-2656
Effects of acceptor composition and mechanism of @PROTEIN$-mediated cellular free @COMPOUND$ efflux.	1	18827283-620
Among the known mechanisms of reverse @COMPOUND$ transport (RCT), ATP binding cassette transporter G1 (@PROTEIN$)-mediated free cholesterol (FC) transport is the most recent and least studied.	1	18827283-621
Here, we have characterized the efficiencies of different acceptors using baby hamster kidney (BHK) cells transfected with human @PROTEIN$ cDNA, which is inducible upon treatment with @COMPOUND$.	1	18827283-622
@COMPOUND$ treatment significantly attenuated TNF-alpha, IL-6, and @PROTEIN$ 6 h after CLP.	1	18827741-766
@COMPOUND$ treatment significantly attenuated TNF-alpha, @PROTEIN$, and IL-1beta 6 h after CLP.	1	18827741-766
@COMPOUND$ treatment significantly attenuated @PROTEIN$, IL-6, and IL-1beta 6 h after CLP.	1	18827741-766
@PROTEIN$ vesicles and red blood cells as carriers of @COMPOUND$ prior to oxygen for resuscitation after hemorrhagic shock in a rat model.	1	18827742-767
@PROTEIN$ vesicles and red blood cells as carriers of carbon monoxide prior to @COMPOUND$ for resuscitation after hemorrhagic shock in a rat model.	1	18827742-767
Reduced responses of alpha-MSH or @PROTEIN$-beta-END IRM to CRH and the invalid suppression by @COMPOUND$ reflect a state of dysfunction of the melanotroph-type POMC system in nonsurvivors.	0	18827746-775
Reduced responses of alpha-MSH or Nac-beta-END IRM to CRH and the invalid suppression by @COMPOUND$ reflect a state of dysfunction of the melanotroph-type @PROTEIN$ system in nonsurvivors.	0	18827746-775
Reduced responses of alpha-MSH or Nac-beta-END IRM to @PROTEIN$ and the invalid suppression by @COMPOUND$ reflect a state of dysfunction of the melanotroph-type POMC system in nonsurvivors.	0	18827746-775
Reduced responses of @PROTEIN$ or Nac-beta-END IRM to CRH and the invalid suppression by @COMPOUND$ reflect a state of dysfunction of the melanotroph-type POMC system in nonsurvivors.	0	18827746-775
Systemic, hepatosplanchnic, and renal hemodynamics; oxygen exchange; energy metabolism (lactate/pyruvate and ketone body ratios); ileal mucosal and renal cortex microcirculation; systemic inflammation (@PROTEIN$, IL-6); nitrosative/oxidative stress (@COMPOUND$ reactive species, nitrates+ nitrites); and endothelial/coagulation dysfunction (asymmetric dimethylarginine, von Willebrand factor, thrombin-antithrombin complexes, platelet count) were assessed before and 12, 18, and 22 h of peritonitis.	0	18827747-776
Systemic, hepatosplanchnic, and renal hemodynamics; @COMPOUND$ exchange; energy metabolism (lactate/pyruvate and ketone body ratios); ileal mucosal and renal cortex microcirculation; systemic inflammation (TNF-alpha, IL-6); nitrosative/oxidative stress (thiobarbituric acid reactive species, nitrates+ nitrites); and endothelial/coagulation dysfunction (asymmetric dimethylarginine, @PROTEIN$, thrombin-antithrombin complexes, platelet count) were assessed before and 12, 18, and 22 h of peritonitis.	0	18827747-776
Systemic, hepatosplanchnic, and renal hemodynamics; oxygen exchange; energy metabolism (lactate/pyruvate and ketone body ratios); ileal mucosal and renal cortex microcirculation; systemic inflammation (TNF-alpha, @PROTEIN$); nitrosative/oxidative stress (@COMPOUND$ reactive species, nitrates+ nitrites); and endothelial/coagulation dysfunction (asymmetric dimethylarginine, von Willebrand factor, thrombin-antithrombin complexes, platelet count) were assessed before and 12, 18, and 22 h of peritonitis.	0	18827747-776
Systemic, hepatosplanchnic, and renal hemodynamics; oxygen exchange; energy metabolism (lactate/@COMPOUND$ and ketone body ratios); ileal mucosal and renal cortex microcirculation; systemic inflammation (TNF-alpha, @PROTEIN$); nitrosative/oxidative stress (thiobarbituric acid reactive species, nitrates+ nitrites); and endothelial/coagulation dysfunction (asymmetric dimethylarginine, von Willebrand factor, thrombin-antithrombin complexes, platelet count) were assessed before and 12, 18, and 22 h of peritonitis.	0	18827747-776
Systemic, hepatosplanchnic, and renal hemodynamics; oxygen exchange; energy metabolism (@COMPOUND$/pyruvate and ketone body ratios); ileal mucosal and renal cortex microcirculation; systemic inflammation (TNF-alpha, IL-6); nitrosative/oxidative stress (thiobarbituric acid reactive species, nitrates+ nitrites); and endothelial/coagulation dysfunction (asymmetric dimethylarginine, @PROTEIN$, thrombin-antithrombin complexes, platelet count) were assessed before and 12, 18, and 22 h of peritonitis.	0	18827747-776
Systemic, hepatosplanchnic, and renal hemodynamics; oxygen exchange; energy metabolism (lactate/@COMPOUND$ and ketone body ratios); ileal mucosal and renal cortex microcirculation; systemic inflammation (TNF-alpha, IL-6); nitrosative/oxidative stress (thiobarbituric acid reactive species, nitrates+ nitrites); and endothelial/coagulation dysfunction (asymmetric dimethylarginine, von Willebrand factor, @PROTEIN$-antithrombin complexes, platelet count) were assessed before and 12, 18, and 22 h of peritonitis.	0	18827747-776
Systemic, hepatosplanchnic, and renal hemodynamics; oxygen exchange; energy metabolism (lactate/@COMPOUND$ and ketone body ratios); ileal mucosal and renal cortex microcirculation; systemic inflammation (TNF-alpha, IL-6); nitrosative/oxidative stress (thiobarbituric acid reactive species, nitrates+ nitrites); and endothelial/coagulation dysfunction (asymmetric dimethylarginine, @PROTEIN$, thrombin-antithrombin complexes, platelet count) were assessed before and 12, 18, and 22 h of peritonitis.	0	18827747-776
Systemic, hepatosplanchnic, and renal hemodynamics; @COMPOUND$ exchange; energy metabolism (lactate/pyruvate and ketone body ratios); ileal mucosal and renal cortex microcirculation; systemic inflammation (TNF-alpha, @PROTEIN$); nitrosative/oxidative stress (thiobarbituric acid reactive species, nitrates+ nitrites); and endothelial/coagulation dysfunction (asymmetric dimethylarginine, von Willebrand factor, thrombin-antithrombin complexes, platelet count) were assessed before and 12, 18, and 22 h of peritonitis.	0	18827747-776
Systemic, hepatosplanchnic, and renal hemodynamics; oxygen exchange; energy metabolism (lactate/pyruvate and ketone body ratios); ileal mucosal and renal cortex microcirculation; systemic inflammation (TNF-alpha, IL-6); nitrosative/oxidative stress (@COMPOUND$ reactive species, nitrates+ nitrites); and endothelial/coagulation dysfunction (asymmetric dimethylarginine, von Willebrand factor, @PROTEIN$-antithrombin complexes, platelet count) were assessed before and 12, 18, and 22 h of peritonitis.	0	18827747-776
Systemic, hepatosplanchnic, and renal hemodynamics; @COMPOUND$ exchange; energy metabolism (lactate/pyruvate and ketone body ratios); ileal mucosal and renal cortex microcirculation; systemic inflammation (@PROTEIN$, IL-6); nitrosative/oxidative stress (thiobarbituric acid reactive species, nitrates+ nitrites); and endothelial/coagulation dysfunction (asymmetric dimethylarginine, von Willebrand factor, thrombin-antithrombin complexes, platelet count) were assessed before and 12, 18, and 22 h of peritonitis.	0	18827747-776
Systemic, hepatosplanchnic, and renal hemodynamics; oxygen exchange; energy metabolism (lactate/pyruvate and ketone body ratios); ileal mucosal and renal cortex microcirculation; systemic inflammation (TNF-alpha, IL-6); nitrosative/oxidative stress (thiobarbituric acid reactive species, nitrates+ nitrites); and endothelial/coagulation dysfunction (@COMPOUND$, von Willebrand factor, @PROTEIN$-antithrombin complexes, platelet count) were assessed before and 12, 18, and 22 h of peritonitis.	0	18827747-776
Systemic, hepatosplanchnic, and renal hemodynamics; oxygen exchange; energy metabolism (@COMPOUND$/pyruvate and ketone body ratios); ileal mucosal and renal cortex microcirculation; systemic inflammation (TNF-alpha, IL-6); nitrosative/oxidative stress (thiobarbituric acid reactive species, nitrates+ nitrites); and endothelial/coagulation dysfunction (asymmetric dimethylarginine, von Willebrand factor, @PROTEIN$-antithrombin complexes, platelet count) were assessed before and 12, 18, and 22 h of peritonitis.	0	18827747-776
Systemic, hepatosplanchnic, and renal hemodynamics; oxygen exchange; energy metabolism (@COMPOUND$/pyruvate and ketone body ratios); ileal mucosal and renal cortex microcirculation; systemic inflammation (@PROTEIN$, IL-6); nitrosative/oxidative stress (thiobarbituric acid reactive species, nitrates+ nitrites); and endothelial/coagulation dysfunction (asymmetric dimethylarginine, von Willebrand factor, thrombin-antithrombin complexes, platelet count) were assessed before and 12, 18, and 22 h of peritonitis.	0	18827747-776
Systemic, hepatosplanchnic, and renal hemodynamics; oxygen exchange; energy metabolism (lactate/pyruvate and ketone body ratios); ileal mucosal and renal cortex microcirculation; systemic inflammation (TNF-alpha, IL-6); nitrosative/oxidative stress (thiobarbituric acid reactive species, nitrates+ nitrites); and endothelial/coagulation dysfunction (@COMPOUND$, @PROTEIN$, thrombin-antithrombin complexes, platelet count) were assessed before and 12, 18, and 22 h of peritonitis.	0	18827747-776
Systemic, hepatosplanchnic, and renal hemodynamics; oxygen exchange; energy metabolism (lactate/pyruvate and ketone body ratios); ileal mucosal and renal cortex microcirculation; systemic inflammation (@PROTEIN$, IL-6); nitrosative/oxidative stress (thiobarbituric acid reactive species, nitrates+ nitrites); and endothelial/coagulation dysfunction (@COMPOUND$, von Willebrand factor, thrombin-antithrombin complexes, platelet count) were assessed before and 12, 18, and 22 h of peritonitis.	0	18827747-776
Systemic, hepatosplanchnic, and renal hemodynamics; oxygen exchange; energy metabolism (lactate/pyruvate and ketone body ratios); ileal mucosal and renal cortex microcirculation; systemic inflammation (TNF-alpha, IL-6); nitrosative/oxidative stress (@COMPOUND$ reactive species, nitrates+ nitrites); and endothelial/coagulation dysfunction (asymmetric dimethylarginine, @PROTEIN$, thrombin-antithrombin complexes, platelet count) were assessed before and 12, 18, and 22 h of peritonitis.	0	18827747-776
Systemic, hepatosplanchnic, and renal hemodynamics; oxygen exchange; energy metabolism (lactate/pyruvate and ketone body ratios); ileal mucosal and renal cortex microcirculation; systemic inflammation (TNF-alpha, @PROTEIN$); nitrosative/oxidative stress (thiobarbituric acid reactive species, nitrates+ nitrites); and endothelial/coagulation dysfunction (@COMPOUND$, von Willebrand factor, thrombin-antithrombin complexes, platelet count) were assessed before and 12, 18, and 22 h of peritonitis.	0	18827747-776
Systemic, hepatosplanchnic, and renal hemodynamics; oxygen exchange; energy metabolism (@COMPOUND$/pyruvate and ketone body ratios); ileal mucosal and renal cortex microcirculation; systemic inflammation (TNF-alpha, @PROTEIN$); nitrosative/oxidative stress (thiobarbituric acid reactive species, nitrates+ nitrites); and endothelial/coagulation dysfunction (asymmetric dimethylarginine, von Willebrand factor, thrombin-antithrombin complexes, platelet count) were assessed before and 12, 18, and 22 h of peritonitis.	0	18827747-776
Systemic, hepatosplanchnic, and renal hemodynamics; oxygen exchange; energy metabolism (lactate/@COMPOUND$ and ketone body ratios); ileal mucosal and renal cortex microcirculation; systemic inflammation (@PROTEIN$, IL-6); nitrosative/oxidative stress (thiobarbituric acid reactive species, nitrates+ nitrites); and endothelial/coagulation dysfunction (asymmetric dimethylarginine, von Willebrand factor, thrombin-antithrombin complexes, platelet count) were assessed before and 12, 18, and 22 h of peritonitis.	0	18827747-776
Systemic, hepatosplanchnic, and renal hemodynamics; @COMPOUND$ exchange; energy metabolism (lactate/pyruvate and ketone body ratios); ileal mucosal and renal cortex microcirculation; systemic inflammation (TNF-alpha, IL-6); nitrosative/oxidative stress (thiobarbituric acid reactive species, nitrates+ nitrites); and endothelial/coagulation dysfunction (asymmetric dimethylarginine, von Willebrand factor, @PROTEIN$-antithrombin complexes, platelet count) were assessed before and 12, 18, and 22 h of peritonitis.	0	18827747-776
The purpose of this retrospective study was to compare the effects of @PROTEIN$ and @COMPOUND$ in the management of HIT.	0	18827975-862
The outer membrane @PROTEIN$ is involved in @COMPOUND$ tolerance and overproduction in Escherichia coli.	1	18828007-864
Gene expression analysis revealed that the @PROTEIN$ gene encoding the outer membrane channel is essential for @COMPOUND$ tolerance in E. coli cells.	1	18828007-866
The present study was performed to elucidate the relationship between the expression of ABCB1/MDR1 and ABCC1/@PROTEIN$ with resistance to either @COMPOUND$ or PM00104.	1	18828019-168
The present study was performed to elucidate the relationship between the expression of ABCB1/MDR1 and @PROTEIN$/MRP1 with resistance to either @COMPOUND$ or PM00104.	1	18828019-168
The present study was performed to elucidate the relationship between the expression of @PROTEIN$/MDR1 and ABCC1/MRP1 with resistance to either @COMPOUND$ or PM00104.	1	18828019-168
The present study was performed to elucidate the relationship between the expression of ABCB1/@PROTEIN$ and ABCC1/MRP1 with resistance to either @COMPOUND$ or PM00104.	1	18828019-168
The previous amphotericin B, @PROTEIN$, hyperbaric @COMPOUND$ and nasal and left maxillary sinus surgical debridement therapy was ineffective in stopping the progression of the infection to the brain.	0	18828793-1124
The previous @COMPOUND$, @PROTEIN$, hyperbaric oxygen and nasal and left maxillary sinus surgical debridement therapy was ineffective in stopping the progression of the infection to the brain.	0	18828793-1124
Bacterial strains differed in their ability to synthesize @COMPOUND$ and hydrogen cyanide compounds, as well as in their @PROTEIN$ activity.	0	18829132-1261
Bacterial strains differed in their ability to synthesize auxin and @COMPOUND$ compounds, as well as in their @PROTEIN$ activity.	0	18829132-1261
Toll-like receptor (@PROTEIN$) 4 is a critical receptor and signal transducer for @COMPOUND$ (LPS), a major component of Gram-negative bacteria.	1	18829266-1329
Postprandial @COMPOUND$ and @PROTEIN$.05) in HTAG.	0	18829281-1345
Colonization of germ-free (GF) mice has been shown to induce the gastrointestinal form of the @COMPOUND$-dependent glutathione peroxidases, @PROTEIN$.	1	18829286-1353
Colonization of germ-free (GF) mice has been shown to induce the gastrointestinal form of the @COMPOUND$-dependent @PROTEIN$, GPx2.	1	18829286-1353
The purpose of this study was to investigate whether or not the role of docosahexaenoic acid (DHA) supplementation on cognitive capability was related with brain-derived neurotrophic factor (@PROTEIN$), @COMPOUND$ (NO) and dopamine (DA) in aged mice.	0	18829287-2771
The purpose of this study was to investigate whether or not the role of docosahexaenoic acid (DHA) supplementation on cognitive capability was related with @PROTEIN$ (BDNF), nitric oxide (NO) and @COMPOUND$ (DA) in aged mice.	0	18829287-2771
The purpose of this study was to investigate whether or not the role of @COMPOUND$ (DHA) supplementation on cognitive capability was related with brain-derived neurotrophic factor (@PROTEIN$), nitric oxide (NO) and dopamine (DA) in aged mice.	0	18829287-2771
The purpose of this study was to investigate whether or not the role of docosahexaenoic acid (DHA) supplementation on cognitive capability was related with @PROTEIN$ (BDNF), @COMPOUND$ (NO) and dopamine (DA) in aged mice.	0	18829287-2771
The purpose of this study was to investigate whether or not the role of @COMPOUND$ (DHA) supplementation on cognitive capability was related with @PROTEIN$ (BDNF), nitric oxide (NO) and dopamine (DA) in aged mice.	1	18829287-2771
The purpose of this study was to investigate whether or not the role of docosahexaenoic acid (DHA) supplementation on cognitive capability was related with brain-derived neurotrophic factor (@PROTEIN$), nitric oxide (NO) and @COMPOUND$ (DA) in aged mice.	0	18829287-2771
Model analysis of local @COMPOUND$ delivery with liposome-encapsulated @PROTEIN$.	1	18829372-151
Liposome-encapsulated @PROTEIN$ (LHs) are comparable to red blood cells (RBCs) in terms of @COMPOUND$ (O(2))-carrying capacity.	1	18829372-152
Moreover, both lung and plasma concentrations of the pro-inflammatory cytokines tumour necrosis factor-alpha and @PROTEIN$ were higher in @COMPOUND$-treated animals at this time-point.	1	18829677-1475
The role of @COMPOUND$+)-insensitive @PROTEIN$, if any, in sperm volume regulation was studied in transgenic mice.	0	18829704-1495
Therefore, the @COMPOUND$+)-sensitive @PROTEIN$, which was localized in elongated spermatids and spermatozoa, is a likely candidate for a water channel responsible for physiological sperm volume regulation crucial to in vivo fertilization.	1	18829704-1496
Increased intrahepatic vascular tone in cirrhosis has been attributed to a decrease of hepatic @COMPOUND$ (NO) secondary to disturbances in the post-translational regulation of the enzyme @PROTEIN$.	0	18829979-1580
@PROTEIN$ deficiency is a rare autosomal disorder of de novo @COMPOUND$ synthesis, which results in the accumulation of succinylpurines in body fluids.	1	18830228-1650
Both patients had an increased @COMPOUND$/SAICAr ratio of 1.6, and exhibited a novel homozygous missense mutation (c.674T&gt;C; p.Met225Thr) in the exon 6 of the @PROTEIN$ gene.	1	18830228-1651
The profile of global DNA and @PROTEIN$ (ER)-alpha gene methylation during cancer development was determined by analysis of @COMPOUND$ (5-MeC) using immunohistochemical (IHC) staining, dot blot analysis or a quantitative gene methylation assay (QGMA).	0	18830381-1696
The profile of global DNA and @PROTEIN$ (ER)-alpha gene methylation during cancer development was determined by analysis of 5-methylcytosine (5-@COMPOUND$) using immunohistochemical (IHC) staining, dot blot analysis or a quantitative gene methylation assay (QGMA).	0	18830381-1696
Zebularine suppresses the apoptotic potential of @COMPOUND$ via cAMP/PKA/@PROTEIN$ pathway against human oral squamous cell carcinoma cells.	1	18830594-1807
Zebularine suppresses the apoptotic potential of 5-fluorouracil via @COMPOUND$/PKA/@PROTEIN$ pathway against human oral squamous cell carcinoma cells.	0	18830594-1807
Complex modulation of L-type @COMPOUND$+) current inactivation by @PROTEIN$ in isolated rabbit cardiomyocytes.	1	18830620-1813
Donor testicular cells were prepared from heterozygous chicken beta actin (CAG)/enhanced @PROTEIN$ (EGFP)-transgenic rats (EGFP Tg rats) during the second week after birth and injected into the seminiferous tubules of the MT-myc Tg rats (line-A and-B; both subfertile) or rats pretreated with @COMPOUND$ to remove endogenous spermatogonia.	0	18830680-1821
Donor testicular cells were prepared from heterozygous chicken beta actin (@PROTEIN$)/enhanced green fluorescent protein (EGFP)-transgenic rats (EGFP Tg rats) during the second week after birth and injected into the seminiferous tubules of the MT-myc Tg rats (line-A and-B; both subfertile) or rats pretreated with @COMPOUND$ to remove endogenous spermatogonia.	0	18830680-1821
Donor testicular cells were prepared from heterozygous chicken @PROTEIN$ (CAG)/enhanced green fluorescent protein (EGFP)-transgenic rats (EGFP Tg rats) during the second week after birth and injected into the seminiferous tubules of the MT-myc Tg rats (line-A and-B; both subfertile) or rats pretreated with @COMPOUND$ to remove endogenous spermatogonia.	0	18830680-1821
Models of noncoupled dinuclear @COMPOUND$ centers in @PROTEIN$.	1	18830721-1832
Toward this goal, models of the noncoupled @COMPOUND$ centers found in the enzymes peptidyl alpha-hydroxylating monooxygenase (@PROTEIN$), dopamine beta-monooxygenase (DBM), and nitrite reductase (NiR) were designed into the small soluble protein azurin.	1	18830721-1833
Toward this goal, models of the noncoupled @COMPOUND$ centers found in the enzymes peptidyl alpha-hydroxylating monooxygenase (PHM), dopamine beta-monooxygenase (DBM), and nitrite reductase (NiR) were designed into the small soluble protein @PROTEIN$.	1	18830721-1833
Toward this goal, models of the noncoupled @COMPOUND$ centers found in the enzymes peptidyl alpha-hydroxylating monooxygenase (PHM), dopamine beta-monooxygenase (DBM), and nitrite reductase (@PROTEIN$) were designed into the small soluble protein azurin.	1	18830721-1833
Toward this goal, models of the noncoupled @COMPOUND$ centers found in the enzymes peptidyl alpha-hydroxylating monooxygenase (PHM), @PROTEIN$ (DBM), and nitrite reductase (NiR) were designed into the small soluble protein azurin.	1	18830721-1833
The models are significant because they maintain the existing type 1 (T1) @COMPOUND$, electron transfer site of @PROTEIN$ while including the second designed type 2 (T2) copper center that mimics the T2 catalytic sites in the target enzymes.	1	18830721-1834
Intraprotein electron transfer (IET) from @COMPOUND$ (FMN) to heme is essential in NO synthesis by NO synthase (@PROTEIN$).	1	18830722-1835
Intraprotein electron transfer (IET) from flavin mononucleotide (FMN) to @COMPOUND$ is essential in NO synthesis by NO synthase (@PROTEIN$).	1	18830722-1835
Intraprotein electron transfer (IET) from flavin mononucleotide (@COMPOUND$) to heme is essential in NO synthesis by NO synthase (@PROTEIN$).	1	18830722-1835
The esterase and @PROTEIN$ activities were determined by the hydrolysis of pNPB and @COMPOUND$, respectively.	1	18830729-1841
The @PROTEIN$ and lipase activities were determined by the hydrolysis of pNPB and @COMPOUND$, respectively.	1	18830729-1841
In the present work, the activity of the enzymes xylose reductase (XR); @COMPOUND$ dehydrogenase (XD); and glucose-6-phosphate dehydrogenase (@PROTEIN$) during cultivation of Candida guilliermondii on rice straw hemicellulosic hydrolysate was measured and correlated with xylitol production under different pH values (around 4.5 and 7.5) and initial xylose concentration (around 30 and 70 g l(-1)).	1	18830730-1843
In the present work, the activity of the enzymes @PROTEIN$ (XR); @COMPOUND$ dehydrogenase (XD); and glucose-6-phosphate dehydrogenase (G6PD) during cultivation of Candida guilliermondii on rice straw hemicellulosic hydrolysate was measured and correlated with xylitol production under different pH values (around 4.5 and 7.5) and initial xylose concentration (around 30 and 70 g l(-1)).	1	18830730-1843
QSAR studies for the inhibition of the transmembrane @PROTEIN$ isozyme XIV with @COMPOUND$ using PRECLAV software.	1	18830873-1896
QSAR studies for the inhibition of isozyme XIV of human @PROTEIN$ (CA, EC 4.2.1.1) by a series of @COMPOUND$ including clinically used derivatives (acetazolamide, methazolamide, ethoxzolamide, dichlorophenamide, dorzolamide, brinzolamide, benzolamide, and zonisamide) are presented.	1	18830873-1897
Inhibition of human @PROTEIN$ by @COMPOUND$ and irreversible formation of advanced glycation end products.	1	18830874-1898
The affinity of @PROTEIN$ for gluconeogenic substrate @COMPOUND$ altered after preincubation with MG in the same manner, but less intensively.	1	18830874-1900
Inhibitory effects of Cefazolin and @COMPOUND$ on the activity of mushroom @PROTEIN$.	1	18830875-307
Inhibitory effects of @COMPOUND$ and Cefodizime on the activity of mushroom @PROTEIN$.	1	18830875-307
The order of the cytotoxicity of the compounds was; IV &gt; III &gt; II &gt; I &gt; V. @COMPOUND$, had the highest Hammett and log P values (0.23 and 4.21, respectively) and exerted both highest cytotoxicity and strongest @PROTEIN$ inhibition.	1	18830876-308
Tests were carried out on cell cultures of human keratinocytes and mouse 3T3 fibroblasts incubated with radiolabeled acetate, and on homogenates prepared from yeast cells expressing human @PROTEIN$, incubated with radiolabeled @COMPOUND$.	0	18830877-1907
Hepatic antioxidant status viz, @COMPOUND$ (GSH), glutathione reductase (GR), glutathione peroxidase (GPx), quinone reductase (QR), @PROTEIN$ (CAT 0.001).	0	18830880-1910
Hepatic antioxidant status viz, @COMPOUND$ (GSH), @PROTEIN$ (GR), glutathione peroxidase (GPx), quinone reductase (QR), catalase (CAT 0.001).	0	18830880-1910
Hepatic antioxidant status viz, reduced glutathione (@COMPOUND$), glutathione reductase (GR), @PROTEIN$ (GPx), quinone reductase (QR), catalase (CAT 0.001).	0	18830880-1910
Hepatic antioxidant status viz, @COMPOUND$ (GSH), glutathione reductase (GR), @PROTEIN$ (GPx), quinone reductase (QR), catalase (CAT 0.001).	0	18830880-1910
Hepatic antioxidant status viz, reduced glutathione (@COMPOUND$), glutathione reductase (GR), glutathione peroxidase (GPx), quinone reductase (QR), catalase (@PROTEIN$ 0.001).	0	18830880-1910
Hepatic antioxidant status viz, reduced glutathione (@COMPOUND$), glutathione reductase (GR), glutathione peroxidase (GPx), quinone reductase (QR), @PROTEIN$ (CAT 0.001).	0	18830880-1910
Hepatic antioxidant status viz, reduced glutathione (@COMPOUND$), @PROTEIN$ (GR), glutathione peroxidase (GPx), quinone reductase (QR), catalase (CAT 0.001).	0	18830880-1910
Hepatic antioxidant status viz, @COMPOUND$ (GSH), glutathione reductase (GR), glutathione peroxidase (GPx), quinone reductase (QR), catalase (@PROTEIN$ 0.001).	0	18830880-1910
Inhibition of rat liver @PROTEIN$ and L by the peptide aldehyde @COMPOUND$ and its analogues.	1	18830882-1911
The concentration required for 50% inhibition (IC(50)) by @COMPOUND$ was 88 nM for cathepsin B and 163 nM for @PROTEIN$.	1	18830882-1913
The concentration required for 50% inhibition (IC(50)) by @COMPOUND$ was 88 nM for @PROTEIN$ and 163 nM for cathepsin L.	1	18830882-1913
Preliminary structure-activity relationships and a molecular modeling study for 9a have revealed that the @COMPOUND$ moiety plays a key role in the interaction of this series of derivatives with @PROTEIN$ by acting as an anchor in its peripheral anionic site.	1	18830885-1914
Heme oxygenase-1 (@PROTEIN$) and @COMPOUND$ (NO) which may play an important role in regulatory and protective processes in cells were assayed upon nickel treatment.	0	18830972-1951
@PROTEIN$ (HO-1) and @COMPOUND$ (NO) which may play an important role in regulatory and protective processes in cells were assayed upon nickel treatment.	0	18830972-1951
One potential target for reducing T cell migration is inhibition of the @COMPOUND$+)-activated neutral protease @PROTEIN$.	1	18831007-1971
One potential target for reducing T cell migration is inhibition of the @COMPOUND$+)-activated @PROTEIN$ calpain.	0	18831007-1971
A shift toward proinflammatory microglial activation is indicated by the release of interleukin-6, @PROTEIN$-alpha, and @COMPOUND$ and the oxidative burst in rat primary microglial cells, an activation and differentiation process similar to the proinflammatory response of microglia to exposure to lipopolysaccharide.	0	18831010-1974
A shift toward proinflammatory microglial activation is indicated by the release of @PROTEIN$, tumor necrosis factor-alpha, and @COMPOUND$ and the oxidative burst in rat primary microglial cells, an activation and differentiation process similar to the proinflammatory response of microglia to exposure to lipopolysaccharide.	0	18831010-1974
@COMPOUND$, a newer anticonvulsant, does not undergo @PROTEIN$ metabolism and does not alter the pharmacokinetics of chemotherapy, antiemetics, and corticosteroids, which are metabolized by the liver.	0	18831033-1984
The human AU @PROTEIN$/enoyl-Coenzyme A hydratase (AUH) is a 3-hydroxy-3-methylglutaconyl-CoA dehydratase in the @COMPOUND$ degradation pathway.	1	18831052-2002
The human AU RNA binding protein/enoyl-Coenzyme A hydratase (@PROTEIN$) is a 3-hydroxy-3-methylglutaconyl-CoA dehydratase in the @COMPOUND$ degradation pathway.	1	18831052-2002
@PROTEIN$ is responsible for the sulfation and inactivation of @COMPOUND$ (E2) at physiological concentrations.	1	18831980-2703
The main mechanism of resistance to @COMPOUND$ was extra-chromosomal amplification of the @PROTEIN$ gene.	1	18832050-2295
In the LNCaP prostate cancer cell line, induction of apoptosis and caspase-3/7 activities by staurosporine (STS) abolished ((3)H) @COMPOUND$ (3) binding and @PROTEIN$ protein, suggesting that the VDR may be targeted for inactivation by caspases during apoptosis.	0	18832097-2311
In the LNCaP prostate cancer cell line, induction of apoptosis and caspase-3/7 activities by @COMPOUND$ (STS) abolished ((3)H) 1,25-dihydroxy vitamin D (3) binding and @PROTEIN$ protein, suggesting that the VDR may be targeted for inactivation by caspases during apoptosis.	0	18832097-2311
The use of lipoproteins as a substrate for @COMPOUND$ synthesis remains unclear, and the expression of lipoprotein receptors (very-low-density lipoprotein receptor (@PROTEIN$), low-density lipoprotein receptor (LDLR), and scavenger receptor-BI (SR-BI 12 h) has not been characterized.	0	18832102-2313
The use of lipoproteins as a substrate for @COMPOUND$ synthesis remains unclear, and the expression of lipoprotein receptors (very-@PROTEIN$ (VLDLR), low-density lipoprotein receptor (LDLR), and scavenger receptor-BI (SR-BI 12 h) has not been characterized.	0	18832102-2313
The use of lipoproteins as a substrate for @COMPOUND$ synthesis remains unclear, and the expression of lipoprotein receptors (very-low-density lipoprotein receptor (VLDLR), low-density lipoprotein receptor (LDLR), and scavenger receptor-BI (@PROTEIN$ 12 h) has not been characterized.	0	18832102-2313
The use of lipoproteins as a substrate for @COMPOUND$ synthesis remains unclear, and the expression of lipoprotein receptors (very-low-density lipoprotein receptor (V@PROTEIN$), low-density lipoprotein receptor (LDLR), and scavenger receptor-BI (SR-BI 12 h) has not been characterized.	0	18832102-2313
These data suggest that an ovulatory stimulus rapidly mobilizes stored cholesterol esters for use as a @COMPOUND$ substrate and that as these are depleted, new cholesterol esters are obtained through an LDLR- and/or @PROTEIN$-mediated mechanism.	0	18832102-2314
These data suggest that an ovulatory stimulus rapidly mobilizes stored cholesterol esters for use as a @COMPOUND$ substrate and that as these are depleted, new cholesterol esters are obtained through an @PROTEIN$- and/or SR-BI-mediated mechanism.	0	18832102-2314
The @COMPOUND$-enhanced degradation of @PROTEIN$ involves both proteasomal and lysosomal activities.	1	18832185-2341
As this effect might be related to deregulation of @PROTEIN$ (Cx43) synthesis, trafficking, or degradation, we investigated the impact of @COMPOUND$ on these events.	1	18832185-2343
As this effect might be related to deregulation of connexin 43 (@PROTEIN$) synthesis, trafficking, or degradation, we investigated the impact of @COMPOUND$ on these events.	1	18832185-2343
Inhibition of either proteasomes or lysosomes with their specific inhibitors largely restored total @PROTEIN$ protein levels, thus suggesting that both proteasomes and lysosomes may participate in the @COMPOUND$-enhanced Cx43 internalization and degradation.	1	18832185-2345
Finally, @COMPOUND$ also interfered with restoration of gap junction plaques following the inhibition of @PROTEIN$ transport to plasma membrane.	1	18832185-2346
Taken together, multiple modes of action seem to contribute to downregulation of @PROTEIN$ in @COMPOUND$-treated rat liver epithelial cells.	1	18832185-2347
@COMPOUND$ demonstrates potent inhibition of @PROTEIN$-4 activity with excellent tolerability at doses of up to and including 200 mg qd.	1	18832295-2399
The accelerated rate of kindling was partially repressed by inhibiting N-methyl-D-aspartic acid receptor (NMDAR) with @COMPOUND$ or @PROTEIN$ receptor with 2-methyl-6-(phenylethynyl)-pyridine (MPEP).	0	18832330-479
The accelerated rate of kindling was partially repressed by inhibiting N-methyl-D-aspartic acid receptor (NMDAR) with MK-801 or @PROTEIN$ receptor with 2-methyl-6-(phenylethynyl)-pyridine (@COMPOUND$).	1	18832330-479
The accelerated rate of kindling was partially repressed by inhibiting N-methyl-D-aspartic acid receptor (NMDAR) with MK-801 or @PROTEIN$ receptor with @COMPOUND$ (MPEP).	1	18832330-479
Here, PCA is applied to three problems in @PROTEIN$ research: (i) distinguishing origins of heparin preparations, (ii) structural analysis of heparin derivatives, and (iii) classification of @COMPOUND$ (CS).	1	18832453-2471
The CL(int) was obtained using either individual or combined cofactors for cytochrome P450 (P450) and UGT enzymes with @COMPOUND$ activation and in the presence and absence of 2% bovine serum albumin (@PROTEIN$).	0	18832476-2484
The CL(int) was obtained using either individual or combined cofactors for cytochrome P450 (P450) and UGT enzymes with @COMPOUND$ activation and in the presence and absence of 2% bovine @PROTEIN$ (BSA).	0	18832476-2484
By using purified bovine @PROTEIN$, the reduction was observed in the presence of @COMPOUND$ (P)H. These results suggest that FLU-1 N-OH is involved in flutamide-induced hepatotoxicity and that cytosolic reduction of FLU-1 N-OH plays a major role in protection against flutamide-induced hepatotoxicity.	1	18832480-801
Recent studies have provided important insight into the homeoprotein LIM homeobox transcription factor 1alpha (@PROTEIN$) and its role in the commitment of cells to a midbrain @COMPOUND$ (mDA) fate in the developing mouse.	1	18832589-2551
Recent studies have provided important insight into the homeoprotein @PROTEIN$ homeobox transcription factor 1alpha (Lmx1a) and its role in the commitment of cells to a midbrain @COMPOUND$ (mDA) fate in the developing mouse.	1	18832589-2551
An acute increase in @COMPOUND$ tension led to Smad activation within 30 minutes, even in the absence of exogenous @PROTEIN$ treatment.	0	18832593-1025
Recognition of @COMPOUND$ components of pectin by @PROTEIN$.	1	18832596-2558
By using a combination of fluorescence microscopy, flow cytometry, and force spectroscopy, it has been possible to demonstrate, for the first time, specific binding of a pectin @COMPOUND$ to the recombinant form of human @PROTEIN$.	1	18832596-2559
@PROTEIN$ has been identified as an endoplasmic reticulum (ER)-resident @COMPOUND$+) sensor that regulates store-operated calcium entry (SOCE) in immune cells and platelets, but the identity of the platelet SOC channel has remained elusive.	1	18832659-2578
A sensitive and specific ELISA detects @COMPOUND$-containing @PROTEIN$ in HDL.	1	18832772-2632
A wide range of reactive intermediates oxidizes methionine residues to @COMPOUND$ (MetO) in @PROTEIN$ (apoA-I), the major HDL protein.	1	18832772-2633
A wide range of reactive intermediates oxidizes methionine residues to @COMPOUND$ (MetO) in apolipoprotein A-I (@PROTEIN$), the major HDL protein.	1	18832772-2633
The renin-angiotensin-@COMPOUND$ system: approaches to guide @PROTEIN$ inhibition in patients with coronary artery disease.	0	18832826-1553
It was identified as producer of extended-spectrum @PROTEIN$ (ESBL) by double-disk synergy test between @COMPOUND$-clavulanate and cefotaxime, ceftriaxone, ceftazidime and aztreonam.	1	18834674-2651
It was identified as producer of extended-spectrum @PROTEIN$ (ESBL) by double-disk synergy test between amoxicillin-clavulanate and cefotaxime, ceftriaxone, @COMPOUND$ and aztreonam.	1	18834674-2651
It was identified as producer of extended-spectrum @PROTEIN$ (ESBL) by double-disk synergy test between amoxicillin-clavulanate and @COMPOUND$, ceftriaxone, ceftazidime and aztreonam.	1	18834674-2651
It was identified as producer of extended-spectrum @PROTEIN$ (ESBL) by double-disk synergy test between amoxicillin-clavulanate and cefotaxime, @COMPOUND$, ceftazidime and aztreonam.	1	18834674-2651
It was identified as producer of extended-spectrum @PROTEIN$ (ESBL) by double-disk synergy test between amoxicillin-clavulanate and cefotaxime, ceftriaxone, ceftazidime and @COMPOUND$.	1	18834674-2651
It was identified as producer of extended-spectrum @PROTEIN$ (ESBL) by double-disk synergy test between amoxicillin-@COMPOUND$ and cefotaxime, ceftriaxone, ceftazidime and aztreonam.	1	18834674-2651
The binding of @COMPOUND$ to human @PROTEIN$ was used as the model system in order to evaluate the performance of automated SPME.	1	18834690-355
@COMPOUND$ (NO) and interlukin-6 (@PROTEIN$) are highly reactive mediators that have been shown to play different roles in a variety of different biological process.	0	18834707-357
Mitochondrial @PROTEIN$ (ALDH-2)--maker of and marker for nitrate tolerance in response to @COMPOUND$ treatment.	1	18834868-391
Mitochondrial aldehyde dehydrogenase (@PROTEIN$-2)--maker of and marker for nitrate tolerance in response to @COMPOUND$ treatment.	1	18834868-391
Mitochondrial aldehyde dehydrogenase (@PROTEIN$-2)--maker of and marker for @COMPOUND$ tolerance in response to nitroglycerin treatment.	1	18834868-391
Mitochondrial @PROTEIN$ (ALDH-2)--maker of and marker for @COMPOUND$ tolerance in response to nitroglycerin treatment.	1	18834868-391
According to the oxidative stress concept, increased vascular @COMPOUND$ and peroxynitrite production as well as an increased sensitivity to vasoconstrictors secondary to activation of @PROTEIN$ as well as vascular NADPH oxidases contribute to the development of tolerance.	0	18834868-392
According to the oxidative stress concept, increased vascular superoxide and @COMPOUND$ production as well as an increased sensitivity to vasoconstrictors secondary to activation of @PROTEIN$ as well as vascular NADPH oxidases contribute to the development of tolerance.	0	18834868-392
mitochondrial aldehyde dehydrogenase (@PROTEIN$-2)) and mitochondria as potential sources of reactive @COMPOUND$ species (ROS).	0	18834868-393
mitochondrial @PROTEIN$ (ALDH-2)) and mitochondria as potential sources of reactive @COMPOUND$ species (ROS).	0	18834868-393
Finally, we will address the question whether @PROTEIN$-2 inactivation by nitroglycerin could be a useful marker for clinical nitrate tolerance and discuss the redox-regulation of this enzyme by oxidative stress and @COMPOUND$.	0	18834868-395
Finally, we will address the question whether @PROTEIN$-2 inactivation by @COMPOUND$ could be a useful marker for clinical nitrate tolerance and discuss the redox-regulation of this enzyme by oxidative stress and dihydrolipoic acid.	0	18834868-395
Finally, we will address the question whether @PROTEIN$-2 inactivation by nitroglycerin could be a useful marker for clinical @COMPOUND$ tolerance and discuss the redox-regulation of this enzyme by oxidative stress and dihydrolipoic acid.	0	18834868-395
Sex steroids enhance @PROTEIN$ and @COMPOUND$ oxidation in Chang liver cells.	0	18834871-397
The present study was designed to assess the effect of sex steroids (testosterone and 17beta-estradiol) on @PROTEIN$ receptor expression, insulin binding and @COMPOUND$ oxidation in human liver cell line.	0	18834871-398
The present study was designed to assess the effect of sex steroids (@COMPOUND$ and 17beta-estradiol) on @PROTEIN$ receptor expression, insulin binding and glucose oxidation in human liver cell line.	1	18834871-398
The present study was designed to assess the effect of sex steroids (testosterone and @COMPOUND$) on @PROTEIN$ receptor expression, insulin binding and glucose oxidation in human liver cell line.	1	18834871-398
The present study was designed to assess the effect of sex steroids (@COMPOUND$ and 17beta-estradiol) on @PROTEIN$ expression, insulin binding and glucose oxidation in human liver cell line.	1	18834871-398
The present study was designed to assess the effect of sex steroids (testosterone and 17beta-estradiol) on @PROTEIN$ expression, insulin binding and @COMPOUND$ oxidation in human liver cell line.	0	18834871-398
The present study was designed to assess the effect of sex steroids (testosterone and @COMPOUND$) on @PROTEIN$ expression, insulin binding and glucose oxidation in human liver cell line.	1	18834871-398
It is predicted to possess all the expected features of proPO members, including two putative @PROTEIN$ copper-binding motifs with six @COMPOUND$ residues and a thiol ester-like motif, sharing 67% amino acid sequence identity with PmproPO1.	0	18834900-402
It is predicted to possess all the expected features of proPO members, including two putative @PROTEIN$ copper-binding motifs with six histidine residues and a @COMPOUND$-like motif, sharing 67% amino acid sequence identity with PmproPO1.	0	18834900-402
Examination of @COMPOUND$-induced expression of the small heat shock protein gene, @PROTEIN$, in Xenopus laevis A6 kidney epithelial cells.	1	18834946-408
In the present study, we have characterized the effect of @COMPOUND$ on the accumulation of the small heat shock protein (@PROTEIN$), HSP30, in Xenopus laevis A6 kidney epithelial cells.	1	18834946-409
In the present study, we have characterized the effect of @COMPOUND$ on the accumulation of the small heat shock protein (HSP), @PROTEIN$, in Xenopus laevis A6 kidney epithelial cells.	1	18834946-409
Immunocytochemical analysis of @COMPOUND$-treated A6 cells revealed @PROTEIN$ accumulation primarily in the cytoplasm in a punctate pattern supplemented with larger HSP30 staining structures.	1	18834946-410
Also, @PROTEIN$ co-localized with the F-actin cytoskeleton at higher @COMPOUND$ concentrations.	1	18834946-411
Also, HSP30 co-localized with the F-@PROTEIN$ cytoskeleton at higher @COMPOUND$ concentrations.	0	18834946-411
In order to suppress the emergence of such resistant variants, we introduced charged and hydrophilic amino acids, @COMPOUND$ (E) and lysine (K), at the solvent accessible site of @PROTEIN$.	1	18834950-413
In order to suppress the emergence of such resistant variants, we introduced charged and hydrophilic amino acids, glutamic acid (E) and @COMPOUND$ (K), at the solvent accessible site of @PROTEIN$.	1	18834950-413
Cloning, expression, and characterization of @COMPOUND$-induced @PROTEIN$ from the earthworms Metaphire posthuma and Polypheretima elongata.	1	18834958-415
In this study we report the sequences of @PROTEIN$ cDNA from two species of Megascoleidae earthworms, Metaphire posthuma and Polypheretima elongata, by mRNA differential display after exposure of the organisms to @COMPOUND$.	1	18834958-416
Complementary (c)DNA was verified as the @PROTEIN$ gene by the characteristics of its predicted translation product, namely a high @COMPOUND$ content, conserved CXC motifs, and a molecular weight of around 8 kDa.	1	18834958-417
These earthworms could be used to evaluate heavy-metal pollution in soil due to the inducible @PROTEIN$ by @COMPOUND$ exposure.	1	18834958-420
Despite the reciprocal relationship that exists between inflammation and thrombosis, we asked whether thrombosis can develop without inflammation, and whether stress-related hormones (@PROTEIN$ and @COMPOUND$) influence platelet-mediated thrombosis.	0	18834983-429
The most active compound to emerge from the in vitro and in vivo murine studies was 2b, suggesting an antimalarial activity via inhibition of @PROTEIN$ hydrolysis, however, not as efficient as @COMPOUND$.	0	18835067-453
The culture medium was analyzed for pH value, concentration of free calcium and @COMPOUND$ and @PROTEIN$.	0	18835228-501
Surprisingly, no role of @PROTEIN$/2 or STAT-3 was found in the protein-mediated protection of hepatocytes during @COMPOUND$ exposure.	0	18835260-516
Surprisingly, no role of ERK1/2 or @PROTEIN$-3 was found in the protein-mediated protection of hepatocytes during @COMPOUND$ exposure.	0	18835260-516
Mutations at M57 (M57L) and H210 (H210G, H210M, and H210N), both of which are involved in interactions with the C2 carbonyl oxygen in uracil or @COMPOUND$, cause substantial reductions in XDG and @PROTEIN$ activities.	0	18835277-527
Mutations at M57 (M57L) and H210 (H210G, H210M, and H210N), both of which are involved in interactions with the C2 carbonyl @COMPOUND$ in uracil or xanthine, cause substantial reductions in XDG and @PROTEIN$ activities.	0	18835277-527
Mutations at M57 (M57L) and H210 (H210G, H210M, and H210N), both of which are involved in interactions with the C2 carbonyl oxygen in @COMPOUND$ or xanthine, cause substantial reductions in XDG and @PROTEIN$ activities.	0	18835277-527
Most interestingly, a proline substitution at the G63 position switches the Gme SMUG1 enzyme to an exclusive @PROTEIN$ as demonstrated by the uniform excision of @COMPOUND$ in both double-stranded and single-stranded DNA and the complete loss of XDG activity.	1	18835277-528
Most interestingly, a proline substitution at the G63 position switches the Gme @PROTEIN$ enzyme to an exclusive UDG as demonstrated by the uniform excision of @COMPOUND$ in both double-stranded and single-stranded DNA and the complete loss of XDG activity.	1	18835277-528
Most interestingly, a @COMPOUND$ substitution at the G63 position switches the Gme @PROTEIN$ enzyme to an exclusive UDG as demonstrated by the uniform excision of uracil in both double-stranded and single-stranded DNA and the complete loss of XDG activity.	1	18835277-528
Most interestingly, a proline substitution at the G63 position switches the @PROTEIN$ SMUG1 enzyme to an exclusive UDG as demonstrated by the uniform excision of @COMPOUND$ in both double-stranded and single-stranded DNA and the complete loss of XDG activity.	1	18835277-528
Most interestingly, a @COMPOUND$ substitution at the G63 position switches the Gme SMUG1 enzyme to an exclusive @PROTEIN$ as demonstrated by the uniform excision of uracil in both double-stranded and single-stranded DNA and the complete loss of XDG activity.	1	18835277-528
Most interestingly, a @COMPOUND$ substitution at the G63 position switches the @PROTEIN$ SMUG1 enzyme to an exclusive UDG as demonstrated by the uniform excision of uracil in both double-stranded and single-stranded DNA and the complete loss of XDG activity.	1	18835277-528
@PROTEIN$-@COMPOUND$ coated microspheres: role of the inner gel in binding and release of the KRFK peptide.	1	18835344-566
Furthermore, increased production of high inducible nitric oxide synthase (iNOS) and @PROTEIN$ (COX-2) expressions were detected in the hippocampus and cerebral cortex of @COMPOUND$ and cholesterol co-treated mice by immunohistochemical analysis.	1	18835350-570
Furthermore, increased production of high inducible @PROTEIN$ (iNOS) and cyclooxygenase 2 (COX-2) expressions were detected in the hippocampus and cerebral cortex of @COMPOUND$ and cholesterol co-treated mice by immunohistochemical analysis.	1	18835350-570
Furthermore, increased production of high inducible nitric oxide synthase (iNOS) and cyclooxygenase 2 (@PROTEIN$) expressions were detected in the hippocampus and cerebral cortex of @COMPOUND$ and cholesterol co-treated mice by immunohistochemical analysis.	1	18835350-570
Furthermore, increased production of high inducible nitric oxide synthase (@PROTEIN$) and cyclooxygenase 2 (COX-2) expressions were detected in the hippocampus and cerebral cortex of @COMPOUND$ and cholesterol co-treated mice by immunohistochemical analysis.	1	18835350-570
We report herein some novel phenomena between hemin-H(2)O(2)-NO(2)(-) and @COMPOUND$ (SIN-1)-mediated oxidation and nitration reactions of glutamate dehydrogenase (@PROTEIN$).	1	18835362-575
We report herein some novel phenomena between hemin-H(2)O(2)-NO(2)(-) and @COMPOUND$ (SIN-1)-mediated oxidation and nitration reactions of @PROTEIN$ (GDH).	1	18835362-575
After intravenous administration of either DOTAP/@COMPOUND$ or DOTMA/cholesterol liposomes, serum @PROTEIN$ and ALT levels were normal, suggesting that liver injury as well as cytokine production was caused by lipoplexes, but not by cationic liposomes.	0	18835442-614
After intravenous administration of either DOTAP/cholesterol or @COMPOUND$/cholesterol liposomes, serum @PROTEIN$ and ALT levels were normal, suggesting that liver injury as well as cytokine production was caused by lipoplexes, but not by cationic liposomes.	0	18835442-614
After intravenous administration of either @COMPOUND$/cholesterol or DOTMA/cholesterol liposomes, serum @PROTEIN$ and ALT levels were normal, suggesting that liver injury as well as cytokine production was caused by lipoplexes, but not by cationic liposomes.	0	18835442-614
@COMPOUND$ was the most potent regulator of @PROTEIN$ affinity, with concentrations of 5 mmol L(-1) causing an increase in p(50) from 5 to 19 mm Hg at pH 7.5, while the order of potency of the other phosphates was IHP&gt;ATP&gt;BPG.	1	18835585-659
Functional inactivation of @PROTEIN$/@COMPOUND$ in human mesothelioma.	0	18835652-693
The tumor suppressor @COMPOUND$ is encoded by the neurofibromatosis type 2 gene (@PROTEIN$) which is located on chromosome 22q12 and mutations in this gene have been found in 40% of mesothelioma.	1	18835652-694
No main effect of group assignment on TSST responses was found for @PROTEIN$, @COMPOUND$ or POMS scores.	0	18835662-698
The objective of this study was to determine: (i) the prevalence of resistance in current clinical isolates of Streptococcus pneumoniae, Staphylococcus aureus, Haemophilus influenzae, Moraxella catarrhalis and Klebsiella pneumoniae; (ii) the prevalence of production of extended-spectrum @PROTEIN$ (ESBLs) and @COMPOUND$ resistance in S. aureus; and (iii) regional differences in the prevalence of ESBL production and clonality of K. pneumoniae isolates.	1	18835763-723
@COMPOUND$-induced expression of the orphan nuclear receptor @PROTEIN$ in MA-10 Leydig cells involves a CaMKI pathway.	1	18835829-730
@COMPOUND$-induced expression of the orphan nuclear receptor Nur77 in MA-10 Leydig cells involves a @PROTEIN$ pathway.	1	18835829-730
In Leydig cells, androgen biosynthesis is controlled primarily by the pituitary gonadotropin luteinizing hormone (LH) acting via its receptor (LH-R), which in turn activates the @PROTEIN$/@COMPOUND$ (cAMP) signaling pathway.	1	18835829-731
In Leydig cells, androgen biosynthesis is controlled primarily by the pituitary gonadotropin luteinizing hormone (LH) acting via its receptor (LH-R), which in turn activates the @PROTEIN$/cyclic adenosine monophosphate (@COMPOUND$) signaling pathway.	1	18835829-731
Here, we report that @COMPOUND$-mediated induction of @PROTEIN$ expression at the protein, mRNA, and promoter levels in MA-10 cells involves different mechanisms.	1	18835829-732
In addition, our detailed analysis of the @PROTEIN$ promoter in MA-10 cells revealed that distinct regulatory elements are involved in basal and @COMPOUND$-induced Nur77 transcription.	1	18835829-733
Expression of @PROTEIN$ during germ cell apoptosis in testis of cynomolgus monkey after @COMPOUND$ and heat treatment.	0	18835830-734
Comparing expression of @COMPOUND$ and @PROTEIN$ in testicular tissue from men with obstructive and nonobstructive azoospermia.	0	18835831-735
Together, these results provide compelling evidence that @PROTEIN$ does not have a klotho-independent role in the regulation of systemic phosphate and @COMPOUND$ homeostasis.	0	18835926-762
Based on fasting @PROTEIN$ and @COMPOUND$, several indices of insulin sensitivity have been developed in adults.	0	18835976-780
LDL from all subjects stimulated both the basal and @PROTEIN$-induced @COMPOUND$ and cortisol release from adrenocortical cells.	1	18835979-782
LDL from all subjects stimulated both the basal and @PROTEIN$-induced aldosterone and @COMPOUND$ release from adrenocortical cells.	1	18835979-782
Here we present evidence of distinct @COMPOUND$-induced modulation of @PROTEIN$ functions using high-resolution live-cell imaging approaches.	1	18835981-786
Quantitative analysis yielded 0.81 and 1.8 microM for EC(50) values of @COMPOUND$-induced cell edge translocation of abl-KD-@PROTEIN$ (GFP) and wild-type abl-GFP, respectively.	1	18835981-787
Association of the @PROTEIN$ gene polymorphisms 2677G&gt;T/A and 3435C&gt;T with clinical outcomes of @COMPOUND$ monotherapy in metastatic breast cancer patients.	1	18836089-2732
We evaluated the association between clinical outcome (safety and efficacy) of @COMPOUND$ monotherapy in metastatic breast cancer patients with @PROTEIN$ gene polymorphisms 2677G&gt;T/A or 3435C&gt;T.	1	18836089-2733
@PROTEIN$/KC was detected as early as 6 hours after @COMPOUND$ instillation and returned to basal levels after Day 8.	1	18836137-847
DF2162 treatment reduced @COMPOUND$-induced expression of @PROTEIN$, a marker of angiogenesis, in the lung.	1	18836137-848
This was prevented by pretreatment of cells with the phosphatidylinositol 3-kinase (@PROTEIN$) inhibitor @COMPOUND$ or pharmacological inhibition of PKB.	1	18836482-927
This was prevented by pretreatment of cells with the phosphatidylinositol 3-kinase (PI3K) inhibitor @COMPOUND$ or pharmacological inhibition of @PROTEIN$.	0	18836482-927
@COMPOUND$ (KYNA) is an agonist of the G-protein-coupled receptor @PROTEIN$, which is predominantly expressed in gastrointestinal tissues.	1	18836681-1004
Kynurenic acid (@COMPOUND$) is an agonist of the G-protein-coupled receptor @PROTEIN$, which is predominantly expressed in gastrointestinal tissues.	1	18836681-1004
Molecular dynamics simulation techniques have been used to study the unbinding pathways of @COMPOUND$) from the ligand-binding pocket of the vitamin D receptor (@PROTEIN$).	1	18836710-1021
Activation of the Na+/K+-ATPase by @PROTEIN$ and @COMPOUND$ as a putative negative feedback mechanism in pancreatic beta-cells.	0	18836740-1043
Inhibiting @PROTEIN$ signalling in SUR1 (-/-) beta-cells blunted the @COMPOUND$-induced decrease of (Ca(2+))(c).	0	18836740-1046
Relaxation to @PROTEIN$ (10(-8) M) was unaffected by L-NAME (3 x 10(-4) M) and indomethacin (10(-6) M) suggesting no involvement of @COMPOUND$ or prostaglandins in the CGRP-induced relaxation.	0	18836843-1091
Relaxation to @PROTEIN$ (10(-8) M) was unaffected by L-NAME (3 x 10(-4) M) and @COMPOUND$ (10(-6) M) suggesting no involvement of nitric oxide or prostaglandins in the CGRP-induced relaxation.	0	18836843-1091
In the mouse model of demyelination-remyelination induced by oral administration of @COMPOUND$, in situ hybridization showed an upregulation of the @PROTEIN$ gene in three different white matter areas (corpus callosum, dorsal fornix, and external capsule) during the remyelination period.	1	18836851-1099
Cells positive for DDR1 mRNA were also positive for oligodendrocyte markers (OLIG2, @COMPOUND$, and @PROTEIN$) but not for markers of oligodendrocyte precursors (NG2), myelin markers (CNPase), microglia (CD11b), or reactive glia (GFAP).	0	18836851-1100
Cells positive for DDR1 mRNA were also positive for oligodendrocyte markers (OLIG2, @COMPOUND$, and APC) but not for markers of oligodendrocyte precursors (NG2), myelin markers (@PROTEIN$), microglia (CD11b), or reactive glia (GFAP).	0	18836851-1100
Cells positive for DDR1 mRNA were also positive for oligodendrocyte markers (OLIG2, @COMPOUND$, and APC) but not for markers of oligodendrocyte precursors (NG2), myelin markers (CNPase), microglia (CD11b), or reactive glia (@PROTEIN$).	0	18836851-1100
Cells positive for @PROTEIN$ mRNA were also positive for oligodendrocyte markers (OLIG2, @COMPOUND$, and APC) but not for markers of oligodendrocyte precursors (NG2), myelin markers (CNPase), microglia (CD11b), or reactive glia (GFAP).	1	18836851-1100
Cells positive for DDR1 mRNA were also positive for oligodendrocyte markers (OLIG2, @COMPOUND$, and APC) but not for markers of oligodendrocyte precursors (@PROTEIN$), myelin markers (CNPase), microglia (CD11b), or reactive glia (GFAP).	0	18836851-1100
Cells positive for DDR1 mRNA were also positive for oligodendrocyte markers (@PROTEIN$, @COMPOUND$, and APC) but not for markers of oligodendrocyte precursors (NG2), myelin markers (CNPase), microglia (CD11b), or reactive glia (GFAP).	0	18836851-1100
By conducting this initial screen on EMT6 cells and applying protein function and genomic structure criteria to genes identified as upregulated in response to @COMPOUND$/TSA, we were able to identify two characterized breast cancer TSGs (Timp3 and Rprm) and four putative TSGs (Atp1B2, @PROTEIN$, FoxJ1 and Smpd3) silenced in this line.	1	18836996-1126
By conducting this initial screen on EMT6 cells and applying protein function and genomic structure criteria to genes identified as upregulated in response to @COMPOUND$/TSA, we were able to identify two characterized breast cancer TSGs (@PROTEIN$ and Rprm) and four putative TSGs (Atp1B2, Dusp2, FoxJ1 and Smpd3) silenced in this line.	1	18836996-1126
By conducting this initial screen on EMT6 cells and applying protein function and genomic structure criteria to genes identified as upregulated in response to @COMPOUND$/TSA, we were able to identify two characterized breast cancer TSGs (Timp3 and Rprm) and four putative TSGs (Atp1B2, Dusp2, @PROTEIN$ and Smpd3) silenced in this line.	1	18836996-1126
By conducting this initial screen on EMT6 cells and applying protein function and genomic structure criteria to genes identified as upregulated in response to @COMPOUND$/TSA, we were able to identify two characterized breast cancer TSGs (Timp3 and Rprm) and four putative TSGs (Atp1B2, Dusp2, FoxJ1 and @PROTEIN$) silenced in this line.	1	18836996-1126
Therapeutic strategy to rescue mutation-induced exon skipping in @PROTEIN$ by adaptation of @COMPOUND$ snRNA.	1	18837008-1129
As a therapeutic strategy, @COMPOUND$ snRNAs were adapted to the novel @PROTEIN$ mutation and tested for its potential to reverse missplicing.	1	18837008-1130
Urinary concentrations of @COMPOUND$, dihydrogenistein, O-desmethylangolensin, and equol exceeded @PROTEIN$ aglycone equivalents.	0	18837469-2746
Urinary concentrations of dihydrodaidzein, dihydrogenistein, O-desmethylangolensin, and @COMPOUND$ exceeded @PROTEIN$ aglycone equivalents.	0	18837469-2746
Urinary concentrations of dihydrodaidzein, dihydrogenistein, @COMPOUND$, and equol exceeded @PROTEIN$ aglycone equivalents.	0	18837469-2746
Urinary concentrations of dihydrodaidzein, @COMPOUND$, O-desmethylangolensin, and equol exceeded @PROTEIN$ aglycone equivalents.	0	18837469-2746
Concentrations of @COMPOUND$, @PROTEIN$, C-peptide, nonesterified fatty acids, triacylglycerol, total and exogenous glucose kinetics were assessed for 6 h postprandially.	0	18837470-2752
After 120 min, @COMPOUND$ and @PROTEIN$ responses declined, but remained higher after the Pol 0.05) in parallel to the inhibition of lipolysis.	0	18837470-2754
Keeping @COMPOUND$ out of DNA: physiological role, structure and catalytic mechanism of @PROTEIN$.	1	18837522-1374
To prevent @COMPOUND$ incorporation into DNA, representatives of the dUTP nucleotidohydrolase (@PROTEIN$) enzyme family eliminate excess dUTP.	1	18837522-1375
The @PROTEIN$ binding pocket is highly specific for @COMPOUND$.	1	18837522-1376
@COMPOUND$ chain coordination involves Mg2+ and is analogous to that of @PROTEIN$.	1	18837522-1377
In these respective pathogens, Plasmodium falciparum and Mycobacterium tuberculosis, the biosynthesis of @COMPOUND$ relies exclusively on @PROTEIN$ activity.	1	18837522-1378
Furthermore, NaHS enhanced inhibitory effects of apocynin, N-acetyl-l-cysteine (NAC), reduced glutathione (GSH), catalase (@PROTEIN$), superoxide dismutase (SOD), Nomega-nitro-@COMPOUND$ (L-NAME) on ROS production and redox enzymes levels induced by Met.	0	18837652-1413
Furthermore, NaHS enhanced inhibitory effects of apocynin, @COMPOUND$ (NAC), reduced glutathione (GSH), catalase (CAT), superoxide dismutase (@PROTEIN$), Nomega-nitro-l-arginine methyl ester (L-NAME) on ROS production and redox enzymes levels induced by Met.	0	18837652-1413
Furthermore, NaHS enhanced inhibitory effects of @COMPOUND$, N-acetyl-l-cysteine (NAC), reduced glutathione (GSH), catalase (CAT), superoxide dismutase (@PROTEIN$), Nomega-nitro-l-arginine methyl ester (L-NAME) on ROS production and redox enzymes levels induced by Met.	0	18837652-1413
Furthermore, NaHS enhanced inhibitory effects of apocynin, N-acetyl-l-cysteine (NAC), @COMPOUND$ (GSH), @PROTEIN$ (CAT), superoxide dismutase (SOD), Nomega-nitro-l-arginine methyl ester (L-NAME) on ROS production and redox enzymes levels induced by Met.	0	18837652-1413
Furthermore, NaHS enhanced inhibitory effects of apocynin, N-acetyl-l-cysteine (NAC), reduced glutathione (@COMPOUND$), catalase (CAT), superoxide dismutase (@PROTEIN$), Nomega-nitro-l-arginine methyl ester (L-NAME) on ROS production and redox enzymes levels induced by Met.	0	18837652-1413
Furthermore, NaHS enhanced inhibitory effects of @COMPOUND$, N-acetyl-l-cysteine (NAC), reduced glutathione (GSH), @PROTEIN$ (CAT), superoxide dismutase (SOD), Nomega-nitro-l-arginine methyl ester (L-NAME) on ROS production and redox enzymes levels induced by Met.	0	18837652-1413
Furthermore, NaHS enhanced inhibitory effects of apocynin, N-acetyl-l-cysteine (NAC), @COMPOUND$ (GSH), catalase (CAT), superoxide dismutase (@PROTEIN$), Nomega-nitro-l-arginine methyl ester (L-NAME) on ROS production and redox enzymes levels induced by Met.	0	18837652-1413
Furthermore, NaHS enhanced inhibitory effects of @COMPOUND$, N-acetyl-l-cysteine (NAC), reduced glutathione (GSH), catalase (@PROTEIN$), superoxide dismutase (SOD), Nomega-nitro-l-arginine methyl ester (L-NAME) on ROS production and redox enzymes levels induced by Met.	0	18837652-1413
Furthermore, NaHS enhanced inhibitory effects of apocynin, N-acetyl-l-cysteine (NAC), reduced glutathione (@COMPOUND$), catalase (CAT), @PROTEIN$ (SOD), Nomega-nitro-l-arginine methyl ester (L-NAME) on ROS production and redox enzymes levels induced by Met.	0	18837652-1413
Furthermore, NaHS enhanced inhibitory effects of @COMPOUND$, N-acetyl-l-cysteine (NAC), reduced glutathione (GSH), catalase (CAT), @PROTEIN$ (SOD), Nomega-nitro-l-arginine methyl ester (L-NAME) on ROS production and redox enzymes levels induced by Met.	0	18837652-1413
Furthermore, NaHS enhanced inhibitory effects of apocynin, N-acetyl-l-cysteine (NAC), @COMPOUND$ (GSH), catalase (CAT), @PROTEIN$ (SOD), Nomega-nitro-l-arginine methyl ester (L-NAME) on ROS production and redox enzymes levels induced by Met.	0	18837652-1413
Furthermore, NaHS enhanced inhibitory effects of apocynin, N-acetyl-l-cysteine (NAC), reduced glutathione (@COMPOUND$), catalase (@PROTEIN$), superoxide dismutase (SOD), Nomega-nitro-l-arginine methyl ester (L-NAME) on ROS production and redox enzymes levels induced by Met.	0	18837652-1413
Furthermore, NaHS enhanced inhibitory effects of apocynin, @COMPOUND$ (NAC), reduced glutathione (GSH), catalase (CAT), @PROTEIN$ (SOD), Nomega-nitro-l-arginine methyl ester (L-NAME) on ROS production and redox enzymes levels induced by Met.	0	18837652-1413
Furthermore, NaHS enhanced inhibitory effects of apocynin, @COMPOUND$ (NAC), reduced glutathione (GSH), @PROTEIN$ (CAT), superoxide dismutase (SOD), Nomega-nitro-l-arginine methyl ester (L-NAME) on ROS production and redox enzymes levels induced by Met.	0	18837652-1413
Furthermore, NaHS enhanced inhibitory effects of apocynin, N-acetyl-l-cysteine (NAC), @COMPOUND$ (GSH), catalase (@PROTEIN$), superoxide dismutase (SOD), Nomega-nitro-l-arginine methyl ester (L-NAME) on ROS production and redox enzymes levels induced by Met.	0	18837652-1413
Furthermore, NaHS enhanced inhibitory effects of apocynin, N-acetyl-l-cysteine (NAC), reduced glutathione (GSH), catalase (CAT), superoxide dismutase (@PROTEIN$), Nomega-nitro-@COMPOUND$ (L-NAME) on ROS production and redox enzymes levels induced by Met.	0	18837652-1413
Furthermore, NaHS enhanced inhibitory effects of apocynin, N-acetyl-l-cysteine (NAC), reduced glutathione (@COMPOUND$), @PROTEIN$ (CAT), superoxide dismutase (SOD), Nomega-nitro-l-arginine methyl ester (L-NAME) on ROS production and redox enzymes levels induced by Met.	0	18837652-1413
Furthermore, NaHS enhanced inhibitory effects of apocynin, @COMPOUND$ (NAC), reduced glutathione (GSH), catalase (@PROTEIN$), superoxide dismutase (SOD), Nomega-nitro-l-arginine methyl ester (L-NAME) on ROS production and redox enzymes levels induced by Met.	0	18837652-1413
Furthermore, NaHS enhanced inhibitory effects of apocynin, N-acetyl-l-cysteine (NAC), reduced glutathione (GSH), @PROTEIN$ (CAT), superoxide dismutase (SOD), Nomega-nitro-@COMPOUND$ (L-NAME) on ROS production and redox enzymes levels induced by Met.	0	18837652-1413
Furthermore, NaHS enhanced inhibitory effects of apocynin, N-acetyl-l-cysteine (NAC), reduced glutathione (GSH), catalase (CAT), @PROTEIN$ (SOD), Nomega-nitro-@COMPOUND$ (L-NAME) on ROS production and redox enzymes levels induced by Met.	0	18837652-1413
It controls the expression of a total of 11 genes, the @PROTEIN$ regulon, in a @COMPOUND$-dependent manner.	1	18837698-1429
In this article, the intracellular signal transduction mechanisms mediating the actions of some of these regulators, including GTH-releasing hormones, @PROTEIN$, @COMPOUND$, ghrelin, sex steroids, activin, and follistatin from experiments with goldfish are reviewed and discussed in relation with recent findings.	0	18838074-1535
In this article, the intracellular signal transduction mechanisms mediating the actions of some of these regulators, including GTH-releasing hormones, pituitary adenylate cyclase-activating polypeptide, @COMPOUND$, @PROTEIN$, sex steroids, activin, and follistatin from experiments with goldfish are reviewed and discussed in relation with recent findings.	0	18838074-1535
In this article, the intracellular signal transduction mechanisms mediating the actions of some of these regulators, including @PROTEIN$-releasing hormones, pituitary adenylate cyclase-activating polypeptide, @COMPOUND$, ghrelin, sex steroids, activin, and follistatin from experiments with goldfish are reviewed and discussed in relation with recent findings.	0	18838074-1535
Goldfish gonadotropes possess multiple pharmacologically distinct intracellular Ca2+ stores that together with voltage-sensitive Ca2+ channels, Na+/H+ exchangers, protein kinase C, @COMPOUND$, NO, protein kinase A, ERK/@PROTEIN$, and Smads allows for integrated control by different neuroendocrine factors.	0	18838074-1536
Goldfish gonadotropes possess multiple pharmacologically distinct intracellular Ca2+ stores that together with voltage-sensitive Ca2+ channels, Na+/H+ exchangers, protein kinase C, @COMPOUND$, NO, protein kinase A, @PROTEIN$/MAPK, and Smads allows for integrated control by different neuroendocrine factors.	0	18838074-1536
Goldfish gonadotropes possess multiple pharmacologically distinct intracellular Ca2+ stores that together with voltage-sensitive Ca2+ channels, Na+/H+ exchangers, @PROTEIN$, @COMPOUND$, NO, protein kinase A, ERK/MAPK, and Smads allows for integrated control by different neuroendocrine factors.	0	18838074-1536
Goldfish gonadotropes possess multiple pharmacologically distinct intracellular Ca2+ stores that together with voltage-sensitive Ca2+ channels, Na+/H+ exchangers, protein kinase C, @COMPOUND$, NO, @PROTEIN$, ERK/MAPK, and Smads allows for integrated control by different neuroendocrine factors.	0	18838074-1536
An enzymatic reaction between @COMPOUND$ and @PROTEIN$ produced oxygen bubbles and thus many internal pores within microsphere were naturally developed.	1	18838089-1541
The foregoing three main anatomic loci of control are regulated by intermittent time-delayed signal exchange, principally via gonadotropin-releasing hormone (@PROTEIN$), luteinizing hormone (LH) and testosterone/@COMPOUND$ (Te/E(2)).	0	18838102-1545
The foregoing three main anatomic loci of control are regulated by intermittent time-delayed signal exchange, principally via @PROTEIN$ (GnRH), luteinizing hormone (LH) and testosterone/@COMPOUND$ (Te/E(2)).	0	18838102-1545
The foregoing three main anatomic loci of control are regulated by intermittent time-delayed signal exchange, principally via @PROTEIN$ (GnRH), luteinizing hormone (LH) and @COMPOUND$/estradiol (Te/E(2)).	0	18838102-1545
The foregoing three main anatomic loci of control are regulated by intermittent time-delayed signal exchange, principally via gonadotropin-releasing hormone (@PROTEIN$), luteinizing hormone (LH) and @COMPOUND$/estradiol (Te/E(2)).	0	18838102-1545
We present a robust and simple method for the direct detection of multiple point mutations in the Mycobacterium tuberculosis @PROTEIN$ gene during the development of @COMPOUND$ (RIF) resistance using an electrochemical genosensor.	1	18838266-1623
The main source of extracellular @COMPOUND$ stems from a coordinated two-step enzymatic conversion of precursor nucleotides via the @PROTEIN$ (CD39) and the ecto-5'-nucleotidase (CD73).	1	18838482-1670
The main source of extracellular @COMPOUND$ stems from a coordinated two-step enzymatic conversion of precursor nucleotides via the ecto-apyrase (@PROTEIN$) and the ecto-5'-nucleotidase (CD73).	1	18838482-1670
The main source of extracellular @COMPOUND$ stems from a coordinated two-step enzymatic conversion of precursor nucleotides via the ecto-apyrase (CD39) and the @PROTEIN$ (CD73).	1	18838482-1670
Critical role of @PROTEIN$ in prostacyclin production by human endothelial cells under modification of @COMPOUND$ tone.	0	18838483-2012
Critical role of @PROTEIN$ in @COMPOUND$ production by human endothelial cells under modification of hydroperoxide tone.	1	18838483-2012
We aimed at evaluating the relative contribution of cyclooxygenase (@PROTEIN$)-1 and COX-2 to the synthesis of prostacyclin in endothelial cells under static conditions in the presence or absence of exogenous @COMPOUND$ and/or altered intracellular redox balance.	0	18838483-2013
We aimed at evaluating the relative contribution of cyclooxygenase (COX)-1 and @PROTEIN$ to the synthesis of prostacyclin in endothelial cells under static conditions in the presence or absence of exogenous @COMPOUND$ and/or altered intracellular redox balance.	0	18838483-2013
We aimed at evaluating the relative contribution of cyclooxygenase (COX)-1 and @PROTEIN$ to the synthesis of @COMPOUND$ in endothelial cells under static conditions in the presence or absence of exogenous arachidonic acid and/or altered intracellular redox balance.	1	18838483-2013
We aimed at evaluating the relative contribution of cyclooxygenase (@PROTEIN$)-1 and COX-2 to the synthesis of @COMPOUND$ in endothelial cells under static conditions in the presence or absence of exogenous arachidonic acid and/or altered intracellular redox balance.	1	18838483-2013
In contrast, @PROTEIN$.24, CYP2D6.26, and CYP2D6.27 allelic isoforms all showed active drug-metabolizing activities toward both codeine and @COMPOUND$ O-demethylation.	1	18838503-1683
In contrast, @PROTEIN$.24, CYP2D6.26, and CYP2D6.27 allelic isoforms all showed active drug-metabolizing activities toward both @COMPOUND$ and dextromethorphan O-demethylation.	1	18838503-1683
Mechanism-based inactivation of @PROTEIN$ by tienilic acid and (+/-)-@COMPOUND$ : a comparison of kinetics and probe substrate selection.	1	18838506-1689
Mechanism-based inactivation of @PROTEIN$ by @COMPOUND$ and (+/-)-suprofen : a comparison of kinetics and probe substrate selection.	1	18838506-1689
In vitro experiments were conducted to compare k(inact), K(I) and inactivation efficiency (k(inact)/K(I)) of @PROTEIN$ (P450) 2C9 by @COMPOUND$ and (+/-)-suprofen using (S)-flurbiprofen, diclofenac, and (S)-warfarin as reporter substrates.	1	18838506-1690
In vitro experiments were conducted to compare k(inact), K(I) and inactivation efficiency (k(inact)/K(I)) of @PROTEIN$ (P450) 2C9 by tienilic acid and (+/-)-@COMPOUND$ using (S)-flurbiprofen, diclofenac, and (S)-warfarin as reporter substrates.	1	18838506-1690
@PROTEIN$ activity was evaluated by measuring @COMPOUND$+) entry or pore formation using spectrofluorometry or flow cytometry.	1	18838523-1691
These Ca2+-independent @PROTEIN$ display remarkable specificity for the length of the sn-2 residue, but this selectivity is lost as the residue gains @COMPOUND$ functions.	0	18838739-1780
At the end of treatment, BMI, WHR, HbA1c, fasting @COMPOUND$, @PROTEIN$, HOMA-IR, alanine aminotransferase values decreased in both groups.	0	18839053-1886
Among these indicators is @COMPOUND$ (PS) translocation from the inner to the outer leaflet of the plasma membrane, which can be detected by annexinV (@PROTEIN$) conjugation.	1	18839068-1905
Among these indicators is @COMPOUND$ (PS) translocation from the inner to the outer leaflet of the plasma membrane, which can be detected by @PROTEIN$ (ANXA5) conjugation.	1	18839068-1905
Effects of chronic inflammation and @COMPOUND$ tolerance on the expression of phospho-ERK 1/2 and phospho-@PROTEIN$ in the injured tissue.	1	18839150-1938
Effects of chronic inflammation and @COMPOUND$ tolerance on the expression of phospho-@PROTEIN$/2 and phospho-P38 in the injured tissue.	1	18839150-1938
The results of the present study show that @PROTEIN$ phosphorylation is unaltered by inflammation or @COMPOUND$ tolerance, each one individually, in the plantar tissue.	0	18839150-1940
In contrast, no significant differences in phospho-@PROTEIN$ expression were observed between nave and tolerant animals acutely injected with saline or @COMPOUND$ in presence of CFA inflammation.	0	18839150-1941
These results suggest that @PROTEIN$ but not p38 could be implicated in the development of @COMPOUND$ tolerance during peripheral inflammation.	1	18839150-1942
The anterior pituitary gland contains five types of cells secreting specific hormones (growth hormone, @PROTEIN$ (ACTH), gonadotropic hormone, prolactin, and thyroid-stimulating hormone), and the double staining results indicated that @COMPOUND$ is localized to the ACTH-secreting cells.	0	18839155-1946
The anterior pituitary gland contains five types of cells secreting specific hormones (growth hormone, adrenocorticotropic hormone (ACTH), gonadotropic hormone, @PROTEIN$, and thyroid-stimulating hormone), and the double staining results indicated that @COMPOUND$ is localized to the ACTH-secreting cells.	0	18839155-1946
The anterior pituitary gland contains five types of cells secreting specific hormones (@PROTEIN$, adrenocorticotropic hormone (ACTH), gonadotropic hormone, prolactin, and thyroid-stimulating hormone), and the double staining results indicated that @COMPOUND$ is localized to the ACTH-secreting cells.	0	18839155-1946
In addition to @COMPOUND$ and hyperforin, the anticancer drug paclitaxel has also been shown to be an inducer of CYP3A4 via activation of the pregnane X receptor (@PROTEIN$).	0	18839173-1953
In addition to rifampicin and @COMPOUND$, the anticancer drug paclitaxel has also been shown to be an inducer of CYP3A4 via activation of the pregnane X receptor (@PROTEIN$).	0	18839173-1953
In addition to rifampicin and hyperforin, the anticancer drug @COMPOUND$ has also been shown to be an inducer of CYP3A4 via activation of the @PROTEIN$ (PXR).	1	18839173-1953
In addition to rifampicin and @COMPOUND$, the anticancer drug paclitaxel has also been shown to be an inducer of CYP3A4 via activation of the @PROTEIN$ (PXR).	0	18839173-1953
In addition to @COMPOUND$ and hyperforin, the anticancer drug paclitaxel has also been shown to be an inducer of CYP3A4 via activation of the @PROTEIN$ (PXR).	0	18839173-1953
In addition to rifampicin and hyperforin, the anticancer drug @COMPOUND$ has also been shown to be an inducer of CYP3A4 via activation of the pregnane X receptor (@PROTEIN$).	1	18839173-1953
A comprehensive literature review of clinical studies in children evaluating s-@PROTEIN$ or CysC-based formulas and plasma @COMPOUND$ or creatinine-based formulas against an exogenous reference method using receiver operating characteristics (ROC) curves or Bland-Altman plots is presented.	0	18839216-1978
The comparison of s-@PROTEIN$ with plasma @COMPOUND$ indicated that s-CysC was superior to plasma creatinine in five of 13 studies; four studies showed no difference, and, in four studies, no statistical comparison was made.	0	18839216-1979
S-@PROTEIN$ is most likely superior to plasma @COMPOUND$ and at least equal to creatinine-based formulas.	0	18839216-1980
@PROTEIN$-based prediction equations are at least as good as @COMPOUND$-based formulas but cannot replace exogenous methods.	0	18839216-1981
By combining endosperm @PROTEIN$/SDH suppression with embryo LKR/SDH suppression through crosses, the @COMPOUND$ level in embryo was reduced and resulted in higher lysine accumulation in mature kernels.	1	18839315-2028
By combining endosperm LKR/@PROTEIN$ suppression with embryo LKR/SDH suppression through crosses, the @COMPOUND$ level in embryo was reduced and resulted in higher lysine accumulation in mature kernels.	1	18839315-2028
We examined the relationship between @PROTEIN$ and serum calcium, @COMPOUND$, 1,25(OH)(2)D(3), and PTH levels in haemodialysis patients.	0	18839328-2042
Resistin, an adipokine-linked obesity with type 2 diabetes, impairs @COMPOUND$-stimulated @PROTEIN$ secretion (GSIS) in beta-cells.	1	18839335-2050
Intracellular @COMPOUND$ (-) is required for the motor function of @PROTEIN$, a unique plasma membrane molecular motor of these cells.	1	18839360-2057
@PROTEIN$ was immunostained with mouse anti-FLAG primary antibody and @COMPOUND$-conjugated goat anti-mouse IgG secondary antibody.	1	18839361-2058
Intramuscular triacylglycerol does not appear to be a ubiquitous marker of @PROTEIN$ resistance, although specific IMCL intermediates such as long-chain fatty acyl-CoAs, ceramide, and @COMPOUND$ may inhibit insulin signal transduction.	1	18839419-2085
Light stimulates @COMPOUND$ hydrolysis via the G-protein @PROTEIN$, which directly binds to and activates phosphodiesterase.	1	18840097-2250
Inhibition of gamma-glutamyl transferase (@PROTEIN$, EC 2.3.2.2)-catalyzed extracellular GSH degradation with @COMPOUND$ significantly blocked GSH efflux, suggesting that GSH breakdown is a driving force for GSH export.	0	18840413-2365
We injected females with human chorionic gonadotropin (@PROTEIN$), estradiol, estradiol plus progesterone, saline, or HCG plus @COMPOUND$ (an aromatase blocker) and tested their responses to mating calls.	0	18840446-2377
We injected females with human chorionic gonadotropin (@PROTEIN$), @COMPOUND$, estradiol plus progesterone, saline, or HCG plus fadrozole (an aromatase blocker) and tested their responses to mating calls.	0	18840446-2377
We injected females with human chorionic gonadotropin (@PROTEIN$), estradiol, estradiol plus @COMPOUND$, saline, or HCG plus fadrozole (an aromatase blocker) and tested their responses to mating calls.	0	18840446-2377
Here we use an array of flow cytometric analyses to characterize silkworm hemocytes with various molecular probes, such as @COMPOUND$, green fluorescence protein, monoclonal antibodies, and fluorescent @PROTEIN$.	0	18840462-2386
Amino acid 1092 (AA1092) in @PROTEIN$ 1 of coxsackievirus B3 (CVB3) is located in close vicinity to the central @COMPOUND$ group of capsid binders (i.e.	1	18840470-2387
@PROTEIN$ is a polypeptide hormone that is present in mammals and its main function is the maintenance of adequate @COMPOUND$ level.	1	18840474-2388
In vivo assays confirmed that the three resulting genotypes differed in their ability to produce @COMPOUND$ in response to intravenous insulin injection implicating @PROTEIN$ as the primary cause of the observed hypocortisolism.	1	18840497-2407
In vivo assays confirmed that the three resulting genotypes differed in their ability to produce @COMPOUND$ in response to intravenous @PROTEIN$ injection implicating CYP17 as the primary cause of the observed hypocortisolism.	1	18840497-2407
In addition, @PROTEIN$ facilitates bi-directional flux of @COMPOUND$ by modifying the phospholipid content of the plasma membrane.	1	18840501-434
Overall, @PROTEIN$ is the cell surface receptor responsible for selective uptake of lipoprotein @COMPOUND$ and its ultimate delivery to sites of hormone synthesis in steroidogenic tissues.	1	18840501-435
Susceptibility to esophageal cancer may be modified by functional polymorphisms in genes along the @COMPOUND$ metabolic pathway, such as methylenetetrahydrofolate reductase (@PROTEIN$).	1	18840514-2413
Susceptibility to esophageal cancer may be modified by functional polymorphisms in genes along the @COMPOUND$ metabolic pathway, such as @PROTEIN$ (MTHFR).	1	18840514-2413
We looked at the toxicity of non-drug-containing liposomes on (3)H-@COMPOUND$ incorporation by @PROTEIN$ (Con A)-stimulated human lymphocytes, splenocytes and Epstein-Barr virus (EBV)-transformed human B-cell lymphoblastoid cell line (LCL).	1	18840516-2417
We looked at the toxicity of non-drug-containing liposomes on (3)H-@COMPOUND$ incorporation by concanavalin A (@PROTEIN$)-stimulated human lymphocytes, splenocytes and Epstein-Barr virus (EBV)-transformed human B-cell lymphoblastoid cell line (LCL).	1	18840516-2417
The anti-inflammatory effect of these compounds and a @COMPOUND$ control, scopoletin, on interleukin-6 (IL-6), @PROTEIN$ (TNF), and macrophage chemotactic protein-1 (MCP-1) release was studied using lipopolysaccharide (LPS)-stimulated alveolar macrophages.	0	18840548-2430
The anti-inflammatory effect of these compounds and a @COMPOUND$ control, scopoletin, on @PROTEIN$ (IL-6), tumor necrosis factor (TNF), and macrophage chemotactic protein-1 (MCP-1) release was studied using lipopolysaccharide (LPS)-stimulated alveolar macrophages.	1	18840548-2430
The anti-inflammatory effect of these compounds and a @COMPOUND$ control, scopoletin, on interleukin-6 (IL-6), tumor necrosis factor (TNF), and macrophage chemotactic protein-1 (@PROTEIN$) release was studied using lipopolysaccharide (LPS)-stimulated alveolar macrophages.	0	18840548-2430
The anti-inflammatory effect of these compounds and a coumarin control, @COMPOUND$, on interleukin-6 (IL-6), tumor necrosis factor (@PROTEIN$), and macrophage chemotactic protein-1 (MCP-1) release was studied using lipopolysaccharide (LPS)-stimulated alveolar macrophages.	0	18840548-2430
The anti-inflammatory effect of these compounds and a @COMPOUND$ control, scopoletin, on interleukin-6 (@PROTEIN$), tumor necrosis factor (TNF), and macrophage chemotactic protein-1 (MCP-1) release was studied using lipopolysaccharide (LPS)-stimulated alveolar macrophages.	0	18840548-2430
The anti-inflammatory effect of these compounds and a coumarin control, @COMPOUND$, on interleukin-6 (IL-6), @PROTEIN$ (TNF), and macrophage chemotactic protein-1 (MCP-1) release was studied using lipopolysaccharide (LPS)-stimulated alveolar macrophages.	0	18840548-2430
The anti-inflammatory effect of these compounds and a coumarin control, @COMPOUND$, on @PROTEIN$ (IL-6), tumor necrosis factor (TNF), and macrophage chemotactic protein-1 (MCP-1) release was studied using lipopolysaccharide (LPS)-stimulated alveolar macrophages.	0	18840548-2430
The anti-inflammatory effect of these compounds and a coumarin control, @COMPOUND$, on interleukin-6 (IL-6), tumor necrosis factor (TNF), and macrophage chemotactic protein-1 (@PROTEIN$) release was studied using lipopolysaccharide (LPS)-stimulated alveolar macrophages.	0	18840548-2430
The anti-inflammatory effect of these compounds and a @COMPOUND$ control, scopoletin, on interleukin-6 (IL-6), tumor necrosis factor (@PROTEIN$), and macrophage chemotactic protein-1 (MCP-1) release was studied using lipopolysaccharide (LPS)-stimulated alveolar macrophages.	0	18840548-2430
The anti-inflammatory effect of these compounds and a coumarin control, @COMPOUND$, on interleukin-6 (@PROTEIN$), tumor necrosis factor (TNF), and macrophage chemotactic protein-1 (MCP-1) release was studied using lipopolysaccharide (LPS)-stimulated alveolar macrophages.	0	18840548-2430
We previously determined that @PROTEIN$ Tyr51 is a canonical and Trp150 an anti-canonical TEM-1-contact residue, where canonical refers to the @COMPOUND$ substitution resulting in a matched change in the hydrophobicity of binding free energy.	1	18840610-2455
We previously determined that BLIP Tyr51 is a canonical and Trp150 an anti-canonical @PROTEIN$-contact residue, where canonical refers to the @COMPOUND$ substitution resulting in a matched change in the hydrophobicity of binding free energy.	1	18840610-2455
This explains the anti-canonical nature of the Trp150 to @COMPOUND$ substitution, and also reveals a strong long distance coupling between Trp150 and Asp49 of @PROTEIN$, because these two residues are more than 25 angstroms apart.	1	18840610-2456
This effect is independent of any change in neutrophil adhesion or adhesion molecule expression but is related to the ability of statins to reduce @COMPOUND$-induced @PROTEIN$ activity in neutrophils.	1	18840670-2486
This was confirmed by the ability of the @PROTEIN$ precursor @COMPOUND$ to rescue the statin-mediated reduction in neutrophil transendothelial migration.	1	18840670-2487
Suppression of @COMPOUND$-induced @PROTEIN$ 2 expression in astrocytes by a novel diindolylmethane analog protects striatal neurons against apoptosis.	1	18840677-1304
Suppression of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced @PROTEIN$ 2 expression in astrocytes by a novel @COMPOUND$ analog protects striatal neurons against apoptosis.	1	18840677-1304
We hypothesized that conditioned medium from macrophages pretreated with palmitate or LPS would directly affect @PROTEIN$ action and @COMPOUND$ uptake in muscle cells.	0	18840759-2541
Surprisingly, and opposite to its effects on adipose cells, conditioned medium from LPS-treated macrophages stimulated myoblast insulin-stimulated @COMPOUND$ uptake, @PROTEIN$ translocation, and Akt phosphorylation without affecting stress kinases or inflammation indexes.	0	18840759-2542
Surprisingly, and opposite to its effects on adipose cells, conditioned medium from LPS-treated macrophages stimulated myoblast @PROTEIN$-stimulated @COMPOUND$ uptake, GLUT4 translocation, and Akt phosphorylation without affecting stress kinases or inflammation indexes.	1	18840759-2542
Surprisingly, and opposite to its effects on adipose cells, conditioned medium from LPS-treated macrophages stimulated myoblast insulin-stimulated @COMPOUND$ uptake, GLUT4 translocation, and @PROTEIN$ phosphorylation without affecting stress kinases or inflammation indexes.	0	18840759-2542
The essential role of glucagon and @PROTEIN$ and the importance of distributed control of @COMPOUND$ fluxes are highlighted in this review.	1	18840763-2544
The essential role of @PROTEIN$ and insulin and the importance of distributed control of @COMPOUND$ fluxes are highlighted in this review.	1	18840763-2544
Because both TCDD and HFD are associated with increased breast cancer risk, we examined their effects on metabolic syndrome-associated phenotypes in three mouse models of breast cancer: 7,12-dimethylbenz(a) @COMPOUND$ (DMBA), Tg(MMTV-Neu)202Mul/J (@PROTEIN$), and TgN(MMTV-PyMT)634Mul/J (PyMT), all on an FVB/N genetic background.	0	18840765-2545
Because both TCDD and HFD are associated with increased breast cancer risk, we examined their effects on metabolic syndrome-associated phenotypes in three mouse models of breast cancer: 7,12-dimethylbenz(a) anthracene (@COMPOUND$), Tg(MMTV-Neu)202Mul/J (@PROTEIN$), and TgN(MMTV-PyMT)634Mul/J (PyMT), all on an FVB/N genetic background.	0	18840765-2545
@PROTEIN$ kinase inhibition by @COMPOUND$ ameliorates diabetes-induced microvascular damage.	1	18840783-2553
Involvement of the @PROTEIN$/Rho kinase (ROCK) pathway in diabetic microvasculopathy and therapeutic potential of @COMPOUND$, a selective ROCK inhibitor, are investigated.	1	18840783-2554
This study investigated the acute effects of treatment with @COMPOUND$ on dipeptidyl peptidase-4 (DPP-4) activity, glucagon-like peptide 1 (@PROTEIN$) concentration, pancreatic hormone levels, and glucose metabolism.	0	18840785-2556
This study investigated the acute effects of treatment with @COMPOUND$ on @PROTEIN$ (DPP-4) activity, glucagon-like peptide 1 (GLP-1) concentration, pancreatic hormone levels, and glucose metabolism.	0	18840785-2556
This study investigated the acute effects of treatment with @COMPOUND$ on dipeptidyl peptidase-4 (DPP-4) activity, glucagon-like peptide 1 (GLP-1) concentration, @PROTEIN$ levels, and glucose metabolism.	0	18840785-2556
This study investigated the acute effects of treatment with @COMPOUND$ on dipeptidyl peptidase-4 (DPP-4) activity, @PROTEIN$ (GLP-1) concentration, pancreatic hormone levels, and glucose metabolism.	0	18840785-2556
This study investigated the acute effects of treatment with @COMPOUND$ on dipeptidyl peptidase-4 (@PROTEIN$-4) activity, glucagon-like peptide 1 (GLP-1) concentration, pancreatic hormone levels, and glucose metabolism.	0	18840785-2556
The primary aims were to determine the effects of @PROTEIN$-4 inhibition on GLP-1 clearance and on hepatic @COMPOUND$ uptake.	0	18840785-2557
The primary aims were to determine the effects of DPP-4 inhibition on @PROTEIN$ clearance and on hepatic @COMPOUND$ uptake.	0	18840785-2557
In the present study we determined the effect of @PROTEIN$ on the secretome by comparing incorporation rates of (13)C-labeled @COMPOUND$ in the presence and absence of insulin.	0	18840871-2587
@PROTEIN$ as an alternative to @COMPOUND$ in the evaluation of symptoms during treatment of patients with neuroendocrine Tumors.	0	18840995-2643
@PROTEIN$ cytokine profile may be related to the risk of the vaginal erosions following placement of @COMPOUND$ meshes.	1	18841321-2736
However, compared to osmotic stress alone, in the seedlings treated with microwave irradiation plus osmotic stress the concentration of malondialdehyde decreased, while the activities of nitricoxide synthase, catalase, @PROTEIN$, superoxide dismutase and the concentration of nitric oxide, @COMPOUND$ and glutathione increased.	0	18841385-2745
However, compared to osmotic stress alone, in the seedlings treated with microwave irradiation plus osmotic stress the concentration of malondialdehyde decreased, while the activities of nitricoxide synthase, catalase, @PROTEIN$, superoxide dismutase and the concentration of @COMPOUND$, ascorbic acid and glutathione increased.	0	18841385-2745
However, compared to osmotic stress alone, in the seedlings treated with microwave irradiation plus osmotic stress the concentration of malondialdehyde decreased, while the activities of nitricoxide synthase, @PROTEIN$, peroxidase, superoxide dismutase and the concentration of nitric oxide, @COMPOUND$ and glutathione increased.	0	18841385-2745
However, compared to osmotic stress alone, in the seedlings treated with microwave irradiation plus osmotic stress the concentration of malondialdehyde decreased, while the activities of nitricoxide synthase, catalase, peroxidase, @PROTEIN$ and the concentration of @COMPOUND$, ascorbic acid and glutathione increased.	0	18841385-2745
However, compared to osmotic stress alone, in the seedlings treated with microwave irradiation plus osmotic stress the concentration of malondialdehyde decreased, while the activities of nitricoxide synthase, @PROTEIN$, peroxidase, superoxide dismutase and the concentration of @COMPOUND$, ascorbic acid and glutathione increased.	0	18841385-2745
However, compared to osmotic stress alone, in the seedlings treated with microwave irradiation plus osmotic stress the concentration of malondialdehyde decreased, while the activities of @PROTEIN$, catalase, peroxidase, superoxide dismutase and the concentration of nitric oxide, @COMPOUND$ and glutathione increased.	0	18841385-2745
However, compared to osmotic stress alone, in the seedlings treated with microwave irradiation plus osmotic stress the concentration of malondialdehyde decreased, while the activities of @PROTEIN$, catalase, peroxidase, superoxide dismutase and the concentration of nitric oxide, ascorbic acid and @COMPOUND$ increased.	0	18841385-2745
However, compared to osmotic stress alone, in the seedlings treated with microwave irradiation plus osmotic stress the concentration of malondialdehyde decreased, while the activities of nitricoxide synthase, catalase, peroxidase, @PROTEIN$ and the concentration of nitric oxide, @COMPOUND$ and glutathione increased.	0	18841385-2745
However, compared to osmotic stress alone, in the seedlings treated with microwave irradiation plus osmotic stress the concentration of malondialdehyde decreased, while the activities of nitricoxide synthase, catalase, peroxidase, @PROTEIN$ and the concentration of nitric oxide, ascorbic acid and @COMPOUND$ increased.	0	18841385-2745
However, compared to osmotic stress alone, in the seedlings treated with microwave irradiation plus osmotic stress the concentration of malondialdehyde decreased, while the activities of nitricoxide synthase, catalase, @PROTEIN$, superoxide dismutase and the concentration of nitric oxide, ascorbic acid and @COMPOUND$ increased.	0	18841385-2745
However, compared to osmotic stress alone, in the seedlings treated with microwave irradiation plus osmotic stress the concentration of malondialdehyde decreased, while the activities of @PROTEIN$, catalase, peroxidase, superoxide dismutase and the concentration of @COMPOUND$, ascorbic acid and glutathione increased.	0	18841385-2745
However, compared to osmotic stress alone, in the seedlings treated with microwave irradiation plus osmotic stress the concentration of malondialdehyde decreased, while the activities of nitricoxide synthase, @PROTEIN$, peroxidase, superoxide dismutase and the concentration of nitric oxide, ascorbic acid and @COMPOUND$ increased.	0	18841385-2745
The oxidative stress in the mollusk was observed at the U site during spring and at the R site during summer and autumn according to the differences in Mn-superoxide dismutase and @PROTEIN$ activities, O (2) (*-) production, lipid peroxidation, and @COMPOUND$ levels.	0	18841409-2761
The oxidative stress in the mollusk was observed at the U site during spring and at the R site during summer and autumn according to the differences in Mn-@PROTEIN$ and catalase activities, O (2) (*-) production, lipid peroxidation, and @COMPOUND$ levels.	0	18841409-2761
These results suggest that @COMPOUND$ by activation of ERK1/2 and @PROTEIN$/Akt signal pathways protects SH-SY5Y cells from H(2)O(2)-induced apoptosis.	1	18841465-2774
These results suggest that @COMPOUND$ by activation of @PROTEIN$/2 and PI3K/Akt signal pathways protects SH-SY5Y cells from H(2)O(2)-induced apoptosis.	1	18841465-2774
These results suggest that @COMPOUND$ by activation of ERK1/2 and PI3K/@PROTEIN$ signal pathways protects SH-SY5Y cells from H(2)O(2)-induced apoptosis.	1	18841465-2774
This decrease was not modified by @PROTEIN$ or @COMPOUND$, demonstrating that ONOO (-) was responsible for the effect.	0	18841468-2776
This decrease was not modified by @PROTEIN$ or Trolox, demonstrating that @COMPOUND$ (-) was responsible for the effect.	0	18841468-2776
Cell viability (MTT colorimetric determination) and transmembrane mitochondrial potential (J-C1 fluorescence) were concentration-dependently reduced 24 h after NaN (3); neither nuclear fragmentation by @COMPOUND$, nor @PROTEIN$ positivity by flow cytometry were detected, ruling out the occurrence of apoptosis.	0	18841470-2778
Plasma @COMPOUND$ and @PROTEIN$ in Huntington's disease.	0	18841471-2779
We assessed plasma @COMPOUND$ (pHVA) and plasma @PROTEIN$ (pPRL), two correlates of dopaminergic activity, in 116 subjects with CAG repeats expansion in the HD gene, 26 presymptomatic (18 females) and 90 with overt symptomatology (43 females).	0	18841471-2780
Profile of serum @PROTEIN$ and IL-10 shortly after ovariectomy and @COMPOUND$ replacement in rats.	0	18841529-2811
Profile of serum IL-1beta and @PROTEIN$ shortly after ovariectomy and @COMPOUND$ replacement in rats.	0	18841529-2811
A low plasma @PROTEIN$ @COMPOUND$ (HDL-c) concentration is an important risk factor for the development of atherosclerotic cardiovascular disease.	1	18842264-225
A hydrogel was fabricated by chemically crosslinking alpha-@PROTEIN$ with @COMPOUND$ at high pressure CO(2).	1	18842297-227
We evaluated whether inhibition of @PROTEIN$ (hsp90) function by @COMPOUND$ derivatives could induce the degradation of signal transducers that drive cancer cell growth and thereby promote apoptosis.	1	18842335-233
We evaluated whether inhibition of heat shock protein 90 (@PROTEIN$) function by @COMPOUND$ derivatives could induce the degradation of signal transducers that drive cancer cell growth and thereby promote apoptosis.	1	18842335-233
The cancer cells could find an alternate pathway to make this protein that does not require @COMPOUND$ secretion, or the cancer cells may actually utilize progesterone and thus make @PROTEIN$ in a similar fashion to normal pregnancy.	0	18842348-234
Cytochrome P450 (CYP) 1A1 and @PROTEIN$ are inducible by @COMPOUND$ (dioxin) in the human breast cancer cell line, MCF-7.	1	18842620-268
Cytochrome P450 (@PROTEIN$) 1A1 and CYP1B1 are inducible by @COMPOUND$ (dioxin) in the human breast cancer cell line, MCF-7.	1	18842620-268
@PROTEIN$ (CYP) 1A1 and CYP1B1 are inducible by @COMPOUND$ (dioxin) in the human breast cancer cell line, MCF-7.	1	18842620-268
@COMPOUND$ treatment leads to recruitment of the aryl hydrocarbon receptor to the enhancer regions but not to the proximal promoter regions of both the @PROTEIN$ and CYP1B1 genes.	0	18842620-269
@COMPOUND$ treatment leads to recruitment of the aryl hydrocarbon receptor to the enhancer regions but not to the proximal promoter regions of both the CYP1A1 and @PROTEIN$ genes.	0	18842620-269
@COMPOUND$ treatment leads to recruitment of the @PROTEIN$ to the enhancer regions but not to the proximal promoter regions of both the CYP1A1 and CYP1B1 genes.	1	18842620-269
These results suggest that nucleosomal remodeling is less significant for @COMPOUND$-mediated induction of @PROTEIN$ than that of CYP1A1 and may be related to the more modest inducibility of the former.	1	18842620-270
These results suggest that nucleosomal remodeling is less significant for @COMPOUND$-mediated induction of CYP1B1 than that of @PROTEIN$ and may be related to the more modest inducibility of the former.	1	18842620-270
These observations provide novel insights into the functional roles of the endogenous coactivators in @COMPOUND$ induction of the human CYP1A1 and @PROTEIN$ genes in their natural chromosomal configurations.	1	18842620-271
These observations provide novel insights into the functional roles of the endogenous coactivators in @COMPOUND$ induction of the human @PROTEIN$ and CYP1B1 genes in their natural chromosomal configurations.	1	18842620-271
Decreased oral absorption of @COMPOUND$ after liver ischemia-reperfusion injury in rats: the contribution of CYP3A and P-@PROTEIN$ to the first-pass metabolism in intestinal epithelial cells.	0	18842703-297
The different mechanisms might be explained by the different sensitivity of @PROTEIN$ isoforms to Ca2+, @COMPOUND$+, and Ba2+.	1	18842954-373
Each residue was modified with one to three @COMPOUND$ units, and the most dominant @PROTEIN$ glycoform was modified with nine hexose units.	1	18842962-374
Following @COMPOUND$ there was a time-dependent redistribution of total @PROTEIN$ from predominantly intracellular vesicles to the apical plasma membrane, clathrin-coated vesicles, early endosomal compartments, and lysosomes.	1	18843259-489
The relationships among obesity, metabolic syndrome, ED, sex hormone-binding globulin (@PROTEIN$) and serum total and free @COMPOUND$ levels are complex and often confusing to the physician.	1	18843273-456
The transcription factors @PROTEIN$ and retinoid X receptors participate in @COMPOUND$-induced locomotor activities.	1	18843482-535
We now show that treatment of cells with phosphomimic @PROTEIN$ (uPA138E/303E, @COMPOUND$ 138 and 303 substituted with glutamic acid) strongly inhibits matrix-induced cell migration.	1	18844213-796
When cells were subjected to hypoxia (1% @COMPOUND$), the expression of @PROTEIN$ had a significant increase in cancer cells.	1	18844219-799
We further demonstrate that loss of @PROTEIN$ stress fibers is due to a @COMPOUND$, protein kinase A-mediated pathway that results in Rho inhibition.	1	18844235-806
We further demonstrate that loss of actin stress fibers is due to a @COMPOUND$, @PROTEIN$-mediated pathway that results in Rho inhibition.	1	18844235-806
We further demonstrate that loss of actin stress fibers is due to a @COMPOUND$, protein kinase A-mediated pathway that results in @PROTEIN$ inhibition.	1	18844235-806
The nuclear NF-kappaB @PROTEIN$ expression after treatment with the SFN-@COMPOUND$ combination was also evaluated by western blot analysis.	0	18844240-810
Treatment ACCs cells with SFN and @COMPOUND$ in combination, led to synergistic inhibition on cell growth and a decreased expression in nuclear NF-kappaB @PROTEIN$ protein.	1	18844240-812
Our results demonstrate synergism between SFN and @COMPOUND$ at higher doses against the ACC-M and ACC-2 cells, which was associated with the decreased expression of nuclear NF-kappaB @PROTEIN$ protein.	1	18844240-813
In order to further analyse the protective mode of action, the superoxide anion scavenging activity of two extracts was evaluated in a @COMPOUND$/@PROTEIN$ system.	1	18844290-828
In order to further analyse the protective mode of action, the @COMPOUND$ anion scavenging activity of two extracts was evaluated in a xanthine/@PROTEIN$ system.	0	18844290-828
Human genetic diseases that affect N-glycosylation result from the defective synthesis of the N-linked sugar moiety (@COMPOUND$) of @PROTEIN$.	1	18844296-833
Rats subcutaneously injected with ISO (85 mg/kg) at an interval of 24 h for 2 days resulted in a significant increase in the levels of mitochondrial lipid peroxides with a significant decrease in the activities/levels of mitochondrial antioxidants (@PROTEIN$, catalase, glutathione peroxidase, glutathione-S-transferase and @COMPOUND$).	0	18844325-840
Rats subcutaneously injected with ISO (85 mg/kg) at an interval of 24 h for 2 days resulted in a significant increase in the levels of mitochondrial lipid peroxides with a significant decrease in the activities/levels of mitochondrial antioxidants (superoxide dismutase, catalase, glutathione peroxidase, @PROTEIN$ and @COMPOUND$).	0	18844325-840
Rats subcutaneously injected with ISO (85 mg/kg) at an interval of 24 h for 2 days resulted in a significant increase in the levels of mitochondrial lipid peroxides with a significant decrease in the activities/levels of mitochondrial antioxidants (superoxide dismutase, @PROTEIN$, glutathione peroxidase, glutathione-S-transferase and @COMPOUND$).	0	18844325-840
Rats subcutaneously injected with ISO (85 mg/kg) at an interval of 24 h for 2 days resulted in a significant increase in the levels of mitochondrial lipid peroxides with a significant decrease in the activities/levels of mitochondrial antioxidants (superoxide dismutase, catalase, @PROTEIN$, glutathione-S-transferase and @COMPOUND$).	0	18844325-840
Antiobesity effect of @COMPOUND$ involves the @PROTEIN$ and PPAR-gamma signal pathways.	1	18844326-841
Antiobesity effect of @COMPOUND$ involves the AMPK and @PROTEIN$ signal pathways.	1	18844326-841
This inhibitory effect of @COMPOUND$ on adipocyte differentiation was accompanied by @PROTEIN$ inhibition in rosiglitazone-treated cells.	1	18844326-842
Taken together, these results suggest that the antiobesity effect of red ginseng rich constituent, @COMPOUND$, involves the @PROTEIN$ signaling pathway and PPAR-gamma inhibition.	1	18844326-843
Taken together, these results suggest that the antiobesity effect of red ginseng rich constituent, @COMPOUND$, involves the AMPK signaling pathway and @PROTEIN$ inhibition.	1	18844326-843
They can be oxidized by @PROTEIN$ (SSAO), leading to the production of toxic aldehydes such as formaldehyde and @COMPOUND$ as well as hydrogen peroxide and ammonia.	1	18845121-1115
They can be oxidized by @PROTEIN$ (SSAO), leading to the production of toxic aldehydes such as formaldehyde and methylglyoxal as well as @COMPOUND$ and ammonia.	1	18845121-1115
They can be oxidized by @PROTEIN$ (SSAO), leading to the production of toxic aldehydes such as formaldehyde and methylglyoxal as well as hydrogen peroxide and @COMPOUND$.	1	18845121-1115
They can be oxidized by @PROTEIN$ (SSAO), leading to the production of toxic aldehydes such as @COMPOUND$ and methylglyoxal as well as hydrogen peroxide and ammonia.	1	18845121-1115
They can be oxidized by semicarbazide-sensitive amine oxidase (@PROTEIN$), leading to the production of toxic aldehydes such as formaldehyde and methylglyoxal as well as @COMPOUND$ and ammonia.	1	18845121-1115
They can be oxidized by semicarbazide-sensitive amine oxidase (@PROTEIN$), leading to the production of toxic aldehydes such as @COMPOUND$ and methylglyoxal as well as hydrogen peroxide and ammonia.	1	18845121-1115
They can be oxidized by semicarbazide-sensitive amine oxidase (@PROTEIN$), leading to the production of toxic aldehydes such as formaldehyde and @COMPOUND$ as well as hydrogen peroxide and ammonia.	1	18845121-1115
They can be oxidized by semicarbazide-sensitive amine oxidase (@PROTEIN$), leading to the production of toxic aldehydes such as formaldehyde and methylglyoxal as well as hydrogen peroxide and @COMPOUND$.	1	18845121-1115
Selenocystine is taken up well by the b(0,+) rBAT system, while @COMPOUND$ is a low-affinity substrate only for @PROTEIN$ and PAT1.	1	18845132-1120
Selenocystine is taken up well by the b(0,+) rBAT system, while @COMPOUND$ is a low-affinity substrate only for SIT1 and @PROTEIN$.	1	18845132-1120
Experiments using a classical inhibitor of phosphotyrosine @PROTEIN$, @COMPOUND$, also showed that the ecto-phosphatase activity was inhibited in a dose-dependent manner.	1	18845148-1121
Both promoters are partially regulated by @COMPOUND$ via @PROTEIN$ and other RARs.	1	18845237-1145
Our data suggest a developmental role of PBRs in erythropoiesis in chickens, possibly via the regulation of @COMPOUND$ availability for the assembly of functional @PROTEIN$.	1	18845277-1178
Our data suggest a developmental role of @PROTEIN$ in erythropoiesis in chickens, possibly via the regulation of @COMPOUND$ availability for the assembly of functional hemoglobins.	1	18845277-1178
Circulating @COMPOUND$, adiponectin, leptin, @PROTEIN$, hsCRP and insulin levels were determined both at baseline and after TLC intervention and statin treatment.	0	18845302-1193
Circulating @COMPOUND$, adiponectin, leptin, TNF-alpha, hsCRP and @PROTEIN$ levels were determined both at baseline and after TLC intervention and statin treatment.	0	18845302-1193
Circulating @COMPOUND$, adiponectin, @PROTEIN$, TNF-alpha, hsCRP and insulin levels were determined both at baseline and after TLC intervention and statin treatment.	0	18845302-1193
VEGF, @PROTEIN$ and @COMPOUND$ levels in exhaled breath condensate and serum of patients with lung cancer.	0	18845357-1202
@PROTEIN$, TNF-alpha and @COMPOUND$ levels in exhaled breath condensate and serum of patients with lung cancer.	0	18845357-1202
The aim of the present study was to evaluate the levels of VEGF, @COMPOUND$ and @PROTEIN$ in EBC and serum of patients with primary lung cancer prior to the initiation of any treatment, in order to evaluate their possible diagnostic role.	0	18845357-1203
The aim of the present study was to evaluate the levels of @PROTEIN$, @COMPOUND$ and TNF-alpha in EBC and serum of patients with primary lung cancer prior to the initiation of any treatment, in order to evaluate their possible diagnostic role.	0	18845357-1203
Furthermore, associations between VEGF, @COMPOUND$ and @PROTEIN$ levels in EBC and serum with clinicopathologic factors were investigated.	0	18845357-1204
Furthermore, associations between @PROTEIN$, @COMPOUND$ and TNF-alpha levels in EBC and serum with clinicopathologic factors were investigated.	0	18845357-1204
@PROTEIN$, VEGF and @COMPOUND$ levels in EBC and serum were analyzed by an immunoenzymatic method (ELISA).	0	18845357-1205
TNF-alpha, @PROTEIN$ and @COMPOUND$ levels in EBC and serum were analyzed by an immunoenzymatic method (ELISA).	0	18845357-1205
Currently, adreno-corticotrophic hormone (@PROTEIN$), steroids and @COMPOUND$ (VGB) form the mainstay of its treatment.	0	18845383-1219
The addition of a protein kinase C (PKC) activator, @COMPOUND$, rescued PhIP-inhibited @PROTEIN$ expression in LTA-stimulated cells.	1	18845389-1221
Diabetes was induced in C57BL/6 Gal-3(+/+) and Gal-3 (-/-) mice and disease monitored by blood @COMPOUND$ level, immuno-histology, insulin content of islets and expression of the proinflammatory cytokines, @PROTEIN$, IFN-gamma, IL-17, and iNOS in pancreatic lymph nodes.	0	18845486-1248
Diabetes was induced in C57BL/6 Gal-3(+/+) and Gal-3 (-/-) mice and disease monitored by blood @COMPOUND$ level, immuno-histology, @PROTEIN$ content of islets and expression of the proinflammatory cytokines, TNF-alpha, IFN-gamma, IL-17, and iNOS in pancreatic lymph nodes.	0	18845486-1248
Diabetes was induced in C57BL/6 Gal-3(+/+) and Gal-3 (-/-) mice and disease monitored by blood @COMPOUND$ level, immuno-histology, insulin content of islets and expression of the proinflammatory cytokines, TNF-alpha, IFN-gamma, @PROTEIN$, and iNOS in pancreatic lymph nodes.	0	18845486-1248
Diabetes was induced in C57BL/6 Gal-3(+/+) and Gal-3 (-/-) mice and disease monitored by blood @COMPOUND$ level, immuno-histology, insulin content of islets and expression of the proinflammatory cytokines, TNF-alpha, IFN-gamma, IL-17, and @PROTEIN$ in pancreatic lymph nodes.	0	18845486-1248
Diabetes was induced in C57BL/6 Gal-3(+/+) and Gal-3 (-/-) mice and disease monitored by blood @COMPOUND$ level, immuno-histology, insulin content of islets and expression of the proinflammatory cytokines, TNF-alpha, @PROTEIN$, IL-17, and iNOS in pancreatic lymph nodes.	0	18845486-1248
They secreted @PROTEIN$ in response to @COMPOUND$ and could correct hyperglycemia in vivo when cotransplanted with vascular cells.	1	18845629-1303
This action was mimicked solely by 100 nm CH-275, a selective agonist at the somatostatin type 1 receptor (@PROTEIN$), but not by 100 nm BIM-23027, L-362855, or @COMPOUND$ ; agonists selective for the other four SSTRs known to exist in MIN6.	0	18845633-1305
A functional @PROTEIN$ system is essential for @COMPOUND$ antiobesity action.	1	18845634-1306
Deletion of the G protein-coupled receptor 30 impairs glucose tolerance, reduces bone growth, increases blood pressure, and eliminates @COMPOUND$-stimulated @PROTEIN$ release in female mice.	1	18845638-1311
The aim of this study was to assess in rats the effect of protein feeding on the: 1) distribution of endogenous @COMPOUND$ production (EGP) among gluconeogenic organs, and 2) repercussion on the @PROTEIN$ sensitivity of glucose metabolism.	1	18845639-1312
Transcription of @PROTEIN$ in the rodent ovary and placenta: alternative modes of @COMPOUND$ dependent and independent regulation.	1	18845640-1315
The substrate for the synthesis of all steroid hormones is cholesterol, and its conversion to the first steroid, @COMPOUND$, by the cholesterol side-chain cleavage cytochrome P450 (@PROTEIN$) enzyme complex takes place in the inner mitochondrial membranes.	1	18845640-1316
The substrate for the synthesis of all steroid hormones is cholesterol, and its conversion to the first steroid, @COMPOUND$, by the cholesterol side-chain cleavage @PROTEIN$ (CYP11A1) enzyme complex takes place in the inner mitochondrial membranes.	1	18845640-1316
Collectively, these studies identify a novel role for @COMPOUND$ (3) and the @PROTEIN$ in the control of adipocyte metabolism and lipid storage in vivo.	0	18845643-1319
Direct @PROTEIN$ (MR) activation with @COMPOUND$ has deleterious effects on the cerebral vasculature.	1	18845645-1323
Therefore, we hypothesized that systemic @PROTEIN$ inhibition with @COMPOUND$ (CBX) would cause remodeling of the middle cerebral artery (MCA) and increase the damage caused by cerebral ischemia.	1	18845645-1325
In this study, we attempted to evaluate the effects of @COMPOUND$ on F-@PROTEIN$ and microtubular cytoskeletons in human hepatoma HepG2 cells and its possible molecular mechanisms.	1	18845661-1336
Consequently, @COMPOUND$-caused cytoskeletal interruption led to suppression of @PROTEIN$ expression and its metabolizing activity.	1	18845661-1337
Because many drug-drug interactions may occur at the level of drug transporting proteins, we studied interactions of @COMPOUND$ with apical ATP-binding cassette (ABC) @PROTEIN$.	1	18845662-1339
Furthermore, in Sf9-@PROTEIN$ membrane vesicles @COMPOUND$ inhibited transport of methotrexate in a concentration-dependent manner.	0	18845662-1341
To test this hypothesis, we measured the effect of @PROTEIN$ on RyR2 channels from mice and sheep and on intact mouse cardiomyocytes loaded with the Ca(2+) fluorescent indicator @COMPOUND$ acetoxymethyl ester.	0	18845675-1354
To test this hypothesis, we measured the effect of AMT on @PROTEIN$ channels from mice and sheep and on intact mouse cardiomyocytes loaded with the Ca(2+) fluorescent indicator @COMPOUND$ acetoxymethyl ester.	0	18845675-1354
To test this hypothesis, we measured the effect of @PROTEIN$ on RyR2 channels from mice and sheep and on intact mouse cardiomyocytes loaded with the Ca(2+) fluorescent indicator Fura-2 @COMPOUND$ ester.	0	18845675-1354
To test this hypothesis, we measured the effect of AMT on @PROTEIN$ channels from mice and sheep and on intact mouse cardiomyocytes loaded with the Ca(2+) fluorescent indicator Fura-2 @COMPOUND$ ester.	0	18845675-1354
Most cells contain @COMPOUND$ sulfoxide reductases, which catalyze a @PROTEIN$-dependent reduction of methionine sulfoxide back to methionine.	1	18845767-1393
The intracellular free methionine and @COMPOUND$ pools were not altered, nor was the specific activity of the key enzyme, @PROTEIN$.	0	18845767-1394
The intracellular free @COMPOUND$ and S-adenosylmethionine pools were not altered, nor was the specific activity of the key enzyme, @PROTEIN$.	0	18845767-1394
Activity of muscle citrate synthase and @PROTEIN$, as well as maximal @COMPOUND$ uptake and 10-km performance time, remained unaltered in both groups.	0	18845781-1399
Activity of muscle @PROTEIN$ and 3-hydroxyacyl-CoA dehydrogenase, as well as maximal @COMPOUND$ uptake and 10-km performance time, remained unaltered in both groups.	0	18845781-1399
MIN6 cells excreted insulin, @PROTEIN$, @COMPOUND$ and ghrelin.	0	18845907-1434
MIN6 cells excreted insulin, glucagon, @COMPOUND$ and @PROTEIN$.	0	18845907-1434
They expressed mRNAs of insulin I and II, proglucagon, @COMPOUND$, @PROTEIN$ (PP) and ghrelin which were shown in the mouse pancreatic islet core and periphery obtained by LCM.	0	18845907-1435
They expressed mRNAs of insulin I and II, proglucagon, @COMPOUND$, pancreatic polypeptide (PP) and @PROTEIN$ which were shown in the mouse pancreatic islet core and periphery obtained by LCM.	0	18845907-1435
They expressed mRNAs of @PROTEIN$ I and II, proglucagon, @COMPOUND$, pancreatic polypeptide (PP) and ghrelin which were shown in the mouse pancreatic islet core and periphery obtained by LCM.	0	18845907-1435
@PROTEIN$, @COMPOUND$ and ghrelin were detectable in the culture medium.	0	18845907-1436
Glucagon, @COMPOUND$ and @PROTEIN$ were detectable in the culture medium.	0	18845907-1436
@PROTEIN$ (MTs) are @COMPOUND$-rich, metal-binding proteins that are useful biomarkers for monitoring pollution by heavy metals.	1	18846314-1555
The deduced amino acid sequence has 18 @COMPOUND$ residues, implying that S. henanense @PROTEIN$ binds six equivalents of bivalent metal ions (Cd) as opposed to the seven in its mammalian counterparts.	1	18846314-1558
Their health status was assessed by medical conditions, family history, BMI, past or present clinical manifestations, 25 (OH)D, Calcium, @PROTEIN$, @COMPOUND$, HbA1C, PTH, Mg and creatinine analysis.	0	18846317-1559
Their health status was assessed by medical conditions, family history, BMI, past or present clinical manifestations, 25 (OH)D, Calcium, alkaline phosphatase, phosphorus, HbA1C, @PROTEIN$, Mg and @COMPOUND$ analysis.	0	18846317-1559
Their health status was assessed by medical conditions, family history, BMI, past or present clinical manifestations, 25 (OH)D, Calcium, alkaline phosphatase, @COMPOUND$, HbA1C, @PROTEIN$, Mg and creatinine analysis.	0	18846317-1559
Their health status was assessed by medical conditions, family history, BMI, past or present clinical manifestations, 25 (OH)D, Calcium, @PROTEIN$, phosphorus, HbA1C, PTH, Mg and @COMPOUND$ analysis.	0	18846317-1559
Treatment of Platelet Rich Plasma (PRP) with the dialyzed supernatant from the leucocyte suspension incubated with 80 microM @COMPOUND$ resulted in parallel syntheses of NO and @PROTEIN$ as determined by methemoglobin assay and enzyme linked immunosorbent assay respectively.	1	18846318-1561
Muscular oxidative stress and inflammation induced by @COMPOUND$ or MS were assessed by measurements of isoprostanes and @PROTEIN$ levels.	1	18846383-1582
In control rats, @COMPOUND$, @PROTEIN$ and MS significantly enhanced the HFV response.	0	18846383-1583
Pre-treatment with @PROTEIN$ abolished the post-MS-enhanced HFV response whereas diclofenac lowered the peak HFV response to MS and @COMPOUND$.	0	18846383-1584
Pre-treatment with @PROTEIN$ abolished the post-MS-enhanced HFV response whereas @COMPOUND$ lowered the peak HFV response to MS and H2O2.	0	18846383-1584
@COMPOUND$ injection and MS elicited significant and similar increases in isoprostanes and @PROTEIN$.	1	18846383-1585
The decreased level of GSH as well as @PROTEIN$ and GSH-Px activities in @COMPOUND$-treated mice were significantly increased by NTA pretreatment.	1	18846462-1626
In this study, fluorescence microscopy and elemental analysis were exploited to show that the 3,4-dihydroxyphenyl-L-alanine (@COMPOUND$) residues of mussel @PROTEIN$ colocalize with Fe and Ca distributions in the cuticle of Mytilus galloprovincialis mussel byssal threads.	1	18847291-1916
We measured pain using a visual analog pain scale at five time points in 0-48 h, oxycodone use for pain, @COMPOUND$ for fever, C-reactive protein (@PROTEIN$), and total and percent gammadeltaT-cells.	0	18847329-1933
Association between @PROTEIN$ resistance, @COMPOUND$ intolerance, and hypertension in pregnancy.	0	18847384-1963
These results suggest that @PROTEIN$ resistance and relative @COMPOUND$ intolerance are associated with an increased risk of new-onset hypertension in pregnancy, particularly preeclampsia, and support the hypothesis that insulin resistance may play a role in the pathogenesis of this disorder.	0	18847384-1966
These @PROTEIN$ are likely to perform similar functions to those reported for other mammalian ADHs in the metabolism of ingested and endogenous @COMPOUND$ and aldehydes.	1	18848532-2325
@PROTEIN$ and II form a ubiquitous @COMPOUND$-dependent pathway for the detoxification of reactive and mutagenic ketoaldehydes.	1	18848584-2351
@PROTEIN$ (17beta-HSD1) is responsible for the catalytic reduction of the weak estrogen estrone (E1) into the highly potent @COMPOUND$ (E2).	1	18848601-2359
17beta-Hydroxysteroid dehydrogenase type 1 (@PROTEIN$) is responsible for the catalytic reduction of the weak estrogen estrone (E1) into the highly potent @COMPOUND$ (E2).	1	18848601-2359
Blood was collected before and repeatedly afterward for determination of NF-kappaB activity, leukocyte subset numbers, @COMPOUND$, norepinephrine, and in vitro-stimulated @PROTEIN$ production.	0	18848620-2373
Blood was collected before and repeatedly afterward for determination of NF-kappaB activity, leukocyte subset numbers, cortisol, @COMPOUND$, and in vitro-stimulated @PROTEIN$ production.	0	18848620-2373
Higher NF-kappaB stress responses were associated with lower @COMPOUND$ stress responses (beta=-.37, p=.05), higher pre-stress @PROTEIN$ production (beta=.38, p=.043), and high chronic in combination with low acute stress, or vice versa (beta=-.61, p=.06).	0	18848620-2374
The combination of @COMPOUND$-rich repeat (LRR) and immunoglobulin-like (Ig) domains is found in the domain architecture of the @PROTEIN$ neurotrophin receptor protein.	1	18848646-2382
Given the significant biological roles of @PROTEIN$ and such newly identified proteins, we have searched the public database for human proteins with LRR and Ig domains (collectively termed the @COMPOUND$-rich repeat and Ig domain-containing protein, LRRIG protein, in this study), and have analyzed the mRNA expression pattern of mouse orthologs of obtained human LRRIG proteins at embryonic day 10.	0	18848646-2383
Quantum chemical studies for oxidation of @COMPOUND$ by @PROTEIN$.	1	18848727-2425
Since @COMPOUND$ oxidation has recently been shown to involve @PROTEIN$, the study on its mechanism at molecular level using quantum chemical calculations for the model of cytochrome active site is reported here.	1	18848727-2426
Pretreatment with oligonol diminished the levels of proliferating cell nuclear antigen and expression of @PROTEIN$ in papillomas and carcinomas, respectively, as compared to @COMPOUND$ plus TPA treatment alone.	1	18848748-2442
Pretreatment with oligonol diminished the levels of @PROTEIN$ and expression of COX-2 in papillomas and carcinomas, respectively, as compared to @COMPOUND$ plus TPA treatment alone.	1	18848748-2442
TnBP (@COMPOUND$) and polysorbate 20 during the manufacture of the factor VIII/@PROTEIN$ concentrate Optivate has been investigated.	0	18848782-2443
Euthyroid animals with a palpation score &gt;or=3 were significantly older, had higher body weights, lower alkaline phosphatase, alanine aminotransferase, phosphate, and urine specific gravity, but higher @PROTEIN$ and @COMPOUND$ concentrations than hyperthyroid cats.	0	18848797-2450
Euthyroid animals with a palpation score &gt;or=3 were significantly older, had higher body weights, lower alkaline phosphatase, alanine aminotransferase, @COMPOUND$, and urine specific gravity, but higher @PROTEIN$ and creatinine concentrations than hyperthyroid cats.	0	18848797-2450
Euthyroid animals with a palpation score &gt;or=3 were significantly older, had higher body weights, lower @PROTEIN$, alanine aminotransferase, @COMPOUND$, and urine specific gravity, but higher lipase and creatinine concentrations than hyperthyroid cats.	0	18848797-2450
Euthyroid animals with a palpation score &gt;or=3 were significantly older, had higher body weights, lower @PROTEIN$, alanine aminotransferase, phosphate, and urine specific gravity, but higher lipase and @COMPOUND$ concentrations than hyperthyroid cats.	0	18848797-2450
A role for @PROTEIN$ receptors in @COMPOUND$ signalling pathways involved in the regulation of IL-12 and IL-23 in microglial cells.	1	18848818-2462
2-Deoxyglucose decreased @COMPOUND$H/NAD (+) and NADPH/NADP(+) ratios by 59 and 50%, respectively, and intact cell @PROTEIN$ activity by 74%; lactate restored NADH/NAD (+), but not NADPH/NADP(+) or NQO1 activity.	0	18848878-2491
We propose that the coordinated regulation of @PROTEIN$ cytoskeletal reorganization and macropinocytosis-mediated retrograde membrane trafficking may contribute to @COMPOUND$+)-induced axon growth inhibition.	1	18848894-880
Cocaine stimulated @PROTEIN$, @COMPOUND$, and LH, whereas cocaine+nalbuphine in combination produced a smaller increase in ACTH, and decreased cortisol and LH.	0	18848957-982
Thus it appears that nalbuphine attenuated cocaine's effects on @PROTEIN$, @COMPOUND$, and LH.	0	18848957-983
In this work we show that in FaO rat hepatoma cells inhibition of the @PROTEIN$ (EGFR) with the tyrphostin @COMPOUND$ enhances TGF-beta-induced cell death, coincident with an elevated increase in ROS production and GSH depletion.	1	18848961-2547
In this work we show that in FaO rat hepatoma cells inhibition of the epidermal growth factor receptor (@PROTEIN$) with the tyrphostin @COMPOUND$ enhances TGF-beta-induced cell death, coincident with an elevated increase in ROS production and GSH depletion.	1	18848961-2547
Membrane inlet mass spectrometry was used to observe @COMPOUND$ in the well-studied reaction of nitrite with @PROTEIN$.	1	18848984-2561
Diminished levels of L-arginine and endothelial @PROTEIN$ (eNOS) uncoupling through deficiency of @COMPOUND$ (BH(4)) may contribute to endothelial dysfunction.	1	18849028-2571
Diminished levels of L-@COMPOUND$ and endothelial nitric oxide synthase (@PROTEIN$) uncoupling through deficiency of tetrahydrobiopterin (BH(4)) may contribute to endothelial dysfunction.	0	18849028-2571
Diminished levels of L-arginine and endothelial nitric oxide synthase (@PROTEIN$) uncoupling through deficiency of @COMPOUND$ (BH(4)) may contribute to endothelial dysfunction.	1	18849028-2571
Diminished levels of L-@COMPOUND$ and endothelial @PROTEIN$ (eNOS) uncoupling through deficiency of tetrahydrobiopterin (BH(4)) may contribute to endothelial dysfunction.	0	18849028-2571
Serum testosterone, estradiol, sex hormone binding globulin (@PROTEIN$), and @COMPOUND$ levels were measured in 1947 postmenopausal women aged 45-84 years (30% White, 14% Chinese-American, 31% Black, and 25% Hispanic) and not on hormone therapy.	0	18849030-2572
Serum testosterone, @COMPOUND$, sex hormone binding globulin (@PROTEIN$), and dehydroepiandrosterone levels were measured in 1947 postmenopausal women aged 45-84 years (30% White, 14% Chinese-American, 31% Black, and 25% Hispanic) and not on hormone therapy.	0	18849030-2572
Total and bioavailable testosterone were positively associated with common cIMT independent of age, BMI, hypertension, smoking, HDL-@COMPOUND$, LDL-cholesterol and @PROTEIN$ sensitivity (p=0.009 and p=0.002, respectively).	0	18849030-2573
In addition to lipid peroxidation, the activities of antioxidant enzymes such as superoxide dismutase, @PROTEIN$, glutathione peroxidase, glutathione reductase and glutathione S-transferase and two non-enzymatic antioxidants (ascorbic acid and @COMPOUND$) were investigated in order to understand their variation with respect to pollution status of the sampling locations.	0	18849055-2585
In addition to lipid peroxidation, the activities of antioxidant enzymes such as superoxide dismutase, catalase, glutathione peroxidase, @PROTEIN$ and glutathione S-transferase and two non-enzymatic antioxidants (ascorbic acid and @COMPOUND$) were investigated in order to understand their variation with respect to pollution status of the sampling locations.	0	18849055-2585
In addition to lipid peroxidation, the activities of antioxidant enzymes such as @PROTEIN$, catalase, glutathione peroxidase, glutathione reductase and glutathione S-transferase and two non-enzymatic antioxidants (ascorbic acid and @COMPOUND$) were investigated in order to understand their variation with respect to pollution status of the sampling locations.	0	18849055-2585
In addition to lipid peroxidation, the activities of antioxidant enzymes such as superoxide dismutase, catalase, glutathione peroxidase, glutathione reductase and @PROTEIN$ and two non-enzymatic antioxidants (@COMPOUND$ and reduced glutathione) were investigated in order to understand their variation with respect to pollution status of the sampling locations.	0	18849055-2585
In addition to lipid peroxidation, the activities of antioxidant enzymes such as superoxide dismutase, @PROTEIN$, glutathione peroxidase, glutathione reductase and glutathione S-transferase and two non-enzymatic antioxidants (@COMPOUND$ and reduced glutathione) were investigated in order to understand their variation with respect to pollution status of the sampling locations.	0	18849055-2585
In addition to lipid peroxidation, the activities of antioxidant enzymes such as superoxide dismutase, catalase, glutathione peroxidase, @PROTEIN$ and glutathione S-transferase and two non-enzymatic antioxidants (@COMPOUND$ and reduced glutathione) were investigated in order to understand their variation with respect to pollution status of the sampling locations.	0	18849055-2585
In addition to lipid peroxidation, the activities of antioxidant enzymes such as superoxide dismutase, catalase, @PROTEIN$, glutathione reductase and glutathione S-transferase and two non-enzymatic antioxidants (ascorbic acid and @COMPOUND$) were investigated in order to understand their variation with respect to pollution status of the sampling locations.	0	18849055-2585
In addition to lipid peroxidation, the activities of antioxidant enzymes such as @PROTEIN$, catalase, glutathione peroxidase, glutathione reductase and glutathione S-transferase and two non-enzymatic antioxidants (@COMPOUND$ and reduced glutathione) were investigated in order to understand their variation with respect to pollution status of the sampling locations.	0	18849055-2585
In addition to lipid peroxidation, the activities of antioxidant enzymes such as superoxide dismutase, catalase, @PROTEIN$, glutathione reductase and glutathione S-transferase and two non-enzymatic antioxidants (@COMPOUND$ and reduced glutathione) were investigated in order to understand their variation with respect to pollution status of the sampling locations.	0	18849055-2585
In addition to lipid peroxidation, the activities of antioxidant enzymes such as superoxide dismutase, catalase, glutathione peroxidase, glutathione reductase and @PROTEIN$ and two non-enzymatic antioxidants (ascorbic acid and @COMPOUND$) were investigated in order to understand their variation with respect to pollution status of the sampling locations.	0	18849055-2585
This study shows that changes in lipid peroxidation, @PROTEIN$, catalase, glutathione reductase, glutathione S-transferase and @COMPOUND$ in tissues of P. viridis can be used as molecular biomarkers in environmental monitoring programs.	0	18849055-2586
This study shows that changes in lipid peroxidation, superoxide dismutase, @PROTEIN$, glutathione reductase, glutathione S-transferase and @COMPOUND$ in tissues of P. viridis can be used as molecular biomarkers in environmental monitoring programs.	0	18849055-2586
This study shows that changes in lipid peroxidation, superoxide dismutase, catalase, @PROTEIN$, glutathione S-transferase and @COMPOUND$ in tissues of P. viridis can be used as molecular biomarkers in environmental monitoring programs.	0	18849055-2586
This study shows that changes in lipid peroxidation, superoxide dismutase, catalase, glutathione reductase, @PROTEIN$ and @COMPOUND$ in tissues of P. viridis can be used as molecular biomarkers in environmental monitoring programs.	0	18849055-2586
At the same time, both types of conduits were permeable to three compounds tested including @COMPOUND$, lysozyme and bovine @PROTEIN$, indicating the suitability of the conduits for free exchanges of nutrients.	0	18849069-2591
At the same time, both types of conduits were permeable to three compounds tested including @COMPOUND$, @PROTEIN$ and bovine serum albumin, indicating the suitability of the conduits for free exchanges of nutrients.	0	18849069-2591
The inhibitory effect of @COMPOUND$ on the migration of ES-2 ovarian carcinoma cells involves a @PROTEIN$-dependent pathway.	1	18849110-2608
This inhibitory effect is possibly mediated by a @COMPOUND$-dependent activation of the small GTPase @PROTEIN$ via Epac.	1	18849110-2609
This inhibitory effect is possibly mediated by a @COMPOUND$-dependent activation of the small GTPase Rap1 via @PROTEIN$.	1	18849110-2609
Gender differences in corticotropin and @COMPOUND$ secretion and @PROTEIN$ mRNA expression in the paraventricular nucleus of the hypothalamus and the central nucleus of the amygdala in response to footshock stress or psychological stress in rats.	0	18849120-2614
Gender differences in @PROTEIN$ and @COMPOUND$ secretion and corticotropin-releasing factor mRNA expression in the paraventricular nucleus of the hypothalamus and the central nucleus of the amygdala in response to footshock stress or psychological stress in rats.	0	18849120-2614
Although females in both proestrus and diestrus showed significant increases in plasma @PROTEIN$ and @COMPOUND$ and CRF mRNA expression in the PVN in response to PS, no significant responses of the HPA axis to PS were found in males.	0	18849120-2615
Although females in both proestrus and diestrus showed significant increases in plasma ACTH and @COMPOUND$ and @PROTEIN$ mRNA expression in the PVN in response to PS, no significant responses of the HPA axis to PS were found in males.	0	18849120-2615
BDNF, NGF, adrenocorticotropic hormone (ACTH), @COMPOUND$ and growth hormone (GH) were determined at baseline on postnatal days (@PROTEIN$) 14, 30 and 60 by means of specific ELISA and RIA procedures.	0	18849121-2616
@PROTEIN$, NGF, adrenocorticotropic hormone (ACTH), @COMPOUND$ and growth hormone (GH) were determined at baseline on postnatal days (PND) 14, 30 and 60 by means of specific ELISA and RIA procedures.	0	18849121-2616
BDNF, NGF, @PROTEIN$ (ACTH), @COMPOUND$ and growth hormone (GH) were determined at baseline on postnatal days (PND) 14, 30 and 60 by means of specific ELISA and RIA procedures.	0	18849121-2616
BDNF, NGF, adrenocorticotropic hormone (ACTH), @COMPOUND$ and growth hormone (GH) were determined at baseline on postnatal days (PND) 14, 30 and 60 by means of specific ELISA and @PROTEIN$ procedures.	0	18849121-2616
BDNF, @PROTEIN$, adrenocorticotropic hormone (ACTH), @COMPOUND$ and growth hormone (GH) were determined at baseline on postnatal days (PND) 14, 30 and 60 by means of specific ELISA and RIA procedures.	0	18849121-2616
BDNF, NGF, adrenocorticotropic hormone (@PROTEIN$), @COMPOUND$ and growth hormone (GH) were determined at baseline on postnatal days (PND) 14, 30 and 60 by means of specific ELISA and RIA procedures.	0	18849121-2616
BDNF, NGF, adrenocorticotropic hormone (ACTH), @COMPOUND$ and @PROTEIN$ (GH) were determined at baseline on postnatal days (PND) 14, 30 and 60 by means of specific ELISA and RIA procedures.	0	18849121-2616
A substrate regeneration cycle coupling @PROTEIN$ with l-@COMPOUND$ (AsA: 0, 1.0, 3.0, 10.0 and 50.0 mmol/l; as reducing reagent system) was applied to the chemo-mechanical reaction unit in order to amplify the output signal of the tonometric biosensor.	0	18849159-2635
In vitro and in vivo models simulating the bee sting have been developed using live honeybees and, as the envenomation sites, pig ears and rat legs; MALDI MSI has been used to map, over time, the diffusion and distribution of three venom allergens (@COMPOUND$ m 1, Api m 4, and Api m 6) and two venom toxins (apamine and @PROTEIN$).	0	18849171-2637
The effect was lactose-inhibitable and required galectin-3 affinity for @COMPOUND$, a saccharide typically found on @PROTEIN$, since a mutant lacking this activity was without effect.	1	18849325-2674
The effect was lactose-inhibitable and required @PROTEIN$ affinity for @COMPOUND$, a saccharide typically found on cell surface glycoproteins, since a mutant lacking this activity was without effect.	1	18849325-2674
Despite widespread expression of @PROTEIN$ (EGF) receptors (EGFRs) and EGF family ligands in non-small-cell lung cancer (NSCLC), EGFR-specific tyrosine kinase inhibitors (TKIs) such as @COMPOUND$ exhibit limited activity in this cancer.	0	18849352-2679
Despite widespread expression of epidermal growth factor (EGF) receptors (@PROTEIN$) and EGF family ligands in non-small-cell lung cancer (NSCLC), EGFR-specific tyrosine kinase inhibitors (TKIs) such as @COMPOUND$ exhibit limited activity in this cancer.	0	18849352-2679
It is noteworthy that FGF2 and FGF9 as well as @PROTEIN$ IIIc and/or FGFR2 IIIc mRNA and protein are frequently coexpressed in NSCLC cell lines, especially those that are insensitive to @COMPOUND$.	0	18849352-2680
It is noteworthy that @PROTEIN$ and FGF9 as well as FGFR1 IIIc and/or FGFR2 IIIc mRNA and protein are frequently coexpressed in NSCLC cell lines, especially those that are insensitive to @COMPOUND$.	0	18849352-2680
It is noteworthy that FGF2 and @PROTEIN$ as well as FGFR1 IIIc and/or FGFR2 IIIc mRNA and protein are frequently coexpressed in NSCLC cell lines, especially those that are insensitive to @COMPOUND$.	0	18849352-2680
It is noteworthy that FGF2 and FGF9 as well as FGFR1 IIIc and/or @PROTEIN$ IIIc mRNA and protein are frequently coexpressed in NSCLC cell lines, especially those that are insensitive to @COMPOUND$.	0	18849352-2680
Preprandial concentrations of glucose, @PROTEIN$, @COMPOUND$, and IGF-I fluctuated over time without significant treatment effect.	0	18849389-2687
Preprandial concentrations of @COMPOUND$, NEFA, lactate, and @PROTEIN$ fluctuated over time without significant treatment effect.	0	18849389-2687
Preprandial concentrations of glucose, NEFA, @COMPOUND$, and @PROTEIN$ fluctuated over time without significant treatment effect.	0	18849389-2687
Preprandial concentrations of @COMPOUND$, @PROTEIN$, lactate, and IGF-I fluctuated over time without significant treatment effect.	0	18849389-2687
In late gestation, the postprandial increases in @COMPOUND$ and @PROTEIN$ were delayed, and smaller, after a high-fiber meal than after a control meal.	0	18849389-2688
During lactation, @COMPOUND$ and @PROTEIN$ profiles after a standard meal did not differ between sows from treatment groups.	0	18849389-2689
Effects of gram-negative bacterial @COMPOUND$ (LPS) and supplemental dietary Met on N balance, serum hormones and @PROTEIN$, and plasma urea-N and AA were evaluated in 20 Angus-cross steers (BW = 262+/-6.3 kg).	0	18849391-1967
Effects of gram-negative bacterial lipopolysaccharide (LPS) and supplemental dietary Met on N balance, serum hormones and @PROTEIN$, and plasma @COMPOUND$-N and AA were evaluated in 20 Angus-cross steers (BW = 262+/-6.3 kg).	0	18849391-1967
Diet samples, feed refusals, feces, and urine were collected daily for 5 d. Rectal temperature and serum concentrations of @COMPOUND$, prolactin, tumor necrosis factor-alpha, and @PROTEIN$ 0.01).	0	18849391-1968
Diet samples, feed refusals, feces, and urine were collected daily for 5 d. Rectal temperature and serum concentrations of @COMPOUND$, prolactin, @PROTEIN$-alpha, and haptoglobin 0.01).	0	18849391-1968
Diet samples, feed refusals, feces, and urine were collected daily for 5 d. Rectal temperature and serum concentrations of @COMPOUND$, @PROTEIN$, tumor necrosis factor-alpha, and haptoglobin 0.01).	0	18849391-1968
Plasma @COMPOUND$-N was greater for+LPS than-LPS steers (LPS; P = 0.03), and serum @PROTEIN$ was not affected (P &gt; or = 0.26) by LPS or Met.	0	18849391-1969
Domain shape annealing is observed from branched to rounded shapes after @PROTEIN$ activity quenching by @COMPOUND$, with a decay halftime of approximately 10 min.	0	18849413-2041
Using neighborhood approaches, we were able to assign seven novel functional partners in @PROTEIN$ synthesis, @COMPOUND$ metabolism, and quorum sensing to BLUF domain-containing proteins (involved in light sensing).	0	18849420-2060
Chondroitin lyases (or @PROTEIN$) are a family of enzymes that depolymerize @COMPOUND$ (CS) and dermatan sulfate (DS) galactosaminoglycans, which have gained prominence as important players in central nervous system biology.	1	18849565-2744
We have assessed the impact of the functional C-1019G variant of the @PROTEIN$ receptor on the response to @COMPOUND$ or haloperidol in a prospective, randomized, double-blind study.	1	18849890-22
We have assessed the impact of the functional C-1019G variant of the @PROTEIN$ receptor on the response to risperidone or @COMPOUND$ in a prospective, randomized, double-blind study.	1	18849890-22
This downregulation was abolished following treatment with the histone deacetylase (HDAC) inhibitor trichostatin A (TSA) and cytosine methylation inhibitor @COMPOUND$ (5-Aza), suggesting that an epigenetic regulatory mechanism may be involved in @PROTEIN$ silencing by hypoxia.	1	18850007-61
This downregulation was abolished following treatment with the histone deacetylase (HDAC) inhibitor @COMPOUND$ (TSA) and cytosine methylation inhibitor 5-aza-2-deoxycytidine (5-Aza), suggesting that an epigenetic regulatory mechanism may be involved in @PROTEIN$ silencing by hypoxia.	1	18850007-61
@COMPOUND$ overcomes cell-adhesion-mediated drug resistance through downregulation of @PROTEIN$ expression in multiple myeloma.	1	18850009-63
@COMPOUND$-@PROTEIN$ conjugate selectively overcomes multidrug resistance in leukaemia cells.	1	18850074-89
The purpose of this study was to examine the distribution and action of @COMPOUND$-@PROTEIN$ conjugate (DOXTRF) in a leukaemia cell line (HL60), a multidrug-resistant leukaemia cell line (HL60ADR) and a normal tissue cell line (human fibroblasts).	1	18850074-90
Purification of an @PROTEIN$ involved in the conversion of methional to @COMPOUND$ in Oenococcus oeni IOEB 8406.	1	18850096-105
Purification of an @PROTEIN$ involved in the conversion of @COMPOUND$ to methionol in Oenococcus oeni IOEB 8406.	1	18850096-105
An @COMPOUND$ (P)H-dependent @PROTEIN$ involved in the reduction of methional was then purified to homogeneity.	1	18850096-106
An NAD (P)H-dependent @PROTEIN$ involved in the reduction of @COMPOUND$ was then purified to homogeneity.	1	18850096-106
Sequencing of the purified enzyme and amino acid sequence comparison with the database revealed the presence of a conserved sequence motif specific to the medium-chain zinc-containing @COMPOUND$ (P)H-dependent @PROTEIN$.	1	18850096-107
The purified @PROTEIN$ does not seem to be involved in the modification of buttery and lactic notes or to be involved in the specific formation of volatile @COMPOUND$ during MLF.	0	18850096-108
The function of the purified @PROTEIN$ remains unclear, although the role of the sulfur atom in @COMPOUND$ molecules in the interaction between enzyme and substrate was evidenced.	0	18850096-109
The function of the purified @PROTEIN$ remains unclear, although the role of the @COMPOUND$ in methional molecules in the interaction between enzyme and substrate was evidenced.	0	18850096-109
All strains tested positive for @PROTEIN$ activity while none where capable of @COMPOUND$ degradation.	0	18850241-169
In the present work we studied the effect of @PROTEIN$ and-3 on neuronal @COMPOUND$ release and the short-term regulation of tyrosine hydroxylase in the olfactory bulb.	0	18850267-174
Results showed that both endothelins increased tyrosine hydroxylase activity through the activation of a non-conventional endothelin G-protein coupled receptor, coupled to the stimulation of @PROTEIN$ and C, as well as @COMPOUND$+)/calmodulin-dependent protein kinase II.	0	18850267-175
Results showed that both endothelins increased tyrosine hydroxylase activity through the activation of a non-conventional endothelin G-protein coupled receptor, coupled to the stimulation of @PROTEIN$ A and C, as well as @COMPOUND$+)/calmodulin-dependent protein kinase II.	0	18850267-175
Results showed that both endothelins increased tyrosine hydroxylase activity through the activation of a non-conventional endothelin G-protein coupled receptor, coupled to the stimulation of protein kinase A and C, as well as @COMPOUND$+)/@PROTEIN$-dependent protein kinase II.	1	18850267-175
The data presented here indicate a substantial decline in antioxidant defences by actions of corticosterone, evidenced by coordinate decreases in the activities in the brain, liver and heart of free-radical scavenging enzymes superoxide dismutase (SOD), catalase (CAT), @PROTEIN$ (GST) and glutathione reductase (GR), as well as the non-enzymatic antioxidants glutathione (@COMPOUND$) and serum urate.	0	18850490-228
The data presented here indicate a substantial decline in antioxidant defences by actions of corticosterone, evidenced by coordinate decreases in the activities in the brain, liver and heart of free-radical scavenging enzymes superoxide dismutase (@PROTEIN$), catalase (CAT), glutathione S-transferase (GST) and glutathione reductase (GR), as well as the non-enzymatic antioxidants glutathione (@COMPOUND$) and serum urate.	0	18850490-228
The data presented here indicate a substantial decline in antioxidant defences by actions of corticosterone, evidenced by coordinate decreases in the activities in the brain, liver and heart of free-radical scavenging enzymes @PROTEIN$ (SOD), catalase (CAT), glutathione S-transferase (GST) and glutathione reductase (GR), as well as the non-enzymatic antioxidants glutathione (@COMPOUND$) and serum urate.	0	18850490-228
The data presented here indicate a substantial decline in antioxidant defences by actions of corticosterone, evidenced by coordinate decreases in the activities in the brain, liver and heart of free-radical scavenging enzymes superoxide dismutase (SOD), catalase (@PROTEIN$), glutathione S-transferase (GST) and glutathione reductase (GR), as well as the non-enzymatic antioxidants glutathione (@COMPOUND$) and serum urate.	0	18850490-228
The data presented here indicate a substantial decline in antioxidant defences by actions of corticosterone, evidenced by coordinate decreases in the activities in the brain, liver and heart of free-radical scavenging enzymes superoxide dismutase (SOD), @PROTEIN$ (CAT), glutathione S-transferase (GST) and glutathione reductase (GR), as well as the non-enzymatic antioxidants glutathione (@COMPOUND$) and serum urate.	0	18850490-228
The data presented here indicate a substantial decline in antioxidant defences by actions of corticosterone, evidenced by coordinate decreases in the activities in the brain, liver and heart of free-radical scavenging enzymes superoxide dismutase (SOD), catalase (CAT), glutathione S-transferase (GST) and @PROTEIN$ (GR), as well as the non-enzymatic antioxidants glutathione (@COMPOUND$) and serum urate.	0	18850490-228
The data presented here indicate a substantial decline in antioxidant defences by actions of corticosterone, evidenced by coordinate decreases in the activities in the brain, liver and heart of free-radical scavenging enzymes superoxide dismutase (SOD), catalase (CAT), glutathione S-transferase (@PROTEIN$) and glutathione reductase (GR), as well as the non-enzymatic antioxidants glutathione (@COMPOUND$) and serum urate.	0	18850490-228
@PROTEIN$ receptors are membrane cation channels gated by extracellular @COMPOUND$.	1	18851707-551
End-point measures were HOMA (homoeostasis model assessment)-IR, androgens, lipids, inflammatory markers (hsCRP (high-sensitivity C-reactive protein)) and endothelial function (FMD (flow-mediated dilation), ADMA (@COMPOUND$), PAI-1 (plasminogen activator inhibitor-1) and vWF (@PROTEIN$)).	0	18851710-552
End-point measures were HOMA (homoeostasis model assessment)-IR, androgens, lipids, inflammatory markers (hsCRP (high-sensitivity C-reactive protein)) and endothelial function (FMD (flow-mediated dilation), @COMPOUND$ (asymmetric dimethylarginine), PAI-1 (plasminogen activator inhibitor-1) and vWF (@PROTEIN$)).	0	18851710-552
Addition of SOD (@PROTEIN$) doubled the amount of @COMPOUND$ detected.	1	18851713-556
Addition of @PROTEIN$ (superoxide dismutase) doubled the amount of @COMPOUND$ detected.	1	18851713-556
Drug-resistant cancer cells became sensitive to @COMPOUND$ treatment when @PROTEIN$ was expressed in cytosol.	1	18851895-635
All the analyzed resistant mutants exhibited both increased @COMPOUND$ efflux and increased transcription of mmpS5-@PROTEIN$ genes, encoding a hypothetical efflux system belonging to the resistance-nodulation-division (RND) family of transporters.	0	18851927-647
All the analyzed resistant mutants exhibited both increased @COMPOUND$ efflux and increased transcription of @PROTEIN$-mmpL5 genes, encoding a hypothetical efflux system belonging to the resistance-nodulation-division (RND) family of transporters.	0	18851927-647
This study investigated the effects of atorvastatin on @PROTEIN$ and ABCC1 mRNA expression on peripheral blood mononuclear cells (PBMC) and their relationship with gene polymorphisms and lowering-@COMPOUND$ response.	0	18851956-1598
This study investigated the effects of atorvastatin on ABCB1 and @PROTEIN$ mRNA expression on peripheral blood mononuclear cells (PBMC) and their relationship with gene polymorphisms and lowering-@COMPOUND$ response.	0	18851956-1598
While the three @PROTEIN$ isotypes showed comparable Km and k(cat) for L-serine and acetyl-CoA, they showed remarkable differences in their sensitivity to inhibition by @COMPOUND$.	1	18851994-2766
While the three @PROTEIN$ isotypes showed comparable Km and k(cat) for @COMPOUND$ and acetyl-CoA, they showed remarkable differences in their sensitivity to inhibition by L-cysteine.	1	18851994-2766
We propose that multiple @PROTEIN$ isotypes with different properties may play complementary roles in the regulation of the @COMPOUND$ biosynthetic pathway in E. histolytica under different conditions, e.g.	1	18851994-2767
At 1 min before the exposure rats were treated with one of the following: intravenous @PROTEIN$, 4.4 mg/kg; intraperitoneal (ip) @COMPOUND$, 25mg/kg; or ip trolox, 500 microg/kg.	0	18852015-684
At 1 min before the exposure rats were treated with one of the following: intravenous @PROTEIN$, 4.4 mg/kg; intraperitoneal (ip) ilomastat, 25mg/kg; or ip @COMPOUND$, 500 microg/kg.	0	18852015-684
Treatment with @PROTEIN$ or @COMPOUND$ eliminated these PF changes, yielding results comparable with controls for each of these parameters.	0	18852015-685
While @PROTEIN$ and @COMPOUND$ both alleviated the PF perturbations, surprisingly only aprotinin reduced the observed pathology, both grossly and histologically.	0	18852015-686
These early results indicate that treatment with @PROTEIN$ and to a lesser extent @COMPOUND$ reduces some of the direct inflammatory response and damage associated with SM-induced lung injury.	0	18852015-687
Spermine oxidase (@PROTEIN$) is a FAD-containing enzyme involved in animal cell polyamines (PA) homeostasis, selectively active on @COMPOUND$ and producing H(2)O(2), spermidine, and the 3-aminopropanal.	1	18852063-706
@PROTEIN$ (SMO) is a FAD-containing enzyme involved in animal cell polyamines (PA) homeostasis, selectively active on @COMPOUND$ and producing H(2)O(2), spermidine, and the 3-aminopropanal.	1	18852063-706
Pretreatment with DEX abrogated @PROTEIN$ inhibition by sst (2)-preferring analogue @COMPOUND$ in TT.	1	18852217-740
@COMPOUND$ enhances the activity of nuclear factor-kappaB pathway through @PROTEIN$ and BLT2 receptors in atherosclerosis.	1	18852255-2230
@PROTEIN$ activity and total nitrite and @COMPOUND$ concentrations in serum: novel biochemical markers for type 2 diabetes.	0	18853098-1027
The aim of this study was to evaluate the activity of semicarbazide-sensitive amine oxidase (@PROTEIN$) and the total nitrite and @COMPOUND$ (NO(x)) concentrations in serum from type 2 diabetic patients and control subjects in order to evaluate if they could be used as novel diabetic markers.	0	18853098-1028
The aim of this study was to evaluate the activity of @PROTEIN$ (SSAO) and the total nitrite and @COMPOUND$ (NO(x)) concentrations in serum from type 2 diabetic patients and control subjects in order to evaluate if they could be used as novel diabetic markers.	0	18853098-1028
Serum lipid, creatinine, @COMPOUND$, @PROTEIN$, HbA(1C) and urinary albumin concentration were measured.	0	18853099-1030
Serum lipid, @COMPOUND$, uric acid, @PROTEIN$, HbA(1C) and urinary albumin concentration were measured.	0	18853099-1030
@COMPOUND$ activity showed highest correlations to @PROTEIN$ II and microtubule targeting drugs.	1	18853102-1107
Ulcerated tissues were processed to assess ulcer area, @COMPOUND$, @PROTEIN$ (PCNA) and cleaved caspase-3.	0	18853145-1060
Ulcerated tissues were processed to assess ulcer area, @COMPOUND$, proliferating cell nuclear antigen (@PROTEIN$) and cleaved caspase-3.	0	18853145-1060
Serum NO, @PROTEIN$ and @COMPOUND$ were measured.	0	18853166-1068
Serum @COMPOUND$ and @PROTEIN$ levels were significantly lower in FM patients than controls.	0	18853166-1069
This article discusses the physiology of proximal @COMPOUND$ (+)/H(+) exchange, the multiple mechanisms of @PROTEIN$ regulation, and the reciprocal relationship between NHE3 and NHE8 at the lumen of the proximal tubule.	0	18853182-1073
This article discusses the physiology of proximal @COMPOUND$ (+)/H(+) exchange, the multiple mechanisms of NHE3 regulation, and the reciprocal relationship between NHE3 and @PROTEIN$ at the lumen of the proximal tubule.	0	18853182-1073
@COMPOUND$ and DHEA-sulfate response to rapid adrenocorticotropic hormone (@PROTEIN$) stimulation was inadequate.	0	18853185-1077
Cortisol and @COMPOUND$ response to rapid @PROTEIN$ (ACTH) stimulation was inadequate.	0	18853185-1077
Cortisol and @COMPOUND$ response to rapid adrenocorticotropic hormone (@PROTEIN$) stimulation was inadequate.	0	18853185-1077
@COMPOUND$ and DHEA-sulfate response to rapid @PROTEIN$ (ACTH) stimulation was inadequate.	0	18853185-1077
The effects of industrial storage on the changes of the cell viability and the activities of intracellular alcohol dehydrogenase (@PROTEIN$) and glucose-6-phosphate dehydrogenase (G6PDH) in brewer's yeast, and the corresponding capacity for the bioconversion of ethyl-3-oxobutanoate (@COMPOUND$) to ethyl (S)-3-hydroxybutanoate ((S)-EHB), were investigated.	1	18853207-1083
The effects of industrial storage on the changes of the cell viability and the activities of intracellular alcohol dehydrogenase (@PROTEIN$) and glucose-6-phosphate dehydrogenase (G6PDH) in brewer's yeast, and the corresponding capacity for the bioconversion of ethyl-3-oxobutanoate (EOB) to ethyl (@COMPOUND$ ((S)-EHB), were investigated.	1	18853207-1083
The effects of industrial storage on the changes of the cell viability and the activities of intracellular alcohol dehydrogenase (ADH) and glucose-6-phosphate dehydrogenase (@PROTEIN$) in brewer's yeast, and the corresponding capacity for the bioconversion of @COMPOUND$ (EOB) to ethyl (S)-3-hydroxybutanoate ((S)-EHB), were investigated.	1	18853207-1083
The effects of industrial storage on the changes of the cell viability and the activities of intracellular @PROTEIN$ (ADH) and glucose-6-phosphate dehydrogenase (G6PDH) in brewer's yeast, and the corresponding capacity for the bioconversion of @COMPOUND$ (EOB) to ethyl (S)-3-hydroxybutanoate ((S)-EHB), were investigated.	1	18853207-1083
The effects of industrial storage on the changes of the cell viability and the activities of intracellular alcohol dehydrogenase (@PROTEIN$) and glucose-6-phosphate dehydrogenase (G6PDH) in brewer's yeast, and the corresponding capacity for the bioconversion of ethyl-3-oxobutanoate (EOB) to ethyl (S)-3-hydroxybutanoate ((S)-@COMPOUND$), were investigated.	1	18853207-1083
The effects of industrial storage on the changes of the cell viability and the activities of intracellular @PROTEIN$ (ADH) and glucose-6-phosphate dehydrogenase (G6PDH) in brewer's yeast, and the corresponding capacity for the bioconversion of ethyl-3-oxobutanoate (EOB) to ethyl (S)-3-hydroxybutanoate ((S)-@COMPOUND$), were investigated.	1	18853207-1083
The effects of industrial storage on the changes of the cell viability and the activities of intracellular @PROTEIN$ (ADH) and glucose-6-phosphate dehydrogenase (G6PDH) in brewer's yeast, and the corresponding capacity for the bioconversion of ethyl-3-oxobutanoate (@COMPOUND$) to ethyl (S)-3-hydroxybutanoate ((S)-EHB), were investigated.	1	18853207-1083
The effects of industrial storage on the changes of the cell viability and the activities of intracellular alcohol dehydrogenase (ADH) and glucose-6-phosphate dehydrogenase (@PROTEIN$) in brewer's yeast, and the corresponding capacity for the bioconversion of ethyl-3-oxobutanoate (EOB) to ethyl (S)-3-hydroxybutanoate ((S)-@COMPOUND$), were investigated.	1	18853207-1083
The effects of industrial storage on the changes of the cell viability and the activities of intracellular alcohol dehydrogenase (ADH) and glucose-6-phosphate dehydrogenase (@PROTEIN$) in brewer's yeast, and the corresponding capacity for the bioconversion of ethyl-3-oxobutanoate (EOB) to ethyl (@COMPOUND$ ((S)-EHB), were investigated.	1	18853207-1083
The effects of industrial storage on the changes of the cell viability and the activities of intracellular @PROTEIN$ (ADH) and glucose-6-phosphate dehydrogenase (G6PDH) in brewer's yeast, and the corresponding capacity for the bioconversion of ethyl-3-oxobutanoate (EOB) to ethyl (@COMPOUND$ ((S)-EHB), were investigated.	1	18853207-1083
The effects of industrial storage on the changes of the cell viability and the activities of intracellular alcohol dehydrogenase (ADH) and glucose-6-phosphate dehydrogenase (@PROTEIN$) in brewer's yeast, and the corresponding capacity for the bioconversion of ethyl-3-oxobutanoate (@COMPOUND$) to ethyl (S)-3-hydroxybutanoate ((S)-EHB), were investigated.	1	18853207-1083
The effects of industrial storage on the changes of the cell viability and the activities of intracellular alcohol dehydrogenase (@PROTEIN$) and glucose-6-phosphate dehydrogenase (G6PDH) in brewer's yeast, and the corresponding capacity for the bioconversion of @COMPOUND$ (EOB) to ethyl (S)-3-hydroxybutanoate ((S)-EHB), were investigated.	1	18853207-1083
The intracellular levels of @PROTEIN$ and G6PDH after permeabilization of these stored cells with cetyltrimetylammonium bromide (@COMPOUND$) were much higher, which showed only slight decrease within 2 weeks during the industrial storage.	1	18853207-1084
The intracellular levels of ADH and @PROTEIN$ after permeabilization of these stored cells with cetyltrimetylammonium bromide (@COMPOUND$) were much higher, which showed only slight decrease within 2 weeks during the industrial storage.	1	18853207-1084
Streptokinase (SK), @PROTEIN$ (GOx) and @COMPOUND$ (PC) were immobilized onto PGLD to obtain a blood compatible bioconjugate with glucose sensing properties.	0	18853234-1098
Treatment of RPE cells with high @COMPOUND$-induced a significant increased of @PROTEIN$, accompanied by an increase in cell damage, NO and nitrotyrosine levels.	1	18854222-1462
High @COMPOUND$ causes increased cell damage and NO generation in RPE cells by a process of @PROTEIN$ expression that requires the activation of p38MAPK and ERK.	1	18854222-1464
High @COMPOUND$ causes increased cell damage and NO generation in RPE cells by a process of iNOS expression that requires the activation of p38MAPK and @PROTEIN$.	0	18854222-1464
High @COMPOUND$ causes increased cell damage and NO generation in RPE cells by a process of iNOS expression that requires the activation of @PROTEIN$ and ERK.	0	18854222-1464
A crude peel extract and purified fraction of Flemingia vestita, as well as a crude rhizome extract of Stephania glabra and fractions were tested with respect to the activity of @PROTEIN$, NO efflux and @COMPOUND$ concentration in the cestode Raillietina echinobothrida in order to find out the possible mode of anthelmintic action of these plant-derived components.	0	18854226-1467
Our data suggest that @PROTEIN$ translocates to the contractile system and anchors to TnI in a @COMPOUND$+)-dependent manner in the human heart, contributing to the maintenance of contractile force.	1	18854307-761
Our data suggest that PKCalpha translocates to the contractile system and anchors to @PROTEIN$ in a @COMPOUND$+)-dependent manner in the human heart, contributing to the maintenance of contractile force.	1	18854307-761
In this study, we describe the crystal structure of yeast @PROTEIN$ in complex with @COMPOUND$ (chitobiose).	1	18854368-1518
Mutagenesis studies confirm the critical role of the @COMPOUND$-interacting residues in substrate binding and suggest that efficient oligosaccharide binding is required for @PROTEIN$ activity.	1	18854368-1519
Prediction of the effect of erythromycin, @COMPOUND$, and their metabolites, alone and in combination, on @PROTEIN$ inhibition.	0	18854379-1521
Prediction of the effect of @COMPOUND$, diltiazem, and their metabolites, alone and in combination, on @PROTEIN$ inhibition.	0	18854379-1521
Previous studies have suggested a regulatory relationship between serum @COMPOUND$, vitamin D, and fibroblast growth factor 23 (@PROTEIN$), a hormone that promotes renal excretion of phosphate.	1	18854401-1524
Previous studies have suggested a regulatory relationship between serum phosphorus, @COMPOUND$, and fibroblast growth factor 23 (@PROTEIN$), a hormone that promotes renal excretion of phosphate.	1	18854401-1524
This condition is caused by mutations in the PTH/@PROTEIN$ receptor that result in ligand-independent @COMPOUND$ accumulation, thus rendering the receptor constitutively active.	1	18854401-1525
This condition is caused by mutations in the @PROTEIN$/PTHrP receptor that result in ligand-independent @COMPOUND$ accumulation, thus rendering the receptor constitutively active.	1	18854401-1525
Adiponectin, an adipokine secreted by the white adipose tissue, plays an important role in regulating @COMPOUND$ and lipid metabolism and controlling energy homeostasis in @PROTEIN$-sensitive tissues.	0	18854421-1530
@PROTEIN$ is involved in @COMPOUND$-stimulated proglucagon expression and hormone production but not hormone secretion in pancreatic alpha- and intestinal L-cell lines.	1	18854429-993
Both @PROTEIN$ and PKA are effectors of the second messenger @COMPOUND$.	1	18854429-994
Since a polypeptide lacking the @COMPOUND$-rich region (P-region) of @PROTEIN$ (103Q) cannot form aggresomes, this domain serves as an aggresome-targeting signal.	1	18854435-1007
Expression of @COMPOUND$ : @PROTEIN$ in gastric mucosa, intestinal metaplasia, and gastric carcinoma.	0	18854599-1421
@COMPOUND$ : @PROTEIN$ (ppGalNAc-T6) is one of the enzymes responsible for the initial step in O-glycosylation.	1	18854599-1422
In addition, SAH caused large increases in markers of inflammation, including @PROTEIN$ and NFkappaB, and markers of cell injury or cell death, including IgG endocytosis and caspase-3 activation, with @COMPOUND$ significantly reducing these effects.	1	18854840-1661
We conclude that block of @PROTEIN$ by @COMPOUND$ may ameliorate several pathologic effects associated with inflammation that lead to cortical dysfunction after SAH.	1	18854840-1662
Intrinsic fluorescence of @COMPOUND$-214 in @PROTEIN$ was monitored upon addition of the chemicals.	1	18854981-1711
The COMT enzyme breaks down extracellular @COMPOUND$ (DA) and has a particularly important role in the prefrontal cortex (PFC) where @PROTEIN$ are sparse.	1	18854987-1716
The @PROTEIN$ enzyme breaks down extracellular @COMPOUND$ (DA) and has a particularly important role in the prefrontal cortex (PFC) where DA transporters are sparse.	1	18854987-1716
CYP719A subfamily of @PROTEIN$ oxygenases and @COMPOUND$ alkaloid biosynthesis in Eschscholzia californica.	0	18854999-1723
The metal-@COMPOUND$ connectivity of recombinant Cd(7)-MT10 @PROTEIN$ from the sea mussel Mytilus galloprovincialis has been investigated for the first time by means of multinuclear, multidimensional NMR spectroscopy.	1	18855021-1734
Radical scavenging activity of lipophilized products from @PROTEIN$-catalyzed transesterification of @COMPOUND$ with cinnamic and ferulic acids.	1	18855035-1741
Lipase-catalyzed transesterification of @COMPOUND$ with cinnamic and ferulic acids using an immobilized @PROTEIN$ from Candida antarctica (E.C.	1	18855035-1742
@PROTEIN$-catalyzed transesterification of @COMPOUND$ with cinnamic and ferulic acids using an immobilized lipase from Candida antarctica (E.C.	1	18855035-1742
Validation of a food frequency questionnaire measurement of dietary acrylamide intake using @PROTEIN$ adducts of acrylamide and @COMPOUND$.	1	18855107-1775
Effects of weight loss on visceral and abdominal subcutaneous adipose tissue blood-flow and @PROTEIN$-mediated @COMPOUND$ uptake in healthy obese subjects.	1	18855190-2056
The study established that SPZ attenuated myocardial I/R injury through overexpression of @PROTEIN$, leading to enhancement of @COMPOUND$ bioavailability and tissue oxygenation.	1	18855521-439
The study established that @COMPOUND$ attenuated myocardial I/R injury through overexpression of @PROTEIN$, leading to enhancement of nitric oxide bioavailability and tissue oxygenation.	1	18855521-439
Currently, @COMPOUND$ (PLP)-dependent @PROTEIN$ (CBS) is thought to be the major H(2)S-producing enzyme in the brain.	1	18855522-1934
The purpose of this study was to propose a new preparation method to fabricate @PROTEIN$-loaded poly(lactic-coglycolic acid) (@COMPOUND$) microparticles satisfying protein loading, release profiles, burst release, and particularly stability of the encapsulated protein.	1	18855911-2115
This injury induces central sensitization leading to tactile allodynia and is mediated by activation of @COMPOUND$+) permeable AMPA/kainate receptors through @PROTEIN$ and PKA.	1	18855936-2128
Stimulation of choline @PROTEIN$ by @COMPOUND$, a neural cell adhesion molecule ligand.	1	18855942-2132
Transport properties of PIs by the drug efflux transporters P-gp and @PROTEIN$ (MRP1) were assessed by measuring the cellular uptake of (3)H-@COMPOUND$ or (3)H-ritonavir in P-gp and MRP1 overexpressing cells as well as hCMEC/D3.	1	18855943-2134
Transport properties of PIs by the drug efflux transporters P-gp and @PROTEIN$ (MRP1) were assessed by measuring the cellular uptake of (3)H-atazanavir or (3)H-@COMPOUND$ in P-gp and MRP1 overexpressing cells as well as hCMEC/D3.	1	18855943-2134
Incubation of L6 myotubes with palmitate (for 16 h) increases intramyocellular ceramide and reduces @PROTEIN$-stimulated PKB activation and @COMPOUND$ uptake.	0	18922131-2288
Incubation of L6 myotubes with palmitate (for 16 h) increases intramyocellular ceramide and reduces insulin-stimulated @PROTEIN$ activation and @COMPOUND$ uptake.	0	18922131-2288
This is the first @PROTEIN$ with a known primary structure and a glutamine instead of @COMPOUND$ residue at position 179 in the highly conserved-6 subsite, shown to be involved in substrate binding.	1	18922514-2447
This is the first @PROTEIN$ with a known primary structure and a @COMPOUND$ instead of glycine residue at position 179 in the highly conserved-6 subsite, shown to be involved in substrate binding.	1	18922514-2447
Functional @PROTEIN$ is not required for macrophage @COMPOUND$ efflux to human serum.	0	18922527-2451
The AbfR/S two-component system is required to activate the expression of the suite of enzymes that remove the numerous side chains from @COMPOUND$, but not the @PROTEIN$ that hydrolyze the beta1,4-linked xylose polymeric backbone of this polysaccharide.	0	18922794-2589
In agreement with molecular modeling predictions, the inhibitory action of pPTME and PTME toward intracellular @PROTEIN$ of LN229 cells exceeded that of the previous designed lead compound @COMPOUND$.	1	18922879-2629
Treatment with acidified saline reduced fetal basal pH from 7.35+/-0.01 to 7.29+/-0.01 but did not alter basal cardiovascular variables, blood @COMPOUND$, or plasma concentrations of catecholamines, @PROTEIN$, and cortisol.	0	18922958-2662
Treatment with acidified saline reduced fetal basal pH from 7.35+/-0.01 to 7.29+/-0.01 but did not alter basal cardiovascular variables, blood glucose, or plasma concentrations of catecholamines, @PROTEIN$, and @COMPOUND$.	0	18922958-2662
During hypoxemia, treatment with acidified saline increased the magnitude of the fetal bradycardia and femoral vasoconstriction and concomitantly increased chemoreflex function and enhanced the increments in plasma concentrations of catecholamines, @PROTEIN$, and @COMPOUND$.	0	18922958-2663
The induction of @PROTEIN$ by YC-1 was unchanged by the sGC inhibitor, 1H-(1,2,4)oxadiazolo(4,3-alpha)quinozalin-1-one (ODQ) or by the protein kinase pyrimidin-4-ylamine (@COMPOUND$).	0	18923065-2678
The induction of @PROTEIN$ by @COMPOUND$ was unchanged by the sGC inhibitor, 1H-(1,2,4)oxadiazolo(4,3-alpha)quinozalin-1-one (ODQ) or by the protein kinase pyrimidin-4-ylamine (BAY 41-2272).	1	18923065-2678
The induction of @PROTEIN$ by YC-1 was unchanged by the sGC inhibitor, 1H-(1,2,4)oxadiazolo(4,3-alpha)quinozalin-1-one (ODQ) or by the protein kinase @COMPOUND$ (BAY 41-2272).	0	18923065-2678
The induction of @PROTEIN$ by YC-1 was unchanged by the sGC inhibitor, 1H-(1,2,4)oxadiazolo(4,3-alpha)quinozalin-1-one (@COMPOUND$) or by the protein kinase pyrimidin-4-ylamine (BAY 41-2272).	0	18923065-2678
The potentiation was not altered by the beta(1) subunit or mediated by ARA-S metabolites, stimulation of known cannabinoid receptors, G proteins, @PROTEIN$, or @COMPOUND$+)-dependent processes; it was lost after patch excision or after membrane cholesterol depletion but was restored after cholesterol reconstitution.	0	18923087-1871
The potentiation was not altered by the beta(1) subunit or mediated by ARA-S metabolites, stimulation of known cannabinoid receptors, G proteins, @PROTEIN$, or Ca(2+)-dependent processes; it was lost after patch excision or after membrane @COMPOUND$ depletion but was restored after cholesterol reconstitution.	0	18923087-1871
Modulation of Rac1 activity by @COMPOUND$/@PROTEIN$ regulates pulmonary endothelial barrier function.	0	18923147-2705
Modulation of @PROTEIN$ activity by @COMPOUND$/DDAH regulates pulmonary endothelial barrier function.	1	18923147-2705
Endometriosis is associated with @COMPOUND$ resistance in the baboon (Papio anubis) oviduct: evidence based on the localization of @PROTEIN$ 1 (OVGP1).	0	18923157-2713
Endometriosis is associated with @COMPOUND$ resistance in the baboon (Papio anubis) oviduct: evidence based on the localization of oviductal glycoprotein 1 (@PROTEIN$).	1	18923157-2713
In this study we evaluated @PROTEIN$ and steroid receptor expression in oviducts of baboons with endometriosis during the midsecretory phase and determined whether @COMPOUND$ resistance associated with endometriosis also occurs in the oviduct.	1	18923157-2714
These data imply that the normal antagonism of @COMPOUND$ on ESR and @PROTEIN$, which results in their downregulation during the window of implantation, is absent in animals with endometriosis.	1	18923157-2715
These data imply that the normal antagonism of @COMPOUND$ on @PROTEIN$ and OVGP1, which results in their downregulation during the window of implantation, is absent in animals with endometriosis.	1	18923157-2715
In this study, we evaluated the distribution of the principal CD44 ligand @COMPOUND$ (HA) and the expressions of HA synthases (HAS: @PROTEIN$, HAS2, and HAS3) during atresia in pig ovaries.	0	18923162-2719
In this study, we evaluated the distribution of the principal CD44 ligand @COMPOUND$ (HA) and the expressions of @PROTEIN$ (HAS: HAS1, HAS2, and HAS3) during atresia in pig ovaries.	0	18923162-2719
In this study, we evaluated the distribution of the principal CD44 ligand @COMPOUND$ (HA) and the expressions of HA synthases (HAS: HAS1, HAS2, and @PROTEIN$) during atresia in pig ovaries.	0	18923162-2719
In this study, we evaluated the distribution of the principal CD44 ligand @COMPOUND$ (HA) and the expressions of HA synthases (HAS: HAS1, @PROTEIN$, and HAS3) during atresia in pig ovaries.	0	18923162-2719
Transgenic mice that overexpress rat @PROTEIN$ in their proximal tubule cells were given either @COMPOUND$, perindopril, or hydralazine while untreated or apocynin-treated non-transgenic littermates served as controls.	0	18923387-2775
Transgenic mice that overexpress rat @PROTEIN$ in their proximal tubule cells were given either apocynin, @COMPOUND$, or hydralazine while untreated or apocynin-treated non-transgenic littermates served as controls.	0	18923387-2775
Transgenic mice that overexpress rat @PROTEIN$ in their proximal tubule cells were given either apocynin, perindopril, or @COMPOUND$ while untreated or apocynin-treated non-transgenic littermates served as controls.	0	18923387-2775
Requirement of @PROTEIN$ for antidepressive efficiency of @COMPOUND$ : implication in adult hippocampal neurogenesis.	1	18923397-2783
Collectively, these findings suggest that @PROTEIN$ is required for the antidepressive action of @COMPOUND$ via regulating adult hippocampal neurogenesis.	1	18923397-2785
Although no significant change in the apparent K(m) was revealed in animals that exhibited an escalation in the rate of cocaine intake, an increased @COMPOUND$ uptake rate was found suggesting an upregulation of @PROTEIN$ number in response to a history of high cocaine intake.	1	18923398-2787
Previous work has shown that repeated @COMPOUND$ treatment causes downregulation of the norepinephrine transporter (@PROTEIN$) and persistent antidepressant-like effects on behavior, ie effects observed 2 days after discontinuation of drug treatment when acute effects are minimized.	1	18923402-2788
Previous work has shown that repeated @COMPOUND$ treatment causes downregulation of the @PROTEIN$ (NET) and persistent antidepressant-like effects on behavior, ie effects observed 2 days after discontinuation of drug treatment when acute effects are minimized.	1	18923402-2788
Treatment for 14 days with 70 mg/kg per day venlafaxine, which inhibits both the @PROTEIN$ and SERT, or 10 mg/kg per day @COMPOUND$, a monoamine oxidase inhibitor, produced antidepressant-like effects on behavior without altering NET or SERT expression.	0	18923402-2790
Treatment for 14 days with 70 mg/kg per day venlafaxine, which inhibits both the NET and @PROTEIN$, or 10 mg/kg per day @COMPOUND$, a monoamine oxidase inhibitor, produced antidepressant-like effects on behavior without altering NET or SERT expression.	0	18923402-2790
Studies in schizophrenia identify robust decreases in genes for GABA function, including glutamic acid decarboxylase, HINT1, @COMPOUND$ transport and GluRs, BDNF and @PROTEIN$, numerous 14-3-3 protein family members, and decreases in genes for CNS synaptic and metabolic functions, particularly glycolysis and ATP generation.	0	18923405-2791
Studies in schizophrenia identify robust decreases in genes for GABA function, including glutamic acid decarboxylase, HINT1, glutamate transport and GluRs, @PROTEIN$ and TrkB, numerous 14-3-3 protein family members, and decreases in genes for CNS synaptic and metabolic functions, particularly glycolysis and @COMPOUND$ generation.	0	18923405-2791
Studies in schizophrenia identify robust decreases in genes for GABA function, including glutamic acid decarboxylase, HINT1, @COMPOUND$ transport and GluRs, BDNF and TrkB, numerous @PROTEIN$ family members, and decreases in genes for CNS synaptic and metabolic functions, particularly glycolysis and ATP generation.	0	18923405-2791
Studies in schizophrenia identify robust decreases in genes for GABA function, including glutamic acid decarboxylase, HINT1, glutamate transport and GluRs, BDNF and @PROTEIN$, numerous 14-3-3 protein family members, and decreases in genes for CNS synaptic and metabolic functions, particularly glycolysis and @COMPOUND$ generation.	0	18923405-2791
Studies in schizophrenia identify robust decreases in genes for GABA function, including glutamic acid decarboxylase, @PROTEIN$, glutamate transport and GluRs, BDNF and TrkB, numerous 14-3-3 protein family members, and decreases in genes for CNS synaptic and metabolic functions, particularly glycolysis and @COMPOUND$ generation.	0	18923405-2791
Studies in schizophrenia identify robust decreases in genes for GABA function, including glutamic acid decarboxylase, @PROTEIN$, @COMPOUND$ transport and GluRs, BDNF and TrkB, numerous 14-3-3 protein family members, and decreases in genes for CNS synaptic and metabolic functions, particularly glycolysis and ATP generation.	0	18923405-2791
Studies in schizophrenia identify robust decreases in genes for GABA function, including glutamic acid decarboxylase, HINT1, glutamate transport and GluRs, BDNF and TrkB, numerous @PROTEIN$ family members, and decreases in genes for CNS synaptic and metabolic functions, particularly glycolysis and @COMPOUND$ generation.	0	18923405-2791
Studies in schizophrenia identify robust decreases in genes for GABA function, including glutamic acid decarboxylase, HINT1, @COMPOUND$ transport and GluRs, @PROTEIN$ and TrkB, numerous 14-3-3 protein family members, and decreases in genes for CNS synaptic and metabolic functions, particularly glycolysis and ATP generation.	0	18923405-2791
Brains from persons with major depressive disorder reveal decreased expression for genes in @COMPOUND$ transport and metabolism, neurotrophic signaling (eg, @PROTEIN$, BDNF and VGF), and MAP kinase pathways.	0	18923405-2792
Brains from persons with major depressive disorder reveal decreased expression for genes in @COMPOUND$ transport and metabolism, neurotrophic signaling (eg, FGF, @PROTEIN$ and VGF), and MAP kinase pathways.	0	18923405-2792
Brains from persons with major depressive disorder reveal decreased expression for genes in @COMPOUND$ transport and metabolism, neurotrophic signaling (eg, FGF, BDNF and @PROTEIN$), and MAP kinase pathways.	0	18923405-2792
However, detection of @COMPOUND$ and Zn in @PROTEIN$ after PAGE-LA-ICP-MS depends on the conditions of the PAGE method because possible metal losses can occur (either with SDS-PAGE or with native PAGE).	1	18923823-499
Recent studies have suggested that a decrease in the specific activity of the 2-@PROTEIN$ complex (ODHC) is important for @COMPOUND$ overproduction by Corynebacterium glutamicum.	1	18923827-111
To evaluate the potential of using heme-containing lipocalin nitrophorin 1 (@PROTEIN$) as a template for protein engineering, we have replaced the native axial heme-coordinating @COMPOUND$ residue with glycine, alanine, and cysteine.	0	18923851-130
To evaluate the potential of using heme-containing lipocalin nitrophorin 1 (@PROTEIN$) as a template for protein engineering, we have replaced the native axial heme-coordinating histidine residue with glycine, @COMPOUND$, and cysteine.	0	18923851-130
To evaluate the potential of using heme-containing lipocalin nitrophorin 1 (@PROTEIN$) as a template for protein engineering, we have replaced the native axial heme-coordinating histidine residue with @COMPOUND$, alanine, and cysteine.	0	18923851-130
To evaluate the potential of using heme-containing lipocalin nitrophorin 1 (@PROTEIN$) as a template for protein engineering, we have replaced the native axial heme-coordinating histidine residue with glycine, alanine, and @COMPOUND$.	0	18923851-130
Two crystal structures of the H60C_ @PROTEIN$ in complex with @COMPOUND$ and histamine were solved to 1.7- and 1.96-A resolution, respectively.	1	18923851-133
Two crystal structures of the H60C_ @PROTEIN$ in complex with imidazole and @COMPOUND$ were solved to 1.7- and 1.96-A resolution, respectively.	1	18923851-133
Both structures show that the H60C mutation is well tolerated by the protein scaffold and suggest that heme-@COMPOUND$ coordination in H60C_ @PROTEIN$ requires some movement of the heme within its binding cavity.	0	18923851-134
Both structures show that the H60C mutation is well tolerated by the protein scaffold and suggest that @COMPOUND$-thiolate coordination in H60C_ @PROTEIN$ requires some movement of the heme within its binding cavity.	0	18923851-134
Anticancer effect of @COMPOUND$ via @PROTEIN$ dependent and independent mechanisms in human gastric cancers cells.	1	18923901-159
Real-time polymerase chain reaction analysis of hypoxic, NO-@COMPOUND$ treated PC-3 cells showed downregulation of lysyl oxidase and @PROTEIN$ mRNA expression.	1	18924134-216
Real-time polymerase chain reaction analysis of hypoxic, NO-@COMPOUND$ treated PC-3 cells showed downregulation of @PROTEIN$ and carbonic anhydrase IX mRNA expression.	1	18924134-216
Established risk cardiovascular factors like hypertension, atherogenic dyslipidaemia, and @COMPOUND$ intolerance occur in the setting of @PROTEIN$ resistance and central adiposity, with genetic and environmental influences modulating the ultimate risk.	1	18925358-887
Despite this lack of oxidative and cytotoxic action, exposure of hepatoma cells to @COMPOUND$+) resulted in a significant activation of @PROTEIN$ that was abrogated by inhibitors of PI3K.	1	18925359-508
Gas exchange was monitored and blood samples were collected during exercise for GH, @PROTEIN$, insulin, and blood glucose and @COMPOUND$ determination.	0	18925413-539
Gas exchange was monitored and blood samples were collected during exercise for GH, ACTH, @PROTEIN$, and blood @COMPOUND$ and lactate determination.	0	18925413-539
Gas exchange was monitored and blood samples were collected during exercise for GH, ACTH, @PROTEIN$, and blood glucose and @COMPOUND$ determination.	0	18925413-539
Gas exchange was monitored and blood samples were collected during exercise for GH, @PROTEIN$, insulin, and blood @COMPOUND$ and lactate determination.	0	18925413-539
The chimera was at least fourfold less sensitive to inhibition by okadaic acid, but was stimulated by nickel ions and @COMPOUND$, characteristics of @PROTEIN$ not of PP1.	1	18925649-643
The chimera was at least fourfold less sensitive to inhibition by okadaic acid, but was stimulated by @COMPOUND$ and chlorogenic acid, characteristics of @PROTEIN$ not of PP1.	1	18925649-643
The chimera was at least fourfold less sensitive to inhibition by okadaic acid, but was stimulated by @COMPOUND$ and chlorogenic acid, characteristics of PP2B not of @PROTEIN$.	0	18925649-643
The chimera was at least fourfold less sensitive to inhibition by okadaic acid, but was stimulated by nickel ions and @COMPOUND$, characteristics of PP2B not of @PROTEIN$.	0	18925649-643
Because o-quinones are very unstable, we used an oxymetric method to characterize the kinetics of this substrate, based on measurements of the @COMPOUND$ consumed in the @PROTEIN$ reaction.	1	18925653-646
Plasma levels of @COMPOUND$, cortisol, and @PROTEIN$ were measured.	0	18925655-1527
Plasma levels of citalopram, @COMPOUND$, and @PROTEIN$ were measured.	0	18925655-1527
An increase in @COMPOUND$ and @PROTEIN$ concentrations was observed from the EOI until 60 min after the EOI.	0	18925655-1528
Different lag-time of pulse-released nerve growth factor (@PROTEIN$) from genipin-crosslinked gelatin within @COMPOUND$ (PCL) conduits was evaluated in large-gap peripheral nerve repair.	0	18925830-712
Different lag-time of pulse-released nerve growth factor (@PROTEIN$) from @COMPOUND$-crosslinked gelatin within polycaprolactone (PCL) conduits was evaluated in large-gap peripheral nerve repair.	0	18925830-712
In this study, 10% (w/v) gelatin was mixed with @PROTEIN$, crosslinked with 0%, 0.1%, 0.5%, and 1% (w/v) @COMPOUND$, and then sucked into the wall of PCL conduits.	0	18925830-713
It was found from this group that @COMPOUND$ was the best alternative to warfarin for examining the interactions of drugs at Sudlow site I on @PROTEIN$.	1	18926542-922
Effects of @PROTEIN$/ANKK1 gene variations and clinical factors on @COMPOUND$ efficacy in schizophrenic patients.	1	18926547-923
Effects of DRD2/@PROTEIN$ gene variations and clinical factors on @COMPOUND$ efficacy in schizophrenic patients.	1	18926547-923
The majority of patients with acute depression shows an exaggerated plasma corticotrophin (@PROTEIN$) and @COMPOUND$ response to this test that normalizes gradually during successful antidepressant therapy.	0	18926641-955
We examined plasma @PROTEIN$ and @COMPOUND$ responses to the dex/CRH test in acutely depressed inpatients treated either with mirtazapine (n=55) or a monoamine reuptake inhibitor (n=105) according to doctor's choice and compared the test results with healthy controls (n=40).	0	18926641-956
Both extracts increased AMP-kinase phosphorylation and @PROTEIN$ phosphorylation by 2.5-to 4-fold, but with different time courses: maximal phosphorylation with @COMPOUND$ was evident within 30 min of treatment, whereas with black tea phosphorylation was slower to develop, with maximal phosphorylation occurring &gt; or =3 hours after treatment.	1	18926682-975
However, the ethyl ester of commipheric acid (150 mg/kg, twice daily) lowered fasting blood @COMPOUND$ and plasma @PROTEIN$, and plasma triglycerides without affecting food intake or body weight.	0	18926687-978
This finding led the authors to propose that @PROTEIN$ may be involved in the pathogenesis of psoriasis through its potential role in @COMPOUND$ biosynthesis and stimulation of keratinocyte proliferation.	1	18926804-1008
In this study, we began the characterization of @PROTEIN$ protein in order to determine whether it might play a role in @COMPOUND$ biosynthesis.	0	18926804-1010
The preference for NAD(+) suggests that @PROTEIN$ is likely to function in the oxidative direction in vivo, further supporting its potential role in the oxidation of retinol to retinaldehyde for @COMPOUND$ biosynthesis in human keratinocytes.	1	18926804-1011
Identification of Aldh1a, @PROTEIN$ and RAR orthologs in protostomes pushes back the @COMPOUND$ genetic machinery in evolutionary time to the bilaterian ancestor.	1	18926806-1012
As release of @COMPOUND$ can be a rate-limiting step for @PROTEIN$ activity, NADH binding was evaluated for R166wt and R166H enzymes.	1	18926807-1161
@COMPOUND$ is the most powerful intracellular antioxidant and plays a role in the detoxification of a variety of electrophilic compounds and peroxides via catalysis by glutathione-S-transferases (@PROTEIN$) and glutathione peroxidases (GPx).	1	18926849-1039
@COMPOUND$ is the most powerful intracellular antioxidant and plays a role in the detoxification of a variety of electrophilic compounds and peroxides via catalysis by glutathione-S-transferases (GST) and @PROTEIN$ (GPx).	1	18926849-1039
@COMPOUND$ is the most powerful intracellular antioxidant and plays a role in the detoxification of a variety of electrophilic compounds and peroxides via catalysis by @PROTEIN$ (GST) and glutathione peroxidases (GPx).	1	18926849-1039
Peripheral @PROTEIN$ gastroprotection against @COMPOUND$ : the role of exendin, NO, CGRP, prostaglandins and blood flow.	0	18926859-1152
Peripheral GLP-1 gastroprotection against @COMPOUND$ : the role of exendin, NO, @PROTEIN$, prostaglandins and blood flow.	0	18926859-1152
@COMPOUND$ was administered through an orogastric cannula right after the injection of @PROTEIN$ (1, 10, 100, 1000 or 10,000 ng/kg; i.p.).	0	18926859-1154
It inhibited Trypanosoma brucei @PROTEIN$ with an IC(50) value of 240 microM and has been shown to be a competitive reversible inhibitor (Ki=200+/-10 microM) of this enzyme with respect to its cofactor @COMPOUND$ (+).	1	18926889-1065
We have also described LD between @PROTEIN$ alleles and HLA class II DRB1 allelic groups and found significant LD between DRB104-G01B, DRB113-G010401, DRB114-G010108, DRB115-@COMPOUND$, DRB103-G0101A and DRB103-G01B.	0	18926911-1076
We have also described LD between HLA-G alleles and HLA class II @PROTEIN$ allelic groups and found significant LD between DRB104-G01B, DRB113-G010401, DRB114-G010108, DRB115-@COMPOUND$, DRB103-G0101A and DRB103-G01B.	0	18926911-1076
@COMPOUND$ oligonucleotide-induced expression of truncated @PROTEIN$ in the brains of mdx mice, but not in the muscle, ameliorated the abnormal freezing response to restraint.	1	18927146-1139
It is suggested that in this animal model, characterized by TSH elevation and low-grade inflammation, an increased expression and function of @PROTEIN$, resulting in @COMPOUND$ generation, accounts for an impaired NO availability.	1	18927216-1186
Selective elevation of adiponectin production by the natural compounds derived from a medicinal herb alleviates @PROTEIN$ resistance and @COMPOUND$ intolerance in obese mice.	0	18927219-1190
These changes were associated with an alleviation of hyperglycemia, @COMPOUND$ intolerance, and @PROTEIN$ resistance.	0	18927219-1192
Vernakalant was metabolized rapidly via 4-O-demethylation by @PROTEIN$ (CYP)2D6 to its major metabolite RSD1385, which then circulated predominantly as an inactive @COMPOUND$ conjugate.	0	18927241-1195
Vernakalant was metabolized rapidly via 4-O-demethylation by cytochrome P450 (@PROTEIN$)2D6 to its major metabolite RSD1385, which then circulated predominantly as an inactive @COMPOUND$ conjugate.	0	18927241-1195
We assessed in vivo carotid sinus nerve activity (CSNA) at baseline, in response to acute hypoxia, in response to infused @COMPOUND$, and in response to infused endothelin-1 (@PROTEIN$) with and without MK-801, an NMDA receptor blocker.	0	18927268-1200
We assessed in vivo carotid sinus nerve activity (CSNA) at baseline, in response to acute hypoxia, in response to infused @COMPOUND$, and in response to infused @PROTEIN$ (ET-1) with and without MK-801, an NMDA receptor blocker.	0	18927268-1200
Thus, CS-mediated down-regulation of @PROTEIN$ in human macrophages and lung epithelial cells in vitro and in mouse lung in vivo involves the induction of @COMPOUND$/threonine phosphorylation and proteasomal degradation, which may have implications for steroid resistance and abnormal inflammation caused by cigarette smoke.	0	18927347-1235
Thus, CS-mediated down-regulation of @PROTEIN$ in human macrophages and lung epithelial cells in vitro and in mouse lung in vivo involves the induction of serine/@COMPOUND$ phosphorylation and proteasomal degradation, which may have implications for steroid resistance and abnormal inflammation caused by cigarette smoke.	0	18927347-1235
Immunofluorescence microscopy of live human umbilical vein endothelial cells showed that @PROTEIN$ multimers rapidly formed strings several hundred micrometers long on the cell surface after stimulation with @COMPOUND$.	1	18927433-1257
Soluble P-selectin reduced the number of platelet-decorated @PROTEIN$ strings in the absence of @COMPOUND$+) and Mg(2+) but had no effect in the presence of these cations.	1	18927433-1258
To examine the relationship of functional expression of @PROTEIN$ to prognosis in AML, we studied marrow samples from 175 adult AML patients who underwent induction chemotherapy with anthracycline and @COMPOUND$ on Southwest Oncology Group trials.	0	18927435-1259
Independent lines of research involving biochemical and behavioral approaches in normal and/or genetically modified mice provide converging evidence for an involvement of the signaling molecules Akt and glycogen synthase kinase-3 (@PROTEIN$) in the regulation of behavior by dopamine and serotonin (@COMPOUND$).	1	18928402-1632
Independent lines of research involving biochemical and behavioral approaches in normal and/or genetically modified mice provide converging evidence for an involvement of the signaling molecules @PROTEIN$ and glycogen synthase kinase-3 (GSK3) in the regulation of behavior by dopamine and @COMPOUND$ (5-HT).	1	18928402-1632
Independent lines of research involving biochemical and behavioral approaches in normal and/or genetically modified mice provide converging evidence for an involvement of the signaling molecules Akt and glycogen synthase kinase-3 (@PROTEIN$) in the regulation of behavior by dopamine and @COMPOUND$ (5-HT).	1	18928402-1632
Independent lines of research involving biochemical and behavioral approaches in normal and/or genetically modified mice provide converging evidence for an involvement of the signaling molecules @PROTEIN$ and glycogen synthase kinase-3 (GSK3) in the regulation of behavior by @COMPOUND$ and serotonin (5-HT).	1	18928402-1632
Independent lines of research involving biochemical and behavioral approaches in normal and/or genetically modified mice provide converging evidence for an involvement of the signaling molecules Akt and glycogen synthase kinase-3 (@PROTEIN$) in the regulation of behavior by @COMPOUND$ and serotonin (5-HT).	1	18928402-1632
Independent lines of research involving biochemical and behavioral approaches in normal and/or genetically modified mice provide converging evidence for an involvement of the signaling molecules @PROTEIN$ and glycogen synthase kinase-3 (GSK3) in the regulation of behavior by dopamine and serotonin (@COMPOUND$).	1	18928402-1632
Inhibition of @PROTEIN$ by @COMPOUND$ in vivo suppressed the inflammatory response in mice infected with F. tularensis LVS and conferred a survival advantage.	1	18929413-2021
The capacity for osmotic adjustment, superoxide dismutase (@PROTEIN$) and ascorbate peroxidase (APX) activities and @COMPOUND$ content were also elevated in the transgenic Arabidopsis plants.	0	18929429-2031
The capacity for osmotic adjustment, superoxide dismutase (SOD) and ascorbate peroxidase (@PROTEIN$) activities and @COMPOUND$ content were also elevated in the transgenic Arabidopsis plants.	0	18929429-2031
The capacity for osmotic adjustment, @PROTEIN$ (SOD) and ascorbate peroxidase (APX) activities and @COMPOUND$ content were also elevated in the transgenic Arabidopsis plants.	0	18929429-2031
To prevent the effects of interfering anionic species, such as uric acid and ascorbic acid, on the sensor response, the Pt-Ir electrode was coated with @COMPOUND$, and then @PROTEIN$ was immobilized on the coated electrode.	0	18929477-2059
To prevent the effects of interfering anionic species, such as @COMPOUND$ and ascorbic acid, on the sensor response, the Pt-Ir electrode was coated with Nafion, and then @PROTEIN$ was immobilized on the coated electrode.	0	18929477-2059
To prevent the effects of interfering anionic species, such as uric acid and @COMPOUND$, on the sensor response, the Pt-Ir electrode was coated with Nafion, and then @PROTEIN$ was immobilized on the coated electrode.	0	18929477-2059
A naturally occurring glycine to @COMPOUND$ mutation at position 169 (G169D) in the putative transmembrane domain 4 (@PROTEIN$) makes mice susceptible to Salmonella typhimurim, Leishmania donovani, and Mycobacterium bovis.	1	18929666-2130
A naturally occurring @COMPOUND$ to aspartic acid mutation at position 169 (G169D) in the putative transmembrane domain 4 (@PROTEIN$) makes mice susceptible to Salmonella typhimurim, Leishmania donovani, and Mycobacterium bovis.	1	18929666-2130
Serum free @COMPOUND$ in association with @PROTEIN$ as a diagnostic marker of acute myocardial infarction.	1	18930039-2213
The aim of this study was to monitor the level of serum free @COMPOUND$ in combination with @PROTEIN$ (Myo) and creatine kinase (total activity and CK-MB level) for usefulness as a predictor of AMI in ICU patients.	0	18930039-2214
Curcuminoids inhibited @PROTEIN$ in the in-vitro assay with IC(50) value of 19.67, @COMPOUND$ 16.84, demethoxycurcumin 33.14 and curcumin 67.69 microM.	1	18930076-2223
L-@COMPOUND$ was the most effective promoter of @PROTEIN$ absorption compared with others CPPs.	1	18930084-2225
A dose-dependent relationship of L-@COMPOUND$ and @PROTEIN$ bioavailability was statically significant.	1	18930084-2226
There was no significant difference in the release of @PROTEIN$ in nasal lavage fluid and the integrity of nasal respiratory epithelium when L-@COMPOUND$ was present.	0	18930084-2227
Osteoblasts up-regulate the expression of extracellular @PROTEIN$ following attachment to @COMPOUND$).	1	18930122-2233
Pharmacological stimulation of @PROTEIN$ channels with @COMPOUND$ (10 nM) selectively enhanced the frequency of glutamate-mediated spontaneous (sEPSCs) and miniature excitatory postsynaptic currents (mEPSCs) recorded from putative striatal medium spiny neurons.	1	18930149-2366
Consistently, the totality of striatal neurons responded to capsaicin (10 nM or 10 microM) after prevention of desensitization of @PROTEIN$ channels with the protein kinase C (PKC) activator phorbol 12-myristate 13-acetate (@COMPOUND$).	1	18930149-2367
Consistently, the totality of striatal neurons responded to @COMPOUND$ (10 nM or 10 microM) after prevention of desensitization of @PROTEIN$ channels with the protein kinase C (PKC) activator phorbol 12-myristate 13-acetate (PMA).	1	18930149-2367
Consistently, the totality of striatal neurons responded to capsaicin (10 nM or 10 microM) after prevention of desensitization of @PROTEIN$ channels with the protein kinase C (PKC) activator @COMPOUND$ (PMA).	1	18930149-2367
The effects of capsaicin and of @COMPOUND$ were absent after pharmacological or genetic inactivation of @PROTEIN$ channels.	1	18930149-2368
The effects of @COMPOUND$ and of PMA were absent after pharmacological or genetic inactivation of @PROTEIN$ channels.	1	18930149-2368
Finally, we provided evidence for @COMPOUND$ as an endovanilloid substance in the striatum, since genetic inhibition of anandamide degradation resulted in a tonic activation of @PROTEIN$ channels modulating glutamate but not GABA release.	1	18930149-2369
With the exception of significantly elevated serum @PROTEIN$ after @COMPOUND$, no effects in the secondary outcome measures were detected.	1	18930474-2338
The cellular response to dsRNA or its synthetic analog @COMPOUND$ (poly I:C) results in IRF-3-, @PROTEIN$- and NF-kB-mediated activation of type 1 IFNs and pro-inflammatory cytokines critical for innate antiviral immune responses.	1	18930547-2375
The cellular response to dsRNA or its synthetic analog polyinosinic-polycytidylic acid (@COMPOUND$) results in @PROTEIN$-, IRF-7- and NF-kB-mediated activation of type 1 IFNs and pro-inflammatory cytokines critical for innate antiviral immune responses.	1	18930547-2375
The cellular response to dsRNA or its synthetic analog @COMPOUND$ (poly I:C) results in @PROTEIN$-, IRF-7- and NF-kB-mediated activation of type 1 IFNs and pro-inflammatory cytokines critical for innate antiviral immune responses.	1	18930547-2375
The cellular response to dsRNA or its synthetic analog polyinosinic-polycytidylic acid (@COMPOUND$) results in IRF-3-, @PROTEIN$- and NF-kB-mediated activation of type 1 IFNs and pro-inflammatory cytokines critical for innate antiviral immune responses.	1	18930547-2375
@COMPOUND$ toxicity is aggravated in people deficient of 6-glucose phosphate dehydrogenase or @PROTEIN$.	1	18930565-2381
Levels of interleukin-8 (@PROTEIN$) and @COMPOUND$ were measured in epithelial lining fluid (ELF) from central and peripheral airways separately collected using a bronchoscopic microsampling technique.	0	18930648-795
Levels of @PROTEIN$ (IL-8) and @COMPOUND$ were measured in epithelial lining fluid (ELF) from central and peripheral airways separately collected using a bronchoscopic microsampling technique.	0	18930648-795
Fluoroimmunoassay based on the fluorescent property of quantum dot was used along with immunoassay to detect 2,4-D. CdTe capped with mercaptopropionic acid, was conjugated using N-(3-dimethylaminopropyl)-N-ethylcarbodiimide hydrochloride (EDC) and a coupling reagent like @COMPOUND$ (NHS) to alkaline phosphatase (@PROTEIN$) which was in turn conjugated to 2,4-D molecule.	1	18930650-823
Fluoroimmunoassay based on the fluorescent property of quantum dot was used along with immunoassay to detect 2,4-D. CdTe capped with mercaptopropionic acid, was conjugated using N-(3-dimethylaminopropyl)-N-ethylcarbodiimide hydrochloride (EDC) and a coupling reagent like @COMPOUND$ (NHS) to @PROTEIN$ (ALP) which was in turn conjugated to 2,4-D molecule.	1	18930650-823
The SoxN protein is proposed to harbor the heme b of lower reduction potential and the @COMPOUND$ (s), and @PROTEIN$ the other heme b.	0	18930705-2444
Seleno-L-methionine (SeMet) can be oxidized to L-methionine selenoxide (MetSeO) by flavin-containing monooxygenase 3 (@PROTEIN$) and rat liver microsomes in the presence of @COMPOUND$.	1	18930712-2448
Regulatory roles for Tiam1, a guanine nucleotide exchange factor for @PROTEIN$, in @COMPOUND$-stimulated insulin secretion in pancreatic beta-cells.	0	18930714-667
Regulatory roles for Tiam1, a guanine nucleotide exchange factor for Rac1, in @COMPOUND$-stimulated @PROTEIN$ secretion in pancreatic beta-cells.	1	18930714-667
Regulatory roles for @PROTEIN$, a guanine nucleotide exchange factor for Rac1, in @COMPOUND$-stimulated insulin secretion in pancreatic beta-cells.	0	18930714-667
Using various biochemical, pharmacological and molecular biological approaches, we have recently reported regulatory roles for Rac1, a @PROTEIN$, in @COMPOUND$-stimulated insulin secretion (GSIS).	0	18930714-668
Using various biochemical, pharmacological and molecular biological approaches, we have recently reported regulatory roles for Rac1, a small G-protein, in @COMPOUND$-stimulated @PROTEIN$ secretion (GSIS).	1	18930714-668
Using various biochemical, pharmacological and molecular biological approaches, we have recently reported regulatory roles for @PROTEIN$, a small G-protein, in @COMPOUND$-stimulated insulin secretion (GSIS).	0	18930714-668
@COMPOUND$-bound form) and membrane association of @PROTEIN$ in INS 832/13 cells and rat islets.	0	18930714-670
Interestingly, however, in contrast to the inhibitory effects of @COMPOUND$, @PROTEIN$ gene depletion potentiated GSIS in these cells; such a potentiation of GSIS was sensitive to extracellular calcium.	0	18930714-671
This vector allows the co-expression of alpha-Hb as a fusion protein with @PROTEIN$ (GST-alpha-Hb) and beta-Hb with an additional @COMPOUND$ at the N-terminal extremity (rbeta-Hb).	0	18930760-2475
This vector allows the co-expression of alpha-Hb as a fusion protein with Glutathione S-Transferase (@PROTEIN$-alpha-Hb) and beta-Hb with an additional @COMPOUND$ at the N-terminal extremity (rbeta-Hb).	0	18930760-2475
@PROTEIN$ (SOD), catalase (CAT), and glutathione peroxidase (GSH-Px) activities as well as thiobarbituric acid reactive substances (TBARSs) and @COMPOUND$ (NO) levels were analysed in erythrocyte and plasma of rats.	0	18930779-791
Superoxide dismutase (SOD), @PROTEIN$ (CAT), and glutathione peroxidase (GSH-Px) activities as well as thiobarbituric acid reactive substances (TBARSs) and @COMPOUND$ (NO) levels were analysed in erythrocyte and plasma of rats.	0	18930779-791
@PROTEIN$ (SOD), catalase (CAT), and glutathione peroxidase (GSH-Px) activities as well as @COMPOUND$ reactive substances (TBARSs) and nitric oxide (NO) levels were analysed in erythrocyte and plasma of rats.	0	18930779-791
Superoxide dismutase (SOD), catalase (CAT), and @PROTEIN$ (GSH-Px) activities as well as @COMPOUND$ reactive substances (TBARSs) and nitric oxide (NO) levels were analysed in erythrocyte and plasma of rats.	0	18930779-791
Superoxide dismutase (SOD), catalase (CAT), and @PROTEIN$ (GSH-Px) activities as well as thiobarbituric acid reactive substances (TBARSs) and @COMPOUND$ (NO) levels were analysed in erythrocyte and plasma of rats.	0	18930779-791
Superoxide dismutase (SOD), @PROTEIN$ (CAT), and glutathione peroxidase (GSH-Px) activities as well as @COMPOUND$ reactive substances (TBARSs) and nitric oxide (NO) levels were analysed in erythrocyte and plasma of rats.	0	18930779-791
Superoxide dismutase (@PROTEIN$), catalase (CAT), and glutathione peroxidase (GSH-Px) activities as well as thiobarbituric acid reactive substances (TBARSs) and @COMPOUND$ (NO) levels were analysed in erythrocyte and plasma of rats.	0	18930779-791
Superoxide dismutase (@PROTEIN$), catalase (CAT), and glutathione peroxidase (GSH-Px) activities as well as @COMPOUND$ reactive substances (TBARSs) and nitric oxide (NO) levels were analysed in erythrocyte and plasma of rats.	0	18930779-791
Superoxide dismutase (SOD), catalase (@PROTEIN$), and glutathione peroxidase (GSH-Px) activities as well as @COMPOUND$ reactive substances (TBARSs) and nitric oxide (NO) levels were analysed in erythrocyte and plasma of rats.	0	18930779-791
Superoxide dismutase (SOD), catalase (@PROTEIN$), and glutathione peroxidase (GSH-Px) activities as well as thiobarbituric acid reactive substances (TBARSs) and @COMPOUND$ (NO) levels were analysed in erythrocyte and plasma of rats.	0	18930779-791
The erythrocyte @PROTEIN$ activity was higher in @COMPOUND$ group and there was a statistically significant increase, when compared with the erdosteine plus ischemia/reperfusion group.	1	18930779-793
The ethidium bromide (EB) demyelinating model was associated with vitamin E (Vit E) and @COMPOUND$ (Ebs) treatment to evaluate @PROTEIN$ (AChE) activity in the striatum (ST), hippocampus (HP), cerebral cortex (CC) and erythrocytes.	0	18930802-2496
The ethidium bromide (EB) demyelinating model was associated with vitamin E (Vit E) and @COMPOUND$ (Ebs) treatment to evaluate acetylcholinesterase (@PROTEIN$) activity in the striatum (ST), hippocampus (HP), cerebral cortex (CC) and erythrocytes.	0	18930802-2496
The ethidium bromide (EB) demyelinating model was associated with @COMPOUND$ (Vit E) and ebselen (Ebs) treatment to evaluate @PROTEIN$ (AChE) activity in the striatum (ST), hippocampus (HP), cerebral cortex (CC) and erythrocytes.	0	18930802-2496
The ethidium bromide (EB) demyelinating model was associated with @COMPOUND$ (Vit E) and ebselen (Ebs) treatment to evaluate acetylcholinesterase (@PROTEIN$) activity in the striatum (ST), hippocampus (HP), cerebral cortex (CC) and erythrocytes.	0	18930802-2496
A search of publicly available microarray data reveals that expression of mitochondrial manganese superoxide dismutase (@PROTEIN$), responsible for the conversion of superoxide (O(2)(-)) to @COMPOUND$ (H(2)O(2)), is consistently increased in high-grade and advanced-stage bladder tumors.	1	18930813-875
A search of publicly available microarray data reveals that expression of mitochondrial manganese @PROTEIN$ (Sod2), responsible for the conversion of superoxide (O(2)(-)) to @COMPOUND$ (H(2)O(2)), is consistently increased in high-grade and advanced-stage bladder tumors.	1	18930813-875
In vivo @PROTEIN$ blockade by @COMPOUND$ significantly increased infarct volumes at 24 h in mice undergoing 30 min of transient middle cerebral artery occlusion (tMCAO).	1	18930826-2517
Glutathione S-transferases (@PROTEIN$) are multifunctional phase II detoxification enzymes that catalyze the attachment of electrophilic substrates to @COMPOUND$.	1	18930833-2520
@PROTEIN$ (GSTs) are multifunctional phase II detoxification enzymes that catalyze the attachment of electrophilic substrates to @COMPOUND$.	1	18930833-2520
It can use a dithiol-disulfide active-site to transfer reducing equivalents from @COMPOUND$ to thioredoxin (@PROTEIN$), via the cofactor FAD.	1	18930846-916
It can use a dithiol-disulfide active-site to transfer reducing equivalents from @COMPOUND$ to @PROTEIN$ (Trx), via the cofactor FAD.	1	18930846-916
@PROTEIN$ (HIF-1alpha) is a transcription factor that plays an essential role in @COMPOUND$ homeostasis.	1	18930903-626
Hypoxia-inducible factor-1alpha (@PROTEIN$) is a transcription factor that plays an essential role in @COMPOUND$ homeostasis.	1	18930903-626
However, @PROTEIN$, a protein with no active site @COMPOUND$, was covalently modified in vitro by 0.5mM 10-fluoroethoxyphosphinyl-N-biotinamido pentyldecanamide, chlorpyrifos oxon, diisopropylfluorophosphate, dichlorvos, sarin, and soman.	0	18930948-1088
The mechanism of lysoPAF-mediated inhibition of neutrophils involves an elevation in the intracellular @COMPOUND$ level, and pharmacological blockade of @PROTEIN$ completely reverses the inhibitory effect of lysoPAF.	1	18931035-2612
Sympathetic neurogenic Ca2+ signalling in rat arteries: ATP, @COMPOUND$ and @PROTEIN$.	0	18931047-2620
Sympathetic neurogenic Ca2+ signalling in rat arteries: @COMPOUND$, noradrenaline and @PROTEIN$.	0	18931047-2620
DnaB (BA) demonstrated a strong DNA @PROTEIN$ activity that required ATP or @COMPOUND$.	1	18931108-2645
@PROTEIN$ (BA) demonstrated a strong DNA helicase activity that required ATP or @COMPOUND$.	1	18931108-2645
@PROTEIN$ (BA) demonstrated a strong DNA helicase activity that required @COMPOUND$ or dATP.	1	18931108-2645
DnaB (BA) demonstrated a strong DNA @PROTEIN$ activity that required @COMPOUND$ or dATP.	1	18931108-2645
MerH was found to transport mercuric ions in Escherichia coli via a pair of essential @COMPOUND$ residues but only when coexpressed with the @PROTEIN$.	0	18931130-230
HmuY and @PROTEIN$ are @COMPOUND$ binding proteins required for P. gingivalis growth.	1	18931136-2657
The effect of tropomyosin on @PROTEIN$ filaments was independent of ionic strength, but became stronger as the @COMPOUND$ concentration increased.	1	18931257-1820
The effect of @PROTEIN$ on actin filaments was independent of ionic strength, but became stronger as the @COMPOUND$ concentration increased.	1	18931257-1820
We showed that, compared with the untreated CF serous cells, a 24-hour pre-incubation period with 200 nM salmeterol induced an 83% increase in delF508-@PROTEIN$-mediated @COMPOUND$ efflux.	1	18931328-2696
Activation of Bax and @PROTEIN$ was demonstrated in peripheral blood mononuclear cells, and induction of apoptosis was related to overall @COMPOUND$ exposure, as monitored by the plasma concentration of oligonucleosomal DNA/histone complexes.	0	18931344-2072
Activation of @PROTEIN$ and Bak was demonstrated in peripheral blood mononuclear cells, and induction of apoptosis was related to overall @COMPOUND$ exposure, as monitored by the plasma concentration of oligonucleosomal DNA/histone complexes.	0	18931344-2072
Liver @COMPOUND$ DNA adducts and acrylamide and glycidamide N-terminal valine @PROTEIN$ adducts were also determined.	0	18931380-2724
Liver glycidamide DNA adducts and acrylamide and glycidamide N-terminal @COMPOUND$ @PROTEIN$ adducts were also determined.	1	18931380-2724
Liver glycidamide DNA adducts and @COMPOUND$ and glycidamide N-terminal valine @PROTEIN$ adducts were also determined.	0	18931380-2724
The acyl @PROTEIN$ peptide features a unique post-translational modification of O-n-octanoylation at @COMPOUND$ 3, and is the only gastrointestinal signal that increases meal size.	1	18931475-2743
Tests of the blood samples obtained at the ED revealed leucocytosis (11 070.6+/-4302.5/microl), increased blood @COMPOUND$, @PROTEIN$, CK and CK-MB levels.	0	18931618-2800
Molecular and biochemical characterization of a distinct @PROTEIN$ involved in @COMPOUND$ production from Aeromonas media.	1	18931836-26
TyrA had a relatively higher affinity to @COMPOUND$ substrate L-dihydroxyphenylalanine (L-dopa) than many other @PROTEIN$.	0	18931836-28
TyrA had a relatively higher affinity to diphenol substrate L-dihydroxyphenylalanine (@COMPOUND$) than many other @PROTEIN$.	0	18931836-28
@PROTEIN$ had a relatively higher affinity to @COMPOUND$ substrate L-dihydroxyphenylalanine (L-dopa) than many other tyrosinases.	0	18931836-28
TyrA had a relatively higher affinity to diphenol substrate L-@COMPOUND$ (L-dopa) than many other @PROTEIN$.	0	18931836-28
@PROTEIN$ had a relatively higher affinity to diphenol substrate L-dihydroxyphenylalanine (@COMPOUND$) than many other tyrosinases.	1	18931836-28
@PROTEIN$ had a relatively higher affinity to diphenol substrate L-@COMPOUND$ (L-dopa) than many other tyrosinases.	1	18931836-28
EDTA or glutathione notably inhibited the enzymatic activities of @PROTEIN$, whereas @COMPOUND$ and SDS activated them.	1	18931836-29
These results suggest that @PROTEIN$ is the first reported distinct tyrosinase involved in @COMPOUND$ production in the genus Aeromonas.	1	18931836-30
These results suggest that TyrA is the first reported distinct @PROTEIN$ involved in @COMPOUND$ production in the genus Aeromonas.	1	18931836-30
@PROTEIN$ from goldfish white muscle: regulatory properties and redistribution under exposure to high environmental @COMPOUND$ level.	1	18931932-360
Both sodium and potassium ions activated goldfish @PROTEIN$ at low concentrations, with maximal activation at about 80 mM of each @COMPOUND$ salt, whereas higher concentrations became inhibitory.	0	18931932-361
Magnesium and calcium ions also inhibited goldfish muscle @PROTEIN$, as did phosphate and @COMPOUND$ ; at a concentration of 8 mM, each anion reduced activity by about 66%.	1	18931932-362
Magnesium and calcium ions also inhibited goldfish muscle @PROTEIN$, as did @COMPOUND$ and fluoride ; at a concentration of 8 mM, each anion reduced activity by about 66%.	1	18931932-362
Age-associated impairment of @PROTEIN$ phosphorylation in primary rat hepatocytes is remediated by @COMPOUND$ through PI3 kinase, PTEN, and PP2A.	1	18931933-364
Age-associated impairment of Akt phosphorylation in primary rat hepatocytes is remediated by @COMPOUND$ through PI3 kinase, @PROTEIN$, and PP2A.	1	18931933-364
Age-associated impairment of Akt phosphorylation in primary rat hepatocytes is remediated by @COMPOUND$ through @PROTEIN$, PTEN, and PP2A.	1	18931933-364
Age-associated impairment of Akt phosphorylation in primary rat hepatocytes is remediated by @COMPOUND$ through PI3 kinase, PTEN, and @PROTEIN$.	1	18931933-364
Unfolding and inactivation of abalone (Haliotis diversicolor) @PROTEIN$ during denaturation by @COMPOUND$.	1	18931946-74
Unfolding and inactivation of @PROTEIN$ from abalone (Haliotis diversicolor) during denaturation by @COMPOUND$ (GuHCl) of different concentrations has first been studied.	1	18931946-75
We aim to study a possible benefit of a common nitrogen oxide donor, anti-anginal drug, nicorandil (N-(2-hydroxyethyl) nicotinamide nitrate ester), in managing acute gastric ulcers through studying its effect on some relevant intermediates to ulcerogenesis as lipid peroxidation, tumor necrosis factor-alpha (@PROTEIN$), and @COMPOUND$ (NO).	0	18931948-76
We aim to study a possible benefit of a common nitrogen oxide donor, anti-anginal drug, nicorandil (N-(2-hydroxyethyl) nicotinamide nitrate ester), in managing acute gastric ulcers through studying its effect on some relevant intermediates to ulcerogenesis as lipid peroxidation, @PROTEIN$-alpha (TNF-alpha), and @COMPOUND$ (NO).	0	18931948-76
NADH/NAD (+) ratio can be normalized by the activation or overexpression of nicotinamide nucleotide transhydrogenase (@PROTEIN$--&gt; @COMPOUND$+ NAD (+).	1	18932012-102
NADH/NAD (+) ratio can be normalized by the activation or overexpression of @PROTEIN$ (NNT--&gt; @COMPOUND$+ NAD (+).	1	18932012-102
@COMPOUND$/NAD (+) ratio can be normalized by the activation or overexpression of nicotinamide nucleotide transhydrogenase (@PROTEIN$--&gt; NADPH+ NAD (+).	1	18932012-102
@COMPOUND$/NAD (+) ratio can be normalized by the activation or overexpression of @PROTEIN$ (NNT--&gt; NADPH+ NAD (+).	1	18932012-102
An efficient electrocatalytic biosensor for sulfite detection was developed by co-immobilizing sulfite oxidase and @PROTEIN$ with polyaniline @COMPOUND$ in a layer-by-layer assembly.	0	18932024-913
An efficient electrocatalytic biosensor for sulfite detection was developed by co-immobilizing @PROTEIN$ and cytochrome c with polyaniline @COMPOUND$ in a layer-by-layer assembly.	0	18932024-913
After 10 days of treatment, otomicroscopic evaluation of tympanic membranes and measurement of anti-inflammatory mediators such as @PROTEIN$, nitrite/nitrate, glutathione peroxidase and @COMPOUND$ were performed.	0	18932046-599
After 10 days of treatment, otomicroscopic evaluation of tympanic membranes and measurement of anti-inflammatory mediators such as superoxide dismutase, nitrite/nitrate, @PROTEIN$ and @COMPOUND$ were performed.	0	18932046-599
The levels of @COMPOUND$ and @PROTEIN$ were lower in ginkgo groups but not significantly.	0	18932046-600
These results indicate that cloned embryos have aberrant DNA methylation in the @COMPOUND$ sites of the PE region of @PROTEIN$, and this may contribute directly to abnormal expression of this gene in cloned embryos.	1	18932201-188
Xenopus follicle-enclosed oocytes are endowed with @PROTEIN$ located in the follicular cell membrane ; their stimulation by @COMPOUND$ elicits an electrical response that includes generation of a fast inward current (F(Cl)) carried by Cl(-).	1	18932209-190
Moreover, the dopaminergic and glutamatergic regulation of @PROTEIN$ gene activation by @COMPOUND$ was investigated.	1	18932227-940
The acute @COMPOUND$-mediated activation of @PROTEIN$ gene was regulated by D1 but not D2 dopamine receptors.	1	18932227-941
Activation of @PROTEIN$ gene may contribute to the @COMPOUND$-mediated synaptic and behavioral plasticity.	1	18932227-942
Eukaryotes plus their archaebacterial sisters form the clade neomura, which evolved from a radically modified derivative of an actinobacterial posibacterium that had replaced the ancestral eubacterial murein peptidoglycan by N-linked @PROTEIN$, radically modified its DNA-handling enzymes, and evolved cotranslational protein secretion, but not the isoprenoid-@COMPOUND$ lipids of archaebacteria.	0	18935970-1419
Eukaryotes plus their archaebacterial sisters form the clade neomura, which evolved from a radically modified derivative of an actinobacterial posibacterium that had replaced the ancestral eubacterial murein @COMPOUND$ by N-linked @PROTEIN$, radically modified its DNA-handling enzymes, and evolved cotranslational protein secretion, but not the isoprenoid-ether lipids of archaebacteria.	1	18935970-1419
@COMPOUND$, a new inhibitor of non-apoptotic death, rescued cells from death by @PROTEIN$, although the effect was also partial and temporary.	1	18935973-1420
Here we show the first direct quantitative evidence for @PROTEIN$ binding to the cap analog @COMPOUND$.	1	18935985-1424
van't Hoff analysis of @COMPOUND$-@PROTEIN$ equilibrium reveals a binding reaction that is enthalpy driven and entropy favored with TDeltaS degrees contributing 15% to the overall value of DeltaG degrees.	1	18935985-1425
eIFiso4G was shown to enhance the interaction of @PROTEIN$ with @COMPOUND$ cap analog by 2.4-fold.	1	18935985-1426
In granulosa-lutein cells, STAR transcript abundance was not affected by BMP6, whereas @COMPOUND$-induced expression of CYP11A1, HSD3B1, @PROTEIN$ and oxytocin transcripts was reduced.	1	18936084-1443
In granulosa-lutein cells, STAR transcript abundance was not affected by BMP6, whereas @COMPOUND$-induced expression of @PROTEIN$, HSD3B1, CYP19A1 and oxytocin transcripts was reduced.	1	18936084-1443
In granulosa-lutein cells, STAR transcript abundance was not affected by BMP6, whereas @COMPOUND$-induced expression of CYP11A1, @PROTEIN$, CYP19A1 and oxytocin transcripts was reduced.	1	18936084-1443
In granulosa-lutein cells, STAR transcript abundance was not affected by @PROTEIN$, whereas @COMPOUND$-induced expression of CYP11A1, HSD3B1, CYP19A1 and oxytocin transcripts was reduced.	1	18936084-1443
In granulosa-lutein cells, STAR transcript abundance was not affected by BMP6, whereas @COMPOUND$-induced expression of CYP11A1, HSD3B1, CYP19A1 and @PROTEIN$ transcripts was reduced.	1	18936084-1443
In both cell types, follistatin attenuated the suppressive effect of activin A and @PROTEIN$ on @COMPOUND$-induced P4 secretion but had no effect alone.	1	18936084-1444
@COMPOUND$ (1-ABT) is generally considered to be a nonselective mechanism-based inactivator of both human and non-human @PROTEIN$ (P450) enzymes.	1	18936109-1448
@COMPOUND$ is present in lipid deposits in the primate retina: potential implication in the induction of @PROTEIN$ and CNV formation.	1	18936140-1459
ETEC infection also caused a drastic inhibition of host @PROTEIN$ activity, as measured by @COMPOUND$ fluorescence.	0	18936181-1478
@COMPOUND$ is a nonnucleoside inhibitor of the hepatitis C virus (HCV) nonstructural protein 5B (@PROTEIN$) polymerase, and boceprevir is an inhibitor of the NS3 serine protease.	1	18936191-1737
Mutations known to confer resistance to @COMPOUND$ (@PROTEIN$ C316Y) and boceprevir (NS3 V170A) were present in the combination-resistant replicons.	1	18936191-1739
Mutations known to confer resistance to @COMPOUND$ (NS5B C316Y) and boceprevir (@PROTEIN$ V170A) were present in the combination-resistant replicons.	0	18936191-1739
Increased apoptosis of a human salivary gland (HSG) cell line occurred only in the presence of @COMPOUND$ (LPS-) and interferon (@PROTEIN$)-gamma-stimulated human monocytic THP-1 cells, which was reversed when caspase-1 in THP-1 cells was targeted by siRNA.	0	18936772-1665
A role for @COMPOUND$ and @PROTEIN$ combination in protecting from liver injury in a model of type 2 diabetes with hyperlipidemia.	0	18936912-1717
Genetic type 2 diabetic Goto-Kakizaki rats were fed with a high-fat diet to test hepatic effects of type 2 diabetes with hyperlipidemia and the effect of @COMPOUND$ and @PROTEIN$, individually and in combination, in systemic and hepatic inflammatory and oxidative stress markers.	0	18936912-1718
Combination of @PROTEIN$ and @COMPOUND$ further improved glycemic and lipid profiles and decreased circulating C-reactive protein levels and liver inflammatory and oxidative stress markers.	0	18936912-1719
@PROTEIN$ and @COMPOUND$ combination leads to better glycaemic and lipid profiles and to better protection against liver inflammation and oxidative stress, giving a superior level of liver protection in type 2 diabetic with hyperlipidemia.	0	18936912-1720
Effect of genetic polymorphisms of @PROTEIN$ and MDR1 on @COMPOUND$ concentration during the early stage after renal transplantation in Chinese patients co-treated with diltiazem.	0	18936931-1732
Effect of genetic polymorphisms of @PROTEIN$ and MDR1 on cyclosporine concentration during the early stage after renal transplantation in Chinese patients co-treated with @COMPOUND$.	0	18936931-1732
Effect of genetic polymorphisms of CYP3A5 and @PROTEIN$ on cyclosporine concentration during the early stage after renal transplantation in Chinese patients co-treated with @COMPOUND$.	0	18936931-1732
Effect of genetic polymorphisms of CYP3A5 and @PROTEIN$ on @COMPOUND$ concentration during the early stage after renal transplantation in Chinese patients co-treated with diltiazem.	0	18936931-1732
The aim of this study was to assess the influence of the cytochrome (CYP450)3A5 and multidrug resistance (@PROTEIN$) gene polymorphisms on @COMPOUND$ (CsA) trough concentration during the early stage after renal transplantation in Chinese patients co-treated with diltiazem.	0	18936931-1733
The aim of this study was to assess the influence of the cytochrome (CYP450)3A5 and multidrug resistance (@PROTEIN$) gene polymorphisms on cyclosporine A (CsA) trough concentration during the early stage after renal transplantation in Chinese patients co-treated with @COMPOUND$.	0	18936931-1733
The-417- and-593 bp promoter regions were sufficient for @PROTEIN$ gene activation by ethylene and @COMPOUND$ treatments, respectively.	1	18936963-1743
The-417- and-593 bp promoter regions were sufficient for @PROTEIN$ gene activation by @COMPOUND$ and methyl jasmonate treatments, respectively.	1	18936963-1743
Reversible two-step unfolding of @COMPOUND$-human @PROTEIN$ : a (1)H-NMR relaxometric and circular dichroism study.	1	18936983-1746
Human serum albumin (@PROTEIN$) participates in @COMPOUND$ scavenging, the bound heme turning out to be a reactivity center and a powerful spectroscopic probe.	1	18936983-1747
Human @PROTEIN$ (HSA) participates in @COMPOUND$ scavenging, the bound heme turning out to be a reactivity center and a powerful spectroscopic probe.	1	18936983-1747
Here, the reversible unfolding of @COMPOUND$-@PROTEIN$ has been investigated by (1)H-NMR relaxometry, circular dichroism, and absorption spectroscopy.	1	18936983-1748
The purified enzymes were a monomer with an apparent molecular mass of 32 kDa (Chi32) and 46 kDa (Chi46), respectively, and showed @PROTEIN$ activity bands with 0.01% @COMPOUND$ chitin as a substrate after SDS-PAGE.	0	18936994-1754
Possible relation of @COMPOUND$-induced @PROTEIN$ expression to the upregulation of VEGF and BDNF mRNA levels in rat C6 glioma cells.	1	18937073-2436
Possible relation of @COMPOUND$-induced HO-1 expression to the upregulation of @PROTEIN$ and BDNF mRNA levels in rat C6 glioma cells.	1	18937073-2436
Possible relation of @COMPOUND$-induced HO-1 expression to the upregulation of VEGF and @PROTEIN$ mRNA levels in rat C6 glioma cells.	1	18937073-2436
Based on this hypothetical idea, the direct effect of @COMPOUND$ on the expression of genes encoding @PROTEIN$ (HO-1), vascular endothelial growth factor (VEGF), and brain-derived neurotrophic factor (BDNF) in glial cells was examined using rat C6 glioma cells as an in vitro model system.	1	18937073-2437
Based on this hypothetical idea, the direct effect of @COMPOUND$ on the expression of genes encoding heme oxygenase-1 (@PROTEIN$), vascular endothelial growth factor (VEGF), and brain-derived neurotrophic factor (BDNF) in glial cells was examined using rat C6 glioma cells as an in vitro model system.	1	18937073-2437
Based on this hypothetical idea, the direct effect of @COMPOUND$ on the expression of genes encoding heme oxygenase-1 (HO-1), vascular endothelial growth factor (VEGF), and @PROTEIN$ (BDNF) in glial cells was examined using rat C6 glioma cells as an in vitro model system.	1	18937073-2437
Based on this hypothetical idea, the direct effect of @COMPOUND$ on the expression of genes encoding heme oxygenase-1 (HO-1), vascular endothelial growth factor (@PROTEIN$), and brain-derived neurotrophic factor (BDNF) in glial cells was examined using rat C6 glioma cells as an in vitro model system.	1	18937073-2437
Based on this hypothetical idea, the direct effect of @COMPOUND$ on the expression of genes encoding heme oxygenase-1 (HO-1), vascular endothelial growth factor (VEGF), and brain-derived neurotrophic factor (@PROTEIN$) in glial cells was examined using rat C6 glioma cells as an in vitro model system.	1	18937073-2437
Furthermore, we study the @PROTEIN$ activation after As(2)O(3) treatment and the HCC cells proliferation after combination of As(2)O(3) with PI3K inhibitor @COMPOUND$.	0	18937079-1799
@COMPOUND$ is a pesticide whose acute toxicity is due to inhibition of @PROTEIN$.	1	18937214-1831
The interaction of propafenone (@COMPOUND$) enantiomers with human plasma, human @PROTEIN$ (HSA), alpha(1)-acid glycoprotein (AGP), as well as with plasma from rat, rabbit, and cow was investigated using indirect chiral high performance liquid chromatography (HPLC) and ultrafiltration techniques.	0	18937289-1865
The interaction of propafenone (@COMPOUND$) enantiomers with human plasma, human serum albumin (@PROTEIN$), alpha(1)-acid glycoprotein (AGP), as well as with plasma from rat, rabbit, and cow was investigated using indirect chiral high performance liquid chromatography (HPLC) and ultrafiltration techniques.	0	18937289-1865
The interaction of @COMPOUND$ (PPF) enantiomers with human plasma, human serum albumin (@PROTEIN$), alpha(1)-acid glycoprotein (AGP), as well as with plasma from rat, rabbit, and cow was investigated using indirect chiral high performance liquid chromatography (HPLC) and ultrafiltration techniques.	0	18937289-1865
The interaction of @COMPOUND$ (PPF) enantiomers with human plasma, human @PROTEIN$ (HSA), alpha(1)-acid glycoprotein (AGP), as well as with plasma from rat, rabbit, and cow was investigated using indirect chiral high performance liquid chromatography (HPLC) and ultrafiltration techniques.	0	18937289-1865
@COMPOUND$-Epac2-mediated activation of @PROTEIN$ in developing male germ cells: RA-RhoGAP as a possible direct down-stream effector.	1	18937323-1876
@COMPOUND$-@PROTEIN$-mediated activation of Rap1 in developing male germ cells: RA-RhoGAP as a possible direct down-stream effector.	1	18937323-1876
Taken together, our results, obtained with endogenously expressed proteins, are consistent with a @COMPOUND$/Epac2/@PROTEIN$-mediated signaling that could exert its action, among others, through RA-RhoGAP to promote the progression of spermatogenesis.	1	18937323-1878
Taken together, our results, obtained with endogenously expressed proteins, are consistent with a @COMPOUND$/@PROTEIN$/Rap1-mediated signaling that could exert its action, among others, through RA-RhoGAP to promote the progression of spermatogenesis.	1	18937323-1878
Cholesterol promotes basal and @COMPOUND$-induced ATPase activity of P-@PROTEIN$ (P-gp).	1	18937360-1888
Elucidation of the human @PROTEIN$ (HSA) binding site for the Cu-PTSM and @COMPOUND$ radiopharmaceuticals.	1	18937368-1889
Elucidation of the human @PROTEIN$ (HSA) binding site for the @COMPOUND$ and Cu-ATSM radiopharmaceuticals.	1	18937368-1889
Elucidation of the human serum albumin (@PROTEIN$) binding site for the @COMPOUND$ and Cu-ATSM radiopharmaceuticals.	1	18937368-1889
Elucidation of the human serum albumin (@PROTEIN$) binding site for the Cu-PTSM and @COMPOUND$ radiopharmaceuticals.	1	18937368-1889
This study examines the structural basis for @PROTEIN$ binding of @COMPOUND$ and Cu-ATSM via competition with drugs having known albumin binding sites.	1	18937368-1891
This study examines the structural basis for @PROTEIN$ binding of Cu-PTSM and @COMPOUND$ via competition with drugs having known albumin binding sites.	1	18937368-1891
@COMPOUND$ from @PROTEIN$.	1	18937368-1892
At 8:1 warfarin: @PROTEIN$ @COMPOUND$ levels increased 300-500%.	1	18937368-1893
@COMPOUND$ was observed except at high ibuprofen: @PROTEIN$ ratios, where secondary ibuprofen binding to the IIA site may cause modest radiopharmaceutical displacement.	0	18937368-1894
0.05) in the overall @COMPOUND$-mediated @PROTEIN$ response.	1	18937625-2531
@COMPOUND$-stimulated @PROTEIN$ levels were not significantly different from controls.	1	18937625-2532
The inducible form of @PROTEIN$ (NOS2) plays an important role in sepsis incurred as a result of infection with Gram-negative bacteria that elaborate @COMPOUND$.	1	18937643-2052
The inducible form of nitric oxide synthase (@PROTEIN$) plays an important role in sepsis incurred as a result of infection with Gram-negative bacteria that elaborate @COMPOUND$.	1	18937643-2052
Atypical sialylated N-@COMPOUND$ structures are attached to neuronal @PROTEIN$.	1	18937645-884
@COMPOUND$ linkages were identified for @PROTEIN$, Kv3.1, 3.3, 3.4, 1.1, 1.2 and 1.4, by evaluating their electrophoretic migration patterns in adult rat brain membranes digested with various glycosidases.	1	18937645-885
No regional difference in @PROTEIN$ occupancy by the second-generation antipsychotic drug @COMPOUND$ in humans: a positron emission tomography study.	1	18937879-2138
In this study, regional distribution of @PROTEIN$ occupancy by @COMPOUND$ was determined in order to elucidate the limbic and cortical selectivity of second-generation antipsychotics.	1	18937879-2139
Striatal and extrastriatal @PROTEIN$ binding @COMPOUND$, respectively.	0	18937879-2140
TP53, BCL-2 and @PROTEIN$ analysis in 199 ovarian cancer patients treated with @COMPOUND$-platinum regimens.	0	18937971-2150
TP53, @PROTEIN$ and BAX analysis in 199 ovarian cancer patients treated with taxane-@COMPOUND$ regimens.	0	18937971-2150
TP53, BCL-2 and @PROTEIN$ analysis in 199 ovarian cancer patients treated with taxane-@COMPOUND$ regimens.	0	18937971-2150
TP53, @PROTEIN$ and BAX analysis in 199 ovarian cancer patients treated with @COMPOUND$-platinum regimens.	0	18937971-2150
@PROTEIN$, BCL-2 and BAX analysis in 199 ovarian cancer patients treated with taxane-@COMPOUND$ regimens.	0	18937971-2150
@PROTEIN$, BCL-2 and BAX analysis in 199 ovarian cancer patients treated with @COMPOUND$-platinum regimens.	0	18937971-2150
@PROTEIN$, an intracellular sensor of bacteria-derived @COMPOUND$ (MDP) has been implicated as a key player in intestinal immune health and disease.	1	18938111-2180
Exposure of HEK293 cells to BK produced a concentration-dependent rise in intracellular Ca(2+) (EC(50)=36.5+/-8.0 x 10(-9)M), a rapid increase in @COMPOUND$ phosphorylation of @PROTEIN$ (EC(50)=9.8+/-0.4 x 10(-9)M), and elevation in ECAR by approximately 20%.	1	18938142-2192
@PROTEIN$ expression coupled with infusion of the IGF binding protein inhibitor @COMPOUND$ significantly prevented corticospinal motor neuron death 0.05), but did not promote corticospinal axon regeneration.	1	18938163-2196
A significant decrease was observed in GABA (A) alpha(1), @PROTEIN$ (67), and CRF, but not NR2A, mRNAs in adult rats that consumed @COMPOUND$ in comparison to controls.	1	18938187-2204
A significant decrease was observed in GABA (A) alpha(1), GAD (67), and CRF, but not @PROTEIN$, mRNAs in adult rats that consumed @COMPOUND$ in comparison to controls.	0	18938187-2204
A significant decrease was observed in @COMPOUND$ (A) alpha(1), GAD (67), and CRF, but not @PROTEIN$, mRNAs in adult rats that consumed ethanol in comparison to controls.	0	18938187-2204
A significant decrease was observed in GABA (A) alpha(1), GAD (67), and @PROTEIN$, but not NR2A, mRNAs in adult rats that consumed @COMPOUND$ in comparison to controls.	1	18938187-2204
A significant decrease was observed in @COMPOUND$ (A) alpha(1), GAD (67), and @PROTEIN$, but not NR2A, mRNAs in adult rats that consumed ethanol in comparison to controls.	0	18938187-2204
A significant decrease was observed in @COMPOUND$ (A) alpha(1), @PROTEIN$ (67), and CRF, but not NR2A, mRNAs in adult rats that consumed ethanol in comparison to controls.	0	18938187-2204
We showed previously that activation of the angiotensin type 1 receptor (AT1R), which belongs to the G protein-coupled receptor (GPCR) family, leads to c-Src-dependent @COMPOUND$ phosphorylation of beta2-adaptin, a subunit of the clathrin adaptor @PROTEIN$.	1	18938240-2219
We showed previously that activation of the angiotensin type 1 receptor (AT1R), which belongs to the G protein-coupled receptor (GPCR) family, leads to @PROTEIN$-dependent @COMPOUND$ phosphorylation of beta2-adaptin, a subunit of the clathrin adaptor AP-2.	1	18938240-2219
Genotoxic effect of 2,4,6-@COMPOUND$ on @PROTEIN$ gene in zebrafish liver.	1	18939895-2826
Extensive neutrophil infiltration and chemoattractant factor interleukin 8 (@PROTEIN$) expression in IL-10 KO mice were observed after @COMPOUND$ administration.	1	18940183-691
Extensive neutrophil infiltration and chemoattractant factor @PROTEIN$ (IL-8) expression in IL-10 KO mice were observed after @COMPOUND$ administration.	1	18940183-691
In addition, increased signal transducer and activator of transcription factors (@PROTEIN$) 1 and STAT3 were observed in @COMPOUND$ treated IL-10 KO mice.	1	18940183-692
In addition, increased signal transducer and activator of transcription factors (STAT) 1 and @PROTEIN$ were observed in @COMPOUND$ treated IL-10 KO mice.	1	18940183-692
Interaction of @PROTEIN$ and @COMPOUND$ in endemic dilated cardiomyopathy.	1	18940188-92
We studied the gene-environment interaction in the pathogenesis of KD by assessing the association of low blood @COMPOUND$ and polymorphisms in @PROTEIN$ (GPx-1) gene.	1	18940188-93
We studied the gene-environment interaction in the pathogenesis of KD by assessing the association of low blood @COMPOUND$ and polymorphisms in glutathione peroxidase-1 (@PROTEIN$) gene.	1	18940188-93
However, under the pressure of a death stimulus such as @COMPOUND$ treatment, L. infantum @PROTEIN$ is released from the single mitochondrion and translocates to the nucleus, where it is thought to participate in the process of DNA degradation that is associated with programmed cell death.	1	18940204-495
Results revealed that HCH administration lead to an increase in hepatic lipid peroxidation associated with reduction in, levels of glutathione (@COMPOUND$), activity of superoxide dismutase (@PROTEIN$), catalase and glucose-6-phosphate dehydrogenase.	0	18940228-124
Results revealed that HCH administration lead to an increase in hepatic lipid peroxidation associated with reduction in, levels of @COMPOUND$ (GSH), activity of superoxide dismutase (@PROTEIN$), catalase and glucose-6-phosphate dehydrogenase.	0	18940228-124
Results revealed that HCH administration lead to an increase in hepatic lipid peroxidation associated with reduction in, levels of glutathione (@COMPOUND$), activity of @PROTEIN$ (SOD), catalase and glucose-6-phosphate dehydrogenase.	0	18940228-124
Results revealed that HCH administration lead to an increase in hepatic lipid peroxidation associated with reduction in, levels of @COMPOUND$ (GSH), activity of @PROTEIN$ (SOD), catalase and glucose-6-phosphate dehydrogenase.	0	18940228-124
Results revealed that HCH administration lead to an increase in hepatic lipid peroxidation associated with reduction in, levels of glutathione (@COMPOUND$), activity of superoxide dismutase (SOD), @PROTEIN$ and glucose-6-phosphate dehydrogenase.	0	18940228-124
Results revealed that HCH administration lead to an increase in hepatic lipid peroxidation associated with reduction in, levels of @COMPOUND$ (GSH), activity of superoxide dismutase (SOD), @PROTEIN$ and glucose-6-phosphate dehydrogenase.	0	18940228-124
However, these events were blocked by treatment with the antioxidant, @COMPOUND$ (NAC), as well as @PROTEIN$ overexpression.	0	18940247-147
It decreased TG levels in tyloxapol-induced hyperlipidemia and increased @PROTEIN$ @COMPOUND$ (HDL-C) and reduced atherogenic index in normotensive rats.	1	18940267-156
This analysis reveals @PROTEIN$ as major and unsuspected gates of @COMPOUND$+) entry that contribute, depending on context, to activation of transcription factors, apoptosis, vascular contractility, platelet activation, and cardiac hypertrophy, as well as to normal and abnormal cell proliferation.	1	18940894-262
A single bout of exercise increases @COMPOUND$ uptake and fatty acid oxidation in skeletal muscle, with a corresponding activation of AMP-activated @PROTEIN$ (AMPK).	1	18940938-278
A single bout of exercise increases @COMPOUND$ uptake and fatty acid oxidation in skeletal muscle, with a corresponding activation of AMP-activated protein kinase (@PROTEIN$).	1	18940938-278
Changes in @COMPOUND$ consumption and the RQ ratio during sedentary and low-intensity exercise were not different between alpha(1)-@PROTEIN$-DN and WT.	0	18940938-280
@PROTEIN$-mediated @COMPOUND$ efflux generates microparticles in addition to HDL through processes governed by membrane rigidity.	1	18941142-329
@COMPOUND$ treatment, in vivo or ex vivo, increased nuclear NFkappaB activation in cerebral arteries and increased levels of the proinflammatory products of NFkappaB activation, @PROTEIN$ (COX-2) and inducible nitric oxide synthase (iNOS).	1	18941467-423
@COMPOUND$ treatment, in vivo or ex vivo, increased nuclear NFkappaB activation in cerebral arteries and increased levels of the proinflammatory products of NFkappaB activation, cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (@PROTEIN$).	1	18941467-423
@COMPOUND$ treatment, in vivo or ex vivo, increased nuclear NFkappaB activation in cerebral arteries and increased levels of the proinflammatory products of NFkappaB activation, cyclooxygenase-2 (COX-2) and inducible @PROTEIN$ (iNOS).	1	18941467-423
@COMPOUND$ treatment, in vivo or ex vivo, increased nuclear NFkappaB activation in cerebral arteries and increased levels of the proinflammatory products of NFkappaB activation, cyclooxygenase-2 (@PROTEIN$) and inducible nitric oxide synthase (iNOS).	1	18941467-423
Effects of DHT on COX-2 and @PROTEIN$ were attenuated by @COMPOUND$.	0	18941467-424
Effects of @COMPOUND$ on COX-2 and @PROTEIN$ were attenuated by flutamide.	1	18941467-424
Effects of DHT on @PROTEIN$ and iNOS were attenuated by @COMPOUND$.	0	18941467-424
Effects of @COMPOUND$ on @PROTEIN$ and iNOS were attenuated by flutamide.	1	18941467-424
In conclusion, activation of the NFkappaB-mediated COX-2/@PROTEIN$ pathway by the selective androgen receptor agonist, @COMPOUND$, results in a state of vascular inflammation.	1	18941467-426
In conclusion, activation of the NFkappaB-mediated @PROTEIN$/iNOS pathway by the selective androgen receptor agonist, @COMPOUND$, results in a state of vascular inflammation.	1	18941467-426
After MRI, one group of animals had BBB permeability measured in the WM with (14)C-@COMPOUND$, and another had Evans blue (EB) injected for fluorescent microscopy for MMP-2, @PROTEIN$, tight junction proteins (TJPs), and in situ zymography.	0	18941468-399
After MRI, one group of animals had BBB permeability measured in the WM with (14)C-sucrose, and another had @COMPOUND$ (EB) injected for fluorescent microscopy for @PROTEIN$, MMP-9, tight junction proteins (TJPs), and in situ zymography.	0	18941468-399
After MRI, one group of animals had BBB permeability measured in the WM with (14)C-sucrose, and another had @COMPOUND$ (EB) injected for fluorescent microscopy for MMP-2, @PROTEIN$, tight junction proteins (TJPs), and in situ zymography.	0	18941468-399
After MRI, one group of animals had BBB permeability measured in the WM with (14)C-@COMPOUND$, and another had Evans blue (EB) injected for fluorescent microscopy for @PROTEIN$, MMP-9, tight junction proteins (TJPs), and in situ zymography.	0	18941468-399
The electrons released from @COMPOUND$ by @PROTEIN$ were transferred to CTC in the reaction medium, and CTC reduction activity could be assessed spectrophotometrically and spectrofluorometrically.	1	18941714-1885
Effects of dissolved @COMPOUND$ tension and agitation rate on the production of heat-shock protein @PROTEIN$ 96 by MethA tumor cell suspension culture in stirred-tank bioreactors.	0	18941797-421
Goldfish scales were incubated either with 20:3n-9 or with @COMPOUND$ at 15 degrees C for 6 and 18 h. Both osteoblastic and osteoclastic activities in the scale were assessed by measuring alkaline phosphatase (@PROTEIN$) and tartrate-resistant acid phosphatase, respectively.	0	18941818-549
Goldfish scales were incubated either with 20:3n-9 or with @COMPOUND$ at 15 degrees C for 6 and 18 h. Both osteoblastic and osteoclastic activities in the scale were assessed by measuring @PROTEIN$ (ALP) and tartrate-resistant acid phosphatase, respectively.	0	18941818-549
MC3T3-E1 cells (an osteoblast cell line derived from the mouse) were incubated with 20:3n-9 or @COMPOUND$ at 37 degrees C for 6 and 18 h. @PROTEIN$ activity in cell lysate was measured.	0	18941818-550
Reactive oxygen species induce phosphorylation of @COMPOUND$ 118 and 167 on @PROTEIN$ alpha.	1	18941890-590
Both kinases have been implicated in the phosphorylation of @COMPOUND$ 118 and serine 167 on @PROTEIN$, respectively.	1	18941890-591
Our data show for the first time that ROS can induce post-translational modifications of @PROTEIN$ at @COMPOUND$ 118 and serine 167, and may lead to ERalpha down-regulation in human breast cancer cells.	1	18941890-592
Therapeutic efficacy of 177Lu-CHX-A''-DTPA-hu3S193 radioimmunotherapy in prostate cancer is enhanced by @PROTEIN$ inhibition or @COMPOUND$ chemotherapy.	0	18942092-662
Expression of the @PROTEIN$-GFP fusion protein was observed exclusively upon @COMPOUND$ induction and was uniformly distributed throughout the intestinal epithelium.	1	18942097-665
On hexanoamide the @PROTEIN$ exhibited a K(m) value of 5.5 mM compared to 0.07 mM for @COMPOUND$.	1	18942140-690
On @COMPOUND$ the @PROTEIN$ exhibited a K(m) value of 5.5 mM compared to 0.07 mM for p-nitroacetanilide.	1	18942140-690
@PROTEIN$ is an important neuronal calcium sensor (NCS) protein, which have been implicated in a wide range of @COMPOUND$+) signaling events in neurons and photoreceptors.	1	18942727-207
Recoverin is an important neuronal calcium sensor (@PROTEIN$) protein, which have been implicated in a wide range of @COMPOUND$+) signaling events in neurons and photoreceptors.	1	18942727-207
A decrease in @PROTEIN$ (7)R expression was observed in cultured OPCs after exposure to oxygen-@COMPOUND$ deprivation (OGD) for 2 h in vitro.	1	18942747-893
Reactivity of @COMPOUND$ with the (4Fe-4S) cluster of @PROTEIN$ from Escherichia coli.	1	18945212-1760
The rate constant for the initial reaction between NO and the @PROTEIN$ (@COMPOUND$ is estimated to be (7.0+/-2.0)x10(6) M(-2) x s(-1) at 25 degrees C, which is approx.	1	18945212-1763
Acylcarnitines have been suggested to play a role in @PROTEIN$ resistance, as well as other @COMPOUND$ metabolites.	0	18945215-1768
In the present study we investigated whether muscle long-chain acylcarnitines increase during fasting and we investigated their relationship with @COMPOUND$/fat oxidation and @PROTEIN$ sensitivity in lean healthy humans.	0	18945215-1769
@COMPOUND$ attenuates the HFS-induced, @PROTEIN$-mediated LTP in a dose-dependent manner in rat striatum.	1	18945217-1773
These results suggest that @PROTEIN$ delivers @COMPOUND$ to mitochondria where regulatory oxysterols are generated.	1	18945429-1846
17beta-Hydroxysteroid dehydrogenase type 1 (@PROTEIN$) is a key enzyme of @COMPOUND$ biosynthesis, which might play an important role in follicular development of the ovary.	1	18945563-2825
@PROTEIN$ (HSD17B1) is a key enzyme of @COMPOUND$ biosynthesis, which might play an important role in follicular development of the ovary.	1	18945563-2825
@PROTEIN$ promoter hypermethylation correlates with a survival benefit from @COMPOUND$ in patients with recurrent anaplastic astrocytoma but not glioblastoma.	1	18945611-1922
To investigate the correlation between O(6)-methylguanine-DNA-methyltransferase (@PROTEIN$) promoter methylation and benefit from @COMPOUND$ in patients with recurrent high-grade glioma.	1	18945611-1923
@COMPOUND$ binding to human @PROTEIN$ : a study of protein conformation and binding affinity.	1	18945624-1926
Adenosine nucleotide translocase (@PROTEIN$) translocates ADP/@COMPOUND$ across the inner mitochondrial membrane.	1	18945756-2007
This review will focus on recent evidence that @COMPOUND$, @PROTEIN$ and neuropeptide Y act by converging on neuronal cyclic nucleotide-dependent pathways to alter the autonomic phenotype in both health and disease.	1	18945757-720
This review will focus on recent evidence that @COMPOUND$, natriuretic peptides and @PROTEIN$ act by converging on neuronal cyclic nucleotide-dependent pathways to alter the autonomic phenotype in both health and disease.	1	18945757-720
Deletion of the first @COMPOUND$-rich region of the varicella-zoster virus @PROTEIN$ ectodomain abolishes the gE and gI interaction and differentially affects cell-cell spread and viral entry.	1	18945783-756
Glucocorticoid-activated GR repressed @PROTEIN$ gene induction by @COMPOUND$ (LPS).	1	18945810-2026
Inhibition of P-@PROTEIN$-mediated @COMPOUND$ resistance by reversibly linked quinine homodimers.	1	18945821-2039
The data provide the first demonstration for the presence of @PROTEIN$ in primary cilia of renal epithelial cells, and a functional @COMPOUND$-signaling pathway, which targets ciliary channel function and may help control the sensory function of the primary cilium.	0	18945824-860
The endothelial (Ca(2+))(@COMPOUND$) response to @PROTEIN$ (100 nM) was significantly attenuated.	1	18945826-2045
The endothelial (@COMPOUND$+))(CYT) response to @PROTEIN$ (100 nM) was significantly attenuated.	1	18945826-2045
The purpose of this research was to enhance intranasal drug targeting to the CNS by incorporating a vasoconstrictor (phenylephrine (PHE)) into nasal formulations containing therapeutic @PROTEIN$ (hypocretin-1 (HC) or the dipeptide L-Tyr-D-Arg (D-@COMPOUND$)).	0	18945930-874
The purpose of this research was to enhance intranasal drug targeting to the CNS by incorporating a vasoconstrictor (phenylephrine (PHE)) into nasal formulations containing therapeutic neuropeptides (@PROTEIN$ (HC) or the dipeptide L-Tyr-D-Arg (D-@COMPOUND$)).	0	18945930-874
@COMPOUND$ dinucleotides identified in Bhlhb2, Pparg, @PROTEIN$, and Egr1 binding sites at the Prkce gene promoter were densely methylated in males and females and were unaffected by cocaine exposure.	1	18945988-1510
@COMPOUND$ dinucleotides identified in Bhlhb2, @PROTEIN$, E2f, and Egr1 binding sites at the Prkce gene promoter were densely methylated in males and females and were unaffected by cocaine exposure.	1	18945988-1510
@COMPOUND$ dinucleotides identified in Bhlhb2, Pparg, E2f, and Egr1 binding sites at the @PROTEIN$ gene promoter were densely methylated in males and females and were unaffected by cocaine exposure.	1	18945988-1510
@COMPOUND$ dinucleotides identified in @PROTEIN$, Pparg, E2f, and Egr1 binding sites at the Prkce gene promoter were densely methylated in males and females and were unaffected by cocaine exposure.	1	18945988-1510
@COMPOUND$ dinucleotides identified in Bhlhb2, Pparg, E2f, and @PROTEIN$ binding sites at the Prkce gene promoter were densely methylated in males and females and were unaffected by cocaine exposure.	1	18945988-1510
